Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 71.9;U-266/70: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	24.8	13.1	22.0	24.6	31.3	19.4	28.7	12.1	27.5	18.1	29.0	29.8	18.8	21.2	20.6	25.2	29.8	15.0	20.4	31.0	22.6	17.4	16.0	20.3	24.6	27.4	33.5	16.1	13.9	27.9	10.8	14.8	25.9	25.5	16.1	15.9	16.9	20.9	15.5	32.0	30.6	21.8	23.4	29.2	30.0	21.4	41.3	30.0	9.2	19.9	19.0	27.9	22.8	27.4	21.6	18.0	16.3	17.5	2.9	8.2	9.8	3.6	2.2	4.8	7.2	5.6	6.2	6.4	2.7	2.2	2.4	2.9	2.4	4.1	7.7	6.6	2.8	5.1	2.5	6.0	5.0	1.7	18.4	6.9	5.2	1.8	6.6	2.8	1.8	6.8	4.6	15.2	1.7	3.2	4.0	6.8	6.6	4.8	25.7	2.0	2.1	2.7	6.7	2.9	2.7	5.2	5.4	3.3	71.9	4.5	1.6	8.3	3.2	2.3	0.9	7.9	11.0	4.9	2.4	9.3	2.2	2.9	2.2	1.6	36.6	25.8	10.7	0.8	5.1	4.9	16.3	17.5	6.9	5.0	14.0	3.5	21.6	3.9	5.1	18.0	17.5	3.6	5.1	12.0	2.9	12.6	15.4	8.2	9.8	22.0	31.3	12.1	27.5	22.6	17.4	33.5	16.1	25.5	30.0	14.9	17.6	38.7	19.8	23.6	5.2	35.3	10.2	26.8	25.0	5.2	0.0	9.1	18.3	21.3	11.0	33.7	13.8	0.0	45.0	6.9	17.8	14.6	32.3	22.1	25.5	0.0	9.1	22.7	40.0	14.8	14.4	35.8	43.9	83.8	13.0	9.8	28.3	14.0	8.9	14.6	2.6	25.8	27.2	30.7	73.7	32.4	5.5	15.0	14.5	23.5
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Group enriched"	"Detected in some"	6	"Melanocytes: 42.2;monocytes: 92.8"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.1	0.0	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.9	0.0	45.1	0.0	0.0	0.1	0.0	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	31.4	13.7	0.0	0.0	25.6	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1	0.0	4.0	12.0	0.1	7.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.0	1.8	0.0	0.0	3.1	6.9	42.2	92.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	3.8	0.1	6.2	0.0	0.0
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485133-693111	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Approved	Vesicles		NA	NA		5300	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	15.9	13.8	16.6	18.2	19.9	8.8	16.7	17.0	20.8	16.4	13.5	22.2	9.3	12.8	14.3	12.5	18.7	10.5	13.6	16.7	17.0	19.0	14.5	15.3	16.8	18.2	19.7	11.6	12.6	11.0	22.8	22.0	26.4	22.4	12.5	15.5	24.4	13.4	12.9	15.7	17.5	14.5	14.1	22.2	18.4	13.4	25.7	17.1	24.8	21.5	12.2	20.2	16.5	14.5	12.5	12.1	8.9	13.6	12.2	18.8	11.4	10.3	8.0	13.4	14.6	12.3	11.1	8.2	9.4	11.0	11.3	13.5	10.2	5.6	7.7	23.2	11.2	17.0	9.1	15.0	16.4	13.5	24.1	16.0	9.8	9.7	10.1	15.4	10.4	9.9	9.6	13.4	8.0	9.4	11.2	18.9	15.3	19.2	5.7	14.0	9.0	13.9	10.2	13.6	9.3	7.7	13.2	11.6	15.5	10.1	11.3	13.2	7.7	7.5	4.6	14.8	26.3	11.9	6.4	27.4	10.2	7.6	12.7	8.7	14.1	28.1	8.2	10.4	8.7	31.3	8.9	7.8	8.6	15.7	9.5	18.8	12.5	15.9	16.4	12.1	12.0	15.2	14.5	2.5	12.2	13.6	9.9	17.2	11.4	16.6	19.9	17.0	20.8	17.0	19.0	19.7	11.6	22.4	17.1	3.0	16.4	4.4	3.0	4.2	8.1	7.6	0.0	6.7	5.7	5.2	7.9	11.8	6.6	5.8	8.8	8.4	4.0	0.0	4.4	5.8	4.5	4.9	4.7	8.3	8.7	7.9	2.4	9.8	9.8	2.7	6.4	5.6	5.0	8.2	5.9	4.8	6.2	4.9	8.5	6.9	9.0	0.0	6.2	17.2	17.9	6.8	10.8	15.2	5.1	6.0
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.3"	"Cell type enhanced"	"Detected in some"	9	"monocytes: 3.6;Sertoli cells: 6.5;Spermatocytes: 7.6;Spermatogonia: 4.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;U-266/84: 5.1;WM-115: 5.5"	"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034511: AB_2674203, HPA063449: AB_2685014"	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.5	0.1	0.1	0.5	0.1	3.3	0.6	0.0	0.0	1.4	0.4			1.3	0.9	0.7	0.9	0.2	0.6	0.5	0.2	0.1	0.6	0.8	1.0	0.2	0.3		0.8	0.0	0.0	0.8	1.1		1.4	0.2		0.5	0.1	0.0	0.9	0.3	1.0	0.6	1.0	0.1	4.3			0.7		0.2	0.3	1.2	1.6	1.6	0.0	0.7	0.0	1.9	0.6	0.7	0.0	0.0	1.8	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.8	0.1	0.3	0.5	0.1	0.4	0.0	0.5	0.0	0.4	1.3	4.4	0.9	0.0	0.0	0.4	0.0	1.5	0.0	0.3	0.4	0.4	0.0	0.1	1.1	1.7	1.0	0.5	0.0	0.5	2.4	2.8	0.0	1.4	0.9	0.8	2.5	0.2	0.6	1.0	0.2	0.3	0.0	0.7	0.5	0.1	0.1	0.4	0.7	0.8	1.5	0.4	2.3	5.1	1.0	0.1	0.6	5.5	0.0	0.7	0.0	0.7	0.3	0.5	1.6	1.1	0.9	0.0	0.8	1.0	1.9	0.0	0.0	0.0	1.6	0.7	0.6											0.0	0.0	0.5	0.6	0.6	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.7	0.7	0.0	0.0	0.5	1.0	0.4	0.5	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.5	0.9	0.0	1.1	0.0	1.7	6.5	0.5	7.6	4.7	1.5	1.3	1.5	0.2	0.3
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312440-1314748	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 65.5;vagina: 39.9"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 53.7;Collecting duct cells: 38.4;Suprabasal keratinocytes: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;HaCaT: 16.4;Hep G2: 34.5;OE19: 46.8;RT4: 14.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.6	0.5	2.3	0.6	4.0	0.5	1.4	1.6	5.9	7.1	1.9	3.2	0.0	6.9	1.1	0.7	7.2	3.2	31.8	0.5	2.2	1.9	7.1	3.6	5.8	0.5	2.7	1.5	0.5	10.1	0.5	1.8	1.2	3.8	18.2	0.8	7.5	35.8	1.3	0.6	16.8	0.8	6.6	1.9	0.5	65.5	0.6	0.8	0.8	3.1	7.8	11.7	26.3	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.2	5.6	0.0	0.0	14.0	8.5	0.0	0.2	0.0	0.0	16.4	0.0	0.7	0.0	0.0	0.4	0.0	3.0	34.5	0.0	0.0	0.9	0.0	6.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.2	0.0	0.0	0.0	0.1	14.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.0	1.6	5.9	2.2	1.9	2.7	1.5	3.8	0.8	14.9	8.8	0.0	2.1	53.7	0.0	0.8	0.0	2.7	13.6	38.4	0.0	0.0	1.7	2.4	0.0	0.0	0.0	0.0	12.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.0	6.9	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	39.6	0.0	0.0	0.0	3.1
FOXF2	"FKHL6, FREAC2"	ENSG00000137273	"Forkhead box F2"	Q12947	6	1389576-1395603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.5;intestine: 24.0;retina: 58.7"	"Cell type enhanced"	"Detected in some"	10	"Fibroblasts: 3.1;Leydig cells: 2.3;Melanocytes: 1.7;Peritubular cells: 2.5;Smooth muscle cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 40.0;HEK 293: 13.3;U-2197: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.29e-2)"	1.4	0.4	3.5	3.4	4.4	0.1	2.2	1.7	3.9	1.3	24.0	2.3	0.0	7.6	0.2	1.2	28.5	0.4	2.0	0.5	2.8	2.4	0.2	0.3	13.6	0.6	3.7	3.2	0.2	0.7	0.8	5.5	11.5	2.2	13.2	12.3	58.7	0.8	1.0	0.6	0.9	15.8	4.8	2.1	0.2	12.6	0.8	1.4	0.0	2.5	2.7	2.4	9.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.9	0.6	0.5	1.9	2.9	0.0	8.3	40.0	3.6	1.6	0.1	0.0	0.0	1.8	2.6	3.9	6.5	6.9	0.3	1.6	0.0	13.3	0.0	3.1	0.0	3.6	0.0	0.2	0.5	2.8	0.0	3.4	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	2.1	0.0	2.8	0.8	0.0	0.1	0.0	3.3	6.3	16.3	1.5	0.2	0.0	0.0	0.0	2.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.4	1.7	3.9	2.8	2.4	3.7	3.2	2.2	1.4	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.2	3.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.2	1.7	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	1.4	0.0	0.4	0.1	0.1	0.0	0.0	0.0
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.3	0.8	0.2	39.8	1.8	2.1	1.2	3.7	4.4	2.3	1.9	2.8	1.5	0.0	4.3	2.2	1.7	8.4	3.8	2.7	1.9	2.3	38.8	1.5	2.2	1.3	1.2	0.5	2.6	7.0	3.8	3.2	3.6	1.2	3.4	0.2	1.0	0.0	1.0	1.6	0.0	0.8	0.1	3.7	3.2	0.0	1.6	0.2	15.6	5.6	1.5	3.4	4.6	0.0	2.6	2.1	1.1	0.6	0.8	5.1	3.1	2.6	3.9	0.1	0.3	0.0	1.4	1.9	4.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6	0.0	1.1	0.0	25.0	15.8	0.0	5.6	0.0	26.8	14.8	10.4	0.0	4.5	1.7	3.4	0.4	40.9	0.0	0.0	15.0	0.4	3.6	7.7	0.0	0.0	1.1	0.0	0.0	36.2	0.3	0.9	15.0	1.4	1.7	0.0	0.2	0.3	11.8	0.0	26.5	4.6	0.0	0.0	27.0	0.2	1.9	5.6	0.7	0.0	0.3	55.7
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245692	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 143.7;Mucus-secreting cells: 229.6;Undifferentiated cells: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		41000			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	5.1	4.0	6.6	29.6	8.7	3.2	7.6	6.0	6.8	12.9	34.9	2.7	10.4	42.1	4.1	6.4	29.2	4.9	38.5	4.9	5.6	4.6	9.3	15.1	7.8	11.8	4.1	3.7	4.3	27.1	19.3	8.9	3.0	4.0	8.6	34.2	6.3	40.4	7.6	3.3	4.9	43.7	4.4	3.1	6.0	38.4	9.0	3.4	9.3	5.6	9.0	19.6	6.1	6.7	10.5	13.9	6.8	12.3	12.0	12.4	7.3	13.0	3.0	2.2	15.5	3.6	9.8	5.3	3.6	7.6	6.8	6.4	6.7	7.6	6.2	11.2	3.9	6.7	5.1	6.7	12.8	7.9	8.5	8.1	6.0	3.4	31.4	4.0	9.6	6.7	10.8	4.4	5.3	11.2	6.6	7.9	21.4	3.9	2.9	4.3	7.4	13.2	11.4	3.3	70.9	10.4	6.9	5.0	32.0	16.4	17.2	12.4	2.9	3.3	5.2	8.0	10.5	4.8	6.1	3.4	5.2	3.9	5.2	6.4	6.6	9.3	6.6	3.4	6.7	6.9	6.8	12.3	1.4	7.9	7.6	10.6	10.5	9.5	7.8	13.9	5.5	8.3	11.1	3.8	12.0	6.1	5.8	12.4	7.3	6.6	8.7	6.0	6.8	5.6	4.6	4.1	3.7	4.0	3.4	0.0	5.0	14.9	13.0	3.8	4.4	2.4	15.3	13.4	5.7	36.6	0.0	15.2	101.2	29.5	3.9	19.6	143.7	0.0	61.4	22.6	9.3	41.6	4.6	9.9	12.1	7.9	107.1	16.0	7.3	3.6	11.2	7.1	21.9	16.2	229.6	3.1	49.3	77.7	15.6	27.3	0.6	12.9	10.7	4.2	35.3	5.4	14.0	18.1	123.8	40.1
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"HEL: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.2	0.6	1.2	1.0	1.2	0.6	0.7	1.6	0.5	0.4	0.5	1.1	1.1	1.6	0.8	0.2	1.9	0.2	0.5	0.7	0.2	0.6	12.7	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.6	0.5	0.2	0.1	0.1	0.3	0.5	0.1	1.4	0.2	0.4	0.0	0.9	0.0	0.0	0.9	0.3	1.0	0.6	0.3	0.2	0.5	1.1	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.3	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3	3.0	0.6	0.0	0.1	0.1	0.8	1.2	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.3	0.0	0.3	1.0	0.0	1.8	0.0	0.2	0.0	0.0	1.4	2.9	0.2	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.1
WRNIP1	"bA420G6.2, FLJ22526, WHIP"	ENSG00000124535	"Werner helicase interacting protein 1"	Q96S55	6	2765414-2786952	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	15.4	23.1	29.9	19.8	32.1	31.2	22.4	42.5	33.5	22.2	21.9	23.3	25.7	17.7	19.8	29.7	32.8	28.0	24.7	28.8	30.9	30.1	23.3	25.8	21.2	23.4	27.4	26.2	23.2	37.4	39.2	31.2	32.3	21.3	22.5	22.6	23.9	34.6	22.0	29.0	27.8	19.6	18.5	20.2	20.7	19.3	24.6	24.2	34.1	31.6	36.0	25.3	18.8	29.2	3.4	4.2	9.1	2.8	3.7	6.5	2.3	31.5	15.9	16.2	26.5	17.2	14.9	21.6	14.5	20.4	26.8	26.7	25.1	14.8	28.4	39.7	18.7	29.1	24.6	26.5	29.2	26.2	28.3	29.1	29.7	18.1	39.2	19.6	18.6	20.6	15.1	23.9	24.6	26.8	18.7	33.9	27.0	22.6	10.3	19.5	30.9	27.5	33.8	13.9	21.8	19.8	22.0	23.7	28.8	28.4	19.5	49.0	14.0	17.2	17.5	33.8	26.7	22.5	21.0	18.4	20.1	15.2	17.4	35.1	13.3	23.1	22.1	7.9	20.3	27.2	9.1	2.6	3.4	6.5	2.8	2.1	3.4	4.7	4.8	2.1	2.4	5.5	5.2	1.1	3.7	1.4	4.2	6.5	2.3	29.9	32.1	42.5	33.5	30.9	30.1	27.4	26.2	21.3	24.2	17.9	10.5	3.7	10.8	28.8	23.9	17.3	35.7	21.4	7.9	10.4	7.9	26.5	3.3	12.6	42.1	18.0	18.7	0.0	11.8	20.2	14.8	14.5	9.2	21.9	11.1	7.9	38.2	30.1	13.8	11.0	20.8	12.7	20.3	7.2	24.1	18.0	15.9	11.5	20.8	11.3	16.5	6.5	11.8	21.4	24.7	28.1	21.3	4.5	23.0	13.2
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2842006	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2;lymphoid tissue: 108.0"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 1231.2;Pancreatic endocrine cells: 832.6;Urothelial cells: 969.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 35.4;OE19: 44.9;U-937: 40.3"					"Low region specificity"	"Detected in many"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"		NA	NA		49000000	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	11.4	15.1	3.5	13.4	7.0	75.8	6.4	2.9	3.3	25.1	23.6	5.7	5.3	26.0	6.6	8.6	119.2	7.6	18.1	8.3	3.5	3.9	11.4	36.9	32.6	37.4	7.5	1.8	7.8	66.7	8.3	10.4	11.9	6.2	6.5	16.7	6.7	23.5	3.6	21.8	4.4	49.2	5.6	6.8	34.8	18.0	3.9	5.3	9.4	14.0	98.9	108.0	7.2	20.8	12.8	38.3	48.5	49.6	21.7	16.7	38.7	12.2	14.3	0.8	0.1	3.1	6.6	12.4	3.6	10.3	4.3	7.7	13.4	35.4	0.1	26.0	7.5	4.7	7.7	1.4	3.3	3.2	17.5	2.6	21.5	4.8	10.3	11.4	3.8	13.9	8.2	5.5	2.1	0.9	2.1	13.9	0.0	7.6	2.9	3.8	5.7	0.5	10.0	1.4	44.9	6.8	1.1	0.1	12.5	14.6	2.6	2.7	1.5	8.3	3.2	17.9	1.8	1.6	12.2	8.6	1.4	3.4	3.0	1.0	0.0	0.6	0.1	5.2	40.3	0.7	27.1	49.6	28.5	16.1	25.7	14.5	12.8	15.6	14.8	38.3	9.6	16.1	16.1	48.5	21.7	19.5	14.8	16.7	38.7	3.5	7.0	2.9	3.3	3.5	3.9	7.5	1.8	6.2	5.3	223.4	258.8	81.5	94.2	31.1	3.4	14.8	79.0	356.0	278.7	43.6	2.0	101.3	48.0	311.2	1.1	94.3	291.2	0.0	1231.2	123.8	51.6	118.4	423.5	23.6	168.5	9.5	92.5	77.3	370.6	2.2	32.2	222.8	67.4	532.0	195.5	45.7	832.6	135.3	26.2	60.4	14.9	12.9	48.9	1.9	5.5	33.2	83.4	85.3	160.0	969.8
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887266-2903280	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.0;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 116.9;monocytes: 105.6;Syncytiotrophoblasts: 226.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 59.1;SuSa: 62.4;U-698: 25.4"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		4900000	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	5.6	5.1	3.3	15.9	4.1	7.2	2.6	3.6	6.7	3.9	2.1	4.4	1.3	1.7	1.9	1.9	4.6	4.1	5.3	4.9	3.4	3.6	2.5	7.6	13.7	39.6	4.8	3.9	3.8	1.3	4.7	4.9	24.5	4.7	2.6	2.9	3.5	7.5	1.3	2.0	1.0	5.5	2.4	7.1	14.4	2.0	4.4	2.0	6.4	4.2	2.1	18.9	3.4	3.8	10.3	6.4	2.9	38.0	18.8	17.9	12.3	0.0	2.5	0.0	0.0	0.1	0.0	59.1	0.5	0.1	0.6	0.9	0.7	4.8	9.6	6.0	0.5	0.0	0.0	7.1	0.0	0.5	3.1	0.7	0.9	0.9	1.4	3.4	0.0	0.0	2.7	0.0	1.0	0.0	0.0	12.9	0.8	4.4	0.1	0.4	0.2	0.0	0.0	8.2	0.0	0.0	0.9	0.0	0.1	0.4	0.0	0.4	0.1	5.8	0.0	0.0	62.4	0.0	0.1	13.4	0.0	0.1	0.0	0.0	0.0	12.1	25.4	0.0	0.0	0.0	1.7	18.3	0.1	17.9	38.0	14.7	8.3	13.0	16.8	6.1	10.3	12.1	17.5	2.9	18.8	22.0	6.4	13.0	12.3	3.3	4.1	3.6	6.7	3.4	3.6	4.8	3.9	4.7	2.0	17.9	24.9	31.6	1.9	31.4	1.5	4.2	2.5	13.4	14.8	5.2	0.0	62.3	0.0	14.4	0.9	42.0	1.6	0.0	0.2	116.9	44.8	2.2	45.1	6.8	16.6	7.9	14.9	60.2	47.5	2.5	4.0	98.8	84.4	105.6	3.1	4.8	6.2	5.8	16.6	1.4	2.9	12.9	18.1	0.5	2.2	32.2	226.0	48.4	3.5	7.4
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 821.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		5100000	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	31.6	38.8	21.1	23.5	34.8	17.3	29.6	13.4	20.8	31.8	44.6	35.2	38.1	54.9	30.3	30.3	36.0	35.9	42.4	58.7	21.1	21.3	32.4	20.1	36.2	45.3	33.7	20.4	45.3	85.3	26.5	23.7	38.5	28.5	37.8	30.9	32.6	23.4	32.6	51.0	12.0	85.5	36.6	32.4	41.4	29.9	55.5	28.9	5.9	32.6	34.2	23.7	31.7	24.5	8.4	30.8	34.2	31.3	23.6	18.6	24.0	30.4	20.0	6.6	27.3	17.9	40.0	20.4	28.5	34.6	22.6	26.4	7.0	22.1	0.2	32.9	32.2	25.8	46.3	18.3	29.0	21.2	40.0	8.3	17.9	23.9	11.8	31.4	0.3	10.9	23.0	20.3	21.5	5.6	39.6	53.5	0.2	23.2	0.5	40.2	21.6	0.2	0.3	3.9	34.7	38.5	2.0	12.3	25.6	28.5	7.4	0.4	16.9	23.4	3.5	31.6	25.6	15.4	14.6	38.2	23.1	8.5	51.3	19.2	0.6	0.1	0.6	17.8	18.0	23.7	13.9	31.3	34.2	16.8	30.4	8.3	8.4	9.5	11.1	30.8	6.9	11.3	18.6	2.8	23.6	24.6	3.1	1.3	24.0	21.1	34.8	13.4	20.8	21.1	21.3	33.7	20.4	28.5	28.9	47.6	66.6	38.9	56.1	18.2	24.1	116.6	30.6	123.1	58.0	71.5	19.6	135.2	84.6	164.5	478.1	107.4	297.6	0.0	298.9	268.0	77.3	94.3	101.6	31.0	159.4	28.6	70.0	185.4	162.5	821.7	77.1	104.2	60.8	173.1	110.7	143.7	252.9	244.7	79.9	156.8	48.0	77.6	110.5	190.3	30.0	23.1	135.0	42.4	162.8	77.4
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"monocytes: 212.8;Proximal tubular cells: 716.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.7	21.6	13.2	29.0	23.3	13.8	14.2	12.4	15.9	11.5	12.9	22.7	4.9	11.2	45.3	21.3	26.9	9.8	13.5	8.6	9.0	26.1	11.5	6.9	26.5	22.7	19.0	6.9	22.1	8.5	10.3	13.9	13.0	16.5	11.1	14.6	39.2	6.7	9.5	28.4	7.9	12.8	17.9	26.9	18.0	14.7	15.7	32.7	17.3	6.8	2.8	5.1	18.8	8.0	39.4	24.7	11.0	4.8	19.1	10.8	4.2	14.4	5.4	14.6	33.1	3.4	12.7	21.0	21.3	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5	8.9	17.3	8.1	35.0	31.3	32.4	60.5	50.9	22.7	10.3	24.4	9.8	36.3	137.6	19.8	39.2	32.9	25.6	23.3	55.3	41.3	45.4	32.3	12.8	167.7	66.5	39.7	4.6	20.3	34.6	38.3	33.1	71.3	64.1	212.8	19.0	47.3	40.8	17.3	38.5	716.7	18.8	25.8	46.2	7.0	10.1	36.0	26.1	17.3	20.9	42.3
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	24.5	12.0	6.9	15.7	12.4	10.5	28.0	11.9	11.0	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9.0	9.4	18.6	18.5	15.2	19.2	15.0	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.8	10.3	10.6	22.0	14.1	5.7	15.0	20.4	15.9	18.3	9.2	6.6	8.9	14.5	21.5	16.7	11.0	12.8	12.3	17.4	18.4	6.9	11.5	4.5	6.7	12.4	9.9	14.7	19.0	11.0	14.7	10.7	13.0	13.7	5.5	12.9	5.1	15.3	12.3	6.8	10.8	6.5	11.5	8.5	8.3	7.6	10.0	14.2	19.1	8.9	8.8	9.9	6.2	16.6	21.9	11.4	7.1	16.6	17.4	9.3	6.6	11.1	7.9	10.2	9.5	7.3	5.5	19.2	1.1	3.0	6.4	6.1	3.7	4.9	2.0	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11.0	7.5	6.8	11.8	6.6	10.2	9.4	6.0	8.1	8.8	8.6	9.7	3.4	6.9	12.7	21.4	20.5	8.7	11.8	7.3	5.0	8.1	1.6	15.8	13.6	0.0	11.3	5.6	9.8	8.2	10.4	12.3	10.1	4.8	6.3	11.6	5.1	0.4	6.4	11.1	3.3	17.2	15.4	7.2	10.3	10.1	5.6	8.2	21.0	19.4	15.1	0.9	2.5	8.7	10.0	12.5	9.3	12.2
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 61.6;liver: 47.9"	"Cell type enhanced"	"Detected in many"	12	"Proximal tubular cells: 218.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		13000	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	12.8	9.8	8.4	5.1	12.1	4.0	8.1	6.0	10.1	6.7	19.4	6.3	4.5	19.8	6.1	17.8	8.8	7.1	8.2	6.8	7.5	9.6	61.6	47.9	3.8	4.9	7.8	5.9	5.1	9.8	4.8	8.4	3.7	10.3	5.9	6.4	6.4	8.4	4.1	12.0	6.4	29.1	7.0	6.9	2.7	6.5	7.0	3.8	4.9	4.6	8.8	5.6	6.2	5.6	15.8	13.1	7.3	11.2	11.1	11.7	6.5	13.9	11.0	18.0	16.0	11.3	10.6	8.6	7.1	12.0	15.9	14.0	13.0	15.0	16.6	14.3	11.7	14.8	13.8	16.2	16.5	37.0	19.7	10.5	8.1	8.3	16.8	3.6	10.0	4.4	8.5	7.6	15.6	23.1	9.8	23.3	13.3	7.2	8.5	24.5	20.5	12.2	6.0	13.4	14.7	24.7	12.8	20.2	16.5	12.8	15.8	17.3	13.6	10.6	5.7	27.5	23.1	17.4	4.9	8.2	19.9	16.5	11.8	13.2	7.1	21.6	13.7	4.3	5.8	22.4	7.3	8.7	0.1	7.7	11.2	9.9	15.8	8.9	7.6	13.1	11.8	8.5	11.7	1.0	11.1	6.3	7.3	4.7	6.5	8.4	12.1	6.0	10.1	7.5	9.6	7.8	5.9	10.3	3.8	6.0	9.4	4.7	8.7	7.9	11.6	3.9	35.7	45.5	14.8	15.7	19.6	23.1	59.7	24.9	0.4	7.1	17.1	0.0	11.8	27.7	12.2	7.5	2.3	62.1	19.8	15.9	15.4	3.7	1.8	0.7	13.8	10.5	30.4	21.6	10.1	11.0	17.9	10.8	13.1	218.9	7.2	6.5	9.5	6.7	21.5	8.2	11.7	5.3	16.3	6.8
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153669-3157526	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 158.3"	"Cell type enhanced"	"Detected in all"	7	"Horizontal cells: 487.8;Suprabasal keratinocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.0;monocytes: 2.6;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"AF22: 49.5;CACO-2: 50.0;SuSa: 77.3;WM-115: 55.3"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (1.61e-4)"	19.6	9.1	59.4	8.7	46.9	26.8	7.9	46.5	158.3	5.4	8.7	9.1	1.2	11.1	6.7	13.5	17.2	4.8	10.9	6.1	56.5	76.0	7.7	16.9	4.1	5.4	58.4	43.3	2.6	14.3	1.6	6.9	11.0	78.6	6.1	4.5	4.6	5.8	8.0	7.3	24.7	13.8	17.7	24.3	2.3	17.6	2.9	5.4	0.1	1.9	10.4	4.7	5.4	5.8	6.0	0.9	0.7	2.6	0.6	5.5	1.8	10.6	9.0	49.5	11.1	6.3	7.0	2.9	23.7	8.9	16.2	23.6	50.0	3.6	5.3	14.6	22.4	16.1	5.1	17.5	5.3	5.6	25.6	11.6	1.8	2.6	15.1	6.5	0.2	1.8	7.3	6.3	17.0	1.1	5.9	7.5	2.2	6.3	1.8	14.5	4.7	2.8	0.5	42.4	3.1	11.6	2.4	4.6	4.0	5.5	5.4	12.4	11.3	5.9	1.8	33.9	77.3	3.8	0.3	14.9	11.0	12.0	23.7	12.7	0.7	0.8	3.6	4.0	1.4	55.3	0.0	1.9	0.0	4.0	2.6	4.4	6.0	3.9	5.5	0.9	1.2	2.1	3.7	0.7	0.6	2.0	0.3	5.3	1.8	59.4	46.9	46.5	89.2	56.5	76.0	58.4	43.3	78.6	5.4	14.9	16.2	11.3	50.6	276.6	98.5	16.7	48.4	24.1	15.9	12.2	15.7	2.1	184.1	43.1	50.4	30.8	111.0	70.0	155.6	48.0	118.0	26.1	34.6	48.9	44.2	487.8	70.0	11.1	6.5	18.3	19.2	38.9	123.2	125.4	69.8	243.3	112.9	105.2	14.5	26.4	58.8	6.5	107.2	21.2	12.6	322.2	5.1	10.7	23.3	53.3
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3224261-3231730	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 125.4"	"Group enriched"	"Detected in many"	6	"Distal tubular cells: 351.5;Horizontal cells: 406.8;Muller glia cells: 726.9"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"AF22: 73.9;CACO-2: 54.3;NTERA-2: 36.2;RPMI-8226: 37.2;SCLC-21H: 110.9;SH-SY5Y: 53.8;SuSa: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	3.8	5.9	53.6	5.9	63.1	1.5	4.4	23.2	125.4	4.7	4.6	22.6	0.0	2.8	4.0	29.7	2.5	2.0	3.6	2.1	34.3	48.6	6.6	1.4	1.6	6.0	56.7	18.6	1.5	2.9	1.4	4.8	3.9	36.1	2.1	3.1	2.3	3.6	4.3	4.5	3.0	4.7	5.5	80.5	1.8	3.3	1.7	16.2	0.0	1.6	0.0	4.6	2.1	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	73.9	22.3	0.0	0.0	0.0	0.4	0.9	2.7	6.0	54.3	0.2	0.0	0.7	0.5	0.0	0.0	28.9	0.0	1.6	0.0	13.2	0.0	0.0	4.2	0.2	0.0	0.8	0.4	0.0	0.3	0.0	0.9	0.0	0.0	0.8	0.1	0.7	0.0	0.1	0.0	36.2	0.0	2.3	0.0	3.5	37.2	0.3	0.0	110.9	53.8	0.0	0.2	0.3	35.3	0.4	0.0	0.0	0.0	12.6	0.6	0.0	7.3	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	53.6	63.1	23.2	39.2	34.3	48.6	56.7	18.6	36.1	16.2	0.0	0.0	1.5	2.5	7.7	30.9	33.1	10.2	0.0	0.0	7.0	15.7	0.1	351.5	10.8	3.0	6.0	0.2	0.0	3.0	0.4	24.0	2.8	0.0	0.8	2.5	406.8	64.0	1.3	0.0	4.1	0.3	0.0	87.7	6.4	0.5	726.9	19.6	0.0	0.0	1.4	34.7	0.0	27.8	1.2	6.8	2.4	0.7	0.0	0.4	0.7
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	13.9	12.7	12.6	13.0	26.1	14.3	16.0	18.5	14.4	15.8	15.1	11.8	11.3	17.3	16.7	23.1	16.9	13.4	18.7	12.9	11.4	14.0	13.1	18.1	11.0	15.2	10.7	12.2	13.8	30.9	8.9	16.2	9.6	10.7	15.5	8.9	13.6	21.0	18.8	36.6	17.9	16.8	18.1	10.6	11.9	17.4	13.3	9.8	13.5	17.2	16.5	14.6	13.1	11.3	25.6	18.5	12.2	20.1	16.2	24.4	13.2	21.5	10.6	6.4	15.7	5.8	8.6	11.0	9.8	7.3	9.4	15.3	8.9	7.5	7.2	26.7	5.8	7.6	10.1	5.3	6.5	6.1	12.2	22.8	5.8	10.9	23.0	6.9	16.7	6.2	7.3	7.3	6.8	10.2	5.4	11.7	14.5	22.5	5.6	5.0	20.6	9.5	31.0	7.8	11.1	20.9	12.8	3.5	40.1	7.4	8.6	27.4	8.0	4.3	6.2	20.9	6.3	7.9	7.5	11.1	8.0	7.6	8.9	9.4	18.2	25.7	13.3	5.6	12.1	10.8	6.2	20.1	12.2	14.8	18.4	17.0	25.3	24.4	17.8	15.5	25.6	24.4	20.9	4.8	16.2	18.1	18.5	20.5	13.2	12.6	26.1	18.5	14.4	11.4	14.0	10.7	12.2	10.7	9.8	20.8	13.9	20.9	23.8	24.7	28.8	18.6	35.7	16.0	19.4	41.8	7.9	32.9	71.3	34.8	24.9	32.9	22.0	0.0	76.0	30.2	26.7	25.6	21.9	55.5	30.7	23.8	21.9	29.4	18.9	9.7	34.2	21.2	28.7	31.5	27.1	15.1	47.9	24.6	21.5	42.5	26.2	45.3	30.9	29.8	76.7	33.4	10.1	20.6	32.0	22.6
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457022	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.4	2.2	9.0	4.6	16.2	8.1	9.3	8.4	14.8	5.6	17.4	30.8	3.4	19.6	3.6	11.8	16.8	11.3	7.5	2.2	11.0	8.1	6.9	12.6	8.0	3.9	28.6	8.7	3.0	14.9	14.8	6.5	8.3	17.8	14.2	14.4	5.7	10.0	2.8	5.9	14.9	20.3	3.0	17.5	4.6	26.0	7.2	21.0	5.2	4.1	9.8	9.9	3.8	9.9	0.1	0.7	0.8	0.3	0.3	1.4	1.9	2.4	5.6	12.5	13.9	4.4	5.0	16.0	0.4	0.1	0.7	0.3	12.5	0.4	0.6	1.4	2.7	11.1	3.6	2.5	6.6	0.2	2.0	7.7	5.8	2.1	11.0	0.6	0.3	0.4	1.2	13.0	12.1	0.6	2.6	0.4	3.2	5.2	3.3	0.4	2.9	0.5	1.4	4.3	13.7	2.3	1.3	0.8	9.9	0.0	15.3	1.4	0.2	3.3	4.8	4.1	13.3	18.5	0.1	3.1	7.3	2.3	9.4	1.5	7.5	0.1	0.2	12.8	0.4	4.4	0.0	0.3	0.0	0.4	0.0	0.2	0.0	1.0	0.4	0.2	0.1	1.4	0.9	0.8	0.3	0.2	0.7	0.0	1.9	9.0	16.2	8.4	14.8	11.0	8.1	28.6	8.7	17.8	21.0	6.0	13.7	0.5	4.2	10.3	7.9	2.4	10.2	33.5	17.0	5.2	7.9	12.2	0.0	2.5	73.9	8.4	29.0	23.3	7.0	0.9	1.4	19.2	0.0	10.0	9.8	0.0	4.1	6.7	8.0	171.9	1.7	2.0	3.3	10.8	52.1	9.1	5.7	14.4	0.7	2.4	3.4	0.0	0.9	2.1	1.1	11.0	7.7	1.0	22.6	3.9
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3752026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 79.6"	"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 93.5;Extravillous trophoblasts: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA019246: AB_2670113"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	26.3	5.5	5.9	5.9	6.5	0.4	30.6	3.2	6.6	11.1	10.3	6.4	5.3	10.7	10.1	14.4	13.9	8.3	18.5	10.8	6.5	4.4	13.4	79.6	14.2	5.8	7.5	3.1	6.2	10.0	3.4	4.3	32.9	6.2	9.1	3.1	7.5	12.3	8.1	11.9	11.7	16.9	20.6	7.0	6.1	8.9	3.9	6.9	1.0	16.8	11.5	5.8	14.9	21.0	4.2	0.3	0.5	0.0	0.0	0.9	0.3	11.7	5.0	8.2	5.5	26.0	19.7	26.4	21.4	16.5	18.3	14.2	8.3	2.3	0.0	13.9	35.0	13.5	8.8	1.6	5.9	8.7	11.9	1.6	0.0	3.6	7.4	43.5	0.0	0.0	17.8	19.4	11.3	24.4	15.1	20.0	0.8	0.0	1.5	14.3	0.7	0.0	0.1	0.3	2.3	6.0	0.6	4.4	0.4	6.9	9.9	0.9	0.4	14.2	14.6	28.7	11.4	1.2	0.7	20.8	15.5	6.6	6.0	14.5	0.0	0.0	0.0	3.5	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.3	4.2	0.1	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.3	5.9	6.5	3.2	6.6	6.5	4.4	7.5	3.1	6.2	6.9	44.7	10.4	4.2	93.5	42.8	0.4	6.9	15.3	5.3	12.5	7.0	0.0	26.6	10.0	30.2	0.4	37.0	1.3	0.0	44.5	114.0	36.1	45.1	3.5	57.1	21.2	0.0	0.0	36.2	9.1	0.2	21.0	17.8	23.6	37.9	0.8	14.3	55.0	0.0	17.0	16.8	0.7	0.0	31.6	0.5	3.8	29.0	65.6	2.9	0.0	38.2
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849386-3851317	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6;MCF7: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	7.2	9.5	13.4	5.7	20.6	3.1	5.7	18.7	16.7	6.7	6.8	11.0	8.4	10.1	8.3	6.7	5.5	11.2	8.1	16.0	12.8	14.2	12.9	12.0	6.2	7.1	11.4	14.9	14.4	12.7	5.8	7.7	3.4	9.7	8.2	3.0	5.9	15.2	9.8	41.1	7.9	6.9	10.2	10.8	7.7	7.9	10.2	9.9	5.8	11.8	5.7	5.5	7.5	13.3	14.9	10.1	3.4	9.1	19.4	20.5	5.6	3.1	4.3	0.0	0.0	2.6	2.4	0.2	3.8	1.8	2.6	3.3	0.0	5.9	3.4	4.1	2.7	1.0	2.4	0.0	1.5	1.9	42.6	2.3	0.0	10.2	0.0	2.7	0.0	0.0	2.7	3.0	2.0	0.6	0.8	2.6	0.0	0.0	0.0	2.3	13.4	0.0	4.7	0.9	2.0	2.0	0.0	0.0	0.0	1.2	0.0	6.0	5.3	6.2	3.9	0.2	0.0	4.2	3.8	3.5	0.0	0.4	5.1	0.0	0.0	9.2	0.0	1.4	0.3	7.1	3.4	4.7	2.4	7.1	6.1	16.8	14.9	13.6	9.2	6.1	12.9	11.3	7.1	1.9	19.4	9.1	10.1	20.5	5.6	13.4	20.6	18.7	16.7	12.8	14.2	11.4	14.9	9.7	9.9	14.9	6.5	6.5	5.9	5.7	17.4	15.7	5.1	4.0	7.9	12.2	3.9	3.3	28.2	10.7	24.9	4.1	2.2	0.0	9.9	4.8	5.8	2.7	3.5	18.8	8.7	14.3	1.2	8.6	4.1	25.0	7.8	4.0	11.8	10.0	3.3	19.1	7.9	3.6	10.3	32.6	12.6	0.0	7.9	34.4	39.6	5.8	0.8	4.5	3.3	1.6
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	23.2	21.6	19.6	24.0	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6.0	14.7	12.0	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15.0	14.5	13.0	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21.0	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19.0	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.7	12.8	20.2	13.8	11.5	10.7	9.8	14.3	15.7	15.6	15.8	12.2	7.5	24.1	18.0	16.1	12.8	13.2	25.4	12.4	22.5	11.3	18.6	27.1	14.7	10.9	8.8	29.9	14.8	9.7	8.2	11.1	6.9	7.6	15.5	11.8	37.1	8.9	15.3	8.6	21.9	10.0	12.1	12.9	11.9	24.9	19.5	23.4	10.0	16.6	15.7	10.3	16.6	10.4	12.6	16.8	16.2	15.0	16.6	15.4	8.9	10.1	13.8	10.1	15.8	28.1	8.4	13.7	18.7	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9.0	10.2	9.3	8.0	8.0	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21.0	20.2	101.3	91.8	89.2	53.8	74.1	81.8	69.0	61.1	89.7	101.2	92.5	84.4	51.4	61.3	56.7	8.7	82.4	58.2	46.7	49.5	40.6	50.2	53.8	86.8	76.7	36.1	100.1	72.3	68.2	59.0	11.9	91.5	57.7	33.7	71.3	57.5	80.9	52.5	57.5	83.8	50.1	181.0	58.2	43.9	67.7	79.4	79.8	53.2	69.3	57.5	63.7
FAM217A	"C6orf146, MGC43581"	ENSG00000145975	"Family with sequence similarity 217 member A"	Q8IXS0	6	4049434-4087344	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"testis: 16.9"	"Group enriched"	"Detected in some"	23	"Early spermatids: 174.7;Late spermatids: 307.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Low region specificity"	"Detected in many"							HPA035455	Uncertain					NA	NA					"HPA035455: AB_10669905"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.54e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.51e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.4	1.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.3	0.1	0.3	0.4	0.5	1.3	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	10.6	2.7	0.0	0.0	0.0	0.0	0.0
C6orf201	dJ1013A10.5	ENSG00000185689	"Chromosome 6 open reading frame 201"	Q7Z4U5	6	4079206-4130951	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	46	"testis: 27.6"	"Group enriched"	"Detected in some"	22	"Early spermatids: 387.3;Late spermatids: 525.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.69e-3)"	"unprognostic (3.47e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.08e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	6.7	3.4	0.0	0.0	0.0	0.0	0.0	387.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	525.7	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.4	0.0	0.0	20.4	3.2	0.0	0.2	0.0	0.0	0.0
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 363.1;Proximal tubular cells: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.3	20.5	30.5	2.0	25.3	25.9	27.6	24.7	7.3	2.7	0.7	31.9	27.5	25.1	9.4	18.4	14.7	40.2	6.7	21.1	9.4	13.7	39.3	11.9	8.5	4.7	20.9	9.0	23.5	13.2	37.6	57.5	30.4	30.8	6.9	26.1	7.1	24.0	21.2	11.0	1.7	34.8	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.3	30.8	24.5	4.0	58.0	20.8	11.4	18.4	15.0	10.5	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3	26.8	25.1	23.1	44.0	16.3	13.3	158.2	86.6	121.8	59.1	34.9	11.8	242.5	363.1	46.4	49.2	44.3	33.7	46.7	154.5	15.1	57.4	23.5	22.0	167.8	55.4	17.5	50.1	41.7	22.4	39.8	58.7	24.7	33.7	36.1	38.2	54.7	71.1	41.2	47.7	504.9	43.8	25.8	23.7	25.7	33.2	11.2	85.2	49.0	60.0	20.4
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035578: AB_2674685"	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	18.4	9.2	13.3	14.2	14.4	19.3	16.5	8.1	15.8	19.8	16.2	13.3	20.6	8.2	22.2	15.5	19.6	14.7	11.7	14.5	11.0	8.6	9.9	6.9	11.8	12.7	12.5	10.7	13.3	8.5	12.7	8.3	35.4	12.8	12.5	15.8	11.0	12.8	15.3	24.7	23.2	12.2	17.7	8.5	12.6	13.3	10.1	12.9	11.3	11.7	12.5	15.2	17.7	24.8	1.8	11.2	5.1	2.1	2.3	2.4	1.9	11.8	10.4	15.0	12.6	11.8	8.0	17.4	11.4	9.2	10.8	11.4	8.4	8.3	2.5	11.9	8.8	16.5	10.5	12.2	13.8	13.1	8.3	10.9	10.1	10.2	7.6	15.0	13.1	11.7	6.5	24.8	12.3	18.9	6.6	10.5	9.4	18.3	7.6	5.4	10.6	7.5	12.2	15.5	8.4	11.5	9.3	13.4	20.6	7.2	9.7	12.9	7.8	13.9	12.1	18.0	44.7	7.3	13.0	13.9	12.8	11.3	9.3	13.2	17.6	28.3	9.3	4.3	8.6	13.9	5.1	2.1	0.8	2.4	1.1	1.7	1.4	1.7	1.8	2.5	1.8	1.0	1.7	0.6	2.3	1.2	11.2	0.2	1.9	13.3	14.4	8.1	15.8	11.0	8.6	12.5	10.7	12.8	12.9	17.9	6.5	17.1	15.7	33.2	16.2	16.5	15.3	10.7	10.3	14.0	21.6	10.7	13.3	9.8	56.5	19.6	27.4	70.0	8.8	19.3	13.4	20.9	5.7	9.0	9.0	42.9	31.0	18.4	13.2	47.4	5.5	12.7	8.5	21.6	25.3	22.3	13.6	31.7	7.8	6.6	24.9	6.5	19.6	5.9	24.7	36.6	53.3	12.8	21.7	54.5
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994732-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	6.9	16.8	10.8	7.2	10.7	6.7	11.1	3.5	11.9	6.0	5.5	4.2	6.3	4.6	6.1	6.6	11.9	5.5	4.7	5.5	10.0	8.8	5.6	10.8	3.9	10.1	9.9	5.8	6.2	7.8	5.2	8.6	5.6	9.1	5.3	5.3	1.5	4.0	6.7	7.7	9.8	3.6	7.5	5.3	6.8	4.3	10.5	8.0	6.1	5.6	13.0	8.3	9.1	6.9	7.8	12.3	0.0	11.1	7.9	8.4	5.0	6.4	10.8	3.4	9.7	6.4	8.1	10.9	6.4	3.2	12.3	9.8	14.7	5.0	14.0	28.3	6.6	16.9	6.9	7.0	9.9	11.2	5.3	14.2	8.8	7.0	19.9	7.5	11.3	5.0	6.3	8.5	12.2	12.2	2.7	12.0	12.9	13.9	2.8	8.9	18.4	5.7	19.5	5.7	7.7	17.6	12.2	6.5	25.6	6.2	7.0	12.3	3.6	6.0	5.8	6.4	9.5	10.5	9.4	5.7	16.2	10.9	10.9	14.5	5.0	21.1	11.0	3.0	19.0	8.3	0.0	6.9	0.0	3.4	11.1	5.0	7.8	5.9	4.1	12.3	6.5	8.1	7.2	0.0	7.9	3.5	5.9	8.4	5.0	10.8	10.7	3.5	11.9	10.0	8.8	9.9	5.8	9.1	8.0	0.0	0.6	4.5	7.0	11.0	0.2	3.6	0.0	5.3	4.5	1.8	0.0	11.1	10.0	8.1	5.5	7.0	0.4	0.0	8.1	10.7	6.0	3.1	0.0	5.8	9.9	0.0	2.9	6.7	2.1	2.1	5.2	3.4	8.5	1.8	3.1	1.3	3.9	2.3	4.6	11.7	0.2	0.0	7.2	11.4	26.8	12.9	8.0	1.9	6.8	7.0
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5084581-5089487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 8.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 16.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"					"Group enriched"	"Detected in some"	4	"classical monocyte: 1.7;intermediate monocyte: 1.2;myeloid DC: 2.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.9;PC-3: 4.7;THP-1: 16.4;U-266/70: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain					NA	NA					"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	1.9	3.5	3.3	0.6	4.0	0.1	1.0	0.1	2.3	2.1	1.7			0.4	1.2	1.9	2.0	1.1	0.6	8.3	1.8	1.4	0.8	6.4	0.4	0.7	2.4		1.7	0.0	0.0	0.0	1.3		2.0	0.8		0.4	3.0	0.9	0.9	0.5	0.9	0.1	5.3	0.5	0.3			0.1		0.5	3.2	2.2	0.3	2.4	0.4	2.9	0.3	0.2	0.5	0.0	0.3	0.1	0.0	1.9	1.2	0.1	0.3	0.5	0.3	0.4	0.1	0.3	0.0	4.9	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.5	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.9	0.1	0.0	4.7	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.6	0.0	0.0	0.4	0.1	16.4	0.0	0.0	0.0	1.0	0.6	2.9	2.3	0.1	0.9	0.0	0.1	0.4	1.7	0.0	0.0	1.2	0.0	0.3	0.2	0.0	2.4	0.2	0.0	0.1	0.3	0.3	2.9	0.1	0.0	0.5											0.0	0.0	0.0	0.4	0.5	0.7	16.7	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.3	3.7	0.3	0.0	0.0	3.5	0.0	1.2	0.6	1.9	0.0	0.9	1.9	0.0	1.8	0.3	0.0	0.4	1.9	2.8	1.2	0.1	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.0	0.8
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5102593-5260939	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030362	Approved		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.1	21.0	21.6	14.9	18.7	17.9	19.3	11.0	26.6	17.8	13.8	11.5	11.2	8.4	20.2	22.8	15.6	22.5	11.2	21.0	16.7	16.1	16.1	13.7	12.7	20.9	16.2	16.9	32.4	23.2	10.3	32.3	13.3	15.0	13.6	18.2	14.6	12.9	11.3	13.4	18.3	10.3	18.9	15.8	17.2	14.2	18.4	14.3	20.7	24.2	14.9	20.4	16.2	15.4	18.3	19.3	2.0	11.2	13.7	18.2	10.3	11.0	11.4	14.7	12.2	14.9	20.7	13.3	9.2	16.4	11.9	12.4	18.2	6.1	16.6	20.5	10.9	15.6	8.9	18.1	11.5	10.7	24.6	16.4	7.9	7.0	28.8	9.7	17.6	6.7	18.6	19.0	12.2	18.7	12.9	10.2	14.5	19.8	6.1	10.1	5.4	16.6	27.4	14.4	16.5	14.9	15.2	11.1	27.2	14.1	8.5	20.5	15.1	8.8	4.9	26.7	19.2	15.0	17.4	10.4	12.9	10.1	13.2	16.9	8.4	29.1	15.7	8.1	13.6	22.1	0.7	9.8	0.8	7.3	11.2	10.1	18.3	11.3	7.8	19.3	12.8	18.2	16.5	2.0	13.7	9.5	11.9	9.4	10.3	21.6	18.7	11.0	26.6	16.7	16.1	16.2	16.9	15.0	14.3	23.8	15.2	47.7	41.4	65.4	15.4	24.6	20.4	17.4	22.7	17.4	7.9	43.6	26.6	39.1	25.3	32.7	6.5	0.0	37.6	60.8	51.2	45.2	41.4	25.5	54.0	11.1	31.0	37.4	41.3	73.8	42.8	46.6	65.8	88.4	22.3	33.2	36.9	7.0	33.2	63.5	14.1	32.3	42.9	81.4	81.1	72.4	39.5	33.8	40.0	45.7
FARS2	"dJ236A3.1, FARS1"	ENSG00000145982	"Phenylalanyl-tRNA synthetase 2, mitochondrial"	O95363	6	5261044-5771580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 61.5;Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018148, HPA028836"	Approved					NA	NA					"HPA018148: AB_1848426, HPA028836: AB_10601377"	"unprognostic (2.73e-1)"	"unprognostic (4.08e-3)"	"prognostic favorable (5.14e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.31e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	14.2	19.0	10.6	16.5	14.5	13.2	14.8	16.5	18.8	14.7	13.5	16.4	13.4	9.6	15.3	12.7	13.7	19.8	11.6	19.0	10.5	9.0	18.4	18.5	13.0	21.8	8.9	15.0	11.7	14.0	18.9	29.2	11.4	10.6	12.2	15.2	19.3	15.3	13.5	22.8	15.4	13.0	13.2	8.5	15.0	13.9	15.4	11.0	20.6	19.7	16.0	22.0	13.1	12.9	13.9	16.8	3.2	10.3	14.9	17.5	10.9	8.3	8.1	8.7	9.3	10.8	13.0	7.2	9.3	10.9	12.0	11.9	10.9	6.5	11.8	14.4	8.9	11.7	8.4	11.1	14.9	12.6	35.2	7.4	4.7	7.2	9.4	5.6	11.3	7.0	10.3	14.7	13.8	9.8	7.1	14.5	13.4	13.9	2.7	8.8	8.6	12.0	12.5	5.3	13.0	7.8	12.0	10.8	23.2	11.5	10.0	14.9	7.5	8.5	6.8	10.4	11.9	13.6	12.3	8.2	13.2	6.0	7.6	11.8	5.7	19.7	6.4	7.2	6.7	16.2	0.1	9.4	3.2	15.6	10.3	13.9	13.9	14.1	14.5	16.8	11.3	15.6	15.5	0.7	14.9	7.3	9.9	17.5	10.9	10.6	14.5	16.5	18.8	10.5	9.0	8.9	15.0	10.6	11.0	8.9	13.6	6.7	13.6	13.2	8.5	15.7	10.2	24.1	2.3	8.7	2.0	16.3	23.2	12.0	61.5	10.7	6.2	0.0	11.4	17.4	9.5	7.3	21.9	10.6	13.8	0.0	10.3	10.4	15.2	54.1	5.8	10.0	5.0	10.0	8.1	11.3	7.1	10.5	6.7	25.4	9.3	0.0	7.3	7.9	9.1	11.5	8.9	20.1	10.8	9.7
NRN1	NRN	ENSG00000124785	"Neuritin 1"	Q9NPD7	6	5997999-6007605	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 32.1;brain: 59.3"	"Group enriched"	"Detected in many"	4	"Endothelial cells: 56.9;Extravillous trophoblasts: 52.2;Ito cells: 80.4"	"Cancer enhanced"	"Detected in all"		"glioma: 38.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 5.7;neutrophil: 5.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.6;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.3;ASC TERT1: 29.0;fHDF/TERT166: 37.6;JURKAT: 34.8;REH: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.24e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.37e-3)"	32.1	3.7	38.8	4.0	21.5	0.7	16.8	53.3	59.3	6.1	5.8	3.5	1.1	2.6	5.9	2.9	5.4	6.2	6.9	9.9	40.2	9.8	3.2	3.1	9.3	5.3	10.0	22.1	2.5	1.9	1.9	3.5	25.5	23.4	3.2	3.4	4.1	3.7	5.2	10.0	7.8	3.4	6.8	5.6	9.3	3.2	0.8	1.8	0.0	3.0	2.8	2.5	7.8	5.7	0.7	0.5	5.6	0.4	0.0	5.7	0.2	4.2	0.2	0.4	0.1	37.3	29.0	5.7	0.7	0.0	3.1	4.3	0.0	0.0	0.0	0.6	37.6	6.6	0.1	11.1	0.0	3.0	6.9	5.7	3.5	0.2	0.0	0.0	14.6	11.6	4.6	0.0	2.8	0.0	0.0	14.9	34.8	0.1	0.2	11.0	1.0	22.2	0.7	0.1	0.0	0.0	49.3	12.6	0.1	0.0	0.1	6.6	2.4	0.0	0.2	3.5	0.1	0.1	4.4	3.1	15.1	0.4	5.7	9.3	0.0	0.5	0.3	22.8	0.3	2.3	1.0	0.3	0.0	0.3	0.4	5.7	0.7	0.4	0.7	0.0	0.0	0.0	0.1	5.6	0.0	0.3	0.5	0.2	0.2	38.8	21.5	53.3	58.3	40.2	9.8	10.0	22.1	23.4	1.8	0.0	2.2	3.7	0.0	9.3	6.2	2.2	2.5	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	56.9	0.0	0.0	0.4	52.2	3.2	0.4	0.0	0.0	1.5	3.2	0.0	80.4	3.4	0.0	0.9	1.4	15.1	0.0	0.0	4.7	0.3	0.0	0.0	0.0	12.7	0.0	5.0	0.3	0.1	9.8	1.1	0.0	0.0	0.6
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144085-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.1"	"Cell type enriched"	"Detected in many"	6	"Hofbauer cells: 646.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.6;myeloid DC: 33.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 33.7;monocytes: 27.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2.0	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5.0	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0.0	33.7	6.6	27.6	0.0	0.1	63.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.5	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	27.6	0.2	0.1	4.9	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	6.6	0.0	0.1	2.4	0.0	63.5	2.2	6.5	2.2	1.8	2.0	2.2	5.8	1.4	7.5	2.5	0.0	3.4	0.8	0.0	16.7	0.0	7.5	10.2	4.0	0.0	0.0	0.0	4.0	0.0	0.0	3.8	4.7	0.0	0.0	0.0	3.4	16.5	0.0	1.1	0.8	646.4	0.0	0.0	4.3	113.2	4.2	4.0	57.6	18.6	1.0	0.0	0.7	0.1	0.0	0.7	3.1	4.1	58.2	9.2	1.4	1.0	13.2	8.5	0.0	0.0	0.0
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 44.6"	"Group enriched"	"Detected in many"	8	"B-cells: 109.7;Hofbauer cells: 173.4;Kupffer cells: 183.5;Macrophages: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 58.2;myeloid DC: 58.7"	"Group enriched"	"Detected in many"	43	"B-cells: 47.7;dendritic cells: 58.7;monocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.9;NB-4: 11.3;RPMI-8226: 67.8;THP-1: 27.2;U-698: 9.4;U-937: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		83000			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	10.2	5.0	9.9	18.2	12.9	11.5	2.9	1.6	5.3	3.9	3.2	15.4	0.0	1.5	1.8	1.5	2.0	2.8	7.4	2.5	8.9	7.0	2.8	5.2	13.3	31.2	16.5	4.1	2.1	2.0	0.8	2.8	6.3	9.3	2.5	4.3	2.3	4.5	3.0	0.9	1.5	13.0	4.6	19.9	44.6	2.5	1.1	12.7	2.9	1.7	0.3	32.7	8.4	1.7	47.7	58.7	1.2	58.2	0.7	0.7	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	2.4	0.0	67.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	12.7	0.0	0.5	58.2	0.4	0.1	32.1	0.1	47.7	0.1	0.1	58.7	35.6	0.7	0.4	1.2	0.7	11.6	2.3	0.2	25.7	9.9	12.9	1.6	5.3	8.9	7.0	16.5	4.1	9.3	12.7	0.0	19.6	109.7	0.0	1.8	0.0	0.5	2.5	1.4	2.3	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	1.6	2.8	0.0	1.1	0.8	173.4	0.0	0.0	5.5	183.5	12.8	0.3	157.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.3	0.9	0.0	2.0	1.6	1.3	0.0	0.1
RREB1	HNT	ENSG00000124782	"Ras responsive element binding protein 1"	Q92766	6	7107597-7251980	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001756, HPA034843"	Approved		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA001756: AB_1856477, HPA034843: AB_2674357"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.92e-1)"	17.4	13.3	3.4	17.9	3.6	24.1	15.9	1.4	3.3	15.8	16.8	3.6	13.5	9.7	18.5	16.3	26.6	9.4	19.1	8.5	3.8	2.1	12.7	18.5	14.4	15.9	4.2	1.8	12.5	26.4	14.6	11.2	15.9	4.6	13.7	8.3	15.2	23.6	18.5	30.5	16.5	20.3	14.5	5.2	20.0	9.6	10.6	4.4	12.8	15.9	17.1	24.9	12.5	17.5	3.0	7.8	8.6	3.6	5.2	2.3	2.0	7.0	6.7	5.6	6.5	5.2	3.4	23.1	2.7	3.9	3.1	4.3	10.4	5.5	3.3	5.9	5.2	3.6	5.1	8.1	8.7	3.5	4.7	6.5	13.1	4.7	13.1	7.2	7.2	10.0	5.8	7.1	5.0	7.6	2.2	4.2	7.9	23.0	0.0	3.5	8.4	4.3	20.2	2.6	5.1	5.9	6.8	6.9	5.3	5.3	13.4	1.6	1.4	6.1	8.9	5.8	9.1	6.7	16.9	6.5	6.2	4.0	4.4	3.6	2.3	2.5	5.1	1.8	6.0	5.0	6.0	3.6	8.6	2.2	3.1	1.7	3.0	1.3	1.4	2.4	1.6	2.3	2.1	2.8	5.2	3.2	7.8	0.8	2.0	3.4	3.6	1.4	3.3	3.8	2.1	4.2	1.8	4.6	4.4	23.8	26.6	13.7	15.3	27.9	0.6	21.6	33.1	12.0	20.5	34.9	66.8	22.4	6.6	13.6	33.8	23.2	42.6	0.0	14.2	29.1	17.1	24.7	9.3	56.8	29.4	0.0	30.5	36.2	57.4	3.6	18.4	36.8	21.9	10.8	34.2	11.7	19.0	28.8	18.0	15.8	27.5	51.8	10.2	7.9	14.3	30.4	38.3	16.7	40.3	46.8
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	37.8	38.5	22.5	35.8	25.7	37.3	29.9	30.8	24.1	41.6	26.9	28.6	35.7	27.4	33.2	34.2	38.7	25.7	27.7	27.8	21.6	29.8	41.4	99.0	30.0	41.7	25.1	18.8	36.5	53.6	21.7	40.3	37.1	24.7	26.0	33.3	25.9	55.8	39.9	24.2	21.8	31.5	32.6	31.4	40.1	28.2	18.6	24.6	32.0	36.8	28.2	34.6	34.3	26.0	22.8	60.3	33.8	50.3	24.9	33.9	54.1	20.0	20.5	15.9	29.3	43.2	30.8	24.8	46.4	38.3	31.7	38.3	27.9	16.7	27.1	82.1	47.3	29.2	18.1	19.0	26.5	43.9	28.3	16.1	28.9	24.1	58.0	44.9	53.2	32.8	27.2	29.2	36.3	74.8	24.5	34.8	13.6	32.3	32.7	34.8	24.1	14.5	14.0	13.4	22.7	23.3	19.8	20.0	101.4	27.7	28.7	21.5	10.0	28.2	15.6	43.1	50.1	25.3	23.6	30.8	34.2	26.1	26.4	39.6	33.8	50.1	21.9	16.6	30.1	62.4	33.8	50.3	33.2	26.9	36.8	33.9	22.8	30.1	30.1	60.3	17.7	28.8	28.8	28.4	24.9	31.1	42.0	31.8	54.1	22.5	25.7	30.8	24.1	21.6	29.8	25.1	18.8	24.7	24.6	26.8	37.9	78.9	52.1	69.0	70.6	38.3	91.7	32.1	53.4	123.9	94.2	69.1	13.3	83.2	10.0	65.3	48.5	23.3	89.4	184.0	80.1	92.1	46.2	127.8	119.1	66.7	59.8	77.3	135.2	9.6	72.8	143.0	89.4	55.1	89.0	65.4	68.5	31.6	68.6	56.7	95.4	25.8	62.9	44.0	54.3	65.9	101.8	73.0	76.6	57.0
CAGE1	"bA69L16.7, CT95, CTAG3"	ENSG00000164304	"Cancer antigen 1"	Q8TC20	6	7326656-7389743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 13.2"	"Group enriched"	"Detected in some"	16	"Early spermatids: 105.2;Late spermatids: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SuSa: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029832	Uncertain					NA	NA					"HPA029832: AB_10602412"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.25e-4)"	"unprognostic (4.80e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-6)"	"unprognostic (4.71e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.60e-1)"	0.2	0.2	0.3	0.2	1.5	0.4	0.2	0.9	1.1	0.2	0.2	0.6	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	1.2	0.9	0.7	0.0	0.2	1.8	0.1	1.8	0.2	1.4	0.2	0.2	0.5	0.6	0.1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	13.2	0.0	0.8	0.2	0.8	0.2	0.2	0.2	1.1	1.2	1.5	0.4	0.4	0.6	0.0	0.1	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.3	0.7	0.3	0.6	0.4	0.0	0.5	0.3	0.6	0.5	0.1	0.7	0.2	0.0	0.2	0.4	0.5	0.1	0.2	0.2	0.0	0.6	0.2	0.2	0.4	0.2	0.5	1.3	0.1	0.9	0.2	0.3	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.4	0.6	0.3	0.6	1.1	0.3	1.8	0.2	0.6	0.4	0.7	0.4	0.4	0.3	0.5	0.8	1.0	0.2	0.4	0.3	1.0	0.4	0.5	0.6	0.3	0.4	0.3	0.4	0.3	0.1	1.1	0.4	0.4	1.5	0.4	0.4	1.2	0.2	0.0	0.3	1.5	0.9	1.1	0.5	0.2	0.7	0.0	1.4	0.0	0.0	0.0	0.8	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	105.2	0.1	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	45.2	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.7	0.0	0.4	4.6	2.1	0.3	0.1	0.5	0.0	0.5
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	13.8	10.6	7.7	13.2	13.0	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4.0	7.3	15.4	6.0	15.6	12.3	8.5	11.8	8.0	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15.0	8.2	7.6	4.4	7.2	16.8	11.2	9.2	11.0	9.6	6.5	9.0	7.4	12.9	3.9	19.9	17.1	7.8	7.8	7.8	18.1	7.7	11.5	13.1	19.5	10.6	7.1	13.8	9.5	30.5	13.9	6.8	10.7	9.7	20.0	4.3	7.9	15.0	27.0	4.7	8.4	10.0	20.7	14.5	15.4	14.2	10.5	15.9	9.4	21.6	5.0	7.4	24.0	11.8	8.1	4.9	14.0	19.4	7.4	10.1	7.9	9.8	7.4	6.5	14.5	6.4	12.2	29.6	3.0	15.7	15.0	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15.0	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13.0	12.2	13.5	8.0	8.1	11.6	9.4	13.3	9.2	6.0	26.6	22.4	26.7	46.9	9.2	20.4	2.5	25.4	45.5	7.0	9.8	29.8	3.3	13.2	34.2	23.9	5.8	0.0	10.2	28.8	22.0	11.9	32.4	8.9	20.4	4.8	6.9	17.2	6.5	6.5	18.4	16.7	16.9	11.8	10.4	5.5	10.9	5.8	18.7	9.0	10.4	19.4	26.4	55.6	78.8	56.7	23.3	22.0	15.3	20.6
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 801.2;Cardiomyocytes: 699.5;Suprabasal keratinocytes: 1763.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HaCaT: 49.6;HBEC3-KT: 35.7;hTCEpi: 112.8;SuSa: 35.9"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		110000000	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.8	6.3	0.0	0.0	0.9	1.4	46.0	4.1	3.6	2.0	2.0	18.0	5.5	0.0	5.9	6.6	1.6	49.6	7.6	35.7	0.3	0.0	8.8	0.0	3.6	24.1	0.0	0.1	0.1	0.3	112.8	1.8	20.6	5.0	0.0	0.1	0.0	0.0	3.6	9.8	0.0	0.1	0.9	10.1	3.1	0.0	0.0	5.3	7.6	5.6	2.1	0.0	4.6	9.9	0.0	35.9	11.7	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1	47.6	14.2	5.1	114.0	801.2	2.1	699.5	132.5	179.3	220.6	57.6	13.7	231.6	1.7	136.3	1.3	28.8	238.5	0.0	97.9	229.6	43.4	178.6	3.5	162.5	23.9	0.0	167.6	3.1	1.6	0.5	0.9	5.6	96.2	4.6	145.6	14.8	137.3	200.0	0.0	11.0	27.9	0.0	22.7	1.4	2.5	1763.9	322.6	2.9	145.6	184.4
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590199-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	9.5	7.1	12.3	11.7	14.9	15.6	12.6	28.9	13.3	10.5	10.3	7.0	13.6	9.9	11.7	8.6	9.4	9.2	7.1	12.2	11.9	7.5	10.7	12.7	8.6	11.7	14.1	8.1	14.4	10.5	7.3	11.0	9.2	11.4	10.5	10.1	5.9	10.1	13.0	15.8	11.0	11.5	10.5	17.8	11.2	9.6	5.3	14.3	15.3	10.4	7.1	10.0	9.9	30.2	3.3	2.7	6.0	2.0	2.7	3.7	1.7	5.7	4.6	9.7	18.0	5.2	7.7	6.5	6.6	6.1	7.2	8.0	9.8	4.7	13.6	7.1	5.4	6.9	7.4	12.0	7.1	11.1	10.4	11.7	9.8	14.7	18.8	5.5	11.6	6.5	5.4	11.0	8.1	6.2	8.6	6.2	12.2	13.6	2.2	10.0	3.2	19.0	16.9	13.1	9.9	5.2	20.5	8.4	18.2	6.5	5.1	15.0	4.1	12.8	3.3	11.3	18.7	6.5	4.1	6.9	9.6	4.3	5.6	11.3	3.5	19.4	8.4	3.2	9.3	17.1	0.4	2.0	1.0	2.0	1.4	3.4	1.7	2.4	2.6	2.4	3.3	2.1	3.7	6.0	2.7	0.8	2.7	1.7	1.7	12.3	14.9	28.9	13.3	11.9	7.5	14.1	8.1	11.4	14.3	17.9	9.3	14.1	18.6	31.7	17.1	25.2	5.1	8.1	21.6	8.7	19.6	13.5	10.0	15.9	2.2	20.2	18.4	0.0	17.5	12.7	12.9	15.7	23.1	19.5	13.7	4.8	10.9	13.5	16.4	2.2	16.4	16.3	8.5	21.6	15.0	15.3	10.9	15.2	15.6	13.5	17.2	6.5	17.9	10.2	17.9	29.6	13.6	17.5	13.8	18.0
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726797-7881422	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.4"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 9.0;Ito cells: 19.0"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	8	"basophil: 4.0;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	21000	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	10.5	1.5	1.7	1.3	2.8	0.0	7.7	0.2	1.1	2.5	2.7			1.9	2.1	0.0	1.5	1.1	1.6	3.8	1.7	1.4	6.6	1.4	5.8	0.7	2.2		5.8	0.1	0.0	2.8	17.4		1.5	2.2		1.1	2.2	1.4	1.7	2.0	2.0	1.9	3.4	3.4	1.5			0.5		1.8	2.9	1.7	0.3	0.4	4.0	0.0	0.0	0.2	2.1	0.3	0.9	0.1	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.4	0.6	0.1	0.4	0.0	0.0	0.0	2.0	5.6	8.7	0.5	0.3	0.3	6.0	0.0	0.0	0.2	1.0	3.8	59.0	0.0	0.0	30.6	0.0	0.1	0.0	0.0	0.3	0.2	4.2	0.2	0.0	5.3	0.2	0.0	4.4	0.0	25.7	0.0	0.0	3.9	0.0	0.0	27.0	0.0	1.7	0.1	0.8	3.9	13.4	0.0	0.9	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.0	2.1											0.0	0.3	0.0	0.0	0.2	0.0	2.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.5	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	19.0	1.0	1.8	0.0	0.0	1.7	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910814	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Mucus-secreting cells: 19.0;Pancreatic endocrine cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.6;plasmacytoid DC: 17.5"	"Group enriched"	"Detected in many"	21	"B-cells: 9.6;dendritic cells: 17.5"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 162.2;U-266/84: 344.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		14000000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	20.2	15.7	3.7	42.1	6.3	6.0	61.9	4.6	6.8	28.8	69.8	7.5	18.3	35.0	28.3	20.9	25.3	21.5	30.2	28.6	4.4	5.2	23.2	96.2	24.5	117.9	5.9	4.3	26.1	63.3	7.9	10.6	22.4	7.2	17.6	29.0	10.9	71.5	29.1	10.1	9.9	33.6	16.3	7.5	84.2	36.8	12.3	5.2	6.4	18.0	19.8	48.2	35.8	21.7	9.6	17.5	0.0	0.5	0.0	0.6	0.3	9.5	9.4	6.5	22.0	56.8	24.3	10.7	21.5	21.0	15.0	16.3	14.0	7.1	10.1	38.0	33.0	16.6	7.6	11.6	10.6	17.1	8.6	9.9	15.5	8.2	25.2	16.6	17.5	15.5	16.6	15.6	14.3	15.8	33.2	80.3	6.4	9.6	73.9	10.2	8.5	4.1	10.6	8.6	15.1	20.5	7.3	9.5	162.2	12.1	8.7	10.2	5.5	27.7	16.9	12.1	32.5	8.6	7.7	22.0	17.2	12.0	14.7	22.7	86.2	344.1	17.9	8.8	11.1	23.5	0.0	0.2	0.0	0.6	0.5	0.5	9.6	0.1	0.4	0.7	3.3	0.1	0.3	0.0	0.0	0.0	17.5	0.5	0.3	3.7	6.3	4.6	6.8	4.4	5.2	5.9	4.3	7.2	5.2	0.0	4.5	0.0	0.0	0.8	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.8	0.0	8.2	0.1	0.7	1.0	23.3	9.2	1.2	1.7	0.4	1.1	2.4	1.3	0.0	4.7	5.5	1.5	0.0	0.0	0.3	3.3	1.0	19.0	0.0	10.3	0.0	0.4	0.2	0.2	6.5	0.4	0.0	0.1	0.1	1.0	0.0	7.0	0.1
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064414	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	12.2	13.9	10.1	11.0	11.1	4.8	14.1	8.8	8.9	12.0	9.7	9.0	6.4	5.9	14.3	10.5	10.7	9.2	8.2	9.7	7.6	7.0	23.2	14.7	8.0	11.8	10.3	6.0	14.2	8.8	17.2	8.6	9.2	7.4	12.0	7.8	10.6	9.6	13.6	11.3	10.3	10.0	13.4	12.4	12.0	9.2	8.2	9.2	24.1	14.6	7.2	13.8	12.1	10.4	15.7	14.8	16.9	11.2	15.1	15.2	11.4	3.7	3.9	8.7	11.2	9.6	12.0	5.9	4.0	5.6	5.8	5.7	8.1	3.5	12.7	27.4	5.0	6.5	3.4	6.4	3.1	8.2	12.6	6.9	7.6	3.0	14.7	8.6	13.0	8.8	5.3	8.1	5.8	8.7	8.9	10.2	10.4	15.5	2.3	8.1	4.0	15.1	8.6	4.7	8.7	5.6	12.5	10.0	20.0	10.8	3.2	8.2	4.3	4.1	6.2	12.3	16.5	7.8	6.8	4.4	9.1	6.6	5.3	3.4	10.3	20.6	11.5	3.7	10.7	9.3	13.6	9.0	16.9	11.5	11.2	14.8	15.7	14.8	14.6	14.8	14.8	15.2	15.1	2.1	15.1	6.1	6.0	13.0	11.4	10.1	11.1	8.8	8.9	7.6	7.0	10.3	6.0	7.4	9.2	11.9	5.8	5.2	7.4	5.4	6.7	6.3	0.0	9.4	7.9	24.4	2.0	9.5	29.9	8.0	7.3	10.6	4.2	0.0	7.5	8.4	6.9	7.4	16.1	0.0	6.9	6.4	1.7	0.0	0.0	5.7	8.9	8.4	3.3	7.2	7.5	10.9	7.8	2.9	11.7	28.5	8.3	0.0	6.2	6.1	12.8	6.6	6.9	6.1	6.8	5.7
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102578	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	10.5	21.8	20.1	14.2	26.9	34.0	18.5	20.0	24.6	10.8	12.2	13.5	12.3	8.2	13.6	19.2	15.9	10.3	9.5	12.5	19.4	27.0	34.9	19.2	9.9	19.7	26.9	16.2	10.8	26.6	19.8	28.6	11.7	41.2	12.5	15.2	9.6	13.5	13.4	14.4	8.4	8.4	13.3	21.3	11.8	14.8	36.3	19.4	9.9	13.9	15.8	20.3	11.6	9.3	20.9	29.6	6.8	15.0	14.0	21.3	13.5	28.1	14.9	24.0	16.5	7.9	13.3	14.6	23.7	15.0	21.4	22.1	24.3	11.8	30.9	52.3	15.4	39.2	11.7	27.1	27.3	36.1	17.3	35.3	24.9	19.7	42.2	14.7	49.3	18.4	11.1	25.8	25.5	26.5	15.0	30.2	25.5	59.5	8.6	20.4	11.8	21.1	40.1	21.6	27.5	24.0	25.9	14.1	48.5	35.0	21.7	35.7	11.1	10.1	22.8	28.2	33.9	18.1	17.0	15.6	17.9	17.7	16.2	34.3	13.5	61.1	43.9	10.0	20.9	28.4	6.2	11.0	6.8	13.5	15.0	19.1	20.9	18.1	17.8	29.6	20.5	20.3	20.6	1.1	14.0	11.2	13.0	21.3	13.5	20.1	26.9	20.0	24.6	19.4	27.0	26.9	16.2	41.2	19.4	14.9	28.8	28.9	35.2	58.5	35.8	20.7	15.3	33.5	37.5	57.6	9.8	71.1	119.3	54.7	233.2	31.6	7.7	23.3	76.4	54.8	31.5	42.5	15.1	26.4	44.1	28.6	38.5	23.4	30.6	155.8	24.5	35.1	40.5	22.6	35.3	32.1	63.6	7.0	22.3	129.8	16.8	12.9	36.0	118.9	83.7	66.6	27.0	27.3	39.8	36.5
SLC35B3	"C6orf196, CGI-19, dJ453H5.1, PAPST2"	ENSG00000124786	"Solute carrier family 35 member B3"	Q9H1N7	6	8413068-8435611	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054661, HPA057801"	Approved					NA	NA					"HPA054661: AB_2682561, HPA057801: AB_2683532"	"unprognostic (2.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.88e-3)"	12.2	12.1	12.1	11.3	22.6	4.0	13.7	11.4	15.8	14.2	23.5	12.5	27.0	16.0	11.9	43.2	12.4	10.9	16.3	12.3	13.5	10.2	18.5	22.2	12.6	12.5	20.0	11.9	10.2	22.0	17.6	16.0	18.7	15.9	14.6	24.7	8.5	19.0	35.4	6.4	13.0	27.1	10.8	20.5	16.4	18.3	9.6	17.5	13.1	20.1	10.0	13.3	15.9	14.9	10.4	9.7	10.2	13.7	19.7	13.0	8.8	11.3	7.5	8.4	12.9	19.3	24.9	6.2	26.0	21.4	9.7	12.9	23.0	10.0	8.8	16.9	19.5	14.2	7.9	8.0	7.2	15.6	13.6	8.6	4.3	5.4	11.5	19.5	7.6	10.4	18.5	11.1	11.0	11.7	13.7	12.9	6.3	9.7	3.6	19.7	9.0	4.9	9.1	5.6	13.0	8.1	4.8	7.2	10.0	23.3	11.4	8.0	6.5	7.8	5.6	12.6	22.5	4.8	13.3	13.0	17.0	4.8	10.9	12.3	9.7	17.3	6.0	8.8	7.2	20.2	10.2	10.1	9.1	10.6	8.9	13.0	8.2	11.1	11.4	9.7	10.4	12.9	10.8	9.5	19.7	13.7	4.6	12.0	8.8	12.1	22.6	11.4	15.8	13.5	10.2	20.0	11.9	15.9	17.5	6.0	11.7	8.1	11.9	11.9	4.2	8.8	15.3	26.8	10.3	27.9	3.9	18.1	6.6	17.9	5.2	15.8	24.7	0.0	21.6	24.2	23.9	20.6	5.8	22.4	17.4	9.5	14.3	19.0	15.5	5.9	14.4	10.1	20.3	17.2	40.9	5.1	15.7	35.3	11.3	22.6	2.7	12.9	18.6	32.1	17.7	15.4	13.7	8.7	28.3	18.2
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 130.5;retina: 48.1"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6"	"Region enhanced"	"Detected in single"		"cerebellum: 4.3"	"Region enhanced"	"Detected in single"		"cerebellum: 8.6"	"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.4	0.3	0.3	0.0	0.3	0.0	19.0	2.2	0.5	4.4	0.8	0.0	18.7	0.2	0.5	17.8	18.3	0.4	1.7	0.7	0.3	0.2	6.4	0.2	0.5	0.1	0.2	0.2	0.3	0.3	0.0	0.4	130.5	0.6	5.8	0.2	48.1	19.4	26.7	0.2	36.0	0.4	0.1	0.4	0.2	0.7	1.6	0.0	0.1	0.4	16.6	9.9	2.4	9.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	16.3	6.3	0.0	28.0	0.1	0.0	6.0	12.1	9.3	9.9	9.8	0.6	6.1	0.9	1.6	3.5	5.7	17.5	1.5	20.7	9.5	31.3	15.8	0.1	14.8	0.0	0.0	0.4	0.4	0.0	30.2	0.0	22.0	5.6	0.0	0.3	0.9	0.0	0.1	3.6	0.0	5.1	0.1	1.0	7.8	1.7	1.5	0.6	5.6	6.6	4.1	0.1	14.9	26.2	23.8	31.6	17.3	0.5	0.0	3.0	0.8	2.1	7.6	0.0	1.4	0.2	1.6	0.5	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.3	0.3	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	37.5	116.1	3.1	2.2	0.0	8.1	15.9	29.6	2.0	245.7	6.6	2.0	4.6	0.8	0.0	0.0	0.3	224.5	5.3	38.8	0.0	0.0	17.7	76.3	1.2	0.0	0.0	2.1	0.6	0.2	118.1	0.0	0.5	2.4	2.2	0.0	0.0	0.2	4.2	0.0	2.1	3.9	11.8	120.9	585.5	0.0	0.4	39.3
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 71.5;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2"	"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.2	2.4	26.4	0.0	1.8	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.9	11.0	0.0	1.1	3.0	0.0	0.0	0.3	0.0	1.7	7.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	4.0	0.0	2.4	0.1	2.4	3.8	9.4	2.3	2.6	1.8	0.0	9.2	8.9	10.2	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.6	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9	71.5	26.7	12.3	5.5	4.0	4.3	14.9	2.5	30.8	28.4	7.0	0.0	22.4	10.0	2.4	3.3	5.8	28.4	23.3	22.4	1.0	1.1	21.1	2.3	31.1	12.9	3.2	2.4	8.6	6.3	6.0	0.3	6.9	47.2	9.0	2.8	2.9	9.0	1.7	0.0	8.8	0.5	0.0	0.4	1.9	20.4	1.5	9.2	0.0	7.2	7.0
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 17.7"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 33.5;Early spermatids: 33.2;Late spermatids: 22.3;Spermatocytes: 32.4;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 8.7;NB-4: 7.7"					"Low region specificity"	"Detected in all"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"		No	No			"Nuclear speckles"	"Intermediate filaments"	"HPA051142: AB_2681359"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.6	2.4	5.6	1.4	4.8	0.9	3.0	2.7	4.3	1.2	1.5	4.4	5.5	7.7	1.4	9.0	0.9	8.0	1.2	0.7	4.9	5.3	3.8	1.4	1.7	1.1	4.5	3.2	1.9	7.7	1.5	2.9	1.5	4.4	3.1	1.0	0.7	1.8	1.7	1.2	2.5	2.1	0.9	4.0	1.0	1.6	17.7	2.6	1.6	2.1	1.0	1.6	1.0	2.0	0.7	1.0	4.7	1.0	1.4	6.2	0.6	1.1	2.7	2.5	2.2	0.9	0.0	4.4	0.2	0.1	0.3	0.6	3.0	2.4	0.1	4.0	0.0	2.9	0.2	2.4	0.0	1.0	1.4	4.2	0.6	0.5	0.4	0.0	0.8	0.4	0.5	3.9	1.1	1.5	0.3	0.0	2.5	4.7	0.3	1.1	8.7	1.8	7.7	2.3	1.6	3.0	1.5	0.2	1.0	1.2	0.6	5.0	3.1	0.9	0.6	4.9	2.6	0.2	1.5	0.4	2.0	0.7	1.5	1.8	3.6	7.5	1.5	3.5	1.1	1.9	0.0	0.5	4.7	1.2	1.0	0.4	0.5	1.5	1.3	1.0	0.7	0.7	0.6	0.6	1.4	0.7	0.8	6.2	0.6	5.6	4.8	2.7	4.3	4.9	5.3	4.5	3.2	4.4	2.6	0.0	2.4	0.0	1.7	1.3	1.8	0.5	2.5	33.5	1.2	3.5	2.0	2.4	5.0	3.1	33.2	1.0	1.1	0.0	5.3	2.1	1.5	1.5	0.0	1.6	1.0	1.6	2.9	2.5	0.3	22.3	2.0	0.7	3.3	2.8	0.5	3.8	2.8	2.9	0.0	8.1	0.6	0.0	2.1	32.4	23.4	1.3	1.1	0.0	1.8	0.7
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694695-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 48.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	12.8	9.9	12.0	12.2	9.7	11.5	15.9	9.1	15.7	12.7	8.7	5.8	7.7	5.9	10.5	9.9	15.7	8.7	7.2	8.6	9.2	9.8	12.3	17.5	7.2	16.3	10.9	9.2	13.8	10.6	6.8	9.1	9.1	11.3	48.8	9.8	4.2	10.3	10.4	20.6	7.8	6.8	10.5	10.1	10.9	7.4	6.3	9.9	8.4	9.3	18.5	11.7	8.2	9.1	8.4	11.5	2.4	10.3	8.1	12.3	5.8	14.3	5.6	7.3	12.7	9.2	8.4	10.6	9.4	7.8	14.3	14.1	12.4	6.4	14.5	23.6	8.0	17.9	7.7	15.0	12.1	20.6	8.5	10.1	8.0	5.3	14.2	13.5	22.1	10.5	7.7	10.6	13.9	23.6	4.8	9.5	8.0	24.1	4.2	11.8	8.5	11.0	20.3	16.0	13.4	10.1	11.5	9.6	22.5	10.3	8.6	11.1	9.6	7.0	18.1	20.1	13.0	8.0	8.0	8.2	11.6	8.3	12.4	23.2	10.0	27.3	15.9	4.7	14.9	21.7	1.1	7.1	2.4	8.4	10.3	8.6	8.4	7.6	8.4	10.0	6.4	10.2	12.3	0.3	8.1	8.0	11.5	4.8	5.8	12.0	9.7	9.1	15.7	9.2	9.8	10.9	9.2	11.3	9.9	17.9	10.5	28.3	38.3	59.0	12.9	16.6	17.8	22.7	36.4	10.4	3.9	22.4	16.6	36.8	10.2	17.7	5.4	0.0	23.3	24.5	23.5	36.7	34.6	18.1	32.0	12.7	5.2	16.0	9.9	8.3	19.8	14.9	11.8	19.0	10.5	11.8	25.6	3.5	19.4	17.9	10.1	6.5	25.9	23.4	49.7	43.5	14.6	12.5	19.9	26.0
TMEM14C	"bA421M1.6, C6orf53, HSPC194, NET26"	ENSG00000111843	"Transmembrane protein 14C"	Q9P0S9	6	10722915-10731129	"Predicted membrane proteins"	"Heme biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (4.08e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.34e-1)"	39.3	53.3	29.5	16.6	27.0	37.2	34.3	21.9	33.7	39.4	44.7	30.1	34.3	33.5	40.5	40.4	38.4	35.5	37.5	53.6	24.5	29.2	53.6	57.3	26.3	22.8	32.7	23.7	38.1	46.6	23.4	22.3	41.6	27.8	45.4	24.1	39.9	57.8	39.2	49.2	22.7	45.6	31.3	30.0	25.9	31.2	22.1	23.4	18.6	58.3	36.5	29.0	37.2	29.3	13.1	28.3	26.8	16.5	11.5	14.0	11.5	33.8	19.5	14.0	20.9	30.0	29.4	15.1	20.2	27.8	20.9	22.8	19.0	25.1	22.2	44.3	21.4	44.2	16.3	8.6	24.4	12.2	14.9	14.3	14.2	18.4	25.2	38.4	10.8	10.7	31.9	23.6	17.9	27.9	22.2	10.6	6.0	34.9	8.3	23.8	17.9	7.7	26.0	17.4	15.2	20.8	14.1	20.1	35.2	26.6	11.2	13.4	16.1	19.9	28.0	33.9	24.8	20.0	12.8	28.9	30.5	18.1	12.7	30.0	19.9	34.8	10.0	17.2	14.4	31.5	14.8	16.5	26.8	4.8	15.4	14.0	13.1	11.8	7.0	28.3	10.1	11.5	9.6	1.5	11.5	13.4	26.2	12.7	11.5	29.5	27.0	21.9	33.7	24.5	29.2	32.7	23.7	27.8	23.4	107.2	58.1	60.2	119.5	88.4	41.2	115.1	152.8	105.7	113.7	148.3	7.9	201.0	228.8	170.8	4.3	120.3	160.8	210.2	121.6	231.4	158.6	163.7	136.0	132.0	323.4	15.9	117.7	94.5	107.4	7.8	166.0	187.1	183.9	408.4	155.6	149.9	165.2	175.4	179.3	249.3	37.2	174.6	131.3	31.5	59.3	100.9	163.3	48.9	192.6	120.7
TMEM14B	MGC1223	ENSG00000137210	"Transmembrane protein 14B"	Q9NUH8	6	10747759-10852753	"Predicted membrane proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (5.45e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (5.45e-1)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	30.0	47.6	31.7	17.5	33.3	63.8	31.8	24.4	38.4	23.0	24.6	25.9	24.7	21.7	23.0	30.2	24.1	31.1	21.5	53.0	27.3	26.8	42.8	58.3	18.5	25.8	28.7	21.8	25.4	34.9	16.9	20.2	27.2	31.8	28.1	25.4	37.9	44.6	20.0	54.1	18.7	35.7	20.5	25.7	27.3	26.7	15.3	20.2	36.5	53.7	34.8	31.6	19.1	18.4	48.0	64.6	57.7	43.2	40.8	54.7	53.0	72.3	32.0	14.6	21.8	16.4	21.2	22.8	15.2	26.9	32.8	39.0	31.6	34.7	26.4	38.3	18.0	76.5	16.4	13.0	26.3	51.4	16.9	19.4	21.5	27.7	45.5	24.5	32.3	20.8	17.2	15.3	35.2	35.1	18.7	18.1	23.9	53.1	10.9	26.4	28.4	28.3	39.5	22.5	38.1	25.0	23.5	21.0	61.2	38.9	19.7	25.6	18.9	19.3	38.4	47.6	29.4	27.6	27.9	18.3	25.4	30.5	16.9	52.1	25.7	54.6	34.0	20.4	18.1	38.0	50.0	43.2	57.7	35.6	39.8	48.5	48.0	49.2	40.2	51.7	44.9	54.7	45.4	24.1	40.8	42.3	64.6	51.5	53.0	31.7	33.3	24.4	38.4	27.3	26.8	28.7	21.8	31.8	20.2	74.5	54.4	90.3	74.6	72.8	83.2	130.8	147.7	235.5	76.2	83.7	56.9	155.7	310.0	144.5	13.8	83.9	81.4	210.2	192.6	152.4	109.4	140.9	80.8	138.6	178.9	101.7	77.4	58.3	98.5	36.4	89.2	113.2	114.7	329.2	133.8	116.3	188.8	87.7	70.7	244.0	134.7	25.8	77.3	40.8	119.3	88.1	88.6	88.8	159.5	94.9
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 347.5;Early spermatids: 112.5;Rod photoreceptor cells: 298.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	2.9	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.6	0.0	0.6	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.1	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.4	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7	0.0	5.4	0.0	2.4	0.3	11.3	0.6	0.0	57.6	7.9	3.5	347.5	0.4	0.0	0.3	112.5	1.1	0.0	0.0	0.2	0.7	0.4	1.2	2.3	0.0	0.2	4.8	0.0	1.3	0.0	27.7	0.6	0.9	1.7	0.0	0.0	15.7	0.1	0.0	0.4	0.0	298.8	0.0	1.0	7.0	6.0	0.4	0.7	0.0	0.0	0.8
GCM2	"GCMB, hGCMb"	ENSG00000124827	"Glial cells missing homolog 2"	O75603	6	10873223-10881941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"parathyroid gland: 110.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;HMC-1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (1.55e-1)"					"unprognostic (4.94e-1)"				"unprognostic (2.18e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 54.0"	"Cell type enhanced"	"Detected in some"	10	"Early spermatids: 10.8;granulocytes: 10.4;Spermatogonia: 8.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 7.6;granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.1;HMC-1: 28.4;K-562: 7.1;NB-4: 9.7;SuSa: 6.0;THP-1: 7.3"									HPA034679			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.9	0.4	0.9	0.8	1.0	0.7	0.7	2.6	1.5	0.5	1.1	0.8	3.7	0.4	1.1	8.9	0.6	0.5	0.7	3.0	0.8	0.7	1.6	0.4	10.1	0.5	1.0	0.5	1.5	5.5	54.0	0.7	4.0	0.6	0.8	0.4	2.9	1.2	0.5	1.9	0.6	0.3	0.5	0.9	0.6	0.4	5.1	0.6	0.7	2.5	0.0	2.2	0.5	0.3	0.0	7.6	5.5	0.3	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	9.1	28.4	0.0	0.6	0.0	0.0	0.1	0.0	0.3	7.1	0.0	0.0	0.0	2.3	9.7	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.4	2.5	0.0	2.4	0.0	6.0	0.1	7.3	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	2.9	0.1	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.9	1.0	2.6	1.5	0.8	0.7	1.0	0.5	0.6	0.6	0.0	2.2	0.0	0.0	0.1	2.4	0.3	0.0	1.4	0.0	0.0	0.0	2.1	0.0	0.1	10.8	0.1	0.0	0.0	0.2	1.6	0.3	0.3	10.4	0.0	0.4	3.2	0.0	0.0	0.0	2.3	1.1	0.9	0.0	0.0	0.0	0.5	0.6	0.0	1.4	0.0	0.0	0.0	0.0	3.9	8.1	0.0	1.1	0.0	0.0	0.1
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.2	0.0	0.0	0.0	6.4	0.2	0.5	9.9	17.0	0.0	0.0	0.0	0.0	0.6	17.5	0.0	11.7	0.0	16.4	0.0	10.1	0.1	0.2	12.5	0.5	0.2	2.7	0.1	0.0	7.6	0.0	0.6	0.0	0.5	0.6	0.0	0.2	0.0	6.4	0.1	2.1	0.0	9.6	8.9	17.8	0.0	0.0	0.1	4.5	5.1	0.0	0.0	4.1	9.5	2.0	5.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	5.1	0.0	0.0	0.0	27.5	1.6	0.0	4.8	8.6	0.7	0.0	0.0	0.8	17.8	7.2	2.1	0.0	13.2	1.1	0.0	0.0	0.0	0.0	12.4	0.9	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.4	0.0	10.2	19.4	0.3	12.1	7.9	0.0	1.4	0.0	0.0	0.0
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11094033-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: AB_2685539"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	5.7	4.2	7.5	2.8	13.0	2.0	4.5	13.3	26.4	4.3	3.2	7.7	1.1	3.1	4.6	3.2	8.5	3.0	3.7	5.7	6.5	2.8	3.9	8.7	5.2	2.3	9.5	8.3	3.8	3.2	7.6	2.8	11.4	14.3	4.3	3.3	2.8	5.3	4.6	9.1	13.7	3.9	4.7	4.9	5.1	3.4	9.4	8.1	1.7	3.9	2.1	2.6	3.3	4.9	0.5	2.4	1.3	0.4	1.2	1.0	0.4	5.7	5.0	7.8	6.5	8.1	9.2	8.1	16.2	7.0	8.4	9.4	6.6	1.9	7.3	22.1	5.2	8.3	5.1	16.1	5.7	15.1	4.0	11.7	7.5	5.6	5.2	10.8	13.9	1.8	11.0	15.9	8.6	11.3	6.6	8.8	6.6	10.6	3.0	15.8	3.2	5.9	8.1	3.6	3.9	4.4	7.9	14.3	10.1	5.1	4.6	18.1	10.0	3.4	11.2	18.9	11.3	2.7	5.8	12.5	12.7	9.2	5.2	10.8	5.6	18.7	10.4	3.0	5.9	19.4	1.3	0.3	0.3	1.0	0.4	0.8	0.5	0.4	0.5	0.6	0.3	0.1	0.9	0.1	1.2	0.3	2.4	0.6	0.4	7.5	13.0	13.3	19.6	6.5	2.8	9.5	8.3	14.3	8.1	11.9	1.0	11.2	14.5	66.6	17.0	10.5	5.1	1.4	2.3	10.4	19.6	24.9	3.3	4.9	6.3	10.5	4.0	0.0	6.5	30.2	12.4	11.5	10.4	20.8	12.3	28.6	3.5	7.4	5.3	3.8	2.6	9.5	15.1	4.6	6.9	7.1	7.9	3.5	3.9	6.6	13.9	0.0	10.3	11.3	17.0	34.5	54.5	6.9	7.4	14.0
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111732	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 66.9"	"Cell type enriched"	"Detected in some"	52	"Syncytiotrophoblasts: 481.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"SuSa: 30.4"															NA	NA						"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	1.4	2.0	0.1	0.1	0.1	0.1	0.8	0.2	0.2	0.5	0.8	0.1	0.1	0.3	1.3	0.8	0.7	0.2	0.5	0.5	0.1	0.0	1.5	0.7	1.5	1.0	0.1	0.1	0.1	0.1	15.8	0.1	66.9	0.1	1.2	0.2	0.7	0.9	0.5	0.1	0.9	1.9	0.8	0.1	0.1	1.0	0.3	0.1	0.6	0.2	0.9	0.3	1.5	2.2	0.5	0.0	0.3	0.1	2.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.7	0.4	0.3	2.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	9.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	481.3	0.0	0.0	0.0
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 72.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 437.7;Basal glandular cells: 247.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 49.8;HSkMC: 24.9"	"Low region specificity"	"Detected in all"							"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	72.8	4.7	4.5	14.9	5.6	3.3	35.7	2.2	5.9	14.0	16.6	5.1	14.2	7.1	17.3	21.7	10.3	11.5	15.3	17.3	4.6	4.1	34.6	9.5	58.4	15.0	4.9	3.9	11.1	7.9	4.2	6.1	32.6	6.6	13.4	14.7	12.8	15.4	15.4	22.4	12.3	17.9	12.4	5.3	25.7	10.9	12.2	4.3	18.8	15.8	6.8	18.6	17.6	9.9	5.8	6.0	34.8	19.8	5.1	8.3	6.3	1.5	10.2	9.5	0.1	6.5	0.8	10.0	2.3	2.9	4.4	8.1	3.2	0.6	3.2	49.8	5.1	0.5	4.4	12.7	4.7	5.7	1.4	0.3	0.3	1.5	21.4	3.0	3.4	0.2	24.9	1.4	2.8	0.5	1.6	7.4	0.2	0.0	2.7	9.8	0.4	1.9	1.3	1.4	11.9	1.0	0.5	0.2	1.8	2.2	13.9	0.2	1.7	0.4	11.2	19.3	11.0	0.8	2.6	18.8	3.0	5.3	0.3	5.7	2.8	11.5	3.9	0.0	2.7	12.9	9.1	5.5	15.4	8.3	12.2	6.8	5.0	5.6	8.0	6.0	5.8	3.0	4.7	34.8	5.1	19.8	3.7	5.0	6.3	4.5	5.6	2.2	5.9	4.6	4.1	4.9	3.9	6.6	4.3	437.7	110.8	20.8	247.6	53.8	4.8	7.3	53.5	97.7	139.9	41.8	23.6	41.8	8.3	54.6	6.0	101.8	77.5	0.0	17.3	34.2	31.7	54.5	61.4	16.3	13.3	9.5	103.9	91.4	24.8	2.9	6.9	22.9	23.6	1.8	90.0	104.5	46.5	35.1	27.3	20.3	12.2	25.8	25.0	1.1	0.5	18.1	35.8	41.5	37.6	69.7
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11538278-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"bone marrow: 31.1"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 23.8;Kupffer cells: 40.6;Macrophages: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 18.2;U-937: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	10.1	4.8	11.7	6.4	9.6	31.1	6.1	13.5	18.6	3.1	3.3	4.9	2.0	1.6	4.1	5.2	2.5	2.8	3.0	4.5	10.1	8.8	5.9	12.8	8.8	3.5	8.3	8.7	3.9	3.3	5.8	4.2	4.0	8.4	3.4	2.2	4.2	2.5	3.7	8.3	1.8	2.0	4.7	8.2	5.7	2.4	5.2	6.0	4.2	4.4	1.2	2.2	2.7	3.1	0.2	3.2	2.4	2.9	0.1	0.3	0.5	0.7	1.2	7.5	6.7	1.4	0.1	1.5	0.6	1.7	1.0	1.2	0.4	0.4	5.9	3.4	0.4	1.9	0.0	8.4	0.5	2.7	1.6	4.3	3.3	0.8	1.0	0.5	5.3	3.5	0.5	0.1	1.1	0.0	1.7	0.7	5.6	0.2	0.1	1.5	1.1	6.3	9.2	2.1	0.7	1.0	3.2	7.2	0.9	0.8	1.5	5.1	4.4	0.4	2.4	2.7	11.2	2.4	18.2	0.1	1.4	1.6	2.8	1.7	5.2	10.4	5.3	1.2	13.6	1.8	2.4	2.9	1.5	0.2	1.6	0.1	0.0	0.1	0.1	1.8	0.2	0.3	0.2	1.1	0.1	0.6	3.2	0.0	0.5	11.7	9.6	13.5	13.5	10.1	8.8	8.3	8.7	8.4	6.0	3.0	1.3	0.5	0.7	1.5	12.0	5.2	2.5	0.0	2.3	0.0	3.9	1.8	5.0	0.6	0.4	1.4	0.0	0.0	1.2	0.3	2.3	1.0	1.1	5.8	6.6	23.8	1.7	1.8	40.6	0.2	0.9	21.8	0.0	1.0	0.5	11.8	0.9	0.0	1.4	4.5	8.4	6.5	1.2	5.4	4.6	0.6	1.6	1.7	0.6	0.4
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.7	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.5	0.3	1.6	0.8	0.0	0.7	0.3	1.1	0.7	0.0	4.8	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.9	3.6	10.5	7.5	35.9	0.2	8.6	0.0	1.2	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.1	13.5	0.7	0.1	0.0	0.1	0.6	0.0	0.3	1.3	0.0	0.3	19.4	12.9	0.9	0.3	1.0	0.5	15.2	0.0	2.7	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1	0.0	1.4	1.5	0.2	4.5	0.0	0.0	0.0	0.0	3.4	5.2	0.0	0.1	44.7	0.7	109.7	0.1	113.2	23.3	2.2	0.1	1.0	0.5	5.7	0.0	8.9	0.0	5.2	0.0	0.3	127.1	1.7	1.3	1.7	47.7	36.6	0.0	5.0	73.7	0.7	0.0	0.0	0.0	1.0	1.5	0.8	5.0	0.1	5.7	46.8	0.4
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"Human immunodeficiency virus type I enhancer binding protein 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	22.3	5.5	6.4	20.1	5.6	20.5	13.1	8.0	10.0	11.5	12.6	5.4	13.9	7.0	10.0	10.6	12.9	9.2	10.6	8.8	5.6	7.1	7.3	17.1	13.3	12.4	5.3	6.7	11.6	11.7	23.3	12.2	8.7	7.8	10.5	9.5	7.7	10.9	17.6	8.2	14.1	11.8	12.9	5.9	15.2	7.2	7.3	5.0	23.8	7.7	14.2	16.2	17.3	23.1	5.6	9.6	12.9	4.9	3.6	4.6	0.7	5.2	3.9	5.1	2.8	4.0	5.2	4.9	4.3	3.7	3.6	3.9	2.5	2.8	4.4	9.4	5.2	8.5	5.1	5.0	6.1	4.9	9.5	2.9	2.0	3.7	2.4	3.3	2.3	1.7	3.6	6.2	7.2	11.2	7.5	10.4	3.0	21.1	5.1	7.7	3.9	3.8	2.1	4.3	1.8	2.0	2.1	6.6	6.9	2.1	5.8	4.8	3.5	10.6	8.7	3.0	11.9	5.1	3.1	16.8	9.0	4.0	8.3	4.9	20.5	17.1	7.9	2.7	3.1	3.7	2.4	2.2	2.2	1.4	2.2	1.0	3.4	2.3	0.9	1.3	5.6	4.0	2.3	12.9	3.6	4.9	9.6	4.6	0.7	6.4	5.6	8.0	10.0	5.6	7.1	5.3	6.7	7.8	5.0	26.8	19.2	6.5	21.7	28.6	19.2	7.4	10.2	22.7	26.1	7.0	11.8	2.9	3.3	4.8	2.1	15.5	11.3	0.0	6.3	1.8	12.7	18.9	7.0	11.4	4.9	20.6	10.4	7.4	8.5	1.5	3.4	19.0	18.6	45.9	12.5	13.2	8.5	9.7	4.2	2.7	9.1	0.0	13.4	3.6	3.1	29.2	4.3	7.5	7.1	23.3
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290363-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 804.7;Ductal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	35.7	1.5	8.4	6.2	30.8	3.6	19.2	3.2	22.0	8.2	9.2	4.2	1.1	9.0	7.2	15.3	10.8	8.6	11.9	5.2	19.0	6.2	5.7	2.8	25.1	6.7	10.9	5.5	4.3	8.2	1.6	1.0	16.0	25.1	5.4	12.9	6.9	9.7	8.5	25.6	8.2	6.7	9.7	13.5	10.2	6.8	4.8	5.6	0.2	2.9	3.8	2.1	5.3	4.1	0.2	0.2	1.2	7.9	0.0	0.2	0.0	1.6	9.2	0.1	0.0	0.0	0.0	0.0	2.9	2.6	2.4	2.0	11.9	1.4	0.0	109.7	1.1	1.5	0.8	0.0	1.7	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.4	0.3	0.7	72.7	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.1	1.6	0.1	0.0	0.8	0.0	5.8	1.5	0.1	0.0	0.3	8.7	0.0	20.3	22.4	0.1	53.8	6.2	4.9	0.1	3.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	7.9	0.1	0.0	0.0	8.4	30.8	3.2	22.0	19.0	6.2	10.9	5.5	25.1	5.6	160.8	31.6	0.8	804.7	168.7	0.0	2.0	5.1	0.0	46.6	36.6	0.0	1.4	3.3	273.4	11.4	170.8	145.3	0.0	195.7	0.6	8.2	167.4	1.1	0.8	1.7	1.6	15.0	109.2	6.3	10.0	5.2	3.6	8.5	19.0	12.9	0.2	217.0	147.3	0.4	5.7	0.0	6.5	6.2	1.1	0.4	56.3	0.7	5.7	34.9	116.8
PHACTR1	"dJ257A7.2, KIAA1733, RPEL1"	ENSG00000112137	"Phosphatase and actin regulator 1"	Q9C0D0	6	12716805-13290484	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;brain: 80.3"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 134.6;Horizontal cells: 170.0;Kupffer cells: 97.1;Macrophages: 102.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 80.3"	"Group enriched"	"Detected in many"	13	"memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9"	"Group enriched"	"Detected in many"	17	"B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.7;SK-MEL-30: 15.7;U-266/70: 41.2;U-266/84: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029755, HPA029756, HPA029757"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870"	"unprognostic (7.86e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-4)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.16e-1)"	3.5	1.6	11.6	7.2	80.3	22.6	1.6	4.9	31.4	1.4	1.4	1.3	0.3	2.0	1.3	2.6	1.5	1.9	4.2	9.2	10.9	4.4	3.9	1.9	9.0	8.7	2.7	16.6	1.8	4.2	0.5	6.0	1.7	2.2	1.4	1.5	0.6	1.4	0.7	1.2	2.6	2.9	1.7	2.6	6.5	2.0	2.2	7.2	0.4	1.3	0.0	13.4	3.4	1.4	20.9	25.9	10.1	1.1	0.4	0.2	1.1	0.0	0.1	1.1	0.2	0.0	0.0	3.2	0.3	1.2	1.2	2.1	0.1	0.0	0.2	0.4	0.1	1.6	0.1	0.0	0.0	1.5	4.2	0.3	8.4	0.1	0.1	0.1	7.9	16.7	0.4	0.0	0.0	0.1	0.1	1.5	0.5	3.9	7.1	1.2	0.0	0.1	6.1	1.1	0.0	0.0	4.0	2.2	0.7	1.0	0.1	5.0	1.5	0.0	3.2	15.7	1.6	9.6	1.9	1.7	0.1	0.3	0.0	0.0	41.2	26.8	7.0	0.6	2.3	6.4	0.1	1.1	0.6	0.1	0.9	0.0	7.2	0.1	0.0	7.7	20.9	0.1	0.2	10.1	0.4	0.3	25.9	0.0	1.1	11.6	80.3	4.9	31.4	10.9	4.4	2.7	16.6	2.2	7.2	62.5	37.4	134.6	1.5	3.3	35.3	9.1	2.5	9.4	14.8	59.3	3.9	1.2	26.6	0.6	54.5	8.3	0.4	0.0	2.5	2.0	6.2	0.8	80.7	0.8	76.1	170.0	1.7	15.4	97.1	44.3	4.4	102.6	45.5	18.0	0.1	21.8	1.0	0.0	6.0	0.6	13.0	0.0	4.0	1.2	2.7	2.8	1.6	2.5	0.4	0.7
TBC1D7	"dJ257A7.3, FLJ32666"	ENSG00000145979	"TBC1 domain family member 7"	Q9P0N9	6	13266542-13328583	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034748	Approved					NA	NA					"HPA034748: AB_10671232"	"unprognostic (9.53e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-3)"	"unprognostic (5.54e-2)"	"unprognostic (9.30e-2)"	"prognostic favorable (4.98e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.78e-2)"	8.8	11.8	14.9	13.2	14.3	21.9	13.7	17.5	19.3	10.7	14.7	12.9	10.0	14.2	8.7	20.9	15.8	6.4	10.4	30.4	14.7	13.6	21.2	16.1	13.2	12.3	14.5	13.5	7.6	10.6	7.5	14.1	14.1	14.1	12.9	16.8	17.7	11.6	10.1	13.5	12.4	10.5	10.1	12.8	11.4	9.2	12.4	11.9	19.4	7.8	14.7	14.8	10.7	10.2	8.7	23.0	23.5	12.0	11.1	7.6	5.6	6.6	6.6	9.5	9.7	7.4	4.3	6.6	2.9	3.4	6.4	7.2	13.3	6.0	4.6	20.0	4.9	14.9	5.4	6.4	7.5	5.8	7.2	7.6	12.8	4.5	11.6	17.3	8.2	19.6	5.8	10.7	7.9	5.1	6.4	10.6	14.9	14.3	6.2	8.0	10.8	10.5	19.9	6.4	8.3	6.4	15.7	4.1	19.6	14.2	9.1	18.5	8.2	7.4	14.6	80.5	19.9	14.1	4.9	7.6	6.6	8.2	3.6	4.1	14.8	42.9	21.9	6.2	8.7	13.3	12.5	12.0	14.0	6.7	10.2	4.3	8.7	5.7	5.9	23.0	7.9	5.3	6.4	23.5	11.1	7.2	22.6	7.6	5.6	14.9	14.3	17.5	19.3	14.7	13.6	14.5	13.5	14.1	11.9	11.9	15.2	14.0	8.2	6.6	6.1	22.7	10.2	6.7	6.8	15.7	3.9	36.1	28.2	14.9	6.9	7.9	9.5	23.3	12.6	18.5	8.0	10.1	9.2	13.2	21.5	9.5	8.6	9.2	15.1	3.8	4.0	20.6	10.1	18.0	18.8	6.5	17.8	17.3	4.9	39.8	8.2	12.9	7.2	12.8	33.5	7.9	39.2	8.7	15.7	11.3
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.8;NK-cell: 11.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;NK-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HEL: 18.8;HMC-1: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	15.7	3.8	9.4	4.6	11.5	17.5	8.7	28.5	22.3	5.4	5.0	4.0	0.5	3.5	4.0	2.6	12.1	4.3	11.8	18.5	11.9	7.1	2.1	6.6	8.2	6.6	6.3	14.2	1.7	2.3	3.9	3.3	6.8	6.6	4.4	5.2	1.5	3.4	3.0	15.5	4.7	5.6	8.3	4.2	12.0	8.2	1.5	4.1	1.9	3.9	4.5	6.9	4.7	7.6	2.3	0.2	12.8	0.8	11.4	1.4	0.8	7.4	0.7	0.6	1.3	1.1	1.1	0.8	0.6	0.3	0.4	0.2	0.2	0.5	10.2	10.6	0.7	0.6	6.6	2.0	3.2	0.4	0.7	3.8	18.8	3.9	3.9	1.5	5.4	29.1	0.6	2.5	1.0	2.8	1.6	5.7	2.7	0.6	0.9	0.8	2.4	1.2	3.3	1.0	2.5	2.2	4.1	1.4	5.2	0.3	1.4	3.5	0.6	2.5	0.4	2.4	1.4	0.6	0.5	7.7	0.9	2.0	2.2	3.3	8.5	4.8	12.2	0.8	3.2	0.2	0.1	0.4	12.8	1.4	0.7	0.2	2.3	0.2	0.6	0.2	1.9	0.1	0.5	0.3	11.4	0.8	0.0	0.1	0.8	9.4	11.5	28.5	18.7	11.9	7.1	6.3	14.2	6.6	4.1	0.0	2.6	12.7	4.9	18.0	38.9	87.7	12.7	12.0	0.0	0.0	0.0	0.4	0.0	4.3	0.0	36.2	13.5	46.7	2.7	27.6	5.8	2.3	4.6	16.8	2.4	1.6	8.1	33.2	15.8	0.0	2.3	10.4	11.8	0.0	11.8	2.0	18.1	31.7	1.1	0.5	3.0	12.9	20.8	0.0	1.7	19.6	0.6	34.8	3.3	4.7
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574529-13615158	"FDA approved drug targets, Predicted intracellular proteins"		Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 47.2;Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	5.9	6.2	8.8	6.8	10.4	5.9	9.2	11.1	13.5	4.9	7.2	6.4	12.5	8.1	6.8	6.7	5.7	8.0	6.6	22.9	8.5	8.3	9.9	29.9	9.8	6.9	9.5	6.9	8.8	10.5	12.9	7.6	5.3	8.3	6.5	8.3	6.2	8.6	8.7	25.8	8.8	8.5	6.2	6.9	9.5	7.6	6.6	6.1	7.5	8.5	7.0	6.5	6.8	6.0	9.2	4.6	10.9	9.3	7.3	10.0	5.6	5.8	4.6	5.9	7.6	3.7	4.8	4.4	3.0	3.2	3.3	5.0	7.3	7.0	8.4	18.3	2.4	7.3	9.5	4.1	5.9	5.0	3.8	6.8	5.3	4.2	11.8	6.1	4.3	4.6	5.2	12.1	2.9	10.4	7.2	6.0	11.9	7.5	3.2	3.9	7.1	4.7	8.5	4.9	9.1	7.3	8.4	3.8	15.3	6.8	6.4	9.7	3.5	3.4	5.9	13.4	16.7	6.8	2.8	5.3	5.1	2.9	3.1	3.3	7.8	8.8	5.7	2.9	4.3	4.8	0.5	4.5	10.9	8.1	6.1	8.2	9.2	10.0	7.9	4.6	9.1	9.5	8.5	1.5	7.3	9.3	4.6	7.2	5.6	8.8	10.4	11.1	13.5	8.5	8.3	9.5	6.9	8.3	6.1	26.8	2.7	9.1	9.2	3.7	6.4	47.2	10.2	21.4	17.0	10.4	0.0	17.1	44.7	10.5	2.2	8.7	9.6	23.3	6.0	9.0	4.9	5.7	0.0	22.2	8.5	1.6	5.8	10.4	10.4	0.5	7.5	6.1	5.0	5.4	12.6	8.4	6.7	13.9	5.3	24.0	6.2	0.0	5.0	6.5	7.8	4.0	8.9	6.9	16.5	7.3
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615327-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	35.8	40.5	45.2	41.4	42.3	44.9	36.6	26.7	38.7	30.5	36.7	25.9	29.2	37.2	35.2	36.7	38.6	33.0	36.6	53.4	39.9	38.4	56.9	58.6	28.8	36.6	41.6	30.2	42.4	42.6	54.0	40.5	45.6	36.8	39.5	32.4	23.1	42.3	35.6	59.3	30.6	46.4	36.7	47.7	45.2	34.8	32.5	40.4	34.3	49.5	36.9	36.0	43.3	56.0	50.7	45.5	38.3	38.0	28.8	49.6	30.9	29.8	15.5	14.6	21.0	11.4	13.2	29.7	27.4	14.9	25.7	24.4	29.4	12.6	38.5	54.3	16.6	31.4	18.5	22.0	20.7	25.2	21.6	36.0	33.1	15.4	49.4	24.5	49.1	26.1	12.4	21.8	23.5	14.5	13.4	16.7	21.7	51.3	10.5	22.2	19.2	27.9	54.5	19.1	17.5	26.6	30.2	20.8	59.2	25.6	9.9	37.2	23.9	16.0	38.8	35.8	19.0	24.1	17.9	25.3	23.7	22.3	24.3	48.1	24.6	47.7	47.0	13.6	29.1	35.8	16.0	30.2	38.3	31.0	35.3	36.6	50.7	45.5	38.3	35.9	41.4	49.6	37.8	14.0	28.8	38.0	45.5	46.9	30.9	45.2	42.3	26.7	38.7	39.9	38.4	41.6	30.2	36.8	40.4	86.4	58.0	93.0	81.6	80.6	62.4	203.3	63.7	148.5	80.8	54.1	21.6	114.5	104.5	133.3	133.2	97.2	61.4	70.0	226.4	127.6	86.4	80.3	87.8	56.9	100.9	46.1	35.6	46.6	45.5	19.9	76.5	83.5	96.2	155.9	59.8	89.8	148.3	72.9	74.6	135.1	46.0	64.7	96.7	142.1	122.5	79.2	129.9	82.8	73.6	94.7
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.9;Late spermatids: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	12.4	12.7	15.1	14.0	13.6	30.1	24.8	13.1	24.0	14.5	14.4	9.8	9.8	8.3	13.2	14.3	40.8	9.7	15.5	12.2	15.0	16.0	11.8	16.0	17.9	10.5	18.0	14.3	12.4	11.9	14.7	10.6	15.7	13.7	13.9	11.4	8.3	14.4	11.4	31.8	16.9	9.1	14.7	12.4	9.5	11.0	60.1	12.6	20.9	10.7	20.0	18.0	14.4	21.0	2.0	2.3	3.8	2.0	2.7	8.1	1.2	16.4	7.2	17.5	17.6	23.7	22.1	18.5	20.2	22.8	21.2	22.4	11.0	9.7	14.6	33.0	23.5	16.3	9.0	13.4	11.7	29.3	24.4	12.5	14.7	14.3	20.3	32.9	22.8	11.0	22.2	15.2	25.0	20.8	17.2	17.1	25.8	31.0	11.7	23.5	16.5	26.1	19.1	7.7	15.8	10.2	20.9	13.7	20.7	16.8	19.0	22.0	15.5	16.3	30.2	29.9	34.8	16.1	19.5	16.9	19.3	13.7	15.8	20.7	28.2	34.3	19.8	8.9	14.6	35.7	0.8	1.3	3.8	1.9	1.8	3.8	2.0	4.0	2.0	1.4	1.7	3.8	2.6	1.8	2.7	2.0	2.3	8.1	1.2	15.1	13.6	13.1	24.0	15.0	16.0	18.0	14.3	13.7	12.6	17.9	26.2	5.2	7.4	22.0	22.2	34.0	10.2	14.7	19.4	17.4	13.7	13.9	1.7	7.7	73.9	29.8	11.6	0.0	9.3	7.6	18.5	14.9	9.3	15.6	15.1	6.4	12.7	19.0	23.5	76.0	14.7	15.7	16.9	11.8	16.6	18.6	13.3	3.5	23.3	9.1	16.1	6.5	13.7	65.4	35.1	22.8	23.8	15.3	9.9	10.2
MCUR1	"C6orf79, CCDC90A, FLJ20958"	ENSG00000050393	"Mitochondrial calcium uniporter regulator 1"	Q96AQ8	6	13786557-13814568	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Proximal tubular cells: 205.7;Rod photoreceptor cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078654	Approved					NA	NA					"HPA078654: "	"unprognostic (1.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (5.51e-4)"	"unprognostic (3.40e-1)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (5.86e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.39e-1)"	11.2	7.3	19.9	8.6	16.2	7.6	18.8	11.3	19.4	10.4	15.3	10.3	19.1	22.7	9.1	17.1	12.2	6.3	7.1	12.0	17.2	20.9	27.8	21.4	10.7	8.2	22.1	14.5	5.6	21.9	4.5	9.5	11.7	14.1	8.5	12.4	15.2	13.4	15.6	20.7	22.3	29.5	6.6	16.5	10.6	7.9	6.1	10.1	9.1	20.2	14.3	11.1	6.6	9.0	4.4	7.0	6.0	3.4	4.0	5.2	6.3	10.4	3.2	15.6	16.1	9.4	8.2	9.9	9.4	9.2	10.4	11.0	10.9	5.1	14.1	19.4	6.8	16.4	4.6	9.8	7.8	11.8	9.5	6.0	14.4	5.7	10.7	9.1	14.4	5.7	5.6	7.8	13.3	9.7	7.7	3.6	17.5	10.7	7.7	7.2	4.4	17.4	21.8	10.3	26.9	4.2	12.9	14.0	20.3	12.5	6.4	10.2	11.6	6.3	16.3	24.4	26.1	6.0	6.6	5.0	15.7	8.8	11.2	13.1	9.4	31.3	20.6	7.2	8.5	21.2	6.0	2.9	0.8	3.5	2.5	4.2	4.4	5.0	5.2	7.0	3.9	3.8	3.6	2.1	4.0	3.4	4.6	2.8	6.3	19.9	16.2	11.3	19.4	17.2	20.9	22.1	14.5	14.1	10.1	14.9	23.5	19.3	19.0	39.8	34.3	40.3	25.5	5.3	10.3	54.1	113.9	37.7	117.7	23.3	39.1	29.3	86.7	70.0	27.5	51.7	37.7	49.1	6.9	60.4	75.5	25.4	15.0	25.2	24.4	3.6	20.4	39.2	49.0	45.9	44.1	30.8	28.8	77.7	25.5	205.7	250.4	19.4	35.8	3.5	39.8	50.2	72.1	13.8	33.6	27.1
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980302	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 12.9;brain: 17.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 37.0;RPTEC TERT1: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.2	0.7	7.6	0.6	6.2	12.9	1.2	16.6	17.6	1.2	0.7	7.5	2.0	0.8	1.6	2.5	1.0	2.7	0.9	1.0	11.0	7.3	2.6	0.5	5.7	0.8	6.8	8.5	1.1	3.6	0.5	2.0	2.9	14.3	0.9	0.6	2.2	1.9	4.7	0.9	0.8	1.1	1.0	5.1	0.5	0.6	7.0	2.9	0.0	3.0	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	5.3	0.0	1.8	2.3	0.3	2.7	3.7	7.5	7.3	0.1	0.0	0.0	0.0	2.9	8.2	0.0	6.2	0.0	13.8	0.0	2.0	0.1	37.0	0.0	0.0	0.0	0.0	1.2	0.0	11.6	0.1	8.7	0.1	1.5	0.2	0.0	5.2	0.0	0.0	0.9	3.0	0.0	10.3	1.5	1.3	0.4	29.7	0.0	6.4	6.1	0.2	0.0	10.4	2.0	0.0	1.0	2.8	9.2	2.0	0.1	6.1	0.0	0.0	0.0	6.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	16.6	12.1	11.0	7.3	6.8	8.5	14.3	2.9	0.0	0.0	0.0	0.0	0.2	16.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	14.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.5	1.2	6.5	0.8	3.0	1.9	0.0	0.2	0.0	0.0	0.0
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.0;lymphoid tissue: 64.5"	"Cell type enhanced"	"Detected in many"	22	"granulocytes: 239.5;Macrophages: 184.4;monocytes: 891.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.2;HDLM-2: 26.2;U-698: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454"	Enhanced					NA	NA					"CAB002509: AB_563641, HPA041454: AB_2677489"	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	14.0	8.3	6.1	64.5	5.7	70.0	7.5	14.2	11.8	17.0	2.0	24.7	3.4	1.8	3.7	8.3	3.6	1.8	9.9	2.6	7.3	12.7	9.7	6.0	29.0	19.5	7.8	2.2	9.7	1.6	2.2	4.1	3.4	10.8	5.2	3.8	3.5	16.4	7.8	1.8	2.6	6.9	2.7	11.1	16.5	2.2	4.0	2.8	33.8	2.3	6.2	57.5	16.4	9.8	19.1	5.2	1.3	15.4	2.6	3.6	2.3	6.6	0.3	5.0	6.9	7.3	1.7	0.1	1.8	6.8	3.2	5.7	0.5	4.4	29.2	5.6	0.5	6.7	0.7	1.9	2.1	10.8	26.2	2.8	4.0	8.6	0.8	0.2	5.8	6.4	1.9	0.9	3.1	1.0	1.0	0.1	10.1	0.8	0.0	0.3	2.4	4.6	11.0	2.0	1.2	1.3	4.5	10.9	4.1	2.3	6.6	1.1	2.0	0.4	0.2	5.0	3.0	1.2	4.7	0.1	5.0	3.1	0.7	4.5	0.3	0.0	44.9	1.1	8.0	7.5	0.0	1.7	1.1	2.7	10.7	2.9	11.5	2.5	2.2	5.2	19.1	1.8	2.1	1.3	2.6	15.4	1.8	3.6	2.3	6.1	5.7	14.2	11.8	7.3	12.7	7.8	2.2	10.8	2.8	17.9	74.6	42.7	9.5	44.0	3.5	25.4	2.5	5.3	9.1	10.4	5.9	1.4	3.3	0.6	0.4	16.9	2.6	0.0	1.3	2.2	18.7	12.7	239.5	0.8	140.3	1.6	23.1	3.1	66.8	1.1	0.3	184.4	42.2	891.9	3.3	3.1	1.6	0.0	0.0	15.8	2.6	0.0	26.8	0.9	12.1	33.6	2.3	13.8	3.5	2.8
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522801-15663058	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.0"	"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	7.2	5.0	22.8	10.5	91.0	9.3	7.7	6.7	18.4	6.8	10.5	7.8	4.5	7.2	8.0	12.5	7.2	6.9	7.9	12.0	15.0	18.0	11.3	5.0	8.4	16.9	18.5	10.3	7.3	6.7	13.1	8.5	9.3	13.7	8.1	10.9	13.4	6.7	10.1	15.4	7.1	7.6	11.9	9.4	10.2	7.6	5.5	17.2	9.3	7.8	2.7	19.4	8.6	8.1	17.8	17.9	8.1	7.1	26.9	12.1	6.6	15.8	6.9	5.9	12.7	8.7	9.9	9.1	8.2	10.7	19.7	17.9	9.1	7.4	22.5	22.1	11.6	16.3	5.5	11.6	8.7	18.0	14.4	15.5	15.8	9.0	13.5	15.2	15.9	13.5	9.4	13.4	10.0	14.9	9.0	17.3	15.5	14.9	5.6	11.8	18.6	16.5	25.3	4.1	13.5	10.0	19.6	11.6	17.5	18.4	16.6	12.1	5.1	6.4	15.4	19.3	14.3	11.1	10.2	7.9	11.2	7.3	11.5	15.0	15.1	28.9	15.8	5.2	14.1	21.1	5.9	5.9	8.1	12.1	7.1	8.0	13.7	10.3	10.4	6.4	17.8	9.8	7.9	6.8	26.9	4.9	17.9	6.9	6.6	22.8	91.0	6.7	18.4	15.0	18.0	18.5	10.3	13.7	17.2	11.9	9.9	44.3	12.8	25.8	42.2	26.6	17.8	9.4	6.8	14.0	55.0	37.3	31.5	32.0	38.0	30.8	18.0	0.0	31.0	15.5	19.0	10.2	54.2	4.5	46.0	23.8	13.3	16.0	15.1	14.5	9.5	25.1	35.4	33.3	15.2	31.7	24.9	8.6	14.5	53.8	136.7	6.5	24.2	17.4	12.7	19.3	14.0	27.9	17.5	9.3
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129125-16148248	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 84.0"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 294.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 33.8"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	23.4	12.5	7.3	10.3	10.6	44.2	19.5	5.4	11.4	28.5	14.4	18.9	16.4	7.5	31.8	16.1	12.1	22.2	19.1	9.0	8.6	6.1	13.1	3.5	19.0	19.4	12.9	8.8	22.3	10.5	9.8	6.1	84.0	7.4	20.1	9.7	20.2	16.2	20.9	20.6	16.7	15.7	18.0	7.0	23.5	14.8	15.2	12.2	8.8	39.1	10.9	15.7	19.0	33.7	4.9	1.4	14.2	2.3	3.2	8.4	1.5	2.0	4.1	1.7	2.0	17.3	4.6	4.5	1.4	3.4	3.5	7.6	11.5	2.1	9.2	7.4	2.2	2.4	5.1	8.1	2.5	3.0	3.3	8.4	6.2	4.3	2.1	2.5	4.2	6.1	7.4	3.3	1.8	1.4	1.7	8.0	2.0	17.8	10.9	1.3	7.7	0.1	20.8	4.9	4.9	3.7	2.1	7.9	33.8	3.7	24.6	8.6	3.7	1.8	18.8	9.5	14.8	3.5	10.4	2.3	1.6	4.0	1.2	3.6	10.1	4.4	4.9	1.0	12.3	5.5	8.5	2.3	11.1	8.4	2.2	7.3	4.9	5.3	5.9	1.4	4.9	5.9	5.4	14.2	3.2	2.0	0.7	3.2	1.5	7.3	10.6	5.4	11.4	8.6	6.1	12.9	8.8	7.4	12.2	20.8	36.3	30.2	28.3	87.0	7.3	74.2	35.7	21.4	18.2	21.0	0.0	113.9	8.3	14.9	36.7	33.1	32.6	0.0	16.2	65.2	75.2	27.4	35.7	1.0	27.7	11.1	80.9	34.4	42.6	12.5	35.6	21.9	75.9	26.2	35.2	15.3	8.1	32.3	58.0	18.8	6.6	135.8	92.6	59.7	17.5	73.4	294.6	88.3	34.8	26.9
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238580-16295549	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 72.9;Erythroid cells: 186.9;Glandular cells: 74.5;Melanocytes: 87.7;Peritubular cells: 76.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8;NK-cell: 8.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"HEL: 46.2;HMC-1: 78.9;SK-MEL-30: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		3800000			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	2.8	7.3	14.6	1.4	11.0	9.6	6.5	3.8	6.9	2.7	3.7	9.1	2.0	1.5	4.2	7.9	2.5	22.4	1.9	31.5	13.3	11.5	10.3	2.7	3.7	2.5	14.0	5.7	15.7	7.4	4.4	6.8	3.4	21.3	25.5	1.8	22.0	5.2	4.2	103.3	4.3	1.5	4.3	11.8	3.3	8.3	25.1	10.9	1.4	2.7	16.2	1.5	2.0	1.2	0.7	1.3	7.8	4.2	8.3	1.0	14.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.9	3.8	6.8	13.9	0.3	0.1	0.0	2.2	1.4	4.8	0.0	1.6	0.2	1.1	0.0	1.2	46.2	0.0	0.0	3.0	0.2	78.9	0.9	0.7	2.1	0.0	5.6	12.2	0.1	10.3	0.0	1.2	0.9	0.0	0.9	0.4	0.0	1.8	0.0	10.4	0.0	9.0	1.3	2.3	0.3	0.4	0.8	17.6	3.1	0.7	0.3	3.0	0.1	0.0	0.3	1.8	0.5	0.0	0.0	0.2	4.9	5.3	7.8	2.9	0.4	0.6	4.2	1.0	0.2	0.1	0.4	1.3	0.7	0.0	0.2	3.0	8.3	1.3	1.2	0.0	14.1	14.6	11.0	3.8	6.9	13.3	11.5	14.0	5.7	21.3	10.9	0.0	0.0	0.5	29.7	4.5	0.9	50.8	22.9	8.1	2.3	19.2	0.0	23.1	72.9	10.6	10.2	5.8	0.8	186.9	4.4	2.8	6.1	74.5	56.3	2.9	8.0	0.0	7.5	11.1	2.2	8.5	31.9	4.3	87.7	10.8	2.3	7.3	3.2	0.3	76.0	10.4	0.4	0.0	8.5	4.7	17.0	1.6	5.7	1.3	2.5	5.8
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	8.1	9.1	17.7	11.9	25.1	5.5	9.1	33.7	29.5	14.8	13.5	12.9	10.3	8.2	20.5	9.8	11.1	11.0	12.1	11.8	18.0	11.0	9.1	10.1	14.8	11.6	21.1	17.7	10.7	10.3	18.4	11.6	10.3	16.4	14.2	8.5	9.8	8.4	14.0	26.3	12.0	8.3	19.1	16.1	11.4	10.3	8.1	25.6	4.6	11.8	12.5	7.4	11.7	11.3	0.4	0.8	4.4	1.7	0.1	2.5	0.8	3.4	2.0	0.7	0.0	3.5	4.8	4.6	3.7	8.7	2.3	2.7	2.1	2.2	0.1	5.0	7.1	3.0	3.2	0.2	2.3	3.3	1.9	3.6	0.5	3.2	6.7	5.7	3.2	5.6	3.7	4.5	4.8	4.1	8.9	4.6	0.7	0.0	4.1	1.9	1.7	0.2	3.6	0.7	1.1	3.3	0.2	4.6	3.0	3.1	5.8	0.2	2.0	3.4	4.3	7.0	7.0	2.8	5.5	7.0	3.2	4.9	3.7	3.3	24.3	13.9	0.1	2.0	3.3	7.8	0.7	1.7	0.4	2.5	1.3	1.9	0.4	1.7	2.4	0.8	0.1	0.2	1.5	4.4	0.1	0.7	0.4	1.3	0.8	17.7	25.1	33.7	29.5	18.0	11.0	21.1	17.7	16.4	25.6	44.7	20.4	14.9	54.4	81.3	39.6	30.2	25.5	22.7	26.1	10.4	94.2	0.3	6.6	15.9	3.6	15.7	12.5	0.0	7.4	3.0	26.7	57.3	38.1	25.3	20.8	36.5	1.2	20.3	33.9	1.8	9.8	33.2	30.4	28.9	12.3	24.2	22.2	13.5	26.5	7.7	108.3	51.8	35.3	0.9	1.3	42.7	0.3	44.9	6.8	52.7
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102258-17131372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pancreas: 9.1"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 48.2;Club cells: 10.3;Spermatogonia: 21.3"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEK 293: 4.1;SCLC-21H: 9.8;T-47d: 11.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.1	0.0	0.4	0.1	0.8	0.0	3.7	0.6	0.6	1.6	1.0	2.8	1.4	0.1	0.6	4.7	0.1	21.8	6.0	0.1	0.7	0.9	0.1	0.1	7.7	0.1	0.1	0.1	3.5	9.1	0.0	0.7	0.1	2.5	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.9	1.6	2.8	1.1	0.8	0.8	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.7	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.2	0.8	0.0	4.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.1	0.0	1.1	11.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.7	0.3	0.8	0.6	0.4	0.7	0.3	0.2	0.9	0.8	0.7	2.8	0.8	0.8	1.6	0.2	0.4	0.4	0.8	0.6	0.6	0.7	0.9	0.1	0.1	2.5	0.1	0.0	2.2	0.0	1.2	0.0	0.0	0.4	2.5	48.2	10.3	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	1.0	0.8	0.0	0.4	0.0	0.0	6.5	0.3	7.1	21.3	0.6	0.0	0.0	1.0	0.5
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 165.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	6.0	0.0	0.0	0.0	0.0	9.1	3.3	6.2	6.6	0.0	0.5	0.0	2.9	6.5	9.8	0.0	5.6	0.2	11.3	0.0	0.2	0.0	0.5	3.1	0.2	0.0	0.5	3.3	0.0	1.2	0.2	8.0	0.7	0.0	0.0	0.0	29.0	1.3	0.0	0.0	2.0	0.0	0.7	0.0	29.8	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	4.9	13.9	0.2	0.0	2.1	5.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1	0.0	0.0	0.0	0.2	1.0	1.6	165.8	0.0	20.1	2.3	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	9.2	0.8	0.2	1.1	0.0	0.2	1.6	4.6	0.0	0.0	1.0	0.0	0.0	1.7	0.0	3.9	0.6	0.2	0.0	0.7	0.1	0.0	6.5	16.2	0.3	7.7	0.9	0.7	0.0	1.5	0.1
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393216-17557792	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 165.7"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	5.8	4.1	13.8	3.0	20.1	0.7	3.9	7.5	26.4	5.6	7.7	1.9	2.0	1.9	9.2	5.9	7.0	5.8	3.8	31.2	19.9	8.7	3.3	2.0	2.1	1.1	5.3	17.3	2.1	1.6	3.2	1.7	6.2	8.6	8.4	3.6	2.9	2.5	10.1	165.7	0.9	2.6	13.1	2.0	1.6	3.3	1.1	1.3	0.0	2.3	14.5	1.3	4.6	6.4	0.0	0.0	0.0	0.0	0.0	2.9	0.1	5.1	8.1	15.7	18.7	0.1	0.0	3.4	18.5	13.5	15.2	13.9	2.6	2.3	0.0	17.4	19.8	21.3	2.7	6.9	6.9	22.1	0.0	2.6	0.0	5.2	8.8	1.5	0.0	0.0	1.1	3.4	7.7	3.3	24.9	0.7	0.0	0.0	0.0	32.1	8.3	0.0	0.0	5.9	0.2	4.6	1.7	20.8	0.3	8.0	2.1	2.0	3.9	6.2	20.1	10.9	30.1	22.2	3.7	0.0	12.3	11.7	0.3	16.2	0.0	0.0	0.0	4.1	0.0	16.8	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	20.1	7.5	26.4	19.9	8.7	5.3	17.3	8.6	1.3	3.0	1.0	0.0	3.5	1.6	13.5	110.1	2.5	48.2	5.7	1.8	3.9	14.9	3.3	2.4	0.1	1.0	0.0	0.0	0.6	10.7	8.2	1.4	0.0	1.8	1.9	7.9	5.8	4.9	0.0	0.0	0.6	0.0	0.0	0.0	1.1	5.0	3.6	2.0	4.6	16.1	2.0	32.3	40.1	0.1	2.1	0.6	31.4	0.0	1.5	0.7
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600355-17611719	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 685.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	14.7	13.0	19.8	8.3	21.1	21.1	15.2	23.7	22.6	17.2	16.2	10.8	23.8	12.9	21.4	15.4	11.1	16.7	16.4	11.8	17.7	17.8	18.8	58.7	14.5	14.6	17.3	16.5	22.6	17.8	19.0	16.2	11.5	17.5	16.9	18.1	8.7	16.3	31.4	17.5	13.1	15.9	19.7	17.9	10.5	12.0	28.4	16.4	15.1	18.3	10.5	6.4	15.0	16.2	0.2	0.4	9.0	0.6	2.6	2.0	0.5	4.8	1.9	7.2	17.1	25.0	23.6	5.9	7.9	10.8	4.0	7.1	11.1	1.6	4.2	19.0	13.3	4.4	4.0	10.8	6.8	5.4	3.5	15.4	5.0	6.8	23.7	11.1	3.1	5.2	12.4	11.1	4.6	3.3	13.1	9.0	4.7	10.1	8.6	6.4	5.9	2.3	9.8	3.0	6.0	3.0	6.2	7.0	12.6	13.8	3.9	2.2	11.5	6.1	13.3	12.0	13.0	15.4	4.9	6.9	5.2	1.8	8.0	2.8	7.2	6.0	4.1	4.7	3.7	7.1	4.2	0.5	1.5	1.9	0.6	2.0	0.0	0.9	1.6	0.3	0.2	1.2	1.9	9.0	2.6	0.4	0.4	0.6	0.5	19.8	21.1	23.7	22.6	17.7	17.8	17.3	16.5	17.5	16.4	17.9	19.0	3.0	8.6	11.8	26.8	12.2	15.3	12.0	14.8	27.9	13.7	8.4	5.0	7.4	685.5	9.3	26.4	0.0	6.8	10.4	12.6	10.7	1.1	67.4	5.4	14.3	11.5	23.9	20.0	149.2	33.9	6.5	5.0	1.0	11.3	17.4	7.3	17.5	29.0	11.4	15.3	32.3	17.5	30.6	16.8	13.9	10.2	10.2	13.4	7.0
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706834	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	20.2	14.0	13.8	22.2	15.3	37.5	19.0	24.7	14.9	17.8	15.2	14.4	18.9	9.8	19.7	16.0	21.6	17.8	15.6	15.1	12.3	10.2	13.4	22.9	17.7	21.6	12.2	10.5	21.0	15.1	23.3	17.3	29.2	12.6	15.1	13.4	12.4	16.3	19.9	30.7	19.9	16.3	16.0	11.0	18.7	15.0	26.8	13.8	34.4	15.9	18.9	26.4	18.4	21.1	3.9	3.5	6.5	3.3	5.5	7.6	2.2	19.2	9.7	21.4	18.6	9.5	11.2	20.8	15.1	14.4	23.1	24.8	16.1	9.0	36.6	25.3	13.7	19.2	14.1	25.0	14.9	37.5	19.2	18.6	19.6	10.7	16.6	7.1	28.3	18.3	11.8	12.1	24.1	17.5	8.8	13.6	12.4	45.4	11.8	15.5	10.4	20.9	17.2	16.6	7.4	10.5	27.7	27.4	34.4	10.2	19.1	23.7	13.7	12.9	21.4	12.9	35.4	13.8	10.3	12.4	23.5	13.3	11.0	23.5	15.0	21.5	37.0	5.8	13.1	27.6	2.4	2.5	5.5	5.9	2.4	7.6	3.6	7.1	6.8	3.5	3.9	4.4	4.3	6.5	5.5	3.3	2.0	3.1	2.2	13.8	15.3	24.7	14.9	12.3	10.2	12.2	10.5	12.6	13.8	17.9	21.0	16.6	35.4	67.9	13.1	10.9	10.2	17.4	11.4	15.7	15.7	17.8	1.7	7.7	20.7	23.4	10.7	0.0	5.2	18.0	24.9	29.7	3.5	24.5	15.1	15.9	20.1	12.9	17.1	16.4	16.1	16.8	20.3	6.4	12.1	8.0	12.4	3.5	13.8	9.1	12.5	12.9	23.6	29.1	20.3	69.4	20.0	20.2	14.6	28.0
KIF13A	bA500C11.2	ENSG00000137177	"Kinesin family member 13A"	Q9H1H9	6	17759183-17987623	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 9.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029253, HPA029254"	Uncertain					NA	NA					"HPA029253: AB_10611115, HPA029254: AB_10602094"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (2.96e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.44e-2)"	16.7	15.6	16.2	11.5	19.9	11.9	22.6	15.9	21.4	13.5	18.7	24.8	11.1	19.0	19.3	15.0	14.5	13.7	18.6	31.8	15.0	10.6	10.5	11.2	25.3	5.9	18.8	13.4	15.1	10.6	22.6	9.9	9.7	16.4	17.5	18.3	19.1	12.5	14.1	63.9	19.8	18.3	44.9	17.4	6.0	11.0	6.1	21.2	2.0	20.0	25.6	6.5	23.1	17.3	0.4	0.8	9.5	2.1	0.3	0.1	0.3	9.9	7.4	8.9	5.4	12.2	11.7	10.7	13.8	23.6	12.1	12.5	2.7	2.4	0.1	11.1	23.8	15.3	10.0	6.7	17.4	15.3	1.0	4.0	4.3	18.5	12.9	8.1	0.1	4.3	9.2	14.8	13.1	19.9	15.7	9.8	0.0	15.7	0.1	13.2	4.0	0.0	0.6	7.1	2.3	4.6	5.1	12.2	0.0	7.6	25.5	2.4	4.8	11.3	8.6	15.1	16.1	12.5	0.6	6.9	22.2	6.5	7.2	12.9	0.1	0.0	0.0	8.0	0.3	16.2	3.1	2.1	1.9	0.1	1.7	0.0	0.4	0.1	0.0	0.8	0.4	0.0	0.0	9.5	0.3	0.8	0.1	0.0	0.3	16.2	19.9	15.9	21.4	15.0	10.6	18.8	13.4	16.4	21.2	32.8	37.7	2.2	33.7	50.8	34.1	58.9	20.4	21.4	14.8	19.2	17.7	2.6	10.0	5.8	18.1	25.1	16.3	0.0	7.5	2.7	17.5	21.1	4.7	20.8	10.2	4.8	12.0	10.4	24.1	9.1	14.4	15.6	16.9	5.4	26.5	34.7	7.1	24.6	23.3	8.4	23.8	25.8	21.1	4.9	13.4	39.9	7.6	1.0	29.2	35.6
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122687	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Intestinal endocrine cells: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.2;K-562: 7.8;SCLC-21H: 8.2"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	2.5	3.6	5.0	1.8	6.5	2.1	4.6	2.6	8.5	1.9	3.3	7.1	1.7	3.2	2.0	6.1	2.4	3.5	2.7	3.9	5.0	5.1	1.9	9.0	5.1	4.7	5.4	3.9	3.5	12.2	2.4	2.8	1.0	5.2	3.4	3.0	3.3	5.1	2.8	5.2	8.5	4.3	1.8	5.4	2.4	3.0	2.1	3.8	2.4	3.6	0.9	1.8	2.5	1.8	3.3	7.2	0.6	7.2	2.2	2.5	2.6	3.3	2.0	0.8	0.1	1.8	1.7	0.0	3.5	1.1	1.3	0.7	0.1	2.8	0.1	9.2	2.5	0.2	4.0	0.0	2.2	1.0	0.1	1.2	0.5	1.1	0.2	2.8	0.0	2.2	2.9	3.4	1.3	1.2	0.8	2.8	0.0	7.8	0.1	2.8	3.6	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.1	1.9	3.6	8.2	0.1	6.9	5.8	2.0	0.8	4.2	2.2	0.5	0.2	1.8	2.4	0.0	0.1	0.0	0.1	0.1	0.0	3.5	0.5	6.6	0.6	1.1	7.2	1.2	3.3	1.7	0.8	7.2	2.3	2.5	1.6	0.5	2.2	3.2	0.9	1.8	2.6	5.0	6.5	2.6	8.5	5.0	5.1	5.4	3.9	5.2	3.8	0.0	2.1	0.0	1.0	1.6	0.1	0.4	0.0	0.0	2.3	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.3	0.0	3.2	0.0	0.2	0.1	1.1	1.0	1.1	0.0	3.4	0.0	0.6	0.0	0.6	0.9	1.7	0.0	0.0	0.5	1.7	0.0	0.0	1.1	1.1	0.0	0.4	0.2	0.0	1.6	0.3	0.0	0.4	0.3
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155074	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 48.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA					"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.3	13.2	11.5	6.6	10.2	4.9	5.6	13.1	14.3	4.6	18.2	4.1	6.2	18.4	6.5	10.1	8.9	4.1	7.6	6.5	9.0	8.0	40.2	36.2	6.5	6.2	9.3	7.5	3.8	9.4	12.9	11.6	3.3	8.5	6.2	19.4	6.9	12.9	7.2	7.0	5.7	29.4	6.2	7.2	9.4	6.6	4.1	7.5	5.4	48.2	6.3	5.3	6.4	5.6	1.6	16.9	3.7	23.8	5.4	8.3	8.3	11.9	3.6	4.1	10.0	6.7	13.1	10.0	13.9	15.5	11.9	18.6	8.4	3.0	1.5	10.4	18.3	9.2	6.0	5.7	10.0	19.9	7.9	8.2	9.9	6.2	12.3	7.4	4.5	8.9	7.5	10.8	13.3	8.5	7.8	16.5	6.8	19.5	2.9	8.6	5.5	4.6	6.2	6.7	16.6	10.5	5.8	10.0	6.7	13.8	12.3	6.6	5.1	9.1	16.2	17.8	10.6	11.7	4.5	7.0	27.4	5.3	14.3	19.7	4.1	18.5	3.9	9.8	6.2	27.4	3.4	12.0	3.7	6.5	23.8	8.3	1.5	5.3	6.2	16.9	1.6	4.8	6.5	1.2	5.4	19.6	3.7	8.2	8.3	11.5	10.2	13.1	14.3	9.0	8.0	9.3	7.5	8.5	7.5	14.9	13.3	18.0	32.1	37.9	15.1	15.4	22.9	4.0	6.8	33.2	21.6	17.3	97.8	34.1	1.2	11.7	80.0	0.0	32.7	21.7	11.7	34.2	23.0	79.7	40.7	6.4	23.1	12.3	34.5	1.5	3.7	56.7	23.6	19.8	31.8	22.9	51.4	78.6	9.6	230.3	16.8	0.0	14.7	0.4	8.1	30.2	14.6	23.5	36.6	71.2
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223853	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;granulocytes: 7.6;monocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	7.3	10.5	19.1	12.2	17.8	27.9	13.4	13.5	14.6	8.6	15.6	10.6	7.2	9.8	7.5	8.2	11.7	17.5	7.5	8.1	13.8	9.6	10.0	8.9	12.1	11.4	15.1	12.0	8.8	7.8	3.9	9.8	5.5	13.5	7.0	15.9	7.1	7.6	6.4	19.1	13.3	10.3	10.0	13.0	10.5	7.1	18.7	13.8	16.0	33.5	7.6	11.5	9.2	10.0	1.6	4.2	7.6	9.6	0.3	0.8	1.2	8.4	5.1	7.2	14.9	9.5	15.3	14.2	7.9	8.4	5.2	7.4	8.7	4.9	21.4	19.3	13.1	16.3	10.3	12.1	14.4	11.6	17.9	9.6	10.4	5.6	9.0	4.8	14.5	11.5	7.5	16.8	13.2	12.5	8.5	5.5	10.7	24.7	3.0	9.0	7.7	8.3	6.2	2.2	21.6	8.4	16.6	14.0	15.5	7.5	11.2	19.8	7.6	6.4	15.6	14.8	8.7	15.4	11.8	4.2	10.5	5.5	7.6	9.2	3.0	8.4	12.0	4.2	11.0	24.3	1.3	5.3	7.6	0.6	9.6	0.4	1.3	0.6	0.6	4.2	1.6	0.6	0.2	5.6	0.3	7.5	1.8	0.8	1.2	19.1	17.8	13.5	14.6	13.8	9.6	15.1	12.0	13.5	13.8	0.0	8.0	4.7	3.6	11.3	4.6	9.4	5.1	17.4	14.8	1.8	9.8	2.3	1.7	4.9	0.6	2.4	14.4	0.0	3.8	4.4	3.8	5.9	2.3	6.0	6.8	4.8	6.4	4.9	30.8	0.2	3.4	16.9	6.8	7.2	9.9	6.6	4.9	15.6	6.3	9.1	14.4	0.0	4.7	0.4	12.4	13.9	1.1	4.5	9.7	5.2
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223868-18264823	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB015226, HPA054505, HPA057799"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	30.9	20.0	22.9	41.8	29.5	50.8	28.9	41.5	30.2	31.0	35.8	11.4	24.0	28.2	32.9	19.7	31.0	23.8	19.2	33.5	26.8	14.1	19.3	23.8	29.2	42.7	30.7	17.6	28.3	19.3	20.5	27.8	24.3	27.7	33.9	29.9	11.0	26.8	21.4	40.2	23.2	35.9	51.3	28.1	29.8	24.2	12.6	32.9	58.8	44.9	33.9	38.4	45.1	43.3	40.0	40.2	57.7	49.3	34.0	46.3	35.0	60.9	18.0	47.6	39.7	9.6	16.7	27.7	56.2	31.0	50.7	68.8	29.4	22.9	69.4	59.6	25.3	40.8	36.6	35.2	27.9	85.4	46.7	33.6	42.9	32.3	34.2	9.3	65.3	34.9	8.2	13.9	35.0	27.7	24.0	24.2	25.6	52.1	0.0	32.3	21.9	47.1	29.3	29.2	24.3	20.1	62.8	63.2	40.7	24.4	35.3	29.2	26.8	50.7	44.1	30.6	32.6	39.6	26.9	24.6	59.5	33.0	33.1	69.9	4.2	10.2	73.2	14.2	33.3	55.1	51.1	49.3	21.9	41.4	39.3	46.3	40.0	42.1	42.5	40.2	33.2	33.5	32.0	57.7	34.0	43.9	31.0	40.6	35.0	22.9	29.5	41.5	30.2	26.8	14.1	30.7	17.6	27.7	32.9	113.2	133.1	112.0	157.1	241.0	64.8	174.2	152.8	109.7	146.7	75.0	76.6	208.5	69.6	136.5	15.9	140.0	115.1	443.9	150.2	201.0	139.1	206.8	105.4	107.1	166.8	25.4	84.9	75.5	163.3	15.6	175.4	212.2	96.2	259.7	117.1	119.5	110.8	110.4	180.0	82.7	127.2	207.0	187.2	63.1	177.2	204.1	90.8	150.3	203.5	166.1
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.7	3.3	3.6	0.0	0.1	55.9	15.4	0.6	0.2	4.8	0.0	4.7	4.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.8	1.3	4.0	1.5	16.5	1.2	0.0	0.0	0.8	0.5	0.4	0.0	0.5	0.1	0.3	0.2	0.5	3.3	10.0	3.1	0.5	0.0	0.3	7.1	5.3	0.4	8.4	0.1	16.5	2.6	0.5	0.2	0.3	0.0	0.0	47.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9	41.7	12.9	4.2	36.0	563.5	0.9	10.4	10.2	21.4	36.4	36.6	2.0	9.7	16.6	8.2	1.6	32.1	1.0	0.0	7.7	2.9	12.4	85.1	3.5	17.4	13.8	0.0	1.2	28.8	98.2	1.6	1.1	68.0	57.3	44.1	1.3	16.0	6.0	2.9	2.8	16.3	1.0	0.0	10.1	1.7	2.6	1312.2	1.3	3.2	2.4	20.3
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837386-19840684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"thyroid gland: 154.6"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 188.3;Muller glia cells: 371.8;Smooth muscle cells: 607.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 17.2;AN3-CA: 22.6;EFO-21: 51.6;HEK 293: 28.9;SCLC-21H: 46.6;SuSa: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	33.1	2.1	29.3	5.3	29.6	1.1	16.9	13.2	31.1	21.1	5.1	29.0	7.2	4.9	22.9	7.0	12.1	34.1	6.8	25.2	32.3	20.6	11.7	2.4	14.6	3.5	14.5	19.0	22.9	11.8	2.0	13.1	13.2	24.9	18.7	4.6	5.7	16.0	26.6	1.8	31.3	4.0	14.2	12.5	11.4	11.9	10.8	20.0	0.0	154.6	4.4	3.5	10.5	11.5	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	17.2	22.6	0.5	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	51.6	5.8	0.1	8.8	0.0	0.0	0.2	0.0	28.9	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	2.4	0.0	0.0	0.0	0.0	3.0	6.1	46.6	0.6	0.0	0.8	3.0	15.0	1.4	0.0	0.0	0.1	2.7	0.0	0.7	0.0	0.0	0.5	0.7	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	29.3	29.6	13.2	19.2	32.3	20.6	14.5	19.0	24.9	20.0	89.3	35.7	0.0	188.3	73.7	10.2	30.8	0.0	10.7	26.1	64.6	2.0	7.6	43.1	14.4	1.3	5.8	7.9	0.0	2.9	6.2	57.9	86.7	0.0	0.0	2.5	3.2	87.7	17.2	0.3	4.4	7.5	4.1	84.4	0.0	4.8	371.8	2.1	31.7	0.0	61.2	12.2	0.0	607.2	0.9	0.6	68.6	4.9	0.0	2.8	35.0
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20102145-20212399	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 9.7;Melanocytes: 8.5;Paneth cells: 8.6;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 30.3;HEL: 24.9;T-47d: 22.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	9.9	3.3	1.4	16.5	2.1	6.2	16.5	1.5	1.8	22.5	17.3	6.4	7.1	9.7	18.8	9.9	9.6	18.1	18.8	8.4	1.7	1.7	4.4	4.0	14.0	7.6	6.5	0.7	10.5	4.4	4.7	2.7	3.2	6.2	9.3	15.4	7.2	6.5	9.4	2.2	4.3	21.1	17.2	10.0	4.6	10.6	2.6	3.2	3.9	6.6	6.5	11.1	10.4	12.8	0.3	2.8	6.4	6.8	0.5	4.1	0.9	3.3	3.5	6.6	4.5	0.7	2.2	0.3	5.3	1.5	3.7	4.1	1.9	12.9	0.0	11.1	5.1	2.7	30.3	6.4	2.7	5.2	8.3	3.1	24.9	5.7	0.0	4.1	7.9	8.7	0.9	2.4	1.6	6.7	1.8	2.0	5.2	4.0	4.7	0.8	3.0	4.4	4.7	1.4	2.8	1.8	1.6	7.6	17.5	3.7	6.6	0.2	4.1	1.1	5.3	5.7	12.2	22.9	2.7	1.9	4.4	3.0	2.5	2.2	6.9	15.4	0.0	0.3	5.5	5.3	6.4	4.4	6.0	0.7	4.7	4.1	0.2	1.2	1.7	2.6	0.3	0.3	0.3	5.7	0.5	6.8	2.8	1.3	0.9	1.4	2.1	1.5	1.8	1.7	1.7	6.5	0.7	6.2	3.2	3.0	0.3	0.0	0.6	9.7	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.7	1.9	0.0	0.2	3.6	0.0	1.0	0.1	0.8	0.6	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.3	2.1	8.5	0.0	0.9	2.0	1.3	8.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	13.6	0.2	0.0	2.0	1.3
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.8	5.6	16.1	17.3	5.4	6.0	11.2	9.3	8.1	8.9	9.9	6.9	4.3	15.4	18.0	8.6	8.3	7.2	18.4	8.3	15.0	6.0	13.0	27.9	9.3	7.7	5.8	18.3	16.8	4.8	6.2	8.7	10.7	9.2	6.1	14.7	30.9	9.5	10.1	7.1	20.7	20.5	12.1	5.3	5.8	22.6	14.2	17.7	10.6	11.9	11.6	21.3	8.6	11.9	12.2	10.3	6.1	11.1	8.2	14.4	9.0	7.1	14.7	6.0	19.0	19.3	3.5	11.3	20.4	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1	0.0	1.6	8.2	10.8	8.1	35.1	8.9	7.6	0.0	12.5	7.0	21.6	6.3	8.3	7.0	10.2	5.2	7.9	0.0	5.9	11.3	10.4	18.4	19.7	5.0	14.5	30.2	11.5	19.0	49.7	5.0	2.6	18.9	5.0	8.2	11.3	2.1	11.2	11.6	2.8	20.5	9.2	0.0	8.2	2.7	3.2	7.9	2.6	9.6	12.7	14.2
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	18.5	9.8	10.9	18.0	12.2	14.7	13.9	24.1	10.6	16.6	11.4	14.6	9.6	8.1	19.4	12.1	12.1	13.5	11.4	10.8	9.0	7.8	10.8	9.7	11.9	13.4	12.4	7.7	16.6	14.1	12.0	29.9	12.6	11.2	10.8	12.0	14.3	15.7	11.0	22.2	15.0	11.4	13.7	13.4	13.9	11.7	11.4	13.8	22.9	17.1	13.6	19.4	13.2	12.6	8.1	5.4	3.3	11.2	12.0	9.7	3.6	2.9	1.8	4.3	5.5	2.4	3.3	4.6	3.1	2.8	4.6	6.2	3.3	2.7	7.1	7.9	2.6	5.0	3.0	5.8	3.2	6.2	12.6	3.2	6.1	3.2	4.6	3.2	6.0	4.2	3.0	3.3	4.4	4.1	2.9	4.2	4.4	7.8	2.9	3.4	2.5	7.5	7.1	3.0	3.0	2.0	4.4	5.7	6.7	5.9	3.4	67.5	3.9	3.5	5.7	4.5	3.8	4.1	3.0	4.1	5.5	3.8	2.1	5.8	4.6	12.2	6.2	2.0	3.4	9.1	1.5	3.6	3.3	7.8	5.9	6.5	8.1	7.7	7.7	4.9	7.8	9.7	8.6	1.9	12.0	11.2	5.4	8.2	3.6	10.9	12.2	24.1	10.6	9.0	7.8	12.4	7.7	11.2	13.8	6.0	2.9	13.0	8.3	9.3	7.2	8.0	7.6	2.7	7.9	7.0	5.9	8.1	10.0	7.2	12.7	9.0	4.4	0.0	6.8	8.6	7.2	4.1	12.7	4.4	6.4	11.1	32.0	8.0	7.1	5.1	8.1	7.4	3.3	14.4	7.4	5.8	7.7	5.5	4.2	7.4	10.3	6.5	5.7	10.3	12.8	9.3	7.6	10.5	6.9	5.4
SOX4		ENSG00000124766	"SRY-box 4"	Q06945	6	21592768-21598619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2"	"Region enriched"	"Detected in many"	4	"olfactory region: 66.5"	"Low region specificity"	"Detected in many"			HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	4.2	0.7	2.0	1.9	0.9	6.0	6.3	3.0	6.3	6.7	2.8			3.0	18.0	4.1	2.3	4.2	5.5	2.0	1.1	1.8	4.3	1.3	5.1	0.8	0.6		18.1	5.3	0.0	1.8	1.0		4.1	3.7		9.6	1.4	0.3	4.1	2.7	4.9	0.3	1.0	4.4	2.5			3.4		1.4	6.2	3.6	3.1	21.8	12.8	10.0	3.3	1.1	2.0	1.8	5.2	13.3	55.4	4.9	1.2	21.7	0.8	1.7	1.0	0.9	3.5	3.5	0.6	22.2	1.3	0.7	5.4	6.9	3.8	0.7	7.6	14.5	0.5	2.4	2.3	0.8	1.8	0.4	2.1	3.9	0.4	1.6	14.2	15.6	30.0	0.1	0.0	1.1	4.3	47.6	4.5	9.9	2.6	5.0	21.0	1.1	0.0	9.6	16.7	17.4	31.2	7.7	9.0	2.9	17.3	4.4	6.5	11.9	1.5	5.2	0.3	3.9	0.3	0.0	15.4	0.5	6.5	6.1	12.8	9.8	0.9	0.2	5.5	0.0	2.8	0.1	0.1	4.1	3.1	1.1	0.8	0.4	3.3	10.0	21.8	0.9	2.0											184.6	59.8	33.5	82.0	99.9	88.8	228.6	341.4	161.9	235.4	146.5	11.8	61.5	56.3	757.4	3.9	238.0	78.0	0.0	523.0	358.6	243.9	126.1	56.8	5.8	33.0	46.1	327.2	70.6	85.2	8.3	11.2	56.1	231.2	80.2	156.9	228.7	1059.7	155.6	10.6	77.4	25.8	6.5	198.6	3.7	175.2	81.3	25.3	23.5	265.6	178.0
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22297501	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"pituitary gland: 1739.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 11.3;Late spermatids: 17.4;Rod photoreceptor cells: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	12	"monocytes: 1.0;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;SCLC-21H: 6.7;U-937: 3.2"					"Not detected"	"Not detected"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	NA	NA	53900000	3300000			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1739.5	21.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	17.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569493-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	296	"testis: 97.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 75.8;Late spermatids: 90.5;Spermatocytes: 112.6"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 5.0"									"HPA045679, HPA063707"	Enhanced					NA	NA					"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	6.5	0.0	112.6	23.3	0.0	0.0	0.0	0.0	0.0
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126122-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 67.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 114.4"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0.0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25.0	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5.0	0.0	1.4	0.0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.7	0.1	1.7	0.0	0.0	0.3	0.1	0.0	0.1	1.7	0.6	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	2.0	1.3	0.1	0.2	0.3	0.9	0.7	0.2	2.5	0.5	0.2	0.5	0.0	0.0	14.6	11.7	0.0	0.1	0.9	0.2	1.7	3.5	0.2	0.5	0.6	0.1	0.4	0.8	2.3	0.9	0.7	0.0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.3	1.0	0.1	0.2	0.2	0.0	0.0	21.5	27.7	5.3	34.1	15.3	25.0	12.4	25.4	27.4	5.0	0.0	0.0	0.0	0.0	0.0	24.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 61.1;Ciliated cells: 60.2;Collecting duct cells: 75.0;Distal tubular cells: 48.0;Ductal cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 20.2;EFO-21: 14.1;Hep G2: 22.9;RPTEC TERT1: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Mitotic spindle, Cytosol"	"Microtubules, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	1.5	0.1	0.0	0.4	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2	17.9	11.8	0.0	0.6	0.1	0.0	0.3	61.1	60.2	10.3	75.0	0.0	0.3	48.0	106.8	23.9	0.0	0.0	0.0	7.2	0.0	0.3	1.1	0.0	1.0	0.5	0.0	3.5	0.0	0.0	11.0	0.3	0.0	0.0	3.6	3.4	1.9	20.8	2.9	0.4	39.0	0.0	0.0	0.3	7.7	2.2	0.1	0.1	0.0	1.2	0.5
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358284	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.1;pancreas: 4.3"	"Cell type enhanced"	"Detected in single"	15	"Spermatocytes: 1.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 8.7;EFO-21: 7.0;Hep G2: 8.5"									HPA036021	Approved					NA	NA					"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.3	0.9	0.0	0.1	0.4	0.0	0.0	0.0	9.1	1.3	0.0	0.0	0.0		0.1	4.3	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0
MRS2	MRS2L	ENSG00000124532	"MRS2, magnesium transporter"	Q9HD23	6	24402908-24426194	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017642	Uncertain					NA	NA					"HPA017642: AB_2669628"	"unprognostic (2.12e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-3)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.89e-3)"	"prognostic favorable (5.14e-11)"	"unprognostic (8.75e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.55e-3)"	14.3	18.6	13.0	16.3	16.1	6.2	18.4	27.4	17.8	11.8	14.5	10.9	15.2	15.7	11.5	15.9	14.5	10.3	12.8	34.1	15.6	13.7	24.4	17.7	11.4	14.0	14.9	15.1	13.8	24.1	16.3	18.9	19.1	14.4	14.1	16.6	16.3	16.9	22.3	47.7	14.0	15.0	12.2	12.1	15.4	15.4	7.9	11.4	11.1	17.4	20.9	14.9	13.9	11.6	11.5	19.4	5.4	15.2	11.2	12.4	9.6	13.2	7.6	9.7	17.2	6.2	5.8	20.8	6.2	7.5	8.0	7.2	30.1	6.2	7.9	25.3	5.4	12.1	8.3	9.6	11.9	8.6	9.6	16.9	12.8	6.6	34.4	9.1	14.1	11.3	9.0	9.6	7.9	6.4	9.2	8.3	10.2	17.7	0.0	8.8	10.3	13.3	13.6	25.3	7.6	7.1	0.1	1.7	17.5	35.0	13.7	14.9	9.1	10.3	32.1	16.9	29.4	16.2	10.1	3.7	3.4	5.3	7.1	11.7	14.4	23.7	10.8	4.3	17.2	14.2	2.3	13.1	5.4	9.5	15.2	12.4	11.5	10.2	10.4	19.4	8.2	11.5	10.6	1.5	11.2	13.5	11.4	8.7	9.6	13.0	16.1	27.4	17.8	15.6	13.7	14.9	15.1	14.4	11.4	32.8	18.3	12.7	11.4	6.4	31.0	50.4	17.8	10.7	11.4	19.2	37.3	38.2	44.7	19.2	0.2	9.5	10.6	0.0	16.5	18.6	12.4	12.6	11.5	12.5	19.8	47.7	9.2	16.5	15.1	0.0	11.2	13.9	6.8	15.4	15.0	21.1	14.0	17.5	15.6	32.6	41.5	19.4	8.9	5.6	10.4	9.8	21.2	12.9	23.3	12.3
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 17.5;Cone photoreceptor cells: 64.8;Hepatocytes: 55.7"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;U-698: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.9	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.4	0.1	10.5	1.2	0.2	0.3	0.0	1.7	0.3	0.2	1.3	3.5	1.5	1.4	4.4	0.0	1.8	0.2	0.1	0.2	0.1	0.0	1.2	0.0	2.6	0.7	0.5	0.3	0.7	1.0	0.6	4.0	0.7	0.5	2.0	0.3	0.1	0.4	5.2	3.3	3.5	1.1	0.1	0.5	0.9	0.5	0.5	0.1	1.3	1.3	0.1	1.4	3.1	4.8	10.7	0.2	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6	0.0	3.0	0.0	0.4	0.0	17.5	10.1	0.0	1.4	2.3	1.8	64.8	0.2	0.0	0.3	3.0	1.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	55.7	0.1	14.3	1.7	0.6	1.3	2.3	2.8	0.0	0.0	0.0	0.3	4.3	0.1	0.0	3.2	0.3	10.5	0.0	0.5	0.5	5.3	0.5	0.0	0.0	0.4	2.2
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.1;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	3.0	2.1	3.2	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.7	0.8	41.1	6.2	0.3	0.7	0.0	3.4	0.4	0.5	4.2	5.7	6.4	1.9	13.4	0.5	9.9	0.8	0.3	1.6	0.1	0.0	2.3	0.0	11.3	3.2	0.0	0.6	7.6	12.0	5.9	0.8	5.8	1.5	13.9	0.6	0.4	2.5	6.6	3.7	3.3	3.8	0.4	4.0	0.9	5.9	5.4	0.0	0.4	2.1	0.1	2.1	5.8	8.6	51.4	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8	14.9	22.3	8.8	4.6	1.4	10.6	29.9	5.1	13.4	9.1	7.0	15.7	5.0	1.7	1.8	0.5	3.1	8.4	23.3	0.8	4.3	2.1	5.1	6.9	85.5	3.2	15.9	8.1	6.7	3.8	0.0	3.1	2.0	1.7	0.0	10.5	10.4	1.3	3.5	4.2	24.0	6.5	0.0	1.6	1.4	6.1	2.6	1.6	5.4	16.7	11.5
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646155	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 57.8;Late spermatids: 47.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 1.4;neutrophil: 5.0"	"Group enriched"	"Detected in many"	32	"B-cells: 1.4;granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.9	1.9	9.9	1.3	10.2	0.9	1.1	10.7	23.5	0.9	1.6	4.0	0.0	0.9	0.9	0.9	0.8	4.8	1.4	0.8	9.7	7.7	0.9	0.8	2.2	0.9	5.8	12.1	0.8	3.0	0.8	3.8	1.1	10.2	1.7	1.7	0.0	0.8	0.9	0.8	2.4	1.1	1.1	1.4	1.1	3.2	3.5	2.3	0.0	0.8	0.0	1.1	0.9	0.1	1.4	0.0	5.0	0.0	0.0	0.0	0.0	3.6	4.1	0.2	2.6	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	1.5	1.1	2.0	0.0	4.3	1.7	0.7	0.0	0.0	4.8	1.8	0.0	3.5	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	1.9	0.0	0.2	0.0	1.2	0.1	0.0	0.5	0.2	0.3	0.2	0.0	0.8	0.1	0.2	7.8	0.5	0.1	2.2	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.4	0.8	0.6	6.3	0.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	10.2	10.7	14.9	9.7	7.7	5.8	12.1	10.2	2.3	3.0	0.3	0.0	0.0	0.0	1.8	1.2	0.0	10.7	2.3	0.0	0.0	0.0	0.0	0.2	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	47.2	0.6	0.0	0.0	1.0	0.7	0.2	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.9	1.4	0.0	0.6	0.0	0.3	0.2
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649977-24667033	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.3;intestine: 55.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 434.9;Paneth cells: 431.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.6;neutrophil: 57.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 57.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	6.8	4.8	8.2	15.4	9.2	3.7	5.6	10.8	7.5	6.1	36.0	3.7	4.9	25.8	4.9	5.2	4.9	4.5	6.2	8.1	6.8	6.9	16.4	10.4	6.5	7.1	7.7	6.3	5.7	5.9	4.4	9.4	5.7	6.5	12.3	27.9	3.6	4.9	4.8	5.0	4.8	55.7	6.1	5.8	6.3	5.1	21.1	5.7	8.2	5.3	4.1	7.3	9.6	7.0	5.3	3.3	57.3	3.9	6.9	8.3	5.7	17.7	14.1	16.2	18.6	25.1	25.7	12.6	15.8	20.4	15.2	20.4	19.4	10.1	21.4	27.9	16.6	35.4	13.1	19.6	18.0	20.8	27.4	20.6	20.0	15.0	31.5	16.0	30.7	19.4	17.1	17.0	15.8	14.4	18.1	24.5	20.8	17.9	9.2	22.7	12.7	23.8	19.6	14.4	20.5	12.2	20.8	17.0	23.0	26.1	25.3	20.4	11.7	12.9	32.8	25.8	17.2	15.1	17.8	18.2	14.8	12.4	11.0	23.1	13.3	39.1	29.2	10.2	40.5	23.6	15.6	3.5	7.1	6.9	3.7	8.3	5.3	8.0	7.5	3.3	3.5	6.6	7.2	57.3	6.9	3.9	3.1	7.9	5.7	8.2	9.2	10.8	7.5	6.8	6.9	7.7	6.3	6.5	5.7	6.0	14.7	22.2	25.0	12.6	10.6	16.2	30.6	26.8	20.5	21.0	5.9	16.0	41.4	30.3	141.5	21.2	434.9	0.0	31.2	20.7	17.0	29.4	23.1	27.3	64.5	6.4	50.6	22.7	22.6	63.7	16.7	28.7	11.8	84.8	117.3	17.2	19.7	431.3	21.9	159.2	13.9	32.3	20.6	8.9	20.2	14.4	37.1	27.7	86.0	22.3
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.7"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 754.9;Proximal tubular cells: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	10.0	9.7	13.5	7.0	14.5	4.7	7.9	8.2	13.1	5.8	12.8	5.6	5.9	9.4	5.2	6.2	5.4	5.9	9.9	24.2	11.1	11.6	26.3	41.7	7.0	7.1	13.8	10.6	6.4	9.7	8.9	12.2	6.3	12.3	9.8	11.0	4.0	7.4	6.4	15.7	8.2	8.6	5.5	10.1	6.8	8.1	19.8	8.8	10.5	8.7	8.5	5.2	6.9	4.7	12.8	8.7	11.5	10.5	7.8	12.0	8.8	4.3	5.6	5.7	10.3	8.2	10.3	3.2	3.6	4.3	2.6	4.2	7.5	5.6	8.1	12.3	4.1	14.0	4.8	5.0	7.3	4.1	12.7	4.6	7.6	5.8	5.2	4.1	4.8	3.5	5.9	7.2	3.5	7.0	6.5	6.2	8.4	12.1	4.3	5.2	4.5	8.7	9.4	3.9	8.6	4.5	7.5	5.1	10.2	8.8	4.1	11.5	4.0	4.2	14.4	10.1	7.0	9.9	4.0	7.2	4.8	2.7	1.3	3.4	8.2	20.8	8.2	5.0	17.6	14.3	6.9	10.2	6.4	8.8	10.5	12.0	12.8	9.9	10.0	8.7	8.7	11.7	10.2	11.5	7.8	9.9	7.0	9.5	8.8	13.5	14.5	8.2	13.1	11.1	11.6	13.8	10.6	12.3	8.8	62.5	32.4	18.2	21.9	15.2	15.6	80.7	43.3	40.2	25.0	29.6	15.7	46.4	134.3	36.6	754.9	21.5	50.1	0.0	35.3	23.9	19.9	21.9	13.9	199.8	79.5	4.8	52.6	21.5	21.2	100.1	18.1	27.8	25.3	112.8	85.9	34.6	30.9	101.7	22.6	372.2	30.4	25.8	15.5	41.9	20.4	20.6	33.4	16.2	62.8	21.7
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24720836	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.62e-6)"	38.9	38.3	46.0	42.8	49.9	37.8	52.0	34.3	50.1	30.7	35.4	31.4	49.9	30.8	31.0	42.6	33.1	32.0	41.9	27.8	38.2	40.5	35.1	49.0	54.6	67.6	50.0	36.7	37.8	52.9	35.6	33.6	37.9	33.9	33.6	31.3	33.8	47.4	52.6	31.1	33.7	38.6	28.8	36.4	58.3	38.9	46.0	38.1	75.2	41.5	28.1	56.5	35.6	34.2	48.4	48.7	64.0	62.3	52.7	65.3	103.5	23.0	14.3	17.6	29.8	22.2	28.7	19.3	27.4	35.8	41.3	44.2	17.9	20.8	26.6	43.2	32.1	40.8	19.3	20.1	26.8	45.8	44.8	9.7	27.9	23.3	24.0	37.9	33.9	33.4	22.3	54.1	27.9	37.2	27.6	31.9	16.6	24.5	19.9	38.7	19.1	26.0	51.0	19.4	14.1	14.5	20.9	19.1	26.7	24.6	34.9	29.8	16.8	32.8	37.4	49.7	20.6	32.8	27.2	28.3	37.4	18.1	14.1	37.2	46.8	73.7	33.1	13.4	46.9	36.1	47.7	62.1	64.0	55.7	62.0	58.6	48.4	57.4	60.6	47.7	41.8	57.6	65.3	44.2	52.7	62.3	48.7	53.4	103.5	46.0	49.9	34.3	50.1	38.2	40.5	50.0	36.7	33.9	38.1	77.4	66.5	104.0	40.4	51.1	48.9	29.1	107.0	54.9	46.6	89.0	47.1	43.9	31.5	55.4	110.4	61.6	88.0	93.5	64.0	46.9	51.8	87.1	54.3	110.1	83.6	39.7	92.1	86.5	306.8	40.0	50.0	84.3	47.2	83.8	78.0	40.4	70.7	77.0	44.6	54.9	60.4	51.8	42.8	83.7	91.8	48.9	62.9	96.5	75.2	51.5
GMNN	Gem	ENSG00000112312	"Geminin, DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 95.0"	"Cell type enhanced"	"Detected in many"	8	"Paneth cells: 272.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	4.5	3.9	10.7	11.2	19.0	24.1	10.7	15.6	9.4	4.9	17.1	3.2	9.7	7.6	5.3	6.3	8.0	7.3	4.7	3.7	11.0	10.2	10.8	8.4	4.4	12.0	13.6	9.8	7.2	95.0	2.6	7.5	7.9	10.7	18.4	18.9	3.4	4.2	11.6	3.7	17.3	7.4	5.7	7.9	12.6	9.7	19.6	11.9	26.1	13.2	11.0	9.7	15.2	7.4	8.5	9.2	15.8	6.7	5.3	15.2	5.6	24.9	14.8	37.6	15.5	5.3	5.7	25.1	24.5	13.0	29.5	32.4	28.7	9.0	25.1	31.3	7.9	21.7	14.7	32.5	18.1	31.8	9.3	34.0	34.4	26.4	47.0	5.0	26.7	12.6	4.6	5.9	17.9	7.0	6.1	14.5	19.6	43.2	13.4	20.8	19.5	50.1	28.9	20.5	20.4	11.7	29.2	29.4	32.2	12.4	21.8	30.2	18.6	11.0	18.2	21.6	22.1	19.1	16.4	7.1	18.1	18.3	20.8	41.5	14.9	45.7	47.1	5.5	50.4	25.9	5.3	5.3	15.8	4.6	6.7	5.8	8.5	8.9	7.1	7.4	4.5	6.6	7.3	3.0	5.3	4.7	9.2	15.2	5.6	10.7	19.0	15.6	9.4	11.0	10.2	13.6	9.8	10.7	11.9	6.0	14.1	15.7	25.3	29.3	8.9	9.4	15.3	33.5	52.4	41.8	2.0	52.0	8.3	78.3	58.9	14.3	21.2	0.0	100.1	110.5	15.8	27.7	12.7	15.3	45.0	11.1	24.9	9.8	9.2	17.5	8.9	12.4	21.9	19.8	24.9	29.4	43.9	272.7	10.3	14.6	12.1	19.4	12.3	132.2	59.4	55.6	40.7	17.5	87.0	19.7
C6orf229		ENSG00000260286	"Chromosome 6 open reading frame 229"	H3BNL8	6	24797321-24798889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 6.4;testis: 25.2"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 20.1;Early spermatids: 14.7;Late spermatids: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;CACO-2: 1.1;Daudi: 1.9;NB-4: 1.1;SCLC-21H: 1.6;U-937: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"									NA	NA												"unprognostic (1.28e-1)"							"unprognostic (1.16e-1)"				0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	25.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.1	0.6	6.4	1.0	0.4	1.9	0.1	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.9	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.7	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.4	1.1	0.0	1.1	1.0	0.4	0.9	0.4	1.9	1.3	0.9	1.2	0.6	2.1	1.3	0.9	6.4	0.4	0.3	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	2.3	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
AL512428.1		ENSG00000282804			6	24797373-24809798	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.2;lymphoid tissue: 2.2"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HEK 293: 1.1;HeLa: 1.3;U-138 MG: 1.1;U-251 MG: 1.0;U-266/70: 1.0"															NA	NA																							0.1	0.0		2.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.5	0.0	1.1			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.0	0.0	0.5		0.6	0.7	1.1			0.1		0.9	0.2		0.8	2.1	3.2	0.6	0.0	1.7	0.1	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	1.0	0.0	0.0	0.5	0.0	0.0	0.9	0.5	0.8	1.7	0.6	1.7	0.4	0.4	0.8	0.3	0.8	1.4	1.7	3.2	0.0	0.0	2.1	0.9	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIPOR2	"C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP"	ENSG00000111913	"RHO family interacting cell polarization regulator 2"	Q9Y4F9	6	24804281-25042170	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Differentiation, Hearing, Myogenesis"	"Developmental protein, Signal transduction inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 125.3;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in some"	25	"Ciliated cells: 152.6;Club cells: 34.2;Syncytiotrophoblasts: 69.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 125.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 125.3"	"Cell line enhanced"	"Detected in many"		"AF22: 14.3;Daudi: 33.6;fHDF/TERT166: 32.8;U-266/70: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.05e-3)"	"unprognostic (1.34e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.89e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	8.2	2.5	6.7	38.0	14.9	14.7	4.7	1.8	11.4	8.6	2.5	1.9	1.4	1.9	33.8	4.2	3.4	8.8	5.5	7.3	6.1	6.2	2.7	2.8	13.2	49.7	3.6	9.1	2.5	1.8	0.8	16.9	17.8	2.9	4.4	2.7	3.3	12.5	3.0	12.9	4.0	11.9	10.7	2.2	39.1	3.8	4.1	2.4	21.5	2.5	1.2	42.7	7.7	5.4	25.8	9.1	125.3	21.1	15.8	24.6	18.1	0.4	0.0	14.3	0.2	0.1	0.1	5.2	3.7	7.1	1.7	2.5	0.2	0.2	33.6	0.9	32.8	0.2	0.4	0.0	0.0	0.3	3.4	0.1	8.1	0.5	0.1	0.3	0.2	0.6	1.5	0.1	0.0	0.1	0.1	0.0	1.4	0.4	5.8	0.1	0.1	7.5	0.3	1.1	0.5	0.9	8.0	1.3	0.3	0.0	0.1	0.7	0.1	0.2	0.1	2.5	5.1	0.1	0.2	0.1	0.3	1.5	0.3	0.4	12.2	0.3	1.1	0.3	0.4	2.3	43.1	12.9	41.8	18.1	16.7	19.1	25.8	18.5	18.9	9.1	25.0	24.6	19.1	125.3	15.8	21.1	7.5	15.9	18.1	6.7	14.9	1.8	11.4	6.1	6.2	3.6	9.1	2.9	2.4	3.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	152.6	34.2	5.2	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	11.6	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.0	0.0
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 20.9;Collecting duct cells: 33.2;Distal tubular cells: 39.7;Proximal tubular cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 20.9;RPTEC TERT1: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	8.1	7.2	10.1	7.1	12.3	1.2	9.3	20.0	10.3	8.2	15.3	4.5	8.0	20.8	5.2	10.7	7.7	8.2	11.7	7.5	9.0	5.5	12.8	3.3	11.3	13.7	5.8	8.3	8.3	6.4	9.8	7.0	6.6	6.5	5.2	14.2	7.1	10.0	10.7	1.4	8.3	30.5	7.9	6.2	4.3	10.3	20.8	3.5	6.7	7.7	4.8	7.6	8.7	9.6	4.1	2.6	0.0	3.1	1.5	3.0	0.5	7.5	7.6	2.1	2.7	2.0	1.0	7.4	2.6	5.8	2.8	4.9	8.2	5.7	2.6	8.5	4.1	8.2	8.3	8.2	7.3	2.0	6.5	4.3	6.3	8.9	1.0	5.6	0.2	1.0	1.1	5.0	5.3	8.2	3.4	0.1	1.0	0.2	2.1	1.7	5.9	0.4	0.0	2.9	13.4	3.2	0.9	1.3	20.9	21.6	6.9	5.5	1.2	11.5	19.8	7.5	6.5	4.8	0.2	0.1	2.1	3.6	9.7	2.6	0.3	0.1	4.2	3.2	2.3	7.6	0.0	1.1	0.0	0.0	1.3	0.2	0.7	0.4	0.2	1.1	4.1	3.0	0.5	0.0	1.5	3.1	2.6	0.0	0.5	10.1	12.3	20.0	10.3	9.0	5.5	5.8	8.3	6.5	3.5	17.9	20.9	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.9	33.2	0.0	16.5	39.7	13.8	0.0	0.0	0.0	0.0	13.6	6.5	0.0	0.0	8.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.4	0.0	0.0	13.5	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 576.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.6"	"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	99.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	0.1	0.0	4.7	0.0	0.0	0.1	0.0	576.5	1.8	0.0	0.0	0.6	0.0	0.0	1.8	2.8	0.0	7.8	2.9	0.0	2.2	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0
HIST1H2AA	"bA317E16.2, H2AFR"	ENSG00000164508	"Histone cluster 1 H2A family member a"	Q96QV6	6	25726132-25726527	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	518	"testis: 453.1"	"Group enriched"	"Detected in some"	15	"Spermatocytes: 219.3;Spermatogonia: 217.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"HEK 293: 3.0"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	219.3	217.6	0.0	0.0	0.0	0.0	0.0
HIST1H2BA	"bA317E16.3, H2BFU, STBP, TSH2B"	ENSG00000146047	"Histone cluster 1 H2B family member a"	Q96A08	6	25726777-25727292	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	695	"testis: 617.2"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 7.3;Late spermatids: 2.5;Spermatocytes: 13.4;Spermatogonia: 5.3"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011603, HPA042205, HPA043013"	Enhanced					NA	NA					"CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269"															"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	617.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.4	5.3	0.0	0.0	0.0	0.0	0.0
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 86.6;Enterocytes: 45.7;Hepatocytes: 37.5;Paneth cells: 43.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.8"	"Not detected"	"Not detected"							HPA055564	Approved					NA	NA					"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.8	5.8	0.0	0.2	0.4	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	86.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.8	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	37.5	0.1	0.0	12.6	0.6	1.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	43.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782897-25832059	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	56	"kidney: 67.6;liver: 17.9"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 44.6"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	389	"RPTEC TERT1: 38.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050513			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	67.6	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 62.3"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 127.1"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Cell line enriched"	"Detected in single"	217	"RPTEC TERT1: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	62.3	13.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.9	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930726	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	333	"liver: 80.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 29.7"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA038270	Uncertain					NA	NA					"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"B-cells: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.4	13.9	3.6	4.5	9.0	8.8	14.6	1.6	3.8	7.9	7.4	5.5	8.5	5.6	2.7	4.4	5.2	8.0	1.8	3.6	3.3	1.4	13.8	4.2	7.4	13.9	3.3	5.4	1.9	7.3	7.6	3.9	2.3	4.4	10.4	1.7	4.0	4.8	1.4	0.0	2.7	6.2	4.3	8.2	10.4	7.1	0.1	0.1	3.4	7.1	12.0	0.5	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.3	5.2	9.7	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9	23.8	43.9	100.5	47.4	13.3	0.6	3.5	22.9	17.4	29.6	43.6	0.0	19.8	14.9	19.1	0.9	42.0	39.9	0.0	13.0	17.5	17.0	35.9	34.6	14.8	28.8	0.0	17.4	27.0	84.3	2.2	18.4	61.3	10.1	49.5	29.9	0.3	17.8	40.3	17.7	62.8	0.7	6.5	18.9	0.2	0.2	8.2	17.7	36.2	23.3	78.5
HIST1H1A	"H1.1, H1a, H1F1"	ENSG00000124610	"Histone cluster 1 H1 family member a"	Q02539	6	26017085-26017732	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 57.2"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 131.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.1;REH: 4.4;RPTEC TERT1: 1.5;U-2 OS: 3.9"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.8	1.4	1.0	3.9	0.9	1.1	0.8	0.9	3.3	3.5	0.8	0.0	0.4	0.7	3.6	3.9	6.2	1.1	3.4	2.8	1.0	0.8	3.7	5.3	0.7	1.3	0.8	0.6	7.9	0.8	0.7	1.0	0.7	0.6	0.9	0.9	0.9	0.7	1.5	0.7	2.0	0.8	0.7	0.7	0.9	0.8	57.2	0.0	15.1	2.7	10.6	12.4	1.2	0.8	1.4	1.2	0.0	0.1	0.0	4.9	0.4	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.6	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.4	0.0	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	3.9	0.5	0.0	0.2	0.5	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.0	1.4	2.8	0.3	0.6	0.0	1.7	0.1	0.0	0.0	0.0	1.2	4.9	0.4	1.0	0.9	0.9	3.3	1.0	0.8	0.8	0.6	0.6	0.0	0.0	0.3	0.0	1.0	0.1	0.0	3.4	0.0	1.4	1.2	0.0	0.0	0.1	14.9	0.0	0.3	0.0	0.0	0.0	0.2	3.6	0.6	0.2	1.1	2.1	1.6	0.0	0.0	4.3	0.3	0.9	0.9	0.2	1.7	0.0	0.0	0.5	0.2	0.0	1.8	0.3	1.0	0.0	0.4	4.9	131.8	0.4	0.3	0.0	0.0	0.3
HIST1H3A	"H3/A, H3FA"	ENSG00000275714	"Histone cluster 1 H3 family member a"	P68431	6	26020490-26020900	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1;testis: 78.7"	"Cell type enhanced"	"Detected in some"	5	"Club cells: 2.3;Spermatogonia: 1.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 5.6;U-2 OS: 9.0"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (3.07e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.36e-5)"	"unprognostic (2.85e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.21e-2)"	1.6	2.1	0.8	6.3	0.5	23.5	1.2	8.0	7.2	2.1	1.2	0.0	1.2	0.9	1.9	4.8	3.0	1.5	2.1	2.5	0.9		1.8	1.1	2.1	2.6	0.0	2.5	1.6	2.9	0.9	1.1	1.2	2.4	1.4	1.8	1.6	1.2	1.0	0.9	1.3	1.5	2.3	0.8	2.6	1.3	78.7	0.0	40.1	1.6	4.1	8.4	0.9	0.0	3.9	5.2	14.6	1.6	8.8	3.9	1.5	1.5	0.0	1.7	0.0	1.5	0.7	0.0	2.4	0.0	2.0	4.3	0.0	0.8	1.5	0.9	0.0	0.6	0.0	2.6	0.6	4.0	0.8	3.1	2.5	0.8	0.0	0.0	0.3	2.2	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.2	0.2	0.0	5.6	4.0	1.8	2.2	1.1	2.5	2.7	1.2	0.0	0.5	1.3	1.2	2.5	1.9	3.2	0.5	0.0	0.2	2.0	0.0	0.0	9.0	0.8	1.0	0.5	0.4	0.0	1.1	3.1	2.9	11.1	1.5	4.3	3.9	1.6	3.3	2.1	2.8	2.3	3.0	3.9	2.2	1.7	14.6	8.8	0.9	5.2	3.8	1.5											0.0	1.4	0.8	0.4	0.3	0.6	0.3	0.0	1.4	2.3	0.0	0.0	0.2	0.0	0.0	0.6	0.4	1.8	0.0	0.0	0.2	0.6	0.2	1.1	0.5	0.6	0.0	0.0	0.6	1.5	0.0	0.0	0.6	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.3	1.4	1.9	0.1	0.0	1.9	0.2	0.1
HIST1H4A	H4FA	ENSG00000278637	"Histone cluster 1 H4 family member a"	P62805	6	26021679-26021990	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 87.7"	"Cell type enhanced"	"Detected in some"	9	"Cone photoreceptor cells: 2.0;Enterocytes: 1.1;granulocytes: 1.1;Rod photoreceptor cells: 1.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	4	"neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.8;NB-4: 10.1;REH: 12.6"									"CAB021887, HPA042201"	Supported					NA	NA		30000000			"CAB021887: AB_2279758, HPA042201: AB_2677898"	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.5	0.5	0.0	5.2	0.0	7.1	2.1	16.7	3.2	0.6	1.5	0.0	0.0	5.2	1.5	1.8	3.7	0.3	1.2	3.2	0.0		0.5	0.1	2.0	3.5	0.0	1.8	1.4	0.8	0.1	0.0	0.8	0.2	0.4	1.0	1.6	0.8	1.0	0.8	0.9	1.1	3.6	0.1	2.5	0.7	2.6	0.0	87.7	2.5	3.6	9.6	2.0	0.0	0.8	0.9	14.0	1.0	1.2	1.4	0.2	3.8	1.8	3.5	0.0	0.8	0.0	0.0	0.3	1.3	1.6	2.3	0.0	5.7	2.6	0.9	0.0	0.1	5.0	2.6	0.0	0.5	0.4	1.8	2.6	1.5	0.0	0.0	0.6	6.1	0.0	0.0	0.5	0.0	0.0	1.6	3.6	1.3	4.1	0.0	1.5	13.8	10.1	2.3	1.0	0.0	12.6	2.2	2.2	0.0	0.4	4.3	1.9	1.6	6.2	0.1	0.0	3.3	2.8	0.0	3.1	7.9	3.0	3.0	1.5	2.4	0.0	1.4	4.2	5.9	0.0	1.0	3.4	1.3	0.8	0.2	0.4	1.1	0.3	0.9	0.8	0.4	0.3	14.0	1.2	0.2	0.4	1.4	0.2											0.0	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.3	0.2	0.3	1.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.2	0.0
HIST1H4B	"H4/I, H4FI"	ENSG00000278705	"Histone cluster 1 H4 family member b"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 102.5"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 2.2;Collecting duct cells: 1.8;Enterocytes: 3.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	6	"neutrophil: 25.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.8"	"Low cell line specificity"	"Detected in many"											HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	2.6	1.0	0.3	6.2	0.4	11.3	2.3	6.2	1.0	4.0	3.2	0.0	4.2	1.8	5.7	1.8	5.7	3.3	2.0	1.6	0.2		5.0	1.7	3.0	4.7	0.2	0.0	8.6	19.9	1.0	0.5	2.4	0.4	3.6	1.4	6.0	4.0	3.5	2.3	1.6	2.7	2.0	0.0	6.3	2.2	10.5	0.2	102.5	8.0	3.0	8.9	3.5	4.3	4.3	1.3	25.8	1.2	0.2	1.0	0.3	1.8	0.0	0.2	3.8	0.0	0.0	0.0	2.8	0.3	1.7	1.2	0.7	0.5	1.4	0.6	0.6	1.1	0.5	0.8	0.0	1.0	0.6	3.9	4.8	1.8	2.1	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	5.4	0.5	2.8	4.7	3.7	0.9	0.8	0.6	3.4	1.7	3.0	0.0	1.3	1.0	0.7	0.4	2.1	0.0	0.0	0.5	2.5	0.0	1.1	2.5	2.0	3.7	3.0	2.8	2.3	1.4	1.5	1.9	0.0	0.5	0.7	0.9	0.6	0.9	1.7	1.0	0.8	0.4	4.3	0.8	0.4	25.8	0.2	1.2	1.3	0.7	0.3											0.0	0.0	2.2	0.4	0.3	0.3	0.2	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.1	0.4	0.0	0.8	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.3	0.1	0.2	0.0	0.2	1.1	0.0	0.3	0.7	0.9	0.0	0.2	0.0	0.6	0.1
HIST1H3B	"H3/l, H3FL"	ENSG00000274267	"Histone cluster 1 H3 family member b"	P68431	6	26031650-26032060	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 343.5"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 12.0"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (2.82e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-7)"	"unprognostic (8.52e-2)"	"unprognostic (2.78e-1)"		"unprognostic (1.90e-3)"	1.7	0.7	0.0	36.1	0.0	18.1	3.6	0.0	0.3	0.8	6.9	0.0	0.0	0.3	0.8	2.5	11.8	0.5	1.9	2.4	0.0		0.6	0.3	3.4	10.4	0.0	0.0	0.3	0.3	0.3	0.0	7.8	0.0	0.3	0.8	0.0	1.0	0.3	0.3	0.3	6.3	0.8	0.0	14.7	0.5	26.9	0.0	343.5	0.8	18.2	27.7	0.3	0.0	0.8	0.1	1.2	0.0	0.0	1.4	3.1	1.8	4.6	1.3	4.0	0.0	0.4	0.0	0.2	0.8	0.8	0.7	1.1	1.0	3.0	2.0	0.3	1.2	0.7	1.6	1.2	1.7	2.0	4.4	3.2	6.0	1.3	0.0	2.4	2.1	2.9	0.0	0.6	0.0	0.1	1.0	0.9	6.5	5.9	1.1	1.0	7.4	7.4	3.1	0.7	3.2	4.3	2.9	8.5	0.5	0.0	2.1	1.7	5.1	1.6	0.5	0.1	2.8	1.5	1.4	1.4	4.1	0.7	1.7	9.6	12.0	3.9	3.4	4.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.1	0.5	0.0	0.2	1.2	0.0	0.0	0.0	1.4	3.1											0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.1	0.2	0.0	0.6	0.1
HIST1H2AB	"H2A/m, H2AFM"	ENSG00000278463	"Histone cluster 1 H2A family member b"	P04908	6	26033176-26033568	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 133.2"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 2.2;Early spermatids: 2.6;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 9.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.7	0.3	0.2	7.6	0.0	9.6	2.6	0.2	0.6	0.5	1.7	0.0	0.0	0.3	0.5	0.3	5.0	0.3	0.7	2.6	0.0		0.6	0.3	1.7	5.9	0.0	0.0	0.3	0.3	0.3	0.0	2.6	0.0	0.5	0.3	0.2	0.3	0.3	0.3	0.3	2.2	0.3	0.1	8.2	0.7	8.3	0.0	133.2	0.3	1.5	12.2	0.3	0.0	4.2	1.8	3.4	1.5	1.4	2.4	0.3	0.2	1.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	0.3	1.8	0.9	0.0	0.1	0.6	0.5	0.0	0.6	0.9	2.2	1.1	0.5	9.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	1.0	0.0	1.4	2.0	2.0	3.6	0.0	3.5	1.2	0.7	1.5	0.0	3.0	0.4	0.1	2.1	0.0	0.1	0.1	0.6	1.0	0.0	0.3	4.0	0.3	0.2	1.5	2.5	0.1	0.6	3.7	0.3	0.0	0.1	3.4	0.8	1.5	0.0	4.2	1.5	2.4	1.8	3.1	0.6	0.8	0.7	1.4	0.1	0.2	0.6	0.3											0.0	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.6	0.3	1.0	0.0	0.0	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	1.1	0.0	0.5	0.0	0.4	0.5
HIST1H2BB	"H2B/f, H2BFF"	ENSG00000276410	"Histone cluster 1 H2B family member b"	P33778	6	26043277-26043657	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in some"	10	"Enterocytes: 1.6;Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 3.7;Karpas-707: 3.6;MOLT-4: 4.5;NB-4: 4.9;THP-1: 5.5;U-266/84: 6.1"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.4	0.3	1.0	6.4	0.3	6.6	0.6	0.5	1.0	0.5	1.0	0.0	0.0	1.1	0.4	0.5	4.1	0.6	0.3	1.0	0.2		0.8	0.3	1.7	3.0	0.1	0.4	0.3	0.5	0.3	0.0	0.9	1.0	0.3	0.3	0.2	0.3	0.3	1.3	1.0	0.8	0.3	0.8	5.8	0.5	15.8	0.1	104.9	0.3	4.8	7.4	0.3	0.0	2.1	10.5	4.2	1.1	0.2	3.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.4	1.1	1.6	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.6	0.0	0.3	1.4	0.6	3.7	3.6	0.0	0.0	4.5	4.9	2.2	0.7	2.1	2.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.3	5.5	0.0	0.3	0.3	0.3	0.9	0.8	6.1	0.0	0.7	1.8	1.3	4.2	1.1	0.8	1.5	0.1	3.9	2.1	3.9	1.6	3.3	1.6	2.0	0.8	3.6	0.2	0.4	10.5	2.9	0.6											0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.3	0.1	0.0	0.3	0.0
HIST1H3C	"H3.1, H3/c, H3FC"	ENSG00000278272	"Histone cluster 1 H3 family member c"	P68431	6	26045411-26045821	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 306.0"	"Cell type enhanced"	"Detected in some"	14	"Distal tubular cells: 1.7;Enterocytes: 2.1;Extravillous trophoblasts: 1.6;Spermatogonia: 3.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 11.1"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.27e-2)"	1.7	0.2	0.0	23.3	0.0	12.8	1.8	0.0	0.7	1.0	5.1	0.0	0.0	1.2	0.5	1.5	10.1	0.4	1.6	1.8	0.0		2.8	0.6	3.0	10.9	0.0	0.0	0.2	0.4	0.2	0.0	6.6	0.0	0.6	1.1	0.0	1.0	0.2	0.2	0.7	5.4	0.2	0.0	18.8	1.0	29.9	0.0	306.0	0.2	9.9	25.2	2.3	0.0	2.2	1.0	0.3	0.2	3.3	3.7	1.9	2.6	0.6	1.3	0.0	0.6	0.0	0.0	2.1	0.9	5.1	5.2	0.0	0.4	0.0	0.1	0.5	2.4	1.3	0.0	0.5	3.6	3.7	0.4	4.2	0.5	3.7	0.4	2.7	1.7	0.0	0.4	1.4	0.0	0.7	1.6	0.4	0.0	0.0	0.0	0.0	4.0	5.2	2.3	2.6	5.1	4.7	0.0	0.0	0.6	5.6	0.1	1.7	5.1	3.2	0.5	0.2	1.4	1.6	0.0	0.0	0.0	2.1	3.5	2.4	0.1	0.0	1.5	11.1	3.5	0.0	0.2	0.0	1.5	0.1	0.0	1.5	0.6	1.1	1.0	2.2	0.6	2.2	0.3	3.3	0.0	0.9	3.7	1.9											0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.2	0.0	2.1	0.0	0.0	1.6	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.8	0.0	0.5	0.0	1.0	0.1
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell type enhanced"	"Detected in all"	6	"Glandular cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"K-562: 50.0;SiHa: 47.6;U-2 OS: 93.7;U-266/70: 103.9;U-266/84: 98.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		1800000	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.9	4.2	3.1	3.4	8.1	1.6	0.1	2.9	4.9	14.1	15.0	2.3	4.3	0.4	17.2	3.9	5.1	2.6	1.0	2.3	3.9	5.7	3.7	2.4	4.7	2.6	2.4	1.1	5.9	11.5	3.1	1.8	3.1	4.3	2.2	2.7	50.0	37.6	7.0	2.6	3.0	2.6	1.7	14.5	6.5	1.6	1.4	19.1	8.3	4.3	8.2	2.8	47.6	8.2	3.3	3.1	10.1	1.7	1.0	6.4	93.7	1.9	1.3	103.9	98.7	4.5	4.7	38.9	2.2	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4	65.5	28.8	111.5	307.6	7.2	72.6	41.5	30.6	100.4	35.2	66.3	47.1	37.6	44.7	79.4	2.2	29.5	161.7	256.9	100.4	59.2	37.4	442.5	18.6	102.4	61.4	49.3	37.3	33.7	27.5	4.2	24.2	37.4	3.3	16.2	65.1	147.0	86.1	92.5	10.3	161.0	135.9	25.8	23.3	14.2	90.3	6.9	249.6	48.4	36.8	295.6
HFE	HLA-H	ENSG00000010704	Hemochromatosis	Q30201	6	26087281-26098343	"Disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	7.2	13.7	2.2	4.4	2.7	0.0	6.2	1.2	2.5	6.7	7.1	3.5	10.3	4.2	6.8	13.9	7.6	5.2	13.3	8.9	2.0	1.4	5.4	12.8	9.0	16.1	2.3	2.0	8.1	16.2	14.6	2.2	7.6	4.3	12.6	5.3	13.7	7.0	8.1	3.1	3.2	5.8	10.4	3.2	14.4	6.1	4.9	1.2	2.0	7.7	3.9	5.0	8.6	5.2	3.5	4.6	1.9	10.5	0.2	2.2	3.4	8.2	18.9	0.3	9.2	14.0	10.8	0.0	5.9	14.1	7.6	12.0	1.6	16.8	0.8	16.1	9.7	11.5	5.3	0.0	6.9	9.7	2.1	0.1	0.2	4.5	1.2	2.7	0.0	0.3	11.1	2.0	8.4	0.7	6.7	5.1	0.0	0.3	0.2	6.5	3.4	0.0	0.1	0.4	3.9	0.0	1.1	0.0	0.1	6.3	5.5	0.0	0.0	3.5	0.0	5.1	0.1	26.9	0.9	3.9	5.4	0.5	5.3	5.1	0.1	0.1	0.1	8.0	0.1	11.6	1.2	10.5	0.0	1.7	10.2	1.3	3.5	1.7	2.2	4.6	1.5	0.4	1.2	1.9	0.2	8.2	0.3	0.3	3.4	2.2	2.7	1.2	2.5	2.0	1.4	2.3	2.0	4.3	1.2	3.0	3.2	1.9	2.3	1.4	0.7	2.8	5.1	6.7	7.9	5.2	2.0	1.2	0.0	2.5	0.1	3.0	3.4	0.0	3.0	0.6	3.0	3.8	2.3	8.1	8.8	0.0	1.7	8.6	21.1	0.0	3.4	5.7	0.0	0.0	3.7	3.7	2.5	0.0	5.6	2.2	2.0	0.0	1.4	0.2	1.0	3.0	1.5	0.7	3.7	1.3
HIST1H4C	"dJ221C16.1, H4/g, H4FG"	ENSG00000197061	"Histone cluster 1 H4 family member c"	P62805	6	26103876-26104310	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 172.4;lymphoid tissue: 88.7"	"Group enriched"	"Detected in all"	5	"Erythroid cells: 5349.6;Spermatocytes: 1544.2;Spermatogonia: 2680.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 26.7;PC-3: 14.4"									HPA042201	Supported					NA	Yes		30000000			"HPA042201: AB_2677898"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-4)"	"unprognostic (6.95e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (5.74e-6)"	"unprognostic (2.42e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.79e-3)"	4.8	4.3	6.9	13.2	6.2	23.5	4.6	12.5	8.8	4.6	6.9	0.9	6.4	3.9	4.8	4.2	6.5	4.8	5.0	3.4	6.2	5.6	6.6	6.4	4.2	12.0	5.5	7.9	4.5	19.4	2.3	5.2	5.9	4.3	3.8	7.5	5.2	11.1	5.0	3.6	4.5	5.4	3.5	6.4	7.0	4.8	25.5	4.4	88.7	8.0	12.4	9.9	8.0	5.2	54.3	26.9	45.5	25.4	25.4	46.6	172.4	1.5	1.4	0.5	2.3	0.0	0.2	0.0	0.7	0.6	0.4	0.8	2.1	0.3	0.5	0.7	0.2	0.6	0.8	1.7	0.5	0.4	1.3	26.7	1.0	2.8	3.2	0.7	1.2	0.9	1.2	0.0	0.3	0.0	0.0	0.6	0.4	1.4	1.1	0.4	0.2	5.8	2.9	1.5	0.9	14.4	1.7	0.8	2.5	0.9	0.1	1.5	1.0	0.7	1.0	0.6	0.7	0.7	3.8	0.4	1.6	1.6	0.8	1.3	2.2	2.0	2.5	1.0	2.1	0.8	39.9	25.4	17.8	31.4	10.2	30.0	54.3	40.5	25.6	18.5	48.6	46.6	35.1	45.5	25.4	10.2	26.9	26.7	172.4	6.9	6.2	12.5	8.8	6.2	5.6	5.5	7.9	4.3	4.4	113.2	96.8	203.6	96.4	200.8	385.3	149.9	540.1	141.8	212.7	291.4	178.7	298.1	261.9	329.5	3.7	206.3	206.8	5349.6	321.8	569.2	94.6	66.7	135.8	494.9	220.3	125.5	94.0	248.6	132.2	25.7	128.3	121.7	37.1	83.0	263.6	673.8	310.1	136.8	154.5	261.4	631.5	226.4	105.6	1544.2	2680.9	182.2	184.2	191.9	173.9	53.7
HIST1H1T	"H1FT, H1t"	ENSG00000187475	"Histone cluster 1 H1 family member t"	P22492	6	26107419-26108136	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"testis: 257.2"	"Group enriched"	"Detected in some"	22	"Spermatocytes: 1.9;Spermatogonia: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	44	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;SiHa: 4.0;U-2 OS: 1.0;U-266/84: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065718, HPA068266"	Enhanced					NA	NA					"HPA065718: AB_2685543, HPA068266: AB_2685967"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-2)"		"unprognostic (9.52e-2)"		"unprognostic (9.94e-2)"		"unprognostic (5.12e-1)"		"unprognostic (1.57e-1)"	"unprognostic (7.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"		"unprognostic (6.28e-3)"	0.0	0.0	0.2	0.8	0.3	0.4	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.3	0.1	0.1	0.6	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.2	0.2	0.0	257.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	1.8	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.7	0.2	0.3	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	4.7	0.0	0.1	0.0	0.0	0.0
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"	"Cell line enhanced"	"Detected in many"		"K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	3.0	1.8	0.9	0.9	0.9	0.5	1.1	3.0	1.1	2.0	1.7	2.4	1.8	1.1	5.7	1.0	1.5	2.3	1.2	1.2	1.0	2.7	1.0	0.9	2.7	4.1	1.2	1.4	3.8	12.6	0.7	0.8	0.5	1.0	0.8	0.9	17.0	9.5	3.8	3.4	3.2	3.1	1.0	3.2	5.5	1.4	1.3	7.0	3.5	0.7	4.3	1.4	33.6	2.6	1.2	2.6	14.3	1.3	2.4	2.5	23.5	1.5	1.2	19.4	23.8	5.7	1.1	3.7	1.7	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5	6.0	2.7	3.0	40.5	0.8	3.0	1.8	5.1	21.4	7.9	3.5	0.0	3.9	1.7	6.8	42.1	2.9	9.5	0.0	8.0	5.4	4.1	78.6	4.6	13.0	5.8	0.0	1.7	1.8	3.7	4.5	1.4	4.6	0.0	1.8	7.4	2.9	25.5	9.9	1.1	3.5	3.9	0.0	1.8	1.8	3.2	1.0	35.8	10.1	4.9	103.5
HIST1H2AC	H2AFL	ENSG00000180573	"Histone cluster 1 H2A family member c"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 116.1;lymphoid tissue: 202.5"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 177.7;Urothelial cells: 208.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 116.1"	"Lineage enriched"	"Detected in all"	17	"granulocytes: 116.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.4;OE19: 26.8;SiHa: 26.9;U-2 OS: 27.1;U-266/84: 27.0"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	13.6	14.5	13.6	22.5	16.4	19.0	29.9	7.3	9.8	35.6	21.0	12.2	17.9	18.1	13.2	32.8	27.5	23.6	13.9	12.6	18.5	12.4	21.4	34.1	29.2	28.5	18.6	8.5	23.8	15.7	3.7	13.4	26.2	8.5	37.2	15.0	21.1	10.4	17.0	17.5	15.4	21.6	14.4	27.0	26.4	26.9	16.3	10.4	202.5	24.5	9.2	34.9	29.6	25.8	6.6	4.5	116.1	3.6	1.9	2.1	48.3	5.5	1.6	1.9	0.6	16.1	8.8	0.8	2.8	1.7	8.5	7.3	2.1	1.4	0.2	13.8	5.6	5.7	6.7	1.5	2.9	6.1	5.3	0.9	0.9	0.7	0.3	12.6	0.9	6.4	31.4	5.0	1.8	5.5	10.8	0.5	0.7	13.9	10.2	3.7	4.6	0.9	1.0	2.3	26.8	0.5	0.6	1.0	16.3	8.1	0.6	2.9	1.2	26.9	5.7	8.8	8.2	13.1	1.4	1.8	5.2	27.1	2.3	1.2	13.3	27.0	1.5	1.9	14.0	2.2	36.0	2.0	24.4	1.4	1.5	1.2	3.3	1.5	1.0	1.4	6.6	2.1	1.1	116.1	1.9	3.6	4.5	2.0	48.3	13.6	16.4	7.3	9.8	18.5	12.4	18.6	8.5	8.5	10.4	32.8	12.8	27.7	117.6	2.6	22.0	22.6	15.3	24.1	12.5	68.0	7.9	13.9	23.2	18.9	3.5	18.0	86.9	0.0	11.7	21.5	13.7	177.7	10.4	51.3	13.8	17.5	93.4	16.0	10.5	0.5	13.0	8.0	5.0	12.6	30.9	10.9	33.5	129.8	7.1	77.4	22.6	19.4	16.5	2.4	2.2	7.3	63.5	18.7	26.1	208.4
HIST1H1E	"H1.4, H1e, H1F4, H1s-4"	ENSG00000168298	"Histone cluster 1 H1 family member e"	P10412	6	26156354-26157107	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7;Muller glia cells: 63.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 9.8;U-266/70: 12.1;U-266/84: 13.5;U-87 MG: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"		NA	Yes			"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	6.7	3.6	3.1	14.3	3.5	102.3	10.3	8.1	9.0	10.7	7.7	4.7	4.2	4.1	6.8	7.5	13.7	4.0	11.3	7.4	4.0	3.5	6.6	6.7	13.1	18.4	3.4	2.4	19.3	17.1	3.7	9.0	7.3	3.5	10.2	4.4	9.8	10.0	4.0	4.1	14.4	9.0	7.4	6.8	14.6	5.3	5.9	0.7	123.9	4.6	10.0	18.4	14.3	10.7	39.6	14.6	56.4	12.9	19.2	24.4	9.4	2.4	0.3	0.5	5.3	0.1	0.0	6.4	0.0	0.4	1.2	0.8	0.1	1.5	1.2	0.7	0.1	0.5	1.2	0.3	0.7	0.5	1.7	1.5	0.8	0.5	0.4	0.1	0.7	1.1	0.1	0.3	0.3	0.5	0.1	0.5	1.4	3.9	6.8	0.1	0.5	7.9	7.2	1.9	0.7	0.8	3.6	1.2	9.8	0.3	0.0	3.9	0.9	3.1	0.8	1.1	0.6	1.0	2.6	0.4	2.4	3.7	1.5	2.4	12.1	13.5	5.4	12.3	2.1	1.1	56.4	12.7	30.0	21.1	12.9	24.4	21.4	16.7	19.2	14.3	39.6	12.7	11.6	18.6	19.2	10.9	14.6	16.4	9.4	3.1	3.5	8.1	9.0	4.0	3.5	3.4	2.4	3.5	0.7	32.8	16.3	10.4	23.8	0.6	26.5	9.8	5.1	34.8	45.5	1.8	7.9	5.2	3.3	11.4	0.5	6.7	5.1	46.7	7.4	9.1	1.9	6.7	4.7	8.7	6.9	15.9	0.0	10.4	10.0	1.1	4.4	14.0	1.7	8.2	2.5	63.4	7.0	3.5	1.8	4.1	26.6	6.5	6.4	2.8	6.3	0.0	6.1	26.1	2.5	10.2
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 105.0;Proximal tubular cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.2;U-266/84: 39.2"					"Low region specificity"	"Detected in some"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.2	3.7	2.1	29.3	2.7	1.1	4.7	2.7	6.2	3.9	4.1	4.4	2.4	30.1	5.6	6.9	8.5	2.1	2.0	2.9	11.0	5.2	1.6	9.8	4.3	3.1	2.1	4.6	19.2	3.2	1.7	2.4	2.4	1.5	2.3	16.9	13.5	1.1	19.3	4.8	5.4	3.9	23.1	5.7	1.9	2.4	16.0	5.8	3.9	12.0	5.1	29.9	7.8	4.6	7.6	19.8	0.8	0.9	7.7	20.1	3.1	1.0	37.2	39.2	6.1	1.0	10.0	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6	3.0	5.6	15.9	54.2	1.5	13.9	21.3	12.7	53.5	10.3	21.0	0.0	6.4	19.9	4.3	27.1	2.8	22.0	0.0	3.8	6.2	3.0	105.0	2.3	20.7	3.9	41.3	44.7	1.3	4.0	5.4	6.6	6.9	3.3	3.6	20.2	4.0	12.0	33.1	1.4	75.4	10.4	0.0	1.4	0.9	0.7	2.4	33.0	6.9	14.3	63.6
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 5.6;Glandular cells: 5.8;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.2;REH: 8.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.7	3.0	0.9	3.0	0.4	0.4	3.1	1.0	0.5	0.3	0.8	2.1	0.7	1.4	0.5	1.7	4.3	0.5	1.1	0.6	1.6	1.0	0.5	1.5	0.2	0.2	0.3	2.5	0.6	0.2	0.6	0.3	1.1	0.3	0.9	2.4	1.8	0.1	1.6	4.6	8.2	2.4	1.6	1.0	8.0	0.2	2.6	1.4	1.8	2.7	3.7	4.0	1.5	0.9	1.6	2.8	1.6	0.8	1.5	2.7	1.1	1.9	2.4	4.5	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8											0.0	0.0	5.6	4.5	0.0	4.3	0.3	2.5	2.7	0.0	1.8	3.9	0.7	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.9	0.3	5.8	1.1	1.0	0.8	9.5	1.2	0.6	4.1	0.0	1.4	0.7	0.0	1.0	0.4	1.2	0.2	0.0	0.7	0.4	2.4	0.0	0.0	1.6	0.9	0.0	0.7	0.0	1.6	4.0
HIST1H4D	"H4/b, H4FB"	ENSG00000277157	"Histone cluster 1 H4 family member d"	P62805	6	26188765-26189076	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 71.3"	"Cell type enhanced"	"Detected in some"	6	"Early spermatids: 1.1;Enterocytes: 1.2;Intestinal endocrine cells: 1.2;Muller glia cells: 1.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.9;RT4: 16.0"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	1.4	4.7	1.9	10.1	5.2	6.5	5.6	1.2	4.5	3.9	3.1	0.0	4.5	0.9	3.3	3.5	8.3	6.5	2.0	4.6	1.4		1.6	1.8	1.6	3.5	0.0	4.4	6.5	5.8	0.9	1.3	4.2	1.6	6.0	2.1	1.4	1.4	2.7	0.9	0.9	2.3	2.2	1.6	4.1	2.2	9.8	0.8	71.3	5.3	4.8	9.5	5.5	0.0	6.8	0.6	1.3	0.9	0.2	2.3	0.7	1.3	2.2	1.5	0.0	2.7	0.0	0.8	1.3	0.4	3.6	1.8	3.4	0.8	6.9	0.4	0.0	2.6	0.9	4.5	0.7	1.2	0.5	9.9	1.0	6.8	2.5	0.0	0.7	0.2	0.0	0.0	0.5	1.5	0.0	3.1	0.8	1.7	1.2	0.0	3.5	2.4	4.0	2.3	1.6	0.7	0.7	0.0	0.9	0.9	16.0	0.7	0.4	1.4	0.6	0.9	0.7	1.2	0.5	0.0	0.5	4.4	0.5	1.7	1.6	1.8	0.0	1.1	1.7	1.0	0.1	0.9	0.0	0.9	0.1	0.6	1.4	2.3	0.5	0.6	6.8	0.3	0.6	1.3	0.2	0.5	0.1	0.1	0.7											0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.1	0.6	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.3	0.4
AL031777.3		ENSG00000282988			6	26195595-26199293	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in some"	22	"Cytotrophoblasts: 4.4;Extravillous trophoblasts: 4.1;granulocytes: 3.5;Hofbauer cells: 7.2;Syncytiotrophoblasts: 17.3"									"Cell type enriched"	"Detected in many"	4	"neutrophil: 18.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.7"	"Cell line enhanced"	"Detected in some"		"K-562: 7.9;SiHa: 7.5;U-2 OS: 5.7;U-266/70: 9.5;U-266/84: 6.3"									HPA041189	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"																		1.3	1.3	0.1	10.9	0.2	13.1	4.8	0.3	0.7	3.9	3.4	0.0	2.2	0.7	1.0	2.2	7.1	1.2	1.9	4.2	0.0		1.0	1.1	3.5	12.7	0.0	0.1	2.4	1.2	0.7	0.0	3.4	0.4	2.9	0.9	0.9	1.1	3.2	0.7	0.7	3.2	1.5	2.6	8.5	1.7	4.3	0.1	184.8	0.9	3.9	11.4	4.0	0.0	2.7	1.1	18.7	1.0	0.6	1.1	0.7	0.8	0.5	0.2	0.7	0.2	0.1	0.0	0.7	0.1	1.5	0.4	0.6	0.9	0.8	2.4	0.0	0.2	1.2	0.3	0.0	0.0	2.6	0.3	0.7	2.5	1.5	0.0	0.2	0.8	1.2	0.0	0.8	0.5	0.1	0.2	0.4	7.9	1.6	0.0	1.1	2.9	1.7	0.2	2.5	2.4	0.7	0.2	4.4	0.0	0.0	0.9	0.2	7.5	0.0	0.5	0.0	4.8	0.0	0.8	0.8	5.7	0.0	0.2	9.5	6.3	0.9	0.6	2.2	0.3	4.3	0.0	1.2	0.3	0.3	0.4	0.9	0.6	0.6	0.4	2.7	0.5	0.8	18.7	0.6	1.0	1.1	1.1	0.7											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.6	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.0	3.5	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0
HIST1H3D	"H3/b, H3FB"	ENSG00000197409	"Histone cluster 1 H3 family member d"	P68431	6	26196840-26197250	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 185.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.1;U-266/70: 11.4;U-266/84: 6.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	1.2	2.7	0.6	18.3	0.6	24.3	1.5	2.0	1.3	4.4	4.1	0.0	3.0	2.9	1.0	3.0	8.0	1.2	2.3	1.3	1.2	0.9	2.3	3.1	2.5	8.0	0.8	0.7	4.3	1.0	1.0	1.6	2.6	0.3	6.4	1.2	0.7	3.3	4.3	1.0	1.6	3.8	1.4	2.4	9.2	2.2	12.4	0.0	185.6	1.4	5.9	19.9	3.2	6.8	8.9	3.4	15.3	1.8	1.6	6.6	0.5	0.9	0.2	0.0	2.1	0.0	0.5	0.9	0.0	0.5	0.3	2.6	3.5	0.2	2.2	2.1	0.3	0.0	0.6	0.2	0.5	0.0	3.0	0.8	0.0	1.7	0.0	0.1	0.7	1.1	0.4	0.4	0.0	0.0	0.0	0.3	0.4	0.3	8.1	0.0	1.7	2.2	4.1	0.4	0.0	1.1	2.6	0.0	1.2	0.0	0.3	0.1	0.0	0.0	2.1	1.0	0.2	0.4	2.9	0.0	0.0	4.0	0.0	1.6	11.4	6.2	0.7	2.0	1.7	0.9	8.9	1.4	3.3	2.5	0.8	6.6	5.5	1.6	2.0	3.0	8.9	1.5	2.6	15.3	1.6	1.8	3.4	1.9	0.5	0.6	0.6	2.0	0.6	1.2	0.9	0.8	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
HIST1H2AD	"H2A.3, H2A/g, H2AFG"	ENSG00000196866	"Histone cluster 1 H2A family member d"	P20671	6	26198851-26199243	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 225.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-266/70: 21.2;U-266/84: 6.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	2.6	1.8	0.9	13.8	1.1	14.7	6.3	0.8	1.3	8.0	4.6	0.0	3.2	1.5	2.0	3.1	9.2	1.3	2.8	5.5	1.2	1.3	2.3	3.6	4.8	15.9	1.1	0.5	3.4	1.9	1.1	1.5	4.6	1.0	6.8	2.2	1.5	2.5	4.3	1.2	3.2	4.3	2.3	3.6	10.8	1.8	5.7	0.6	225.6	1.4	5.1	14.3	5.3	8.6	7.0	5.7	16.0	1.8	1.1	3.8	0.8	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.6	0.3	1.9	0.0	2.4	0.3	0.0	1.7	0.3	0.2	0.4	0.0	0.3	0.2	0.1	1.3	0.2	1.6	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	3.5	1.7	0.0	0.1	2.9	1.3	1.7	0.0	0.3	1.5	0.5	1.5	0.4	0.1	1.5	0.3	0.7	1.4	0.1	0.0	0.5	0.5	0.0	1.5	4.1	0.0	1.1	21.2	6.9	2.5	0.8	1.8	0.7	2.2	0.2	3.2	1.1	1.8	1.1	2.0	1.5	3.8	1.0	7.0	1.4	1.1	16.0	1.1	1.3	5.7	2.0	0.8	0.9	1.1	0.8	1.3	1.2	1.3	1.1	0.5	1.0	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 6.7;Basal glandular cells: 3.6;Bipolar cells: 5.4;Glandular cells: 5.5;Urothelial cells: 5.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 21.8;U-266/84: 15.3"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.3	0.9	0.4	0.1	0.3	0.7	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.1	0.4	1.7	3.9	0.0	0.1	3.3	1.4	0.5	0.7	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.2	0.8	0.0	0.3	3.8	0.2	0.1	0.3	1.9	0.0	0.5	21.8	15.3	1.2	0.1	1.0	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2											0.0	0.3	6.7	3.6	0.0	5.4	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.4	0.0	5.5	0.0	0.4	1.0	0.0	0.0	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.4	1.2	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.5	2.5	1.0	5.1
HIST1H4E	"H4/j, H4FJ"	ENSG00000276966	"Histone cluster 1 H4 family member e"	P62805	6	26204552-26206038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.9"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 9.4;Mucus-secreting cells: 9.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.6;U-266/70: 14.9"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	2.2	4.8	2.4	5.4	6.8	13.0	4.6	15.1	17.3	7.3	4.7	5.2	5.1	7.4	4.9	6.6	5.2	6.5	5.0	5.1	2.0		3.0	1.9	2.6	5.1	1.3	5.7	11.2	1.6	2.5	2.6	4.7	2.4	10.5	5.0	6.7	7.5	4.6	1.8	2.2	4.6	6.5	2.0	4.9	4.8	7.7	1.8	71.9	6.5	2.7	7.7	7.8	0.0	10.4	5.1	4.8	8.0	3.7	5.9	2.1	1.3	1.0	1.7	4.0	0.7	0.0	0.9	1.5	0.4	0.7	0.5	0.6	1.5	0.5	2.1	0.4	1.0	2.5	0.9	0.1	1.0	1.1	1.0	0.4	1.6	0.8	0.0	0.6	1.6	0.4	0.1	0.6	0.5	0.4	0.5	1.4	2.9	3.4	0.2	0.5	7.6	3.6	1.7	0.7	1.4	3.4	1.9	3.4	0.7	0.5	4.9	1.2	1.1	1.7	0.5	0.6	1.6	0.7	0.7	2.0	2.8	0.6	1.2	14.9	5.8	2.1	0.4	1.4	1.4	3.2	3.7	2.9	3.8	3.1	5.3	3.9	5.5	3.6	5.1	10.4	5.9	4.5	4.8	3.7	8.0	4.7	3.3	2.1											0.0	1.1	6.0	2.2	0.3	9.4	1.0	2.5	0.0	0.0	0.0	0.0	2.3	0.0	1.7	0.0	1.3	7.9	0.0	0.0	1.2	0.5	7.7	4.7	0.8	3.7	1.6	3.5	2.5	1.9	0.0	0.9	2.0	0.0	1.0	9.5	7.0	0.2	2.9	0.4	1.0	1.5	0.0	0.0	1.7	2.7	0.5	2.9	6.4	5.3	1.3
HIST1H2BG	"H2B.1A, H2B/a, H2BFA"	ENSG00000273802	"Histone cluster 1 H2B family member g"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 58.7;Glandular cells: 91.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 8.9;T-47d: 18.1;U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	0.4	1.5	0.7	16.5	1.2	8.9	20.2	5.1	3.4	4.3	2.9	0.5	5.1	1.8	2.8	4.0	6.6	2.1	1.8	1.7	0.2		1.2	0.6	2.0	7.2	0.1	2.0	1.3	1.9	0.4	0.5	1.6	0.7	10.3	3.0	1.2	5.0	5.8	0.3	1.6	2.2	2.8	4.7	3.1	2.9	6.7	0.3	75.2	1.0	6.9	8.3	4.3	0.0	5.8	14.6	12.0	1.6	1.3	6.2	2.0	2.5	0.1	1.2	0.0	3.9	0.2	0.3	3.1	0.2	2.0	0.8	0.3	2.2	0.0	3.2	0.3	0.8	2.7	1.1	1.0	1.1	2.2	1.3	0.7	1.2	1.1	0.6	0.3	2.1	1.5	0.5	0.6	0.0	0.1	0.4	0.1	7.8	0.1	0.0	1.8	2.2	1.7	1.2	5.9	1.6	1.5	0.7	4.4	1.2	0.6	7.3	1.1	8.9	3.3	1.0	3.4	18.1	0.8	0.2	0.0	1.0	0.3	0.4	16.9	0.1	0.0	0.3	1.1	0.5	12.0	1.2	2.5	2.0	0.9	6.2	3.7	3.1	3.8	4.4	5.8	1.5	1.3	5.6	1.3	1.6	14.6	2.7	2.0											0.0	12.7	29.3	58.7	0.8	40.1	0.7	5.1	4.0	4.5	5.2	5.9	6.3	0.0	4.8	0.6	0.5	27.1	0.0	0.0	6.6	3.2	91.9	9.3	2.5	17.2	23.8	29.8	2.5	3.5	0.0	2.0	8.0	0.0	1.8	17.9	9.5	1.1	16.4	0.0	1.3	3.0	6.5	0.4	1.4	16.2	0.0	20.1	10.7	14.2	42.2
HIST1H2AE	"H2A.1, H2A/a, H2AFA"	ENSG00000277075	"Histone cluster 1 H2A family member e"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 139.6"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 99.4;Glandular cells: 104.2;Urothelial cells: 88.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 26.7"									"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	0.3	1.8	0.9	19.1	0.9	13.5	33.8	4.9	6.2	3.7	3.8	0.2	3.2	2.8	2.2	13.6	7.2	3.0	2.4	2.2	0.5		0.8	1.5	1.9	11.4	0.0	3.0	2.0	1.1	0.4	0.0	2.9	0.5	10.6	1.6	1.4	2.7	2.5	0.1	2.4	3.4	2.0	3.5	5.9	2.0	5.1	0.0	139.6	2.0	7.4	11.4	2.3	0.0	6.1	15.4	11.4	2.1	4.0	4.2	10.1	2.8	0.0	2.1	0.0	3.5	0.7	0.5	0.9	1.4	3.1	2.1	1.4	2.3	0.1	7.8	0.3	2.8	2.4	1.0	1.4	1.2	3.1	2.6	1.9	4.2	1.8	0.6	0.2	2.9	6.2	0.7	1.3	0.1	0.9	1.5	0.5	7.7	2.1	0.2	5.2	6.3	5.4	2.5	9.8	2.6	5.0	1.7	9.9	1.3	1.6	8.6	3.6	7.7	2.6	1.7	1.5	10.6	2.8	0.0	0.1	0.6	1.3	1.2	26.7	0.0	0.0	1.1	3.8	1.9	11.4	2.0	6.3	2.7	2.1	3.8	4.3	3.0	4.2	5.0	6.1	1.6	2.1	9.4	4.0	1.2	15.4	3.6	10.1											3.0	13.0	11.1	99.4	1.3	3.3	0.4	0.0	0.0	2.3	1.8	0.0	6.5	1.7	2.8	2.5	0.5	13.7	0.0	0.0	4.1	2.1	104.2	2.3	2.1	14.1	3.2	10.4	1.8	1.5	1.8	0.9	5.7	0.0	2.8	12.1	1.7	0.3	10.8	0.4	4.0	0.1	0.0	0.2	0.7	9.1	1.3	11.6	10.0	8.1	88.8
HIST1H3E	"H3.1, H3/d, H3FD"	ENSG00000274750	"Histone cluster 1 H3 family member e"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 19.9;tongue: 25.6"	"Cell type enhanced"	"Detected in some"	6	"Hepatocytes: 3.4;Mucus-secreting cells: 2.9;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.9;hTERT-RPE1: 8.5;SCLC-21H: 13.4;T-47d: 8.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	4.8	0.0	2.8	1.2	0.2	2.6	2.4	1.2	2.6	3.6	1.9	5.2	6.1	2.5	6.9	14.5	1.6	3.0	7.4	0.0		0.7	0.9	2.1	4.1	4.1	0.0	2.5	0.6	2.5	0.5	2.9	1.8	4.6	2.4	0.5	4.4	1.8	6.1	1.3	6.1	2.5	1.8	2.3	3.5	19.9	3.2	22.4	3.6	25.6	8.8	2.7	0.3	2.6	3.9	6.5	1.8	0.5	3.1	1.4	2.0	2.2	3.2	1.4	3.8	1.8	0.2	1.5	1.6	0.8	0.6	0.7	1.2	0.0	11.9	0.6	1.1	2.5	0.0	0.4	0.7	3.1	2.8	0.4	1.0	0.7	1.2	0.2	1.9	2.6	2.7	0.3	0.8	8.5	1.2	0.2	0.3	2.4	2.2	1.9	0.4	0.1	0.2	1.5	2.1	1.5	0.6	0.3	6.4	1.2	13.4	1.5	2.1	3.3	3.6	0.5	8.2	1.3	0.6	1.5	0.5	0.4	0.3	0.9	0.3	0.2	0.7	0.1	0.8	0.4	1.8	0.0	1.3	1.5	1.7	1.4	1.8	1.7	1.2	2.6	1.7	1.8	6.5	0.5	1.3	3.9	3.1	1.4											0.0	2.2	0.0	0.5	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	2.0	0.0	0.2	0.2	0.0	0.6	0.0	3.4	0.8	1.6	0.0	1.3	1.2	0.7	0.6	0.0	0.0	1.0	2.9	0.3	0.1	3.5	0.0	1.0	0.0	0.0	0.1	0.1	0.5	0.0	1.1	0.0	0.6	0.1
HIST1H1D	"H1.3, H1d, H1F3, H1s-2"	ENSG00000124575	"Histone cluster 1 H1 family member d"	P16402	6	26234268-26234933	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 182.1"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 15.9;Spermatogonia: 13.2;T-cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.5;MOLT-4: 13.6;NB-4: 6.2;REH: 5.6;SiHa: 5.6;U-266/70: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported					NA	NA					"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"	3.2	1.1	0.4	14.7	0.9	37.5	5.0	2.8	0.9	4.1	5.2	0.1	2.0	1.0	3.9	4.8	10.7	1.3	3.7	2.5	0.8	0.8	1.5	1.1	9.9	21.2	0.6	0.0	3.4	0.9	0.9	0.6	2.3	0.1	3.7	2.4	1.4	1.8	1.0	0.9	6.1	4.9	1.2	4.4	14.2	1.6	4.6	0.0	182.1	1.7	4.5	17.6	8.3	9.2	26.3	17.9	8.6	3.8	12.5	21.2	8.0	1.0	0.8	0.2	0.0	0.4	0.0	8.5	0.4	0.3	1.1	0.8	0.2	1.0	0.0	0.2	0.1	0.5	1.0	0.3	0.0	0.5	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.2	0.3	0.0	0.4	1.2	2.3	2.3	0.1	0.0	13.6	6.2	0.7	0.0	2.5	5.6	0.1	3.2	0.0	0.0	2.8	0.4	5.6	2.4	0.0	0.9	1.1	1.3	0.0	0.4	0.0	0.2	0.9	7.0	3.5	0.4	1.0	1.8	0.7	8.6	3.8	3.2	17.7	2.4	12.6	16.5	16.3	12.0	9.5	26.3	21.2	16.4	1.4	12.5	3.4	17.9	12.1	8.0	0.4	0.9	2.8	0.8	0.8	0.8	0.6	0.0	0.1	0.0	0.0	3.0	9.7	7.4	0.5	0.7	0.7	0.0	9.4	6.8	0.0	0.0	1.0	0.0	0.0	0.0	1.6	2.3	0.0	0.0	15.9	0.4	2.0	7.0	0.0	6.0	0.0	1.2	4.3	4.0	0.0	1.1	7.9	0.0	1.8	2.3	7.0	0.0	0.3	0.0	0.5	0.3	0.0	0.4	0.2	13.2	0.3	3.0	30.2	1.3	2.4
HIST1H4F	"H4, H4/c, H4FC"	ENSG00000274618	"Histone cluster 1 H4 family member f"	P62805	6	26240426-26240737	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 118.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.8;MOLT-4: 11.3;REH: 5.1"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			1.2	0.5	0.0	8.8	0.0	7.1	0.5	0.0	1.7	0.9	1.3	0.0	1.8	0.5	1.2	2.2	5.9	0.5	1.4	1.8	0.0		1.2	0.5	2.1	4.5	0.0	0.0	0.6	0.5	0.5	0.0	4.1	0.0	0.6	1.0	0.1	0.5	0.5	0.5	0.5	1.3	0.5	0.0	9.3	0.8	18.9	0.0	118.4	3.1	3.7	19.1	2.4	0.0	7.9	7.9	14.8	3.6	2.2	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	11.3	1.4	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	4.3	3.9	2.8	3.2	6.2	4.9	5.1	4.6	7.9	4.3	2.7	14.8	2.2	2.4	7.9	1.3	2.0											0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.1	0.2	0.0	0.0	0.0
HIST1H4G	"H4/l, H4FL"	ENSG00000275663	"Histone cluster 1 H4 family member g"	Q99525	6	26246681-26246977	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"AF22: 1.1;CAPAN-2: 1.2;PC-3: 3.4;SCLC-21H: 1.8;THP-1: 2.4"									HPA042201	Supported					NA	NA					"HPA042201: AB_2677898"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.0	2.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H3F	"H3/i, H3FI"	ENSG00000277775	"Histone cluster 1 H3 family member f"	P68431	6	26250195-26250605	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 198.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.5;U-266/84: 9.5"									"HPA042570, CAB070190"	Approved					NA	NA					"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	1.1	0.9	0.0	26.8	0.0	8.0	3.9	0.0	0.2	0.5	4.5	0.0	0.2	1.5	0.7	2.4	8.6	0.4	2.2	4.2	0.0		0.3	0.2	2.5	17.0	0.0	0.0	0.2	0.2	0.2	0.0	3.8	0.0	0.4	0.4	0.0	0.8	0.2	0.7	0.7	4.6	0.5	0.0	10.8	1.1	2.8	0.0	198.6	0.4	11.5	25.3	0.9	0.0	4.5	1.3	0.0	0.6	0.0	0.9	0.4	1.4	0.0	2.2	0.0	0.0	0.0	1.6	1.3	0.0	2.5	0.7	0.0	0.0	0.2	1.1	0.0	0.6	0.9	0.0	1.1	0.0	1.5	0.5	1.7	4.6	0.0	0.0	0.0	2.7	0.0	0.0	0.8	0.0	0.0	1.3	1.8	2.5	1.9	0.0	1.9	3.5	8.5	0.0	0.0	2.5	3.8	0.0	1.3	0.0	0.3	4.4	1.0	1.6	0.8	0.0	0.3	3.2	2.8	0.0	0.4	0.0	0.2	2.0	2.2	9.5	0.0	2.5	3.1	1.1	0.0	0.5	0.0	0.5	0.0	0.1	4.5	0.1	0.0	1.3	1.3	0.3	0.0	0.0	0.0	0.6	0.0	0.9	0.4											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 6.7;Enterocytes: 8.5;Extravillous trophoblasts: 21.0;Paneth cells: 8.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 7.5;U-266/70: 18.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.5	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.5	1.1	0.0	1.8	0.1	1.9	3.6	0.0	0.6	1.9	0.9	0.1	1.4	5.6	0.4	0.0	0.0	4.3	0.3	0.3	0.5	0.5	0.0	0.3	1.0	2.7	6.6	0.1	2.0	3.8	2.7	1.7	0.0	1.9	4.1	0.0	1.0	0.0	2.8	3.4	3.1	4.4	1.5	0.6	0.3	2.2	3.4	0.0	0.6	0.0	0.8	3.2	18.1	4.5	0.0	0.5	1.5	4.0	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3											0.0	0.0	6.7	2.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.5	0.0	0.2	21.0	0.5	1.0	0.0	0.0	6.1	0.0	0.0	0.6	2.2	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	3.8	4.9	3.7	3.6
HIST1H3G	"H3/h, H3FH"	ENSG00000273983	"Histone cluster 1 H3 family member g"	P68431	6	26269405-26271815	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"lymphoid tissue: 247.1"	"Cell type enhanced"	"Detected in some"	23	"Spermatogonia: 11.1;Undifferentiated cells: 2.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SiHa: 10.3;U-266/70: 9.7"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (1.88e-1)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.23e-2)"	0.7	0.4	0.0	14.6	0.0	1.9	1.7	0.0	0.0	0.5	5.2	0.0	0.0	2.1	0.1	2.2	9.1	1.5	0.8	1.1	0.0		0.2	0.0	1.0	7.3	0.0	0.0	0.1	0.0	0.3	0.0	4.8	0.0	0.1	1.6	0.0	0.4	0.4	0.0	0.3	4.7	0.4	0.0	13.6	1.0	5.0	0.0	247.1	1.0	8.0	15.9	0.7	0.0	1.6	0.4	0.6	0.4	0.2	1.5	0.7	1.1	0.2	1.1	0.0	0.1	0.2	0.5	0.5	0.2	1.2	0.5	4.0	0.0	0.0	0.6	0.1	1.2	3.3	1.3	0.6	0.8	1.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.3	0.0	0.3	0.8	0.0	2.3	0.0	2.4	1.1	0.4	2.0	3.6	0.0	0.8	0.0	1.4	0.7	0.8	0.3	0.6	10.3	3.2	0.0	0.0	0.1	0.6	0.3	0.5	0.0	0.0	0.2	9.7	0.3	0.0	0.5	0.0	1.2	0.0	0.0	0.3	0.3	0.1	0.4	1.1	1.5	1.0	0.4	1.6	0.0	0.5	0.6	0.2	0.4	0.0	1.5	0.7											0.0	0.0	0.8	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	0.0	0.0	1.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.7	0.0	2.8	0.1
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.4;MOLT-4: 15.1;THP-1: 6.3"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.9	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.4	0.8	0.0	0.9	0.5	0.5	0.7	0.9	1.8	0.5	0.8	2.7	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	1.8	2.2	0.0	3.9	0.0	0.8	15.1	2.5	2.9	0.6	0.0	4.1	0.0	5.0	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.1	0.0	6.3	0.9	0.9	0.0	0.6	3.1	3.2	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1
HIST1H4H	"H4/h, H4FH"	ENSG00000158406	"Histone cluster 1 H4 family member h"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 119.1"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 15.9;Glandular cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 6.0;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 37.3"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	6.2	3.6	4.4	10.6	4.4	5.2	23.0	6.4	4.6	7.0	6.6	1.2	5.6	6.5	4.5	6.8	13.9	4.0	5.5	8.3	5.2	5.2	5.2	3.3	5.5	4.1	7.1	2.8	9.4	2.8	1.2	4.0	9.0	2.5	16.7	4.0	3.8	3.9	4.5	30.9	3.7	9.9	7.6	10.9	10.9	3.8	11.0	1.9	119.1	9.5	10.3	23.1	7.3	7.3	1.6	1.1	17.5	1.0	0.2	0.8	4.4	2.4	2.5	0.6	0.3	6.0	0.3	1.5	3.9	0.4	1.1	0.3	2.4	0.7	1.1	6.5	1.0	0.7	1.8	0.3	0.5	0.3	3.6	1.1	2.3	4.6	2.4	2.6	0.9	2.1	6.0	0.4	1.2	0.9	0.5	2.0	0.7	7.3	7.3	2.1	3.1	9.5	6.1	1.2	2.7	3.4	6.5	1.4	4.2	0.8	2.5	4.3	0.8	7.9	4.4	2.9	0.6	6.4	3.2	0.6	1.4	12.3	1.2	4.3	9.2	37.3	2.2	0.7	8.6	2.0	1.9	0.6	6.0	0.5	1.0	0.3	0.7	0.4	0.6	0.5	1.6	0.4	0.6	17.5	0.2	0.3	1.1	0.8	4.4	4.4	4.4	6.4	4.6	5.2	5.2	7.1	2.8	2.5	1.9	3.0	9.6	15.9	3.8	1.6	0.2	0.0	0.0	4.0	1.2	3.5	0.0	1.8	3.3	1.4	0.4	0.4	8.9	0.0	0.6	1.3	2.6	15.4	3.5	0.4	1.5	0.0	3.5	1.3	8.2	0.4	1.1	3.1	1.7	2.8	8.7	1.0	1.6	2.9	1.1	5.1	0.2	0.0	2.1	1.8	2.5	1.3	8.7	7.5	5.0	2.4
BTN3A2	BTN3.2	ENSG00000186470	"Butyrophilin subfamily 3 member A2"	P78410	6	26365159-26378320	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"B-cells: 68.5;T-cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 34.9;U-266/70: 34.8"									CAB019392	Uncertain					NA	NA					"CAB019392: "	"unprognostic (3.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.89e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-3)"	12.3	19.7	8.5	23.7	8.3	3.6	10.2	3.7	6.4	14.7	15.3	6.7	10.9	12.3	19.7	17.0	9.8	9.9	16.5	7.8	5.3	6.4	10.8	9.9	21.3	17.0	11.4	4.1	14.0	11.7	3.0	14.8	7.8	8.0	11.2	14.0	8.6	12.1	14.2	4.9	10.1	19.2	9.9	12.8	47.0	13.7	4.5	9.0	19.4	10.3	9.5	27.3	14.3	13.4	19.4	6.2	19.6	13.7	30.5	41.5	20.7	4.1	1.8	2.6	2.7	15.2	17.7	0.9	3.9	18.6	7.4	21.0	1.0	14.0	11.4	14.3	5.5	11.3	3.7	3.6	7.1	6.7	6.7	4.9	11.8	7.7	6.9	8.3	7.1	10.9	10.9	2.9	7.0	3.1	17.6	14.2	21.0	3.1	16.0	5.3	0.5	5.9	11.7	0.1	3.1	1.4	9.1	4.6	34.9	6.8	2.1	1.7	4.8	2.8	2.8	9.7	0.8	2.9	5.8	8.7	8.3	1.7	2.9	4.2	34.8	28.9	6.2	13.4	12.7	7.3	19.6	8.0	17.6	41.5	11.2	31.1	19.4	26.8	36.5	6.2	15.3	27.2	33.3	12.6	30.5	13.7	4.4	32.9	20.7	8.5	8.3	3.7	6.4	5.3	6.4	11.4	4.1	8.0	9.0	29.8	20.3	68.5	10.4	9.2	0.5	3.6	12.7	10.7	5.7	12.2	0.0	12.1	1.7	15.8	0.2	28.9	27.3	0.0	12.0	14.8	15.0	14.9	45.2	9.6	17.2	0.0	9.7	28.3	32.3	1.7	10.3	20.3	3.3	20.8	26.2	7.1	11.3	16.9	9.9	3.3	0.9	12.9	6.0	2.1	0.1	11.7	2.7	124.9	13.3	12.7
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.7;U-266/70: 28.3"									HPA051504	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.0	12.4	3.2	22.6	5.2	2.7	7.5	29.0	5.2	8.5	5.7	5.1	4.8	5.2	10.2	10.6	7.4	6.7	7.9	9.5	4.1	3.7	7.5	6.1	15.6	21.8	4.4	3.3	10.3	5.8	12.9	5.5	2.8	9.7	8.8	8.0	11.5	9.3	7.9	2.7	8.0	9.9	8.2	5.3	18.0	7.2	5.1	4.2	13.0	7.0	6.2	26.0	8.5	7.6	20.2	14.9	7.8	9.1	5.1	6.3	4.7	4.8	3.1	6.3	6.7	2.1	3.3	0.4	5.3	14.0	8.4	14.5	1.9	1.9	4.4	5.8	9.5	6.8	4.5	5.0	4.1	11.2	13.7	8.4	6.9	5.8	3.8	4.4	1.5	2.4	7.1	1.3	16.1	5.5	10.0	7.7	8.7	5.5	34.7	3.7	2.1	5.4	2.0	2.3	0.2	3.1	12.8	9.0	13.5	6.0	2.7	6.0	8.5	3.4	1.3	14.5	3.8	6.4	3.0	9.1	3.1	3.6	2.7	8.1	28.3	17.3	7.7	3.1	6.2	7.7	1.2	8.7	1.5	4.2	9.1	3.9	16.2	3.3	3.7	14.9	20.2	2.8	3.4	7.8	5.1	3.6	6.2	6.3	4.7	3.2	5.2	29.0	5.2	4.1	3.7	4.4	3.3	9.7	4.2	8.9	9.3	13.7	6.2	3.4	0.4	2.2	2.5	4.0	9.1	3.5	0.0	2.0	0.0	8.2	0.2	14.0	1.0	23.3	4.9	0.9	2.1	6.9	18.5	2.5	8.1	0.0	1.7	5.5	8.8	0.0	6.1	18.0	6.8	12.6	7.0	17.3	6.6	0.0	4.6	1.7	0.7	0.0	3.9	0.5	1.3	4.0	0.8	7.5	1.6	3.1
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415216	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 24.4;T-cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA012565	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"	11.3	14.3	6.7	33.5	5.4	10.3	10.2	10.7	5.9	18.5	14.9	10.0	10.1	11.5	22.3	14.1	13.1	9.6	16.5	9.0	5.3	6.1	9.7	11.4	29.9	24.1	7.1	5.4	15.5	9.4	5.6	11.2	8.5	7.8	17.9	12.1	12.3	16.7	10.0	4.8	9.7	20.6	10.2	9.0	45.2	12.5	4.9	6.7	16.5	8.5	9.8	32.9	11.6	12.9	9.8	4.4	17.4	5.9	18.4	23.4	12.1	3.7	3.2	4.7	4.8	13.6	14.5	0.5	3.0	12.0	6.9	20.3	0.1	8.1	9.7	10.6	5.5	10.8	2.5	1.5	4.8	4.0	9.5	3.3	5.1	3.9	2.2	6.1	4.7	4.7	7.8	2.7	6.0	2.7	10.5	9.7	15.7	1.2	12.7	2.8	0.3	8.5	2.9	0.5	1.6	1.0	11.8	2.1	22.0	4.2	4.7	2.5	5.0	1.7	3.6	6.8	0.7	3.3	1.9	2.4	5.3	1.3	1.5	2.9	21.7	22.1	3.5	8.1	10.6	4.0	17.4	5.3	13.5	23.4	5.7	20.9	9.8	14.6	21.7	4.4	5.3	12.7	16.8	11.9	18.4	5.9	2.1	16.9	12.1	6.7	5.4	10.7	5.9	5.3	6.1	7.1	5.4	7.8	6.7	14.9	6.2	15.4	3.5	3.8	4.3	3.5	7.6	5.3	11.4	5.2	0.0	4.5	0.0	5.4	0.1	11.3	9.1	0.0	2.9	3.6	6.6	5.3	24.4	3.4	6.9	0.0	4.6	10.4	11.8	0.4	3.4	8.3	1.7	2.8	14.6	2.9	2.4	7.0	2.5	1.2	0.4	0.0	3.3	0.0	0.1	2.9	1.3	37.4	6.8	4.2
BTN3A3	"BTF3, BTN3.3"	ENSG00000111801	"Butyrophilin subfamily 3 member A3"	O00478	6	26440472-26453415	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;T-cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.6;BJ hTERT+ SV40 Large T+ RasG12V: 21.5"									"HPA007904, HPA011871"	Enhanced					NA	NA					"HPA007904: AB_1078307, HPA011871: AB_1845496"	"unprognostic (1.18e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.13e-3)"	"unprognostic (8.08e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.54e-3)"	13.3	19.1	6.6	22.5	8.1	2.6	10.6	5.5	8.6	11.8	8.5	5.9	8.8	9.8	19.1	14.9	7.0	12.1	11.8	7.7	5.2	6.8	8.7	11.8	19.5	15.3	5.8	8.4	12.0	3.9	3.1	24.0	5.5	6.6	12.0	8.5	9.8	8.9	7.9	2.9	6.6	15.7	10.2	7.3	29.4	8.9	3.5	6.0	11.7	10.6	8.4	20.1	12.8	10.1	9.0	5.3	16.3	10.0	19.2	25.3	13.0	1.8	0.9	0.8	0.8	16.6	31.6	0.2	2.6	14.1	5.9	21.5	0.0	5.9	11.7	11.9	4.2	5.4	1.3	1.2	4.5	2.9	9.8	2.0	5.4	5.2	0.6	12.1	2.8	1.0	16.7	1.8	5.1	1.9	9.4	11.6	4.4	0.2	1.8	3.2	0.0	7.6	2.3	0.0	0.0	1.4	7.7	1.6	11.2	4.6	1.6	1.0	1.9	1.6	1.5	2.8	0.2	0.4	1.6	7.1	2.9	0.6	3.1	1.8	2.0	0.5	1.1	7.6	5.5	3.0	16.3	6.6	5.5	25.2	9.9	20.4	9.0	17.5	25.3	5.3	6.2	17.1	22.9	5.1	19.2	10.0	2.8	19.6	13.0	6.6	8.1	5.5	8.6	5.2	6.8	5.8	8.4	6.6	6.0	8.9	7.7	13.6	2.1	1.5	0.0	4.4	0.0	2.7	6.8	0.0	0.0	2.2	1.7	3.4	3.2	13.2	6.4	23.3	2.1	1.2	6.7	2.2	3.5	2.4	4.4	0.0	1.2	19.0	14.0	15.2	3.7	8.3	3.3	4.6	6.4	2.0	2.6	3.5	2.1	1.0	0.0	6.5	2.1	0.3	0.1	1.8	0.5	29.9	4.4	1.6
BTN2A1	"BT2.1, BTF1, BTN2.1"	ENSG00000112763	"Butyrophilin subfamily 2 member A1"	Q7KYR7	6	26457904-26476621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA019208	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA019208: AB_1845492"	"unprognostic (1.86e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.90e-3)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (4.52e-5)"	15.3	16.7	10.8	16.3	13.7	18.5	17.2	42.2	16.2	14.8	15.8	13.2	17.4	12.2	18.8	15.0	11.5	14.9	12.7	15.6	11.2	14.6	13.1	8.5	17.2	16.3	14.4	10.2	15.8	8.9	7.7	16.9	23.2	16.1	16.5	14.6	12.0	11.1	19.3	12.1	9.5	13.9	21.1	15.6	23.5	12.4	13.0	15.0	11.3	10.8	7.3	14.4	21.4	13.4	4.8	4.7	28.8	4.8	4.8	8.1	3.4	7.4	6.8	13.4	8.3	6.0	4.9	0.6	16.3	13.8	20.1	18.4	6.0	5.0	6.1	22.6	11.6	26.5	3.4	10.6	4.2	19.3	8.8	10.4	3.7	7.3	7.4	9.4	5.2	9.8	6.8	4.0	22.4	7.3	11.9	7.2	12.1	5.8	9.7	17.2	3.2	9.2	8.7	4.6	2.1	5.5	7.6	13.2	6.4	7.5	3.7	14.0	7.7	5.2	6.7	11.6	8.7	2.2	4.6	9.5	15.1	8.1	13.1	18.3	7.9	18.2	5.1	6.0	10.4	23.8	16.7	4.8	15.5	6.5	2.7	5.9	4.8	5.4	7.1	4.3	3.9	5.0	6.4	28.8	4.8	4.1	4.7	8.1	3.4	10.8	13.7	42.2	16.2	11.2	14.6	14.4	10.2	16.1	15.0	14.9	14.3	13.4	6.9	7.1	9.0	16.8	10.2	32.1	10.3	8.7	5.9	5.1	3.3	9.6	2.6	19.4	10.6	0.0	11.3	9.3	14.7	9.5	23.2	5.8	10.2	3.2	8.6	19.0	18.7	4.1	11.8	17.0	10.1	16.2	13.7	6.4	12.3	11.2	12.0	4.7	2.2	38.8	21.7	8.8	11.7	7.0	9.8	21.7	12.1	11.1
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 27.4"	"Cell type enhanced"	"Detected in single"	32	"B-cells: 1.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"					"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.6;naive B-cell: 2.6"	"Lineage enriched"	"Detected in many"	4	"B-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 10.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011126, CAB037340"	Supported				"Secreted in female reproductive system"	NA	NA					"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	27.4	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.6	0.0	1.0	1.6	0.0	1.3			0.0		0.6	0.1	0.0	5.6	0.0	0.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2											0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
HMGN4	"HMG17L3, NHC"	ENSG00000182952	"High mobility group nucleosomal binding domain 4"	O00479	6	26538405-26546254	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077364			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA077364: AB_2686835"	"unprognostic (1.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (9.01e-2)"	"unprognostic (6.07e-3)"	26.3	26.8	16.8	28.9	20.8	16.6	32.0	21.8	26.5	29.0	34.0	16.2	27.5	21.1	42.0	31.7	28.1	32.0	28.6	29.4	14.3	18.2	31.0	10.7	25.5	50.3	15.5	18.3	33.0	24.1	24.4	18.5	23.7	15.9	35.3	31.4	21.1	24.7	36.6	30.8	21.0	32.7	45.3	16.7	33.2	23.1	26.8	15.6	38.2	36.2	24.0	38.1	35.1	34.4	31.8	25.9	57.0	22.1	30.6	39.7	37.7	23.3	9.7	17.2	23.2	23.6	35.9	11.7	20.6	35.1	31.5	42.9	9.2	14.9	28.5	31.4	29.0	29.8	11.1	30.4	25.9	34.6	35.2	28.1	30.0	13.5	16.9	25.9	24.4	30.4	27.0	35.1	24.8	40.7	26.1	29.1	34.8	27.0	46.6	27.9	12.2	40.5	27.7	10.4	18.6	15.9	15.0	20.8	48.6	22.1	16.7	28.9	25.4	17.6	13.4	38.1	21.2	14.7	11.7	22.1	21.4	15.7	19.2	17.5	29.6	79.7	24.5	10.1	56.4	27.3	57.0	19.1	34.9	39.2	18.0	37.5	31.8	39.7	39.6	25.9	27.3	33.6	32.1	28.3	30.6	22.1	20.8	39.4	37.7	16.8	20.8	21.8	26.5	14.3	18.2	15.5	18.3	15.9	15.6	3.0	4.3	10.9	3.3	6.6	0.2	1.2	10.2	1.4	12.5	1.8	0.0	3.0	5.0	1.6	0.3	2.2	2.6	0.0	1.2	8.5	3.7	1.8	8.1	1.0	3.8	0.0	0.0	3.7	3.2	0.0	1.4	9.2	8.5	8.2	1.5	1.9	1.9	1.7	2.5	6.1	0.2	0.0	3.1	0.2	1.1	4.4	6.8	8.5	1.2	1.7
ABT1	Esf2	ENSG00000146109	"Activator of basal transcription 1"	Q9ULW3	6	26596952-26600744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077039			Approved	Vesicles		NA	NA			Vesicles		"HPA077039: AB_2732328"	"unprognostic (1.32e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (3.80e-4)"	13.1	11.0	11.2	14.6	10.7	28.9	13.0	15.8	14.1	13.3	12.1	9.8	13.5	14.5	16.2	14.3	19.4	13.9	9.0	10.8	9.6	7.6	10.1	19.1	11.4	20.4	9.5	9.3	14.2	18.2	8.4	10.9	19.6	8.3	13.5	10.1	9.3	13.4	12.0	16.1	18.2	15.6	9.2	6.3	23.2	13.5	17.9	9.4	23.9	13.1	17.4	22.4	12.9	13.2	32.0	18.5	29.1	20.1	24.9	34.7	37.0	12.6	6.6	9.3	16.0	5.2	5.5	13.6	7.5	7.7	11.4	11.2	11.9	5.6	18.5	17.2	6.1	9.1	8.1	10.7	10.9	6.7	10.2	21.8	12.2	6.0	22.1	8.4	16.6	12.4	7.2	10.2	9.1	5.4	5.3	9.9	14.7	21.1	12.5	6.3	12.8	19.1	21.2	9.5	8.1	8.9	11.6	7.5	19.5	7.1	10.3	12.2	9.8	4.6	12.2	17.8	5.1	11.7	13.5	8.4	8.8	6.4	6.9	15.0	14.7	21.6	16.8	4.1	20.6	13.3	29.1	20.1	24.0	32.8	18.1	31.4	31.2	32.3	32.7	18.5	32.0	34.7	31.2	17.4	24.9	18.0	17.1	34.1	37.0	11.2	10.7	15.8	14.1	9.6	7.6	9.5	9.3	8.3	9.4	14.9	13.3	52.3	27.6	53.1	16.8	5.6	20.4	18.7	15.9	10.4	2.0	79.8	34.9	29.8	33.9	35.1	16.3	0.0	34.0	80.3	20.7	16.1	27.8	21.2	36.8	14.3	32.6	17.8	15.4	58.5	25.6	22.9	15.1	25.2	23.4	20.9	28.3	21.0	22.3	19.1	15.4	19.4	23.2	22.3	36.4	52.2	91.5	58.6	30.2	27.0
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	8.8	9.7	7.7	5.4	10.9	0.4	10.1	10.6	15.4	13.1	8.6	7.9	9.5	6.9	12.7	10.8	6.8	9.2	11.5	13.3	8.4	6.9	9.5	7.0	7.9	6.7	8.8	7.0	14.8	6.9	15.0	18.0	8.6	11.8	12.3	8.6	8.6	8.2	15.5	7.7	5.0	7.9	9.7	10.7	8.7	7.6	8.2	12.5	4.3	13.6	6.7	7.2	11.8	8.4	11.2	7.9	10.5	11.2	17.6	11.4	4.9	5.8	4.4	17.5	20.1	11.5	15.4	6.3	7.8	10.4	10.9	13.2	8.6	3.6	7.1	18.9	6.8	13.7	7.4	13.0	5.1	13.7	10.9	11.8	12.5	5.8	8.4	13.1	0.0	11.4	9.4	18.0	7.2	8.2	13.7	9.4	8.8	14.3	7.6	12.0	3.3	8.8	10.5	5.1	5.4	5.4	9.8	12.4	10.1	6.7	9.3	14.2	15.0	9.3	8.8	16.4	8.9	8.2	8.1	9.3	18.2	7.3	7.4	7.9	8.0	16.0	6.8	3.9	2.0	18.3	3.3	8.7	10.5	11.4	7.4	8.3	11.2	5.8	7.4	7.0	10.5	6.8	9.9	8.3	17.6	11.2	7.9	4.4	4.9	7.7	10.9	10.6	15.4	8.4	6.9	8.8	7.0	11.8	12.5	6.0	8.0	16.7	14.7	3.5	32.6	4.8	10.2	10.7	15.9	8.7	7.9	10.4	29.9	14.8	2.6	13.5	8.7	0.0	8.9	9.8	12.8	21.0	12.7	6.0	11.3	44.5	18.9	14.1	6.5	2.5	27.9	10.4	8.5	8.2	12.9	25.0	13.2	11.8	24.8	11.1	12.6	32.3	14.6	17.0	10.2	5.6	8.0	8.5	9.4	21.0
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 63.4;Erythroid cells: 23.3;Glandular cells: 25.8;Spermatocytes: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"K-562: 42.1;Karpas-707: 24.8;SiHa: 37.9;U-2 OS: 42.0;U-266/70: 35.8;U-266/84: 44.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.8	4.8	1.4	1.3	7.2	0.5	1.9	2.1	1.3	8.5	3.6	4.1	2.2	0.6	6.9	2.3	3.9	2.8	2.1	1.9	4.7	4.5	3.6	1.1	5.5	0.2	0.6	0.5	3.0	3.4	0.2	1.8	0.8	1.2	0.5	1.7	42.1	24.8	2.2	2.0	1.7	2.5	1.7	3.9	4.5	0.9	1.2	3.8	1.0	1.4	9.4	1.1	37.9	2.5	1.1	2.1	0.1	1.5	1.1	2.1	42.0	1.6	0.9	35.8	44.0	10.1	0.5	11.8	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2	0.0	0.0	0.0	10.4	5.5	0.0	2.0	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.4	63.4	0.6	4.0	23.3	0.3	3.2	2.4	25.8	0.0	1.5	3.3	0.0	12.6	4.9	2.6	19.3	1.1	2.4	6.8	4.6	2.6	0.0	2.4	7.0	1.4	0.0	0.0	0.0	3.1	30.9	9.1	4.6	5.1	4.5	2.3	9.5
HIST1H2AG	"H2A.1b, H2A/p, H2AFP, pH2A/f"	ENSG00000196787	"Histone cluster 1 H2A family member g"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 305.4"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"K-562: 9.9;SiHa: 11.5;U-266/84: 31.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	2.4	1.6	1.1	25.1	1.2	6.3	8.7	0.7	1.0	3.3	9.7	0.0	1.0	3.8	2.0	3.7	15.7	1.0	3.2	2.7	1.3	1.6	1.1	2.6	6.0	13.5	2.3	0.0	1.4	0.9	0.3	1.0	8.7	0.3	2.5	2.3	0.3	2.1	1.5	1.1	1.4	7.1	0.9	2.3	20.2	1.8	16.1	0.0	305.4	1.5	12.3	28.9	2.4	2.0	4.4	1.3	9.7	0.8	1.1	3.8	7.7	1.3	1.8	1.6	1.4	4.9	1.0	1.0	0.5	0.7	1.6	0.2	0.8	1.4	0.4	2.0	0.5	1.5	2.8	1.9	0.8	1.1	2.4	1.1	0.7	3.6	0.0	1.0	0.7	1.5	1.8	0.4	0.5	0.5	0.8	0.5	1.3	9.9	4.7	0.1	1.7	1.8	1.1	0.9	2.0	1.2	1.2	1.5	5.1	0.3	0.3	6.1	1.5	11.5	1.8	0.6	0.7	0.0	0.4	0.6	1.8	4.0	1.4	0.7	8.4	31.2	3.2	0.3	1.1	1.1	9.7	0.4	0.7	0.6	0.3	1.3	3.0	2.3	1.6	0.6	4.4	2.2	1.8	3.5	1.1	0.8	1.3	3.8	7.7	1.1	1.2	0.7	0.9	1.3	1.6	2.3	0.0	0.3	0.0	0.0	1.4	2.2	1.4	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	16.3	0.3	7.3	0.0	0.0	2.9	0.3	1.4	0.0	0.4	2.1	4.8	1.2	0.0	0.6	10.6	0.0	1.0	0.0	1.0	3.1	1.2	0.1	10.5	0.0	0.0	0.0	0.0	0.3	2.2	3.0	0.4	2.5	2.5	2.9	1.0
HIST1H4I	"H4/m, H4FM"	ENSG00000276180	"Histone cluster 1 H4 family member i"	P62805	6	27138588-27139881	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 14.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 1.1;Cardiomyocytes: 1.8;Early spermatids: 2.7;Enterocytes: 1.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 29.8;SiHa: 17.9;U-2 OS: 30.7;U-266/84: 31.0"									HPA042201	Approved					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (2.49e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (6.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.02e-2)"	0.1	2.5		2.4		1.7	0.0		0.1	0.0	0.8			2.7	1.1	0.0	1.7	0.0	1.3	0.5			0.0	1.9	0.8	2.6			0.8	2.7	0.0		1.5		2.0	0.0		1.6	0.0	0.0	0.2	2.9	0.0		2.3	3.2	1.8			2.6		0.0	1.9		6.0	5.5	14.5	4.6	2.4	3.4	3.1	1.7	3.5	1.9	1.2	1.3	0.1	2.1	3.3	0.1	0.1	0.1	3.3	2.5	0.5	9.6	0.0	5.3	2.6	0.3	0.1	0.0	2.3	5.1	1.2	5.6	0.1	0.2	1.0	6.2	0.4	0.1	0.0	0.1	3.3	0.1	1.2	29.8	9.2	0.0	5.1	1.5	2.2	0.7	12.3	2.2	1.3	1.1	8.4	0.1	0.9	6.5	2.3	17.9	8.3	1.9	2.3	15.8	0.7	1.1	2.4	30.7	2.8	0.3	9.3	31.0	5.8	1.4	6.7	2.4	9.2	2.6	14.1	1.5	2.0	1.3	4.6	1.3	1.4	2.5	6.0	1.6	1.7	14.5	2.4	4.6	5.5	3.4	3.1											0.0	1.1	0.8	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	0.0	1.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.1	0.3	0.0	0.6	0.0
HIST1H2BK	"H2BFAiii, H2BFT"	ENSG00000197903	"Histone cluster 1 H2B family member k"	O60814	6	27146418-27146798	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 243.8"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 23.8;Basal keratinocytes: 28.0;Melanocytes: 38.8;Suprabasal keratinocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 117.4;U-2 OS: 107.1;U-266/84: 140.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	9.4	6.0	3.0	39.8	4.1	7.8	8.6	2.4	3.6	14.9	11.0	2.5	10.5	8.4	8.0	14.6	19.1	13.5	10.5	9.8	4.3	3.7	4.0	19.3	12.7	25.9	3.6	2.3	8.5	17.4	0.6	5.9	18.7	2.0	16.0	5.3	3.5	11.3	10.7	3.7	6.3	10.3	6.9	7.6	28.0	13.7	30.6	1.9	243.8	8.9	32.3	26.4	11.5	16.7	26.5	22.1	60.7	16.2	5.0	11.5	12.5	6.2	16.3	2.6	4.5	11.7	4.4	9.0	10.4	7.5	15.0	9.7	14.7	8.3	2.0	35.1	5.9	10.5	8.2	3.1	3.2	2.2	9.3	15.7	3.5	10.2	0.5	5.1	2.7	21.3	21.0	2.8	2.5	2.8	4.2	3.0	1.3	117.4	23.8	6.7	17.1	5.0	5.0	2.3	22.7	7.0	3.2	1.7	26.5	5.6	2.8	13.2	7.6	61.8	21.2	5.6	2.4	54.8	3.2	3.4	6.7	107.1	6.2	1.8	32.7	140.9	18.6	3.9	28.0	3.8	33.8	9.4	60.7	4.1	8.3	3.9	20.3	4.2	4.1	9.6	26.5	5.0	3.9	60.1	5.0	16.2	22.1	11.5	12.5	3.0	4.1	2.4	3.6	4.3	3.7	3.6	2.3	2.0	1.9	23.8	9.4	4.3	0.6	28.0	0.0	0.4	0.0	13.4	6.8	0.0	0.0	1.2	0.0	1.3	0.1	2.1	2.6	0.0	1.0	2.6	1.9	0.5	4.7	1.7	0.9	0.0	0.0	2.5	2.2	0.0	0.0	4.9	38.8	4.6	1.0	0.0	2.0	1.1	0.0	0.0	0.0	0.0	1.5	0.4	3.0	29.2	3.2	9.6	1.2	0.5
HIST1H2AH	"dJ86C11.1, H2A/S, H2AFALii"	ENSG00000274997	"Histone cluster 1 H2A family member h"	Q96KK5	6	27147129-27147515	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 301.1"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2"									"CAB004030, HPA041189"	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.8	0.7	0.0	26.0	0.0	20.2	1.5	0.0	0.4	3.1	6.6	0.0	0.6	1.0	1.8	2.6	6.4	1.0	2.7	1.3	0.0		0.5	0.4	4.1	5.4	0.0	0.0	2.4	0.5	0.4	0.0	9.0	0.0	0.6	0.9	0.1	1.7	0.6	0.4	0.6	6.5	0.9	0.0	13.9	0.7	23.5	0.0	301.1	0.6	9.0	27.3	1.9	0.0	16.2	2.2	0.0	2.4	5.1	4.7	2.3	2.6	3.5	1.1	4.9	0.0	0.0	0.7	0.3	0.6	0.6	0.0	2.6	1.0	3.8	0.9	0.0	0.6	0.3	1.0	0.0	0.0	2.1	9.0	4.7	3.0	0.0	0.0	3.2	1.8	0.0	0.0	1.2	0.0	0.0	0.9	1.8	4.8	2.4	0.9	0.4	9.3	10.2	3.2	0.9	1.2	3.4	3.1	5.0	0.0	0.3	2.5	0.6	1.4	0.5	0.2	0.1	1.0	1.5	0.0	0.8	2.8	0.2	2.7	2.9	2.9	6.1	1.3	4.6	0.8	0.0	0.9	0.0	2.6	2.4	1.2	3.8	4.7	4.2	2.2	16.2	2.4	1.6	0.0	5.1	1.5	1.5	0.8	2.3											0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.3	1.7	0.1	1.6	23.3	0.3	1.9	0.3	0.8	1.1	0.0	0.7	0.0	1.7	1.8	1.2	4.3	0.6	0.6	0.0	0.0	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.5	0.2	2.5	1.0	0.6
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 242.8"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4"	"Group enriched"	"Detected in many"	39	"B-cells: 5.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 19.9;RPMI-8226: 10.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.9	0.5	0.9	0.9	0.9	0.0	3.6	0.9	0.9	2.0	3.3	0.9	0.9	2.3	0.9	9.3	3.6	3.3	2.1	0.9	0.9	0.0	1.4	0.9	2.4	0.9	0.9	0.9	1.2	17.1	6.4	1.8	2.1	0.9	1.8	4.1	0.9	4.3	2.5	0.9	2.9	2.8	0.9	0.9	0.9	3.9	0.9	0.9	242.8	8.7	0.9	0.9	2.0	1.1	5.4	0.0	0.0	0.0	0.0	2.3	0.4	3.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	3.4	4.6	0.0	0.7	0.0	0.0	1.5	2.5	3.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.0	0.5	0.0	19.9	0.0	4.0	0.5	0.0	1.6	2.3	1.9	0.0	1.2	0.4	0.0	0.7	1.9	0.5	0.0	0.0	10.7	2.3	3.4	0.0	0.0	1.3	3.0	0.0	4.6	1.9	0.8	0.0	0.0	0.8	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	2.0	5.4	2.3	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	8.9	7.7	0.8	9.8	5.7	0.0	0.4	7.6	2.7	3.4	14.0	0.0	36.3	1.7	6.8	0.5	0.3	16.0	0.0	15.6	21.7	0.4	6.6	5.7	0.0	3.4	0.0	4.1	0.0	0.3	0.0	0.6	0.0	5.0	0.0	17.5	1.0	10.5	19.8	0.0	0.2	0.0	0.0	0.7	1.0	5.3	5.6	26.5	0.0	14.5	7.4
POM121L2	POM121-L	ENSG00000158553	"POM121 transmembrane nucleoporin like 2"	Q96KW2	6	27285903-27312170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	88	"testis: 35.6"	"Cell type enhanced"	"Detected in single"	33	"Spermatocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;HEL: 3.4;HMC-1: 1.9;K-562: 1.5;LHCN-M2: 2.5"									HPA046150	Uncertain					NA	NA					"HPA046150: AB_10960993"		"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"				"unprognostic (1.43e-2)"		"unprognostic (5.88e-3)"				"unprognostic (3.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.03e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.0	2.5	0.6	0.4	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0
ZNF391	dJ153G14.3	ENSG00000124613	"Zinc finger protein 391"	Q9UJN7	6	27374615-27403904	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Ciliated cells: 17.4;Early spermatids: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA050886	Uncertain					NA	NA					"HPA050886: AB_2681262"	"unprognostic (1.59e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.27e-5)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (5.62e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.82e-2)"	4.1	4.3	9.9	1.7	11.8	0.5	6.4	7.0	15.1	7.5	3.3	3.3	3.3	1.6	6.4	6.3	3.6	7.9	2.5	2.4	8.1	4.9	5.6	0.7	3.6	3.4	3.5	9.9	10.1	4.7	6.8	4.6	2.7	6.5	5.5	3.3	3.4	3.9	7.2	1.0	3.4	2.4	5.7	4.3	4.2	3.0	8.8	4.6	2.0	7.9	0.4	3.1	4.4	3.5	3.7	1.2	0.3	0.1	0.8	3.1	0.7	5.0	0.8	3.1	10.7	1.3	1.8	6.3	1.3	1.0	1.8	4.2	2.8	1.1	0.0	4.6	1.2	3.7	1.7	6.1	4.7	3.0	0.0	3.7	1.9	0.2	1.0	2.1	5.4	2.7	5.4	6.1	0.3	4.8	3.7	0.2	8.5	8.2	0.0	0.3	1.0	6.4	7.8	3.8	0.7	3.4	0.0	0.0	1.4	1.2	2.0	1.2	5.0	0.0	7.1	0.6	5.2	1.2	4.7	0.6	5.9	1.9	0.3	3.8	3.4	8.0	0.0	0.3	0.5	6.3	0.3	0.1	0.0	0.9	0.1	2.0	3.7	1.5	0.8	0.0	3.6	3.1	1.9	0.2	0.8	0.0	1.2	0.2	0.7	9.9	11.8	7.0	15.1	8.1	4.9	3.5	9.9	6.5	4.6	0.0	1.4	0.0	0.4	0.8	2.3	0.8	0.0	17.4	4.5	1.8	0.0	1.8	0.0	1.1	42.5	1.5	0.0	0.0	1.2	1.0	1.5	0.3	0.0	0.0	0.9	3.2	1.7	1.8	0.0	2.5	1.7	0.6	0.0	0.0	0.0	3.3	1.0	0.0	2.5	1.0	0.7	0.0	0.9	3.9	2.5	0.3	0.2	0.0	0.9	0.3
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	5.8	5.3	9.9	6.0	12.5	11.3	8.5	10.8	23.4	10.2	6.7	8.6	3.4	5.1	8.5	6.6	6.4	7.1	6.2	4.7	11.8	6.0	10.7	5.2	6.1	8.7	11.5	14.1	9.9	6.0	11.7	9.2	4.5	8.7	7.0	7.1	3.4	7.0	7.1	6.4	8.7	6.0	6.9	10.9	7.4	6.5	13.3	9.9	14.1	8.9	3.7	9.7	7.7	6.8	7.7	4.2	8.1	3.8	7.2	12.0	4.1	4.2	1.3	7.4	13.3	5.3	4.0	2.4	4.1	5.6	4.9	7.5	2.4	2.5	7.7	7.1	2.7	3.3	2.6	6.5	2.6	7.1	7.4	4.0	9.2	4.8	3.3	2.8	10.9	6.6	2.9	4.1	3.5	3.7	5.8	5.2	11.9	7.0	14.3	8.0	2.1	17.5	9.3	4.3	2.3	3.0	23.1	10.3	11.4	3.4	3.9	12.6	6.1	4.7	4.1	6.1	3.8	4.7	9.5	3.5	7.5	4.9	3.3	4.7	6.6	11.0	14.5	1.6	12.8	7.3	2.2	2.8	8.1	8.9	3.8	12.0	7.7	9.4	8.5	4.2	6.6	7.1	9.0	1.5	7.2	2.9	2.6	10.5	4.1	9.9	12.5	10.8	23.4	11.8	6.0	11.5	14.1	8.7	9.9	6.0	7.2	4.5	3.0	3.7	2.1	3.3	2.5	8.1	7.9	1.8	2.0	3.5	6.6	2.0	23.7	4.2	1.3	0.0	2.6	2.5	3.1	3.8	4.7	1.6	2.5	9.5	6.8	3.1	3.5	9.2	3.1	3.1	1.7	1.8	5.0	2.7	2.2	2.8	3.5	3.1	4.1	0.0	5.6	11.2	5.7	3.9	2.4	6.9	3.7	4.2
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell type enhanced"	"Detected in single"	13	"Club cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.2;U-266/84: 13.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.3	3.3	1.0	1.7	0.9	0.5	0.3	0.7	1.6	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.4	1.0	0.0	0.0	0.0	0.2	0.7	2.1	2.2	5.8	0.0	6.1	13.2	4.9	2.2	1.6	3.4	3.1	0.0	1.4	0.0	2.2	3.1	1.1	4.0	1.6	0.2	0.2	1.4	1.0	0.5	0.1	1.7	1.3	1.0	3.3	13.0	4.3	0.4	5.1	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.2
HIST1H2AI	"H2A/c, H2AFC"	ENSG00000196747	"Histone cluster 1 H2A family member i"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 349.3"	"Cell type enhanced"	"Detected in single"	10	"T-cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 17.7;U-266/84: 48.6"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	1.7	1.2	0.7	36.2	0.9	10.7	2.8	0.6	0.7	1.5	6.3	0.0	0.5	2.3	1.1	1.4	14.2	1.4	2.8	4.8	1.1	1.1	1.0	1.3	3.5	25.8	0.6	0.0	1.2	0.4	1.4	0.6	5.4	0.0	1.3	5.8	0.0	1.3	0.3	0.5	1.1	7.1	0.5	4.3	21.9	2.2	4.3	0.0	349.3	1.0	15.2	26.8	2.3	2.0	3.0	2.6	4.8	0.8	2.5	4.0	2.0	0.9	3.7	0.9	0.6	0.4	0.2	0.3	0.7	0.1	1.2	0.9	1.1	0.6	1.0	2.2	0.3	0.6	0.7	0.0	0.6	0.5	3.6	4.8	1.5	5.9	3.1	0.4	0.4	0.8	1.7	0.2	0.4	0.1	1.0	0.2	1.2	17.7	4.2	0.0	4.6	2.6	2.8	0.9	3.1	1.3	1.3	0.0	6.9	1.4	0.7	5.2	1.0	10.3	1.5	0.3	0.3	6.3	0.4	0.2	0.5	2.0	0.4	0.4	3.9	48.6	2.0	0.4	4.1	0.3	0.0	0.5	3.6	0.9	0.8	0.7	2.1	3.2	0.9	2.3	3.0	0.7	0.4	4.8	2.5	0.8	2.6	4.0	2.0	0.7	0.9	0.6	0.7	1.1	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4
HIST1H3H	"H3/k, H3F1K, H3FK"	ENSG00000278828	"Histone cluster 1 H3 family member h"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 55.3;lymphoid tissue: 204.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 9.9;Intestinal endocrine cells: 5.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	6	"basophil: 15.9;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"K-562: 17.8;SiHa: 15.5;U-266/70: 13.2;U-266/84: 32.1"									HPA042570	Approved					NA	Yes					"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.2	2.6	0.0	25.2	0.0	7.5	1.7	0.2	0.3	1.7	4.7	0.0	2.5	2.3	1.6	2.5	9.0	0.6	3.0	1.3	0.0		0.4	3.1	4.4	8.1	0.0	0.0	2.2	1.5	1.4	0.0	3.4	0.1	2.7	5.3	0.5	0.9	2.8	0.8	0.3	3.9	1.0	0.2	11.0	3.1	3.4	0.0	204.8	1.3	10.6	22.6	1.7	0.9	1.1	1.8	15.9	1.1	0.3	2.0	55.3	1.0	3.9	1.7	1.4	2.4	0.3	0.2	0.6	0.4	1.9	0.7	1.2	1.1	0.7	3.7	0.4	1.1	2.1	0.6	0.9	1.2	4.9	2.4	0.9	3.5	5.0	0.6	0.8	1.5	3.2	0.3	0.4	0.4	0.8	0.8	0.9	17.8	8.6	0.3	7.8	1.6	1.9	0.8	7.2	1.5	0.8	0.0	8.9	2.0	0.4	5.2	1.0	15.5	3.2	0.6	0.9	7.5	0.2	0.8	0.8	2.5	0.5	0.2	13.2	32.1	2.7	0.0	4.2	0.2	15.9	1.1	2.1	0.3	0.3	0.4	0.3	0.6	0.5	0.8	1.1	0.4	0.3	10.3	0.3	0.3	1.8	2.0	55.3											0.0	1.0	2.7	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	9.9	0.0	0.2	2.9	0.8	4.6	0.0	1.5	1.8	0.0	5.8	0.0	1.8	0.0	0.6	0.0	1.7	1.0	2.9	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.1	4.3	4.3	1.7	1.4
HIST1H2AJ	"H2A/E, H2AFE"	ENSG00000276368	"Histone cluster 1 H2A family member j"	Q99878	6	27814354-27814740	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 357.7"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8"					"Low region specificity"	"Detected in some"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.6	0.1	0.0	7.2	0.0	16.5	0.2	0.0	0.2	1.0	5.2	0.0	0.0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0.0		0.3	0.4	2.2	3.1	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.4	3.9	0.1	0.0	10.5	0.8	5.2	0.0	357.7	0.1	7.9	23.1	1.5	0.0	4.2	2.7	2.5	0.5	0.4	5.9	5.0	4.0	0.0	1.2	0.0	0.0	0.0	1.0	1.2	1.2	1.1	2.6	2.1	0.2	3.9	0.4	0.7	0.1	1.1	0.0	1.1	0.6	1.9	0.6	5.6	0.5	10.0	0.3	0.0	2.1	0.0	0.3	0.5	0.3	0.0	1.5	2.1	0.0	12.1	0.3	16.8	6.7	6.1	2.0	1.7	3.5	6.0	0.0	2.3	0.2	2.4	0.5	0.8	1.1	1.2	0.5	0.3	0.4	4.1	0.0	0.0	2.4	0.4	0.2	6.2	3.9	3.8	1.3	4.5	2.8	0.0	0.1	0.0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5.0											0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	46.7	0.0	1.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.3
HIST1H2BM	"dJ160A22.3, H2B/e, H2BFE"	ENSG00000273703	"Histone cluster 1 H2B family member m"	Q99879	6	27815044-27815424	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"lymphoid tissue: 232.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7;NB-4: 11.4;REH: 7.3;U-266/70: 13.7;U-698: 7.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.1	0.1	0.0	19.9	0.0	11.6	0.1	0.0	0.2	1.6	3.4	0.0	0.0	0.1	0.7	0.9	8.4	0.1	1.4	0.3	0.0		0.1	0.3	1.8	7.3	0.0	0.0	0.3	0.1	0.1	0.0	1.5	0.0	0.5	1.1	0.0	0.3	0.1	0.1	0.8	3.8	0.1	0.5	13.9	0.5	3.5	0.0	232.2	0.1	9.4	27.6	0.1	0.0	2.6	0.4	0.3	0.3	1.5	1.7	0.0	1.5	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.5	2.1	0.4	0.3	2.3	0.0	0.0	0.5	1.1	0.0	0.0	0.0	1.2	0.0	0.8	0.2	0.8	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.2	17.7	0.0	0.5	4.6	11.4	3.4	1.1	0.8	7.3	0.0	0.4	0.0	0.0	0.2	2.0	0.8	1.1	0.0	0.1	1.0	3.4	0.0	0.0	2.0	1.2	0.1	13.7	0.5	7.0	1.1	1.3	0.9	0.0	0.1	0.1	1.5	0.3	1.7	1.9	1.7	1.5	0.4	2.6	0.1	1.2	0.3	1.5	0.0	0.2	0.6	0.0											0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0
HIST1H4J	"H4/e, H4F2iv, H4FE"	ENSG00000197238	"Histone cluster 1 H4 family member j"	P62805	6	27824108-27824480	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.9;lymphoid tissue: 68.3"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 16.4;monocytes: 16.2;Mucus-secreting cells: 13.9;Paneth cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 58.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 31.9;MCF7: 32.0"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.9	9.4	2.9	15.6	4.1	25.9	4.0	3.7	15.5	5.3	9.9	0.2	6.8	7.9	4.4	4.7	7.6	5.6	6.2	7.5	5.9	1.9	4.0	18.1	8.3	26.7	2.2	7.1	5.2	4.1	0.6	4.5	3.2	2.3	8.0	4.6	0.7	2.0	3.7	0.7	2.7	7.6	3.8	6.0	13.9	7.5	19.3	0.8	68.3	8.6	8.0	10.8	5.4	4.9	12.0	7.7	58.9	10.8	10.6	13.2	10.8	3.9	4.7	10.8	18.2	6.5	2.7	6.3	4.5	2.3	4.4	2.8	8.8	1.3	6.3	8.0	1.9	1.1	9.3	0.2	6.7	1.4	8.9	1.7	4.1	9.5	31.9	3.8	6.1	5.4	8.6	1.9	2.8	1.5	0.6	4.1	3.5	8.0	13.3	0.0	32.0	10.9	6.2	6.8	6.5	10.5	4.5	0.7	4.4	0.6	1.7	5.9	8.1	7.6	4.5	7.1	1.5	5.8	3.0	4.0	2.2	10.8	1.1	0.0	8.6	8.1	10.9	2.8	7.7	4.3	58.9	3.4	14.8	11.7	8.5	8.9	11.0	11.5	12.7	5.2	12.0	6.6	8.3	6.9	10.6	10.8	7.7	13.2	10.8	2.9	4.1	3.7	15.5	5.9	1.9	2.2	7.1	2.3	0.8	0.0	3.0	3.0	0.5	0.2	0.0	0.3	0.0	2.7	2.3	0.0	0.0	0.7	0.0	2.5	0.8	0.7	8.6	0.0	7.3	6.2	0.5	0.7	5.8	3.9	4.0	0.0	16.4	4.3	4.8	0.2	0.0	1.8	0.0	16.2	13.9	0.0	2.0	14.0	0.0	0.3	0.0	0.0	0.3	0.5	2.5	0.0	1.4	1.9	10.5	0.7
HIST1H4K	"dJ160A22.1, H4/d, H4F2iii, H4FD"	ENSG00000273542	"Histone cluster 1 H4 family member k"	P62805	6	27831216-27831527	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lung: 2.9;lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 2: 1.1;Cardiomyocytes: 1.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 2.9;LHCN-M2: 2.9;RT4: 1.6;U-87 MG: 1.7"									HPA042201	Supported					NA	NA		30000000			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	0.7	0.0	1.0	3.1	3.4	0.0	0.0	0.7	2.0	0.4	0.6	0.3	0.0	0.0	0.0	0.5	2.1	0.0	1.3	0.0	0.3		0.1	0.0	2.9	2.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.7	1.1	0.0	0.9	0.0	2.1	0.5	2.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0											0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H2BN	"H2B/d, H2BFD"	ENSG00000233822	"Histone cluster 1 H2B family member n"	Q99877	6	27837760-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	13	"lymphoid tissue: 193.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 27.8;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 8.9;SCLC-21H: 9.8;U-266/84: 9.2"					"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	2.4	7.2	2.3	14.0	3.3	9.3	3.1	4.9	6.2	3.4	4.5	1.0	4.4	1.8	3.4	3.7	7.6	3.2	3.7	6.4	3.7	2.4	2.3	5.3	5.4	8.0	4.1	4.2	5.0	8.3	4.2	3.8	4.5	1.4	4.0	2.5	1.7	3.3	4.7	4.6	2.3	4.3	2.5	9.4	7.0	2.4	6.8	0.5	193.3	6.1	6.2	10.9	3.6	2.2	6.0	6.2	14.6	2.6	1.0	2.8	1.4	1.4	0.2	1.5	1.5	1.2	2.0	0.9	0.7	1.1	0.7	0.8	0.5	0.9	0.8	3.0	0.7	0.9	2.1	1.3	0.5	0.3	1.5	4.5	0.7	3.7	1.4	1.4	1.0	3.7	1.3	0.4	0.1	1.3	1.1	0.2	1.4	8.9	7.0	0.8	1.8	2.9	4.5	1.4	1.2	1.0	2.1	1.0	5.3	0.4	0.9	9.8	2.0	3.5	1.3	3.0	1.0	2.5	0.8	1.5	2.2	2.1	1.2	0.7	6.1	9.2	3.6	0.7	1.7	0.7	2.3	2.6	1.7	2.6	2.4	1.8	5.8	2.0	1.9	5.0	6.0	1.3	1.2	14.6	1.0	1.8	6.2	2.8	1.4	2.3	3.3	4.9	6.2	3.7	2.4	4.1	4.2	1.4	0.5	0.0	3.2	20.4	5.8	0.9	7.5	2.3	0.0	5.3	2.3	0.0	2.0	9.8	1.7	0.1	3.8	2.7	27.8	0.0	0.7	3.9	3.3	5.0	3.5	1.7	9.0	6.4	4.1	1.8	4.3	0.9	2.8	4.9	6.8	1.0	10.0	15.8	0.8	7.0	1.8	2.0	26.9	0.0	8.3	0.9	2.1	2.0	4.2	20.0	5.2	1.7
HIST1H2AK	"H2A/d, H2AFD"	ENSG00000275221	"Histone cluster 1 H2A family member k"	P0C0S8	6	27837947-27838339	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 115.7"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 1.4;granulocytes: 1.1;Melanocytes: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;AN3-CA: 4.9;HeLa: 5.1;SCLC-21H: 4.8;U-266/84: 7.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"																		1.5	4.1	0.0	11.1	0.5	3.2	3.5	0.9	1.3	2.8	2.3	0.2	0.5	1.0	1.7	1.6	4.4	2.7	4.1	2.5	0.0		0.2	0.4	4.4	8.4	0.8	0.0	3.3	0.0	0.0	0.1	1.7	0.3	2.3	0.4	0.9	1.7	1.1	0.7	0.0	1.5	0.3	1.6	7.0	1.3	3.9	0.5	115.7	1.6	2.8	12.3	2.1	0.0	6.0	1.2	0.0	0.6	1.1	3.8	5.1	0.0	4.3	0.0	4.9	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.4	0.0	0.2	0.2	0.8	0.5	2.2	1.0	0.0	0.6	1.4	1.2	1.7	5.1	0.6	0.7	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	1.9	0.0	0.0	0.7	1.6	0.0	0.0	0.2	0.0	0.6	0.4	0.0	1.0	0.3	4.8	0.8	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.5	0.5	0.0	0.3	1.9	7.2	1.0	0.0	0.3	0.5	0.0	0.1	0.0	2.3	0.0	1.8	5.8	2.6	2.4	0.0	6.0	3.8	2.8	0.0	1.1	0.6	1.2	2.7	5.1											0.0	0.3	0.5	0.3	0.1	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0
HIST1H2AL	"dJ193B12.9, H2A/i, H2AFI"	ENSG00000276903	"Histone cluster 1 H2A family member l"	P0C0S8	6	27865355-27865747	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 288.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.2;MOLT-4: 8.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	1.1	0.5	0.0	24.8	0.0	16.4	1.3	0.0	0.5	1.1	4.5	0.0	0.0	1.1	0.8	1.7	7.6	0.3	1.8	1.5	0.0		0.4	0.4	3.4	10.2	0.0	0.0	0.3	0.3	1.5	0.0	5.2	0.0	0.3	0.3	0.0	0.7	0.3	0.3	0.5	4.4	0.3	0.0	12.9	0.7	13.1	0.0	288.3	0.3	9.6	26.4	0.5	0.0	9.6	4.7	8.8	3.6	0.1	2.0	1.1	4.2	1.7	0.9	0.0	0.0	0.0	1.1	1.7	0.7	1.4	1.7	0.0	1.4	3.2	1.2	0.0	1.0	1.2	0.0	0.0	0.4	3.1	7.2	1.2	0.0	1.2	0.0	0.8	1.5	0.0	0.0	0.4	0.0	0.0	0.0	1.7	5.5	3.3	0.5	3.8	8.9	6.4	2.9	1.7	1.3	4.6	0.0	0.5	0.7	2.6	2.1	2.0	1.2	0.0	0.8	0.0	0.4	1.2	0.0	0.2	0.0	1.4	3.0	5.6	0.0	6.5	1.4	4.1	1.3	2.4	2.0	1.3	0.1	1.7	0.0	3.3	1.7	2.0	4.7	9.6	0.7	1.0	8.8	0.1	3.6	3.4	1.7	1.1											0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.1	0.0	0.4	0.5
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell type enhanced"	"Detected in some"	10	"Extravillous trophoblasts: 3.8;Hofbauer cells: 2.6;Kupffer cells: 2.2;Macrophages: 1.8;T-cells: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 14.0;NB-4: 7.7;U-698: 6.0"									"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		510000	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.7	0.4	0.8	0.7	0.8	0.0	0.0	0.1	0.8	1.0	3.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.9	1.9	2.7	1.9	0.1	0.4	14.0	7.7	2.1	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.4	0.3	0.0	0.8	1.0	2.5	0.8	1.4	0.1	1.4	1.1	2.9	0.0	6.0	2.0	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.6	2.2	0.0	0.3	1.8	0.0	0.0	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.6	1.8	0.9	0.1
HIST1H3I	"H3.f, H3/f, H3FF"	ENSG00000275379	"Histone cluster 1 H3 family member i"	P68431	6	27871905-27872315	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 236.8"	"Cell type enhanced"	"Detected in single"	15	"Alveolar cells type 2: 1.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"					"Cell type enhanced"	"Detected in many"		"NK-cell: 12.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 4.6;MOLT-4: 8.4;NB-4: 5.6;REH: 8.8"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	1.0	0.8	0.0	16.7	0.0	7.9	2.4	0.0	0.4	0.9	2.9	0.0	1.6	0.4	0.4	1.4	7.1	0.5	2.9	1.8	0.0		0.4	0.4	1.9	9.2	0.0	0.0	0.4	5.0	0.4	0.0	2.4	0.0	0.5	0.4	0.0	1.0	0.7	0.4	0.4	3.6	0.4	0.0	10.2	0.8	1.8	0.0	236.8	0.6	11.6	14.5	0.4	0.0	4.1	4.7	1.0	1.2	12.4	2.4	2.2	1.3	1.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	2.9	0.4	0.0	0.5	0.9	0.0	0.0	0.5	1.3	1.7	4.6	0.0	0.0	1.0	2.8	0.7	0.7	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.4	5.6	1.3	0.2	0.0	8.8	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.2	0.5	2.4	0.6	2.0	0.8	2.0	1.5	3.3	4.1	1.7	2.2	1.0	12.4	0.5	4.7	1.9	2.2											0.0	1.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1
HIST1H4L	"H4.k, H4/k, H4FK"	ENSG00000275126	"Histone cluster 1 H4 family member l"	P62805	6	27873199-27873510	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 133.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2"					"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 10.3;NB-4: 5.5;REH: 2.6"									HPA042201	Approved					NA	NA		30000000			"HPA042201: AB_2677898"										"unprognostic (1.15e-1)"				"unprognostic (6.05e-4)"				0.4	0.3	0.0	23.6	0.0	4.6	2.8	0.0	0.3	0.4	3.0	0.0	0.5	0.3	0.3	0.3	3.4	0.3	1.2	0.5	0.0		0.3	0.3	1.2	4.2	0.0	0.0	0.3	8.4	0.3	0.0	2.5	0.0	0.3	1.0	0.0	0.5	0.3	0.3	0.3	2.2	0.3	0.0	11.5	0.8	4.0	0.0	133.0	0.3	7.6	16.4	0.3	0.0	7.7	3.8	0.0	1.8	1.7	1.9	0.6	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	10.3	5.5	0.0	1.2	0.0	2.6	0.7	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	1.0	0.0	1.3	0.8	0.3	1.8	1.1	1.9	2.6	7.7	0.5	1.4	0.0	1.7	1.8	3.8	1.3	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H3J	"H3/j, H3FJ"	ENSG00000197153	"Histone cluster 1 H3 family member j"	P68431	6	27890382-27893106	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"lymphoid tissue: 290.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 4.8;U-266/84: 15.5"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.9	0.4	0.2	25.1	0.3	5.7	1.1	0.5	0.4	1.2	5.5	0.0	0.0	0.3	0.4	0.5	9.4	0.4	1.2	0.9	0.4	0.4	0.3	1.2	1.5	8.8	0.4	0.0	0.3	0.4	0.3	0.3	4.7	0.0	0.6	0.3	0.0	0.4	0.6	0.3	1.6	3.7	0.3	1.1	15.1	0.6	2.4	0.0	290.9	0.9	7.8	14.6	1.1	1.1	2.1	2.5	0.0	0.7	0.6	2.5	0.7	1.1	0.7	1.6	0.3	0.6	0.5	0.9	0.0	0.0	1.6	0.2	0.0	0.4	4.8	0.9	0.4	0.8	0.2	1.3	0.4	0.0	0.2	0.9	1.1	1.9	0.0	0.4	0.2	0.3	0.0	0.0	0.7	0.0	0.0	0.8	0.6	2.6	1.2	0.0	1.2	3.7	4.4	2.6	1.3	0.4	1.7	0.5	0.5	0.0	0.0	2.8	1.7	1.8	1.3	0.0	0.5	0.5	0.9	0.0	0.4	0.0	0.2	0.5	3.6	15.5	1.2	0.8	0.6	2.5	0.0	0.0	0.0	1.4	0.3	0.0	0.0	2.3	2.5	2.5	2.1	0.5	1.0	0.0	0.6	0.7	0.0	2.2	0.7	0.2	0.3	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
HIST1H2AM	"H2A.1, H2A/n, H2AFN"	ENSG00000278677	"Histone cluster 1 H2A family member m"	P0C0S8	6	27892757-27893149	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 315.3"	"Cell type enhanced"	"Detected in some"	11	"B-cells: 2.2;Ciliated cells: 4.0;granulocytes: 2.3;T-cells: 3.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 25.2"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	1.2	1.5	0.0	30.7	0.0	9.3	2.3	0.2	0.2	2.1	6.1	0.1	2.3	1.4	1.3	2.6	10.7	0.3	3.9	2.2	0.0		0.6	1.7	4.7	12.7	0.0	0.0	0.4	1.2	0.0	0.0	10.4	0.3	0.9	1.8	0.0	1.3	2.2	0.7	1.0	6.5	0.0	1.1	15.3	1.7	4.8	0.0	315.3	1.3	11.4	28.9	2.5	0.0	10.3	14.7	28.7	6.2	4.8	8.5	7.0	3.2	2.7	2.1	5.1	0.3	0.3	4.5	0.9	0.7	2.6	3.5	1.0	1.3	5.4	3.7	0.8	2.5	2.2	1.6	1.7	1.7	3.5	1.3	2.7	3.4	3.6	0.0	1.6	2.2	1.3	0.0	1.8	0.0	0.2	2.6	3.9	11.6	7.5	0.4	5.3	11.0	7.8	3.8	2.0	1.3	6.7	3.5	9.6	1.3	0.7	8.1	1.5	5.6	0.6	0.7	1.1	4.9	1.6	0.0	1.1	0.1	1.2	1.7	8.1	25.2	12.6	1.5	9.5	1.0	28.7	3.4	12.5	6.8	3.8	4.1	8.9	5.9	5.7	11.4	10.3	2.5	2.8	11.5	4.8	6.2	14.7	8.5	7.0											0.0	0.0	2.2	0.1	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.1	2.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	3.2	0.4	0.0
HIST1H2BO	"H2B.2, H2B/n, H2BFN"	ENSG00000274641	"Histone cluster 1 H2B family member o"	P23527	6	27893463-27893843	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 164.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 29.4"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	1.9	0.4	0.0	14.9	0.0	8.1	1.5	0.0	0.0	0.9	3.9	0.0	0.0	0.9	0.6	1.6	9.9	0.0	0.7	1.5	0.0		0.3	0.5	2.6	7.4	0.0	0.0	0.0	0.0	0.7	0.0	4.4	0.1	0.3	1.5	0.0	1.2	0.0	0.3	1.5	2.1	0.1	0.5	8.1	0.7	1.4	0.0	164.5	0.0	7.1	15.4	1.1	0.0	2.6	2.2	6.5	0.8	1.3	1.7	5.5	2.2	2.9	1.5	4.4	0.7	0.0	2.7	0.8	0.1	5.5	5.4	1.1	1.3	2.6	1.9	0.2	1.2	2.3	2.5	0.5	0.7	1.8	1.9	1.7	4.5	1.7	0.0	0.2	1.1	0.3	0.0	0.4	0.5	0.1	1.4	2.1	6.5	7.3	0.2	0.5	11.2	9.4	1.7	1.7	2.2	6.5	1.5	4.9	0.9	0.3	6.3	1.3	4.7	1.2	0.7	0.5	2.0	0.2	0.0	1.5	0.3	1.7	2.0	8.1	29.4	7.5	0.9	9.5	0.7	1.3	0.3	3.8	0.8	0.6	1.1	1.4	0.8	1.7	2.2	2.6	0.5	0.5	6.5	1.3	0.8	1.7	1.4	5.5											0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0
OR2B2	"hs6M1-10, OR2B2Q, OR2B9, OR6-1"	ENSG00000168131	"Olfactory receptor family 2 subfamily B member 2"	Q9GZK3	6	27911185-27912396	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"liver: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;U-266/84: 2.4"					"Low region specificity"	"Detected in some"									NA	NA																			"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7			0.1		0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2B6	"dJ408B20.2, OR2B1, OR2B1P, OR2B5, OR2B6P, OR5-40, OR5-41, OR6-31"	ENSG00000124657	"Olfactory receptor family 2 subfamily B member 6"	P58173	6	27957241-27958182	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	6	"eosinophil: 1.1;neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.0;K-562: 3.3;U-266/84: 8.5;U-937: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (7.98e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.02e-3)"	"unprognostic (1.58e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.89e-15)"	"unprognostic (1.23e-2)"	"unprognostic (5.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.47e-3)"	0.0	0.4	0.0	0.6	0.0	0.6	0.6	0.2	0.0	0.0	0.2			0.3	0.0	0.4	0.4	0.1	0.0	0.1	0.1	0.1	0.0	1.4	0.5	0.2	0.1		0.0	0.0	0.0	0.0	1.2		1.7	1.2		0.0	0.0	0.0	0.3	0.2	0.0	0.3	1.6	0.3	1.6			0.3		0.4	0.3	0.0	0.0	0.2	1.1	0.1	0.0	0.1	1.3	0.4	0.0	1.1	0.4	0.2	0.0	0.1	0.2	0.1	2.0	0.8	0.0	0.5	0.0	0.7	0.0	0.7	1.2	0.8	0.0	1.1	1.0	0.4	0.0	3.0	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	3.3	2.3	0.1	0.4	0.0	0.4	0.3	0.9	0.2	0.0	0.2	0.6	0.1	0.0	2.7	0.0	2.5	0.6	0.7	0.9	0.5	0.0	0.0	0.2	0.0	0.0	0.1	1.4	8.5	0.3	0.0	4.2	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	1.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
ZNF165	"CT53, ZSCAN7"	ENSG00000197279	"Zinc finger protein 165"	P49910	6	28080975-28089563	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 113.2;Intestinal endocrine cells: 51.6;Syncytiotrophoblasts: 66.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.7;GAMG: 14.0"					"Low region specificity"	"Detected in all"			HPA007247			Approved	"Nuclear speckles,Microtubules"		NA	NA			"Nuclear speckles, Microtubules"		"HPA007247: AB_2797217"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (9.82e-5)"	0.4	0.8	1.2	2.1	1.7	0.7	2.2	1.3	2.4	1.5	2.6	0.9	7.9	2.0	1.1	6.3	2.5	1.8	0.6	0.8	1.7	1.1	3.5	2.7	2.6	0.9	0.8	0.3	0.7	5.4	3.1	7.7	6.2	4.0	1.2	3.6	0.6	2.5	1.3	0.4	1.0	3.4	0.4	0.5	1.0	2.2	23.9	0.5	1.2	3.1	1.4	2.5	1.2	1.2	8.6	4.2	1.6	0.6	0.2	1.7	0.5	10.5	0.7	0.7	0.5	0.3	0.5	18.7	0.4	0.5	0.8	0.7	7.3	7.9	1.0	3.1	0.2	14.0	4.1	1.7	5.2	0.6	0.2	2.9	0.3	1.2	7.9	0.3	1.8	1.4	0.3	2.9	0.6	7.8	0.5	0.2	0.6	1.8	0.3	0.5	3.0	0.3	2.0	1.5	9.6	0.9	1.3	0.6	6.1	4.3	5.2	7.8	0.6	0.8	9.3	0.7	2.1	4.3	0.3	0.1	0.5	0.8	0.3	0.7	2.6	7.0	2.7	0.3	2.0	0.3	0.0	0.3	1.6	0.7	0.6	1.5	6.0	0.9	0.5	1.2	8.6	1.7	1.3	1.1	0.2	0.2	4.2	0.4	0.5	1.2	1.7	1.3	2.4	1.7	1.1	0.8	0.3	4.0	0.5	6.0	9.5	11.5	12.9	7.6	0.8	0.5	2.5	17.4	6.8	3.5	0.0	6.9	3.3	13.6	113.2	0.9	23.8	0.0	10.7	7.5	0.6	4.0	0.0	0.0	1.3	0.0	51.6	0.0	0.6	7.2	0.9	1.5	5.0	2.8	4.7	1.2	17.1	10.5	2.1	1.4	2.4	0.0	1.3	12.3	2.7	10.3	66.6	1.3	5.6	36.9
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124560-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	5.3	6.7	7.6	7.8	8.9	3.5	9.3	26.4	7.7	5.4	9.0	5.5	12.7	11.0	6.0	9.6	6.1	5.4	6.3	3.7	6.9	5.4	9.5	6.9	6.2	11.3	8.0	5.9	4.6	8.3	11.2	11.9	2.8	7.8	7.5	12.0	4.3	10.4	9.9	5.1	8.8	13.0	6.2	10.1	13.4	9.1	3.2	9.3	11.7	7.5	4.2	11.2	7.2	5.4	10.0	11.0	30.5	6.3	9.9	10.7	4.8	0.0	7.2	9.3	6.8	2.6	0.6	7.6	2.5	5.3	6.6	7.1	5.0	4.7	7.1	6.7	2.3	4.6	5.6	6.4	3.6	6.2	10.2	8.9	7.4	5.8	6.9	4.1	5.4	6.3	0.8	6.1	5.5	3.0	7.0	12.0	0.2	1.0	6.1	1.7	7.9	0.0	8.6	1.9	6.0	4.4	8.8	7.1	9.8	7.7	10.2	12.6	13.9	1.2	7.7	8.7	6.3	10.1	2.6	3.7	2.5	5.7	3.7	6.4	3.1	9.8	1.9	1.1	2.7	1.3	30.5	4.9	5.4	8.1	6.3	10.7	10.0	7.2	6.2	5.0	8.1	8.8	7.1	8.9	9.9	6.1	11.0	7.7	4.8	7.6	8.9	26.4	7.7	6.9	5.4	8.0	5.9	7.8	9.3	6.0	1.6	1.4	0.6	1.5	3.8	1.4	5.1	9.4	4.5	7.0	3.9	2.0	5.0	10.1	2.5	3.5	5.6	0.0	11.1	1.0	0.7	0.9	2.3	1.8	1.8	1.6	1.7	3.1	4.6	0.9	0.6	4.0	1.7	5.4	4.7	3.1	8.2	6.8	3.2	5.8	5.5	0.0	1.1	0.7	5.1	1.1	1.5	8.2	7.7	0.6
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141910-28159472	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	16.5	12.1	13.4	10.3	15.6	17.7	16.1	27.7	16.5	17.7	16.3	20.8	12.5	9.2	21.8	19.9	10.0	17.2	11.0	10.7	13.5	9.3	11.2	10.9	14.1	13.9	18.4	13.3	25.0	15.4	21.9	22.6	12.8	14.0	15.1	11.9	17.2	13.9	17.2	12.0	11.5	15.9	18.3	18.2	14.4	14.1	12.8	18.2	18.1	17.1	8.8	14.5	16.7	12.4	3.8	1.9	4.1	4.2	3.0	3.1	1.3	5.8	3.7	18.1	17.9	11.6	10.9	5.7	6.7	12.1	8.5	10.9	4.1	3.5	12.9	10.9	6.4	7.4	5.1	11.5	4.4	12.7	6.9	9.8	11.7	7.1	9.5	10.7	14.3	8.8	11.4	7.6	8.9	13.6	15.2	8.8	11.5	17.9	4.9	9.1	3.0	10.0	12.7	6.8	1.5	4.2	10.7	11.4	10.2	6.3	7.2	13.7	17.3	7.8	3.7	8.5	10.8	4.2	8.1	7.3	13.0	7.5	4.3	8.8	12.0	8.5	10.7	3.7	10.1	6.9	4.1	1.3	1.3	2.7	3.3	3.1	1.5	1.7	1.2	1.0	3.8	2.8	2.3	0.5	3.0	4.2	1.9	1.6	1.3	13.4	15.6	27.7	16.5	13.5	9.3	18.4	13.3	14.0	18.2	3.0	9.4	0.9	2.0	4.2	8.8	6.9	10.2	5.3	5.7	7.0	5.9	3.3	0.0	2.5	2.9	7.0	1.7	0.0	2.5	1.7	5.4	3.9	4.7	7.8	3.6	6.4	6.9	7.4	9.1	3.4	8.3	4.7	1.7	2.8	4.9	7.5	2.4	0.0	8.5	1.4	8.1	0.0	7.2	10.8	5.7	2.5	1.9	6.9	3.9	2.0
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233482	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	12.2	11.0	7.9	12.7	11.9	10.1	16.1	21.2	13.1	17.2	12.7	14.8	13.0	10.2	22.7	15.9	10.4	11.4	14.2	10.2	8.2	9.6	13.0	9.3	10.6	10.5	10.2	7.1	16.0	12.5	13.6	22.4	12.6	11.2	15.8	17.4	12.9	12.3	14.6	8.9	6.9	14.5	17.9	11.9	16.8	11.7	20.1	13.5	4.1	14.5	7.4	11.1	12.2	16.7	5.7	5.6	5.6	4.0	13.0	4.4	2.6	6.8	4.6	16.3	19.3	6.4	6.9	6.0	8.4	7.1	8.1	9.3	4.3	3.5	0.0	12.8	5.3	8.2	4.8	7.9	7.7	9.5	4.5	6.7	10.5	9.3	7.9	8.1	12.3	8.7	5.8	12.2	6.9	10.6	12.6	10.5	0.0	15.5	5.8	12.0	4.0	0.0	20.2	6.0	3.0	5.4	6.4	11.4	7.1	10.2	9.7	14.1	19.4	7.4	5.7	10.0	12.7	6.9	8.4	8.8	16.9	11.7	3.9	14.4	13.2	13.3	2.8	3.5	15.2	9.6	4.8	4.0	5.6	4.4	2.0	3.4	5.7	1.5	3.2	5.6	5.2	0.5	0.9	1.6	13.0	0.9	2.9	1.1	2.6	7.9	11.9	21.2	13.1	8.2	9.6	10.2	7.1	11.2	13.5	8.9	2.2	3.2	4.4	0.8	6.6	3.4	12.7	5.3	12.5	3.5	0.0	3.9	1.7	7.6	14.8	3.6	3.5	0.0	5.5	2.9	3.5	3.6	5.7	1.7	4.5	6.4	5.2	3.7	5.7	2.5	3.4	4.9	3.3	1.8	5.9	4.5	5.2	5.8	4.6	3.7	5.5	6.5	5.0	19.1	12.3	1.0	10.1	2.2	7.0	2.0
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28244623-28252224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 9.4;Spermatocytes: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA009637	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	5.9	6.1	5.8	5.2	8.9	2.7	7.5	13.2	8.3	6.5	5.7	7.5	6.8	6.3	8.5	6.9	5.7	6.7	5.3	4.1	5.6	4.2	5.8	6.0	5.2	10.4	4.9	5.3	8.4	9.4	7.2	7.3	7.3	5.7	6.0	6.7	6.2	6.5	6.9	3.5	6.4	7.1	5.2	6.8	16.1	5.3	15.8	7.3	16.1	5.5	2.4	10.4	6.7	6.4	5.9	12.8	9.3	5.9	6.8	9.1	4.4	3.4	2.6	6.3	9.3	7.4	7.2	6.6	4.2	6.7	6.6	6.6	3.8	3.0	8.4	8.0	5.1	4.1	3.9	6.7	5.7	6.6	3.9	6.2	7.2	5.4	5.2	5.2	13.9	6.1	8.3	6.7	5.9	5.5	7.5	6.5	7.3	7.2	1.8	5.1	3.6	8.1	14.1	4.9	1.5	4.8	7.8	8.5	5.2	3.5	2.6	8.6	7.1	3.6	4.2	7.1	6.7	4.0	6.1	4.3	6.7	4.0	3.6	4.3	5.5	5.2	4.0	2.1	13.5	4.1	9.3	5.7	5.9	6.1	4.7	7.0	5.9	6.0	5.9	9.9	5.1	9.1	8.1	7.4	6.8	5.9	12.8	5.4	4.4	5.8	8.9	13.2	8.3	5.6	4.2	4.9	5.3	5.7	7.3	0.0	0.3	2.0	0.2	0.3	1.3	1.2	2.5	0.0	3.4	1.8	2.0	2.9	0.0	2.4	5.2	1.1	1.5	0.0	1.8	2.3	1.4	0.3	2.3	0.9	4.0	1.6	3.4	4.3	9.4	5.6	2.6	2.3	1.7	1.8	1.3	2.0	1.6	3.1	3.5	1.4	1.8	0.0	0.9	17.1	1.9	0.3	0.9	2.2	2.8	0.3
NKAPL	"bA424I5.1, C6orf194"	ENSG00000189134	"NFKB activating protein like"	Q5M9Q1	6	28259320-28260958	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 35.4"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 224.7;Rod photoreceptor cells: 72.8;Spermatocytes: 169.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;BJ: 2.6;fHDF/TERT166: 4.0;HHSteC: 8.7;HSkMC: 5.7;HUVEC TERT2: 2.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.93e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.78e-2)"	"unprognostic (5.83e-5)"	"unprognostic (6.65e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.47e-2)"	2.8	2.3	3.2	1.4	5.1	0.8	2.6	6.7	5.1	1.4	2.4	1.7	2.7	0.9	1.6	2.8	1.8	1.2	2.2	6.9	2.7	2.6	1.8	1.6	1.5	1.4	3.8	1.2	3.2	2.5	0.7	10.3	1.6	9.9	2.4	1.1	2.0	2.4	4.1	7.0	1.4	1.1	5.1	3.9	2.2	1.6	35.4	4.0	0.0	1.9	2.0	1.2	2.3	3.9	2.2	5.2	4.8	2.6	0.5	0.8	0.4	0.0	0.0	0.0	0.0	6.1	1.8	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	5.7	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	2.1	3.1	0.3	2.6	0.8	2.2	0.1	0.5	1.9	0.4	0.5	0.4	4.8	0.5	2.1	5.2	0.0	0.4	3.2	5.1	6.7	5.1	2.7	2.6	3.8	1.2	9.9	4.0	0.0	0.0	0.5	1.6	0.9	25.4	12.0	2.5	0.0	2.3	1.8	41.2	0.1	8.3	1.5	224.7	3.6	0.0	0.0	0.6	0.0	2.8	1.1	0.0	2.9	2.7	31.8	0.0	3.1	3.8	15.8	5.2	2.6	5.0	3.6	0.0	15.8	1.6	0.0	6.0	3.6	72.8	0.0	4.6	169.4	25.8	0.6	0.2	0.0	0.0	0.5
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.6	4.8	13.7	11.7	14.9	14.3	3.1	11.2	11.2	14.8	15.3	3.5	4.1	3.2	17.4	7.1	11.1	4.3	6.3	8.2	16.3	6.8	6.8	8.5	6.7	7.5	10.3	7.0	5.5	11.9	7.8	11.3	10.3	19.1	14.9	5.0	7.0	6.8	11.6	4.7	7.4	9.6	4.0	3.0	7.3	7.5	11.9	5.4	12.5	5.8	9.9	7.7	6.9	2.9	9.3	11.6	4.8	4.8	9.7	11.9	8.7	4.2	13.6	7.2	9.6	6.2	4.3	7.9	10.3	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6											0.0	3.5	10.4	2.8	0.0	8.6	8.7	0.0	2.7	11.4	0.0	3.9	3.8	3.3	4.2	3.2	6.8	2.6	0.0	4.4	2.7	3.5	3.0	5.8	1.5	5.0	1.6	6.4	4.3	5.0	1.7	8.3	1.9	0.0	1.0	2.3	11.7	3.0	4.0	12.4	4.9	9.7	19.4	2.7	5.5	8.1	0.0	1.1	7.5	2.7	0.9
AL021997.3		ENSG00000276302			6	28267121-28281580	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.2;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 3.8;HEK 293: 5.1;SH-SY5Y: 3.3;U-266/84: 4.6"															NA	NA						"unprognostic (6.64e-2)"	"unprognostic (2.11e-1)"		"unprognostic (6.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	4.0	5.4	3.9	4.4	5.9	2.5	3.0	10.5	8.2	4.3	2.5	5.9	3.9	6.0	4.7	4.4	1.7	2.7	2.3	2.0	4.4		3.9	1.8	2.6	2.8	3.9	6.6	4.5	1.8	4.2	4.2	2.3	5.4	3.8	1.0	2.9	5.0	2.4	3.7	2.3	6.0	3.4	3.5	2.8	3.5	3.9	5.4	1.8	2.8	0.5	2.3	3.0	2.2	0.4	1.3	0.0	0.7	0.0	1.2	0.0	0.3	0.0	0.3	2.2	0.0	0.0	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.8	0.0	1.1	0.9	0.4	1.8	5.1	0.0	0.6	0.0	0.5	1.5	2.0	0.0	0.0	0.0	0.0	0.9	0.0	1.3	1.2	0.9	0.0	0.0	2.1	1.2	0.0	0.0	0.0	0.7	0.5	0.0	0.4	1.0	0.9	3.3	0.0	0.4	1.3	0.6	0.3	0.0	0.0	0.3	0.3	1.7	1.1	3.2	4.6	0.0	0.4	2.7	0.6	0.0	0.7	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5;plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	6.1	4.5	7.4	3.8	7.2	2.8	8.5	9.6	12.8	6.1	7.4	4.0	1.3	3.0	9.2	6.0	4.5	4.3	4.0	7.0	7.1	6.3	5.9	5.1	5.4	3.1	7.0	7.7	6.0	4.0	6.6	8.6	4.3	5.1	6.0	4.6	4.4	3.8	7.4	4.1	3.0	4.0	11.7	7.0	4.9	4.8	5.2	3.6	8.9	4.0	3.1	3.4	5.2	3.8	1.0	4.4	3.5	0.2	1.2	1.2	0.3	5.1	2.8	9.1	12.9	7.4	5.3	3.0	6.8	4.7	8.6	9.8	3.2	2.2	3.4	4.3	4.6	9.8	2.3	9.9	5.5	11.3	3.7	5.7	6.2	5.8	4.0	3.5	7.7	0.8	4.3	2.6	8.5	2.9	4.9	10.5	6.7	8.0	0.4	9.5	1.5	6.5	9.7	3.4	0.1	5.8	11.2	11.6	0.0	4.3	2.8	6.3	12.1	4.6	0.8	5.1	9.5	2.5	4.8	7.4	12.9	8.6	0.9	10.6	3.3	3.3	4.4	2.9	4.5	6.0	3.5	0.1	0.0	0.6	0.2	0.3	0.5	0.2	1.2	0.7	1.0	0.1	0.5	0.0	1.2	0.1	4.4	0.5	0.3	7.4	7.2	9.6	12.8	7.1	6.3	7.0	7.7	5.1	3.6	6.0	0.6	1.4	2.2	0.2	6.7	7.0	0.0	6.7	0.0	0.0	2.0	0.6	0.0	0.9	0.4	4.2	0.3	0.0	2.3	2.8	1.6	1.0	3.5	0.0	1.4	4.8	1.2	1.8	2.9	0.9	1.7	1.1	3.3	3.6	0.3	4.1	1.2	0.0	3.2	3.7	3.9	0.0	1.4	4.2	7.5	0.3	0.3	0.5	1.0	0.5
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 26.8;Early spermatids: 114.2;Late spermatids: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 13.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.7;EFO-21: 21.8;TIME: 16.3;U-2 OS: 26.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.2	4.0	11.3	2.2	12.1	3.5	11.2	36.4	27.6	8.0	9.9	3.6	5.9	3.2	16.3	8.4	9.9	6.8	15.5	6.4	8.0	3.8	5.2	4.5	8.7	1.9	16.7	5.6	17.7	8.1	4.8	8.3	2.3	14.9	7.1	5.1	3.5	6.5	8.3	7.0	11.0	3.5	10.7	21.9	2.1	13.3	18.4	11.8	0.6	21.0	5.6	3.1	7.3	6.9	1.5	2.0	13.4	0.3	1.4	1.5	0.3	1.0	1.4	2.2	10.3	0.3	0.5	3.3	0.5	0.6	0.5	0.4	1.3	15.7	0.2	21.8	0.7	3.2	3.3	1.1	0.9	0.3	1.8	0.9	3.6	8.1	2.4	0.9	7.3	4.5	0.3	8.7	0.6	0.9	1.0	14.9	2.8	3.9	2.8	2.3	1.5	1.2	1.7	0.7	0.7	6.4	3.2	2.0	1.9	1.5	1.3	7.3	2.0	13.9	9.0	2.0	1.7	4.5	2.5	16.3	3.3	26.6	0.7	1.2	1.1	1.6	0.2	0.4	3.5	0.7	13.4	0.3	0.6	1.5	0.2	1.3	1.5	1.2	1.2	0.3	1.3	1.0	1.5	0.3	1.4	0.3	2.0	0.2	0.3	11.3	12.1	36.4	27.6	8.0	3.8	16.7	5.6	14.9	11.8	26.8	3.5	0.0	2.2	0.7	6.5	6.1	5.1	2.7	12.5	3.5	0.0	1.8	6.6	2.4	114.2	4.5	1.6	0.0	7.1	0.8	1.5	1.7	2.3	3.9	0.6	1.6	5.8	2.5	0.3	52.0	3.4	1.1	1.7	1.0	2.2	7.3	4.0	3.5	4.9	4.2	4.9	6.5	1.7	2.3	2.5	1.9	0.7	1.5	2.3	1.3
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349914-28369177	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009637: AB_2668244, HPA060116: AB_2732641"	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	6.7	8.7	5.8	10.3	9.0	2.4	8.8	11.8	10.3	9.3	9.3	12.3	7.2	4.9	11.2	10.5	6.4	8.6	7.5	6.0	6.3	4.9	7.6	7.2	6.8	6.6	7.1	8.9	12.9	7.3	14.4	13.5	8.7	10.6	9.6	8.8	8.7	7.6	10.2	5.1	8.2	7.2	10.5	9.0	9.3	8.8	7.1	8.1	14.9	9.7	3.8	8.3	9.3	8.4	4.8	4.2	9.6	4.0	3.1	4.9	2.1	3.1	1.9	7.5	13.4	6.8	4.8	2.8	2.8	3.1	4.8	6.4	2.5	1.8	4.9	6.6	3.0	5.2	4.3	8.2	3.7	4.9	4.5	3.4	6.4	4.9	4.1	4.8	6.3	2.1	4.3	3.3	5.3	4.5	5.7	7.6	6.3	16.1	3.2	5.7	1.0	3.2	6.1	3.4	1.8	2.0	9.1	5.8	7.0	5.0	2.3	6.0	6.7	5.0	2.7	4.5	10.3	3.8	6.4	4.5	5.1	3.3	3.3	3.5	4.2	6.3	4.5	1.7	8.4	3.4	3.0	2.4	9.6	4.8	4.0	4.9	4.7	3.2	3.7	3.2	4.8	3.0	4.9	3.1	3.1	2.4	4.2	4.2	2.1	5.8	9.0	11.8	10.3	6.3	4.9	7.1	8.9	10.6	8.1	0.0	4.3	0.0	0.4	0.5	1.1	1.6	0.0	4.0	0.0	3.5	7.9	2.2	0.0	1.1	0.6	2.1	1.0	0.0	0.9	1.7	1.0	0.5	2.3	1.5	1.7	0.0	0.0	4.9	4.3	1.5	2.6	1.0	0.0	2.8	2.2	2.2	1.9	0.0	1.4	1.4	1.9	0.0	0.9	0.7	1.1	0.3	0.8	1.9	2.3	0.3
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Club cells: 11.4;Early spermatids: 20.4;Spermatocytes: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA006732"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006637: AB_1080646, HPA006732: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	6.4	5.5	8.0	7.4	8.6	3.7	11.4	12.1	9.0	8.1	7.2	5.7	6.9	4.9	9.4	7.6	4.6	7.3	4.6	4.7	7.2	5.0	6.0	3.8	5.7	8.3	5.0	3.9	11.4	9.0	10.1	14.1	7.0	7.6	8.9	6.0	4.8	6.9	9.9	2.8	4.5	6.6	7.5	5.1	7.2	5.8	9.5	6.9	11.5	10.3	3.7	7.7	9.4	10.2	6.1	2.2	5.2	1.7	3.9	4.5	1.9	5.3	1.7	8.1	0.1	4.2	3.3	5.8	3.7	5.1	5.6	7.8	1.2	2.0	5.1	7.0	2.5	2.8	2.4	0.0	4.5	5.8	0.0	6.6	7.4	5.3	3.7	3.9	2.6	1.9	4.4	4.3	5.6	10.1	6.1	1.5	0.0	10.8	1.2	3.5	0.6	0.0	5.8	5.1	0.5	0.9	8.9	7.4	1.3	4.2	3.5	10.0	10.2	1.9	4.4	6.2	8.5	1.7	6.6	1.5	2.2	4.8	1.7	2.9	3.2	3.3	1.0	2.0	0.7	3.4	5.2	1.6	3.3	3.6	1.0	3.4	4.3	2.7	4.2	2.2	6.1	4.5	3.8	0.5	3.9	1.7	2.0	2.1	1.9	8.0	8.6	12.1	9.0	7.2	5.0	5.0	3.9	7.6	6.9	6.0	3.2	1.7	1.4	0.3	5.6	2.8	0.0	0.0	11.4	0.0	3.9	1.2	1.7	1.3	20.4	1.3	0.5	0.0	2.2	0.9	0.9	1.2	1.1	0.8	0.9	6.4	1.2	4.3	0.6	4.5	1.7	0.6	1.7	1.8	0.9	3.5	1.3	0.0	3.2	0.9	5.4	6.5	1.9	11.3	2.7	0.3	0.5	1.3	2.1	0.5
ZSCAN23	"dJ29K1.3.1, ZNF390, ZNF453"	ENSG00000187987	"Zinc finger and SCAN domain containing 23"	Q3MJ62	6	28431930-28443502	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 2.3;Cone photoreceptor cells: 3.9;Early spermatids: 2.1;Intestinal endocrine cells: 1.7;Rod photoreceptor cells: 2.4;Spermatocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SCLC-21H: 4.8"					"Low region specificity"	"Detected in all"			"HPA035959, HPA035960"	Uncertain					NA	NA					"HPA035959: AB_10696647, HPA035960: AB_2674889"	"unprognostic (6.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.32e-3)"	2.0	2.4	6.0	1.2	6.9	0.6	4.1	11.4	6.8	3.1	2.5	3.0	6.0	1.0	4.3	6.5	1.8	2.5	2.2	2.7	5.4	1.5	2.2	1.2	1.8	1.5	1.7	2.7	6.4	3.7	7.2	8.8	2.2	5.1	4.6	2.2	4.4	3.1	6.7	1.3	1.4	1.9	3.2	3.0	2.2	2.2	3.2	4.5	0.0	4.7	0.7	1.8	2.9	2.8	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	4.0	0.0	1.8	3.7	0.6	1.1	0.2	1.2	2.0	0.0	0.0	0.0	0.7	0.5	0.6	0.4	1.5	1.0	1.3	0.0	2.6	0.2	0.0	0.4	0.5	1.0	0.0	1.4	0.8	0.9	1.3	2.2	0.3	0.6	1.6	0.0	1.0	0.0	0.0	1.1	1.8	0.0	0.8	0.9	1.0	0.0	0.7	1.3	4.8	3.0	0.0	1.0	0.0	3.0	0.0	0.4	0.1	2.8	2.2	0.8	0.0	0.0	0.5	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	6.0	6.9	11.4	6.8	5.4	1.5	1.7	2.7	5.1	4.5	0.0	0.0	0.0	0.1	0.0	2.3	0.4	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.4	0.0	0.0	1.5	0.7	0.0	0.1	0.0	0.0	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 2.5;Late spermatids: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.6"	"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525925-28534952	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 27.7"	"Group enriched"	"Detected in some"	32	"Early spermatids: 10.4;Late spermatids: 26.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.0;NB-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"	NA	NA																	"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 13.2;testis: 17.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 17.9;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0"									HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.8	1.8	2.6	0.4	7.2	0.4	2.3	9.5	4.7	2.3	1.1	0.3	9.3	0.7	1.6	7.5	1.0	3.1	0.7	1.2	2.4	2.3	2.3	3.2	1.9	0.5	1.3	2.9	4.1	3.4	3.2	6.9	3.0	3.5	3.4	1.5	0.8	2.4	13.2	0.5	0.7	0.8	1.1	0.8	0.6	1.0	17.6	0.7	0.0	4.1	0.0	0.6	1.4	1.2	0.5	0.7	1.1	0.7	0.4	1.4	0.2	1.8	1.8	1.9	0.0	0.0	0.0	2.3	0.4	0.0	0.4	1.2	0.0	1.2	0.0	7.8	0.1	3.8	1.0	0.0	2.1	0.4	0.0	5.2	0.5	1.2	1.8	1.3	0.0	0.0	1.1	7.1	0.1	3.5	1.1	0.0	0.0	12.5	0.0	0.1	1.4	0.0	0.1	1.8	0.0	0.9	0.7	0.8	0.1	2.0	2.2	2.0	4.9	0.0	2.0	0.0	2.8	0.0	0.6	0.0	0.0	2.2	0.0	1.2	0.0	6.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.3	0.4	0.1	0.2	0.4	0.4	0.2	0.5	1.4	1.0	1.1	0.4	0.7	0.7	0.1	0.2	2.6	7.2	9.5	4.7	2.4	2.3	1.3	2.9	3.5	0.7	0.0	2.7	0.0	0.8	0.0	1.6	1.6	5.1	1.4	1.2	0.0	2.0	2.0	1.7	1.7	17.9	0.0	0.4	0.0	1.2	1.1	0.4	1.1	0.0	1.6	0.3	0.0	1.2	0.0	0.0	3.2	2.3	0.0	0.0	0.0	1.4	1.1	0.6	0.0	0.0	0.7	1.1	0.0	0.0	27.7	2.9	0.0	0.8	0.0	0.9	0.6
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	1.0	6.1	0.8	1.7	0.7	4.6	1.1	1.4	1.7	1.7	1.4	7.7	8.0	1.3	3.0	7.4	1.1	2.7	0.1	3.0	13.1	11.0	0.5	2.3	1.3	4.6	1.7	1.3	1.7	1.2	0.5	0.1	1.2	8.0	10.6	3.3	0.4	1.3	6.4	2.4	0.0	2.1	7.4	9.1	7.0	14.3	1.1	1.1	3.3	13.1	5.6	3.4	7.4	0.3	3.3	3.6	4.0	3.5	7.1	6.3	2.7	12.2	14.6	12.2	1.8	11.7	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2	14.9	21.9	30.9	26.1	25.2	11.0	14.9	30.6	24.1	19.4	27.9	15.7	41.3	18.3	35.7	9.4	29.1	15.7	23.3	37.7	49.1	24.4	31.4	20.8	36.5	36.4	7.9	26.5	25.2	23.8	4.4	22.2	24.5	8.5	25.2	24.4	9.8	42.8	19.5	17.3	24.1	13.1	19.4	21.1	5.1	11.2	17.1	38.1	26.2	24.4	24.0
ZNF311		ENSG00000197935	"Zinc finger protein 311"	Q5JNZ3	6	28994785-29005316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	8	"Melanocytes: 3.3;Spermatocytes: 5.4;Spermatogonia: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;K-562: 1.2;MCF7: 1.5;RT4: 2.0;SK-MEL-30: 1.3;THP-1: 1.6;U-2 OS: 2.3"									HPA050541	Approved					NA	NA					"HPA050541: AB_2681164"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.14e-1)"	1.2	1.9	2.0	3.3	2.2	0.8	2.6	1.5	2.7	2.5	2.5	1.8	6.4	1.5	1.8	4.6	1.6	4.2	1.7	1.1	1.5	0.9	1.3	1.5	1.6	1.0	4.7	1.2	3.5	1.4	0.8	0.8	0.8	2.6	2.7	1.4	1.6	1.6	3.2	0.8	2.1	1.6	1.7	5.6	1.5	1.5	6.6	1.9	0.0	4.2	0.0	1.2	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	1.6	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.2	1.5	2.7	1.5	0.9	4.7	1.2	2.6	1.9	0.0	0.0	0.0	0.4	0.3	0.5	0.4	0.0	0.0	0.0	1.8	0.0	0.3	1.7	0.8	0.0	0.4	0.5	0.0	0.6	0.4	0.2	0.7	0.0	0.2	0.5	0.0	0.0	2.5	1.0	0.7	0.6	0.0	3.3	1.0	1.4	1.7	1.1	1.1	0.0	0.0	0.8	0.0	0.2	5.4	2.7	0.1	0.0	0.0	0.9	0.3
OR2W1	hs6M1-15	ENSG00000204704	"Olfactory receptor family 2 subfamily W member 1"	Q9Y3N9	6	29044213-29045240	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"testis: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2B3	"OR2B3P, OR6-4"	ENSG00000204703	"Olfactory receptor family 2 subfamily B member 3"	O76000	6	29086208-29087313	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2J1	"dJ80I19.2, hs6M1-4, OR2J1P, OR6-5"	ENSG00000204702	"Olfactory receptor family 2 subfamily J member 1 (gene/pseudogene)"	Q9GZK6	6	29099657-29102701	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2J3	OR6-6	ENSG00000204701	"Olfactory receptor family 2 subfamily J member 3"	O76001	6	29108059-29114770	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.5"															NA	NA																							0.2	0.0	0.1	0.1	0.0	0.6	0.3	0.0	0.2	0.4	0.1			0.4	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.1		0.3	0.5	0.4	0.1	0.3		0.2	0.0		0.1	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.2	2.5			0.2		0.0	0.1	0.2	0.2	0.3	1.2	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.4	1.5	0.3	0.2	0.0	0.5	0.5	0.4	0.2	0.7	0.2	0.4	0.6	0.7	0.1	0.8	0.0	0.8	0.2	0.0	0.4	0.6	0.7	0.0	0.0	0.3	0.1	0.4	0.5	0.2	0.0	0.5	0.4	0.5	0.0	0.8	0.0	0.1	0.2	0.7	0.0	0.3	0.4	0.1	0.0	0.5	0.0	0.4	0.5	0.5	0.9	0.6	0.0	0.3	0.2	0.1	0.2	0.7	0.6	0.3	0.2	0.1	0.3	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.1	1.2	0.0	0.2	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2J2	"dJ80I19.4, hs6M1-6, OR6-8"	ENSG00000204700	"Olfactory receptor family 2 subfamily J member 2"	O76002	6	29170907-29175811	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.6;bone marrow: 1.5;testis: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;Karpas-707: 2.2"															NA	NA																							0.0	0.0	0.3	0.4	0.7	1.5	0.0	0.0	0.0	0.2	0.0			0.2	0.0	0.5	0.0	0.6	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0		0.2	0.1	0.0	0.0	0.1		0.0	0.1		0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.3	3.0			0.5		0.0	0.1	0.0	1.0	0.7	1.6	0.4	0.3	0.5	0.0	0.1	0.3	0.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.2	0.2	0.3	1.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.7	0.0	0.4	0.3	0.0	0.0	0.4	0.1	0.6	0.4	0.7	0.5	0.2	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.3	1.6	0.3	0.4	0.7	0.4	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
OR14J1	"hs6M1-28, OR5U1"	ENSG00000204695	"Olfactory receptor family 14 subfamily J member 1"	Q9UGF5	6	29301701-29313017	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.5;testis: 4.4"	"Group enriched"	"Detected in some"	9	"Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 4.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"													NA	NA																							0.4	0.4	0.4	1.0	0.4	3.0	0.4	0.4	0.7	0.4	0.4			0.8	0.4	1.5	0.4	0.4	0.5	0.4	0.4	0.5	0.4	1.4	0.4	0.8	0.4		0.6	0.4	0.0	0.4	0.4		0.4	0.1		0.7	0.0	0.9	2.0	0.7	0.0	0.4	0.9	0.6	4.4			0.4		0.0	0.4	0.4	1.7	1.0	3.5	0.8	1.0	1.2	0.0	2.3	0.9	1.9	2.1	0.7	0.6	1.3	1.6	0.2	0.2	0.1	1.4	1.8	1.9	2.3	0.4	1.0	1.0	0.3	0.3	0.2	2.2	0.5	1.8	3.6	1.8	0.1	1.9	1.8	0.2	0.2	0.4	0.5	0.8	0.1	1.3	1.5	5.4	0.5	1.1	1.1	1.9	2.4	0.7	0.7	1.1	1.3	1.5	0.4	2.3	1.6	2.2	1.9	1.2	0.7	1.9	1.7	1.5	3.9	2.2	2.0	3.7	1.8	3.4	2.0	1.4	1.7	1.6	1.8	3.5	0.8	0.7	1.2	0.5	0.8	0.9	0.7	0.8	0.3	1.7	0.8	0.8	3.2	1.0	0.8	1.0	0.4	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5V1	hs6M1-21	ENSG00000243729	"Olfactory receptor family 5 subfamily V member 1"	Q9UGF6	6	29353749-29431967	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.1"	"Group enriched"	"Detected in some"	23	"Early spermatids: 13.0;Late spermatids: 13.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046707	Uncertain					NA	NA					"HPA046707: AB_2679763"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR12D3	hs6M1-27	ENSG00000112462	"Olfactory receptor family 12 subfamily D member 3"	Q9UGF7	6	29373423-29375291	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR12D2	hs6M1-20	ENSG00000280236	"Olfactory receptor family 12 subfamily D member 2 (gene/pseudogene)"	P58182	6	29395631-29398008	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR11A1	"hs6M1-18, OR11A2"	ENSG00000204694	"Olfactory receptor family 11 subfamily A member 1"	Q9GZK7	6	29425504-29457071	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Group enriched"	"Detected in some"	73	"Early spermatids: 29.0;Late spermatids: 28.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.3;U-2197: 1.7"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.2	0.0			0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.3	0.0	0.0		0.0	0.3		0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	1.1			0.1		0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
OR10C1	"hs6M1-17, OR10C1P, OR10C2"	ENSG00000206474	"Olfactory receptor family 10 subfamily C member 1 (gene/pseudogene)"	Q96KK4	6	29439306-29440977	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049336	Uncertain					NA	NA					"HPA049336: AB_2680718"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2H1	"OR2H6, OR2H8, OR6-2"	ENSG00000204688	"Olfactory receptor family 2 subfamily H member 1"	Q9GZK4	6	29457181-29464328	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	124	"testis: 12.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 52.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell type enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"HEL: 3.9"									HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2I1P	"HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P"	ENSG00000237988	"Olfactory receptor family 2 subfamily I member 1 pseudogene"		6	29550407-29557721	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 3.0;granulocytes: 1.1;monocytes: 1.8;Pancreatic endocrine cells: 1.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (7.45e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.00e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.34e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (4.00e-6)"	"unprognostic (8.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Group enriched"	"Detected in some"	16	"Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RT4: 13.8"	"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	3.0	1.9	0.0	0.0	0.1	0.0	0.0	22.9	16.0	15.9	0.0	0.0	0.0	1.7	316.2	0.0	0.0	3.3	0.0	231.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	265.1	3.1	0.0	685.5	6.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;HEL: 7.9;U-2 OS: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	14.0	7.4	33.6	7.0	47.2	8.2	4.2	29.1	53.8	6.9	5.6	17.3	3.0	2.3	18.1	1.9	2.9	7.9	4.1	4.6	24.8	21.4	2.9	2.0	6.9	6.6	15.6	33.7	7.8	5.1	1.8	5.8	5.0	22.3	12.8	3.2	4.4	13.0	13.3	8.5	18.3	6.1	5.5	14.9	24.2	6.1	4.3	15.4	0.0	3.9	0.1	5.2	4.0	5.9	1.8	1.7	0.0	0.5	0.0	0.4	0.3	3.0	0.0	1.9	8.1	0.9	2.1	2.1	2.0	0.9	1.8	0.5	2.4	0.1	1.4	2.0	0.0	0.5	2.5	0.9	0.0	0.0	7.3	3.4	7.9	3.5	0.0	1.2	0.3	4.0	0.0	0.0	1.6	0.0	2.3	1.0	4.3	6.7	0.0	0.3	2.0	0.8	0.1	0.6	0.0	1.1	3.5	0.7	0.1	0.3	0.0	0.5	1.3	0.5	0.0	3.3	0.6	1.5	1.2	4.6	3.3	8.4	0.3	3.8	7.1	0.8	0.0	1.8	3.6	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	33.6	47.2	29.1	53.8	24.8	21.4	15.6	33.7	22.3	15.4	11.9	19.8	5.2	6.1	10.5	22.1	8.9	2.5	1.4	18.2	3.5	0.0	0.4	0.0	1.2	2.4	11.9	0.0	0.0	0.7	0.2	9.6	5.4	7.0	0.0	1.1	22.3	6.9	28.8	7.2	1.7	14.1	10.5	0.0	5.4	3.8	9.7	2.2	1.5	24.1	0.7	13.8	12.9	15.5	1.1	1.5	9.7	0.5	1.0	1.2	1.8
OR2H2	hs6M1-12	ENSG00000204657	"Olfactory receptor family 2 subfamily H member 2"	O95918	6	29585121-29590500	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 3.3;epididymis: 11.7;testis: 4.8"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 15.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;NTERA-2: 3.5;TIME: 1.9"															NA	NA						"unprognostic (2.95e-1)"	"unprognostic (3.76e-1)"			"unprognostic (2.33e-2)"			"unprognostic (2.42e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"			0.2	0.1	1.5	0.3	3.3	1.5	0.1	2.2	0.9	0.1	0.1			0.0	0.2	11.7	0.1	0.1	0.1	0.3	1.2	0.9	0.1	0.1	0.2	0.4	0.6		0.2	0.0	0.0	0.7	0.1		0.2	0.1		0.1	0.9	0.1	0.4	0.1	0.1	0.2	0.4	0.2	4.8			0.2		0.2	0.1	0.1	0.4	0.2	0.8	0.1	0.1	0.3	0.0	0.4	0.0	2.3	0.3	0.0	0.0	0.5	0.2	0.1	0.0	0.2	0.0	0.2	0.5	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.2	0.7	0.9	0.7	0.6	0.1	0.6	1.0	0.1	0.1	0.0	0.2	0.3	0.3	0.7	0.4	0.7	0.2	0.1	0.0	0.2	3.5	0.1	0.2	0.4	0.3	0.0	0.0	0.2	0.7	0.2	0.3	0.2	0.0	1.1	0.2	0.2	1.9	0.4	0.9	0.3	0.2	1.0	0.2	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MOG	"BTN6, BTNL11"	ENSG00000204655	"Myelin oligodendrocyte glycoprotein"	Q16653	6	29656981-29672372	"Disease related genes, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 106.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	45	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 3.4;HEK 293: 2.1;SuSa: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021873	Enhanced					NA	NA					"HPA021873: AB_1854055"	"unprognostic (1.33e-1)"				"unprognostic (1.32e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"		"unprognostic (7.87e-2)"	"unprognostic (3.00e-4)"	"unprognostic (4.89e-2)"	"unprognostic (4.90e-2)"			1.9	1.7	22.1	1.7	35.1	1.7	1.7	3.1	30.0	1.7	1.9	79.5	0.0	1.7	1.7	1.7	1.7	1.7	1.7	1.7	40.2	19.6	2.0	1.7	1.8	1.7	49.2	17.1	2.0	1.7	1.7	0.0	1.8	39.8	1.8	2.1	0.0	1.7	2.2	1.7	1.7	2.0	1.7	106.4	1.7	1.7	2.0	46.4	0.0	1.7	0.0	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	22.1	35.1	3.1	30.0	40.2	19.6	49.2	17.1	39.8	46.4	0.0	0.6	0.0	0.3	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672392-29681110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.7;heart muscle: 14.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.2;Extravillous trophoblasts: 3.1;granulocytes: 2.3;Late spermatids: 3.6;Pancreatic endocrine cells: 2.7"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	14	"BEWO: 12.0;SuSa: 3.4"					"Low region specificity"	"Detected in all"			HPA047172	Uncertain					NA	NA					"HPA047172: AB_10960886"	"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.9	0.6	3.8	0.3	4.1	1.1	4.2	0.1	2.3	0.5	0.4	0.4	2.4	0.3	0.5	0.5	0.9	0.3	1.9	14.4	5.5	3.2	0.5	0.3	0.9	6.1	7.6	0.1	0.7	5.2	0.3	0.1	1.5	0.5	0.7	0.6	0.2	2.3	2.1	0.4	0.7	1.2	1.5	12.7	0.8	0.3	1.4	0.1	1.2	0.3	0.7	1.1	1.5	5.5	0.3	0.7	3.8	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.5	0.0	0.6	0.3	0.3	0.3	0.4	0.5	0.7	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.6	0.3	3.8	4.1	0.1	1.4	5.5	3.2	7.6	0.1	0.5	0.1	0.0	1.1	0.0	0.2	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.9	3.1	0.4	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.0	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.5	0.1	0.2	0.0	0.0	0.0
HLA-F		ENSG00000204642	"Major histocompatibility complex, class I, F"	P30511	6	29722775-29738528	"Plasma proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 189.5;monocytes: 255.1;T-cells: 236.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A-431: 25.3;GAMG: 9.9;HEK 293: 9.0;HEL: 6.2;HHSteC: 7.7;JURKAT: 5.4;U-266/70: 6.3;U-937: 9.6"															NA	NA		27000000				"unprognostic (3.07e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.21e-3)"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-2)"	12.2	8.0	3.9	33.3	6.5	3.1	10.8	2.6	3.6	8.2	15.7	2.3	5.2	33.2	9.4	10.7	7.5	7.5	24.8	10.7	2.9	2.8	8.2	7.7	24.0	39.4	4.2	2.6	3.9	4.4	1.5	5.3	2.8	3.9	6.2	4.1	8.9	16.2	5.3	6.7	28.0	21.7	6.4	4.1	43.9	36.5	4.9	3.7	9.7	8.9	11.0	18.7	11.4	8.7	11.6	3.2	28.5	13.8	15.3	20.4	14.8	25.3	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	9.9	1.0	0.0	0.7	0.0	0.5	9.0	6.2	0.2	0.0	7.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	1.6	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.4	0.1	0.1	0.9	0.1	6.3	1.3	0.0	0.0	9.6	0.1	28.5	9.4	20.6	20.4	9.8	13.5	11.6	13.4	16.8	0.6	9.6	13.4	13.3	14.5	15.3	13.8	3.2	13.2	14.8	3.9	6.5	2.6	3.6	2.9	2.8	4.2	2.6	3.9	3.7	35.7	77.4	91.0	27.5	36.4	1.1	8.4	63.7	17.4	22.7	7.0	2.0	0.4	1.7	53.0	1.5	103.7	189.5	0.0	78.8	0.6	20.0	29.0	48.5	24.5	58.1	0.0	21.9	65.1	69.2	0.4	26.2	76.5	27.0	255.1	111.6	5.2	61.8	84.2	19.8	4.9	0.9	45.3	38.4	9.6	1.4	32.9	0.2	236.8	51.5	36.9
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 66.0"	"Cell type enriched"	"Detected in many"	15	"Extravillous trophoblasts: 586.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 1.2;SuSa: 3.9"									CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000				"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.2	0.1	0.0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0.0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0.0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66.0	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	1.1	1.4	6.4	20.3	0.0	0.8	5.1	0.0	0.0	0.0	0.0	7.8	0.0	2.8	16.1	5.2	2.6	0.0	4.7	586.1	11.7	5.5	0.0	1.1	21.9	0.0	16.8	8.0	11.0	5.3	2.3	3.3	11.8	0.0	39.2	0.0	15.5	20.1	2.5	0.2	0.0	0.0	3.3	4.7	3.0	30.7	33.9	6.9	9.7	6.7
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	"P04439, P13746, P16188"	6	29941260-29945884	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 4504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 158.0;fHDF/TERT166: 42.3;HBEC3-KT: 43.4;RPMI-8226: 41.2;U-266/70: 42.1"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	69.4	57.5	16.0	69.1	18.2	41.2	40.8	9.1	20.7	54.4	92.6	20.4	28.6	105.7	38.4	76.2	48.4	27.8	92.3	59.1	14.6	16.6	80.5	47.6	112.0	90.5	19.5	8.9	57.2	30.0	22.5	33.3	38.7	22.7	64.1	38.5	52.4	28.3	19.2	44.0	110.4	129.4	30.3	22.8	150.0	115.9	26.6	12.3	71.1	62.3	38.5	97.7	86.4	41.0	23.0	10.9	65.8	25.2	25.9	46.7	45.4	158.0	4.0	0.0	0.0	25.5	24.1	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.0	42.3	21.5	3.9	0.0	43.4	0.0	0.3	1.6	27.6	1.2	0.8	1.4	0.0	1.8	0.2	0.0	0.3	0.1	0.0	0.0	21.2	0.0	0.1	0.0	0.0	0.1	2.5	0.3	0.0	0.4	3.3	0.3	41.2	29.6	32.5	0.0	1.4	3.5	0.0	1.4	10.4	0.2	3.7	0.6	2.4	0.1	0.7	0.5	42.1	10.7	8.9	0.0	23.3	0.0	65.8	25.2	35.4	38.3	17.9	28.8	23.0	29.6	34.4	4.1	14.9	21.7	29.7	47.9	25.9	19.8	10.9	46.7	45.4	16.0	18.2	9.1	20.7	14.6	16.6	19.5	8.9	22.7	12.3	345.4	508.3	1064.2	718.5	760.7	31.3	128.4	937.6	317.2	366.3	478.1	5.9	16.7	74.6	2692.4	38.8	1227.5	2851.3	186.9	1168.0	15.8	685.4	823.3	585.8	217.5	1814.8	35.0	917.5	1170.5	1323.9	66.9	652.4	1239.0	602.3	4504.1	1496.2	150.9	1505.1	2283.0	455.0	258.2	20.0	549.7	859.0	132.4	24.5	828.4	26.5	2218.3	1070.6	1059.3
ZNRD1	"HTEX-6, hZR14, RPA12, tctex-6"	ENSG00000066379	"Zinc ribbon domain containing 1"	Q9P1U0	6	30058899-30064909	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	11.7	13.5	6.7	14.1	7.2	8.7	17.1	7.4	8.9	12.3	15.3	6.8	9.1	13.2	12.5	10.2	15.4	13.0	10.4	11.0	6.4	6.3	13.4	12.2	14.8	18.8	8.3	6.1	13.6	22.0	10.2	9.4	11.4	6.2	12.5	14.5	9.7	14.7	10.2	13.5	11.2	14.2	9.1	6.3	17.5	12.7	22.9	6.8	37.0	15.0	15.3	18.9	12.2	15.0	8.2	8.4	6.4	5.9	8.1	13.0	7.9	4.1	0.9	4.6	6.5	2.2	2.7	1.7	1.6	2.4	2.9	2.6	4.6	2.9	3.3	1.4	2.6	4.9	3.5	7.6	6.2	3.1	2.3	7.7	7.8	2.1	6.8	9.3	8.2	3.6	5.4	3.6	4.6	15.8	1.7	8.0	16.8	13.1	2.1	1.9	5.5	7.1	17.8	0.0	9.2	5.4	8.7	4.3	6.4	2.5	6.9	1.6	3.1	2.8	4.4	2.6	2.2	3.3	6.8	1.7	3.4	3.0	0.0	5.1	5.2	9.8	10.6	1.2	13.3	4.5	6.2	5.9	5.7	12.5	5.6	13.0	7.3	10.8	11.5	5.6	8.2	9.8	10.2	6.4	8.1	5.2	8.4	10.9	7.9	6.7	7.2	7.4	8.9	6.4	6.3	8.3	6.1	6.2	6.8	20.8	16.8	48.4	63.0	69.8	13.3	13.3	20.4	16.0	22.7	21.0	2.0	21.3	43.1	28.3	106.8	37.6	47.7	0.0	39.7	37.2	41.2	27.6	31.1	25.8	31.4	11.1	42.2	28.8	38.9	11.9	36.8	27.6	28.7	33.3	41.2	14.0	40.2	59.6	23.0	47.3	13.3	19.4	39.1	52.1	5.9	60.3	14.8	62.3	48.4	68.8
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 93.3"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 578.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 18.8;AN3-CA: 25.1;HBEC3-KT: 15.7;HEL: 15.1;JURKAT: 29.4;RPTEC TERT1: 17.5;U-266/84: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	36.0	18.2	18.5	8.3	21.6	4.4	12.9	9.8	31.7	11.0	27.0	17.3	7.9	33.2	16.0	93.3	26.8	33.7	23.9	16.8	16.6	17.6	18.2	22.6	12.9	13.2	15.5	14.5	26.2	33.1	5.9	8.8	21.1	14.6	13.6	4.6	14.0	20.4	8.8	39.0	37.0	28.6	9.4	13.4	16.0	27.2	18.1	11.4	16.9	20.6	10.9	29.6	15.8	12.4	2.6	2.7	4.4	3.5	0.8	3.2	1.8	18.8	0.0	0.0	25.1	11.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	12.1	0.0	0.0	15.7	0.0	0.0	12.9	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.5	8.2	0.0	0.0	0.0	8.5	0.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	16.7	7.3	0.0	0.0	0.0	2.9	2.6	4.4	1.7	3.5	2.0	2.1	1.9	3.1	1.3	2.6	2.7	2.1	2.9	0.8	2.9	2.7	3.2	1.8	18.5	21.6	9.8	31.7	16.6	17.6	15.5	14.5	14.6	11.4	17.9	19.8	58.2	65.2	46.9	29.4	15.0	43.3	24.1	19.4	38.4	5.9	51.3	81.2	116.6	185.3	36.0	115.4	0.0	120.0	106.5	33.8	60.5	77.3	26.0	59.8	12.7	51.5	36.8	38.6	578.9	30.0	49.9	59.1	73.1	76.9	44.8	105.0	77.2	37.8	70.2	30.1	38.8	48.4	51.5	22.6	58.2	62.9	66.0	52.1	78.8
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 43.3;Glandular cells: 56.0;Urothelial cells: 159.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"OE19: 8.8;U-266/84: 6.7"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	5	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"		NA	NA			"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.4	0.0	0.6	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	1.4	0.0	1.2	0.0	0.4	2.2	1.0	0.2	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.1	1.4	0.0	1.8	0.6	0.5	0.0	0.8	0.0	1.1	0.0	8.8	0.0	0.3	0.3	0.0	1.6	0.3	0.2	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.4	0.5	0.0	0.2	1.6	6.7	0.6	0.5	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0	3.0	2.4	0.0	43.3	15.9	0.5	0.3	5.1	1.4	3.4	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.4	0.0	2.9	0.0	0.4	56.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	1.0	1.7	0.0	14.8	0.0	1.1	0.0	0.5	0.0	0.9	0.0	0.2	20.8	0.6	0.0	0.5	159.5
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113106	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2"	"Group enriched"	"Detected in many"	4	"Enterocytes: 222.6;Urothelial cells: 174.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	490	"RT4: 81.4"									HPA074175	Enhanced					NA	NA					"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.1	0.0	0.1	7.4	0.1	0.0	0.1	0.1	0.1	0.2	16.3	0.1	0.1	1.2	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.1	0.1	13.7	0.7	0.1	0.1	4.8	2.0	0.1	0.1	0.1	0.1	0.1	12.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.5	2.2	0.1	0.0	5.0	7.6	4.0	1.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	222.6	0.0	1.5	0.0	0.0	1.1	4.6	0.0	0.1	0.0	5.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	36.6	0.0	4.5	45.6	0.0	0.5	0.0	0.0	0.4	2.3	0.1	0.0	0.0	0.0	6.9	174.9
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136108-30148735	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 13.5;placenta: 39.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"HEL: 5.1"	"Region enriched"	"Detected in single"	19	"thalamus: 3.4"	"Low region specificity"	"Detected in all"			HPA043818	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.2	0.0
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151945-30160934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8"	"Cell type enriched"	"Detected in some"	12	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"EFO-21: 1.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hippocampal formation: 4.0"	HPA043325	Uncertain					NA	NA					"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	3.0	0.0	0.0	1.4	0.1	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	70.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	5.8	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 12.1;intestine: 29.3;liver: 14.1"	"Cell type enhanced"	"Detected in some"	18	"Enterocytes: 70.3;Mucus-secreting cells: 18.4;Paneth cells: 56.1;Proximal tubular cells: 18.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"HEL: 19.5"					"Low region specificity"	"Detected in all"			HPA047527	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	8.6	0.0	0.2	0.2	0.0	12.1	0.0	0.0	0.0	4.3	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	70.3	0.0	1.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	5.7	56.1	0.0	18.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	10.6	0.0
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	11.9	12.6	10.6	20.0	12.2	13.8	13.2	17.6	14.9	10.7	16.1	15.9	14.5	18.5	12.9	18.4	21.5	21.1	18.6	8.4	10.8	11.3	19.5	19.2	12.2	21.3	13.1	8.1	10.9	15.3	16.3	11.5	10.8	12.3	13.4	9.8	17.7	18.4	20.6	9.9	21.5	21.9	14.2	13.1	17.6	15.2	10.9	14.0	13.7	15.8	10.7	21.7	14.7	24.6	3.6	3.8	1.7	4.2	2.1	4.1	3.6	10.2	2.2	0.0	14.5	4.8	2.9	4.8	2.8	3.3	7.3	7.2	0.0	0.4	23.0	8.3	7.1	10.1	11.7	0.0	10.0	2.3	0.0	6.7	3.6	1.6	8.3	4.5	4.5	2.9	3.0	3.5	7.3	4.6	0.0	4.5	11.0	1.6	0.0	0.0	0.0	7.5	11.1	0.0	0.0	3.9	9.9	6.9	3.4	6.0	9.6	0.4	6.2	10.6	4.6	2.9	2.5	3.6	1.5	7.6	5.6	3.9	0.0	0.1	9.2	16.4	12.1	0.0	13.0	9.0	1.7	3.1	0.5	3.9	4.2	3.2	3.2	2.9	3.8	3.8	3.6	1.8	2.7	1.7	2.1	2.6	1.9	4.1	3.6	10.6	12.2	17.6	14.9	10.8	11.3	13.1	8.1	12.3	14.0	26.8	17.1	17.1	21.1	26.8	20.4	11.8	22.9	28.1	13.6	12.2	15.7	16.4	10.0	13.3	0.3	16.1	16.5	0.0	13.7	10.8	12.8	21.2	4.7	45.0	12.2	12.7	21.5	8.6	13.2	1.3	6.9	20.9	16.9	17.2	13.7	11.2	10.2	14.2	11.3	13.0	18.9	6.5	12.5	2.4	12.6	29.6	14.8	22.4	13.3	19.5
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051120, HPA059496"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA051120: AB_2681348, HPA059496: AB_2684040"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	8.6	7.6	5.2	14.3	6.4	11.8	7.4	8.6	7.6	10.2	11.2	7.3	9.7	7.1	10.0	15.2	11.9	8.5	13.6	6.1	5.4	5.5	7.6	9.6	11.1	6.7	7.7	6.3	10.3	9.1	8.9	11.4	11.6	7.1	7.9	7.1	11.4	8.2	15.5	9.9	6.5	10.9	8.8	6.0	13.1	8.0	14.1	7.2	7.8	8.9	8.3	10.1	9.1	12.3	3.4	1.6	8.4	2.5	4.4	5.2	2.1	4.4	0.2	3.9	6.9	1.8	1.8	4.0	2.1	2.5	3.1	2.8	5.3	0.6	5.7	4.1	3.9	1.9	1.5	4.4	3.1	3.2	4.4	4.9	4.5	0.7	1.9	4.0	6.7	5.1	2.1	2.6	3.9	4.3	4.7	1.9	4.9	6.7	4.6	4.0	4.0	1.4	1.4	5.2	1.9	3.3	3.1	0.8	4.3	3.3	4.3	8.4	4.1	1.6	3.3	4.0	3.9	4.5	1.8	1.7	3.4	2.7	4.1	6.9	8.4	10.1	5.9	2.0	2.4	5.2	1.4	1.7	6.8	5.2	2.5	4.6	3.4	3.7	3.8	1.6	3.3	4.4	4.1	8.4	4.4	2.4	1.2	2.9	2.1	5.2	6.4	8.6	7.6	5.4	5.5	7.7	6.3	7.1	7.2	3.0	7.4	11.5	5.5	3.3	4.9	5.2	2.5	5.3	3.4	1.8	5.9	4.0	6.6	4.2	2.7	3.6	5.8	0.0	5.3	4.8	4.4	3.2	5.7	3.9	2.9	3.2	5.2	6.7	7.2	6.6	2.6	4.4	3.3	3.6	4.4	6.5	5.1	8.6	4.2	3.3	7.7	0.0	5.0	20.2	8.1	3.6	8.4	13.8	3.7	4.7
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"esophagus: 1.8;testis: 1.2"	"Group enriched"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.3;Club cells: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.8"									HPA051120	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051120: AB_2681348"	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	1.8	0.6	0.0	0.0			0.4	0.0	0.2	0.0			0.3	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RPP21	"C6orf135, Em:AB014085.3, FLJ22638"	ENSG00000241370	"Ribonuclease P/MRP subunit p21"	Q9H633	6	30345131-30346884	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.6;EFO-21: 22.1;HEK 293: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.78e-5)"	21.9	30.8	16.5	12.4	20.3	10.0	16.7	14.6	21.4	19.4	20.5	10.7	11.0	13.5	20.1	11.4	38.6	26.2	12.6	16.2	13.1	14.6	15.9	16.7	8.3	13.2	13.6	11.7	22.1	27.7	4.1	11.2	10.7	12.5	19.1	3.3	10.2	11.3	16.1	32.5	45.9	15.4	27.4	12.3	11.8	22.8	9.8	10.9	12.3	19.1	8.9	15.6	19.2	16.6	20.1	11.5	11.1	13.1	6.7	17.7	9.6	17.5	0.0	0.0	20.6	8.0	5.7	9.7	4.5	4.0	6.2	6.4	0.3	0.0	13.0	22.1	2.2	7.1	0.1	0.0	9.4	1.5	6.1	24.1	9.6	0.0	2.3	15.3	0.0	0.0	1.6	1.3	0.2	1.1	3.0	0.0	18.2	3.0	5.5	2.5	0.9	0.0	0.7	15.3	0.0	0.0	5.5	0.0	0.6	8.5	8.5	20.0	2.3	0.0	4.4	11.3	1.5	0.0	0.6	0.3	0.0	0.0	14.7	0.1	4.9	12.4	5.7	0.0	1.2	0.0	11.1	13.1	8.4	6.6	11.5	9.1	20.1	11.7	6.9	11.5	16.8	14.1	8.0	4.0	6.7	12.5	4.6	17.7	9.6	16.5	20.3	14.6	21.4	13.1	14.6	13.6	11.7	12.5	10.9	6.0	13.6	16.4	9.6	31.7	3.5	1.1	12.7	16.0	38.7	24.4	0.0	12.9	6.6	30.5	3.0	6.7	27.4	46.7	52.0	15.8	10.5	6.7	12.7	14.3	9.2	1.6	40.9	11.1	14.6	1.4	12.7	14.9	23.6	15.4	27.1	2.3	36.4	37.7	9.9	17.7	3.0	6.5	19.4	17.7	23.2	35.4	9.5	22.4	32.6	9.6
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"		6	30489467-30494205	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Endothelial cells: 1478.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;U-266/70: 35.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	81.4	19.4	12.6	42.9	16.9	81.7	49.9	6.5	14.9	37.6	32.7	23.2	15.5	2.1	41.2	30.6	40.1	28.2	44.0	36.7	15.1	13.3	34.8	56.5	129.7	76.7	19.9	10.5	29.1	14.6	33.9	11.6	33.1	24.9	32.2	28.6	33.9	23.1	27.5	34.8	97.2	36.8	22.9	21.7	97.1	50.5	18.1	14.6	35.0	45.7	36.4	72.4	45.9	33.3	23.0	7.8	90.2	28.9	23.2	37.1	56.3	11.3	1.8	0.7	6.7	25.2	20.0	0.0	0.0	0.0	0.0	0.0	4.7	23.1	7.4	11.5	10.1	19.8	14.0	1.5	5.8	0.0	7.5	4.8	8.8	2.2	0.0	0.0	0.0	3.2	15.7	10.9	8.0	0.0	0.0	0.0	4.8	1.1	0.1	6.0	0.0	0.0	0.0	0.0	3.8	0.0	1.6	0.0	9.7	10.2	6.4	0.0	0.5	7.8	6.2	0.0	0.1	0.0	15.1	11.2	7.1	0.0	0.0	1.4	35.8	20.4	2.9	0.0	6.7	18.6	56.6	14.0	52.5	37.0	24.6	31.5	23.0	28.1	37.1	7.8	22.5	28.5	28.4	90.2	23.2	28.9	6.6	29.4	56.3	12.6	16.9	6.5	14.9	15.1	13.3	19.9	10.5	24.9	14.6	288.8	451.7	691.8	327.5	430.6	2.0	80.3	247.1	216.8	225.2	116.9	5.9	69.1	14.9	371.5	3.5	1478.5	407.9	46.7	585.9	231.5	281.0	321.3	504.0	75.0	648.8	4.8	207.4	1236.3	939.1	5.9	122.3	661.4	442.1	534.8	437.5	90.5	562.6	382.2	71.8	70.5	5.3	174.6	453.2	9.2	3.3	372.8	300.2	1180.5	194.8	500.2
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	14.2	9.2	15.6	12.9	18.6	7.7	13.4	18.8	29.2	13.3	7.9	12.1	7.6	4.3	15.2	15.1	8.4	17.4	10.6	6.9	14.6	14.1	13.5	9.3	12.8	9.7	13.1	17.3	25.9	13.0	40.3	11.6	11.1	14.3	9.0	13.2	9.3	10.1	15.3	8.0	13.8	7.8	16.9	13.9	8.8	8.8	31.7	12.5	12.8	13.5	7.6	16.7	11.1	10.6	1.4	0.3	0.8	0.7	1.2	3.6	1.7	7.4	1.5	4.3	12.4	8.2	9.7	0.3	2.3	4.6	1.9	3.0	10.7	4.6	3.4	4.4	7.4	19.0	5.0	11.1	9.1	3.2	1.2	6.5	5.5	5.3	1.0	0.0	1.0	3.6	8.3	7.3	14.9	5.0	0.0	0.8	13.4	9.6	0.4	4.7	1.7	2.6	0.2	2.4	5.9	1.2	5.7	2.7	3.7	6.4	3.2	3.7	3.6	3.0	2.2	1.3	1.5	2.1	3.4	4.4	7.8	2.2	1.4	2.6	5.8	6.3	6.8	0.2	4.7	9.4	0.8	0.5	0.7	2.7	0.7	3.6	1.4	2.9	3.4	0.3	1.2	0.6	1.1	0.7	1.2	0.7	0.3	1.7	1.7	15.6	18.6	18.8	29.2	14.6	14.1	13.1	17.3	14.3	12.5	41.7	42.8	28.9	84.1	52.7	40.0	11.2	33.1	8.1	21.6	24.4	39.3	59.0	19.9	34.2	92.0	43.0	23.2	23.3	30.7	56.3	42.9	42.6	31.1	14.1	25.3	15.9	44.2	40.5	18.7	144.9	33.6	17.8	27.0	12.6	21.6	29.3	24.9	22.6	30.1	23.0	31.9	38.8	46.4	86.6	45.5	35.5	133.9	30.5	23.4	49.4
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30556886-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	7.6	5.6	9.7	5.5	7.4	4.0	3.5	15.0	13.8	5.4	4.5	5.6	3.1	2.5	7.3	15.3	3.6	6.2	4.0	3.2	10.1	12.1	4.3	3.8	4.9	6.1	5.9	7.6	13.5	5.4	10.6	8.8	3.4	8.0	4.4	5.3	6.9	2.6	6.9	3.1	6.5	3.4	3.8	4.6	5.0	5.9	8.6	5.7	11.1	4.9	1.7	5.6	6.4	4.0	2.0	2.3	1.5	1.2	1.3	1.9	0.4	0.6	1.6	5.3	10.0	2.6	0.9	0.0	0.0	0.0	0.0	0.0	4.6	0.5	4.6	3.9	0.9	3.5	0.6	12.6	1.0	0.0	2.7	4.5	6.7	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	0.0	0.0	8.8	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.2	0.0	6.8	2.3	0.6	0.0	0.0	0.0	3.1	0.7	4.0	0.0	0.0	0.0	7.6	8.5	4.4	0.0	2.6	2.9	1.5	1.2	0.3	0.5	0.3	1.0	1.0	1.6	1.2	1.0	2.0	0.9	1.9	1.0	1.3	0.6	2.3	0.0	0.4	9.7	7.4	15.0	13.8	10.1	12.1	5.9	7.6	8.0	5.7	8.9	22.1	16.0	6.3	5.0	9.0	2.4	7.6	14.7	13.6	3.5	13.7	12.1	6.6	4.0	0.6	5.0	7.9	0.0	8.1	6.2	9.1	4.6	11.5	3.9	7.0	6.4	7.5	9.2	6.2	1.8	9.5	7.7	10.1	10.0	7.6	8.0	4.9	5.3	9.6	8.2	18.5	6.5	7.2	8.1	5.9	5.0	8.2	10.2	6.5	3.4
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571376-30597179	"Plasma proteins, Predicted intracellular proteins"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	16.1	12.5	12.1	11.8	13.9	31.9	12.4	12.1	15.7	11.4	13.7	9.8	9.5	7.1	17.0	9.6	14.6	10.9	10.6	13.1	12.0	7.3	15.5	18.3	13.5	9.4	10.6	10.5	12.5	14.0	23.1	16.6	21.6	13.7	12.4	13.6	9.2	14.1	15.3	70.6	21.3	17.6	15.2	12.7	13.9	19.6	22.0	13.2	14.7	13.8	14.9	13.0	14.2	13.5	10.1	9.3	4.1	7.9	11.9	14.3	6.5	12.1	5.4	7.1	9.7	8.0	5.2	3.2	10.3	5.3	7.1	9.9	18.0	3.0	10.2	11.2	6.4	9.8	8.8	10.5	6.0	13.9	7.2	9.1	12.4	7.6	5.6	2.5	12.6	4.1	4.7	6.2	11.1	2.8	1.9	2.3	2.9	22.6	3.7	7.9	2.7	6.6	2.8	4.9	4.2	3.3	20.8	7.0	10.7	5.5	11.0	6.5	13.4	5.6	15.6	3.1	3.5	3.9	3.4	7.1	13.9	4.2	3.3	5.6	13.6	22.0	17.7	1.5	14.7	10.1	4.1	7.9	3.4	14.3	6.7	12.2	10.1	10.4	12.8	7.1	9.1	9.5	9.7	3.7	11.9	7.3	9.3	5.9	6.5	12.1	13.9	12.1	15.7	12.0	7.3	10.6	10.5	13.7	13.2	47.6	84.6	56.7	79.8	76.5	41.7	75.9	38.2	49.5	78.5	55.8	62.8	83.9	51.4	84.1	80.0	46.5	74.6	46.7	75.7	116.4	50.0	62.6	85.4	115.0	44.1	52.4	48.7	34.4	39.0	122.9	35.9	46.8	33.7	67.7	40.5	42.0	84.8	38.6	48.8	58.5	108.2	71.1	55.1	135.4	94.1	74.2	138.9	55.4	45.7	74.3
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600400-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	11.5	19.1	10.8	19.6	12.6	5.2	17.4	18.8	16.2	20.4	13.0	24.2	17.0	12.6	14.7	13.0	14.7	15.2	16.4	9.7	15.9	10.3	14.0	20.4	14.6	14.1	14.5	12.4	16.0	21.6	28.8	17.9	10.1	10.4	14.9	15.5	19.6	12.8	21.0	14.1	12.8	13.0	15.4	14.1	17.4	15.6	21.6	11.8	33.5	16.6	12.5	17.0	14.7	13.2	4.8	6.1	6.2	5.4	1.8	5.7	3.5	5.4	6.8	8.7	7.1	7.9	5.4	4.6	5.4	7.0	7.9	6.6	7.3	3.4	5.3	4.0	4.6	7.1	8.5	10.2	10.1	6.0	5.8	5.5	6.6	5.9	3.5	8.1	5.8	6.5	6.4	5.9	6.9	14.4	6.2	7.1	10.5	6.1	6.7	6.9	6.8	7.3	4.9	4.4	4.7	4.8	7.7	9.0	10.3	7.9	6.8	12.1	5.3	7.1	6.8	6.1	7.1	6.8	7.1	4.4	6.1	5.3	6.7	4.4	12.4	6.7	5.8	5.7	6.7	5.3	6.2	5.1	5.6	5.3	4.5	5.7	4.8	3.7	4.3	5.6	4.0	3.5	3.9	6.2	1.8	5.4	6.1	3.9	3.5	10.8	12.6	18.8	16.2	15.9	10.3	14.5	12.4	10.4	11.8	29.8	32.3	50.6	46.1	62.0	63.4	50.4	25.5	45.5	28.4	26.2	123.7	37.8	29.9	22.0	27.0	59.5	73.1	0.0	20.0	22.1	35.9	41.1	42.8	30.7	28.6	33.4	68.5	38.6	27.8	7.7	42.8	51.6	35.4	33.3	69.9	54.1	26.0	52.6	28.3	33.7	94.6	32.3	49.7	44.2	23.8	68.1	74.0	50.1	58.1	29.5
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617709-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	17.1	18.9	9.9	10.3	10.7	5.4	16.0	8.5	13.1	11.6	13.4	12.8	11.9	12.8	9.3	15.5	15.5	16.5	12.3	26.6	9.0	8.0	22.4	49.1	10.5	17.3	13.1	9.3	16.4	21.8	17.4	10.2	11.8	9.1	10.9	16.4	10.1	17.1	18.0	55.4	13.7	14.0	10.4	12.4	14.4	13.5	10.2	11.2	13.5	21.5	31.1	15.6	11.2	9.3	15.7	8.9	6.3	10.2	12.4	15.2	11.2	9.7	5.9	4.7	6.7	7.2	9.7	8.7	3.6	8.4	11.5	7.1	9.2	4.6	10.0	8.4	5.7	8.6	7.8	10.9	10.2	11.3	6.0	11.6	9.7	4.6	10.7	6.3	9.1	4.2	8.4	12.8	9.4	26.1	7.8	6.4	9.5	14.7	9.6	10.4	7.4	6.0	5.6	3.4	7.8	7.6	8.0	6.4	19.1	10.7	4.1	10.3	3.3	3.2	13.6	13.7	4.6	17.6	4.8	3.7	7.5	7.3	4.3	6.2	8.2	9.8	8.5	3.6	13.8	11.0	6.3	8.0	4.0	9.1	10.1	12.3	15.7	12.1	9.8	8.9	14.7	15.2	12.2	0.6	12.4	10.2	8.1	11.4	11.2	9.9	10.7	8.5	13.1	9.0	8.0	13.1	9.3	9.1	11.2	56.6	44.3	53.6	61.6	32.6	43.2	135.7	101.9	53.5	46.6	45.4	60.9	106.9	164.2	89.2	46.6	63.4	48.4	23.3	80.0	101.6	52.1	46.2	36.9	95.6	72.2	41.3	30.1	49.1	44.0	26.6	65.0	42.1	57.3	93.8	55.1	39.2	65.0	59.6	42.1	161.2	51.1	51.8	67.0	22.6	60.7	39.3	80.7	41.7	80.3	30.1
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 67.3;Late spermatids: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.9;AN3-CA: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	4.8	3.8	16.8	5.4	16.8	4.4	4.1	12.5	20.7	5.5	4.9	16.3	3.0	4.6	10.2	21.0	3.2	8.3	5.4	3.9	15.7	15.9	4.4	3.8	3.9	4.8	14.0	12.2	10.1	4.4	4.4	10.6	4.3	13.0	9.8	5.3	4.1	5.4	4.0	4.5	6.9	6.1	4.9	13.5	4.3	7.9	7.0	12.8	3.3	4.3	1.7	5.6	4.0	3.8	1.7	2.6	2.6	1.7	0.7	2.1	0.8	2.0	1.1	10.9	8.1	1.5	1.1	0.4	0.3	0.1	0.4	0.8	2.9	2.1	0.3	1.7	1.7	3.4	2.4	4.0	1.4	0.1	1.5	4.7	0.1	0.4	2.7	0.7	0.2	1.3	2.2	0.9	0.7	0.0	1.3	0.9	5.6	1.6	0.2	2.0	1.8	1.6	0.7	0.7	3.3	0.2	0.9	0.3	0.6	2.0	3.0	0.6	4.3	0.7	1.0	0.7	0.3	4.4	0.5	0.8	3.1	2.2	0.1	0.8	1.6	2.1	1.0	2.5	4.8	3.2	2.6	1.7	1.3	0.8	1.5	1.0	1.7	1.0	0.8	1.6	1.2	2.1	1.6	0.3	0.7	1.1	2.6	0.9	0.8	16.8	16.8	12.5	20.7	15.7	15.9	14.0	12.2	13.0	12.8	0.0	1.0	0.0	12.1	4.9	9.3	1.3	5.1	5.3	1.2	14.0	9.8	9.9	6.6	9.5	67.3	4.9	7.3	0.0	3.9	5.7	6.2	9.0	1.1	1.6	5.3	1.6	17.2	3.7	1.8	33.6	3.7	3.7	0.0	12.6	9.3	11.5	7.5	10.5	8.1	3.7	9.6	6.5	4.2	9.9	9.3	4.6	7.4	5.0	10.2	12.3
C6orf136	Em:AB023049.8	ENSG00000204564	"Chromosome 6 open reading frame 136"	Q5SQH8	6	30647039-30653210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 69.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046804	Uncertain					NA	NA					"HPA046804: AB_2679815"	"unprognostic (1.94e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.16e-8)"	"unprognostic (2.33e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (7.51e-4)"	7.4	13.4	13.5	7.1	19.0	7.5	6.9	22.6	30.0	8.1	22.5	11.9	8.4	24.2	6.2	16.4	9.6	8.4	6.8	16.9	13.5	15.1	14.4	11.7	9.2	8.1	15.8	18.1	5.2	13.3	20.4	12.3	7.0	24.9	7.3	21.3	8.4	8.9	12.1	21.3	14.3	21.5	7.7	11.7	8.2	9.1	7.6	9.5	3.6	10.7	13.0	6.8	10.0	5.8	3.5	2.5	2.2	1.2	1.1	3.9	1.2	3.7	6.2	3.3	2.9	5.1	6.3	5.8	1.4	1.7	3.8	5.3	4.0	2.7	3.2	2.3	1.1	3.2	5.1	0.5	0.2	4.1	2.8	4.7	1.7	4.3	2.4	1.4	5.3	5.5	2.8	5.7	2.8	3.5	3.8	1.5	5.3	4.3	2.4	0.8	6.3	2.3	5.8	3.7	5.9	3.4	4.5	3.1	6.5	8.3	5.5	8.0	1.5	1.9	6.5	4.3	1.3	3.2	1.2	0.7	1.1	5.6	2.2	4.8	6.4	7.4	2.2	2.0	4.7	2.5	0.1	1.2	0.2	2.0	1.0	2.6	3.5	2.4	1.4	1.2	2.3	3.9	2.3	2.2	1.1	1.1	2.5	1.7	1.2	13.5	19.0	22.6	30.0	13.5	15.1	15.8	18.1	24.9	9.5	0.0	4.1	10.4	10.9	8.2	16.6	22.2	12.7	4.0	4.5	34.9	3.9	14.7	49.7	15.7	11.6	9.3	69.1	0.0	15.5	9.0	7.8	8.5	12.7	9.4	13.5	11.1	22.0	6.7	3.5	13.1	7.2	8.6	10.1	11.8	43.6	13.0	14.3	49.1	6.0	20.3	18.9	6.5	5.7	23.6	47.3	9.4	14.1	10.1	40.5	15.5
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673037	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	12.8	15.8	12.7	16.8	14.0	12.1	14.4	16.8	14.9	13.3	16.2	12.3	15.8	19.3	16.3	13.3	14.9	14.4	14.6	12.4	11.4	7.1	18.0	19.2	13.9	18.2	13.6	8.6	15.6	19.1	24.3	16.6	11.3	13.5	16.4	13.6	14.4	18.0	18.2	23.2	18.4	19.8	16.4	11.0	22.6	14.9	36.8	14.9	18.8	21.6	12.1	16.5	13.2	15.3	4.5	5.9	8.7	7.6	7.1	5.8	4.4	9.7	4.1	6.0	9.3	6.8	4.7	7.1	8.1	6.5	11.7	9.1	9.2	4.0	7.4	7.6	7.2	8.8	9.4	9.8	7.3	9.4	10.4	8.1	7.3	7.4	5.1	6.0	18.4	9.8	4.2	7.1	9.5	8.2	4.7	3.6	9.4	12.1	7.3	5.8	8.1	5.2	9.3	5.7	5.2	5.7	8.8	6.4	7.9	6.2	7.7	7.1	5.8	9.0	9.5	6.6	5.6	7.2	5.6	3.9	7.5	5.2	7.3	11.8	8.7	13.4	7.2	3.6	10.1	9.6	6.0	6.0	8.7	5.8	7.5	5.3	4.4	5.3	4.8	5.9	4.5	4.4	5.0	5.8	7.1	7.6	4.8	5.1	4.4	12.7	14.0	16.8	14.9	11.4	7.1	13.6	8.6	13.5	14.9	20.8	18.1	15.7	10.1	9.6	11.0	13.3	7.6	41.5	26.1	5.2	37.3	16.9	8.3	15.7	71.1	9.2	13.9	23.3	16.1	16.8	9.6	8.3	39.5	7.5	12.3	4.8	5.8	9.8	10.5	36.4	13.3	13.6	5.0	22.6	11.7	9.8	18.4	24.6	11.7	7.8	49.9	19.4	12.2	73.1	30.6	9.4	16.0	16.6	10.1	9.1
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.5"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"eosinophil: 54.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 35.0;U-937: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	17.2	7.1	5.6	24.7	7.9	34.0	16.1	1.7	4.7	12.6	15.9	6.2	4.6	5.3	17.5	7.3	11.5	10.9	13.9	10.1	6.5	3.4	6.1	8.3	20.2	44.9	7.2	1.8	14.9	4.0	2.3	2.9	13.3	6.0	11.2	3.7	7.3	7.9	6.1	6.6	9.5	11.3	13.9	9.8	37.4	9.1	4.9	6.2	48.2	7.8	7.8	23.6	18.2	18.0	4.2	3.4	54.5	4.1	10.2	11.9	5.2	10.0	1.6	6.0	7.2	4.3	11.6	0.2	6.0	7.0	5.3	3.6	1.2	2.0	9.8	5.5	10.5	12.0	6.7	3.0	6.6	2.8	8.2	0.6	23.6	2.9	1.2	3.4	6.1	35.0	7.1	7.7	13.1	11.8	6.3	4.3	16.6	4.3	4.9	6.2	1.1	8.7	12.1	0.0	0.3	0.4	27.8	5.3	8.0	3.1	0.6	0.4	2.0	5.6	2.2	11.1	0.3	1.6	8.4	14.2	21.0	5.3	0.0	14.9	1.8	9.6	12.1	6.0	36.4	24.5	8.1	2.8	54.5	11.7	4.1	8.5	3.1	5.7	11.9	1.8	4.2	4.7	9.0	13.2	10.2	3.0	3.4	9.4	5.2	5.6	7.9	1.7	4.7	6.5	3.4	7.2	1.8	6.0	6.2	3.0	20.7	66.3	25.5	96.9	1.3	2.8	10.2	6.7	4.5	8.7	0.0	2.5	0.0	20.1	23.9	64.4	0.4	0.0	7.1	17.8	32.0	15.2	51.9	7.8	175.4	3.2	1.7	30.7	131.5	14.6	25.6	119.9	37.1	233.6	0.5	0.9	18.0	0.0	21.9	1.3	2.9	25.8	79.5	0.5	1.4	52.1	3.3	186.8	0.4	22.5
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	14.2	5.6	1.4	6.5	2.4	10.0	11.4	2.2	2.5	16.2	6.6	2.9	5.8	2.6	15.3	5.3	11.4	7.7	7.4	7.5	1.5	1.4	7.3	3.0	8.1	15.7	2.1	1.5	13.7	5.7	3.6	1.7	11.3	2.4	10.4	4.2	5.4	4.2	7.0	4.5	9.0	6.0	7.4	2.4	9.6	4.2	9.7	2.2	23.3	5.0	14.4	11.9	9.9	9.2	4.2	3.7	1.6	3.8	0.8	1.6	1.0	3.8	3.7	6.9	4.8	1.1	3.8	0.8	1.9	3.9	6.2	5.7	3.9	2.7	6.5	1.4	4.0	2.8	6.0	3.8	6.5	1.8	9.0	2.0	4.0	5.3	5.1	1.4	3.1	6.1	2.3	2.4	6.0	2.3	2.1	4.8	5.4	3.5	6.0	4.2	3.4	4.8	3.3	1.4	4.3	2.2	11.7	4.6	7.9	2.7	2.0	2.6	2.2	2.2	2.8	1.2	2.2	4.5	3.0	1.9	5.7	3.1	3.2	3.5	2.2	4.0	2.3	0.9	8.3	7.3	0.9	3.8	0.2	1.0	1.1	0.8	4.2	1.1	1.6	3.3	4.1	0.5	0.6	1.6	0.8	0.4	3.7	0.8	1.0	1.4	2.4	2.2	2.5	1.5	1.4	2.1	1.5	2.4	2.2	3.0	1.3	16.4	5.8	8.8	0.2	1.6	10.2	0.0	6.8	1.8	2.0	15.7	3.3	9.9	8.4	11.7	0.2	0.0	5.0	23.5	13.6	1.2	12.7	0.8	15.3	3.2	1.2	1.8	21.2	44.7	5.2	14.9	3.3	27.9	1.9	1.1	5.2	0.0	5.6	0.6	1.5	6.5	9.2	4.5	1.7	5.5	4.2	8.6	3.0	2.6
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717889	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 15.7;AN3-CA: 12.3;HEK 293: 29.8"					"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	10.8	3.6	5.7	9.5	5.9	4.9	5.5	10.2	8.0	6.9	6.3	8.5	3.8	3.8	9.9	5.1	3.7	8.3	5.0	5.0	5.2	2.4	5.1	6.2	5.1	5.4	4.9	3.7	11.3	5.7	3.1	12.5	3.1	6.0	6.4	2.9	9.4	5.5	3.5	11.1	11.7	6.4	6.1	5.5	7.1	7.7	26.7	5.3	11.4	11.9	2.4	13.0	5.2	5.4	2.0	1.8	0.4	0.2	3.8	1.2	0.3	15.7	1.1	1.2	12.3	3.9	3.9	1.0	1.3	0.7	2.7	1.1	1.0	1.7	2.6	6.7	7.8	6.4	1.6	2.4	4.5	2.5	2.2	29.8	1.9	3.0	0.7	0.5	1.1	1.4	1.0	0.9	4.2	2.0	0.3	0.4	6.4	3.9	2.9	0.4	1.5	0.7	0.2	0.9	0.8	0.8	2.2	1.3	2.9	4.5	3.4	2.6	1.3	0.6	3.2	0.5	2.2	2.9	2.2	1.0	1.0	1.5	2.0	1.5	1.9	7.3	6.8	0.3	4.4	2.1	0.4	0.1	0.3	1.1	0.2	0.9	0.8	0.9	1.2	0.2	2.0	1.0	0.8	0.1	3.8	0.1	1.8	0.0	0.3	5.7	5.9	10.2	8.0	5.2	2.4	4.9	3.7	6.0	5.3	14.9	15.4	9.7	4.8	3.9	10.7	6.3	7.6	8.1	6.8	5.2	7.9	4.4	3.3	3.8	3.4	5.6	1.0	0.0	5.4	9.5	7.3	2.5	16.2	11.4	5.6	4.8	6.4	5.5	5.9	2.1	7.2	4.5	1.7	8.2	2.6	10.0	4.8	0.0	5.6	2.8	17.0	12.9	5.0	75.3	17.2	3.1	1.6	6.9	4.4	0.8
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30720201-30725426	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.7"	"Cell type enhanced"	"Detected in all"	6	"Extravillous trophoblasts: 1893.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes		510000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	51.6	27.7	30.0	31.8	33.2	78.8	30.0	30.9	57.2	43.3	37.0	24.3	18.7	10.8	58.5	39.7	39.9	41.0	29.6	33.1	23.7	48.2	31.4	74.1	32.7	62.1	27.8	24.0	81.5	27.0	15.3	16.3	41.1	39.9	32.2	34.2	30.6	27.9	24.3	29.6	37.6	24.3	37.6	27.4	47.7	29.1	19.7	14.4	198.7	26.9	36.8	91.5	39.7	34.3	15.4	17.5	8.6	15.4	12.3	18.2	19.8	42.4	15.7	61.3	26.6	17.4	30.0	0.5	0.0	0.0	0.0	0.0	29.9	16.2	21.2	26.3	19.6	16.4	14.7	49.5	44.5	0.0	11.9	31.3	0.5	0.0	17.2	8.3	57.8	28.5	22.3	10.4	0.0	0.5	13.5	21.6	46.9	16.7	0.0	27.0	30.7	41.8	0.2	0.0	13.5	18.5	0.0	0.6	12.5	35.8	24.2	10.7	35.9	23.1	10.2	0.4	39.9	26.7	5.3	13.3	64.5	28.7	0.0	0.2	19.8	38.1	49.2	12.7	57.5	81.6	4.9	7.7	8.6	15.5	12.2	18.2	15.4	12.1	17.6	6.2	10.0	12.3	12.2	4.3	12.3	15.4	17.5	14.2	19.8	30.0	33.2	30.9	57.2	23.7	48.2	27.8	24.0	39.9	14.4	122.1	48.4	184.6	261.7	511.8	64.2	96.8	186.0	50.9	100.1	162.3	37.3	493.5	263.6	1083.5	6.9	247.2	97.2	700.8	929.9	1893.7	657.3	117.4	203.1	240.5	829.2	103.3	156.9	268.2	310.8	15.4	372.8	361.3	305.4	1224.5	123.1	172.7	843.8	91.2	223.1	178.3	51.0	116.4	444.0	46.2	42.8	376.4	184.3	200.5	178.2	168.9
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 54.3;hTERT-RPE1: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	5.1	2.1	5.0	5.8	5.1	7.9	2.6	5.2	7.2	9.3	8.3	2.7	2.5	3.5	5.7	11.9	54.3	3.8	4.9	2.0	5.7	10.7	4.7	4.5	2.0	2.7	12.2	0.8	5.9	8.5	3.0	5.5	10.7	33.1	6.4	2.8	3.2	5.6	9.7	1.7	2.9	1.2	1.6	3.3	5.9	3.8	5.6	4.8	3.6	1.5	4.7	4.5	3.9	2.8	19.7	5.7	4.5	0.9	4.3	17.8	5.8	3.1	14.7	3.8	3.7	3.5	2.4	3.7	11.2	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7	83.4	85.1	32.7	93.5	25.4	14.4	80.8	56.0	88.3	63.7	80.3	5.9	67.0	104.5	62.0	46.3	117.8	81.2	23.3	74.8	57.5	67.5	53.3	140.8	42.9	116.2	19.1	66.0	127.7	63.0	109.6	57.2	92.7	67.4	121.8	59.2	44.6	72.3	101.7	35.7	125.1	17.0	51.8	58.7	108.0	26.7	23.5	51.5	43.6	72.5	97.7
IER3	"DIF-2, IEX-1, IEX-1L, PRG1"	ENSG00000137331	"Immediate early response 3"	P46695	6	30743199-30744554	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 142.2"	"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 1054.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"A-431: 40.4;EFO-21: 15.2;HBEC3-KT: 50.4;RPTEC TERT1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA043847	Approved					NA	NA					"HPA043847: AB_2678699"	"unprognostic (2.83e-3)"	"unprognostic (9.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (5.57e-4)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.77e-2)"	30.1	24.1	1.9	43.2	1.5	3.0	6.1	0.8	2.7	21.5	9.0	4.7	77.8	2.7	7.3	12.5	47.2	10.0	16.7	22.8	2.1	1.3	17.9	15.9	20.1	6.0	3.1	0.5	11.2	17.7	2.7	3.8	10.3	5.1	9.9	2.7	6.4	10.8	142.2	5.8	14.2	4.2	7.2	5.4	12.1	18.6	5.5	1.7	3.9	4.5	37.1	27.8	33.9	22.5	0.4	0.0	1.6	0.4	0.0	0.4	0.0	40.4	0.0	0.0	4.8	1.2	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.2	2.6	4.3	0.0	0.0	50.4	0.0	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	6.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	1.5	0.8	1.8	2.1	1.3	3.1	0.5	5.1	1.7	193.5	141.7	10.9	611.5	406.6	1.2	8.3	135.0	77.6	313.9	96.0	0.0	32.4	69.6	1054.7	1.1	105.7	199.7	0.0	630.2	37.5	548.2	532.9	122.3	15.3	304.1	3.2	141.8	63.8	77.5	1.3	9.2	412.4	224.4	450.0	306.7	13.5	576.2	307.8	6.3	10.9	2.9	25.8	695.2	0.0	1.9	287.7	69.5	14.1	220.4	511.6
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.7	6.5	9.2	1.9	0.6	0.9	5.7	0.5	0.1	0.3	0.0	8.7	10.5	0.1	11.0	1.7	9.6	31.8	2.0	24.5	0.1	10.9	3.5	0.0	6.0	2.3	1.8	0.0	0.4	1.2	12.7	0.1	0.2	5.8	0.7	0.5	5.7	0.2	1.4	12.5	0.7	0.0	1.6	10.9	1.3	1.3	6.9	0.7	4.7	32.5	1.6	0.9	1.8	14.7	7.1	3.2	36.5	0.2	1.5	4.6	4.3	0.4	4.6	0.2	0.0	0.8	3.0	0.0	4.0	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0	32.8	24.0	2.2	62.3	47.2	5.2	19.9	38.2	33.5	31.8	85.5	0.0	53.4	5.0	115.9	10.8	4.9	88.3	23.3	66.9	19.7	6.5	54.7	1.1	0.4	5.4	6.4	44.4	1.8	0.8	16.6	7.8	2.2	15.1	22.6	55.1	145.4	62.4	74.8	4.9	5.6	7.4	6.5	8.9	0.7	4.5	45.4	38.9	0.0	54.4	76.8
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908184-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"granulocytes: 6.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074336			Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA074336: AB_2686679"	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	11.2	13.8	13.4	16.1	13.3	10.5	17.8	27.3	17.7	12.2	9.8	9.7	9.1	7.1	12.4	12.8	13.0	11.8	11.2	8.4	12.6	8.4	13.3	18.6	10.2	11.6	10.3	14.8	14.6	9.9	8.5	12.9	9.8	11.2	9.6	10.0	7.5	13.4	16.8	10.9	12.1	12.9	10.4	13.4	11.3	10.7	9.9	12.4	13.1	12.7	8.9	9.5	9.5	10.4	2.3	3.4	5.5	2.2	1.3	3.0	1.7	7.5	3.8	6.6	7.4	5.9	4.1	6.2	2.0	1.9	4.2	3.5	6.0	3.9	7.1	3.4	5.7	5.0	6.3	8.0	10.1	2.7	6.4	6.5	5.7	5.1	3.9	3.5	0.0	5.4	5.4	7.0	5.9	0.0	6.5	3.7	4.7	15.0	2.9	4.5	7.0	5.8	8.4	5.2	4.7	1.5	10.0	4.9	3.7	10.6	3.3	2.7	1.9	3.8	2.8	2.7	3.6	7.5	4.0	3.2	5.7	7.1	5.0	9.7	4.5	6.3	7.7	2.8	8.9	3.5	5.5	2.2	1.4	2.1	1.7	1.7	2.3	2.1	2.1	3.4	2.2	2.5	3.0	0.0	1.3	1.3	2.8	2.5	1.7	13.4	13.3	27.3	17.7	12.6	8.4	10.3	14.8	11.2	12.4	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.4	0.0	0.0	2.0	0.4	1.7	0.5	0.0	0.7	0.0	0.0	0.6	0.3	0.2	0.1	6.9	0.5	0.3	0.0	0.0	0.6	1.2	0.0	0.9	0.2	1.7	0.0	0.0	0.2	0.0	0.2	0.7	0.8	0.1	0.0	0.5	1.6	0.4	0.9	0.2	0.5	0.2	0.0
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30908242-30926459	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	7.2	7.8	6.3	12.5	8.6	6.9	6.8	21.4	11.4	4.2	6.5	8.9	6.2	6.2	8.8	6.2	20.6	6.3	7.4	4.9	7.4	6.4	12.0	13.5	7.3	12.9	5.6	9.3	8.8	12.5	8.5	9.7	5.1	7.9	6.0	8.1	4.6	8.2	10.5	9.4	11.0	7.4	4.4	6.3	7.8	8.6	8.3	3.4	13.4	8.2	4.6	10.0	4.8	6.1	1.8	1.3	0.1	0.9	0.2	1.8	0.5	8.6	6.9	3.7	14.8	3.1	2.3	0.1	1.2	0.8	1.2	1.1	6.0	4.9	6.5	5.1	0.9	3.4	0.0	10.4	0.0	1.9	3.4	8.9	7.8	5.8	0.6	2.7	1.6	0.0	1.8	2.6	3.7	0.8	0.4	0.9	11.0	0.0	7.4	3.0	0.0	2.5	0.0	0.9	0.0	0.9	6.1	0.0	6.3	4.9	0.0	4.5	0.1	0.0	3.3	3.7	3.2	10.1	4.1	1.6	9.2	0.6	0.5	0.1	6.8	10.5	13.5	0.0	0.3	6.1	0.0	0.2	0.0	1.1	0.9	1.8	1.8	1.0	1.6	1.0	0.7	0.6	0.3	0.1	0.2	0.6	1.3	1.2	0.5	6.3	8.6	21.4	11.4	7.4	6.4	5.6	9.3	7.9	3.4	6.0	15.1	9.3	4.8	3.5	6.2	11.0	10.2	6.7	4.5	8.7	0.0	7.5	1.7	5.3	1.2	3.8	10.5	0.0	6.1	9.2	3.5	2.0	12.7	19.2	8.2	7.9	12.6	8.6	7.5	0.5	3.7	4.9	1.7	8.2	7.2	2.9	6.7	5.9	3.9	10.7	5.7	0.0	3.4	9.1	8.1	3.6	2.9	7.5	8.6	3.3
SFTA2	SFTPG	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"lung: 104.5"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 497.3;Alveolar cells type 2: 624.9;Cholangiocytes: 170.7;Club cells: 204.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 121.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"B-cells: 1.7;T-cells: 1.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 13.8;CAPAN-2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (5.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-1)"		"unprognostic (6.37e-2)"		"unprognostic (2.27e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-4)"	"unprognostic (8.84e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.95e-2)"	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.2	0.1	0.1	0.5	0.0	0.2	0.1	13.6	1.4	6.3	0.2	0.1	0.0	1.6	0.1	104.5	0.1	0.1	0.1	0.3	1.1	0.4	0.1	0.6	0.2	0.2	0.0	0.1	1.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	2.0	1.3	0.1	0.1	1.0	0.4	0.3	0.1	5.4	1.7	0.1	0.1	0.0	0.0	1.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	7.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	1.5	0.5	0.1	1.7	1.3	1.7	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	497.3	624.9	0.0	0.1	0.1	0.4	0.0	170.7	14.7	204.8	50.6	0.0	0.0	3.3	18.0	2.9	0.7	0.0	0.0	32.4	0.0	0.2	0.3	11.6	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.3	0.2	0.0	0.0	0.0	1.1	57.0	0.0	0.4	0.3	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	1.3
DPCR1	"bCX105N19.6, C6orf37, PBLT"	ENSG00000168631	"Diffuse panbronchiolitis critical region 1"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"gallbladder: 53.4;stomach 1: 70.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 42.0;Cholangiocytes: 48.4"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;OE19: 4.7;RPTEC TERT1: 1.3"									HPA014036	Enhanced					NA	NA					"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	4.8	0.0	53.4	0.0	0.0	0.0	0.0	2.5	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	42.0	0.0	0.2	0.0	0.0	0.0	48.4	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 251.5;lymphoid tissue: 126.1"	"Group enriched"	"Detected in some"	17	"Alveolar cells type 2: 4.8;Club cells: 9.1;Urothelial cells: 11.2"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Cell line enriched"	"Detected in single"	14	"Karpas-707: 4.3"									HPA052028	Enhanced					NA	NA					"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	34.7	0.2	0.0	0.0	0.2	1.3	0.2	251.5	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	33.7	126.1	0.2	33.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2
MUC22	PBMUCL1	ENSG00000261272	"Mucin 22"	E2RYF6	6	31010474-31035402	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"esophagus: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA							"unprognostic (2.38e-1)"			"unprognostic (1.57e-1)"	"unprognostic (1.46e-1)"		"unprognostic (1.91e-1)"		"unprognostic (4.03e-1)"			"unprognostic (1.46e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 8.3;U-2 OS: 3.7"					"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"	NA	NA					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSORS1C1	"C6orf16, SEEK1"	ENSG00000204540	"Psoriasis susceptibility 1 candidate 1"	Q9UIG5	6	31114750-31140092	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"testis: 52.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 289.3;Late spermatids: 996.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;hTCEpi: 5.5;JURKAT: 2.4;U-2 OS: 1.7"									HPA045049			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045049: "	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.72e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.30e-1)"	0.9	0.7	1.1	0.7	2.8	0.7	0.8	0.5	1.5	3.4	6.9	2.2	2.6	0.7	7.7	6.4	2.1	1.1	7.5	0.7	0.7	0.6	1.0	0.7	3.7	0.7	4.4	0.0	1.9	1.5	0.7	0.4	1.7	3.0	1.7	1.1	0.2	0.9	1.8	0.7	2.0	6.0	6.5	3.4	0.7	1.1	52.2	0.9	0.0	1.8	1.1	0.7	3.6	3.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	5.5	0.6	1.0	0.0	0.0	2.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.8	0.5	1.5	0.7	0.6	4.4	0.0	3.0	0.9	17.9	2.7	0.0	3.6	7.8	0.0	2.0	17.8	0.0	3.4	8.7	0.0	0.1	0.0	13.8	289.3	3.6	20.7	0.0	1.9	0.4	8.0	2.6	0.0	0.0	0.3	0.0	2.9	3.7	0.0	996.1	8.6	0.0	3.3	1.0	4.6	0.5	9.4	8.0	6.3	0.7	0.0	6.5	1.4	117.0	17.9	9.3	0.1	0.0	4.7	2.3
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115090-31120446	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"placenta: 19.2;skin 1: 109.3;tongue: 29.7"	"Group enriched"	"Detected in some"	6	"granulocytes: 4.6;Suprabasal keratinocytes: 4.5"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"A-431: 5.9"	"Group enriched"	"Detected in some"	5	"amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0"	"Not detected"	"Not detected"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	29.7	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.1
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137536-31139350	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9"	"Group enriched"	"Detected in some"	15	"Melanocytes: 8.5;Suprabasal keratinocytes: 6.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;HaCaT: 1.6;SiHa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061228	Enhanced				"Secreted in other tissues"	NA	NA					"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	58.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	13.8	0.0	35.9	0.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.5
CCHCR1	"C6orf18, HCR"	ENSG00000204536	"Coiled-coil alpha-helical rod protein 1"	Q8TD31	6	31142439-31158238	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 50.1"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 64.7;Late spermatids: 110.5;Spermatocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054167			Supported	Cytosol		NA	NA			Cytosol		"HPA054167: AB_2682403"	"unprognostic (6.68e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-2)"	2.4	2.7	5.6	2.8	6.2	1.2	3.1	5.2	6.4	3.7	4.5	2.9	9.1	9.4	6.3	5.6	3.9	8.0	2.9	2.5	4.0	2.7	4.3	2.9	3.0	5.5	4.1	5.6	5.5	7.6	1.7	2.5	1.5	4.5	5.3	3.2	3.4	3.5	6.8	10.1	7.0	5.9	3.9	2.6	3.4	6.6	50.1	3.8	4.3	6.2	3.1	4.2	3.4	4.0	2.0	3.4	1.4	2.1	2.5	4.3	2.3	22.0	1.7	6.2	0.9	3.8	4.5	5.8	1.9	0.6	0.3	0.7	8.8	0.4	2.9	10.5	4.9	13.8	0.9	0.3	8.9	0.9	3.2	14.1	10.4	7.3	6.7	2.2	0.2	6.9	5.8	1.0	4.1	0.9	4.5	4.7	16.3	4.1	6.1	2.6	1.6	3.8	11.6	0.3	0.8	0.1	7.0	8.3	5.4	5.7	2.2	17.4	2.9	7.2	0.0	1.8	3.8	2.4	5.5	0.6	9.2	2.9	0.2	5.5	14.3	8.2	11.9	1.9	2.5	0.9	0.3	2.1	1.4	2.9	0.9	2.5	1.3	2.6	4.3	1.5	2.0	4.0	4.0	0.6	2.5	1.2	3.4	4.0	2.3	5.6	6.2	5.2	6.4	4.0	2.7	4.1	5.6	4.5	3.8	3.0	3.2	4.8	12.9	8.7	8.6	6.9	7.6	8.1	9.1	3.5	0.0	2.2	10.0	8.2	64.7	4.9	32.8	0.0	9.4	6.0	6.1	6.6	0.0	5.7	5.9	14.3	28.2	1.8	4.6	110.5	9.2	3.6	6.8	12.6	26.1	5.8	8.3	10.5	11.0	7.3	1.9	6.5	4.7	80.8	16.7	5.1	1.1	4.6	28.1	6.4
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158542-31167159	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3"	"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA065994			Approved	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA065994: "	"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.3	1.5	1.3	12.4	4.1	2.3	5.2	8.2	3.9	7.0	5.6	2.3	3.7	9.2	4.2	6.2	11.2	3.2	3.8	3.4	1.7	1.1	4.3	1.6	4.8	18.0	3.0	1.0	4.6	3.6	0.4	0.9	1.5	2.0	5.5	4.0	2.3	4.1	6.7	2.5	11.5	6.0	3.9	1.8	8.6	5.9	3.1	1.8	31.3	2.8	14.4	13.8	4.8	6.7	2.0	0.9	0.2	0.3	1.2	3.8	1.2	33.2	0.3	0.3	0.0	2.3	3.0	0.3	0.2	0.0	0.0	0.0	2.1	0.0	0.0	7.5	8.2	19.8	0.0	0.0	12.4	0.0	0.2	18.7	2.9	1.9	0.8	0.0	0.1	8.8	1.2	0.0	0.9	0.0	1.8	7.4	17.0	0.0	16.2	3.2	0.1	0.4	5.3	0.0	0.0	0.0	0.4	2.0	0.2	2.9	0.1	20.6	0.2	0.2	0.0	0.2	2.7	0.0	2.4	0.0	20.6	0.1	0.1	0.1	5.3	6.0	10.2	0.0	0.1	0.1	0.0	0.3	0.0	0.7	0.0	3.8	1.6	1.9	3.4	0.9	2.0	2.4	0.9	0.2	1.2	0.1	0.0	2.6	1.2	1.3	4.1	8.2	3.9	1.7	1.1	3.0	1.0	2.0	1.8	3.0	1.1	6.0	2.1	4.5	2.6	1.2	0.0	0.0	3.4	3.5	0.0	0.6	6.6	1.6	0.3	3.3	1.1	0.0	1.6	7.2	2.7	1.0	1.1	0.2	7.5	1.6	1.2	1.3	1.9	0.4	4.6	4.3	11.8	10.0	3.3	3.3	0.8	0.0	6.0	0.3	0.5	0.0	6.8	0.5	12.8	3.3	0.3	5.1	7.7	0.9
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 15.3;Collecting duct cells: 8.7;Enterocytes: 8.4;Pancreatic endocrine cells: 8.5"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HAP1: 49.8;NTERA-2: 132.5;SuSa: 87.3"									"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.2	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	2.3	2.3	1.2	1.2	4.9	3.1	5.7	1.2	5.2	4.3	1.2	1.2	0.0	11.1	5.0	2.0	1.2	1.2	1.2	1.2	8.8	0.0	1.2	1.2	1.2	4.7	1.0	1.2	1.2	3.0	1.2	1.8	5.9	1.2	1.2	1.2	6.3	2.2	1.2	1.2	1.2	1.2	1.2	11.2	1.2	3.0	1.8	1.8	1.0	1.1	0.9	0.3	0.5	0.2	7.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.6	49.8	0.6	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	132.5	0.2	0.0	0.1	0.1	0.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	87.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	1.4	1.0	0.5	0.8	0.7	0.5	1.0	0.4	0.4	0.2	3.0	0.9	0.6	1.8	1.1	0.5	1.8	0.3	0.3	1.2	1.2	1.2	1.2	1.2	0.0	1.2	1.2	1.2	1.2	0.0	1.4	0.5	2.4	4.6	0.7	0.4	15.3	1.4	1.2	8.7	2.0	0.0	0.0	4.8	0.0	0.7	8.4	0.0	5.8	0.1	0.5	3.6	0.0	1.5	0.1	0.0	1.2	0.6	0.0	0.0	0.0	0.8	1.7	1.0	3.1	0.0	8.5	3.7	0.7	2.1	0.9	0.0	1.2	0.0	0.4	3.3	0.1	0.0	2.9	3.8
HLA-C	"D6S204, HLA-JY3, PSORS1"	ENSG00000204525	"Major histocompatibility complex, class I, C"	P10321	6	31268749-31272130	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"monocytes: 2958.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 95.2;EFO-21: 105.3;RPTEC TERT1: 60.2;U-266/70: 63.6;U-266/84: 49.5"														"Intracellular and membrane"	NA	NA						"unprognostic (2.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.16e-2)"	48.6	34.7	14.8	87.9	17.9	38.3	32.9	7.8	14.3	33.1	51.3	11.7	8.7	1.8	36.4	92.7	25.1	49.7	37.6	62.2	13.9	9.9	41.4	92.2	165.9	100.3	21.5	2.8	47.5	16.6	1.4	21.1	34.5	19.5	35.8	11.2	29.2	25.9	20.5	25.0	42.3	117.4	18.2	18.0	142.8	40.1	20.3	17.0	36.5	33.5	12.7	58.9	64.2	42.8	0.2	0.2	2.0	1.2	0.5	0.6	22.3	95.2	0.1	0.0	0.0	16.1	12.7	0.2	0.4	0.1	0.1	0.3	0.1	0.0	0.0	105.3	24.4	27.6	0.0	0.0	24.2	0.0	0.1	22.1	0.1	1.1	0.0	0.1	0.0	0.1	10.8	0.0	0.0	0.0	36.1	0.0	12.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.2	0.0	0.2	60.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	26.1	8.8	0.3	0.3	63.6	49.5	36.1	0.0	1.0	0.0	1.0	1.2	1.5	0.5	0.5	0.4	0.2	0.3	0.4	0.2	0.2	0.3	0.3	2.0	0.5	0.2	0.1	0.6	22.3	14.8	17.9	7.8	14.3	13.9	9.9	21.5	2.8	19.5	17.0	211.4	409.9	1149.9	655.0	647.6	33.3	51.2	807.7	139.2	119.4	458.9	9.8	31.0	71.3	1526.8	20.1	1077.8	1941.0	116.8	1346.9	819.1	662.9	867.9	336.0	402.2	1566.8	93.8	463.1	1295.2	1614.9	19.9	469.7	1295.6	793.0	2958.6	1103.0	189.8	1039.6	2357.8	313.6	218.5	23.3	1183.5	495.5	145.4	25.7	569.6	101.7	2445.0	861.9	788.0
HLA-B	AS	ENSG00000234745	"Major histocompatibility complex, class I, B"	"P01889, P30480, P30486, Q29836, Q31610, Q31612"	6	31269491-31357188	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 6264.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 71.3;EFO-21: 65.1;U-266/70: 165.1;U-698: 45.2"									CAB015418	Enhanced					NA	NA					"CAB015418: AB_831547"	"unprognostic (2.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.16e-3)"	"unprognostic (8.51e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.69e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.83e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-2)"	83.5	40.1	11.7	91.4	14.2	11.0	52.6	6.7	13.1	41.4	96.5	18.2	15.6	2.0	52.8	51.5	46.1	30.8	100.3	76.8	11.9	13.4	63.3	57.1	194.5	214.9	17.3	10.5	40.2	21.8	16.2	20.2	39.5	19.1	70.4	56.1	45.4	108.9	23.4	37.4	56.4	164.1	20.6	23.8	200.6	43.2	32.1	11.9	54.1	44.5	19.1	136.3	117.6	48.6	45.6	41.4	118.7	56.5	46.5	64.3	81.8	71.3	0.0	0.0	0.0	1.7	12.2	0.4	0.0	0.3	0.1	0.2	0.0	0.5	2.6	65.1	12.7	26.9	30.0	14.8	13.0	0.0	0.2	3.5	0.9	0.0	0.0	9.6	0.0	0.6	24.0	0.0	0.0	1.6	22.4	0.0	5.2	0.1	3.5	0.0	0.0	0.3	18.5	0.3	0.0	0.0	2.2	0.4	0.4	19.7	0.0	0.1	0.5	0.6	0.1	0.1	0.0	11.3	0.7	15.3	3.8	0.6	0.6	0.2	165.1	36.7	45.2	0.2	0.7	0.1	20.6	56.5	59.1	64.3	42.7	62.2	45.6	54.9	58.5	41.4	35.1	42.1	55.2	118.7	46.5	37.4	33.9	56.2	81.8	11.7	14.2	6.7	13.1	11.9	13.4	17.3	10.5	19.1	11.9	848.6	1033.3	1739.6	668.1	1035.7	22.9	112.5	1307.0	539.4	564.1	368.2	5.9	26.5	58.0	3170.1	45.1	1951.2	1835.2	93.5	1580.0	116.6	879.8	887.8	599.9	510.9	2564.6	57.2	803.7	1588.0	2761.1	31.5	597.1	2461.9	845.2	6264.3	1963.1	186.6	1772.9	2170.7	288.5	177.4	25.0	1293.5	783.2	642.1	29.1	877.9	42.6	2497.5	1111.5	867.3
MICA	PERB11.1	ENSG00000204520	"MHC class I polypeptide-related sequence A"		6	31399784-31415315	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 15.8;ASC TERT1: 16.1;GAMG: 37.0;HBEC3-KT: 14.4;HSkMC: 25.0;hTERT-RPE1: 16.5;RPTEC TERT1: 16.4"															NA	NA						"unprognostic (1.94e-1)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.01e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.12e-2)"	10.4	9.7	3.0	7.0	4.3	0.7	8.3	3.0	6.8	11.0	9.5	4.4	16.9	0.7	9.0	14.7	6.9	7.9	13.1	10.8	3.9	1.0	19.1	7.5	15.3	6.5	4.3	3.2	15.1	10.9	13.4	2.8	4.3	12.6	12.6	5.6	13.8	6.5	2.1	6.2	5.4	7.6	3.7	7.9	7.7	6.2	24.6	3.4	1.2	8.7	10.2	3.4	6.3	11.9	1.7	1.8	4.5	1.9	0.3	2.5	1.7	15.8	0.0	0.0	0.0	12.5	16.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	9.2	13.3	37.0	6.5	11.4	14.4	0.3	0.0	5.3	0.0	10.4	0.2	4.5	0.0	0.6	25.0	0.0	0.0	0.2	16.5	0.0	1.1	1.3	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	16.4	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.3	10.5	0.0	0.2	0.4	0.1	1.7	8.4	0.6	0.1	0.0	0.7	0.0	1.3	4.5	1.7	1.9	2.0	1.4	1.3	2.0	1.8	1.7	2.5	1.4	3.7	0.3	1.0	0.2	1.5	1.7	3.0	4.3	3.0	6.8	3.9	1.0	4.3	3.2	12.6	3.4	29.8	9.8	5.2	25.1	35.5	0.4	6.5	10.2	10.7	9.1	17.4	0.0	0.2	0.0	31.3	1.7	18.5	23.1	0.0	39.1	0.5	19.0	25.8	9.2	8.3	13.3	0.0	2.4	25.8	16.1	1.1	13.8	20.7	32.1	19.0	17.9	8.7	34.5	14.0	14.9	5.6	0.6	19.4	34.9	14.0	3.8	30.1	0.7	13.8	11.4	17.9
MICB	PERB11.2	ENSG00000204516	"MHC class I polypeptide-related sequence B"	Q29980	6	31494881-31511124	"Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Cytolysis, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 26.5"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Hofbauer cells: 9.9;Kupffer cells: 12.9;monocytes: 10.0;T-cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.6;U-266/84: 26.5"									HPA064618			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA064618: AB_2685301"	"unprognostic (3.63e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (7.04e-5)"	"unprognostic (2.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.94e-9)"	"unprognostic (1.91e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.21e-2)"	3.3	1.2	0.8	9.1	0.8	6.1	3.5	3.0	1.0	1.8	1.6	0.9	0.0	1.0	2.1	1.3	2.1	1.1	1.7	2.2	1.0	0.6	2.9	1.3	6.9	7.8	1.2	0.8	1.3	2.9	0.2	0.6	0.8	1.2	1.1	1.9	1.1	1.9	0.7	0.8	1.0	5.0	1.7	1.5	11.7	1.4	2.3	1.1	8.1	2.4	0.7	8.1	3.2	26.5	2.2	2.1	4.1	4.8	1.9	4.4	1.9	2.4	0.8	0.0	0.0	1.5	2.5	0.0	1.7	1.7	2.2	2.9	0.0	0.3	2.8	6.2	3.2	7.1	0.6	0.7	2.9	0.8	2.4	2.6	3.2	0.5	1.1	0.5	1.0	2.7	3.1	0.6	3.8	2.2	2.3	1.4	4.4	3.3	5.9	2.6	0.0	0.9	4.2	0.3	0.0	0.4	3.4	0.0	5.9	2.6	0.1	0.0	0.0	1.1	0.0	0.5	0.9	1.5	1.2	1.4	1.7	0.0	1.5	0.0	11.6	26.5	6.2	0.4	8.7	3.7	4.1	3.1	4.0	2.9	3.6	3.6	2.2	2.9	3.9	2.1	2.0	1.6	3.1	3.1	1.9	4.8	1.3	4.4	1.9	0.8	0.8	3.0	1.0	1.0	0.6	1.2	0.8	1.2	1.1	3.0	1.0	5.1	0.6	2.6	0.0	0.3	2.5	0.0	1.2	0.0	0.0	0.1	1.7	1.2	0.0	1.9	0.3	23.3	0.6	0.2	3.3	1.7	0.0	0.0	9.9	0.0	0.0	3.1	12.9	0.0	0.3	8.1	1.7	10.0	0.7	0.0	1.5	2.0	0.4	0.3	0.0	0.0	3.9	0.7	1.5	1.0	0.1	10.0	1.7	1.1
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528717-31530232	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	188	"kidney: 63.6"	"Group enriched"	"Detected in some"	34	"Distal tubular cells: 339.8;Proximal tubular cells: 251.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	339.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	251.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.3	13.5	6.6	13.7	11.8	7.8	3.5	3.9	10.1	9.1	4.1	4.0	3.1	11.8	16.9	14.1	5.6	15.3	26.0	9.6	2.7	40.9	5.5	4.8	9.7	4.5	7.5	6.1	18.2	15.6	10.2	32.1	18.0	6.3	18.0	24.1	2.5	8.4	2.1	6.6	27.4	5.7	6.0	2.9	5.6	6.0	3.7	20.4	4.0	6.2	17.2	6.9	3.1	4.0	13.2	2.3	6.5	3.5	1.3	4.9	1.3	9.0	10.3	12.8	25.3	0.8	10.5	5.4	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8	20.8	37.5	38.9	22.5	12.8	19.8	3.5	7.6	48.2	27.3	3.5	21.6	11.5	5.0	7.9	0.9	17.1	14.7	0.0	7.0	10.1	12.1	18.4	34.8	5.8	8.7	14.3	16.6	10.4	8.9	2.2	15.0	21.5	8.5	8.2	7.4	10.4	7.8	9.3	11.0	4.1	27.3	25.8	12.7	6.0	5.9	11.8	14.2	27.4	8.6	20.7
ATP6V1G2	"ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10"	ENSG00000213760	"ATPase H+ transporting V1 subunit G2"	O95670	6	31544462-31548427	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"brain: 91.9"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 76.0;Horizontal cells: 28.6;Muller glia cells: 16.3"	"Cancer enriched"	"Detected in many"	11	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;JURKAT: 4.7;Karpas-707: 7.1"									"CAB004616, HPA068667"	Enhanced					NA	NA					"CAB004616: AB_667829, HPA068667: "	"unprognostic (9.95e-2)"	"unprognostic (8.75e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.41e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.02e-1)"	2.8	3.3	41.8	3.5	25.7	1.8	1.6	91.9	53.3	1.8	2.3	8.1	0.0	1.5	2.5	2.4	2.2	1.8	1.9	2.9	39.4	27.1	2.6	1.6	2.0	4.7	26.6	29.5	3.1	2.1	2.9	1.2	1.7	43.7	2.6	2.0	2.0	2.0	3.3	4.3	2.0	2.7	2.1	16.3	3.4	1.9	2.7	6.4	0.0	2.3	0.0	4.8	1.7	0.2	0.7	0.7	0.0	0.1	0.8	1.5	0.1	0.2	1.7	3.1	1.5	1.3	1.7	0.0	0.6	0.0	0.0	0.2	0.0	0.9	1.7	0.7	0.6	0.4	1.4	0.1	0.6	0.1	6.4	0.0	0.5	0.0	0.9	0.2	0.7	0.6	1.3	0.8	0.5	0.3	2.3	0.5	4.7	0.7	7.1	0.8	0.2	3.3	1.1	0.0	0.2	0.5	0.8	0.0	0.7	0.0	0.0	2.8	3.8	0.0	0.0	0.0	0.8	2.0	0.3	1.6	1.9	0.3	0.1	0.0	0.7	1.5	2.4	0.7	0.7	1.4	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.8	0.7	0.7	1.2	1.5	0.0	0.8	0.0	0.0	1.1	0.1	41.8	25.7	91.9	53.3	39.4	27.1	26.6	29.5	43.7	6.4	0.0	0.3	0.0	0.5	0.3	76.0	2.0	0.0	0.0	0.0	1.8	13.7	0.1	8.3	0.2	0.0	0.5	0.2	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.5	28.6	13.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.2	16.3	0.1	0.0	2.1	5.0	9.5	0.0	3.1	0.0	0.7	0.1	0.1	1.9	0.0	0.1
NFKBIL1	"IKBL, NFKBIL"	ENSG00000204498	"NFKB inhibitor like 1"	Q9UBC1	6	31546870-31558829	"Disease related genes, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;ASC TERT1: 5.1;HEK 293: 21.0;JURKAT: 8.6;U-266/70: 9.4;U-266/84: 7.8;U-698: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006298			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006298: AB_1079480"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.97e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.50e-2)"	19.3	20.7	7.9	8.8	8.8	4.9	16.4	9.8	13.7	9.8	13.0	7.4	11.4	4.9	9.2	23.0	15.1	24.5	12.8	6.5	7.1	6.9	8.5	8.7	16.1	9.8	7.4	7.3	16.1	18.6	4.9	10.1	6.8	6.7	11.5	4.9	7.0	11.8	13.9	24.3	28.8	8.8	11.2	6.8	19.1	16.7	12.9	8.3	6.3	12.7	7.6	5.1	13.8	11.3	0.3	2.0	1.6	1.7	1.5	0.9	0.5	0.0	3.6	0.0	0.1	4.9	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.4	0.0	0.0	4.1	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	7.8	4.9	0.0	0.0	0.0	0.6	1.7	0.6	0.9	0.4	0.5	0.3	0.1	0.5	1.6	0.3	0.3	0.7	1.6	1.5	1.3	2.0	0.6	0.5	7.9	8.8	9.8	13.7	7.1	6.9	7.4	7.3	6.7	8.3	6.0	5.1	17.7	22.5	18.4	15.6	4.4	25.5	8.1	2.3	24.4	2.0	18.5	33.2	23.3	5.5	16.2	28.0	0.0	27.6	23.3	18.1	21.9	6.9	13.6	21.3	6.4	7.5	16.5	21.6	5.3	23.6	15.1	8.5	25.2	22.6	24.7	28.1	22.1	24.4	18.5	15.2	25.8	20.2	11.2	9.2	16.4	24.7	13.1	21.7	15.9
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 25.3"	"Group enriched"	"Detected in some"	4	"B-cells: 13.7;T-cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;MOLT-4: 3.6;U-266/84: 1.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	NA	NA	8150				"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.4	0.1	0.2	25.3	0.6	1.1	0.1	1.3	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.1	0.3	0.4	2.0	7.2	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.0	0.6	0.4	0.2	2.4	0.5	0.3	0.2	2.8	0.2	0.3	10.0	0.4	6.0	0.0	11.2	0.2	0.5	17.5	0.7	0.1	0.2	0.0	0.5	0.6	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.6	1.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.6	13.7	0.0	0.1	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	2.1	0.5	0.4	0.0	7.5	0.0	0.0
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575567-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 32.8;Macrophages: 42.1;T-cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 10.2;HMC-1: 9.8;NB-4: 29.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100				"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	2.3	1.2	0.6	15.6	1.0	14.6	1.2	0.4	1.8	1.7	1.3	3.7	0.3	1.3	1.1	0.4	1.5	0.9	2.3	2.0	0.5	0.3	2.6	1.9	9.5	8.0	0.8	0.0	0.6	0.7	0.5	0.5	3.2	2.0	0.7	0.7	0.4	2.2	0.8	0.4	2.7	4.1	0.7	1.0	28.0	1.0	0.4	0.5	2.1	0.6	5.3	14.7	1.2	0.4	1.3	1.2	3.5	10.8	0.5	6.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	1.9	0.0	0.0	0.0	0.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	4.1	6.5	6.6	1.3	3.1	2.4	1.2	1.3	0.9	1.0	3.5	0.5	10.8	0.7	2.2	2.1	0.6	1.0	0.4	1.8	0.5	0.3	0.8	0.0	2.0	0.5	0.0	4.0	13.4	0.2	7.4	0.1	2.0	5.1	1.4	2.3	0.0	2.0	0.3	0.0	6.7	0.1	2.8	0.0	0.0	2.9	1.5	2.1	0.9	11.6	0.0	32.8	0.0	0.0	1.3	8.7	0.0	0.3	42.1	5.0	1.0	0.1	0.1	10.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	3.6	0.9	34.1	0.0	0.3
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;lymphoid tissue: 81.5"	"Cell type enriched"	"Detected in many"	4	"B-cells: 1026.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;Daudi: 19.8;HDLM-2: 11.2;HMC-1: 5.8;NB-4: 12.8;REH: 12.2;U-698: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048884	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	1.0	0.2	0.2	35.9	0.2	3.4	0.5	0.1	0.1	0.2	1.5	0.0	0.0	1.3	0.2	0.3	2.7	0.4	0.7	1.9	0.2	0.1	4.2	1.3	4.2	27.8	0.2	0.0	0.5	0.8	0.0	0.2	0.3	0.1	0.7	0.6	0.5	6.1	0.3	0.1	0.6	18.0	0.3	0.3	69.7	2.0	0.2	0.0	81.5	1.1	0.8	41.6	1.6	0.5	44.1	15.6	17.8	3.6	5.2	39.3	10.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	19.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	12.8	0.0	0.0	0.0	12.2	0.0	2.7	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	2.5	0.4	17.8	3.7	2.0	26.8	42.5	39.3	17.3	0.6	44.1	33.5	14.2	14.5	5.2	3.6	15.6	22.2	10.7	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	13.6	1026.5	0.2	14.4	0.2	0.4	0.0	0.0	4.5	85.5	0.0	0.3	1.7	211.4	1.9	3.8	0.0	0.0	97.9	0.2	5.6	1.2	13.9	2.8	8.9	0.0	0.0	6.7	27.5	0.0	0.6	21.2	40.5	10.0	0.3	1.0	243.4	1.5	0.0	8.6	0.1	6.5	10.8	0.1	1.1	10.8	0.2	247.3	0.4	0.3
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell shape, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;bone marrow: 60.9;lymphoid tissue: 72.4"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 354.0;Kupffer cells: 1112.1;Macrophages: 1026.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 38.4;eosinophil: 60.8;intermediate monocyte: 95.8;myeloid DC: 34.1;neutrophil: 99.1;non-classical monocyte: 115.3"	"Group enriched"	"Detected in all"	12	"dendritic cells: 34.1;granulocytes: 99.1;monocytes: 115.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.9;HMC-1: 23.3;MOLT-4: 11.7;NB-4: 24.2;THP-1: 58.1;U-937: 30.9"															NA	NA						"unprognostic (1.08e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	4.6	3.1	5.2	14.9	7.3	60.9	2.4	1.0	4.0	1.5	3.3	7.7	0.2	4.2	1.3	3.9	1.9	2.2	2.8	3.2	4.9	5.4	2.8	11.9	16.2	25.7	9.7	1.9	2.3	1.6	0.7	2.2	7.0	6.2	2.7	2.6	2.6	3.0	1.7	1.0	2.3	4.1	4.2	13.6	72.4	2.8	0.9	6.6	12.6	1.5	1.2	5.8	4.1	1.7	1.9	34.1	99.1	115.3	1.6	7.0	35.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.1	0.1	0.1	3.8	0.0	11.9	0.0	0.0	0.2	8.7	23.3	0.0	0.1	0.0	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	11.7	24.2	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	30.9	0.0	8.6	38.4	60.8	0.8	95.8	7.0	1.9	1.3	1.7	34.1	1.8	0.9	0.8	99.1	1.6	115.3	6.0	0.9	35.7	5.2	7.3	1.0	4.0	4.9	5.4	9.7	1.9	6.2	6.6	32.8	129.2	43.8	0.3	31.3	0.0	1.7	7.6	20.1	23.9	10.4	0.0	2.5	0.0	0.6	0.9	11.7	0.0	0.0	0.2	2.3	12.2	0.3	68.2	2.6	354.0	0.0	0.0	27.0	1112.1	3.2	3.4	1026.6	42.2	27.9	0.0	0.5	0.1	0.0	1.1	2.2	0.2	25.8	3.6	0.6	2.2	24.7	4.5	39.9	0.0	0.3
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31592985	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 28.5;lymphoid tissue: 18.5"	"Group enriched"	"Detected in some"	5	"B-cells: 22.0;T-cells: 69.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 28.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 28.5"	"Cell line enriched"	"Detected in some"	4	"NB-4: 9.5"															NA	NA						"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	1.8	0.1	0.2	10.5	0.2	4.3	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.2	0.3	0.5	0.9	0.2	0.3	1.2	0.6	0.1	0.5	1.3	3.9	11.4	0.2	0.0	0.5	1.1	0.0	0.1	0.8	0.1	0.3	0.3	0.1	8.4	0.4	0.1	0.3	5.8	0.2	0.2	18.5	0.4	0.8	0.0	3.6	0.4	0.1	12.8	1.0	0.3	6.1	0.0	0.1	0.2	6.4	28.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	10.5	0.0	28.5	6.1	1.2	5.2	0.0	4.4	0.5	3.3	0.1	6.4	0.2	0.0	1.7	2.5	0.2	0.2	0.1	0.1	0.6	0.1	0.2	0.0	0.1	0.0	0.0	3.4	22.0	0.0	3.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	9.2	0.2	0.3	0.0	0.0	1.8	1.2	0.0	0.3	0.4	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	0.6	1.5	0.1	69.1	0.0	0.0
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615184-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.2;lymphoid tissue: 99.3"	"Group enriched"	"Detected in many"	19	"Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2"	"Group enriched"	"Detected in many"	33	"dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2"	"Cell line enhanced"	"Detected in some"		"HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	13.5	9.5	13.0	27.7	23.8	39.8	7.8	1.8	10.0	5.2	8.0	17.0	0.1	6.1	3.2	8.3	3.6	5.6	9.8	5.8	10.2	10.2	15.4	12.6	19.9	40.5	16.9	3.1	4.9	3.4	2.0	4.9	17.0	12.8	6.1	9.7	4.6	5.7	4.3	3.5	2.9	10.8	11.1	28.5	99.3	4.8	2.6	16.2	71.7	3.6	1.7	9.8	11.2	3.5	0.7	35.9	51.7	119.2	0.3	2.1	59.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	1.7	37.2	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.2	59.1	0.1	0.0	0.0	9.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.5	67.4	3.2	0.2	104.8	0.2	0.7	0.3	0.3	35.9	0.1	2.1	1.7	51.7	0.3	119.2	3.3	0.1	59.6	13.0	23.8	1.8	10.0	10.2	10.2	16.9	3.1	12.8	16.2	23.8	84.5	70.4	0.6	28.8	0.0	5.5	25.5	18.7	35.2	40.1	0.0	9.9	0.0	0.0	1.1	13.5	0.4	0.0	0.4	10.9	24.2	0.3	64.9	8.9	1482.8	0.0	1.2	43.0	1886.5	1.5	6.9	1383.0	37.1	40.5	0.0	0.0	0.1	5.8	0.7	3.1	0.0	51.8	17.6	0.3	1.5	24.7	19.0	27.4	0.4	0.0
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620720-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 26.4;HEK 293: 48.2;U-266/70: 24.8;U-266/84: 26.3;U-698: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	10.9	18.4	20.7	28.9	22.1	5.0	12.2	25.2	29.1	15.0	24.6	18.4	11.9	4.8	19.7	51.5	47.2	32.3	13.8	24.2	18.4	13.2	16.0	10.2	41.7	14.9	14.3	20.4	29.3	12.2	4.8	18.5	8.6	15.9	30.9	7.1	15.0	12.3	15.9	35.1	28.8	23.0	12.8	11.5	43.5	34.6	46.3	16.7	27.1	16.8	10.4	14.4	16.0	13.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.0	11.9	11.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.5	13.4	0.0	0.0	0.0	26.4	0.0	0.0	48.2	0.1	0.1	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	24.8	26.3	25.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	22.1	25.2	29.1	18.4	13.2	14.3	20.4	15.9	16.7	0.0	5.6	32.9	25.1	29.2	36.4	5.9	22.9	4.0	3.4	38.4	56.9	23.5	5.0	21.7	40.5	23.2	27.9	0.0	22.0	18.4	28.7	31.4	10.4	23.6	28.8	35.0	37.4	33.2	22.9	13.8	45.5	23.5	18.6	25.2	37.1	21.4	27.4	37.9	42.1	12.2	34.7	19.4	30.3	66.6	44.4	24.8	15.3	26.2	41.7	23.6
BAG6	"BAT3, D6S52E, G3"	ENSG00000204463	"BCL2 associated athanogene 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 339.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	20.8	30.1	16.1	18.4	21.7	16.9	18.1	22.1	31.2	23.9	23.8	22.3	17.9	38.2	25.1	38.6	19.9	23.8	21.4	25.5	15.1	14.1	20.6	41.8	25.7	18.1	15.9	15.6	22.0	22.2	6.6	20.7	27.0	17.5	20.5	30.7	24.4	20.9	19.6	50.5	22.3	31.0	17.3	13.2	23.7	26.1	101.8	16.2	39.9	22.9	30.4	27.1	18.3	19.3	4.8	8.4	8.2	7.5	3.2	6.3	3.1	1.9	14.4	16.8	3.4	8.4	13.0	3.8	3.4	2.7	3.3	3.6	35.8	1.6	2.5	26.0	27.8	20.7	2.4	2.0	29.5	5.4	4.1	39.5	11.1	1.8	22.7	12.6	3.3	33.0	10.4	11.9	2.9	3.9	15.0	9.7	20.4	21.0	11.6	24.1	5.6	2.0	19.6	2.1	3.2	2.6	4.9	2.3	4.6	14.4	5.2	2.4	4.5	1.3	4.1	3.3	4.3	30.2	27.7	1.9	11.4	8.7	2.0	3.3	15.2	20.0	22.1	15.5	2.7	3.6	8.2	5.7	6.6	6.3	7.5	5.0	4.4	4.4	4.1	4.5	4.8	3.5	4.2	5.8	3.2	6.8	8.4	3.0	3.1	16.1	21.7	22.1	31.2	15.1	14.1	15.9	15.6	17.5	16.2	44.7	36.5	27.4	30.3	28.5	26.7	70.2	43.3	36.1	39.8	34.9	17.7	53.0	26.6	57.4	195.1	37.0	85.3	23.3	43.3	57.5	32.9	30.2	48.4	36.0	49.4	47.7	73.6	38.1	38.8	339.6	30.8	35.7	27.0	30.7	49.7	29.6	55.0	57.5	37.1	40.2	39.7	38.8	37.2	93.9	52.8	31.0	99.9	35.4	49.8	33.1
APOM	"ApoM, G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 94.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 596.8;Proximal tubular cells: 592.0"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	18000000000	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	1.3	1.5	1.8	1.5	1.6	6.8	1.9	1.3	2.0	1.3	1.8	2.2	1.9	2.4	2.3	3.0	1.6	1.5	1.4	1.5	1.5	1.3	15.2	94.6	1.0	3.6	1.7	1.9	3.7	3.3	1.4	1.9	0.7	1.6	1.1	0.9	2.1	3.1	1.6	2.2	2.4	2.4	1.5	2.4	1.3	1.4	6.6	1.1	3.6	2.7	1.7	3.1	1.1	1.0	3.3	1.6	5.8	2.1	1.0	2.2	1.0	2.2	1.1	2.5	4.1	2.1	2.5	0.5	1.5	2.7	1.0	2.4	1.5	3.2	3.4	0.8	2.7	2.0	3.6	1.5	1.6	2.1	2.1	2.6	2.4	1.8	3.2	3.3	4.3	1.2	3.3	1.6	1.0	3.0	2.2	0.9	3.4	4.3	2.2	2.7	3.3	3.6	4.2	2.2	1.6	0.5	2.2	1.8	3.9	2.8	3.2	2.2	1.0	2.2	0.2	1.8	1.2	4.5	3.1	0.4	1.5	0.5	2.9	0.6	4.0	3.5	4.1	1.3	6.6	0.6	5.8	1.9	1.7	1.1	0.9	1.7	3.3	1.3	1.1	1.6	1.9	1.7	1.8	1.7	1.0	2.1	1.4	2.2	1.0	1.8	1.6	1.3	1.8	1.5	1.3	1.7	1.9	1.6	1.1	0.0	6.1	14.3	4.6	5.7	1.2	1.4	10.2	2.7	2.3	14.0	3.9	1.6	64.6	3.5	42.6	1.4	9.3	0.0	6.1	0.8	4.3	3.2	4.7	596.8	4.8	0.0	4.1	6.7	11.4	29.3	8.6	3.4	5.0	0.0	2.5	13.2	5.1	3.1	6.0	592.0	2.3	0.0	2.7	19.1	5.5	5.6	1.0	8.7	3.3	3.7
C6orf47	"D6S53E, G4"	ENSG00000204439	"Chromosome 6 open reading frame 47"	O95873	6	31658298-31660772	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;fHDF/TERT166: 6.4;HBEC3-KT: 9.0;HEK 293: 7.5;RT4: 8.7;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"							HPA045281	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045281: AB_10961000"	"unprognostic (5.99e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.59e-3)"	7.3	9.1	5.4	7.7	7.1	3.4	14.0	7.7	10.2	8.1	11.7	8.3	9.8	2.6	10.8	18.4	14.2	8.9	13.9	13.6	5.1	4.9	10.3	9.2	14.3	16.0	6.1	4.8	11.7	18.7	2.7	8.0	8.7	6.0	9.0	10.0	9.7	9.2	10.5	11.8	23.3	14.8	15.4	6.3	13.0	10.2	4.0	5.3	11.5	11.3	10.9	11.8	11.5	8.3	3.5	1.5	1.7	2.1	0.0	3.0	1.1	0.0	5.8	0.0	4.3	7.3	1.0	0.0	0.5	0.4	1.8	0.5	0.0	0.8	1.9	4.6	6.4	0.0	0.0	0.0	9.0	0.2	0.1	7.5	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.9	5.0	8.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.8	6.4	0.0	0.0	4.2	0.2	0.7	2.0	0.0	2.5	0.0	0.8	1.6	3.0	2.1	0.1	3.5	1.1	0.5	0.5	0.0	2.1	1.9	1.7	0.0	0.0	1.5	2.1	1.1	5.4	7.1	7.7	10.2	5.1	4.9	6.1	4.8	6.0	5.3	6.0	10.4	11.6	21.5	22.2	16.6	1.2	17.8	0.0	5.7	12.2	7.9	15.4	21.6	19.9	0.0	10.8	34.2	0.0	25.4	12.5	13.0	20.0	11.5	7.8	16.4	6.4	6.4	12.9	13.5	0.0	15.0	15.3	8.5	18.0	18.2	14.3	22.8	25.9	20.5	18.2	12.3	32.3	15.2	0.9	8.3	23.5	19.9	20.0	22.3	44.3
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661229-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	8.6	8.0	8.4	9.8	9.0	8.1	11.3	9.8	11.9	8.8	17.5	12.3	4.3	5.6	10.8	10.8	9.3	14.4	8.8	14.6	7.7	6.9	11.7	10.4	11.1	12.1	9.0	6.8	20.8	10.6	1.1	11.5	13.8	9.0	10.8	9.4	11.6	13.7	8.4	16.9	12.2	11.6	7.2	8.8	12.0	9.8	26.7	10.2	40.3	13.8	9.3	10.1	10.7	10.0	3.9	4.8	11.4	3.7	4.7	5.4	2.8	3.2	3.3	1.7	5.0	8.5	6.5	4.7	3.1	4.9	3.8	4.5	0.4	5.0	10.6	5.4	3.3	3.7	4.8	0.0	8.3	2.2	5.9	5.1	11.2	0.0	3.3	5.6	3.2	3.9	2.9	3.8	10.3	7.3	6.3	3.7	10.3	2.6	9.3	3.9	2.5	10.7	3.7	0.0	4.8	1.1	3.9	6.8	6.5	5.1	2.5	13.3	7.9	4.1	1.8	4.5	5.0	4.8	8.0	3.9	6.5	6.9	0.0	0.0	5.9	8.4	3.3	7.4	7.3	4.1	10.9	3.7	11.4	5.4	3.0	5.1	2.4	4.1	3.2	3.8	3.9	5.2	4.3	10.6	4.7	3.1	4.8	5.2	2.8	8.4	9.0	9.8	11.9	7.7	6.9	9.0	6.8	9.0	10.2	35.7	20.0	26.8	20.9	22.1	26.8	33.6	25.5	16.0	18.2	17.4	33.4	24.3	38.1	26.7	27.1	28.6	27.3	0.0	20.7	31.7	23.0	23.7	33.6	28.2	24.1	11.1	26.0	22.1	26.4	38.0	31.9	22.9	18.6	47.7	22.5	36.1	20.0	26.2	23.3	53.2	41.2	19.4	35.7	161.5	75.2	29.9	39.4	34.1	25.0	17.4
CSNK2B	"Ckb1, Ckb2"	ENSG00000204435	"Casein kinase 2 beta"	P67870	6	31665236-31670343	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004349, HPA005944, CAB013087, CAB016059"	Approved					NA	NA					"CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.72e-2)"	28.1	30.5	26.6	28.8	28.0	30.3	27.6	26.9	42.9	29.9	32.7	30.8	24.0	13.9	26.2	101.7	51.5	30.1	32.0	43.8	24.4	23.1	41.1	49.8	34.4	33.8	25.4	24.6	32.9	42.1	3.5	26.4	39.6	23.6	34.3	26.0	30.4	30.3	32.5	40.8	58.3	31.6	32.2	26.6	33.3	26.9	66.0	20.8	60.2	38.5	41.8	33.4	28.3	25.9	20.6	24.9	21.3	22.8	16.3	20.2	16.0	0.0	6.6	0.0	10.9	6.6	11.1	8.1	15.3	26.4	31.2	29.5	0.0	9.6	23.5	8.2	11.2	7.6	0.0	0.0	26.9	30.6	11.4	27.4	0.0	0.0	0.0	16.9	25.7	0.0	21.4	0.0	0.0	0.0	0.0	0.1	13.0	0.0	0.0	0.0	0.0	14.6	0.0	7.8	17.6	0.0	11.9	0.0	15.0	14.9	8.8	0.0	18.6	0.1	0.0	11.6	7.1	0.1	0.0	7.5	13.1	15.8	14.8	0.0	9.7	15.1	14.9	9.3	0.0	11.8	16.5	22.8	21.3	16.2	22.3	16.0	20.6	16.7	16.7	21.1	16.4	14.4	12.7	18.4	16.3	14.1	24.9	20.2	16.0	26.6	28.0	26.9	42.9	24.4	23.1	25.4	24.6	23.6	20.8	47.6	61.3	116.2	104.5	165.3	59.1	72.4	79.0	78.9	69.4	96.0	11.8	179.7	228.8	159.2	342.7	124.4	178.9	23.3	152.4	207.2	146.1	108.2	129.0	116.0	254.7	46.1	120.6	101.3	177.4	185.4	142.4	189.2	145.1	172.3	148.8	98.5	153.7	196.4	117.8	289.9	31.0	135.8	118.5	386.2	176.3	162.9	235.8	124.6	164.7	113.8
AL662899.2		ENSG00000263020			6	31666102-31673546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"bone marrow: 83.6"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Club cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005944, HPA048307"	Uncertain					NA	NA					"HPA005944: AB_1847290, HPA048307: AB_2680348"	"unprognostic (7.19e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	8.9	7.7	7.6	9.3	9.9	83.6	8.8	16.9	14.5	10.0	9.0	10.0	7.6	7.7	8.0	10.4	10.4	10.9	10.7	9.8	7.4	7.4	11.8	17.2	8.6	10.4	6.8	7.8	12.1	10.7	7.7	8.3	13.3	7.4	10.2	9.4	9.9	10.0	9.8	13.2	15.1	12.9	8.1	6.1	19.1	8.7	11.1	6.4	21.0	11.8	14.4	11.0	9.2	8.3	1.3	2.2	0.4	1.0	1.0	1.1	0.3	1.1	0.9	1.7	2.1	0.0	0.0	0.4	0.0	0.4	1.8	0.7	1.3	1.9	1.6	0.9	1.3	2.2	1.3	0.4	3.8	4.3	1.1	3.1	2.8	0.9	0.6	1.6	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.8	1.3	1.3	0.5	1.1	2.6	2.9	0.2	1.5	0.6	0.0	1.8	0.0	0.0	0.0	0.0	1.3	3.8	0.9	0.8	0.2	0.0	0.7	0.8	0.4	2.0	4.3	0.0	0.0	0.0	0.7	3.7	0.4	1.3	1.6	0.3	0.5	0.4	0.2	0.3	1.1	1.3	0.0	0.4	0.1	0.2	0.2	0.8	0.3	1.0	1.0	2.2	0.2	0.3	7.6	9.9	16.9	14.5	7.4	7.4	6.8	7.8	7.4	6.4	3.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G5B	"C6orf19, G5b"	ENSG00000240053	"Lymphocyte antigen 6 family member G5B"	Q8NDX9	6	31670167-31673776	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Rod photoreceptor cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											HPA048307	Approved				"Secreted - unknown location"	NA	NA					"HPA048307: AB_2680348"	"unprognostic (2.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (8.34e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-4)"	"unprognostic (7.27e-3)"	"unprognostic (1.98e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.98e-4)"	7.2	2.4	3.7	4.8	3.7	14.7	6.1	17.5	5.5	4.8	5.3	3.7	14.9	3.4	7.8	6.6	3.7	5.8	3.7	3.7	3.7	1.5	3.7	3.7	6.5	6.2	3.7	3.7	8.9	3.7	1.0	5.0	4.3	7.2	5.2	6.6	5.6	4.3	4.1	5.2	13.3	6.5	5.3	3.7	7.7	4.2	10.3	3.7	6.0	6.2	3.7	7.2	3.9	4.7	0.4	0.5	0.0	0.4	0.6	1.4	0.0	4.2	4.7	9.4	12.8	2.2	4.7	12.0	8.4	2.6	6.0	6.0	5.7	5.5	10.3	2.3	10.4	3.9	6.9	2.2	11.0	9.7	4.1	14.6	9.8	5.0	4.4	1.8	12.1	8.1	10.0	6.6	8.8	4.2	8.5	3.2	7.8	5.9	6.2	4.1	3.8	6.6	9.4	5.2	1.2	2.1	9.3	2.9	4.5	2.8	11.8	6.6	10.7	3.8	1.5	2.8	12.1	3.8	8.2	6.1	12.0	6.3	5.4	2.0	11.2	7.8	9.6	4.2	11.7	3.6	0.0	0.4	0.0	1.4	0.2	0.1	0.0	0.3	1.1	0.5	0.4	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	3.7	3.7	17.5	5.5	3.7	1.5	3.7	3.7	7.2	3.7	3.0	0.0	1.5	1.0	0.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.8	0.6	0.0	0.2	0.4	0.0	1.2	0.6	0.0	0.0	0.6	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	1.1	0.5	0.0	0.8	0.9
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HDLM-2: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.0	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.1	0.0	0.9	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.0	0.1	1.8	0.0	0.2	1.1	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0											3.0	1.0	0.0	1.7	1.4	3.1	0.8	2.5	17.4	1.2	1.8	2.0	0.4	3.3	1.5	9.4	4.3	2.9	0.0	4.3	0.1	1.2	2.4	4.7	1.7	5.2	0.0	3.4	7.4	6.5	4.4	1.1	2.2	1.7	1.8	1.7	5.7	3.7	2.5	1.4	3.8	0.9	0.0	1.9	12.9	13.4	0.6	0.2	4.4	2.5	0.9
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A"	O95870	6	31686949-31703444	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 14.2;Paneth cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.2;neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.6;BJ hTERT+ SV40 Large T+: 2.1;Daudi: 2.2;HEL: 1.4;hTEC/SVTERT24-B: 1.2;RPMI-8226: 1.4;SH-SY5Y: 2.7;U-138 MG: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		1400000			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	6.0	9.0	7.7	10.5	8.9	11.8	9.6	15.1	11.2	10.2	8.5	6.7	6.0	5.5	8.4	5.5	18.8	13.0	21.8	11.6	7.0	8.6	7.0	11.8	10.2	7.8	12.6	5.4	6.1	12.1	5.5	16.2	8.8	11.0	9.5	5.5	5.9	6.2	9.1	12.2	9.1	10.0	6.5	12.5	7.2	7.5	15.4	10.9	9.2	18.2	5.0	6.7	7.8	5.2	0.2	0.4	4.3	0.3	0.1	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	0.0	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.5	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.2	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	4.3	0.1	0.1	0.0	0.0	1.2	7.7	8.9	15.1	11.2	7.0	8.6	12.6	5.4	11.0	10.9	0.0	5.1	0.0	0.3	0.3	1.2	0.4	0.0	1.4	1.2	0.0	0.0	3.0	3.3	14.2	1.0	0.7	10.0	0.0	11.6	1.3	1.9	0.4	1.1	0.8	2.9	0.0	12.0	0.6	2.7	0.0	0.9	1.7	3.3	12.6	10.0	0.5	12.1	15.6	0.4	0.6	1.3	0.0	1.4	2.5	1.1	0.9	4.5	3.2	12.0	0.2
AL662899.1		ENSG00000204422			6	31686962-31714072	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.3"	"Cell type enriched"	"Detected in single"	7	"Club cells: 2.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	25	"HEL: 10.9"															NA	NA								"unprognostic (1.83e-1)"							"unprognostic (2.84e-1)"						"unprognostic (3.49e-1)"		0.1	0.0	2.9	0.1	0.5	3.8	0.1	0.1	5.3	0.4	0.7	0.1	0.1	0.0	0.5	0.7	0.9	0.2	0.4	0.1	1.8	0.2	0.1	0.1	1.1	0.1	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.7	0.1	0.5	0.1	0.2	0.1	0.1	2.7	0.1	0.1	0.1	1.7	0.0	0.9	0.1	0.6	2.3	0.1	0.1	0.1	0.8	0.8	1.3	2.9	1.5	0.7	0.9	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	10.9	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	1.3	1.7	0.9	1.5	0.6	0.5	0.6	0.6	1.3	0.8	0.4	0.4	2.9	0.7	1.4	1.1	0.6	1.5	2.9	0.5	0.1	5.3	1.8	0.2	0.1	0.1	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706885-31710595	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enriched"	"Detected in single"	141	"HEL: 14.0"									HPA008053	Uncertain					NA	NA		12000000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	1.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6F-LY6G6D		ENSG00000250641	"LY6G6F-LY6G6D readthrough"		6	31706904-31717918	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"skin 1: 9.3;testis: 4.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.7"									HPA008053	Uncertain					NA	NA					"HPA008053: AB_1840160"			"unprognostic (5.02e-2)"		"unprognostic (1.31e-1)"	"unprognostic (3.47e-1)"				"unprognostic (5.90e-2)"		"unprognostic (1.07e-2)"			"unprognostic (2.66e-1)"	"unprognostic (2.42e-1)"		0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.7	0.1	0.0	0.0	0.4	0.0	9.3	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	111	"HEL: 23.1"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.4;skin 1: 21.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 6.2"	"Region enhanced"	"Detected in some"		"cerebellum: 6.8"					HPA054412	Uncertain				"Intracellular and membrane"	NA	NA					"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.6	0.2	0.1	0.0	0.7	0.2	0.1	0.0	0.6	5.1	2.7	0.3	1.7	0.1	0.5	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	5.6	0.6	0.3	0.3	7.4	0.1	21.4	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.7	0.0	0.6	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in single"	30	"granulocytes: 9.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		7400000	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
LY6G6C	"C6orf24, G6c, NG24"	ENSG00000204421	"Lymphocyte antigen 6 family member G6C"	O95867	6	31718648-31721845	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 10.2;Late spermatids: 8.8;Suprabasal keratinocytes: 56.1;Syncytiotrophoblasts: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HaCaT: 1.9;MCF7: 2.4;OE19: 1.2;SuSa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.35e-1)"		"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.85e-1)"	"unprognostic (8.80e-7)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.38e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	1.9	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.4	0.1	5.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.5	0.0	0.1	0.1	0.0	2.4	0.1	0.2	89.7	0.0	0.1	0.0	0.1	0.1	0.2	0.0	1.8	0.1	56.1	24.8	0.1	4.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	0.4	0.1	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.0	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.2	0.0	0.4	0.1	0.0	0.0	2.4	0.1	0.9	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	1.6	0.0	0.0	10.2	0.1	0.7	0.0	0.0	1.0	0.6	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	2.1	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	56.1	17.0	0.0	1.7	2.3
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.7;ASC TERT1: 13.4;EFO-21: 17.1;fHDF/TERT166: 10.6;SK-MEL-30: 10.7;U-2 OS: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1800000	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.7	13.4	0.7	0.6	0.3	0.4	0.1	4.4	0.7	0.2	17.1	10.6	0.0	0.8	0.0	6.2	0.0	0.1	9.0	0.5	0.5	0.1	0.3	0.9	0.0	8.6	0.1	0.8	0.1	0.7	0.1	9.7	0.2	2.3	0.0	3.6	0.5	2.5	0.1	1.4	0.2	0.3	0.5	0.0	7.6	0.7	0.4	1.0	0.3	0.0	10.7	0.7	0.7	0.9	1.2	0.8	12.7	0.2	0.1	2.7	9.3	2.5	7.4	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9	26.8	17.1	39.8	83.5	59.4	4.0	32.5	38.2	33.5	17.0	78.5	27.5	13.7	150.9	113.3	87.7	94.4	114.4	0.0	28.5	24.3	96.9	77.4	109.8	27.2	186.9	0.0	143.9	57.7	101.8	14.7	167.1	97.2	97.8	79.4	47.6	79.4	71.2	98.2	143.9	116.9	22.9	103.5	127.7	2.6	12.4	51.8	15.1	33.1	63.1	53.8
CLIC1	"G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		78000000	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	64.5	22.9	7.4	33.7	11.3	35.3	41.1	2.5	8.3	38.7	50.3	9.0	27.1	24.5	30.0	29.2	59.0	26.3	60.8	35.5	7.9	7.7	70.8	28.3	58.6	59.6	13.9	3.7	34.8	30.3	11.1	17.0	72.3	12.1	42.2	43.5	20.0	37.7	33.6	18.3	45.0	54.9	31.5	13.6	79.9	34.8	16.7	9.2	52.9	46.1	37.4	58.5	49.2	40.0	39.0	30.5	70.9	39.4	33.5	37.2	67.9	27.2	12.6	20.8	10.8	13.8	29.2	10.3	12.1	24.9	22.2	18.7	29.0	20.5	11.2	17.7	43.2	28.1	16.4	15.5	36.3	30.1	8.9	8.1	21.3	10.8	25.0	17.9	37.2	30.2	18.1	19.2	37.5	35.9	24.5	37.2	10.5	24.6	35.5	42.7	18.1	17.3	48.5	1.8	29.7	18.5	3.0	11.3	26.3	50.0	17.0	3.9	4.6	10.0	11.6	16.9	15.1	8.0	52.7	24.6	31.0	21.9	9.6	38.3	11.6	21.7	15.0	15.0	28.1	31.9	45.8	36.5	48.1	37.2	39.4	30.3	39.0	22.5	34.5	30.5	30.4	7.0	21.9	70.9	33.5	33.8	17.2	31.0	67.9	7.4	11.3	2.5	8.3	7.9	7.7	13.9	3.7	12.1	9.2	65.5	61.3	354.7	452.1	853.4	0.0	16.5	257.4	207.5	94.4	225.1	0.0	468.2	510.6	945.1	18.6	330.4	596.8	70.0	880.9	648.8	394.1	631.9	536.3	52.1	938.8	0.0	366.1	247.4	525.8	10.3	216.6	766.3	497.7	307.4	477.4	70.1	1089.0	792.5	176.8	468.7	6.7	200.5	405.4	19.4	13.4	811.1	479.0	498.6	571.6	861.7
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739948-31762834	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 6.9;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in many"											HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	3.6	2.7	3.2	8.0	4.4	6.8	4.1	1.6	4.4	3.9	5.8	6.9	9.3	3.0	9.8	8.5	4.7	5.8	15.2	2.0	3.2	2.1	10.5	4.7	4.3	5.7	4.0	3.6	6.9	4.0	1.6	6.5	3.0	4.1	7.9	5.3	12.4	4.7	9.2	2.3	12.3	5.2	6.0	5.7	7.6	6.8	15.9	3.8	12.0	4.3	2.7	10.6	3.6	4.0	1.0	0.5	9.3	0.9	0.1	0.8	0.0	2.0	2.0	2.3	4.7	0.8	0.8	0.7	0.6	0.2	0.8	0.3	1.2	2.6	2.5	0.7	0.6	0.7	2.9	0.0	1.2	0.3	0.4	1.1	2.4	0.6	1.4	0.3	1.9	2.0	0.8	0.5	1.9	2.4	1.0	0.9	3.7	4.9	6.1	0.7	2.6	3.6	4.2	0.9	0.4	0.4	1.3	1.0	3.9	1.4	0.4	0.6	2.5	0.8	0.0	0.0	1.7	1.3	2.8	0.7	1.7	3.5	0.0	1.6	2.7	1.0	2.9	0.8	4.0	3.6	9.3	0.4	0.0	0.7	0.3	0.2	1.0	0.4	0.2	0.2	0.5	0.1	0.0	0.0	0.1	0.9	0.5	0.8	0.0	3.2	4.4	1.6	4.4	3.2	2.1	4.0	3.6	4.1	3.8	0.0	2.9	0.0	0.5	0.5	0.7	0.3	0.0	1.4	1.2	3.5	17.7	0.6	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.2	0.4	0.5	3.5	0.0	0.4	0.0	1.2	0.6	0.3	0.0	1.1	1.0	0.0	0.0	1.1	0.4	0.3	0.0	0.7	0.6	6.9	0.0	0.5	2.6	5.1	0.4	0.5	0.0	1.7	0.3
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell type enriched"	"Detected in single"	27	"Ciliated cells: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.3;JURKAT: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071699			Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.4	0.2	0.2	0.0	2.8	1.0	0.8	0.1	0.2	0.0	1.6	0.0	0.7	0.1	0.0	3.1	3.8	7.3	1.0	0.2	0.3	0.1	0.2	0.0	1.1	1.4	0.3	0.5	6.4	0.4	1.1	0.0	3.7	2.8	2.3	0.0	0.3	0.8	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.4	0.9	0.3	0.0	0.2	0.1	2.9	0.0	0.3	2.1	2.0	2.0	0.2	2.7	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.5	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.2	0.5	0.7	0.3	0.1	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.4	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.2	0.0	0.6	0.2	3.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.3	0.0	2.1	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.5	1.3	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3	0.0	0.6	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.4	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 205.7;Late spermatids: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.2;U-266/84: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		23000	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.2	6.4	3.6	2.8	8.7	8.8	2.7	6.6	4.0	2.6	1.4	7.7	10.9	5.5	5.0	2.4	10.2	6.7	4.0	5.6	14.4	3.8	5.1	6.1	4.7	15.3	12.6	4.2	2.4	2.6	6.1	1.9	3.3	3.5	10.6	10.5	4.2	3.5	6.9	0.7	6.1	3.2	4.3	9.0	1.7	25.2	5.1	2.9	3.9	1.5	0.7	8.6	3.7	2.2	5.2	6.1	1.1	4.6	4.2	6.1	14.5	15.0	25.9	6.3	3.3	3.1	5.1	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5	6.0	8.2	11.1	8.3	7.3	7.0	7.8	7.6	8.1	9.1	15.7	5.9	19.8	8.3	30.5	205.7	9.2	18.8	23.3	36.1	40.7	10.4	7.3	9.2	21.9	26.7	1.6	22.5	6.2	9.2	188.8	19.2	12.0	6.8	10.0	12.5	7.2	28.7	5.8	12.7	11.4	12.4	19.4	8.1	24.4	29.8	11.3	13.8	6.9	19.2	7.0
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806984	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		26000	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	20.3	17.4	15.7	21.7	19.4	21.0	18.7	14.4	17.7	21.1	19.5	14.0	11.8	17.9	23.6	15.2	21.8	21.5	20.7	17.5	14.4	12.8	17.5	15.1	18.0	33.5	20.7	17.5	19.4	20.3	9.6	15.1	17.9	20.3	19.7	21.3	10.8	12.8	14.0	19.5	17.1	15.3	21.5	26.7	22.1	16.7	16.5	19.4	51.8	23.4	19.5	26.9	21.8	20.9	18.2	10.8	8.7	5.7	12.3	15.3	10.1	10.2	5.0	8.8	11.3	5.0	6.9	9.3	6.4	4.1	9.2	8.2	5.7	3.9	10.9	9.0	5.3	8.5	4.1	11.6	10.9	8.3	11.5	14.9	12.5	3.1	5.8	6.1	12.4	4.5	5.2	5.0	8.5	8.8	4.3	9.6	11.2	16.3	7.1	6.5	7.4	14.9	28.4	8.1	7.7	10.9	9.2	7.0	16.0	7.6	3.0	8.9	7.7	6.9	6.2	12.5	4.8	6.8	9.9	5.0	5.5	9.6	6.3	10.3	7.4	12.6	13.9	2.8	14.8	8.5	8.7	5.7	3.6	9.4	5.2	12.4	18.2	10.1	10.6	9.5	16.1	9.7	11.9	1.2	12.3	4.4	10.8	15.3	10.1	15.7	19.4	14.4	17.7	14.4	12.8	20.7	17.5	20.3	19.4	20.8	23.4	106.9	62.3	51.7	30.5	12.2	40.8	18.7	22.7	52.4	5.9	114.2	96.2	89.8	18.3	82.4	26.4	70.0	118.6	172.4	68.7	55.0	82.9	52.9	122.6	28.6	51.9	62.0	59.2	20.0	46.1	69.2	87.7	110.0	89.7	34.6	82.0	49.1	46.3	86.4	26.4	45.3	57.7	49.6	178.0	56.1	57.7	108.4	103.8	39.9
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815065	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"testis: 29.1;vagina: 17.0"	"Group enriched"	"Detected in many"	19	"Early spermatids: 201.6;Late spermatids: 418.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.8;U-266/70: 2.8;U-266/84: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		49000000	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	0.4	0.5	1.8	0.5	2.2	0.5	1.2	1.4	3.1	0.5	0.7	1.5	0.0	0.3	0.8	3.0	0.8	1.5	0.3	0.5	2.0	1.1	0.9	0.7	1.7	0.7	4.5	0.8	1.1	1.5	0.3	0.7	1.0	2.6	1.2	0.6	0.2	0.4	1.5	3.9	0.6	0.8	0.5	4.6	1.1	0.8	29.1	3.2	0.0	2.0	0.0	0.7	0.5	17.0	0.3	0.0	0.4	0.1	0.0	1.7	1.1	0.0	1.7	0.0	0.0	1.9	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	1.0	0.0	0.0	6.8	0.0	0.0	0.2	0.2	1.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.2	0.0	0.0	0.2	0.3	0.0	2.8	2.4	0.0	1.7	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.0	1.3	0.0	0.3	1.5	1.6	0.3	0.0	0.0	0.0	1.7	1.1	1.8	2.2	1.4	3.1	2.0	1.1	4.5	0.8	2.6	3.2	0.0	0.6	0.0	0.6	0.8	2.1	3.6	0.0	1.4	1.2	0.0	7.9	0.4	0.0	0.7	201.6	1.0	0.5	0.0	0.2	0.4	0.5	1.1	0.0	0.9	1.1	3.2	1.7	3.1	2.4	418.3	4.6	1.5	5.0	1.8	0.6	3.3	0.3	0.8	2.1	0.3	2.8	0.0	1.4	16.4	7.7	0.1	0.3	2.5	1.0	0.3
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815464-31817946	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"breast: 216.1;vagina: 741.6"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5"	"Cell line enriched"	"Detected in some"	10	"HEK 293: 310.1"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes		77000000	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	29.1	74.5	35.3	18.4	48.0	3.5	216.1	40.4	36.0	8.8	22.6	27.4	41.1	3.6	33.1	32.3	36.7	14.5	14.6	40.3	37.5	28.8	35.3	49.5	54.7	14.1	89.2	10.8	15.1	31.2	3.5	23.8	22.1	67.4	47.8	11.4	6.1	28.3	52.7	66.7	57.9	17.3	36.4	47.0	35.6	19.3	10.9	85.9	1.3	26.8	16.3	11.8	41.3	741.6	1.0	0.5	8.8	4.7	1.2	4.5	0.5	0.0	31.3	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.7	0.0	0.0	0.0	2.3	0.0	0.2	310.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	4.5	1.8	4.7	1.0	1.0	2.5	2.3	0.5	0.4	1.2	1.1	8.8	1.2	2.5	0.5	4.5	0.5	35.3	48.0	40.4	36.0	37.5	28.8	89.2	10.8	67.4	85.9	137.0	84.3	135.2	6419.7	321.9	290.0	857.6	71.4	100.4	76.2	120.4	357.4	38.6	34.9	77.7	73.7	681.4	145.3	0.0	18.8	85.4	940.7	2245.3	456.0	74.4	220.0	193.9	449.0	109.9	284.5	25.8	558.4	1365.8	796.3	117.2	187.3	954.1	43.5	340.1	151.0	60.4	639.2	148.8	1629.0	48.6	175.8	294.0	87.2	208.8	111.9	2114.2
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827735-31830255	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"vagina: 508.1"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"A549: 24.5;Karpas-707: 72.8"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	21.9	89.9	25.0	20.3	31.1	5.7	129.4	30.8	23.6	8.4	14.6	17.0	36.6	6.2	19.9	40.5	24.4	13.2	12.6	29.2	25.5	22.5	18.6	28.7	30.8	6.3	61.9	8.5	29.3	36.7	35.1	21.6	6.4	53.8	31.1	8.4	5.6	39.7	48.5	102.8	11.3	11.0	27.9	33.4	10.0	20.5	11.8	55.1	0.9	32.1	14.3	9.7	43.4	508.1	1.1	0.6	1.4	1.3	0.4	0.4	0.3	0.2	24.5	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	7.6	1.3	0.0	1.0	0.0	0.0	0.0	0.5	7.6	0.0	0.2	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	72.8	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.0	0.1	5.1	0.0	0.1	11.9	0.1	0.1	0.0	0.0	0.0	0.5	1.3	1.4	0.1	0.2	0.1	0.2	0.4	0.0	0.6	1.1	0.0	0.0	0.8	0.4	0.7	0.5	0.3	0.3	25.0	31.1	30.8	23.6	25.5	22.5	61.9	8.5	53.8	55.1	104.2	64.8	61.6	2896.7	212.6	40.4	440.6	20.4	54.9	58.0	66.3	123.7	73.9	16.6	33.6	1.7	185.0	221.9	0.0	13.7	87.7	515.0	1002.7	354.9	16.3	116.6	44.5	304.9	19.6	74.0	3.1	204.3	481.3	609.0	26.2	172.9	237.3	22.8	291.0	51.6	32.9	140.4	103.5	978.7	12.8	50.3	194.0	217.2	75.6	121.8	675.8
C6orf48	"D6S57, G8"	ENSG00000204387	"Chromosome 6 open reading frame 48"	Q9UBA6	6	31834608-31839766	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 54.8;hTERT-HME1: 79.7"															NA	NA						"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.48e-3)"	"unprognostic (3.56e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-1)"	18.2	25.5	29.6	24.3	28.4	30.3	22.4	12.3	19.3	36.1	19.6	23.7	14.4	12.2	36.8	29.2	23.7	34.4	27.8	12.9	24.2	19.9	33.1	13.6	21.3	30.2	29.5	20.9	102.5	25.1	12.9	18.8	17.9	22.0	28.8	16.4	26.7	18.3	21.8	20.3	14.7	14.0	30.0	37.1	21.8	16.3	49.1	21.4	29.4	54.0	11.8	29.1	31.7	38.2	30.9	22.2	3.9	13.0	17.5	48.2	28.4	4.3	4.1	4.8	8.5	35.2	23.1	6.3	8.6	17.5	12.5	12.2	23.8	3.6	11.5	17.0	16.0	5.5	4.7	5.3	9.6	15.6	5.8	10.3	8.8	8.5	13.4	54.8	11.2	6.8	13.9	32.4	5.1	79.7	17.7	4.5	8.8	11.1	11.5	13.6	9.8	8.7	19.4	2.9	3.1	5.6	9.3	3.5	6.6	7.2	5.0	11.4	8.5	3.4	6.9	34.8	4.3	17.2	34.2	4.9	11.0	3.9	7.3	12.6	15.5	14.6	6.6	2.3	15.3	5.4	3.9	13.0	1.0	9.8	10.6	20.5	30.9	25.4	14.9	22.2	30.0	48.2	30.0	1.2	17.5	7.8	18.6	17.3	28.4	29.6	28.4	12.3	18.5	24.2	19.9	29.5	20.9	22.0	21.4	62.5	81.7	241.4	135.9	181.3	65.3	27.1	165.6	52.2	116.0	69.8	49.1	257.7	233.8	65.8	264.4	188.4	38.3	46.7	131.4	117.6	244.7	165.5	172.2	34.5	185.1	47.7	179.2	134.4	195.6	107.4	571.8	180.2	231.2	210.2	136.9	53.7	99.4	77.2	530.0	209.8	85.9	103.5	260.7	232.2	67.2	128.0	212.7	209.7	127.0	96.7
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.6;intestine: 65.7"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 245.0;Enterocytes: 364.2;Exocrine glandular cells: 194.5;Glandular cells: 195.5;Mucus-secreting cells: 268.8;Paneth cells: 234.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046977, HPA054176"	Enhanced					NA	NA					"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.3	2.4	0.2	11.2	0.3	0.2	2.1	0.2	0.3	5.9	43.6	0.3	7.6	23.7	2.9	3.0	0.6	10.9	34.6	0.2	0.2	0.0	20.4	0.3	9.1	0.6	0.2	0.2	4.9	7.3	0.0	5.0	5.1	0.5	25.7	8.6	0.3	12.0	4.4	0.2	0.1	65.7	1.2	0.2	0.6	23.7	0.8	0.2	0.4	0.5	0.7	4.2	6.3	1.9	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	13.2	0.0	0.1	0.0	0.4	0.0	2.0	0.0	0.2	0.0	1.1	0.0	0.1	0.4	0.3	2.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.5	0.2	20.8	29.0	6.7	17.5	0.5	0.0	0.3	30.6	245.0	54.6	62.8	0.0	0.2	3.3	91.8	2.2	0.5	364.2	0.0	194.5	0.3	1.8	195.5	2.3	0.0	0.5	0.0	44.9	0.0	0.0	2.9	1.4	2.0	0.0	2.8	268.8	0.4	123.2	234.4	0.4	56.6	0.6	0.0	0.4	0.2	0.2	0.4	0.6	0.0	158.0	88.5
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.6	6.4	0.0	2.8	1.5	4.1	2.8	2.3	3.2	2.6	0.0	0.0	0.0	6.3	4.5	3.3	0.0	0.0	6.9	1.5	4.2	9.6	0.0	0.0	0.0	0.0	10.3	0.0	3.9	1.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	7.3	0.0	15.8	0.0	0.0	6.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.3	2.7	0.0	0.0	3.0	3.4	2.6	5.7	0.0	9.1	12.4	3.0	3.9	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9	14.9	11.8	22.3	5.6	7.4	59.2	4.5	22.9	9.4	19.4	24.4	39.3	19.7	6.6	12.9	33.8	11.9	8.9	0.0	10.6	12.5	13.2	5.8	13.9	6.4	14.1	36.5	21.7	20.3	9.1	44.9	25.3	9.9	18.6	16.2	15.5	28.2	11.0	5.8	21.5	7.8	48.2	25.8	8.5	6.1	30.6	9.7	4.7	14.9	15.0	2.6
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 132.7"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 2: 116.0;Hepatocytes: 339.0;Hofbauer cells: 221.2"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 17.3;Karpas-707: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			CAB016775	Supported				"Secreted to blood"	NA	NA		52000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	9.2	3.2	0.9	4.8	1.5	0.8	5.0	1.2	1.3	2.0	5.3	1.8	1.6	2.5	2.0	4.8	1.9	3.3	3.2	5.4	0.8	0.8	13.1	132.7	19.4	13.1	1.2	0.3	2.7	2.1	0.8	2.8	7.6	1.7	1.8	4.3	2.9	2.4	1.5	0.7	1.6	6.6	3.5	1.8	12.1	1.9	2.0	1.0	1.8	1.2	0.8	3.4	2.7	1.5	0.2	0.5	0.8	6.5	0.1	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	17.3	0.3	0.0	0.2	0.9	0.1	0.2	0.0	0.2	0.0	0.3	0.1	54.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	2.4	0.1	0.1	0.2	0.2	0.0	0.2	6.7	1.0	0.2	0.3	0.0	0.1	2.9	0.0	0.1	6.4	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.2	0.8	0.1	6.5	0.0	0.1	1.2	0.9	1.5	1.2	1.2	0.8	0.8	1.2	0.3	1.7	1.0	23.8	116.0	3.0	1.0	3.0	1.4	0.4	10.2	9.4	6.8	1.8	0.0	1.6	0.0	0.4	0.1	0.7	2.8	23.3	2.4	1.8	15.8	5.9	3.5	339.0	221.2	1.6	2.4	25.2	60.2	0.8	6.4	8.4	3.3	10.0	4.1	0.0	7.1	15.3	1.1	30.0	0.8	0.0	2.3	0.6	0.9	2.5	3.3	3.2	3.9	2.5
ZBTB12	"C6orf46, D6S59E, G10, NG35"	ENSG00000204366	"Zinc finger and BTB domain containing 12"	Q9Y330	6	31899607-31901992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 3.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047161, HPA070639"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047161: AB_2679962, HPA070639: "	"unprognostic (2.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (8.98e-3)"	2.2	3.2	5.0	3.4	4.6	1.8	3.0	4.5	5.5	5.3	2.7	7.4	5.7	4.8	5.7	2.3	2.9	5.3	2.6	2.8	5.5	3.6	1.6	1.4	2.2	2.5	8.6	2.9	7.4	2.2	2.5	2.1	2.3	4.0	6.5	1.2	3.2	4.5	2.4	3.3	1.8	3.7	7.3	4.7	3.2	3.3	2.4	9.9	3.5	6.5	1.8	1.6	4.4	6.7	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.7	6.2	5.4	1.2	1.4	0.5	1.1	1.1	2.2	1.6	2.1	2.9	2.7	2.6	1.3	4.3	0.7	3.1	2.1	0.9	7.1	8.5	2.3	0.0	4.2	2.2	8.8	4.2	1.2	0.8	0.9	1.7	3.1	0.1	3.1	2.6	1.6	1.3	2.8	4.5	6.3	6.4	1.5	1.0	9.9	1.3	0.0	1.3	1.6	3.4	11.4	1.1	0.6	3.1	1.5	0.0	2.7	0.9	3.4	1.1	1.5	0.1	2.3	8.3	2.8	1.5	0.9	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.6	4.5	5.1	5.5	3.6	8.6	2.9	4.0	9.9	0.0	0.0	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AL645922.1		ENSG00000244255			6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	7	"liver: 115.5"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 9.4;Club cells: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;Hep G2: 1.6;Karpas-707: 2.4;U-266/84: 1.0"									"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA			"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				5.3	0.9	0.6	2.9	0.7	0.3	3.9	0.6	0.7	0.7	3.7	0.3	0.0	0.8	0.9	3.0	0.9	1.1	0.8	4.4	0.7	0.6	10.8	115.5	15.8	9.7	0.7	0.0	1.5	0.7	0.3	0.7	5.0	0.6	0.8	0.6	1.1	0.8	0.3	0.8	0.7	4.3	1.5	0.8	9.7	1.3	1.3	0.0	0.3	0.7	0.0	1.3	1.5	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.7	0.6	0.7	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Group enriched"	"Detected in many"	8	"Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1"									"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.1	6.0	0.0	0.0	0.3	1.6	0.6	0.0	7.1	0.1	5.3	11.6	0.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.6	0.0	0.7	0.1	19.1	0.1	0.9	0.6	0.6	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.2	1.7	0.0	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.4	0.6	1.9	0.5	3.2	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3	0.0	20.0	14.0	0.7	0.7	0.1	0.4	20.4	24.1	40.9	5.2	0.0	0.0	3.3	523.0	0.0	2.4	5.0	0.0	173.6	0.1	6.0	9.0	0.0	158.3	0.8	0.0	2.4	11.6	13.2	0.0	2.6	1.2	0.0	31.5	6.7	0.8	492.1	11.8	0.0	11.2	0.7	0.0	3.8	0.1	0.0	1.6	1.4	1.9	11.2	1.8
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959110	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 512.1;Late spermatids: 1326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	19.4	21.1	18.5	17.6	20.4	18.4	26.8	10.2	18.2	22.8	20.4	19.0	23.5	15.8	20.7	30.2	21.7	30.4	20.4	22.6	18.5	17.0	19.2	13.5	17.0	20.9	18.5	18.7	21.2	46.1	12.4	18.0	23.7	27.5	14.4	17.9	12.7	24.9	22.4	40.4	19.6	18.1	19.5	28.0	16.3	18.1	58.1	18.2	28.3	20.8	16.9	14.7	15.3	18.8	23.6	25.2	28.8	33.4	20.7	22.5	23.4	17.3	12.4	17.4	13.5	6.2	10.2	13.9	12.9	14.0	11.8	6.5	18.7	9.9	13.4	14.5	13.5	29.3	12.7	6.1	6.4	6.9	11.3	13.6	8.0	13.4	23.5	10.2	15.6	9.1	9.1	17.3	10.4	19.5	21.9	10.9	12.1	12.9	16.0	13.4	28.8	22.9	10.2	6.7	21.3	4.3	20.4	13.8	21.0	14.8	16.2	11.1	18.3	10.1	11.2	24.3	12.6	16.8	29.8	10.0	10.8	22.0	11.4	24.0	26.2	27.1	14.9	7.0	9.9	21.0	20.0	25.4	28.8	21.6	30.5	21.8	23.6	22.2	22.5	25.2	23.6	20.1	20.4	14.5	20.7	33.4	18.5	20.5	23.4	18.5	20.4	10.2	18.2	18.5	17.0	18.5	18.7	27.5	18.2	14.9	27.5	38.2	55.6	41.9	14.9	41.2	76.5	119.1	33.0	31.4	11.8	84.5	112.7	75.5	512.1	48.4	82.2	0.0	118.3	93.8	44.0	50.5	43.9	30.6	74.9	11.1	32.8	41.1	50.2	1326.0	65.9	48.4	47.2	80.2	58.5	50.2	89.2	84.2	42.5	78.5	22.9	32.3	48.1	183.6	96.5	36.5	95.7	52.9	62.6	48.2
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959080-31969755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 19.2"	"Low region specificity"	"Detected in all"							"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	14.5	32.8	12.4	19.4	15.2	19.0	11.3	15.4	20.2	11.6	12.6	16.0	10.6	36.7	12.5	37.4	14.8	11.7	10.3	12.3	10.7	8.2	12.6	27.8	17.9	13.9	12.3	10.1	13.6	13.1	3.8	21.6	11.3	12.7	17.2	11.1	14.6	11.5	14.3	17.1	14.3	15.7	17.8	10.6	21.7	22.7	10.7	13.7	17.4	14.9	7.5	15.0	13.6	10.7	2.2	2.3	1.1	4.3	0.4	3.2	1.2	0.3	8.1	7.2	0.7	2.1	4.1	8.3	5.8	3.4	4.4	7.6	0.4	0.1	0.3	12.6	8.6	6.9	5.8	0.0	10.0	3.5	8.3	15.9	0.0	0.5	0.7	0.0	0.3	0.4	10.3	8.8	0.1	0.1	6.0	0.0	9.7	0.1	7.2	0.0	0.5	0.5	0.7	10.2	0.0	0.1	1.1	0.1	0.5	2.3	0.1	0.3	0.4	9.3	0.1	5.0	6.3	0.4	7.8	6.6	8.6	2.9	10.3	0.2	16.0	19.2	3.4	12.3	0.4	0.3	1.0	1.3	0.3	2.4	4.3	1.6	1.5	2.2	1.6	2.3	2.2	3.2	2.6	1.1	0.4	2.9	0.6	0.2	1.2	12.4	15.2	15.4	20.2	10.7	8.2	12.3	10.1	12.7	13.7	14.9	9.9	13.0	4.1	2.5	5.7	6.7	2.5	10.7	4.5	7.0	7.9	10.4	1.7	8.8	2.3	5.8	20.0	0.0	7.4	6.8	3.9	7.1	8.1	15.3	8.2	0.0	12.1	9.2	4.7	1.6	8.6	4.6	6.8	8.2	12.1	6.3	7.9	14.0	5.6	5.1	7.8	0.0	5.0	3.9	8.3	3.1	10.4	7.7	9.0	4.2
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972292	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 374.6;Late spermatids: 209.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	4.3	18.4	8.3	8.0	11.0	4.2	7.0	15.5	12.4	7.1	5.0	6.5	8.6	7.8	6.4	6.4	4.0	7.9	6.0	8.4	7.7	6.5	8.5	8.7	5.1	4.3	9.0	6.5	10.5	12.3	9.4	12.4	4.7	7.4	7.6	4.2	5.8	5.5	6.8	5.6	3.4	4.1	6.3	4.9	7.2	7.6	32.8	7.3	3.4	8.8	4.7	4.3	6.4	5.5	2.2	3.2	1.5	1.9	3.0	3.3	1.5	3.0	1.3	0.5	14.3	1.7	1.0	1.5	1.7	2.7	4.5	3.7	2.2	2.9	1.0	3.2	5.8	0.8	4.1	1.5	3.2	1.6	1.9	4.4	2.0	2.9	2.9	3.9	0.0	2.7	2.2	2.9	1.8	3.0	2.2	6.6	1.1	2.5	3.2	1.8	4.4	0.1	2.4	0.7	1.9	0.1	0.1	2.0	1.8	5.3	0.8	7.4	5.6	3.3	1.4	3.7	0.5	0.0	4.5	0.9	0.8	4.9	2.8	3.7	1.9	3.4	2.4	2.6	4.6	2.2	0.0	1.0	1.5	1.1	1.9	3.3	1.4	1.4	1.8	3.2	2.2	1.3	1.6	0.6	3.0	1.2	1.2	0.6	1.5	8.3	11.0	15.5	9.4	7.7	6.5	9.0	6.5	7.4	7.3	6.0	11.1	11.2	13.5	7.6	12.9	6.5	7.6	8.1	6.8	3.5	15.7	12.3	16.6	7.5	374.6	6.3	6.1	0.0	10.8	7.9	10.8	9.4	5.8	9.7	5.9	4.8	15.5	6.7	4.9	209.7	16.4	6.7	11.8	4.6	7.0	16.2	6.4	8.6	11.7	11.7	14.7	12.9	10.8	58.1	11.8	4.8	16.8	13.1	6.8	7.3
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.9;HEL: 3.6;HL-60: 3.8;REH: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031510, HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031510: AB_10603119, HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	6.4	8.2	3.8	4.3	6.5	2.9	4.0	9.9	6.3	5.7	6.6	5.5	4.2	2.2	6.0	5.5	5.3	3.5	5.3	3.6	5.0	3.5	3.9	6.6	4.1	2.5	4.3	7.5	5.7	12.4	4.7	4.6	6.3	4.0	6.2	2.7	5.6	2.9	6.7	6.1	6.8	2.6	5.9	3.7	7.0	6.3	7.9	4.2	2.6	4.7	4.1	3.8	4.4	4.2	2.1	2.7	0.4	3.8	0.9	1.1	0.5	0.0	0.3	0.0	1.1	3.0	1.7	0.0	2.4	0.3	0.5	1.1	0.0	2.0	1.5	0.6	1.2	0.0	2.1	0.0	0.6	0.9	4.9	0.9	3.6	1.0	0.2	1.5	3.8	0.0	1.6	0.1	0.9	0.3	1.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.6	0.1	0.0	4.5	2.5	1.2	0.0	0.0	1.0	0.9	0.3	0.6	0.2	0.0	1.7	0.0	0.0	0.0	1.1	1.1	0.0	0.1	2.3	0.1	1.9	0.6	0.1	0.0	3.8	0.1	0.6	1.4	0.7	2.1	0.9	0.1	2.7	1.0	1.1	0.5	0.4	0.9	1.4	1.5	0.1	0.5	3.8	6.5	9.9	6.3	5.0	3.5	4.3	7.5	4.0	4.2	8.9	19.2	8.6	14.6	11.6	11.5	7.5	10.2	33.5	22.7	21.0	19.6	30.1	33.2	22.2	63.7	15.8	13.1	0.0	24.4	16.5	21.1	11.5	9.2	19.6	16.6	9.5	18.6	13.5	11.9	51.4	18.7	8.9	16.9	8.2	15.4	23.5	20.7	14.4	17.3	132.6	19.7	32.3	16.9	29.9	17.8	15.8	41.5	21.8	11.2	9.8
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982024-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease mutation, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.5"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 36.1;Ciliated cells: 8.1;Club cells: 25.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.4;HSkMC: 36.1;U-266/70: 8.4;U-266/84: 16.0"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	98000000000			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	2.7	17.5	1.3	4.3	1.1	0.0	3.3	0.0	0.1	0.4	3.0			2.9	1.6	5.8	0.7	3.5	0.8	2.7	0.7	0.9	12.8	49.5	6.7	1.4	0.9		8.0	2.6	0.0	2.2	0.0		1.5	1.7		1.3	0.0	0.0	0.1	1.2	0.0	0.7	2.9	4.1	0.3			8.1		1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	25.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.4	16.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											8.9	36.1	0.0	0.0	0.0	0.0	4.7	0.0	8.1	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014762-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 30.7;liver: 52.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 95.9;Cardiomyocytes: 44.1;Club cells: 42.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 53.7"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		97000000000			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	3.7	30.7	0.9	0.0	0.7	0.0	1.3	0.0	0.9	0.7	2.3			0.9	1.4	0.0	0.0	4.7	2.4	2.6	0.4	0.9	7.2	52.4	2.0	0.7	0.7		7.2	2.7	1.0	1.8	0.5		0.5	2.7		2.0	0.4	0.0	0.0	1.0	3.8	0.6	1.4	0.8	0.7			5.7		1.6	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	3.3	0.2	0.0	10.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	95.9	0.0	0.0	0.0	0.0	44.1	0.0	14.7	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.1	3.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038265-32041670	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"adrenal gland: 170.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 14.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.8;Hep G2: 1.9;Karpas-707: 3.2"					"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	0.1	170.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	6.7	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	7.4	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.3	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.1	14.4	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.2	0.5	0.0	0.0	1.7	0.4	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.0
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041154-32115334	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 29.2;Endothelial cells: 24.3;Erythroid cells: 23.3;Fibroblasts: 26.1;Ito cells: 12.9;Leydig cells: 25.0;Melanocytes: 30.4;Suprabasal keratinocytes: 23.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.3;ASC TERT1: 18.5;U-2197: 14.9;U-87 MG: 7.4"														"Secreted to extracellular matrix"	NA	NA		1100000000				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	45.1	66.2	1.0	12.2	1.8	3.8	61.5	7.7	1.5	28.3	14.5	0.6	17.6	4.2	31.6	38.0	25.7	7.5	33.3	39.3	1.0	1.4	3.3	5.4	22.3	8.7	2.2	0.4	41.0	3.1	1.5	1.8	7.6	1.4	9.0	2.7	3.0	7.1	7.9	17.9	8.4	10.2	49.2	4.4	7.9	5.4	11.4	0.3	0.4	6.7	36.6	4.5	33.0	32.2	0.0	0.0	0.1	0.1	0.0	0.2	1.7	0.1	0.2	0.2	0.1	11.3	18.5	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.5	0.0	2.6	0.0	0.3	0.2	0.1	0.4	0.0	0.4	0.0	0.4	0.6	0.3	0.0	0.1	0.0	0.1	0.3	0.0	3.4	0.2	0.0	0.2	0.0	0.1	0.1	0.2	1.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	14.9	0.0	0.4	0.3	0.2	7.4	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	1.0	1.8	7.7	1.5	1.0	1.4	2.2	0.4	1.4	0.3	3.0	3.7	0.0	0.1	29.2	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	2.7	24.3	0.0	23.3	0.0	0.9	26.1	0.2	0.0	1.0	0.7	0.0	0.0	12.9	0.3	2.0	25.0	1.3	30.4	0.0	0.0	1.0	0.0	0.0	4.2	0.2	0.5	0.0	4.7	3.0	1.8	23.2	0.8	0.0	0.2	0.2
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		31000000	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	11.7	19.4	23.1	13.7	29.4	24.9	14.3	20.2	19.1	17.8	20.2	15.4	9.8	11.2	19.2	32.7	20.0	27.7	15.4	11.0	19.4	11.4	13.5	14.0	15.6	17.0	20.6	16.5	22.6	18.4	38.1	16.1	21.1	16.9	16.8	18.8	14.1	16.2	14.0	7.1	17.8	15.9	9.4	12.8	22.8	20.2	19.5	17.0	21.7	21.2	11.8	21.0	18.0	16.4	4.4	5.7	6.6	4.1	5.6	4.9	4.4	0.7	2.9	8.1	3.0	6.0	6.8	2.9	3.3	3.1	7.3	9.1	9.4	15.7	14.3	11.5	29.1	10.5	4.6	10.9	21.8	5.3	2.9	12.0	1.0	15.1	10.0	19.9	1.1	17.4	11.4	9.7	1.3	20.2	18.4	19.7	26.9	18.9	19.0	18.5	7.4	10.0	7.0	2.4	14.0	0.5	0.7	3.5	6.4	6.5	1.4	0.5	0.8	14.2	7.7	19.2	3.7	24.2	1.8	8.5	4.0	4.4	6.4	9.8	19.1	8.2	6.7	9.2	6.6	9.8	6.6	2.2	1.9	4.9	4.1	4.7	4.4	2.8	2.3	5.7	3.4	1.8	3.5	2.5	5.6	3.7	3.8	4.5	4.4	23.1	29.4	20.2	19.1	19.4	11.4	20.6	16.5	16.9	17.0	11.9	14.6	95.8	29.3	22.0	84.7	1.7	45.9	28.1	10.3	52.4	90.3	71.4	5.0	39.2	2.4	30.3	49.8	0.0	37.3	41.1	28.7	30.1	16.1	18.3	46.0	41.3	51.5	37.4	39.0	3.2	65.6	45.4	30.4	53.3	48.7	43.1	31.4	49.1	48.8	11.3	83.5	58.2	28.4	71.1	55.1	22.1	74.6	74.8	52.7	35.4
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FK506 binding protein like"	Q9UIM3	6	32128707-32130291	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.6	5.6	4.1	2.7	4.7	4.6	7.1	12.1	6.2	4.4	4.5	3.9	8.9	6.0	4.1	8.7	12.7	7.0	4.5	6.0	4.1	3.5	5.9	6.7	4.5	7.7	7.1	2.4	7.0	13.2	6.2	5.0	6.9	5.8	3.8	4.9	3.7	8.0	3.6	5.1	11.5	4.4	5.1	3.6	7.8	6.6	7.6	6.8	10.5	11.6	2.8	6.8	4.7	6.3	3.4	3.7	8.3	4.8	3.3	4.6	1.5	0.0	2.0	4.4	11.9	6.6	4.7	3.8	2.9	3.3	5.5	5.3	9.5	4.0	3.3	3.4	5.1	7.4	2.2	6.2	5.7	3.8	5.9	7.6	0.0	6.6	5.3	3.7	0.0	3.6	4.6	5.8	10.7	6.7	4.1	5.8	8.7	11.1	8.3	5.6	3.2	3.6	4.1	3.3	8.6	1.7	3.0	5.8	7.3	5.7	0.7	8.5	2.0	2.9	5.3	6.4	2.3	9.2	6.4	2.5	8.0	6.6	4.1	7.0	4.4	7.7	3.0	3.1	5.4	4.9	4.9	3.4	2.3	4.6	4.8	4.4	2.8	2.6	3.3	3.7	3.4	3.0	2.9	8.3	3.3	2.5	2.9	1.1	1.5	4.1	4.7	12.1	6.2	4.1	3.5	7.1	2.4	5.8	6.8	6.0	5.1	4.7	3.2	10.0	2.9	2.0	5.1	0.0	4.5	1.8	0.0	8.3	5.0	6.7	2.2	4.5	8.1	0.0	5.9	10.6	7.4	3.3	2.3	2.8	4.5	9.5	5.8	3.7	3.2	4.0	2.6	4.4	6.8	4.6	4.9	6.4	5.4	3.7	3.2	7.7	4.0	0.0	6.2	8.9	8.3	8.9	11.8	6.5	5.0	4.1
PRRT1	"C6orf31, IFITMD7, NG5"	ENSG00000204314	"Proline rich transmembrane protein 1"	Q99946	6	32148359-32153083	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 41.1"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 64.7;Cardiomyocytes: 82.2;Horizontal cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HEK 293: 1.5;SK-MEL-30: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055149, HPA059099"	Enhanced					NA	NA					"HPA055149: AB_2682717, HPA059099: AB_2732632"	"unprognostic (1.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.08e-5)"	"unprognostic (2.99e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	2.6	4.8	23.9	2.4	25.3	2.2	2.2	35.8	41.1	2.5	2.5	4.9	0.0	2.6	2.6	2.1	2.1	2.4	2.3	2.3	24.4	10.5	2.4	2.2	2.2	2.2	4.9	27.1	6.1	2.4	2.3	3.2	2.5	11.7	2.8	2.3	1.8	2.3	2.7	2.4	2.4	2.4	2.3	3.0	2.4	2.9	2.6	7.7	0.0	2.2	0.0	2.1	2.2	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.8	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.5	0.8	0.1	0.0	5.6	0.0	0.2	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	23.9	25.3	35.8	41.1	24.4	10.5	4.9	27.1	11.7	7.7	0.0	0.0	0.0	8.0	3.5	64.7	82.2	7.6	0.0	0.0	1.8	9.8	5.0	1.7	0.0	0.9	4.5	3.3	0.0	0.0	0.8	3.8	4.6	0.0	2.4	0.9	30.2	8.6	3.1	0.3	1.0	5.8	0.3	3.3	0.0	3.7	15.1	0.3	2.5	6.0	0.0	8.0	0.0	12.7	0.5	1.6	2.4	3.0	0.9	4.5	4.8
AL662884.4		ENSG00000285085			6	32150495-32154373	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Ciliated cells: 4.0;Collecting duct cells: 10.4;Distal tubular cells: 13.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.3;HMC-1: 1.6;JURKAT: 1.2"															NA	NA																							1.7	1.2	3.2	1.3	2.7	0.8	1.1	3.4	3.5	0.8	1.1	1.0	3.7	2.0	1.2	3.2	0.9	1.1	1.2	0.8	2.4		1.1	1.0	0.9	1.0	1.3	1.8	1.2	0.8	0.8	1.1	0.8	1.0	1.2	0.9	1.5	0.8	1.9	0.8	0.8	4.5	0.8	2.3	0.9	1.0	0.8	3.5	0.4	3.6	0.7	0.8	1.1	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.8	1.3	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.6	0.3	0.0	0.3	0.0	0.2	0.0	1.6	0.7	0.2	0.0	0.0	0.8	0.2	1.2	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	10.4	0.0	0.0	13.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPT2		ENSG00000221988	"Palmitoyl-protein thioesterase 2"	Q9UMR5	6	32153441-32163680	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Syncytiotrophoblasts: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.0;EFO-21: 11.8;HEK 293: 20.4;MCF7: 8.7;RPTEC TERT1: 10.1;SK-MEL-30: 13.3;SuSa: 10.4"									HPA000414			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA000414: "	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.03e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.41e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.28e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.24e-3)"	8.5	13.1	10.4	9.3	10.6	3.0	9.6	21.9	11.8	16.1	10.5	13.1	11.7	15.8	13.8	14.9	13.7	14.2	10.6	12.3	10.7	7.5	17.8	13.1	14.3	6.6	12.2	7.7	25.1	7.0	3.1	7.7	14.3	9.8	10.5	9.6	16.1	7.2	11.4	19.1	30.9	6.9	10.4	7.1	11.8	15.2	6.4	11.5	11.5	7.4	13.2	8.1	13.9	12.0	0.2	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	16.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.8	0.0	4.8	1.6	2.6	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.0	1.2	1.3	0.0	7.4	0.0	0.4	1.0	8.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.1	7.0	0.2	13.3	10.4	0.0	0.4	0.0	0.0	6.0	0.0	0.0	0.5	7.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.4	0.0	10.4	10.6	21.9	11.8	10.7	7.5	12.2	7.7	9.8	11.5	0.0	0.3	0.0	2.7	3.0	12.0	5.8	2.5	0.0	3.4	3.5	15.7	11.6	1.7	1.4	0.2	4.6	1.3	0.0	2.6	7.8	4.8	1.0	0.0	3.9	2.4	3.2	4.7	4.9	1.5	1.0	3.7	1.4	6.8	0.0	2.9	7.5	1.3	3.4	2.8	2.3	5.2	0.0	4.7	3.1	4.5	1.9	19.5	1.3	2.8	1.3
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	1.0	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.1	0.7	2.2	0.3	0.0	0.0	1.7	1.0	3.0	0.0	0.3	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	0.0	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0	6.0	5.5	0.0	0.6	1.3	1.4	0.1	0.0	2.7	2.3	1.8	2.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.0	3.4	0.0	0.0	0.0	1.0	1.1	0.2	0.0	1.1	0.0	1.1	0.0	1.2	0.4	0.4	1.9	0.7	0.0	1.2	0.4
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.3	23.8	12.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	11.6	33.7	9.5	3.3	29.1	9.6	0.0	0.0	22.5	0.0	0.0	29.0	0.0	0.0	27.3	13.3	12.4	0.0	12.6	29.0	8.2	23.0	17.3	17.7	29.2	7.3	0.0	6.3	0.0	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	14.6	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.6	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4	14.9	18.1	19.4	9.5	8.0	26.4	3.1	12.7	12.0	7.9	34.9	11.8	28.8	5.0	16.4	52.8	13.5	30.7	0.0	12.4	25.8	14.4	11.5	12.7	27.1	22.0	30.2	28.3	18.4	17.4	64.8	12.4	17.4	8.5	5.4	24.1	34.1	13.6	21.0	20.1	22.3	17.0	0.0	20.8	45.5	20.6	3.1	12.8	12.1	20.4	10.5
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.3	6.9	4.7	18.1	5.2	3.6	3.7	2.1	2.7	4.7	5.4	9.2	4.5	6.9	7.8	5.2	6.7	4.4	8.8	4.9	5.0	4.3	11.9	5.5	7.8	19.0	6.1	0.0	11.3	3.5	6.6	7.9	6.0	8.6	9.5	12.4	14.1	7.5	6.8	7.5	6.7	15.9	0.0	7.5	2.9	4.6	5.3	9.7	13.3	3.4	4.9	10.2	4.2	4.5	4.7	4.4	9.4	19.4	4.2	5.2	5.1	0.0	8.2	4.1	6.2	8.2	3.6	12.3	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6	17.9	31.3	63.3	54.1	85.1	21.8	54.9	81.5	48.2	43.3	87.2	0.0	66.6	240.4	91.9	15.7	46.6	171.7	70.0	79.3	85.9	60.9	53.6	54.4	112.5	61.3	31.8	70.3	41.7	42.8	15.3	55.0	53.8	81.0	88.4	77.1	59.7	70.4	152.6	68.2	293.3	20.3	64.7	69.2	57.6	36.2	73.8	70.4	52.4	93.3	42.3
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184741-32190186	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	15.3	17.7	14.1	14.9	14.8	8.1	12.3	19.3	16.4	17.0	20.8	16.4	36.2	13.7	23.0	39.1	19.7	21.9	19.1	13.6	15.9	10.7	14.8	14.6	26.4	24.0	13.7	10.0	25.0	12.3	10.8	24.3	30.7	12.9	18.4	15.3	15.0	14.6	29.1	17.2	22.0	17.2	22.3	12.2	29.6	22.4	9.9	17.7	17.1	25.6	14.4	20.6	17.4	18.4	0.2	1.8	0.7	0.2	0.0	0.2	0.1	2.3	2.4	12.3	9.5	13.2	16.7	6.9	2.0	4.7	5.4	5.5	3.3	3.7	10.8	12.4	7.2	0.9	6.8	3.8	14.0	5.4	8.0	15.6	8.8	4.3	2.6	11.4	6.1	9.5	22.0	7.7	4.0	11.7	6.7	9.6	17.7	13.3	5.2	2.1	10.7	6.7	13.1	0.1	1.3	1.5	9.0	2.6	12.5	11.8	4.0	4.6	6.4	1.6	3.4	13.4	8.5	8.7	12.6	2.5	4.1	10.6	1.7	2.1	27.7	18.1	13.8	8.7	5.0	6.9	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	0.1	1.8	0.0	0.1	14.1	14.8	19.3	16.4	15.9	10.7	13.7	10.0	12.9	17.7	6.0	14.1	14.8	16.4	16.3	17.4	2.4	25.5	2.7	5.7	15.7	7.9	25.3	3.3	14.4	0.6	11.3	9.8	0.0	11.9	23.0	14.3	16.8	15.0	19.2	16.1	25.4	29.2	25.8	34.2	1.8	18.7	18.4	8.5	9.0	15.8	19.8	12.1	14.0	18.4	7.7	4.6	6.5	18.9	0.7	3.4	16.9	39.5	15.0	14.4	15.7
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;lymphoid tissue: 66.2"	"Group enriched"	"Detected in many"	5	"B-cells: 274.2;Hofbauer cells: 247.8;Kupffer cells: 319.4;Macrophages: 253.8;monocytes: 287.7;T-cells: 292.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 26.4;NB-4: 14.6;THP-1: 15.3;U-937: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA		160000				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"	7.1	3.3	3.4	28.8	5.3	20.6	4.4	1.3	3.6	2.3	3.9	5.2	0.4	3.4	2.2	4.2	4.1	4.2	5.5	4.7	3.6	3.0	5.2	5.1	17.3	32.2	5.3	1.0	2.1	1.9	0.8	2.5	6.1	4.7	4.0	4.0	4.7	7.2	1.8	1.2	2.5	18.4	2.2	9.1	66.2	4.8	2.0	4.6	53.0	3.4	1.5	33.3	8.1	3.4	5.7	6.3	29.9	6.6	3.4	7.4	4.6	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	1.6	0.7	0.9	0.1	0.6	4.4	2.1	0.7	0.0	0.1	0.0	1.1	0.7	5.5	0.1	6.2	0.0	0.2	1.8	0.0	26.4	0.5	0.0	0.2	0.9	0.3	3.0	4.8	2.9	7.4	0.1	0.0	3.1	14.6	0.0	0.0	0.0	2.5	0.3	6.7	0.3	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.2	15.3	2.9	0.4	1.2	0.0	0.3	0.3	0.3	4.8	0.1	9.0	1.6	4.6	6.5	19.2	5.2	6.6	4.8	5.7	6.9	6.0	6.3	5.3	7.4	5.6	29.9	3.4	6.4	4.4	4.7	4.6	3.4	5.3	1.3	3.6	3.6	3.0	5.3	1.0	4.7	4.6	0.0	2.1	274.2	11.5	10.0	0.0	0.3	2.5	0.0	2.3	3.5	0.0	2.9	0.0	8.2	3.9	21.7	0.5	0.0	4.6	4.3	7.7	4.9	58.6	2.8	247.8	0.0	1.2	23.4	319.4	9.5	1.1	253.8	42.2	287.7	5.7	0.4	12.5	14.4	0.0	2.0	0.3	6.5	8.5	0.6	2.5	7.4	5.3	292.4	4.0	20.7
NOTCH4	INT3	ENSG00000204301	"Notch 4"	Q99466	6	32194843-32224067	"Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.3;lung: 26.2"	"Cell type enhanced"	"Detected in many"	17	"Endothelial cells: 65.0;Ito cells: 155.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		820000				"unprognostic (2.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.13e-1)"	31.3	3.5	3.6	2.9	6.3	1.5	16.7	2.5	8.2	3.4	5.9	1.3	3.3	3.2	5.8	12.1	3.7	4.0	2.7	10.5	4.2	2.1	6.1	5.0	26.2	2.6	4.9	1.1	2.5	3.4	1.5	2.9	6.0	5.5	4.6	2.0	3.7	1.9	4.3	8.5	4.1	2.7	1.5	4.8	3.4	3.6	2.0	5.1	0.0	9.3	4.3	2.0	3.3	12.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.6	6.3	2.5	8.2	4.2	2.1	4.9	1.1	5.5	5.1	0.0	9.6	11.8	23.5	4.6	2.8	6.4	0.0	4.0	6.8	5.2	3.9	0.3	0.0	1.8	31.8	65.0	0.0	0.0	1.0	0.2	3.1	3.1	0.0	0.8	1.6	6.4	5.8	155.3	11.0	26.3	6.6	4.9	3.3	1.0	0.6	19.5	0.3	0.0	4.9	0.8	3.5	0.0	5.9	4.2	1.6	1.4	0.2	2.5	1.0	4.7
C6orf10	TSBP	ENSG00000204296	"Chromosome 6 open reading frame 10"	Q5SRN2	6	32288526-32371912	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 28.6"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 313.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 1.1;U-2197: 1.3"									HPA047479			Approved	Cytosol		NA	NA			Cytosol		"HPA047479: "	"unprognostic (1.00e-1)"	"unprognostic (2.24e-1)"				"unprognostic (1.05e-1)"		"unprognostic (5.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"		"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.56e-2)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0
BTNL2	"BTL-II, BTN7, HSBLMHC1"	ENSG00000204290	"Butyrophilin like 2"	Q9UIR0	6	32393963-32407128	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (4.04e-2)"	"unprognostic (1.54e-1)"			"unprognostic (1.50e-2)"	"unprognostic (8.13e-4)"		"unprognostic (3.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.67e-1)"	"unprognostic (8.03e-2)"		0.0	1.0	0.7	0.0	1.3	0.0	0.1	0.2	0.5	0.2	0.0			1.3	0.3	0.2	0.0	0.3	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.1	0.3		1.2	0.0	0.0	0.5	0.0		1.0	0.0		0.1	0.0	3.0	0.1	0.9	0.0	0.3	0.7	0.5	0.4			0.4		0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439842-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 211.6"	"Group enriched"	"Detected in many"	5	"B-cells: 2551.2;Hofbauer cells: 2965.8;Kupffer cells: 2919.1;Macrophages: 6482.8;monocytes: 9158.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in all"	5	"B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 56.6;HDLM-2: 101.0;REH: 41.1;U-266/70: 24.9;U-698: 58.2;U-87 MG: 40.5"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					NA	NA		1600000			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favorable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	51.8	33.5	14.1	79.1	20.2	1.8	37.3	2.3	10.1	21.1	38.9	21.5	10.9	30.8	16.5	76.8	15.9	33.9	21.8	34.7	13.1	16.2	60.9	17.8	147.2	211.6	27.3	7.4	14.7	10.0	1.7	14.7	9.7	23.5	21.9	33.8	23.5	21.6	12.6	12.9	27.6	86.2	9.0	52.8	127.3	68.7	7.2	21.6	53.7	18.6	25.9	151.6	53.5	15.1	61.7	29.6	9.3	46.8	1.8	2.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	101.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	24.9	0.0	58.2	40.5	0.0	0.0	0.6	29.8	9.3	0.3	46.8	0.1	59.4	0.3	1.7	0.5	61.7	0.2	0.3	2.2	1.8	28.0	29.6	2.7	29.9	14.1	20.2	2.3	10.1	13.1	16.2	27.3	7.4	23.5	21.6	271.0	1055.7	2551.2	15.4	664.8	2.8	17.1	140.1	283.7	312.8	143.1	0.0	12.6	24.9	102.1	5.1	500.2	61.2	70.0	51.5	11.7	106.8	41.9	162.6	8.5	2965.8	1.6	62.4	159.6	2919.1	12.4	27.9	6482.8	733.9	9158.9	74.1	8.3	54.7	48.9	4.2	202.9	18.7	71.1	73.3	3.5	5.0	503.6	21.6	91.4	51.9	59.2
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517343-32530287	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 71.8;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 354.6;Hofbauer cells: 502.6;Kupffer cells: 564.1;Macrophages: 808.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 26.4"	"Group enriched"	"Detected in many"	10	"B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 112.0;HMC-1: 28.3;U-698: 33.5;U-87 MG: 44.2"									HPA043151	Supported					NA	NA					"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	21.8	14.2	2.9	22.1	3.9	3.7	16.2	2.0	3.2	16.7	21.7	7.0	6.4	2.3	8.7	22.1	9.5	12.6	6.6	9.1	4.3	4.0	32.2	9.3	71.8	60.4	7.3	0.8	4.9	4.9	0.0	6.0	4.9	5.4	9.5	10.2	11.2	9.0	2.7	7.4	8.8	34.7	4.7	12.2	64.8	40.3	4.6	4.5	15.3	9.5	11.2	27.6	21.8	6.5	13.3	26.4	1.5	16.0	0.9	1.8	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	112.0	1.1	0.0	0.0	0.0	0.0	0.1	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	9.9	0.0	0.6	0.1	0.3	0.0	7.6	0.1	33.5	44.2	0.3	0.0	0.0	10.1	1.5	0.4	16.0	0.0	10.5	0.4	1.1	26.4	13.3	0.0	0.5	0.3	0.9	8.1	5.9	1.8	15.4	2.9	3.9	2.0	3.2	4.3	4.0	7.3	0.8	5.4	4.5	14.9	139.1	354.6	2.3	92.6	0.6	6.9	137.6	5.3	7.9	14.0	3.9	1.1	1.7	1.1	2.3	236.0	13.4	0.0	6.9	2.7	11.4	6.5	57.8	3.4	502.6	0.0	1.7	114.2	564.1	3.7	14.7	808.2	114.7	129.0	14.9	0.0	18.4	51.8	32.2	19.6	1.4	19.4	37.4	0.7	0.2	79.3	2.6	71.0	3.5	18.2
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	"P01911, P04229, Q29974, Q9GIY3"	6	32578769-32589848	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.6;lung: 95.9"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 1496.4;Macrophages: 3257.5;monocytes: 4435.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 95.6"	"Group enriched"	"Detected in all"	10	"B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 157.6;HMC-1: 22.4;THP-1: 18.9;U-266/70: 21.0;U-698: 27.1;U-87 MG: 43.5"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA					"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	36.8	18.7	9.7	32.2	15.9	8.7	24.9	3.6	10.0	14.2	18.2	11.5	11.2	0.2	10.5	27.2	12.1	13.3	12.0	11.9	8.5	6.9	50.0	15.6	95.9	80.8	18.9	5.4	6.9	8.0	0.0	9.4	5.7	14.8	9.5	23.7	16.1	11.3	2.4	8.2	13.3	42.1	3.8	19.7	62.1	38.1	5.6	13.2	33.6	14.1	3.8	44.7	29.7	17.0	41.3	95.6	6.3	52.5	2.7	4.7	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.2	0.0	0.6	0.0	157.6	1.7	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.5	0.2	0.6	18.9	0.0	0.0	0.1	0.3	0.0	21.0	0.5	27.1	43.5	0.7	0.0	0.2	34.6	6.3	1.8	52.5	0.3	32.7	1.2	3.7	95.6	41.3	0.1	1.6	1.2	2.7	26.9	20.4	4.7	37.7	9.7	15.9	3.6	10.0	8.5	6.9	18.9	5.4	14.8	13.2	137.0	520.2	984.8	8.4	154.2	1.7	28.0	109.5	140.5	174.0	134.3	0.0	2.5	21.6	104.5	3.5	441.7	148.8	0.0	65.2	4.6	54.7	18.7	119.2	3.4	1496.4	0.0	34.5	186.6	1186.4	7.6	13.8	3257.5	205.8	4435.6	52.0	8.3	76.3	364.7	25.1	169.2	9.4	25.8	72.3	1.8	3.4	129.4	5.7	137.1	73.6	61.3
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 91.5;lymphoid tissue: 113.3"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 621.2;Hofbauer cells: 402.6;Macrophages: 675.1;monocytes: 1355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 91.5"	"Group enriched"	"Detected in many"	19	"B-cells: 43.3;dendritic cells: 91.5;monocytes: 32.1"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 176.7"									HPA012315	Enhanced					NA	NA					"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	44.6	8.9	3.9	63.5	6.9	0.7	14.8	1.2	3.1	11.4	13.6	7.4	6.1	0.0	10.6	45.5	8.1	6.1	23.7	4.4	3.8	4.9	23.8	17.2	69.0	48.2	8.7	2.6	16.4	5.1	0.0	6.5	3.7	8.9	5.8	22.1	14.8	11.4	1.2	7.6	11.3	26.1	4.2	19.5	97.0	17.3	2.1	6.7	113.3	8.5	0.5	63.6	42.3	6.6	43.3	91.5	0.4	32.1	1.0	2.9	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	176.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.2	0.1	19.5	3.2	0.0	0.0	0.1	14.8	0.0	0.3	32.1	0.1	42.8	0.4	2.3	91.5	43.3	0.0	0.6	0.4	1.0	8.1	22.7	2.9	15.8	3.9	6.9	1.2	3.1	3.8	4.9	8.7	2.6	8.9	6.7	11.9	132.6	621.2	0.4	44.6	0.0	2.0	12.7	10.7	21.6	0.0	2.0	0.7	1.7	1.4	0.4	35.0	0.3	0.0	3.8	1.1	13.6	1.2	46.5	0.4	402.6	0.0	0.0	9.8	236.5	0.2	2.8	675.1	67.4	1355.3	0.3	0.5	2.1	0.0	0.0	5.1	1.8	6.5	2.0	0.0	0.8	36.4	1.7	27.7	0.4	0.4
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 74.6"	"Group enriched"	"Detected in many"	4	"B-cells: 690.1;Hofbauer cells: 446.2;Macrophages: 1016.1;monocytes: 1484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4"	"Group enriched"	"Detected in all"	6	"B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 114.5"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	23.9	10.0	3.5	40.4	3.0	9.0	17.0	1.0	4.9	11.0	18.8	8.8	4.5	0.0	9.9	42.6	9.6	8.0	21.7	12.7	4.1	5.3	35.4	9.9	61.2	61.1	6.1	4.2	6.3	4.0	0.0	9.2	4.0	7.9	11.3	10.7	13.5	11.8	5.6	7.8	12.4	27.6	4.6	15.5	74.5	32.7	4.6	2.9	63.5	13.3	7.9	74.6	37.9	7.4	35.6	68.2	4.6	27.8	1.5	7.1	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.4	0.0	0.0	3.7	0.0	3.7	0.0	114.5	2.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.6	2.1	0.0	0.0	0.1	0.1	0.0	13.7	0.3	12.6	9.5	0.0	0.0	0.0	27.8	4.6	2.4	24.1	1.1	30.9	1.2	3.7	68.2	35.6	0.0	1.1	1.9	1.5	6.6	21.4	7.1	31.9	3.5	3.0	1.0	4.9	4.1	5.3	6.1	4.2	7.9	2.9	38.7	182.5	690.1	8.0	79.8	4.8	2.5	22.9	21.4	40.9	17.4	9.8	1.7	6.6	16.1	13.8	55.5	8.1	0.0	17.6	1.9	15.3	7.5	36.0	0.9	446.2	0.0	21.9	12.3	206.1	4.7	6.1	1016.1	92.8	1484.2	9.0	1.0	19.0	5.8	9.2	15.4	1.7	6.5	4.2	2.1	2.1	58.1	2.5	41.5	4.1	32.4
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741342-32747215	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.7;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"	22	"B-cells: 96.0;Hofbauer cells: 116.5;Kupffer cells: 86.7;Macrophages: 348.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	6.1	2.7	0.5	1.5	0.5	1.5	3.6	0.0	1.5	6.3	1.8	2.1	0.0	1.5	3.8	1.5	2.5	1.9	27.2	16.5	1.0	0.9	12.5	3.5	37.7	43.6	1.3	0.6	1.5	1.5	1.5	1.5	1.9	3.0	7.9	1.5	6.5	19.9	2.5	1.5	4.7	11.7	1.5	5.9	35.5	2.3	1.5	0.0	40.5	3.5	6.7	51.1	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.2	1.0	0.9	1.3	0.6	3.0	0.0	3.0	2.2	96.0	0.2	20.8	0.0	0.4	0.0	5.3	5.7	3.5	0.0	0.2	0.0	0.0	0.5	8.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	116.5	0.0	2.4	3.1	86.7	0.5	1.1	348.8	23.6	35.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	6.5	0.2	0.0	0.0	20.5	0.3	21.5	0.0	0.7
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763534	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6;skin 1: 25.8"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 25.2;Macrophages: 78.8;Melanocytes: 25.3;Suprabasal keratinocytes: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Group enriched"	"Detected in many"	7	"B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2"	"Group enriched"	"Detected in some"	4	"Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0"									HPA073187	Enhanced					NA	NA					"HPA073187: "	"prognostic favorable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	2.1	0.9	0.4	3.5	0.4	0.3	2.0	0.4	0.3	2.1	0.5	0.6	0.2	0.4	0.3	1.8	5.5	0.6	0.8	0.3	0.3	0.2	1.2	0.4	9.7	3.0	1.3	0.2	0.9	0.2	0.0	0.8	0.2	0.8	0.6	1.1	0.8	2.7	0.8	0.5	25.8	3.1	0.2	1.4	7.2	2.2	0.5	0.3	25.6	1.0	11.3	17.8	1.1	2.3	3.0	3.1	0.3	1.2	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.4	0.2	0.1	0.2	0.8	0.1	0.1	1.2	0.0	2.8	0.0	0.1	3.1	3.0	0.1	0.1	0.3	0.3	0.4	0.5	0.2	1.2	0.4	0.4	0.4	0.3	0.3	0.2	1.3	0.2	0.8	0.3	3.0	8.8	6.7	0.0	25.2	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	2.5	0.0	0.0	0.0	8.2	0.0	0.9	78.8	25.3	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	0.1	0.0	0.0	0.1
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32817048	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.1;lymphoid tissue: 33.0"	"Group enriched"	"Detected in some"	6	"B-cells: 90.0;monocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 42.0;naive B-cell: 51.1"	"Lineage enriched"	"Detected in many"	19	"B-cells: 51.1"	"Group enriched"	"Detected in some"	5	"Daudi: 33.5;U-698: 11.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013846	Enhanced					NA	NA					"HPA013846: AB_1853928"	"prognostic favorable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"	0.7	0.4	0.3	28.8	0.3	2.7	1.4	0.7	0.3	1.2	2.7	0.4	0.0	1.7	0.7	0.5	1.3	0.5	1.4	2.2	0.2	0.4	1.8	0.7	3.3	33.0	0.4	0.2	0.5	0.2	0.0	1.8	0.5	0.8	0.7	2.4	0.7	3.8	0.9	0.4	1.0	12.2	0.2	0.7	28.5	1.4	1.7	0.1	5.8	1.1	0.9	29.8	5.5	0.8	51.1	2.6	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	1.7	33.5	0.1	0.1	0.0	0.2	1.0	1.8	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.6	0.3	11.8	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	2.6	51.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.3	0.3	0.7	0.3	0.2	0.4	0.4	0.2	0.8	0.1	0.0	4.5	90.0	0.1	0.9	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	1.0	0.5	0.0	0.0	0.2	0.3	0.4	0.1	1.1	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.0	3.9	13.5	75.7	0.0	0.6	0.2	0.0	0.0	0.0	0.7	6.5	0.3	0.0	0.2	1.4	0.0	1.0	0.0	0.3
AL669918.1		ENSG00000250264			6	32813767-32838822	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4"									HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Nuclear speckles, Endoplasmic reticulum"		"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	6.5	3.6	2.8	25.5	3.1	3.8	3.6	3.1	3.3	4.8	7.7	3.5	1.0	5.7	4.6	2.5	4.8	3.6	5.7	3.5	2.1	2.6	5.3	10.0	8.5	12.6	3.2	2.8	4.7	2.1	1.7	5.0	2.4	3.6	3.8	3.1	3.6	7.0	1.4	2.5	3.3	15.1	2.7	2.8	18.1	12.3	2.5	3.1	14.0	7.5	3.2	10.6	3.8	3.9	8.6	5.5	8.1	4.8	2.3	4.6	5.1	2.1	3.2	0.0	0.7	1.6	1.7	0.5	0.6	0.3	0.0	0.6	0.0	3.3	17.2	2.0	0.2	0.2	7.8	1.6	1.7	0.6	11.4	0.2	12.4	2.1	0.3	0.5	0.0	0.5	0.0	0.9	0.5	0.2	0.0	0.0	1.9	3.1	2.9	0.2	0.6	1.4	0.9	0.2	0.0	2.9	6.0	0.6	5.5	0.0	0.0	0.3	0.3	0.5	5.3	1.4	0.0	5.1	1.3	0.0	1.3	1.9	0.4	0.7	1.4	2.8	7.6	0.7	3.6	0.4	1.6	3.1	6.1	3.5	3.2	3.4	8.0	2.8	3.9	5.5	8.6	2.1	4.6	8.1	2.3	4.8	5.2	4.2	5.1	2.8	3.1	3.1	3.3	2.1	2.6	3.2	2.8	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838780	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.6;U-251 MG: 28.3"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA		14000	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	12.8	8.4	6.5	22.5	6.9	14.7	9.5	6.3	7.3	8.8	15.0	7.6	3.3	15.3	9.6	5.9	17.4	7.9	11.5	7.7	5.2	6.0	10.8	19.0	18.0	14.0	7.1	6.3	9.7	6.1	2.6	5.8	5.7	7.9	8.2	11.9	7.9	12.1	5.2	5.8	9.6	28.0	7.0	6.1	24.9	7.7	3.3	6.9	25.9	14.7	7.1	20.1	23.6	10.7	0.9	2.8	4.9	5.4	2.9	4.1	1.9	7.9	0.0	0.0	2.3	2.2	3.1	0.0	0.5	1.6	6.2	8.5	2.1	16.3	15.5	3.1	4.0	11.2	8.3	7.1	28.6	2.5	10.5	0.9	1.8	6.1	0.7	1.0	0.0	12.3	0.3	0.4	8.4	13.1	0.0	4.0	0.0	8.6	5.2	0.0	0.6	2.0	1.0	0.3	0.6	4.0	8.4	0.0	5.9	5.2	0.1	0.1	0.0	7.7	16.4	1.6	0.3	0.8	0.0	2.3	8.8	2.0	2.3	28.3	8.1	13.4	14.5	8.1	10.9	1.6	1.7	2.0	1.8	4.1	5.4	2.0	0.9	1.2	2.7	2.0	0.6	1.0	0.6	4.9	2.9	4.1	2.8	1.9	1.9	6.5	6.9	6.3	7.3	5.2	6.0	7.1	6.3	7.9	6.9	0.0	6.9	28.3	12.0	0.0	4.5	2.4	2.5	2.7	6.8	14.0	2.0	1.2	1.7	33.7	0.0	28.7	19.3	0.0	28.6	35.6	4.1	11.3	4.7	5.8	22.4	17.5	3.5	16.0	12.3	0.0	5.2	14.5	0.0	92.8	18.4	18.9	27.4	13.9	5.6	4.7	4.8	0.0	7.5	0.4	1.2	0.0	1.4	24.5	10.3	14.8
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome subunit beta 8"	P28062	6	32840717-32844703	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		No	No		3300000	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	17.0	21.9	7.9	34.8	11.7	14.0	14.9	3.6	7.5	10.0	20.8	5.1	8.8	20.1	12.5	15.3	16.6	13.2	23.8	10.6	6.6	5.7	20.9	30.0	29.0	46.3	9.9	5.1	11.3	12.7	3.6	8.2	9.7	8.8	13.5	24.4	9.2	14.6	11.2	5.1	14.7	37.3	11.5	9.0	42.8	19.4	3.9	9.0	32.2	18.7	18.7	29.0	13.9	12.5	28.9	27.4	37.6	33.2	23.3	29.9	52.2	6.4	2.0	0.1	0.0	2.7	7.1	4.4	1.5	10.2	12.5	18.1	0.0	11.4	25.1	4.8	4.1	9.8	4.5	1.4	6.1	3.4	10.3	0.0	11.1	1.3	0.4	15.0	0.2	4.2	8.0	2.8	7.0	2.4	0.4	8.4	5.4	0.3	5.3	3.1	0.0	5.8	6.1	0.0	0.0	1.6	15.6	0.8	12.4	10.2	1.8	0.1	0.1	2.2	5.4	3.4	0.0	2.4	20.5	2.5	3.7	2.0	3.5	0.2	8.9	8.4	5.6	1.3	14.5	4.7	19.4	29.0	37.4	25.5	33.2	22.1	28.9	21.7	26.4	27.4	26.3	15.1	21.6	37.6	23.3	28.6	23.3	29.9	52.2	7.9	11.7	3.6	7.5	6.6	5.7	9.9	5.1	8.8	9.0	35.7	58.8	174.3	61.0	75.0	1.6	6.1	79.0	62.9	45.5	59.3	0.0	1.7	72.9	173.5	0.5	121.7	242.4	0.0	217.6	10.1	57.2	72.3	49.7	67.1	157.1	6.4	63.1	92.1	135.9	0.6	36.2	111.9	54.0	193.0	164.1	32.8	163.9	247.6	28.7	51.6	2.7	38.8	45.7	0.2	1.2	69.5	2.3	193.7	184.0	98.2
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome subunit beta 9"	P28065	6	32844136-32859585	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.1;lymphoid tissue: 54.9"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.5;REH: 21.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		420000	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	13.3	9.7	5.0	30.0	7.9	10.7	11.6	1.6	5.3	7.6	16.5	6.0	3.4	15.7	8.8	7.1	10.8	7.4	10.8	8.9	5.1	4.7	12.2	12.2	17.7	32.7	7.3	3.7	9.2	5.4	1.2	4.5	5.5	6.3	12.5	5.8	7.7	9.0	3.5	6.2	7.6	36.1	5.7	9.8	54.9	11.2	3.0	6.7	35.4	14.4	9.3	35.2	15.9	8.8	31.8	17.2	69.1	30.5	23.4	31.1	45.7	0.0	1.4	0.0	0.1	1.2	3.0	2.0	0.2	3.3	4.2	9.9	0.0	9.2	29.5	0.4	2.7	10.8	6.0	0.4	6.3	0.6	16.6	0.0	18.0	0.5	1.1	15.9	3.1	1.3	1.4	0.2	2.7	0.4	2.3	1.5	8.5	0.7	5.5	1.4	0.5	13.6	4.2	0.0	0.0	0.9	21.8	0.0	7.0	2.8	0.5	0.0	0.0	2.7	1.8	2.0	0.0	2.4	6.6	1.5	4.6	0.4	8.6	2.6	10.2	15.5	9.4	4.7	11.9	3.8	21.9	22.4	39.3	28.7	30.5	23.8	31.8	23.3	27.5	17.2	23.4	17.5	22.9	69.1	23.4	29.4	12.7	31.1	45.7	5.0	7.9	1.6	5.3	5.1	4.7	7.3	3.7	6.3	6.7	38.7	64.6	199.7	29.6	64.5	1.9	5.3	73.9	30.8	34.2	24.4	0.0	0.9	16.6	87.6	1.0	123.4	127.8	46.7	101.9	4.2	38.3	33.2	76.1	23.2	118.3	0.0	32.1	108.1	113.4	0.7	27.0	117.7	33.7	319.2	103.0	19.5	69.2	118.1	14.9	33.5	1.1	32.3	41.0	1.4	6.5	51.3	1.1	214.2	55.9	33.0
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA		110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.8	1.5	3.4	7.0	9.5	0.1	3.0	6.0	4.0	1.1	6.5	5.5	1.2	2.5	0.4	10.2	1.6	6.7	1.4	2.3	4.4	0.0	2.4	1.3	2.1	1.9	1.2	0.0	1.7	2.2	0.4	5.7	0.8	1.7	1.1	13.3	0.0	0.6	2.0	5.9	1.2	4.0	9.0	0.5	0.0	0.3	1.6	4.3	5.8	0.3	3.9	12.0	0.9	2.6	1.0	6.4	0.0	7.6	10.6	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9	23.8	29.5	66.8	38.2	66.3	4.1	5.3	35.7	8.1	17.0	5.2	0.0	3.2	5.0	68.6	0.4	41.7	52.4	0.0	65.7	73.1	29.1	47.1	26.5	9.7	45.6	14.3	16.1	26.4	22.4	0.0	12.0	40.0	21.9	144.3	54.7	32.1	71.9	35.1	9.9	5.0	3.0	6.5	44.0	0.9	0.7	66.9	4.0	91.4	30.7	39.7
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941070	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"B-cells: 222.5;Hofbauer cells: 281.2;Kupffer cells: 131.2;Macrophages: 353.4;monocytes: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9"	"Group enriched"	"Detected in some"	13	"CAPAN-2: 7.3;Daudi: 10.3;EFO-21: 4.9;U-266/70: 3.9;U-698: 12.6"									"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	12.0	13.0	5.9	20.2	7.5	4.3	7.9	0.4	4.9	8.1	9.7	8.8	2.1	1.2	6.2	10.2	3.3	12.6	6.0	8.0	5.7	4.2	13.1	5.4	20.8	24.0	10.2	2.3	7.4	5.0	1.2	3.2	6.2	8.1	6.3	10.5	6.3	7.8	3.2	2.9	4.5	31.8	1.9	14.5	35.6	6.1	2.1	7.3	10.5	33.7	3.8	34.5	10.6	3.2	19.9	11.5	2.2	11.9	2.2	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	10.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.3	12.6	0.0	0.0	0.0	0.0	11.9	2.2	0.3	10.1	0.4	15.1	0.2	0.5	11.1	19.9	0.1	0.5	0.5	2.2	3.5	11.5	1.0	10.3	5.9	7.5	0.4	4.9	5.7	4.2	10.2	2.3	8.1	7.3	8.9	53.6	222.5	0.9	10.6	0.1	2.2	7.6	10.7	6.8	15.7	0.0	1.4	10.0	10.4	0.5	31.8	3.1	0.0	4.0	1.2	4.7	1.4	14.0	0.6	281.2	0.0	4.1	3.7	131.2	0.7	3.1	353.4	15.1	112.8	1.5	0.5	3.9	0.9	1.8	6.0	1.2	6.5	4.1	0.4	0.5	9.5	2.3	15.0	1.7	2.4
AL645941.2		ENSG00000248993			6	32937364-32953122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lung: 18.7;lymphoid tissue: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 1.3;intermediate monocyte: 1.5;memory B-cell: 2.6;myeloid DC: 1.7;naive B-cell: 1.0;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"B-cells: 2.6;dendritic cells: 1.7;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;SK-MEL-30: 1.4;U-698: 1.3"									HPA012298	Uncertain					NA	NA					"HPA012298: AB_1853927"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.56e-4)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"		"unprognostic (1.08e-1)"		"unprognostic (1.93e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.18e-2)"		"unprognostic (4.73e-2)"		10.0	2.9	1.7	12.1	2.8	2.3	2.4	1.6	2.0	3.0	5.6	3.7	1.7	4.0	2.8	5.5	1.8	1.7	4.3	5.3	1.8	1.8	8.3	1.7	18.7	10.8	3.8	0.0	2.4	5.0	1.7	2.1	1.9	3.6	2.6	2.0	3.0	7.3	3.8	2.8	2.0	12.7	1.9	5.5	13.2	3.5	1.8	2.7	7.3	7.1	4.7	19.3	2.1	1.9	2.6	1.7	0.2	1.5	0.0	0.2	0.6	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.3	0.6	0.0	0.0	0.5	0.4	1.3	0.2	0.2	0.2	0.0	1.3	0.2	0.0	1.5	0.0	2.6	0.0	0.1	1.7	1.0	0.0	0.0	0.1	0.0	0.2	1.1	0.2	0.6	1.7	2.8	1.6	1.6	1.8	1.8	3.8	0.0	3.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-DMA	"D6S222E, RING6"	ENSG00000204257	"Major histocompatibility complex, class II, DM alpha"	P28067	6	32948613-32969094	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"B-cells: 394.3;Hofbauer cells: 370.5;Kupffer cells: 264.8;Macrophages: 648.8;monocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	12	"B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1"	"Group enriched"	"Detected in some"	4	"U-266/70: 15.7;U-698: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012750, HPA017295"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA012750: AB_1853926, HPA017295: AB_2669575"	"unprognostic (1.69e-3)"	"unprognostic (3.52e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.99e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (7.01e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.14e-2)"	22.9	20.5	5.1	27.2	7.9	18.9	17.4	1.0	5.0	11.3	18.4	9.8	5.7	3.2	8.0	25.3	6.7	32.1	11.1	13.1	4.6	5.2	19.3	12.4	50.7	24.5	10.1	2.0	14.9	20.2	2.1	5.0	3.2	9.7	7.6	14.3	8.4	17.3	10.1	4.3	7.3	28.4	4.3	15.2	38.5	23.1	3.5	7.9	17.3	10.0	11.9	42.1	5.9	6.0	7.0	7.9	0.5	4.1	0.3	0.4	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.0	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.7	6.9	40.0	0.3	0.0	0.0	0.0	4.1	0.4	0.2	4.0	0.0	6.8	0.1	0.3	7.9	7.0	0.1	0.2	0.5	0.3	1.1	5.7	0.4	3.1	5.1	7.9	1.0	5.0	4.6	5.2	10.1	2.0	9.7	7.9	68.5	147.1	394.3	13.3	42.8	1.6	3.6	50.9	37.5	51.2	50.6	2.0	3.8	14.9	38.3	2.8	85.6	22.0	23.3	46.1	3.5	19.8	18.9	40.4	2.9	370.5	0.0	2.9	32.5	264.8	4.3	15.0	648.8	75.9	269.7	18.9	4.1	34.9	15.3	17.7	36.3	0.8	19.4	18.6	3.6	4.4	36.6	3.3	44.0	22.6	27.6
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968660-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	26.1	35.1	26.8	30.1	28.9	96.2	26.8	42.2	28.8	34.9	27.4	30.6	46.4	21.2	35.0	28.7	33.2	33.0	27.6	21.7	26.5	20.1	28.9	27.5	28.1	28.2	34.9	19.5	40.6	65.5	28.8	33.7	27.2	29.0	28.5	21.8	29.3	32.6	41.7	28.6	28.7	25.6	27.1	26.4	33.4	32.2	66.9	33.1	38.7	58.5	27.1	33.2	26.8	35.8	12.3	13.0	14.0	11.2	12.9	19.5	12.0	19.1	7.5	18.6	13.6	10.1	9.3	26.1	15.1	18.7	19.1	16.5	8.0	13.3	14.4	16.7	21.4	13.1	10.1	11.8	12.2	16.9	14.1	53.9	13.9	9.4	6.6	14.5	22.8	24.3	9.6	10.6	17.1	15.6	25.9	6.8	11.6	17.5	28.9	7.3	3.8	25.6	4.0	10.4	21.6	7.0	30.3	5.5	20.4	5.1	9.0	28.7	11.4	16.8	21.2	21.2	12.4	14.5	12.9	8.5	26.3	12.5	7.4	18.7	43.0	35.8	36.1	7.4	13.3	15.7	10.2	9.1	14.0	19.5	11.2	17.6	12.3	13.0	13.1	13.0	11.8	9.1	13.5	12.9	12.9	10.9	10.8	16.3	12.0	26.8	28.9	42.2	28.8	26.5	20.1	34.9	19.5	29.0	33.1	71.5	114.1	98.7	188.7	188.4	73.7	146.1	94.3	71.0	75.1	57.6	98.2	75.1	18.3	58.2	233.1	107.9	140.5	23.3	79.1	101.6	100.8	173.4	111.0	77.8	71.2	52.4	248.8	105.0	87.8	140.2	80.6	111.7	118.1	78.5	135.2	56.5	69.4	115.4	72.5	35.3	62.2	38.8	179.1	77.0	117.6	198.4	171.5	138.4	122.8	198.6
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004178-33009612	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.6"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 31.2;B-cells: 33.8;Macrophages: 41.0;monocytes: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.1;naive B-cell: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;HDLM-2: 4.6;REH: 20.7;U-698: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045038	Enhanced					NA	NA					"HPA045038: AB_10959457"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	5.7	5.7	2.2	18.4	3.9	2.0	5.1	1.5	2.1	4.5	4.0	8.3	2.2	5.1	4.6	6.0	2.7	4.6	4.8	9.3	2.8	3.1	10.0	3.4	18.1	24.7	5.5	2.0	5.7	2.9	3.3	3.3	1.0	5.4	5.4	4.7	4.0	4.5	3.2	1.2	2.5	12.3	2.4	9.6	25.5	4.5	1.2	3.9	14.7	3.8	3.2	30.6	3.4	3.1	11.2	9.1	0.3	4.4	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	7.4	0.0	0.3	9.1	11.2	0.1	0.9	0.3	0.1	2.0	2.8	0.7	1.4	2.2	3.9	1.5	2.1	2.8	3.1	5.5	2.0	5.4	3.9	3.0	31.2	33.8	0.5	1.6	0.0	1.1	0.0	0.0	3.4	3.5	0.0	0.1	0.0	1.6	0.0	4.6	0.0	0.0	0.2	0.0	0.9	0.5	4.7	0.0	14.2	0.0	0.0	0.6	16.4	0.0	0.3	41.0	0.0	64.1	0.0	0.9	0.5	0.0	0.0	2.6	0.2	0.0	0.2	0.0	0.2	1.0	0.1	1.3	0.0	0.1
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 59.5"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 1100.8;Hofbauer cells: 1218.6;Kupffer cells: 965.1;Macrophages: 2476.0;monocytes: 4193.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1"	"Group enriched"	"Detected in all"	8	"B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;HDLM-2: 48.6;REH: 12.4;U-698: 11.4"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		92000	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	25.2	12.8	3.3	13.3	3.6	4.7	16.3	3.5	3.3	11.8	6.8	3.1	4.3	8.6	8.5	15.9	8.5	5.7	14.7	11.1	4.2	6.2	12.4	9.7	35.9	20.2	6.2	3.8	3.8	5.4	3.8	5.2	6.5	4.8	7.4	7.3	7.5	7.4	15.7	4.1	5.8	14.7	6.4	20.4	37.6	5.6	8.6	4.1	10.9	14.2	9.5	21.5	8.5	17.8	30.0	59.5	1.3	37.8	4.0	5.6	20.3	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.2	0.1	0.2	0.0	0.0	2.1	15.8	2.2	0.3	3.1	0.0	0.0	0.0	0.0	48.6	1.0	2.6	0.0	0.0	0.0	0.0	5.1	0.7	0.0	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	1.1	3.5	0.0	0.0	0.0	2.4	0.3	11.4	5.5	0.1	1.9	0.3	16.3	1.3	4.6	37.8	1.2	30.0	2.1	5.0	59.5	26.7	0.7	3.4	0.6	4.0	23.2	17.1	5.6	20.3	3.3	3.6	3.5	3.3	4.2	6.2	6.2	3.8	4.8	4.1	77.4	317.2	1100.8	5.1	183.6	2.5	10.5	76.5	80.3	113.7	22.7	0.0	4.2	8.3	15.4	2.1	188.1	6.1	0.0	15.8	5.3	55.4	10.4	62.4	4.5	1218.6	4.8	9.8	60.2	965.1	4.3	16.7	2476.0	286.8	4193.1	9.2	4.8	4.8	4.5	25.8	32.7	3.1	51.8	21.8	0.9	2.9	153.2	5.7	100.5	4.1	8.9
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"	"Group enriched"	"Detected in some"	6	"HDLM-2: 47.2;REH: 22.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		730000	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.0	0.0	0.0	0.0	47.2	2.2	1.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	22.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	6.0	0.1	3.9	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2	62.5	286.9	1312.2	21.4	267.0	12.2	9.3	73.9	46.8	77.3	27.9	15.7	5.1	3.3	33.6	3.2	238.9	10.6	0.0	13.0	4.7	50.0	41.9	61.1	5.5	1159.7	7.9	9.2	88.4	1265.6	4.0	25.3	2334.4	307.1	5192.2	12.2	24.1	8.0	4.0	19.8	36.3	19.2	45.3	33.2	1.2	5.9	203.9	7.6	173.0	6.5	13.9
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pituitary gland: 28.8"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 3.9;Early spermatids: 11.3;Ito cells: 6.7;Muller glia cells: 6.7"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.4;U-698: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA		720000				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.6	0.7	0.8	0.6	1.5	0.2	0.4	6.6	2.8	1.2	0.4	2.5	0.1	1.2	0.6	1.2	0.4	0.3	0.5	1.6	1.1	0.9	0.4	0.8	0.7	0.3	2.7	0.1	0.5	1.7	0.2	28.8	0.5	1.7	0.8	0.2	2.6	2.2	0.6	2.5	1.6	1.5	0.9	2.2	0.8	3.5	4.5	1.8	1.1	2.1	0.9	0.6	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.2	0.1	2.0	0.3	1.6	1.0	0.2	0.7	0.2	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.3	2.1	0.3	0.0	0.1	0.1	0.0	0.1	1.5	0.5	0.8	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.4	0.2	1.2	0.4	0.2	0.8	1.5	0.0	0.1	2.4	1.7	2.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	6.6	1.2	1.1	0.9	2.7	0.1	1.7	1.8	0.0	0.0	0.0	0.1	1.3	1.9	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	11.3	0.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	6.7	1.2	1.0	0.0	0.0	1.7	0.0	0.0	6.7	0.1	0.0	0.4	0.0	1.1	0.0	1.0	0.9	1.5	1.0	0.0	0.0	0.0	0.0
RXRB	"H-2RIIBP, NR2B2, RCoR-1"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200688	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.9;GAMG: 9.4;RH-30: 8.6;RT4: 8.1;T-47d: 8.4;U-698: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA063653"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002003: , HPA063653: AB_2685076"	"unprognostic (3.51e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-3)"	"unprognostic (8.13e-3)"	"unprognostic (9.53e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.53e-3)"	24.9	18.9	13.0	14.0	16.1	9.8	16.0	24.7	23.2	22.8	17.1	17.7	17.3	19.0	17.4	56.6	13.7	18.5	17.1	27.7	13.5	12.3	14.1	17.4	16.5	9.8	16.4	15.6	19.1	16.2	3.6	17.5	19.2	15.5	20.1	8.4	16.0	16.2	22.0	19.7	25.5	14.1	28.4	10.4	19.8	13.9	10.4	18.2	18.5	22.0	10.9	24.5	14.0	14.5	1.9	1.4	5.2	1.2	1.9	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	6.9	0.0	5.2	4.0	0.0	9.4	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	5.2	0.0	0.0	0.2	3.1	0.0	0.0	0.0	8.6	0.0	5.2	8.1	0.0	4.6	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	3.7	0.0	0.0	6.7	5.8	8.4	0.0	0.0	0.0	5.2	0.8	2.9	2.5	0.9	1.8	1.9	2.5	2.4	1.3	0.8	2.4	1.5	1.9	1.9	1.2	1.4	2.5	0.7	13.0	16.1	24.7	23.2	13.5	12.3	16.4	15.6	15.5	18.2	38.7	14.1	14.7	14.6	15.3	25.5	16.1	5.1	9.4	15.9	5.2	19.6	19.4	21.6	16.6	2.2	14.7	19.6	0.0	14.1	13.3	14.6	14.4	10.3	14.9	14.0	17.5	21.1	9.8	14.2	3.2	15.0	8.5	15.1	22.6	20.2	15.7	12.5	17.3	15.2	10.7	19.7	25.8	17.6	14.7	13.6	16.4	24.0	17.9	20.7	11.7
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	14.7	25.1	9.0	12.1	9.5	6.1	15.8	11.9	11.9	24.7	19.8	12.2	43.3	17.3	20.1	24.6	14.4	13.6	25.6	20.7	8.7	8.9	24.6	55.1	20.2	11.6	12.6	9.6	14.4	49.2	37.1	24.2	43.8	18.8	22.8	22.9	16.8	48.0	41.7	10.4	11.3	18.8	20.1	10.6	15.2	21.1	9.5	10.7	9.9	28.2	14.4	17.0	16.6	13.9	2.6	3.4	6.2	2.8	4.2	5.1	2.1	8.5	9.9	15.2	14.1	22.9	15.7	13.3	22.9	30.1	17.8	21.0	16.2	8.3	6.4	11.2	25.5	13.8	9.7	11.5	13.5	15.9	8.1	10.2	10.9	11.6	20.8	16.6	10.8	13.2	14.8	11.4	15.7	17.0	17.6	14.2	6.8	11.9	10.5	12.2	9.7	5.9	6.3	6.5	12.5	9.1	6.4	8.9	10.6	11.9	10.7	9.9	8.0	9.3	22.0	12.5	9.6	21.3	10.1	14.0	16.4	10.0	12.2	15.2	16.5	14.5	5.7	9.9	10.3	18.1	6.2	2.4	2.3	5.1	2.8	4.8	1.8	3.2	3.9	2.3	2.6	2.9	3.3	2.4	4.2	1.6	3.4	3.0	2.1	9.0	9.5	11.9	11.9	8.7	8.9	12.6	9.6	18.8	10.7	23.8	33.3	14.5	25.7	32.1	27.2	29.7	28.1	22.7	33.0	24.4	27.5	88.4	5.0	60.8	0.6	33.7	62.8	23.3	75.1	113.6	62.0	56.4	19.7	31.1	38.7	11.1	24.3	29.4	17.0	1.9	42.6	23.9	38.8	27.9	109.3	41.2	56.0	56.2	40.3	20.1	22.2	19.4	33.9	7.9	10.6	35.8	141.1	27.4	54.4	33.5
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 106.1;Proximal tubular cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		52000			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	1.0	1.3	0.3	0.6	0.4	0.1	0.7	0.0	0.0	1.5	2.5	7.0	2.0	0.1	0.3	4.2	1.0	3.2	0.1	1.2	1.2	0.3	2.0	3.8	3.0	0.0	0.5	0.7	4.3	0.0	7.4	0.0	0.3	2.5	0.1	6.8	0.6	2.3	5.2	0.1	0.3	3.3	0.9	3.0	0.1	14.8	4.1	0.1	2.0	1.1	0.4	5.6	1.3	0.7	9.6	0.2	0.1	0.2	1.2	0.0	0.0	14.6	7.0	2.6	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4	17.9	16.3	6.7	21.5	26.4	10.3	24.3	38.2	26.8	14.8	21.0	5.9	25.7	106.1	24.6	5.1	8.5	30.9	23.3	28.3	10.1	10.0	13.7	6.9	60.4	14.9	1.6	17.2	6.7	8.9	11.1	6.9	10.0	47.2	10.0	23.7	28.7	19.1	21.0	5.6	106.8	11.8	0.0	5.9	7.5	5.5	32.5	14.5	14.0	43.6	21.3
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.6	4.2	4.1	4.3	1.4	9.8	11.2	6.8	4.6	4.7	3.8	3.2	7.0	4.7	4.5	5.8	7.7	3.6	3.4	3.2	8.6	2.9	8.4	5.9	7.2	9.7	4.8	6.9	0.0	3.4	4.1	7.6	3.6	1.7	3.8	12.1	5.4	4.8	0.0	0.3	3.7	1.9	3.1	4.6	4.5	7.0	7.7	5.0	3.7	8.4	5.2	4.0	4.3	11.6	1.1	5.0	8.4	2.3	5.1	3.8	0.0	9.2	6.1	6.2	6.7	3.8	4.4	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8	0.0	22.7	20.1	35.5	24.5	30.5	21.4	17.8	17.4	14.8	21.0	15.7	36.0	13.3	28.6	21.1	23.2	23.3	0.0	30.3	27.6	28.0	27.3	19.6	30.5	26.3	23.8	29.4	30.7	29.6	13.2	37.2	20.0	16.9	20.8	19.8	38.3	26.5	21.0	28.0	26.9	18.0	25.8	22.7	32.9	18.8	26.7	52.7	25.4	21.0	24.7
VPS52	"ARE1, SACM2L"	ENSG00000223501	"VPS52, GARP complex subunit"	Q8N1B4	6	33250272-33272047	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042667, HPA048128"	Approved					NA	NA					"HPA042667: AB_2678105, HPA048128: AB_2680278"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.63e-2)"	17.7	16.7	18.0	11.3	20.7	7.1	11.7	17.0	24.5	12.6	18.3	26.2	6.6	22.1	13.7	21.7	23.5	17.6	12.6	14.7	15.1	9.7	15.0	13.1	12.3	17.9	16.4	16.3	15.0	14.3	2.2	15.1	11.3	18.4	15.8	11.3	14.5	13.2	11.3	19.3	23.8	16.2	13.8	13.7	15.7	12.5	15.1	18.5	14.2	22.0	11.4	17.1	18.4	12.8	4.0	5.8	3.5	6.6	4.7	5.8	3.8	0.0	5.0	3.8	6.3	2.9	3.1	5.9	0.0	0.0	0.0	0.0	7.0	0.0	0.0	4.1	0.0	7.5	7.2	9.0	0.0	0.0	0.0	1.5	0.0	9.1	3.2	5.8	0.0	8.3	0.0	0.0	0.0	4.5	4.3	3.1	4.0	11.0	0.1	0.0	0.0	0.0	0.0	6.0	8.7	4.3	2.2	0.8	9.0	4.0	9.6	0.0	4.3	5.2	13.4	3.2	0.0	0.0	12.2	0.0	3.5	1.8	4.1	8.5	0.0	0.0	6.9	0.0	2.6	0.0	3.4	4.7	3.5	5.8	5.4	5.3	3.0	3.1	4.6	5.8	4.0	4.8	4.7	2.2	4.7	6.6	2.2	4.2	3.8	18.0	20.7	17.0	24.5	15.1	9.7	16.4	16.3	18.4	18.5	11.9	15.4	4.5	5.8	6.0	12.2	0.9	17.8	9.4	6.8	3.5	2.0	13.7	6.6	8.6	5.2	4.2	11.8	0.0	10.2	13.3	5.1	4.9	1.1	16.6	10.1	6.4	6.9	11.1	13.8	5.8	6.4	6.6	6.8	11.8	14.5	12.4	8.6	5.8	8.5	7.2	11.9	12.9	3.4	27.7	12.9	7.5	14.8	3.2	11.9	6.4
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272010-33276510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 484.7"	"Cell type enhanced"	"Detected in all"	5	"Suprabasal keratinocytes: 27922.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050159, HPA055007"	Approved		Supported	Cytosol		NA	NA		90000	Cytosol		"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favorable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	67.0	49.1	43.4	126.4	32.2	109.6	132.5	20.9	37.7	99.8	105.5	17.8	48.6	44.6	83.1	109.2	120.3	66.7	92.9	71.5	31.2	26.1	48.1	69.1	69.1	263.7	34.5	35.4	154.5	484.7	8.9	33.0	56.3	26.6	95.9	65.2	37.0	168.4	53.7	107.6	140.4	56.9	99.6	35.8	89.9	56.8	40.2	32.3	94.1	94.3	155.9	90.6	101.6	114.8	98.8	55.7	7.8	30.3	49.6	92.4	130.1	52.1	30.2	40.1	105.2	68.8	136.2	64.6	52.3	76.2	68.8	52.1	76.1	30.5	171.9	56.4	55.4	33.0	38.4	62.9	82.8	54.1	53.8	98.9	64.1	36.0	100.1	134.2	110.7	34.2	147.1	164.0	52.5	157.0	65.0	65.2	51.3	85.1	54.0	60.6	87.3	55.8	123.3	55.2	61.5	43.6	66.8	64.8	115.1	63.3	67.6	46.1	68.0	20.4	104.8	164.4	30.3	71.8	193.0	53.9	32.4	37.8	34.4	68.4	64.8	131.5	131.7	18.1	120.7	39.4	7.8	30.3	3.9	42.7	27.4	72.8	98.8	83.0	60.9	55.7	80.2	92.4	78.5	3.1	49.6	20.2	50.6	61.4	130.1	43.4	32.2	20.9	37.7	31.2	26.1	34.5	35.4	26.6	32.3	1375.7	2198.7	12042.6	13399.3	18243.0	341.9	558.4	4063.7	1350.4	3447.5	1746.4	217.9	7435.2	4327.1	3565.1	899.4	6848.9	2783.6	2266.0	11029.6	11450.2	6671.8	8883.4	2873.3	3644.3	5551.7	151.0	2974.8	4982.4	5437.2	2221.6	9162.8	7322.1	8013.6	5403.2	6713.5	580.3	7620.3	4990.4	3813.6	4409.9	516.0	1972.6	5953.7	913.9	1583.7	27922.0	7341.1	7120.5	12043.3	13812.9
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277132-33284832	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;SCLC-21H: 3.2;SK-BR-3: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA					"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	7.0	6.9	3.0	9.8	4.0	3.0	6.7	5.3	6.3	7.6	9.0	6.2	13.1	8.0	6.2	7.0	14.0	6.1	9.4	5.7	3.6	3.4	7.1	1.7	6.7	11.9	3.7	3.0	3.1	3.1	5.3	4.4	7.4	4.0	6.5	4.9	6.7	9.1	15.9	2.7	10.9	12.5	4.3	4.6	11.1	7.7	19.0	2.5	14.7	5.6	5.3	9.8	8.6	7.9	7.3	4.1	12.4	8.4	6.3	9.5	5.2	0.0	0.3	0.6	0.2	0.9	1.6	0.8	0.3	0.4	0.0	0.1	0.0	5.1	0.0	0.0	0.7	1.2	2.6	0.0	0.2	0.0	2.8	0.3	0.9	0.4	0.0	1.0	0.0	2.7	2.1	1.3	0.1	0.1	0.0	0.7	2.4	0.0	0.3	0.0	0.1	1.3	1.2	0.2	1.9	0.3	0.2	0.0	0.0	0.0	0.8	3.2	0.4	0.1	5.2	0.4	0.6	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.7	12.4	6.9	10.0	9.5	6.7	7.4	6.0	5.9	8.0	4.1	7.3	5.7	5.1	7.3	6.3	8.4	3.3	6.3	5.2	3.0	4.0	5.3	6.3	3.6	3.4	3.7	3.0	4.0	2.5	11.9	4.5	10.4	5.9	2.9	13.7	3.3	17.8	14.7	7.9	14.0	3.9	15.4	5.0	12.9	25.9	9.8	29.5	0.0	16.5	9.9	5.2	9.6	10.3	0.5	18.3	11.1	12.1	11.1	23.0	54.2	7.2	12.7	8.5	30.7	15.3	11.8	14.7	25.9	5.6	5.3	13.9	6.5	3.8	28.9	3.0	4.3	26.8	14.9	10.1	14.6
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289527	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"BEWO: 15.6;GAMG: 26.8;HMC-1: 15.5;U-698: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043004	Uncertain					NA	NA					"HPA043004: AB_10967417"	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	10.5	12.5	9.9	10.8	9.6	13.0	10.6	6.3	9.5	19.2	13.7	5.8	10.6	24.9	14.6	50.6	11.0	10.2	11.8	7.9	6.3	5.4	15.7	16.9	8.4	5.8	7.0	8.3	14.1	19.3	3.5	11.9	10.4	7.0	9.8	23.1	6.0	10.9	11.8	14.2	13.3	8.2	13.3	4.3	13.2	9.3	15.2	7.8	9.4	10.6	12.3	38.1	14.9	10.8	3.3	7.9	4.3	15.4	6.1	6.5	4.4	0.0	0.0	0.0	0.3	0.0	0.0	15.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	34.0	0.0	0.1	0.0	4.3	4.7	2.1	5.7	9.6	4.1	3.3	4.4	6.5	7.9	3.0	3.7	5.9	0.0	6.1	15.4	2.4	2.9	4.4	9.9	9.6	6.3	9.5	6.3	5.4	7.0	8.3	7.0	7.8	0.0	13.2	30.8	24.9	38.8	14.8	6.1	17.8	5.3	12.5	22.7	5.9	35.5	10.0	31.6	54.9	21.6	14.7	0.0	37.1	40.5	28.6	17.3	21.8	23.8	25.9	12.7	13.3	16.0	16.8	14.7	23.9	22.7	16.9	27.1	15.5	15.8	29.4	13.5	21.5	33.5	8.7	12.9	29.5	38.1	33.8	37.3	31.9	27.7	22.8	28.5
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		110000	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	12.5	19.1	29.2	15.4	27.8	15.0	15.6	13.2	33.9	12.0	17.7	12.9	13.1	13.8	14.4	22.4	15.1	12.5	11.4	16.2	31.6	24.8	19.1	23.2	10.8	15.7	27.0	31.9	14.5	21.3	15.3	14.6	14.0	20.7	12.5	16.2	8.2	15.8	16.0	43.6	10.8	13.7	13.4	20.7	11.3	12.2	33.1	17.5	10.7	12.2	22.5	18.9	11.8	9.8	6.8	5.0	3.4	7.1	3.9	7.5	4.3	15.0	10.1	7.0	14.5	7.9	6.7	11.5	11.6	5.9	10.1	9.7	9.5	7.5	22.2	14.1	6.5	19.4	11.0	11.5	13.3	15.3	14.9	12.2	19.9	11.2	15.8	8.8	15.2	13.0	6.0	15.3	14.3	10.2	8.0	9.9	13.1	24.2	9.6	10.9	10.3	18.2	16.1	11.7	10.0	8.8	15.7	10.3	22.4	16.4	7.2	16.3	19.7	10.1	26.4	16.7	7.4	15.2	22.0	8.3	7.2	10.7	8.9	19.1	19.3	52.6	24.8	7.0	20.2	10.3	3.2	5.1	3.4	4.1	6.5	4.2	5.9	5.6	7.5	4.9	6.8	3.3	4.6	2.7	3.9	7.1	5.0	5.3	4.3	29.2	27.8	13.2	33.9	31.6	24.8	27.0	31.9	20.7	17.5	23.8	8.3	51.5	39.3	49.5	21.5	17.7	71.4	17.4	17.0	52.4	9.8	107.5	102.8	74.2	74.3	28.8	70.3	0.0	89.2	103.2	41.2	43.0	62.1	64.4	70.1	17.5	48.4	19.0	26.8	30.2	57.2	47.3	67.4	83.0	47.0	38.4	78.6	71.9	46.3	154.1	21.2	38.8	32.0	200.4	54.7	55.8	92.7	37.6	54.6	43.9
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33299324	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	12.1	9.2	6.7	10.0	8.4	4.5	6.8	9.4	8.4	8.6	7.0	7.1	15.3	6.7	8.9	9.5	6.5	8.3	9.9	9.1	7.2	3.2	7.5	4.2	9.9	7.2	7.5	4.8	10.7	6.6	4.9	17.1	7.7	8.6	7.5	4.2	7.5	6.8	13.3	19.9	4.6	6.6	6.3	4.9	19.0	7.1	6.4	6.6	4.6	12.8	4.5	6.8	7.5	10.7	0.5	0.7	4.2	0.9	0.7	0.4	0.8	3.6	1.0	4.1	2.1	0.6	0.4	2.0	1.7	1.0	0.5	0.7	0.5	0.9	1.2	6.1	0.3	2.0	0.8	0.8	0.5	0.3	3.0	2.1	2.5	1.0	0.9	0.5	1.8	3.9	0.8	0.5	1.6	0.3	2.6	1.1	1.5	3.1	0.9	0.3	0.7	1.2	2.6	0.1	0.5	1.8	1.2	2.3	1.3	0.8	0.7	3.5	3.4	1.2	2.2	5.2	1.1	1.8	2.1	3.2	2.0	2.9	1.3	4.6	5.1	2.9	3.2	0.6	1.3	3.5	1.6	0.8	2.0	0.4	0.9	0.4	0.5	0.3	0.4	0.7	0.5	0.2	0.3	4.2	0.7	0.2	0.0	0.3	0.8	6.7	8.4	9.4	8.4	7.2	3.2	7.5	4.8	8.6	6.6	14.9	40.4	15.9	31.8	25.2	27.7	22.9	12.7	21.4	30.7	21.0	21.6	22.8	11.6	19.0	3.9	54.2	6.1	0.0	12.7	34.3	17.5	39.0	10.5	10.4	26.5	30.2	27.4	61.4	25.6	10.3	15.5	20.5	16.9	10.8	10.4	20.9	17.4	22.9	13.8	9.7	29.6	25.8	21.7	27.8	16.2	21.2	85.5	20.8	8.3	35.6
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007066	Approved					NA	NA		1100000			"HPA007066: AB_1857769"	"prognostic favorable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	31.8	24.5	10.5	28.0	12.4	19.3	14.1	13.2	13.6	15.8	41.3	10.1	17.1	44.2	13.2	21.2	23.8	15.0	22.4	22.4	10.5	8.5	26.7	48.7	34.8	20.9	8.9	8.3	17.9	16.5	27.3	13.6	28.8	9.2	21.8	11.0	13.9	20.9	16.6	18.5	16.2	46.6	20.6	7.4	46.8	23.2	10.0	8.6	55.2	40.2	17.8	34.6	19.6	13.8	15.7	15.7	26.9	23.6	25.1	24.0	29.1	0.8	0.5	1.7	3.5	3.8	4.8	17.1	8.1	19.9	10.1	12.0	0.0	30.8	7.0	8.4	11.3	21.7	0.8	0.0	6.8	2.0	18.9	2.3	6.1	3.8	4.8	0.0	7.7	9.9	12.2	5.8	0.2	1.5	8.4	0.1	4.1	0.5	19.0	2.0	3.1	6.9	5.9	0.0	0.0	2.1	1.0	0.1	0.5	3.6	0.4	3.0	0.2	0.2	0.7	3.0	0.7	0.5	0.1	14.0	17.4	4.1	0.5	0.6	23.3	15.8	8.9	11.9	7.8	11.9	21.4	14.0	26.9	24.0	15.7	22.5	15.7	18.1	22.6	15.7	10.1	12.7	16.1	22.2	25.1	23.6	14.9	12.5	29.1	10.5	12.4	13.2	13.6	10.5	8.5	8.9	8.3	9.2	8.6	116.1	102.8	162.9	75.3	68.5	32.2	67.4	107.0	56.2	66.0	68.0	31.4	37.9	11.6	213.0	1.6	83.6	237.4	0.0	245.8	64.2	53.4	99.7	90.0	127.8	112.8	19.1	81.2	66.3	105.9	6.8	30.8	113.3	113.1	275.9	144.3	34.6	201.2	164.1	30.1	28.3	28.6	32.3	48.6	0.5	0.6	49.2	41.1	131.1	100.3	112.9
ZBTB22	"BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A"	ENSG00000236104	"Zinc finger and BTB domain containing 22"	O15209	6	33314406-33317942	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA043848			Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA043848: AB_10961146"	"unprognostic (1.32e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.54e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.32e-3)"	7.0	15.4	9.5	5.7	11.0	4.9	8.3	9.0	18.1	11.0	8.0	9.4	6.4	12.0	12.5	20.9	11.6	9.9	11.0	10.1	11.6	7.2	8.8	6.8	10.6	12.4	7.4	14.9	14.8	20.3	37.6	8.2	15.9	8.7	9.2	9.7	8.8	8.8	11.3	7.8	13.1	10.1	11.0	7.7	10.7	8.5	7.5	6.4	7.2	14.9	3.0	8.9	9.9	9.7	1.8	1.8	3.3	1.7	0.6	3.2	0.8	0.2	0.3	7.2	3.7	7.2	3.8	4.3	5.4	8.8	7.2	6.3	0.1	3.3	2.0	4.1	11.7	9.5	0.5	0.3	3.9	4.5	7.3	4.4	6.3	5.6	2.4	0.0	2.0	3.0	12.7	12.9	0.2	3.3	8.4	0.6	5.3	1.3	8.2	3.1	4.6	3.7	6.5	0.0	0.3	1.5	0.4	0.0	4.5	5.3	0.3	7.9	0.4	0.6	0.3	3.3	4.5	0.6	0.3	10.4	3.5	4.8	0.1	0.1	3.5	3.8	2.2	5.7	1.9	5.0	2.0	0.8	3.3	1.3	1.7	0.4	1.8	1.6	1.0	1.1	1.6	3.2	0.8	1.5	0.6	0.7	1.8	0.4	0.8	9.5	11.0	9.0	18.1	11.6	7.2	7.4	14.9	8.7	6.4	0.0	5.3	3.7	13.4	5.7	18.8	3.8	2.5	0.0	2.3	7.0	7.9	5.7	19.9	9.1	0.9	6.7	5.4	0.0	6.3	3.7	6.2	8.5	3.5	1.6	4.7	19.1	7.5	5.5	5.4	1.1	8.6	4.6	1.7	16.2	7.8	14.7	5.6	7.0	6.0	6.2	17.6	12.9	5.0	1.4	1.3	6.5	8.5	6.9	5.9	11.6
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	10.4	14.3	10.7	13.5	11.9	8.8	10.8	11.3	14.8	11.8	12.2	9.4	7.3	11.2	13.2	43.7	13.5	12.6	12.1	9.1	9.7	7.3	9.2	12.0	10.3	18.3	10.2	8.5	13.8	18.6	24.4	10.4	11.6	11.6	13.0	14.1	7.3	10.7	15.2	14.8	11.6	12.7	15.5	8.1	20.4	10.5	20.2	11.5	25.0	16.1	6.8	30.9	11.5	10.9	17.0	5.9	12.6	11.2	15.3	18.2	21.8	2.1	0.0	7.1	2.8	1.2	2.3	4.7	7.0	22.9	17.9	13.2	0.8	2.4	6.9	2.5	5.4	20.5	1.3	0.1	5.7	16.6	8.2	15.6	9.0	12.4	11.1	3.9	9.6	2.6	6.0	8.5	2.0	5.3	5.3	0.5	4.5	5.0	4.5	5.5	5.2	3.8	21.3	0.4	0.1	3.3	5.9	0.1	7.7	1.4	0.7	8.5	2.2	0.0	0.4	3.7	3.5	2.2	0.2	5.9	4.4	5.6	0.2	0.1	7.8	16.2	14.9	3.3	4.4	4.7	7.8	7.5	12.6	16.3	8.0	18.2	16.6	15.4	15.8	5.9	17.0	13.9	14.1	7.4	15.3	11.2	5.9	17.1	21.8	10.7	11.9	11.3	14.8	9.7	7.3	10.2	8.5	11.6	11.5	6.0	21.4	27.0	17.6	52.0	17.3	7.5	15.3	14.7	25.0	12.2	17.7	21.7	19.9	29.4	9.8	20.6	18.0	0.0	33.3	29.5	26.3	21.9	35.9	13.5	21.9	14.3	20.2	11.6	13.7	4.7	16.4	20.8	23.6	60.5	19.5	17.7	46.9	21.0	21.9	11.9	73.3	12.9	23.7	48.8	34.9	53.2	20.7	51.7	20.9	30.2
AL662820.1		ENSG00000285064			6	33321386-33329286	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	10	"retina: 26.6"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;neutrophil: 2.4"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;granulocytes: 2.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"U-266/84: 1.6;U-698: 3.2;U-937: 1.6"															NA	NA																							0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.5	0.0	2.4	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	2.5	0.3	1.6	2.4	0.5	0.0	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 21.5;Erythroid cells: 70.0;Extravillous trophoblasts: 32.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.7	1.8	10.3	10.9	0.2	0.4	6.3	7.8	2.0	6.2	5.2	3.8	4.8	7.1	3.0	1.6	8.2	5.8	2.6	3.6	6.8	4.2	5.9	5.7	8.7	5.5	0.0	4.7	6.4	0.0	0.9	5.1	1.5	0.7	0.6	5.2	1.7	17.6	4.6	2.7	2.8	9.4	4.7	3.0	2.2	7.1	5.8	2.4	0.9	2.4	9.4	4.2	2.8	6.0	1.5	4.1	6.3	4.9	1.4	3.3	10.1	5.4	11.6	5.8	11.0	6.9	0.0	7.0	5.8	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2	0.0	4.5	5.2	0.7	4.9	0.4	0.4	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.6	21.5	1.4	2.9	70.0	0.0	32.5	2.9	0.8	1.1	0.0	11.9	0.0	0.0	2.5	2.5	9.8	0.3	4.9	3.3	5.4	3.4	0.2	0.2	2.8	0.7	0.0	0.5	0.0	1.0	11.2	6.9	3.1	5.6	4.3	4.6	2.4
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	10.7	10.2	12.0	15.5	15.2	23.5	29.0	14.2	12.5	29.7	14.6	9.4	26.4	11.0	18.2	30.7	10.0	16.3	18.3	15.4	13.2	13.3	13.0	10.5	19.7	16.7	16.9	12.0	31.5	24.9	21.1	26.6	7.7	14.6	16.9	6.2	14.6	17.6	28.5	12.9	7.7	12.1	18.9	12.3	18.8	12.7	26.7	12.8	5.0	22.4	9.3	21.3	20.7	29.2	1.5	0.5	3.2	0.4	1.1	4.6	0.9	1.5	2.1	4.8	3.1	2.1	1.2	9.6	3.3	5.2	2.5	2.8	2.9	1.4	0.6	2.0	7.8	16.8	0.5	1.0	1.7	0.6	1.9	1.0	4.5	3.5	1.3	0.4	2.6	11.2	2.5	2.2	4.9	4.4	3.7	1.6	1.6	1.7	3.9	2.0	1.2	0.8	1.6	1.7	0.4	1.5	1.9	0.6	1.6	0.3	2.0	3.2	3.4	1.7	1.8	2.7	0.9	1.3	3.2	3.1	5.0	1.4	2.9	3.5	2.6	4.3	5.2	3.6	2.8	2.9	0.2	0.3	0.7	1.4	0.4	4.6	1.2	2.8	3.5	0.5	1.5	3.3	1.7	3.2	1.1	0.4	0.3	0.9	0.9	12.0	15.2	14.2	12.5	13.2	13.3	16.9	12.0	14.6	12.8	17.9	22.7	25.1	75.0	30.1	69.3	17.0	2.5	12.0	10.3	22.7	35.3	14.3	29.9	11.6	144.2	27.0	13.3	0.0	15.8	11.3	18.6	51.5	69.1	6.2	10.6	42.9	11.5	27.6	8.6	57.2	40.0	15.1	35.4	13.6	13.8	32.4	13.9	11.2	38.5	20.3	62.8	77.6	51.5	61.1	42.1	21.0	31.4	46.8	9.6	66.3
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		35000000	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	26.6	65.6	47.9	28.3	60.1	33.5	47.6	37.7	73.7	47.7	37.9	36.8	53.9	42.1	40.1	78.5	30.5	46.0	48.8	49.6	45.2	44.9	46.3	61.6	39.0	77.4	46.5	37.8	57.7	66.6	43.8	86.1	45.7	39.8	38.8	28.9	34.2	74.3	69.7	34.6	32.7	37.2	32.4	47.0	36.0	38.7	27.3	31.6	52.2	69.7	30.3	31.3	42.6	28.9	56.5	31.4	27.1	32.0	49.9	69.8	60.8	43.8	26.3	42.1	53.3	31.7	31.2	20.4	40.1	75.1	77.6	82.7	26.2	27.4	31.0	31.2	45.9	56.4	26.8	27.3	40.8	43.8	26.2	60.5	32.3	43.6	68.6	41.3	25.1	24.6	41.3	34.5	37.3	31.5	54.0	20.8	32.9	39.6	63.1	56.7	34.1	38.0	53.5	37.7	38.0	34.7	41.8	25.1	81.9	53.4	19.1	82.4	42.0	24.0	41.8	72.8	25.2	30.7	52.8	22.9	42.0	35.7	29.8	41.8	62.0	61.6	33.9	36.3	55.6	34.1	27.1	32.0	16.5	45.7	22.9	63.2	56.5	67.6	52.7	31.4	44.2	68.5	53.2	4.6	49.9	16.8	27.1	69.8	60.8	47.9	60.1	37.7	73.7	45.2	44.9	46.5	37.8	39.8	31.6	122.1	105.5	178.5	242.5	204.8	84.5	113.4	239.5	131.2	121.7	300.1	64.8	309.8	240.4	162.1	64.8	93.9	157.7	23.3	122.9	203.5	204.8	237.5	167.3	299.7	277.3	73.1	280.4	131.3	162.9	285.6	185.2	150.2	300.3	80.2	266.0	150.8	114.3	196.4	180.0	440.5	69.0	90.5	220.1	100.6	65.6	201.4	203.1	245.2	291.8	203.9
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33457541	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 21.8;Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;HMC-1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	4.5	5.0	29.7	11.9	28.6	6.2	4.3	27.2	33.7	7.8	5.9	5.5	2.4	6.0	13.0	5.3	4.2	11.9	6.1	4.4	37.9	7.6	4.0	2.2	5.9	10.3	4.1	38.9	12.8	3.5	10.0	26.1	6.2	7.9	6.3	4.7	3.2	3.7	7.1	2.3	6.2	5.7	11.1	8.7	9.7	4.9	8.7	9.3	8.9	5.6	0.2	7.0	6.9	6.4	1.5	0.1	0.1	0.2	0.0	1.9	0.0	2.0	0.9	20.9	7.7	4.4	4.5	2.7	5.1	3.2	2.8	2.2	8.7	0.9	5.9	1.3	2.4	2.6	3.0	2.6	2.9	2.0	3.4	1.7	14.7	2.3	0.5	2.9	2.2	17.2	3.1	0.9	5.3	2.5	10.8	2.1	4.9	4.6	2.7	2.1	4.4	3.5	3.4	10.5	0.9	2.2	13.8	0.5	2.4	2.1	1.5	5.1	4.1	1.9	3.6	1.6	4.9	7.9	2.1	0.6	6.0	5.9	2.4	0.9	3.2	1.1	4.3	3.4	2.6	1.4	0.0	0.2	0.1	0.3	0.0	0.8	0.1	1.9	0.9	0.0	1.5	0.9	0.2	0.1	0.0	0.1	0.1	0.1	0.0	29.7	28.6	27.2	33.7	37.9	7.6	4.1	38.9	7.9	9.3	0.0	1.3	2.2	1.7	3.2	21.8	1.4	7.6	9.4	4.5	3.5	9.8	0.8	1.7	1.6	4.4	6.2	1.3	0.0	1.2	1.0	8.9	1.5	4.7	0.8	1.6	36.5	9.2	8.6	3.7	1.1	10.6	2.5	3.3	2.8	1.7	5.6	1.7	0.0	12.7	1.9	7.4	19.4	7.8	7.1	6.7	3.8	0.7	12.2	2.8	1.4
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457548	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Suprabasal keratinocytes: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.3;GAMG: 15.7;U-698: 11.6"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	4.5	7.1	5.5	5.4	5.9	4.4	3.3	4.9	7.4	5.4	4.4	6.4	2.4	6.6	4.5	8.7	5.4	4.8	4.2	4.4	5.9	5.1	7.7	5.4	3.7	6.6	4.4	4.5	10.6	11.3	8.5	17.3	4.5	4.2	5.9	7.1	4.6	6.3	3.9	5.7	5.0	3.9	3.8	3.5	5.4	3.7	12.7	3.8	9.7	6.8	4.0	13.7	7.8	4.3	0.8	2.6	8.5	2.2	1.9	4.3	1.0	0.1	0.1	4.6	0.7	2.3	0.1	10.3	0.1	0.2	0.0	0.0	1.6	0.0	1.6	1.5	0.1	15.7	0.0	4.4	1.8	0.6	1.8	0.0	6.1	0.0	0.0	0.0	2.3	6.0	0.2	0.2	2.7	2.7	0.0	0.0	0.3	2.5	0.5	2.0	0.5	0.4	0.0	2.9	0.2	0.4	3.0	2.8	2.0	2.4	2.1	0.5	0.3	3.0	0.1	1.0	0.2	0.5	0.4	1.5	0.3	0.1	0.9	1.1	0.0	1.7	11.6	0.2	1.9	0.0	8.5	1.5	0.5	3.9	1.5	1.9	0.3	1.9	4.3	2.6	0.8	3.6	3.2	1.4	1.9	2.2	0.3	3.2	1.0	5.5	5.9	4.9	7.4	5.9	5.1	4.4	4.5	4.2	3.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	3.1	0.0	0.0	0.7	0.0
BAK1	"BAK, BCL2L7, CDN1"	ENSG00000030110	"BCL2 antagonist/killer 1"	Q16611	6	33572547-33580293	"Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005029	Enhanced					NA	NA					"CAB005029: AB_562051"	"unprognostic (3.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.67e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (4.52e-4)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (6.07e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	8.9	19.8	6.5	14.5	9.3	15.6	5.2	6.7	10.4	7.0	21.2	8.7	6.2	30.9	7.6	7.1	22.1	6.1	14.0	13.8	6.0	5.0	12.7	8.2	9.6	13.0	6.0	7.2	7.1	9.6	6.2	8.7	9.8	7.7	7.9	16.9	8.1	13.1	6.4	10.9	12.6	29.1	8.9	6.2	21.8	14.0	6.0	7.0	15.4	6.8	9.6	18.2	12.2	7.9	12.1	18.8	35.6	27.9	9.2	24.4	20.3	14.7	8.2	8.7	13.1	5.9	5.9	11.1	7.7	6.2	22.1	17.4	16.8	11.6	12.9	13.5	11.2	10.2	15.5	16.6	31.2	9.8	14.7	17.7	8.1	7.7	13.5	15.4	17.4	13.3	9.6	25.0	18.5	21.8	6.4	12.0	11.6	7.3	11.7	8.1	21.6	15.0	11.6	9.7	10.4	20.3	14.6	8.4	23.6	18.7	12.2	10.8	8.1	9.8	31.7	14.6	11.5	10.4	29.6	11.3	11.8	12.5	7.6	9.8	31.1	38.3	10.9	4.0	20.9	12.9	23.8	19.8	35.6	16.3	27.9	18.6	12.1	15.3	16.3	18.8	8.4	8.6	11.2	13.7	9.2	23.4	6.5	24.4	20.3	6.5	9.3	6.7	10.4	6.0	5.0	6.0	7.2	7.7	7.0	3.0	4.3	29.8	10.0	24.2	6.7	5.5	7.6	1.4	2.3	3.5	7.9	12.3	11.6	18.4	4.0	8.4	69.5	0.0	16.4	29.8	11.0	6.4	11.5	2.9	28.0	4.8	21.2	11.6	19.1	1.3	7.2	17.0	20.3	33.3	25.6	5.5	23.0	49.1	11.0	7.6	5.9	12.9	12.2	0.3	0.9	18.9	8.2	27.4	31.9	13.3
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 129.4;Late spermatids: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 52.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	No			Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	7.8	6.0	2.0	17.8	2.4	2.6	9.0	1.7	2.3	6.5	39.6	1.0	35.1	14.8	7.7	15.6	10.0	6.7	28.9	7.2	1.8	1.4	8.6	1.2	21.0	9.7	4.4	1.2	7.3	11.0	1.3	3.9	3.9	4.0	7.2	9.5	5.4	12.7	26.0	2.7	27.9	44.0	6.6	3.5	20.0	21.4	20.1	1.9	10.6	28.4	9.7	18.1	5.2	16.5	2.0	0.2	1.8	0.0	0.1	2.8	0.7	21.8	10.3	1.9	0.1	1.9	6.2	12.8	7.5	19.4	9.5	8.6	14.1	17.1	18.7	8.2	5.4	23.9	21.7	8.8	20.4	4.9	10.9	7.3	0.0	29.3	15.5	4.5	3.3	2.4	4.4	18.5	23.9	52.0	20.9	16.0	7.5	7.3	6.1	10.2	10.4	5.6	1.9	1.9	16.7	15.2	8.6	0.0	11.0	33.8	15.4	17.9	0.6	13.0	19.1	18.7	2.2	6.5	1.8	21.8	12.9	6.4	16.5	16.5	4.2	4.1	8.9	10.3	5.0	7.4	1.8	0.0	0.0	2.8	0.0	2.1	1.5	1.7	2.0	0.2	2.0	1.4	1.7	0.0	0.1	0.0	0.0	2.4	0.7	2.0	2.4	1.7	2.3	1.8	1.4	4.4	1.2	4.0	1.9	44.7	47.5	4.3	10.4	23.6	0.6	1.6	7.6	8.1	18.2	29.6	0.0	0.2	0.0	25.3	129.4	13.2	36.8	0.0	26.2	5.4	5.0	12.7	0.0	0.2	0.5	0.0	23.0	15.4	0.6	168.6	21.6	3.3	11.8	4.6	35.8	0.2	62.5	35.1	13.1	0.0	1.2	6.5	2.0	1.1	3.0	22.2	0.5	10.0	30.7	15.4
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 791.0;Late spermatids: 864.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA039111: AB_2676352"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	13.4	22.9	26.1	13.3	31.4	14.6	17.7	15.0	22.9	12.4	15.8	12.0	12.3	12.8	17.4	23.4	15.2	10.9	9.2	71.0	19.2	23.0	18.3	23.4	8.9	12.3	22.8	22.6	11.5	25.3	7.9	24.5	14.4	20.6	15.7	17.2	18.9	19.6	14.3	76.4	12.2	10.4	20.0	20.0	12.9	15.9	30.9	18.3	12.3	19.0	22.0	14.9	10.9	11.0	39.7	38.9	7.2	39.6	21.9	31.5	34.8	42.7	30.8	34.5	29.9	28.7	28.9	27.2	24.4	24.5	34.0	33.7	49.4	18.1	17.2	39.5	29.4	52.4	23.1	23.4	34.1	30.3	21.9	38.5	33.7	20.4	68.3	47.1	31.4	27.6	29.5	55.0	27.3	44.2	19.7	25.3	33.2	35.9	35.7	39.9	46.0	30.4	65.3	20.9	32.8	35.1	22.0	28.3	58.3	24.1	40.7	59.4	21.1	26.9	41.3	33.7	19.1	36.2	80.0	23.4	39.1	33.2	25.2	50.2	27.5	38.2	29.1	11.8	47.6	45.1	7.2	27.0	5.2	24.0	39.6	29.1	39.7	30.3	27.4	31.9	32.8	31.5	28.4	2.6	21.9	32.7	38.9	31.1	34.8	26.1	31.4	15.0	22.9	19.2	23.0	22.8	22.6	20.6	18.3	26.8	27.7	65.4	71.0	52.0	115.5	791.0	94.3	38.8	39.8	73.3	47.1	122.2	331.5	87.4	273.9	53.4	58.0	93.5	155.9	94.8	61.5	91.6	57.8	134.7	186.1	66.7	95.6	51.5	60.7	864.2	72.8	62.9	79.2	67.7	57.9	48.7	112.6	54.0	78.8	214.9	98.9	0.0	58.5	99.8	96.6	66.7	79.8	40.6	79.2	104.5
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.2	0.2	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	5.8	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2	0.0	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	5.8	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.1	6.5	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1
LEMD2	"dJ482C21.1, NET25"	ENSG00000161904	"LEM domain containing 2"	Q8NC56	6	33771202-33789136	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	18.7	24.1	23.9	22.9	30.4	37.8	23.5	49.0	26.0	25.2	22.0	31.1	17.9	21.8	24.3	28.7	23.6	22.3	20.7	19.6	24.0	18.3	22.5	22.8	23.9	28.3	32.2	17.3	28.1	26.9	31.6	28.5	29.2	25.5	24.9	21.2	28.9	23.5	24.1	17.1	34.9	25.8	25.9	21.8	34.4	21.0	20.0	27.7	18.7	28.0	15.6	27.8	18.3	27.2	5.4	6.9	6.8	4.5	3.0	7.2	2.5	12.7	14.7	25.0	24.2	14.3	15.5	18.8	14.0	21.9	18.1	19.2	11.1	13.8	12.0	19.8	20.1	51.0	22.4	14.5	18.9	12.8	12.5	13.4	4.5	14.8	14.4	30.0	9.0	15.8	16.7	36.1	19.2	33.1	30.0	19.3	16.0	12.6	14.1	15.7	10.9	16.9	22.7	14.3	19.2	8.5	11.1	10.3	10.0	19.3	18.3	17.8	14.2	8.4	26.9	18.2	26.5	18.2	25.2	8.9	25.4	9.9	13.5	16.4	18.3	14.5	8.5	10.0	14.5	30.3	3.8	4.1	6.8	5.9	3.7	7.2	5.2	6.3	5.6	3.9	5.4	5.0	6.0	3.3	3.0	4.5	6.9	6.3	2.5	23.9	30.4	49.0	26.0	24.0	18.3	32.2	17.3	25.5	27.7	3.0	7.0	8.2	11.4	9.6	17.6	9.0	5.1	2.7	2.3	8.7	17.7	22.1	1.7	7.6	19.6	15.7	15.2	23.3	5.8	29.7	12.2	11.1	12.7	6.8	15.3	41.3	5.2	12.3	13.2	30.2	9.8	11.5	11.8	5.4	16.0	14.5	11.1	17.5	15.2	6.0	12.3	19.4	15.9	17.6	7.2	8.9	24.9	11.7	14.3	11.0
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	175	"intestine: 76.0"	"Cell type enriched"	"Detected in single"	34	"Intestinal endocrine cells: 3.4"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.3;RPMI-8226: 1.7;SuSa: 3.1;TIME: 3.4"					"Not detected"	"Not detected"			HPA069392	Enhanced				"Secreted to blood"	NA	NA	450000				"HPA069392: AB_2686136"					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	58.4	0.0	0.0	76.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	30.6	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	3.1	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018645-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"brain: 101.6"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 1.8;Early spermatids: 3.4;Intestinal endocrine cells: 2.9;Late spermatids: 1.5;Spermatogonia: 4.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in many"	21	"cerebellum: 101.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 6.5;SCLC-21H: 26.0"	"Region enhanced"	"Detected in all"		"cerebellum: 83.5"	"Region enriched"	"Detected in all"	4	"cerebellum: 252.6"	CAB022096	Enhanced					NA	NA					"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.2	0.1	0.4	0.3	4.9	0.2	0.2	101.6	7.2	0.6	0.1	0.3	0.1	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.5	0.9	0.2	0.3	0.3	0.2	0.3	0.4	0.2	3.5	0.1	0.0	0.3	4.3	0.3	0.2	0.1	0.1	0.2	0.3	0.6	0.8	0.7	1.1	0.1	0.2	1.6	0.5	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.9	101.6	1.0	0.5	0.9	0.3	0.4	4.3	0.5	0.0	0.0	0.0	0.3	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	4.0	0.0	0.1	0.0	0.0	0.1
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA		18000	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	121.6	48.2	24.7	17.2	11.5	85.4	108.0	49.2	56.3	38.2	21.3	31.5	85.4	57.4	24.8	20.1	24.0	26.1	29.1	87.7	30.4	12.5	19.5	17.6	16.2	42.1	24.4	62.8	20.3	36.6	9.8	69.1	36.1	98.7	115.2	32.8	70.8	2.9	53.1	12.3	54.4	77.4	120.4	60.7	81.6	80.9	0.5	63.3	25.8	11.2	43.2	18.3	5.2	25.0	45.4	40.8	10.0	67.4	99.8	19.9	62.8	28.9	46.0	23.6	36.5	74.1	42.1	26.2	99.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2	26.8	23.7	124.5	686.8	384.1	27.4	24.5	38.2	10.7	36.4	38.4	3.9	784.6	39.7	243.5	6.1	27.0	148.7	46.7	242.2	663.0	71.9	750.7	66.8	10.6	337.7	11.1	112.2	16.0	59.4	17.5	5.2	107.5	86.0	66.7	165.5	27.9	1097.2	162.4	2.5	9.0	27.8	0.0	34.9	38.5	398.0	315.9	688.1	51.7	282.8	1250.0
SMIM29	"C6orf1, LBH, MGC57858"	ENSG00000186577	"Small integral membrane protein 29"	Q86T20	6	34246380-34249470	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 67.8"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 61.3;Ductal cells: 41.8;Hofbauer cells: 88.6;monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA037659, HPA037660"	Uncertain					NA	NA					"HPA037659: AB_2675591, HPA037660: AB_10671881"	"unprognostic (2.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (7.98e-4)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.66e-1)"	9.6	18.5	42.0	10.4	21.8	9.9	12.4	14.8	36.8	10.5	7.6	15.2	4.6	7.1	9.1	24.4	13.3	11.5	12.3	19.0	34.6	34.4	7.9	6.0	13.3	13.5	35.7	16.5	8.8	10.7	7.0	12.2	10.0	25.7	9.7	4.8	12.5	7.5	13.6	7.8	29.2	6.7	8.3	23.9	15.2	9.4	5.2	14.0	5.8	15.2	8.3	11.0	16.0	9.3	22.4	10.4	67.8	15.0	9.8	15.8	11.0	8.9	9.9	2.0	11.7	24.7	20.6	2.0	9.2	19.5	8.5	10.4	2.4	3.4	5.0	7.4	8.2	16.1	5.5	3.7	8.8	2.5	12.9	6.4	3.7	2.5	6.8	13.7	4.4	23.3	11.2	8.4	12.0	12.8	10.8	13.6	3.8	4.8	25.0	19.3	5.7	4.6	8.0	0.7	10.9	7.3	1.6	1.3	7.7	10.2	11.5	9.5	4.5	0.9	6.6	24.0	1.7	4.8	5.2	10.0	19.4	5.3	22.4	7.7	15.9	22.4	1.6	11.4	8.7	28.3	15.3	15.0	67.8	15.8	10.7	10.3	22.4	12.6	13.5	10.4	21.8	8.7	12.5	38.7	9.8	7.6	8.8	15.3	11.0	42.0	21.8	14.8	36.8	34.6	34.4	35.7	16.5	25.7	14.0	8.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	12.5	29.6	0.0	30.4	61.3	41.8	0.0	0.0	0.0	0.0	20.4	10.4	0.0	0.0	11.6	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	77.5	0.0	0.0	25.6	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392674	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		110000	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	10.5	11.4	38.8	9.3	28.6	8.8	12.6	33.4	40.0	15.4	11.4	16.8	10.3	7.7	11.4	25.9	10.8	15.2	8.5	16.9	33.8	30.0	15.3	10.1	11.2	10.5	29.4	25.6	17.4	9.1	27.9	9.3	8.9	26.1	11.4	9.7	11.2	9.4	15.6	50.7	11.2	8.0	11.2	20.3	13.0	8.4	7.3	21.3	5.4	21.3	8.7	12.1	8.6	9.9	4.5	6.4	12.4	5.9	2.1	3.9	2.6	5.4	4.0	10.8	21.1	7.2	12.2	4.7	4.0	6.7	4.1	3.0	4.8	3.8	19.6	5.4	7.1	2.7	4.6	6.1	10.8	7.7	7.3	7.8	21.6	5.6	10.4	7.2	20.3	11.3	11.0	10.0	5.0	9.4	5.3	11.8	10.2	21.4	7.1	6.6	5.7	14.0	23.8	6.9	16.1	4.0	12.3	8.9	20.4	9.4	11.4	15.2	17.0	8.8	12.5	15.9	3.4	12.5	14.6	12.9	8.3	3.0	7.2	8.6	6.1	14.1	14.4	5.0	20.8	12.9	1.9	5.8	12.4	3.4	5.9	3.9	3.4	3.4	3.2	6.4	4.5	3.2	3.7	4.1	2.1	5.8	3.2	2.4	2.6	38.8	28.6	33.4	40.0	33.8	30.0	29.4	25.6	26.1	21.3	14.9	22.4	43.5	59.4	53.1	115.6	43.3	63.7	46.8	14.8	40.1	111.9	28.0	11.6	15.4	3.0	55.9	18.4	0.0	24.5	26.3	42.3	39.4	12.8	52.1	67.2	160.5	47.2	84.7	91.0	4.0	34.8	58.5	50.6	22.6	24.7	115.6	20.8	19.8	59.4	19.2	125.0	58.2	46.4	44.7	78.0	52.7	16.4	20.1	25.2	59.3
RPS10-NUDT3		ENSG00000270800	"RPS10-NUDT3 readthrough"		6	34284887-34426071	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 46.7;Ciliated cells: 21.4;Club cells: 35.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 21.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.2"	"Low cell line specificity"	"Detected in all"											"HPA047027, HPA047268, HPA048084, HPA055953"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.85e-2)"		"unprognostic (8.95e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.17e-8)"	"unprognostic (5.80e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.42e-1)"	14.5	10.9	28.0	24.9	21.7	35.6	12.1	9.9	25.4	22.6	23.0	7.3	16.4	9.5	26.2	17.7	29.9	10.0	12.2	20.8	23.7	23.2	13.4	21.1	16.3	31.8	25.2	4.3	33.2	58.4	5.3	7.6	18.8	5.7	22.5	7.7	9.4	44.6	12.4	49.4	6.4	12.9	18.0	17.2	23.0	14.4	23.4	6.0	18.9	26.4	27.9	22.0	22.0	29.9	3.7	4.7	21.2	4.8	2.9	2.3	2.1	9.6	2.9	8.1	14.4	6.0	4.1	8.4	6.7	3.4	5.1	5.3	3.2	4.5	9.3	13.0	4.2	12.1	6.2	11.1	3.5	6.4	7.6	4.9	16.6	6.0	10.2	1.2	15.9	21.2	1.6	7.3	7.3	15.3	7.0	5.0	10.3	16.2	12.6	6.3	8.4	18.1	9.2	4.5	18.7	1.7	10.1	6.8	5.3	5.0	10.4	12.6	4.1	4.7	5.3	17.7	5.1	7.9	33.5	3.9	7.7	12.7	3.9	10.2	6.7	9.2	15.2	1.0	9.6	12.6	6.9	3.9	21.2	2.1	4.8	2.1	3.7	2.3	2.0	4.7	3.5	2.3	1.9	3.1	2.9	4.1	3.3	2.2	2.1	28.0	21.7	9.9	25.4	23.7	23.2	25.2	4.3	5.7	6.0	32.8	46.7	0.0	0.1	0.7	0.0	0.0	0.0	21.4	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426125	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol		NA	NA		170000	Cytosol		"HPA047268: AB_2680007, HPA048084: AB_2680255"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	84.5	76.6	68.1	142.7	49.5	158.8	142.0	35.9	54.3	130.3	132.7	48.2	97.2	65.1	149.8	103.9	169.7	113.6	74.7	84.9	51.3	44.1	80.7	122.5	96.3	180.1	54.8	31.9	189.4	323.2	20.3	59.1	88.0	39.5	129.7	64.5	59.4	248.9	75.5	153.2	131.9	76.4	105.6	49.4	132.5	85.3	66.7	41.0	110.5	151.0	158.8	127.4	127.1	169.7	150.1	105.0	31.6	61.5	83.1	176.2	227.6	98.7	64.0	66.6	151.0	114.8	169.3	110.1	81.5	112.8	134.7	97.5	155.2	50.5	190.9	84.5	90.2	68.8	74.6	124.3	139.4	81.2	80.1	221.5	85.4	70.6	147.1	158.8	135.0	91.9	187.0	243.0	94.3	179.1	119.1	117.5	108.6	145.6	96.8	100.6	154.1	109.7	202.9	100.4	244.7	94.4	104.1	78.0	180.1	101.2	109.3	111.4	68.2	58.6	98.8	225.6	65.5	128.4	346.0	80.6	60.8	77.8	69.1	132.3	80.2	178.5	160.0	33.1	175.6	109.0	31.6	61.5	18.8	78.9	50.6	116.3	150.1	136.2	111.1	88.7	147.7	176.2	136.7	13.6	83.1	47.2	105.0	90.2	227.6	68.1	49.5	35.9	54.3	51.3	44.1	54.8	31.9	39.5	41.0	333.5	603.3	2152.2	474.9	1201.0	51.9	57.2	950.3	406.9	664.3	249.5	27.5	1272.5	507.3	1182.8	376.5	678.3	1089.4	654.1	2086.5	1615.5	676.8	419.9	573.0	927.7	904.0	49.3	1185.7	891.2	1556.1	890.1	786.1	881.2	600.6	1996.4	2188.6	195.4	1807.7	1595.7	444.1	950.3	80.4	258.7	675.6	285.7	224.9	1448.4	1216.1	1389.4	2844.5	431.7
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535231	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 81.7"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 70.2;Cone photoreceptor cells: 76.6;Horizontal cells: 65.2;Rod photoreceptor cells: 88.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 15.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 15.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 9.9;RPMI-8226: 11.5;T-47d: 18.3;U-266/84: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	1.5	2.1	42.5	2.4	33.8	2.0	1.4	29.3	81.7	1.5	1.7	2.1	0.0	1.8	1.9	1.5	1.4	2.0	1.7	4.7	32.8	21.9	1.6	1.4	1.5	4.4	14.6	32.9	1.7	6.1	1.4	1.2	1.4	31.6	1.8	1.6	5.5	1.6	1.7	1.5	1.4	1.8	1.5	3.7	2.5	2.4	1.9	4.1	0.0	1.4	0.0	3.4	2.0	0.0	0.0	15.0	0.0	0.0	3.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.1	0.0	9.9	0.6	0.0	2.4	0.1	0.0	0.1	0.0	11.5	0.0	0.3	3.6	0.2	0.0	1.9	0.0	0.4	18.3	2.0	0.0	0.0	0.3	0.0	0.0	3.0	13.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	15.0	0.0	0.1	42.5	33.8	29.3	56.3	32.8	21.9	14.6	32.9	31.6	4.1	0.0	0.0	0.0	0.0	0.0	70.2	4.0	0.0	0.0	0.0	0.0	76.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	1.1	88.6	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in many"	6	"Glandular cells: 80.8;Mucus-secreting cells: 228.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055707			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.1	0.0	28.3	9.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.5	0.0	0.0	38.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1	0.0	2.1	0.0	12.1	0.1	0.0	0.1	2.5	0.0	3.4	0.0	0.0	0.0	0.0	3.2	1.1	0.0	8.1	0.0	1.1	0.0	0.0	80.8	0.0	0.0	0.0	0.0	5.2	0.6	0.0	2.9	0.0	0.0	3.3	0.0	228.3	0.0	12.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	26.3	9.7
C6orf106	"dJ391O22.4, FLJ22195"	ENSG00000196821	"Chromosome 6 open reading frame 106"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 106.1;Late spermatids: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Supported	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Nuclear speckles"	"Centrosome, Cytosol"	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	16.5	10.7	12.5	13.7	12.7	7.5	15.2	22.5	18.7	9.5	22.4	6.3	6.7	9.1	9.0	15.5	13.7	8.6	15.9	60.4	11.2	10.0	23.9	35.2	16.9	10.1	14.4	6.8	11.6	12.0	14.1	7.3	11.1	9.0	9.0	9.5	10.3	12.6	16.1	66.3	10.4	14.9	12.3	7.8	9.1	10.0	20.7	8.2	5.8	15.7	26.6	13.3	13.4	11.4	8.6	4.1	18.2	7.3	5.7	9.2	4.7	28.7	13.1	13.1	19.2	31.4	17.3	15.4	19.6	23.0	23.5	29.4	25.7	13.5	33.0	14.8	19.4	32.4	28.7	38.0	16.5	29.9	46.4	14.8	27.6	15.3	24.5	30.7	23.1	30.8	11.6	34.6	23.5	21.5	16.0	18.5	13.8	31.0	14.1	13.2	17.2	16.2	16.0	12.0	46.9	11.8	12.7	16.7	17.5	18.3	28.9	15.6	12.2	29.3	14.3	28.8	28.2	18.1	19.5	18.6	19.5	14.9	20.3	19.5	20.1	45.6	25.6	7.0	20.6	22.5	18.2	3.5	7.3	9.1	6.3	4.8	6.7	6.6	7.2	4.1	8.6	3.6	5.7	4.5	5.7	7.3	2.2	9.2	4.7	12.5	12.7	22.5	18.7	11.2	10.0	14.4	6.8	9.0	8.2	26.8	40.4	23.1	14.9	22.1	17.6	73.3	25.5	33.5	25.0	7.0	19.6	11.7	11.6	14.3	106.1	21.5	21.1	0.0	18.7	6.9	9.9	26.1	25.4	53.9	13.4	12.7	24.1	9.2	17.2	212.0	18.1	18.4	15.1	29.7	17.2	9.4	28.1	19.0	20.8	26.9	18.0	6.5	18.6	9.9	14.0	28.2	18.1	17.3	12.7	30.7
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757406-34773794	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	20.9	24.6	28.3	25.5	29.5	56.2	23.5	19.0	26.7	20.3	28.2	19.0	26.9	26.6	28.5	33.7	28.1	32.1	31.6	56.8	24.4	22.4	26.7	34.9	25.3	36.3	27.4	28.3	26.3	62.5	18.5	19.5	27.1	23.8	22.9	24.3	19.7	30.6	26.5	54.9	20.7	27.3	25.0	29.3	28.6	25.5	66.6	26.3	39.8	36.9	47.2	33.7	24.1	21.0	58.6	53.4	32.6	56.7	38.4	58.3	55.5	47.4	29.4	38.7	50.4	21.0	20.5	29.8	27.2	30.0	54.6	46.2	50.6	18.8	53.4	36.5	33.8	38.2	22.9	58.2	40.7	44.5	35.6	61.4	41.2	25.1	69.7	36.5	52.3	26.3	25.3	39.7	55.4	39.5	21.7	34.5	52.2	66.1	31.2	39.3	39.8	62.6	86.6	42.2	70.8	35.9	43.4	32.7	51.3	35.2	20.3	48.0	34.4	24.4	25.2	59.6	26.2	38.7	79.3	22.9	33.6	39.4	27.3	66.2	34.7	90.1	75.1	15.2	91.7	56.9	26.8	43.8	32.6	35.3	50.1	40.4	58.6	43.5	40.4	50.3	51.0	47.4	43.0	7.9	38.4	56.7	53.4	58.3	55.5	28.3	29.5	19.0	26.7	24.4	22.4	27.4	28.3	23.8	26.3	113.2	104.2	62.5	63.3	39.0	23.7	207.1	84.1	131.2	119.4	64.6	23.6	209.0	160.8	134.3	96.2	66.7	54.9	23.3	135.8	171.0	97.6	66.3	77.5	85.5	197.4	27.0	87.2	63.8	66.9	49.1	51.2	87.8	60.8	201.0	86.3	68.5	129.0	73.7	39.3	158.4	33.1	64.7	62.8	146.4	108.6	39.1	94.7	91.6	100.0	62.6
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	7.6	9.3	7.6	7.6	8.2	18.7	6.7	18.5	10.9	4.8	5.9	7.1	4.7	5.1	5.5	4.4	6.0	5.3	4.5	13.7	6.1	5.8	6.1	10.9	8.0	6.9	5.5	6.8	6.6	13.1	15.1	9.5	8.1	7.7	6.0	6.3	6.8	8.6	5.1	22.2	4.9	5.5	6.4	7.6	6.8	7.2	22.5	5.5	8.5	9.4	3.2	6.8	5.9	10.8	1.5	1.2	1.1	4.5	1.4	1.3	0.8	8.5	6.1	5.5	17.7	2.9	2.1	9.9	5.0	3.4	4.9	7.0	12.1	2.3	12.9	5.5	5.2	8.6	6.5	19.9	2.8	6.7	6.6	6.4	11.4	5.9	10.1	11.8	10.3	7.2	4.8	8.3	3.9	8.4	4.6	6.1	11.3	19.0	5.1	2.1	8.1	7.9	6.7	2.5	6.2	4.3	4.8	8.8	7.7	6.6	7.9	6.6	6.7	12.6	6.6	16.9	5.9	12.7	13.5	3.7	2.4	9.0	3.8	5.5	7.7	11.9	8.2	1.3	14.4	6.0	0.5	1.2	1.1	1.3	1.7	1.3	1.3	1.2	1.3	1.2	1.5	0.6	1.0	0.7	1.4	4.5	0.5	0.4	0.8	7.6	8.2	18.5	10.9	6.1	5.8	5.5	6.8	7.7	5.5	14.9	4.6	1.5	2.5	0.9	9.5	14.6	5.1	4.0	10.3	0.0	19.6	5.6	1.7	5.1	8.0	4.5	3.5	0.0	5.0	3.0	3.5	8.1	1.1	5.1	12.9	4.8	9.1	17.8	11.7	11.0	5.2	8.2	0.0	10.8	3.4	5.6	7.9	2.9	2.5	3.8	11.3	12.9	3.4	13.7	11.9	2.5	4.1	2.6	3.7	5.4
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877778-34888089	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	20.6	25.5	22.2	26.8	28.1	43.1	27.2	30.1	29.8	23.0	23.2	17.5	26.7	21.1	23.6	24.2	23.5	22.7	22.0	33.3	21.5	17.9	20.7	28.7	23.2	28.6	24.8	22.1	27.9	25.4	16.7	18.8	30.6	26.7	23.8	25.3	20.4	20.3	31.0	39.3	31.2	24.2	26.8	23.4	31.1	22.6	32.7	29.0	29.4	23.3	24.6	28.7	22.8	22.6	14.9	20.1	26.5	23.6	13.2	16.7	12.8	14.7	6.5	21.3	37.5	13.3	14.2	18.8	11.9	10.0	20.5	19.8	14.9	9.5	20.3	15.9	11.3	9.9	9.4	26.1	11.0	16.7	12.2	21.0	22.7	13.4	25.0	18.8	28.7	16.0	15.9	18.0	13.8	11.3	12.5	24.9	22.7	35.8	15.7	9.8	26.9	18.3	24.0	19.0	31.0	11.1	20.0	18.9	15.9	15.1	9.6	25.7	23.2	14.0	15.4	26.8	19.1	24.9	36.1	14.3	14.2	18.7	8.2	14.4	14.2	35.0	29.1	5.3	34.4	20.5	26.5	23.6	19.3	12.6	21.0	12.1	11.6	13.4	13.5	20.1	14.9	15.7	14.0	14.6	13.2	16.8	17.7	16.7	12.8	22.2	28.1	30.1	29.8	21.5	17.9	24.8	22.1	26.7	29.0	26.8	15.0	26.1	25.7	40.9	27.7	20.1	17.8	9.4	27.3	40.1	11.8	61.7	54.7	36.9	4.5	33.1	30.6	46.7	54.7	56.3	29.1	24.0	21.9	52.1	38.6	30.2	37.9	55.9	51.2	5.7	31.4	34.5	23.6	33.3	34.7	36.0	41.8	49.1	35.0	24.2	31.6	32.3	23.1	88.2	45.3	51.1	64.2	35.9	39.2	25.5
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889265-35091413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 74.5;Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	13.6	15.6	11.8	10.5	20.7	5.0	11.5	19.2	19.9	8.8	20.3	11.6	33.9	9.8	10.2	11.0	15.4	19.8	9.9	14.8	11.7	8.0	10.3	11.6	14.5	8.0	15.0	8.8	14.6	11.0	13.9	12.8	27.3	12.8	9.3	8.7	19.7	8.5	30.4	14.8	11.6	10.9	13.9	10.6	18.6	12.3	23.6	13.9	9.5	11.3	4.2	9.1	22.7	9.9	1.3	3.4	2.4	4.3	0.5	1.5	1.1	8.1	3.6	8.4	8.1	3.8	3.5	12.9	3.4	3.8	3.8	5.0	10.1	4.9	5.4	5.4	3.3	7.3	8.3	9.7	9.1	4.2	4.3	11.4	3.9	4.7	7.6	2.3	6.2	3.9	4.3	8.4	4.9	6.2	4.4	9.1	6.0	6.7	2.5	3.6	5.4	3.7	7.0	6.1	10.5	4.4	4.8	4.4	5.8	8.3	15.7	32.8	8.2	4.9	8.0	25.0	11.0	6.1	7.2	7.9	4.1	5.2	4.2	4.9	3.8	5.8	2.6	3.2	9.4	11.4	0.0	2.0	1.2	0.9	2.9	1.2	1.3	0.8	1.5	1.5	0.5	1.0	0.8	2.4	0.5	4.3	3.4	1.0	1.1	11.8	20.7	19.2	19.9	11.7	8.0	15.0	8.8	12.8	13.9	74.5	10.7	4.6	6.7	10.8	27.5	21.2	12.7	29.4	9.1	12.2	60.9	7.4	0.0	6.6	11.3	34.4	11.8	0.0	5.1	6.3	8.5	9.5	2.3	4.9	9.8	7.9	12.7	50.3	26.9	8.1	11.8	10.1	5.0	4.6	11.3	21.8	8.6	5.8	28.3	5.6	44.8	19.4	8.9	5.8	4.9	17.9	10.4	2.5	7.7	11.5
TCP11	"D6S230E, FPPR, KIAA0229"	ENSG00000124678	"T-complex 11"	Q8WWU5	6	35118071-35148610	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"testis: 140.4"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1576.7;Late spermatids: 5610.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.8;WM-115: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048311	Supported					NA	NA					"HPA048311: AB_2680351"	"unprognostic (1.35e-1)"	"prognostic favorable (5.02e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.43e-4)"	"unprognostic (8.09e-7)"	"unprognostic (4.06e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.98e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.54e-4)"	"unprognostic (9.41e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	1.7	0.5	1.0	1.2	0.0	0.5	0.0	0.0	0.0	1.6	0.6	0.2	0.0	0.1	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	4.8	0.4	0.8	0.5	0.3	0.0	0.0	1.2	0.0	0.0	0.6	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.8	0.0	0.9	1.3	0.2	0.2	0.5	0.2	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	5.3	2.3	0.0	0.0	0.0	1.7	0.0	1576.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5610.9	27.9	0.0	1.7	0.0	0.0	0.0	0.1	0.0	27.3	0.0	0.0	12.9	0.2	186.1	24.9	0.1	0.0	0.0	0.0	0.1
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35214419-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 38.0"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	110000	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.6	2.6	0.5	1.1	0.4	0.2	0.3	0.3	0.7	1.6	3.3	0.0	2.8	0.2	1.3	7.0	1.5	0.7	0.7	6.4	0.3	0.5	2.3	0.2	1.3	0.2	0.4	0.6	0.9	0.2	0.3	1.6	0.9	0.6	7.0	1.1	6.8	1.1	5.3	0.8	0.7	0.8	13.8	0.6	0.3	1.2	1.7	0.0	0.0	38.0	0.3	0.3	11.4	2.5	1.1	1.6	2.5	0.7	1.1	1.1	0.1	0.0	0.0	10.6	0.1	32.4	43.5	0.1	2.6	1.3	0.0	0.0	0.2	0.0	0.0	0.4	6.2	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.3	0.0	12.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.3	0.7	4.4	0.2	0.0	0.6	12.1	0.5	0.0	0.1	0.0	0.0	0.0	1.9	0.0	10.2	1.4	0.7	1.3	1.1	0.5	0.3	0.8	0.7	0.3	0.1	1.1	0.8	0.8	2.5	1.1	0.5	1.6	0.8	0.1	0.5	0.4	0.3	0.7	0.3	0.5	0.4	0.6	0.6	0.0	0.0	1.1	0.0	0.2	0.0	2.5	3.3	0.0	1.4	3.4	1.8	2.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	1.0	0.1	1.1	0.0	0.3	9.5	10.4	0.0	1.2	2.2	0.9	0.0	1.7	0.0	0.0	2.0	0.1	0.0	3.5	0.0	6.1	0.0	4.7	0.2	1.9	0.0	0.6	0.0	0.0	0.1
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	9.2	20.0	16.0	14.6	18.4	8.5	11.3	27.2	17.8	11.4	11.5	18.1	14.5	11.9	12.5	18.5	10.4	13.7	12.7	20.8	14.8	9.6	14.1	13.0	10.6	15.0	15.3	12.3	19.5	13.9	19.5	31.4	19.7	16.9	15.6	10.2	21.8	16.0	16.6	45.1	10.5	13.1	10.6	13.6	18.3	12.2	19.9	16.4	12.6	24.0	10.3	14.6	12.4	11.0	10.5	7.4	5.4	9.3	9.3	16.0	8.8	6.6	6.1	13.5	14.9	5.7	8.8	9.7	5.7	9.8	9.8	7.8	4.5	9.0	14.5	8.6	8.6	9.4	3.8	11.3	8.7	5.7	21.6	17.0	13.9	9.4	7.2	11.4	7.0	8.3	10.8	5.5	11.2	10.6	6.0	8.8	14.9	10.2	15.3	8.8	14.6	11.7	8.2	6.6	5.4	5.9	11.3	7.0	13.3	8.7	9.3	21.2	7.8	7.0	9.0	17.3	4.7	13.5	22.7	6.7	6.9	6.0	4.7	8.2	15.5	10.7	13.5	6.0	11.0	18.0	3.8	6.6	5.4	16.0	8.6	12.7	10.0	11.7	11.3	7.4	10.5	12.5	13.0	2.0	9.3	9.3	3.7	9.0	8.8	16.0	18.4	27.2	17.8	14.8	9.6	15.3	12.3	16.9	16.4	14.9	8.1	9.5	6.7	5.0	27.5	18.5	7.6	6.7	7.9	8.7	47.1	20.4	18.3	10.5	17.1	10.1	10.5	0.0	13.4	11.0	8.5	5.8	12.7	7.4	9.8	28.6	11.6	6.2	7.8	12.0	10.3	5.8	5.0	6.4	12.5	10.3	7.1	9.7	5.6	10.5	30.2	19.4	8.6	20.9	10.0	5.5	19.0	8.6	9.0	5.8
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6, guanine nucleotide exchange factor"	Q9H4E7	6	35297852-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	2.9	2.0	4.5	34.8	4.6	30.3	3.4	0.9	3.1	4.3	4.7	6.9	4.7	5.3	3.1	11.1	15.3	2.7	6.8	2.6	3.8	2.7	3.1	2.5	7.5	42.7	5.3	1.0	2.0	16.5	0.7	5.1	4.2	4.8	10.6	4.0	2.9	14.1	6.7	0.9	14.4	15.2	2.4	7.1	32.6	8.3	6.7	5.0	42.6	4.7	9.3	51.7	6.7	8.6	13.9	21.0	43.5	13.8	25.9	31.5	20.7	7.5	0.0	0.2	0.2	0.0	0.1	9.6	0.8	1.2	0.2	0.2	0.4	3.2	9.0	2.7	0.4	0.0	5.0	0.0	6.4	0.1	0.3	0.3	10.1	0.1	4.0	0.2	18.2	13.3	1.5	8.2	0.1	7.4	0.0	0.0	27.3	4.5	21.7	0.0	3.9	23.7	31.6	0.4	0.9	0.9	21.9	0.2	12.1	0.8	5.7	0.1	0.0	0.6	1.9	1.7	0.4	5.2	25.3	1.2	0.1	0.2	0.0	0.1	12.4	11.4	7.5	0.0	37.9	0.0	16.3	13.8	43.5	31.5	11.0	25.8	13.9	25.7	31.0	21.0	12.5	27.1	26.1	26.7	25.9	9.9	13.9	26.9	20.7	4.5	4.6	0.9	3.1	3.8	2.7	5.3	1.0	4.8	5.0	6.0	10.1	30.6	16.6	10.5	2.3	0.5	5.1	2.7	6.8	5.2	0.0	20.5	0.0	0.7	44.9	1.7	2.9	0.0	8.6	14.6	1.5	5.8	17.3	0.5	76.8	3.2	4.1	3.7	28.3	127.4	2.6	28.4	6.8	7.2	8.5	0.8	5.8	10.5	1.8	0.2	1.6	0.0	1.2	4.2	0.7	10.3	10.5	75.9	7.2	12.7
PPARD	"FAAR, NR1C2, NUC1, NUCII"	ENSG00000112033	"Peroxisome proliferator activated receptor delta"	Q03181	6	35342558-35428191	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Pancreatic endocrine cells: 63.9;Syncytiotrophoblasts: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017635	Approved					NA	NA					"CAB017635: AB_1128605"	"unprognostic (3.70e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.59e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.00e-2)"	16.4	13.4	20.4	19.4	21.8	8.8	11.3	19.0	29.5	14.0	19.0	20.4	24.5	12.7	15.0	22.7	29.6	13.4	16.7	15.7	23.8	14.5	11.9	19.9	18.1	15.6	22.5	14.6	21.6	11.1	14.2	16.2	30.4	19.8	18.0	13.9	15.4	15.2	20.6	22.5	26.3	16.5	12.8	20.9	20.0	23.4	12.8	20.8	6.2	26.8	9.5	15.8	14.5	19.4	4.4	2.9	6.7	3.5	2.3	5.6	2.5	21.0	3.7	6.0	12.7	8.8	15.6	32.3	17.3	15.5	14.9	12.4	5.0	4.0	3.4	5.0	12.3	8.5	7.6	5.6	16.7	10.5	4.9	5.1	3.2	5.0	7.4	15.6	0.7	3.6	26.5	5.6	22.0	11.3	17.1	6.9	4.2	3.3	3.9	12.4	6.6	2.3	3.4	2.9	7.9	10.3	3.3	10.2	3.4	3.6	18.9	3.3	9.3	6.9	12.0	14.7	4.3	4.5	11.8	14.9	20.4	7.7	12.2	20.5	3.3	4.5	3.7	6.6	6.8	9.1	1.1	3.5	6.7	3.1	3.3	2.2	3.4	3.3	3.0	2.9	4.4	5.6	5.1	5.4	2.3	1.9	1.8	3.2	2.5	20.4	21.8	19.0	29.5	23.8	14.5	22.5	14.6	19.8	20.8	8.9	8.5	3.2	14.7	16.7	6.9	9.9	15.3	2.7	11.4	1.8	2.0	30.8	3.3	30.4	2.6	10.5	25.3	0.0	21.2	25.6	9.7	17.3	23.0	4.5	12.9	4.8	6.3	5.5	5.6	2.9	5.5	14.3	11.8	3.6	7.1	6.5	63.9	8.5	7.8	5.6	7.3	12.9	10.8	5.6	7.6	11.2	82.0	6.9	5.2	34.9
FANCE	"FACE, FAE"	ENSG00000112039	"Fanconi anemia complementation group E"	Q9HB96	6	35452361-35467103	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 82.2;Syncytiotrophoblasts: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	7.2	2.1	2.6	7.0	3.8	7.2	8.5	5.5	3.9	6.7	4.1	4.8	1.5	3.1	6.1	4.7	10.0	4.9	5.4	4.1	2.8	3.2	2.4	1.7	5.5	5.4	2.4	1.8	10.8	6.9	2.7	4.0	21.3	3.9	6.7	4.1	3.7	5.3	4.0	20.8	16.8	4.7	4.1	3.7	4.6	3.8	12.1	3.5	3.0	5.9	10.1	8.5	6.7	15.0	2.4	1.8	1.0	1.0	2.6	3.6	0.9	5.7	2.8	7.9	17.6	5.7	10.2	21.1	6.9	5.9	9.1	7.9	6.7	3.3	19.6	4.6	4.3	6.9	4.3	8.8	5.9	8.8	6.6	7.6	13.7	6.9	4.3	3.1	8.0	5.6	6.4	17.8	11.1	17.1	2.4	5.3	7.6	12.6	7.3	7.6	6.7	3.7	10.0	3.2	6.2	4.5	11.1	7.5	7.4	2.0	6.3	7.8	7.3	4.0	5.6	6.2	7.6	5.5	26.3	3.2	11.0	9.2	7.0	10.8	4.9	16.9	7.1	2.4	14.8	10.3	0.7	1.0	1.0	2.2	0.6	3.0	0.7	2.8	3.6	0.6	2.4	1.9	1.9	0.6	2.6	0.6	1.8	1.7	0.9	2.6	3.8	5.5	3.9	2.8	3.2	2.4	1.8	3.9	3.5	6.0	0.0	0.8	3.9	7.8	0.5	1.7	0.0	0.0	1.2	0.0	0.0	17.8	0.0	1.2	0.2	2.5	0.9	0.0	0.7	82.2	3.8	2.4	0.0	0.0	5.2	0.0	1.2	1.8	1.2	0.0	1.4	1.3	1.7	0.0	2.9	1.5	1.0	0.0	0.7	0.2	1.7	0.0	2.5	6.9	10.4	6.1	39.0	1.0	3.3	2.7
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	66.6	68.9	78.3	73.6	117.4	214.2	88.8	69.1	142.3	97.5	77.8	99.6	64.6	200.2	63.8	93.6	47.9	59.2	105.5	157.7	81.0	69.4	92.9	76.8	63.8	139.1	174.0	112.0	64.1	249.0	185.0	71.4	239.9	158.1	142.7	100.7	90.5	99.0	110.5	117.8	118.1	136.2	82.2	105.4	60.8	93.6	75.5	154.9	123.2	110.4	55.3	81.0	42.5	97.8	195.2	66.0	105.8	204.3	82.3	31.9	57.7	42.3	86.9	62.6	101.9	132.2	40.0	130.7	57.0	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1	497.3	826.2	3505.8	4941.4	4796.5	207.9	239.4	1668.8	799.0	1510.5	567.0	68.7	3327.1	2528.3	1289.0	177.8	1494.7	980.5	513.9	2845.5	4591.2	2345.1	3300.9	883.5	1243.6	1940.9	103.3	1454.5	1261.4	1687.0	354.9	2330.6	2284.0	2282.6	2326.4	2431.8	212.5	2052.4	1855.2	1390.9	2230.9	177.0	756.7	2794.2	210.8	382.0	5789.4	3433.4	2382.6	3597.4	4457.4
TEAD3	"ETFR-1, TEAD5, TEF-5"	ENSG00000007866	"TEA domain transcription factor 3"	Q99594	6	35473597-35497076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 62.8;Syncytiotrophoblasts: 133.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028906	Uncertain					NA	NA					"HPA028906: AB_10603347"	"unprognostic (1.77e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.01e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.92e-2)"	7.3	3.5	2.4	9.3	2.9	0.0	16.7	1.9	3.1	30.4	37.3	1.8	23.3	9.6	33.4	17.5	34.7	20.9	29.6	16.9	3.0	1.1	8.5	8.7	10.5	2.9	2.9	1.5	25.0	6.0	9.8	3.7	72.3	5.9	27.3	9.1	11.3	11.9	28.8	19.1	18.8	20.0	56.9	7.0	6.1	17.8	8.1	1.7	1.2	8.9	13.3	9.5	58.7	23.6	0.0	0.0	2.3	0.3	0.0	0.7	0.0	9.6	1.7	14.9	7.4	6.3	10.6	42.7	12.9	28.4	12.6	12.5	25.1	5.8	0.0	6.6	12.8	4.8	10.6	2.0	6.5	8.4	0.2	2.0	0.0	6.8	15.6	11.6	1.3	0.3	14.9	10.8	11.2	7.6	11.3	0.8	0.9	3.9	0.4	12.0	23.1	0.6	3.3	3.1	7.5	1.6	0.2	5.4	1.1	3.6	21.0	0.3	3.1	4.1	8.1	2.8	16.6	13.6	5.0	1.3	12.0	10.7	4.3	1.1	1.6	1.7	0.0	2.1	0.5	3.3	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	2.4	2.9	1.9	3.1	3.0	1.1	2.9	1.5	5.9	1.7	20.8	12.2	0.0	29.7	16.8	1.1	13.0	12.7	6.7	10.3	7.0	62.8	42.9	3.3	4.9	0.3	1.5	15.3	0.0	6.1	56.9	15.0	21.8	0.0	7.5	5.1	1.6	3.5	3.7	0.0	0.0	21.3	1.1	0.0	1.8	13.8	3.5	10.4	11.5	28.7	4.0	15.7	32.3	26.4	1.4	3.2	21.8	133.4	0.0	12.6	27.8
TULP1	"LCA15, RP14, TUBL1"	ENSG00000112041	"Tubby like protein 1"	O00294	6	35497874-35512938	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction, Vision"		"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"retina: 56.1"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 251.3;Rod photoreceptor cells: 308.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;CACO-2: 1.4;MCF7: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (7.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.60e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.12e-3)"		"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.66e-6)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.11e-2)"	0.3	0.2	0.3	0.6	0.5	0.0	0.3	0.3	0.3	1.0	0.3	0.3	0.3	0.0	1.2	2.3	0.7	1.4	0.3	0.3	2.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.0	0.6	0.8	0.4	2.7	0.0	56.1	1.1	1.9	0.3	2.5	0.3	0.3	0.3	0.3	0.2	0.9	0.3	0.3	0.3	0.3	0.3	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	7.4	0.1	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	4.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.5	0.1	0.2	0.0	0.1	1.1	0.0	0.0	0.4	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	2.4	0.0	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.6	0.0	27.7	0.6	0.0	0.0	0.0	0.0	251.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.0	308.3	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.2
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 325.8;Peritubular cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	5.0	2.2	9.7	14.4	103.4	64.4	0.1	2.7	0.1	1.8	4.1	3.8	0.9	25.0	2.6	0.5	1.5	0.0	5.7	12.1	4.3	9.8	5.5	10.7	1.9	5.3	81.0	6.7	1.1	97.8	49.2	3.1	29.7	1.9	10.5	5.0	11.4	10.2	19.0	3.2	27.9	12.6	2.5	1.1	1.6	12.4	2.5	12.2	8.0	3.0	3.7	2.2	2.2	2.6	0.5	2.2	14.3	7.9	23.2	2.6	2.3	0.3	3.8	4.6	5.3	31.7	0.8	13.2	1.0	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4	11.9	9.9	41.7	52.1	15.7	1.7	110.1	79.0	21.4	13.6	5.2	0.0	0.6	19.9	0.5	8.8	66.1	19.7	163.5	6.9	0.9	22.2	38.7	36.0	165.7	28.8	0.0	20.1	130.8	325.8	11.8	149.0	56.5	6.8	91.0	17.5	3.7	3.3	9.3	205.4	16.3	18.2	142.3	28.8	11.6	19.2	18.6	0.3	117.1	19.5	19.5
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 60.2"	"Group enriched"	"Detected in some"	65	"Early spermatids: 374.1;Late spermatids: 785.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2"	"Not detected"	"Not detected"							"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	0.5	0.4	0.9	0.5	1.2	0.7	0.7	0.5	0.9	0.6	0.5	0.5	0.5	0.0	0.5	5.8	0.5	0.6	0.8	0.5	0.7	0.9	0.5	1.4	0.5	1.1	0.7	0.5	1.0	0.5	0.1	4.8	0.5	0.5	1.1	0.3	0.6	0.5	1.0	0.5	0.5	0.5	0.6	0.5	0.8	0.1	60.2	0.5	0.5	0.7	0.5	0.6	0.5	0.5	0.1	2.9	0.0	1.0	0.2	3.2	0.4	0.0	0.5	3.2	3.8	7.3	3.4	0.0	0.1	0.2	0.3	0.4	0.1	0.2	0.7	0.1	0.1	1.1	0.1	1.1	0.2	0.2	1.6	0.9	0.4	0.1	0.1	3.8	0.0	0.0	9.7	2.3	0.1	1.3	3.7	0.7	2.8	0.1	4.5	1.1	0.4	6.6	0.8	0.5	0.0	0.2	3.0	0.0	0.0	0.8	0.0	0.9	3.2	0.0	0.0	0.5	1.5	2.0	0.3	0.0	0.6	0.3	0.1	0.0	1.0	0.3	7.2	0.3	4.0	0.3	0.0	1.0	0.0	0.1	0.0	1.2	0.0	1.2	0.5	0.7	0.1	0.7	3.2	0.0	0.2	0.1	2.9	0.0	0.4	0.9	1.2	0.5	0.6	0.7	0.9	0.7	0.5	0.5	0.5	0.0	0.0	0.0	1.7	0.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	374.1	0.6	0.0	0.0	0.0	0.0	0.4	0.5	0.0	2.4	0.0	0.0	0.0	0.0	1.6	785.6	7.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	3.9	0.1	0.1	0.0	0.5	8.9	5.4	0.1	0.0	0.0	0.0	0.3
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 124.8"	"Group enriched"	"Detected in some"	6	"Exocrine glandular cells: 3.5;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 3.5;Spermatogonia: 1.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 2.4"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.4"	"Cell line enriched"	"Detected in some"	6	"T-47d: 12.6"									HPA051655	Approved				"Secreted in male reproductive system"	NA	NA					"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	124.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.0	0.4	0.5	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.3	1.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.6	0.0	0.3	12.6	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.4	0.2	0.0	1.1	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781017-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"epididymis: 123.5;pancreas: 103.6"	"Group enriched"	"Detected in some"	40	"Exocrine glandular cells: 32.7;Pancreatic endocrine cells: 14.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 13.9"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.1	1.6	0.0	0.2	0.0	0.8	0.1	0.9	0.1	0.1	0.0	9.6	0.0	0.1	123.5	0.1	0.1	0.0	0.1	1.8	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	103.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	13.9	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.1	0.9	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1551	"pancreas: 4260.9"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 19853.4"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.4;U-2 OS: 3.0;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1100000			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	4260.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.4	2.7	0.4	1.3	1.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	3.0	0.0	1.0	0.0	2.4	1.0	0.0	0.9	0.0	0.5	0.4	1.3	0.1	0.2	0.0	0.3	1.1	0.1	0.4	0.5	0.3	0.0	2.7	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	19853.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	228.2	0.0	0.0	2154.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35805293-35833874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055110	Uncertain					NA	NA					"HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0.0	0.9	0.9	12.0	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0.0	2.2	0.6	2.0	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1.0	0.5	0.8	0.0	0.0	0.8	0.0	0.4	0.3	0.4	1.0	0.3	1.0	0.8	0.5	0.9	0.0	1.5	1.9	3.6	2.2	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.6	1.9	1.3	2.3	2.0	0.6	1.4	0.9	1.8	2.9	3.8	5.6	1.9	0.1	1.7	2.6	1.4	0.7	0.7	1.0	3.1	0.5	3.4	2.0	7.2	2.0	1.2	2.3	1.8	2.4	0.9	1.5	2.0	1.6	1.0	1.2	3.3	3.3	2.2	1.6	1.9	1.1	2.5	3.0	1.3	3.6	2.4	2.1	3.3	1.0	4.1	3.4	2.8	1.1	2.4	1.5	1.0	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0.0	1.0	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0.0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 311.7;Late spermatids: 401.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.9	11.4	16.8	25.0	9.4	12.3	21.2	18.4	17.8	17.2	18.3	32.0	10.1	40.0	15.6	11.3	20.0	15.4	32.8	21.9	31.0	27.3	23.6	21.0	13.4	27.7	8.3	31.1	10.4	7.9	12.0	19.8	26.0	13.7	21.6	22.9	44.5	17.0	14.4	10.6	32.0	24.2	13.7	18.3	12.5	22.5	20.1	24.7	17.3	50.4	35.8	13.1	18.9	18.0	12.7	17.8	10.1	20.7	15.6	16.2	12.7	11.0	23.1	10.0	22.1	37.6	6.4	36.1	14.4	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6	8.9	26.3	24.4	65.1	37.5	33.6	21.8	12.7	32.1	38.7	21.0	35.3	43.2	24.9	50.7	311.7	24.1	38.6	23.3	58.8	43.3	21.3	68.6	7.0	40.0	19.1	9.5	44.4	11.1	17.1	401.7	20.4	16.9	15.1	36.1	44.8	13.4	78.7	42.1	23.3	44.4	84.4	6.5	23.1	154.9	90.6	36.5	33.2	34.8	87.4	132.9
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943514-36024868	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 65.2"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 26.1;Late spermatids: 8.8;Spermatocytes: 42.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;RT4: 2.9;T-47d: 1.0;THP-1: 2.3;TIME: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA					"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.3	0.2	1.3	0.5	2.2	3.7	0.3	4.2	1.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	2.1	0.2	0.2	0.2	1.1	0.7	1.7	0.2	0.3	0.2	0.1	0.2	1.9	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.9	0.2	65.2	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.2	5.4	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.4	0.0	0.0	0.8	2.9	0.8	0.0	0.0	0.0	0.1	0.2	1.0	2.3	1.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	1.3	2.2	4.2	1.8	0.8	2.1	0.7	1.7	1.9	0.1	3.0	1.4	0.0	0.3	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.1	0.0	0.0	0.6	1.2	8.8	0.9	0.4	1.7	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	42.9	0.3	0.1	0.2	0.0	0.0	0.1
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 32.1;neutrophil: 12.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 32.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		7100000	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22.0	20.5	12.5	11.9	16.9	38.8	12.1	24.0	18.9	16.0	16.4	9.3	9.5	16.0	29.8	21.5	29.0	12.0	11.3	17.7	18.5	15.0	27.2	27.3	10.2	23.4	18.3	17.0	16.7	16.5	21.2	25.6	22.5	26.0	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25.0	30.0	2.3	4.0	32.1	4.9	3.0	2.8	2.1	18.5	10.2	11.0	17.7	25.1	25.0	24.2	19.4	25.3	23.0	24.0	24.9	9.6	15.0	19.3	21.3	11.0	13.3	18.1	16.8	24.1	16.9	14.5	34.7	14.5	20.8	13.8	21.9	21.0	17.6	16.4	16.6	16.5	19.2	26.1	26.0	19.2	18.9	15.7	8.8	22.4	26.3	6.7	11.4	10.2	26.7	17.9	13.9	16.2	25.6	8.3	7.0	17.5	13.1	20.3	14.1	15.4	40.9	18.3	20.7	12.0	13.0	17.7	9.3	21.2	15.1	9.4	43.2	16.9	32.1	4.9	3.0	2.4	3.5	2.8	1.5	2.2	2.6	4.0	2.3	2.5	2.4	12.3	3.0	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12.0	11.3	10.2	10.3	29.8	11.5	18.2	10.6	14.2	19.3	23.5	7.6	16.0	19.4	17.4	29.5	38.2	1.7	12.1	2.6	20.2	25.7	0.0	9.9	14.8	20.9	9.0	20.7	39.4	22.3	11.1	16.1	21.5	58.1	3.7	22.7	30.0	10.1	19.8	22.5	12.2	17.6	20.3	25.1	14.0	24.3	12.9	11.5	6.3	7.7	16.7	20.0	23.5	15.6	8.8
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 143.1;Late spermatids: 214.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.6	0.1	0.3	0.2	1.2	5.7	2.7	1.6	0.2	0.2	0.5	16.3	19.4	4.7	1.2	1.5	2.8	15.2	0.0	46.2	0.4	12.0	5.2	0.1	0.5	16.2	2.0	0.1	1.2	4.9	16.4	3.0	0.6	2.3	3.0	0.5	0.3	5.3	0.5	10.3	0.1	1.2	0.1	19.4	0.3	11.6	0.2	27.9	9.0	28.9	19.6	0.3	1.7	0.3	0.1	0.6	22.0	2.5	4.1	1.4	0.2	0.5	0.3	0.3	7.0	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1	26.8	24.1	11.5	34.8	24.3	0.8	1.6	22.9	1.4	22.7	27.9	5.9	41.4	13.3	48.4	89.5	2.3	143.1	0.0	102.6	8.3	3.2	28.0	2.3	1.6	35.8	0.0	63.0	0.6	6.1	214.3	6.6	6.4	16.9	22.6	80.8	1.5	76.0	89.2	9.2	7.9	2.2	0.0	1.0	6.1	1.5	46.5	27.0	20.2	93.7	47.8
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	9.6	21.8	11.9	12.3	11.7	12.3	25.8	22.4	16.7	11.9	15.2	10.9	28.3	13.5	16.0	13.4	9.5	10.8	10.6	10.9	10.3	9.1	15.9	16.5	9.6	7.7	10.4	11.7	15.2	20.8	18.1	18.8	8.7	7.4	15.2	15.3	8.0	16.5	31.0	22.9	14.5	17.0	12.2	9.8	9.8	12.4	22.9	11.8	11.8	18.3	4.4	7.1	13.9	22.3	0.8	0.5	3.0	0.2	0.1	2.0	0.6	6.7	6.5	16.4	12.8	9.1	7.7	14.0	10.2	10.8	14.4	11.4	19.0	6.4	10.5	11.0	10.0	18.2	6.6	14.4	7.3	12.7	9.9	8.9	7.4	6.0	11.2	9.6	5.7	10.4	9.8	6.3	17.1	8.6	10.5	10.7	5.1	15.4	9.7	7.8	9.6	6.5	2.5	8.2	8.3	5.6	19.1	6.7	3.2	4.7	13.9	23.5	7.4	8.3	9.1	8.7	10.6	10.2	15.9	11.2	15.1	12.9	4.1	11.8	8.0	10.3	7.9	2.5	9.2	17.7	3.0	0.2	1.4	1.9	0.2	2.0	0.8	0.5	0.6	0.2	0.4	0.9	0.6	1.5	0.1	0.1	0.5	1.2	0.6	11.9	11.7	22.4	16.7	10.3	9.1	10.4	11.7	7.4	11.8	6.0	10.1	2.9	6.8	8.5	10.1	10.9	12.7	2.7	5.7	5.2	5.9	4.2	0.0	4.7	13.2	7.1	15.1	0.0	9.2	3.7	9.5	10.3	2.3	16.6	3.7	0.0	18.9	11.6	5.0	10.4	10.3	2.5	6.8	5.4	26.5	4.3	10.0	10.5	8.9	11.4	6.7	0.0	6.2	17.9	12.2	9.9	6.9	4.3	13.9	8.4
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36312229	"Disease related genes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 28.5;skin 1: 25.1"	"Cell type enhanced"	"Detected in some"	18	"granulocytes: 4.6;Late spermatids: 1.3;Proximal tubular cells: 1.4;Suprabasal keratinocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 28.5;eosinophil: 9.5"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.5"	"Cell line enriched"	"Detected in some"	5	"U-937: 21.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.8	0.2	0.1	0.5	0.1	3.6	0.5	0.1	0.5	0.3	1.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.5	1.0	1.0	5.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.2	25.1	7.4	0.1	0.8	3.7	1.4	0.8	0.1	0.9	0.1	0.1	0.1	0.1	0.5	0.0	0.9	28.5	1.9	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	21.0	0.0	28.5	1.9	9.5	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.1	0.0	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	3.1	0.1	0.0	0.0	0.1
C6orf222	DKFZp779B1540	ENSG00000189325	"Chromosome 6 open reading frame 222"	P0C671	6	36315757-36336885	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 46.7"	"Cell type enhanced"	"Detected in some"	19	"Enterocytes: 125.0;Exocrine glandular cells: 39.2;Intestinal endocrine cells: 39.2;Mucus-secreting cells: 42.5;Pancreatic endocrine cells: 35.0;Paneth cells: 28.1"	"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Daudi: 2.8;OE19: 6.2;REH: 2.8;RT4: 1.4;U-937: 3.1"					"Low region specificity"	"Detected in all"			"HPA038407, HPA058189"	Uncertain					NA	NA					"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.2	0.1	14.0	0.1	0.1	19.8	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	4.7	0.0	0.1	0.1	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.2	46.7	0.1	0.1	0.1	5.8	1.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	2.8	0.0	0.5	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	0.0	125.0	0.0	39.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	39.2	0.0	0.0	1.1	0.3	0.0	0.0	1.8	42.5	0.0	35.0	28.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.3	0.9
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.2"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.9;Cytotrophoblasts: 25.0;Exocrine glandular cells: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;BJ hTERT+ SV40 Large T+: 8.4;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;HDLM-2: 33.3"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	2.3	2.5	1.7	7.9	1.7	0.9	1.8	0.9	1.5	2.3	15.1	0.9	2.1	14.4	2.0	2.1	4.7	1.9	7.5	0.9	0.9	1.0	3.0	3.6	7.5	4.2	1.1	1.7	3.7	2.4	3.1	9.9	7.2	3.0	5.3	2.2	3.0	8.1	1.5	0.8	15.1	22.2	4.5	1.5	3.3	5.5	1.1	1.3	3.7	5.3	5.5	8.0	4.3	9.8	2.8	0.7	15.4	4.4	0.4	12.0	1.8	2.1	0.3	0.5	1.3	0.0	0.1	16.1	0.2	5.3	8.4	16.0	1.1	4.7	0.7	0.8	0.1	1.4	2.7	0.2	0.9	0.4	33.3	0.6	1.1	0.3	1.2	1.1	0.5	0.6	0.7	1.4	0.4	0.1	0.4	0.2	0.4	0.3	1.0	0.2	0.4	0.7	0.6	1.2	0.7	0.1	3.5	0.3	0.3	0.1	1.3	0.8	0.5	0.8	1.8	0.5	0.8	2.9	1.0	0.7	0.8	0.9	0.4	0.5	0.3	0.5	0.7	0.3	1.9	0.9	0.0	2.9	0.2	1.4	4.4	3.3	2.8	4.5	1.8	0.7	1.1	0.9	1.2	15.4	0.4	1.4	0.0	12.0	1.8	1.7	1.7	0.9	1.5	0.9	1.0	1.1	1.7	3.0	1.3	17.9	17.9	0.0	1.9	1.8	0.2	0.3	0.0	1.4	7.9	0.0	0.0	25.0	0.0	12.2	0.4	0.7	9.3	0.0	20.9	4.3	2.4	3.4	2.3	0.2	2.5	0.0	3.5	0.0	0.8	0.0	1.4	0.5	3.3	10.0	4.6	2.2	12.8	5.8	1.1	0.8	0.6	0.0	8.2	0.9	16.6	3.1	7.1	0.0	4.5	4.3
PXT1	STEPP	ENSG00000179165	"Peroxisomal, testis specific 1"	Q8NFP0	6	36390551-36442889	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 6.4"	"Group enriched"	"Detected in some"	8	"Kupffer cells: 1.9;Spermatocytes: 7.1;Spermatogonia: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2;neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 6.8"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.85e-2)"	"unprognostic (1.12e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.94e-5)"	"unprognostic (2.98e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.61e-3)"	0.2	0.0	0.5	1.0	0.5	0.7	0.2	2.2	1.9	0.1	0.1	0.1	0.1	1.1	0.3	0.7	0.1	0.3	2.7	0.3	0.5	0.2	1.2	0.1	0.4	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	1.8	0.2	0.0	0.1	0.3	0.1	0.7	0.2	0.4	0.1	0.2	0.4	0.1	6.4	0.1	0.1	0.1	0.1	1.0	0.3	0.1	2.2	0.0	1.5	0.2	0.0	0.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.2	0.2	0.0	1.0	0.8	0.1	0.1	0.0	0.4	0.0	0.0	0.5	0.0	6.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.8	0.5	0.0	0.3	0.0	0.0	0.6	1.0	0.0	0.0	0.4	0.2	1.1	0.1	1.3	0.2	0.3	0.0	0.0	0.9	0.0	0.2	0.5	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.2	0.5	0.5	2.2	1.9	0.5	0.2	0.2	0.1	1.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.1	5.1	0.0	0.2	0.0	0.0	0.1
KCTD20	"C6orf69, dJ108K11.3, MGC14254"	ENSG00000112078	"Potassium channel tetramerization domain containing 20"	Q7Z5Y7	6	36442767-36491143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030092	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear speckles"	"HPA030092: AB_10601437"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.94e-2)"	34.3	23.1	18.4	22.8	17.6	20.1	39.0	15.7	21.4	22.2	20.7	18.7	22.4	12.0	25.5	23.1	24.6	22.0	25.1	21.0	16.3	17.1	16.2	29.7	20.5	26.2	18.0	14.4	25.6	12.7	15.7	16.1	21.7	16.5	17.5	16.0	17.9	16.2	19.2	20.4	24.6	17.6	30.8	17.3	24.2	16.6	10.2	13.3	31.6	13.6	18.1	24.9	21.5	18.3	6.2	14.0	19.4	14.4	6.4	8.5	10.9	11.0	5.0	14.7	28.1	20.2	13.0	7.1	13.5	18.7	14.7	16.5	13.0	6.3	37.4	12.2	21.9	8.4	10.3	19.2	9.8	24.5	26.6	10.6	21.3	8.0	13.7	9.4	20.6	14.8	13.1	10.1	11.2	7.2	9.8	15.0	19.9	32.8	21.4	13.8	9.7	23.3	7.8	5.4	8.8	4.6	23.2	16.7	21.0	8.0	12.5	3.5	20.8	11.8	12.0	35.9	15.2	16.5	20.5	17.1	40.0	13.7	11.8	16.7	16.9	39.3	27.1	6.9	28.4	40.7	19.4	14.4	9.2	7.5	13.1	8.5	6.2	5.9	6.2	14.0	5.1	6.2	6.1	10.6	6.4	7.2	7.6	6.9	10.9	18.4	17.6	15.7	21.4	16.3	17.1	18.0	14.4	16.5	13.3	35.7	21.3	25.3	14.7	44.5	17.2	13.2	33.1	21.4	23.9	15.7	9.8	22.6	1.7	14.7	0.4	31.4	13.2	70.0	12.3	15.4	34.9	16.2	52.0	41.2	23.8	14.3	14.6	49.1	52.1	1.5	29.4	33.6	32.1	32.5	15.2	17.9	16.3	14.0	50.2	16.1	9.5	19.4	53.6	5.2	26.0	55.5	19.2	29.9	15.1	27.3
STK38	NDR	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547470	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	19.1	8.4	12.4	39.8	10.0	19.4	32.8	18.8	12.7	16.0	26.3	7.8	14.9	17.0	18.8	16.4	28.1	14.6	18.3	15.3	12.1	7.0	15.0	17.3	21.7	45.9	11.9	6.4	12.3	9.5	7.8	11.0	15.4	9.0	17.0	27.1	11.3	24.8	18.7	14.9	21.8	29.1	28.1	13.1	25.1	16.4	24.4	11.0	34.3	10.6	13.4	28.5	22.4	19.8	10.6	13.1	33.2	30.5	25.8	27.6	22.4	17.8	13.2	14.0	15.1	28.3	21.6	12.2	20.0	16.2	20.8	21.0	10.1	12.3	24.1	15.5	29.7	17.3	19.2	11.6	8.3	24.6	9.8	9.9	17.2	17.2	9.1	14.0	6.5	9.5	14.2	21.9	16.1	10.4	24.0	13.0	12.3	14.0	14.1	29.6	10.7	10.5	17.0	5.8	21.3	11.8	40.8	17.0	6.4	19.7	22.5	16.4	7.8	24.3	11.2	14.0	16.4	12.0	17.2	12.5	16.9	15.0	13.5	12.9	11.8	21.0	17.0	3.8	25.4	16.3	33.2	19.8	15.0	27.6	22.6	21.5	10.6	22.9	24.1	13.1	8.1	20.5	22.3	27.1	25.8	30.5	6.6	21.4	22.4	12.4	10.0	18.8	12.7	12.1	7.0	11.9	6.4	9.0	11.0	17.9	16.5	10.8	8.5	11.9	2.5	15.1	22.9	37.5	50.0	7.0	0.0	11.8	1.7	16.1	5.8	12.4	32.4	0.0	11.2	15.4	19.9	11.5	12.7	13.6	11.7	4.8	13.8	11.1	28.5	4.1	25.0	31.7	16.9	9.0	22.9	6.1	19.6	25.9	28.3	13.6	8.5	12.9	13.7	23.6	9.6	18.4	12.8	23.6	22.1	22.5
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	45.3	27.4	37.4	42.1	38.3	69.5	43.5	42.6	39.1	36.4	41.7	32.9	34.0	25.5	37.2	31.8	42.9	40.8	27.4	37.5	33.0	28.1	34.3	36.9	32.3	51.8	35.8	27.0	53.9	31.3	22.4	47.2	37.4	38.1	40.1	46.6	30.1	30.2	33.0	29.2	36.2	35.8	43.1	31.9	36.4	35.2	27.2	36.7	67.5	35.9	46.7	67.0	49.6	38.6	28.0	73.9	12.9	38.0	37.6	37.6	53.9	52.3	35.0	61.8	47.2	23.9	18.8	38.2	37.5	31.5	63.3	48.8	41.1	37.7	88.1	27.1	41.0	41.4	41.6	81.1	59.7	67.7	41.1	49.9	52.9	27.8	46.2	29.2	70.9	44.8	16.6	20.3	41.2	46.1	20.2	48.0	53.7	63.7	37.4	45.9	40.9	87.1	67.2	65.1	61.6	36.8	77.8	59.2	52.8	44.8	43.7	47.8	45.2	41.7	41.0	56.7	46.2	41.5	76.3	31.3	32.4	47.3	32.4	56.3	36.9	54.6	120.8	27.8	66.1	44.9	12.9	38.0	11.5	32.9	36.2	37.1	28.0	31.1	34.5	73.9	24.0	31.4	32.3	3.7	37.6	24.4	43.7	37.6	53.9	37.4	38.3	42.6	39.1	33.0	28.1	35.8	27.0	38.1	36.7	187.6	233.6	318.3	350.5	417.2	149.0	207.3	150.3	167.3	258.2	118.7	51.1	416.8	308.4	279.1	130.6	291.5	222.5	70.0	281.9	659.0	372.0	205.6	389.0	176.1	317.5	93.8	319.4	203.1	270.2	235.9	196.2	343.3	317.2	322.0	216.3	322.7	247.9	247.6	161.9	198.3	123.9	200.5	442.5	331.9	315.7	389.7	439.9	330.0	297.7	236.4
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687339	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 552.0;Suprabasal keratinocytes: 587.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 21.0;non-classical monocyte: 27.7"	"Group enriched"	"Detected in many"	8	"B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 99.1;HSkMC: 72.8;hTCEpi: 94.2;LHCN-M2: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	81.2	27.0	8.2	21.9	29.8	22.0	38.0	4.8	13.7	25.2	60.8	13.9	10.2	39.8	17.5	17.7	63.5	49.4	47.3	35.9	22.2	8.4	29.1	102.2	55.8	6.3	16.6	4.9	59.1	45.5	12.8	22.8	38.6	44.1	42.0	40.7	8.8	18.0	11.4	98.6	43.5	144.9	40.2	29.6	13.6	25.2	25.3	10.3	6.6	22.7	42.2	27.4	50.5	44.4	8.8	8.5	1.8	27.7	0.2	1.1	13.3	3.0	12.6	9.8	0.2	34.4	61.5	17.9	51.2	41.5	6.4	24.9	1.1	3.0	2.1	1.8	32.1	5.8	7.1	0.4	56.5	10.3	4.1	2.6	0.3	10.5	15.7	99.1	0.0	15.3	72.8	94.2	58.1	18.3	38.4	33.0	0.1	0.5	14.4	73.5	6.5	0.4	1.3	1.2	13.2	1.8	6.2	8.0	3.6	11.2	23.5	4.4	4.2	11.9	1.0	2.4	24.0	3.8	12.8	18.2	11.1	10.5	0.7	4.1	24.3	4.7	6.2	14.3	1.1	30.8	0.0	9.3	0.2	0.2	21.0	0.3	8.8	0.4	0.3	8.0	5.7	0.1	0.1	1.8	0.2	27.7	8.5	1.1	13.3	8.2	29.8	4.8	13.7	22.2	8.4	16.6	4.9	44.1	10.3	77.4	46.3	55.8	285.6	391.3	0.8	136.8	25.5	111.1	48.9	64.6	0.0	32.4	39.7	181.3	0.8	177.8	381.7	0.0	232.1	45.7	194.3	196.1	100.6	63.5	65.3	0.0	168.6	36.2	64.4	2.7	31.9	187.2	207.5	477.9	174.4	59.3	293.5	115.8	15.6	11.0	1.8	25.8	552.0	0.3	1.7	587.4	129.9	10.2	43.4	488.6
RAB44	"dJ431A14.3, RASD3, RASL13"	ENSG00000255587	"RAB44, member RAS oncogene family"		6	36697810-36733183	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 10.0;bone marrow: 36.0"	"Cell type enhanced"	"Detected in some"	26	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.9;granulocytes: 13.9"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	9	"basophil: 10.0;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 10.0"	"Cell line enhanced"	"Detected in some"		"HEL: 8.7;HL-60: 12.2;HMC-1: 37.2;NB-4: 30.6;THP-1: 12.1;U-937: 24.4"					"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"							NA	NA						"unprognostic (8.86e-2)"	"unprognostic (5.58e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.56e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.79e-2)"	1.4	0.0	0.0	1.2	0.1	36.0	0.2	0.0	0.0	1.9	1.0	0.0	0.9	0.4	3.5	0.7	0.6	0.3	7.2	2.6	0.0		0.0	0.2	6.6	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	2.4	0.2	1.1	0.0	1.0	0.0	0.3	0.5	0.5	0.0	0.9	0.4	0.5	0.0	0.9	0.0	1.8	0.3	1.5	0.0	0.0	0.8	10.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	12.2	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	10.0	0.9	7.8	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											3.0	7.9	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36840002	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;brain: 50.3;heart muscle: 28.6"	"Cell type enhanced"	"Detected in many"	16	"B-cells: 43.6;Cardiomyocytes: 20.4;granulocytes: 11.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.3"	"Group enriched"	"Detected in some"	82	"memory B-cell: 27.1;naive B-cell: 12.9"	"Lineage enriched"	"Detected in single"	111	"B-cells: 27.1"	"Group enriched"	"Detected in some"	4	"Daudi: 33.0;HUVEC TERT2: 13.6;U-266/70: 11.4;U-266/84: 9.1;U-698: 15.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 100.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 166.9"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	1.8	1.1	8.1	12.5	50.3	1.1	1.7	1.9	49.4	1.8	4.2	1.3	0.0	3.9	3.7	1.0	1.8	11.3	1.7	28.6	3.7	4.9	1.3	0.5	1.5	14.3	3.6	12.8	2.3	1.0	0.8	3.6	1.3	3.3	2.9	3.6	4.1	2.0	2.2	0.5	1.0	2.9	3.6	3.0	7.1	3.4	11.8	6.2	0.1	1.4	0.0	20.3	5.5	1.9	27.1	0.1	0.2	0.1	0.0	0.1	2.2	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.1	33.0	0.3	0.4	1.6	0.3	0.1	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	2.4	13.6	0.1	0.1	0.9	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.6	0.1	0.0	0.5	3.1	0.2	0.4	0.0	1.3	11.4	9.1	15.5	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.1	0.1	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	2.2	8.1	50.3	1.9	20.4	3.7	4.9	3.6	12.8	3.3	6.2	0.0	5.1	43.6	0.1	0.6	9.8	20.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.9	2.8	5.1	0.0	0.2	0.0	0.6	0.2	11.6	0.4	0.4	0.0	4.1	3.7	1.5	3.5	0.0	0.2	3.3	0.0	0.8	1.0	0.2	10.5	0.4	0.0	1.1	0.0	0.3	0.6	1.4	0.1	0.0	0.5	1.5	0.1
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Supported	Nucleoli		NA	NA			Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.3	11.3	29.9	19.9	4.0	8.5	16.2	14.5	9.7	22.0	18.3	19.8	9.5	22.0	18.4	10.2	29.0	11.6	35.3	24.2	25.2	18.3	29.5	26.0	7.4	26.1	13.4	22.2	10.9	6.3	11.5	16.9	31.6	8.1	19.6	21.3	48.8	10.7	15.8	13.6	26.4	10.2	19.8	27.5	15.3	21.3	26.2	19.7	13.0	10.1	31.8	16.8	9.7	10.4	19.1	23.0	15.2	18.9	11.9	17.0	15.7	12.9	24.2	11.8	30.6	40.1	5.4	41.2	32.3	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0	6.0	6.9	6.7	16.2	2.7	14.1	40.3	7.6	20.1	7.9	5.2	3.9	50.9	19.9	22.9	21.9	9.2	2.6	0.0	17.8	54.4	8.4	9.5	10.4	6.8	25.9	15.9	3.5	3.7	2.8	8.5	6.4	9.5	6.8	11.8	8.5	25.1	18.1	7.0	11.7	10.2	10.5	6.5	8.9	14.4	49.0	4.0	21.2	7.5	10.3	8.6
C6orf89	"BRAP, FLJ25357"	ENSG00000198663	"Chromosome 6 open reading frame 89"	Q6UWU4	6	36871870-36928964	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 322.9;Late spermatids: 482.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 88.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012548	Uncertain					NA	NA					"HPA012548: AB_1845748"	"unprognostic (2.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (3.75e-3)"	"unprognostic (3.85e-1)"	"unprognostic (9.94e-3)"	"unprognostic (8.42e-3)"	28.0	38.1	26.5	20.9	31.9	24.8	31.2	20.2	34.9	38.2	27.9	33.1	38.6	21.3	34.7	40.0	28.3	30.9	27.2	44.0	33.2	26.4	31.4	42.9	25.9	25.3	30.2	28.8	36.8	47.4	47.7	32.4	29.5	31.6	29.8	29.4	27.1	29.6	60.4	38.3	22.7	25.1	35.2	38.0	20.5	28.3	36.3	25.3	16.1	45.5	21.0	23.3	31.3	28.4	8.6	11.7	21.9	16.5	8.5	15.5	10.2	9.2	5.7	8.0	11.4	29.3	20.2	4.7	18.4	23.3	13.1	14.4	5.9	9.9	8.3	14.4	37.8	14.0	10.2	9.7	11.6	19.1	14.8	8.4	12.0	6.2	6.6	14.6	9.7	12.5	17.3	14.5	16.0	15.4	15.6	11.3	15.2	22.8	23.2	20.2	9.2	10.6	3.6	2.9	10.7	6.4	5.2	7.9	15.0	8.7	8.2	14.2	10.1	12.3	6.0	12.8	7.0	14.3	13.2	13.1	18.8	10.8	14.8	14.3	12.5	15.3	88.2	8.4	13.9	19.6	19.6	13.0	16.0	15.4	12.7	15.5	8.6	12.8	14.2	11.7	7.8	9.0	9.5	21.9	8.5	16.5	7.3	12.9	10.2	26.5	31.9	20.2	34.9	33.2	26.4	30.2	28.8	31.6	25.3	35.7	49.1	35.9	21.5	6.1	14.4	61.4	43.3	18.7	26.1	36.6	9.8	28.5	16.6	34.1	322.9	30.6	29.0	46.7	50.3	35.4	25.1	22.7	29.0	42.3	35.3	22.3	16.7	20.9	25.9	482.3	41.7	21.2	10.1	17.2	24.4	52.6	45.1	26.4	47.7	18.1	10.8	19.4	16.4	20.9	30.5	7.9	38.4	20.0	23.3	22.1
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 87.2"	"Cell type enhanced"	"Detected in many"	20	"Fibroblasts: 45.7;Leydig cells: 190.7;Peritubular cells: 140.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 29.9"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 26.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076574	Approved				"Secreted to blood"	NA	NA		3600000000			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	22.2	1.7	2.9	1.4	8.8	0.3	27.9	0.7	4.5	62.7	4.5	21.4	22.5	0.8	11.1	27.0	10.5	5.3	17.4	43.1	4.6	3.5	0.8	0.5	3.7	1.1	9.0	3.9	2.8	2.5	0.6	3.3	1.2	9.3	15.0	3.4	87.2	4.0	14.2	5.5	19.8	2.0	55.5	13.7	0.8	8.5	8.3	9.3	0.1	8.3	8.7	4.8	32.7	49.8	0.7	0.2	0.2	0.0	5.7	29.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	26.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.3	9.8	2.9	0.0	0.7	3.4	1.0	0.2	5.7	0.0	0.2	29.9	1.7	2.9	8.8	0.7	4.5	4.6	3.5	9.0	3.9	9.3	9.3	0.0	1.0	0.0	0.1	19.2	0.0	3.2	0.0	0.0	1.2	1.8	0.0	0.0	1.7	0.0	10.5	2.7	0.0	0.0	0.0	0.0	45.7	0.1	0.0	0.0	0.1	0.0	0.0	17.2	0.0	14.4	190.7	1.0	10.1	0.0	0.0	0.0	0.1	0.0	140.7	0.2	0.0	0.0	2.2	1.9	1.1	16.2	0.1	0.0	0.0	0.1
MTCH1	"CGI-64, PSAP, SLC25A49"	ENSG00000137409	"Mitochondrial carrier 1"	Q9NZJ7	6	36968141-36986298	"Predicted membrane proteins, Transporters"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 146.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015971	Approved					NA	NA					"HPA015971: AB_1854171"	"unprognostic (3.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.32e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.70e-2)"	32.3	50.8	46.3	25.6	57.2	45.2	31.3	28.4	86.3	34.1	26.1	43.1	32.0	25.8	26.7	91.7	25.8	44.0	34.3	47.6	46.9	56.9	31.0	29.6	33.7	23.4	47.1	47.0	38.0	34.7	33.0	52.8	28.9	49.3	34.4	27.5	31.5	34.2	58.8	21.6	37.2	23.2	32.1	45.8	27.7	28.9	21.5	32.4	21.3	98.9	18.3	23.7	23.3	56.3	14.8	17.7	23.9	23.7	10.6	17.6	8.4	28.6	19.4	26.2	32.6	39.7	27.1	15.1	33.7	31.5	47.7	49.8	31.8	17.8	14.4	30.1	56.4	45.9	25.1	28.5	27.1	55.6	15.1	27.6	14.9	33.2	24.2	28.8	9.6	14.0	30.4	21.3	44.0	21.8	41.7	40.7	19.9	26.8	14.8	30.0	32.1	19.2	21.6	25.7	25.8	22.3	17.9	20.4	15.0	26.0	24.0	42.5	18.3	24.5	21.5	29.7	27.5	27.6	26.6	44.9	47.6	38.0	37.2	36.3	13.0	13.1	146.1	17.4	26.5	37.6	6.3	19.0	23.9	8.9	18.9	8.3	10.1	16.7	17.6	17.7	14.8	15.5	9.3	21.7	10.6	23.7	9.8	11.7	8.4	46.3	57.2	28.4	86.3	46.9	56.9	47.1	47.0	49.3	32.4	44.7	85.6	50.2	157.0	101.0	0.0	139.3	96.8	32.1	70.5	66.3	0.0	156.3	142.6	190.2	6.0	114.2	120.7	70.0	149.2	190.3	178.9	169.5	28.8	45.5	161.7	0.0	143.2	73.1	86.8	10.9	128.0	80.4	129.9	242.5	104.4	0.0	154.2	143.8	124.5	103.2	0.0	51.8	128.2	16.3	60.8	107.9	207.7	55.4	120.0	163.4
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.5;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 36.5;Kupffer cells: 86.8;Macrophages: 49.3;monocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 8.8;intermediate monocyte: 25.4;memory B-cell: 9.3;myeloid DC: 13.7;naive B-cell: 7.8;non-classical monocyte: 25.5;plasmacytoid DC: 10.8"	"Group enriched"	"Detected in many"	19	"B-cells: 9.3;dendritic cells: 13.7;monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;Daudi: 12.7;HDLM-2: 12.4;U-698: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved					NA	NA					"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	11.3	4.3	6.7	21.8	10.3	5.4	3.3	1.0	4.6	2.4	3.4	5.9	1.3	3.8	2.2	7.6	3.0	4.1	4.3	2.6	7.2	2.4	3.0	3.3	8.7	21.7	10.3	1.4	1.8	2.3	0.3	2.1	2.8	7.4	2.4	2.9	2.5	4.2	2.2	1.5	3.0	11.2	4.6	8.3	43.1	3.8	1.2	9.2	3.0	3.5	1.8	18.9	5.1	2.5	9.3	13.7	0.8	25.5	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	12.7	0.0	0.0	0.0	0.4	0.0	0.0	0.3	12.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	8.8	0.8	0.0	25.4	0.0	9.3	0.0	0.0	13.7	7.8	0.0	0.0	0.1	0.1	25.5	10.8	0.0	2.1	6.7	10.3	1.0	4.6	7.2	2.4	10.3	1.4	7.4	9.2	6.0	11.9	36.5	2.9	1.8	0.4	2.5	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.7	10.9	0.7	0.0	0.0	0.8	0.2	1.0	1.2	7.0	0.2	15.5	0.0	0.0	3.1	86.8	1.9	1.4	49.3	1.7	32.5	0.0	0.3	0.8	0.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.9	0.3	2.2	0.2	4.6
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.3	2.0	1.1	4.7	2.5	24.0	1.1	3.4	2.3	3.6	4.6	4.3	6.2	1.7	1.3	5.1	3.6	2.1	3.3	2.1	28.1	1.4	35.7	1.3	5.9	4.8	0.6	66.4	8.5	4.1	2.1	1.4	2.5	0.6	1.5	30.6	10.0	0.3	0.8	1.9	3.2	3.8	5.7	2.0	4.8	3.7	7.3	0.6	18.8	10.0	2.0	2.4	0.3	0.6	4.9	0.5	1.0	1.2	1.3	4.0	6.0	1.3	4.7	2.5	119.4	0.5	9.0	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6	20.8	23.1	27.2	134.9	113.6	4.2	17.3	12.7	4.0	22.7	8.7	0.0	27.3	5.0	30.7	3.8	14.3	33.2	46.7	15.5	92.9	73.9	69.5	46.4	27.1	44.8	14.3	35.6	9.2	40.0	10.4	7.5	45.8	42.2	101.0	11.9	4.3	37.7	17.5	2.8	13.0	0.9	0.0	57.5	3.3	34.5	199.7	67.5	126.4	6.6	399.5
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212180-37258155	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 20.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1"					"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.3	2.7	0.4	0.4	1.4	1.3	0.3	0.4	1.1	0.3	0.3	1.6	0.0	0.4	0.2	1.1	1.4	0.4	0.7	0.4	0.3	0.4	0.9	0.5	0.5	0.1	0.9	1.0	1.1	3.1	0.6	2.3	0.2	1.0	0.4	0.3	1.1	1.5	0.1	1.0	0.5	0.4	0.5	1.6	0.2	0.2	20.1	0.9	0.0	0.5	0.0	0.3	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.2	1.3	0.0	0.4	2.8	1.0	3.7	0.7	0.5	0.1	0.2	0.0	1.5	0.5	0.3	0.3	1.1	0.1	0.2	4.8	0.0	0.1	0.3	0.0	2.8	0.5	0.7	3.4	0.2	1.2	5.0	0.4	1.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.2	0.6	0.0	0.1	13.1	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.0	1.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.1	0.4	1.4	0.4	1.1	0.3	0.4	0.9	1.0	1.0	0.9	0.0	1.1	0.0	8.5	2.3	0.4	0.2	0.0	2.7	2.3	1.8	0.0	0.7	3.3	13.1	12.1	2.1	1.2	0.0	13.9	0.4	2.4	6.4	5.7	0.0	0.8	3.2	1.7	0.0	0.0	11.8	0.6	1.4	1.7	0.0	0.2	6.0	14.4	0.0	0.0	1.0	0.5	0.0	0.8	19.2	0.8	2.6	0.9	0.0	0.4	14.2
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	11.5	17.9	9.6	11.0	12.1	26.0	12.8	15.2	17.1	9.7	13.1	11.2	14.3	13.1	13.9	13.0	19.8	14.1	16.8	11.2	10.5	10.5	13.3	8.7	11.7	9.0	8.9	9.9	15.0	20.9	16.8	11.8	13.3	13.1	12.3	13.3	12.2	21.6	11.8	32.7	20.7	16.1	11.5	8.3	11.1	10.6	19.9	8.2	20.7	13.0	10.5	14.4	10.4	13.3	4.6	7.7	8.0	6.6	5.7	6.2	4.6	7.0	3.0	5.6	6.1	5.2	5.2	8.0	4.0	8.3	7.5	9.2	6.8	4.7	6.6	4.2	5.0	10.1	4.9	7.0	6.3	8.4	10.7	5.7	10.5	5.0	9.2	7.5	5.9	9.0	4.4	9.3	7.3	8.7	7.1	10.4	11.2	11.9	1.7	5.3	6.4	8.7	4.5	7.2	8.1	2.8	5.8	5.1	5.2	7.6	5.2	7.3	4.7	4.3	6.3	7.7	7.8	4.5	10.7	10.1	4.5	7.0	3.0	5.2	6.3	6.5	43.8	3.1	9.0	7.0	2.4	5.0	8.0	4.8	6.6	5.6	3.6	5.3	4.6	7.7	4.6	6.2	5.0	2.2	5.7	2.9	2.2	3.6	4.6	9.6	12.1	15.2	17.1	10.5	10.5	8.9	9.9	13.1	8.2	3.0	6.4	2.7	7.2	7.2	5.1	3.5	2.5	12.0	9.1	1.8	3.9	5.5	3.3	10.8	4.4	4.9	11.1	23.3	13.4	7.1	4.1	7.9	5.7	3.6	4.9	0.0	1.7	4.3	4.3	2.9	2.8	4.3	1.7	7.2	5.1	3.8	13.3	5.8	1.1	7.7	4.6	0.0	2.5	5.5	5.1	13.9	5.6	4.9	4.7	10.1
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.7"					"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.6	4.0	9.7	11.5	7.8	11.3	2.8	6.9	8.6	13.2	14.5	6.0	3.7	8.3	4.2	6.7	11.4	6.3	13.5	8.8	13.8	8.7	13.1	14.2	7.0	8.9	4.5	7.6	10.5	5.6	8.5	7.8	9.1	8.1	12.6	9.8	9.6	2.9	7.5	4.4	9.1	9.4	6.7	3.4	5.3	7.2	8.9	5.7	6.7	4.7	19.1	6.4	5.2	5.9	9.5	6.6	5.3	7.4	5.7	8.7	7.7	8.2	10.2	8.6	11.3	40.7	4.2	10.8	10.0	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8	17.9	23.4	13.0	21.7	16.3	26.0	28.3	10.2	28.1	15.9	24.4	37.3	20.9	13.3	20.8	35.2	15.8	8.6	0.0	16.6	21.6	23.9	20.0	27.7	14.7	15.4	47.7	21.4	22.1	14.2	20.2	24.7	13.8	10.1	20.8	16.1	21.5	23.6	15.6	29.0	16.8	29.6	12.9	16.4	43.0	33.1	19.3	4.9	15.8	16.2	17.0
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	7.0	6.7	9.7	15.8	11.0	10.1	11.8	8.4	11.7	21.5	24.1	10.1	4.7	14.7	9.6	12.4	20.2	7.9	12.3	8.7	16.5	10.1	10.9	8.1	7.8	11.2	8.5	11.6	5.5	8.7	6.5	11.8	8.5	11.3	10.0	13.7	17.9	10.8	11.2	11.5	14.7	10.4	4.8	4.7	6.4	11.7	11.5	8.4	6.9	8.6	10.7	8.1	9.5	7.3	12.1	7.3	12.4	9.0	9.2	12.9	9.7	5.1	9.4	12.4	6.4	77.6	5.1	12.2	14.1	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8	8.9	8.6	7.3	3.4	3.2	13.3	7.9	7.6	13.4	15.9	7.0	31.4	14.0	0.0	4.0	20.1	9.0	4.2	23.3	7.4	6.2	6.4	3.4	3.5	7.4	6.6	11.1	8.1	9.2	5.9	8.3	7.2	7.5	3.3	13.6	7.5	10.1	6.4	3.5	6.3	3.5	10.9	6.5	4.9	14.4	9.9	4.1	17.4	8.7	5.4	2.8
CCDC167	"C6orf129, dJ153P14.2"	ENSG00000198937	"Coiled-coil domain containing 167"	Q9P0B6	6	37482920-37499922	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0"	"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	9	"U-698: 175.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045215	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045215: AB_10962866"	"unprognostic (1.82e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (6.99e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.71e-7)"	"unprognostic (1.57e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.95e-1)"	6.4	10.3	16.1	11.6	18.9	12.7	10.2	11.3	15.5	12.6	10.5	12.8	11.4	6.3	8.7	25.2	13.6	11.5	6.2	17.3	13.8	12.1	10.2	29.5	7.0	23.0	18.1	9.1	4.6	14.9	6.9	8.4	9.6	15.8	12.2	13.0	5.0	16.2	7.7	10.5	6.5	8.2	16.7	22.8	15.1	7.5	18.8	16.9	32.1	11.5	11.2	35.5	8.7	8.7	24.8	9.9	23.6	6.0	8.6	70.0	26.4	3.1	7.2	16.6	11.5	4.5	8.0	6.1	3.7	3.0	5.8	6.5	7.6	4.7	17.1	8.5	6.3	11.3	2.4	10.7	8.7	5.9	14.2	19.7	8.1	3.1	19.1	4.8	7.9	3.2	3.7	18.0	6.2	5.7	4.1	18.0	18.0	5.0	14.9	9.9	10.3	14.8	6.5	0.9	9.0	4.6	9.2	5.9	12.6	7.9	6.2	11.3	13.3	5.6	5.5	8.7	15.2	6.0	8.2	4.5	3.9	7.6	2.1	3.8	11.0	10.7	175.0	3.7	17.0	10.9	4.8	6.0	23.6	26.1	5.9	31.1	24.8	43.5	32.8	9.9	17.0	20.1	19.4	1.8	8.6	4.9	6.3	70.0	26.4	16.1	18.9	11.3	15.5	13.8	12.1	18.1	9.1	15.8	16.9	6.0	10.1	32.8	22.2	12.6	8.6	42.5	33.1	16.0	7.9	14.0	7.9	52.7	26.6	58.7	80.7	18.0	15.3	140.2	43.7	96.5	31.5	33.2	15.0	109.5	77.5	14.3	24.2	29.4	18.3	242.2	12.0	25.9	52.3	29.7	18.8	29.8	51.7	14.4	17.7	66.3	8.5	6.5	20.8	95.7	92.0	13.2	24.8	54.9	25.8	27.3
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 94.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	17	"cerebellum: 94.7"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 3.1"	"Group enriched"	"Detected in many"	22	"B-cells: 1.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;HaCaT: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	1.5	3.7	3.4	3.1	2.4	0.0	1.0	94.7	5.1	3.0	1.3	1.5	1.0	0.0	3.0	1.5	1.8	2.1	3.4	1.2	5.0	2.0	0.8	0.5	3.5	3.4	1.7	2.4	8.4	2.6	6.6	2.6	0.5	5.4	1.5	1.1	3.4	0.7	1.2	0.9	6.7	1.5	2.6	4.1	3.9	1.2	1.4	1.3	0.6	1.1	1.7	2.7	1.1	3.1	1.1	0.0	0.0	0.0	0.0	3.1	0.4	0.1	3.8	6.9	2.6	13.8	5.6	3.0	2.7	2.7	3.4	3.9	0.7	0.0	0.9	0.6	1.7	3.6	8.9	0.5	0.0	1.1	6.9	4.0	0.0	0.5	0.0	0.6	0.0	0.9	1.0	0.1	1.4	0.0	8.0	0.0	0.1	0.1	0.0	1.2	0.1	0.0	0.5	0.0	0.1	0.4	7.3	2.4	0.0	0.8	4.2	6.3	0.0	1.5	0.4	3.3	0.2	3.2	0.6	0.5	3.7	1.2	1.3	5.0	0.0	0.1	0.0	5.8	1.1	2.4	0.0	0.0	0.0	1.4	0.0	0.4	1.1	1.2	0.8	0.0	1.0	3.1	0.8	0.0	0.0	0.0	0.0	1.8	0.4	3.4	2.4	94.7	2.7	5.0	2.0	1.7	2.4	5.4	1.3	8.9	0.3	0.0	1.7	2.1	31.7	5.2	0.0	2.7	1.2	3.5	47.1	0.1	0.0	0.6	1.9	1.0	0.0	0.0	0.0	1.2	2.4	1.5	0.0	0.0	0.1	54.0	1.7	1.8	0.0	0.0	9.5	0.0	1.7	0.0	0.0	2.3	0.6	0.0	4.6	0.1	1.3	0.0	3.4	2.3	1.0	2.6	0.6	0.5	0.0	3.8
ZFAND3	"FLJ13222, TEX27"	ENSG00000156639	"Zinc finger AN1-type containing 3"	Q9H8U3	6	37819499-38154624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	23	"Early spermatids: 795.9;Late spermatids: 2445.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016755	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA016755: AB_1859011"	"unprognostic (3.32e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.33e-1)"	26.7	27.5	31.0	26.0	31.1	23.9	37.6	26.2	31.4	28.6	27.0	26.6	26.0	24.5	25.9	31.2	22.2	21.4	33.5	30.5	29.9	24.1	31.6	35.6	24.8	26.1	30.4	22.2	23.9	26.1	33.9	31.6	31.4	24.2	23.7	20.2	24.3	20.3	31.0	77.9	19.4	26.9	35.4	33.4	21.9	25.1	60.5	27.3	26.4	32.1	19.7	19.3	30.7	34.0	3.0	4.4	9.2	2.8	2.9	2.6	1.4	17.2	10.7	37.0	26.2	22.4	23.3	12.8	28.9	33.7	26.1	27.9	21.0	10.2	7.2	22.2	30.7	30.6	11.9	14.1	21.3	35.9	27.4	9.0	21.7	5.6	20.0	52.6	9.0	19.0	29.3	28.1	27.5	46.8	32.1	22.5	17.1	10.3	15.3	19.7	14.9	14.1	7.6	11.0	25.6	11.2	14.9	14.9	8.7	24.7	29.5	23.0	20.2	16.2	14.2	49.7	31.4	21.8	19.1	24.5	27.5	20.9	14.7	18.0	14.9	13.5	21.8	10.3	14.3	28.3	0.7	2.7	8.8	2.6	2.8	1.8	1.9	1.9	2.0	1.3	3.0	1.7	2.6	9.2	2.9	2.1	4.4	2.4	1.4	31.0	31.1	26.2	31.4	29.9	24.1	30.4	22.2	24.2	27.3	20.8	8.6	15.7	25.6	24.3	24.2	20.2	20.4	6.7	3.4	45.4	21.6	27.7	63.0	22.6	795.9	23.8	49.2	23.3	25.1	25.5	23.1	42.8	4.7	43.1	29.1	28.6	15.5	24.5	37.3	2445.8	35.9	24.9	13.5	20.8	27.9	32.1	31.8	24.1	51.9	29.5	21.8	32.3	24.0	65.7	37.2	26.3	72.0	21.8	17.2	47.7
BTBD9	"dJ322I12.1, KIAA1880"	ENSG00000183826	"BTB domain containing 9"	Q96Q07	6	38168451-38640148	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041930	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041930: AB_10795270"	"unprognostic (4.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.64e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (4.20e-13)"	"unprognostic (1.35e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.15e-2)"	5.3	6.6	17.9	5.4	23.9	9.1	5.1	9.8	20.4	5.7	6.6	7.8	7.1	6.3	7.2	5.4	7.8	13.0	7.5	9.2	15.6	11.5	8.4	3.8	12.5	7.4	8.9	13.7	11.5	4.8	28.6	12.9	5.6	10.5	6.8	7.8	7.0	5.3	6.4	7.8	7.4	8.7	6.8	6.1	5.3	5.7	10.2	7.7	4.1	8.5	3.0	7.6	7.5	5.2	5.2	3.9	12.7	5.5	5.0	5.6	2.6	5.9	5.1	8.1	10.1	6.0	8.4	5.8	6.4	8.4	7.0	7.5	6.0	3.5	3.7	4.2	9.6	9.5	4.3	4.4	9.1	8.3	10.3	8.7	7.8	5.2	2.6	4.7	7.9	16.2	6.4	6.9	9.5	9.0	6.4	12.0	6.7	3.8	6.1	7.0	3.7	5.6	2.8	2.1	6.1	4.4	3.3	5.7	7.0	6.7	15.1	10.3	7.3	6.0	5.9	5.8	6.0	6.2	5.4	7.8	6.9	4.3	7.5	6.6	3.6	3.0	4.3	5.4	4.9	7.4	12.7	2.7	4.5	3.8	3.8	5.3	3.9	3.8	3.4	2.5	5.2	4.8	4.3	6.7	5.0	5.5	3.9	5.6	2.6	17.9	23.9	9.8	20.4	15.6	11.5	8.9	13.7	10.5	7.7	3.0	13.2	1.4	2.0	4.0	11.6	10.3	10.2	2.7	9.1	8.7	7.9	2.5	5.0	3.6	14.3	3.6	11.7	0.0	5.1	1.3	3.2	2.5	0.0	2.1	2.2	4.8	4.7	9.8	3.5	18.9	2.8	3.5	1.7	0.0	4.5	5.2	4.9	3.7	3.2	5.1	5.1	0.0	3.8	2.2	2.7	5.1	3.9	5.0	5.1	2.7
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 249.9"	"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.5	8.6	24.8	24.6	11.8	21.3	21.9	16.2	15.4	22.8	23.8	20.9	7.1	20.7	12.8	12.9	27.2	12.3	21.2	20.9	28.9	18.8	32.7	30.6	11.1	19.5	17.7	11.6	249.9	18.2	12.9	21.6	15.5	14.9	24.6	14.7	24.1	13.8	21.3	15.7	18.1	14.8	17.8	16.6	16.9	15.8	30.0	13.5	20.8	14.1	19.3	19.5	11.4	15.9	30.5	17.8	18.4	58.4	10.1	17.8	16.4	15.4	25.6	10.9	20.5	56.8	6.4	30.1	28.5	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4	122.1	136.6	86.9	79.7	57.5	55.3	121.3	48.4	88.3	91.0	85.5	19.6	91.3	210.5	107.2	3.6	70.9	36.2	0.0	64.3	264.4	68.8	192.8	67.2	86.8	68.4	65.2	35.1	200.1	112.1	4.7	77.6	69.2	99.5	129.8	41.3	160.8	66.2	35.7	103.3	107.3	50.7	45.3	65.9	11.9	15.7	77.0	61.2	59.9	55.5	125.1
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715341-39030529	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 36.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 21.1;Late spermatids: 6.9;Spermatocytes: 22.6"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028447	Uncertain					NA	NA					"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	3.5	0.0	0.0	0.0	0.1	0.0	2.6	0.2	0.0	0.1	5.0	0.0	36.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.7	0.0	5.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	3.8	0.0	0.0	0.0	0.0	0.0
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048798-39087743	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 19.0"	"Cell type enhanced"	"Detected in single"	37	"Cardiomyocytes: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;HAP1: 1.3;HMC-1: 1.5;NTERA-2: 3.3;SCLC-21H: 8.1;SH-SY5Y: 1.8"	"Group enriched"	"Detected in some"	5	"basal ganglia: 16.1;hypothalamus: 4.8"	"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (4.06e-3)"			"unprognostic (5.38e-6)"	"unprognostic (1.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.42e-2)"	0.2	0.1	0.1	0.0	1.8	0.0	0.9	0.1	2.2	0.1	0.1	0.8	0.0	2.4	0.1	0.6	0.1	0.0	3.5	4.8	1.4	1.4	0.1	0.0	0.5	1.0	0.1	2.3	0.0	19.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	4.1	0.0	0.4	0.3	0.1	0.0	1.4	0.1	1.8	0.4	0.0	0.4	0.8	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.7	1.4	1.4	0.1	2.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104064-39115189	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.7"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 85.1;Spermatocytes: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles		NA	NA			Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.2	7.2	7.2	5.7	8.7	5.9	11.2	7.1	9.0	7.9	7.3	8.1	6.9	8.8	7.9	10.5	6.5	8.1	9.3	6.7	7.3	6.9	8.1	8.3	6.3	8.2	9.3	6.5	8.4	9.5	4.9	6.1	6.1	7.0	8.5	7.2	6.4	11.1	8.0	5.6	6.6	8.6	6.3	7.0	6.8	6.9	52.7	7.3	18.2	8.4	5.1	9.0	6.2	7.7	14.8	9.3	19.4	12.2	11.7	19.1	9.5	11.4	7.4	6.7	7.9	11.1	14.7	6.9	5.3	5.8	6.4	6.8	10.6	8.1	10.4	7.6	6.9	9.1	7.9	5.8	5.0	6.8	6.5	10.5	6.8	4.5	9.2	9.0	7.7	10.3	10.1	12.4	2.5	6.4	4.5	5.9	15.8	11.5	6.4	7.1	15.7	12.2	12.8	5.8	7.5	3.8	1.7	8.1	4.1	13.4	8.1	18.8	7.6	9.2	8.0	8.1	5.6	13.1	10.2	7.6	8.5	6.2	2.6	6.8	0.1	3.2	12.8	4.9	11.2	6.2	7.6	9.0	19.4	12.2	12.2	14.2	13.1	13.3	11.0	9.3	14.8	19.1	15.8	4.3	11.7	11.9	7.4	17.3	9.5	7.2	8.7	7.1	9.0	7.3	6.9	9.3	6.5	7.0	7.3	3.0	5.9	9.3	11.4	13.7	5.5	17.5	17.8	12.0	5.7	17.4	7.9	28.7	14.9	19.4	85.1	11.3	11.8	0.0	18.9	26.3	17.4	17.9	8.1	18.7	23.2	6.4	8.1	3.1	15.6	40.0	19.0	12.2	11.8	9.0	15.0	13.7	14.7	7.0	18.0	23.0	3.6	6.5	10.3	202.1	11.9	14.4	10.3	10.2	18.4	11.5
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	0.4	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	0.0	4.3	18.0	0.0	0.0	6.1	8.7	4.3	7.9	14.7	0.0	0.0	0.8	7.3	3.0	2.9	1.0	0.8	3.1	4.0	0.0	1.7	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3	0.0	19.2	0.0	1.8	3.3	0.0	0.4	43.3	0.0	6.8	1.8	0.0	22.6	5.0	13.0	0.0	0.2	50.9	0.0	10.8	3.9	1.9	1.8	0.0	23.1	1.8	0.0	0.0	0.0	0.3	0.0	0.6	0.7	1.7	1.0	10.8	0.0	7.5	10.5	0.0	29.1	0.0	0.0	0.4	0.0	0.7	2.4	38.1	1.0	6.4	10.7
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Group enriched"	"Detected in some"	4	"Exocrine glandular cells: 7.3;granulocytes: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 42.5"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 22.4;stomach 1: 11.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enriched"	"Detected in single"	406	"SCLC-21H: 55.9"					"Low region specificity"	"Detected in all"									NA	NA																"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	22.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	11.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.4	4.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725405	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6"	"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 58.9;Muller glia cells: 13.8;Rod photoreceptor cells: 14.4;Spermatocytes: 18.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 20.8;RPMI-8226: 8.1;SCLC-21H: 11.4;SK-MEL-30: 4.6"	"Low region specificity"	"Detected in many"							"HPA038811, HPA058624"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	1.3	1.4	5.1	0.7	9.1	0.9	1.9	2.2	11.4	1.4	1.0	18.8	0.1	1.7	1.0	2.6	1.3	9.9	1.6	1.3	7.3	7.1	1.4	1.3	2.4	1.2	11.8	3.2	1.8	1.6	1.2	5.6	1.2	8.6	1.1	0.9	1.7	1.0	0.9	1.6	1.2	1.1	0.8	10.6	0.9	0.9	12.6	7.8	0.0	2.0	0.0	0.9	0.7	0.4	1.2	2.7	2.5	0.6	1.3	0.7	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.9	0.2	0.5	0.1	0.0	0.1	0.1	0.9	20.8	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.4	8.1	0.2	0.0	11.4	0.1	0.0	0.1	4.6	0.3	0.1	0.0	0.1	0.0	0.1	2.7	0.6	0.2	0.0	0.0	0.6	0.0	1.4	1.9	0.6	0.4	0.5	0.3	0.5	0.7	0.5	0.4	0.2	1.2	0.6	0.7	2.5	1.3	0.4	2.7	0.3	0.1	5.1	9.1	2.2	5.4	7.3	7.1	11.8	3.2	8.6	7.8	0.0	1.1	0.0	0.6	0.1	3.1	1.2	0.0	58.9	2.3	0.0	9.8	0.3	1.7	1.1	7.8	0.7	0.0	0.0	0.7	0.2	1.1	0.2	0.0	0.0	0.2	3.2	2.4	0.0	0.0	8.0	0.3	0.0	0.0	0.0	0.0	13.8	0.1	0.0	0.0	2.4	14.4	0.0	0.6	18.2	2.5	0.4	0.2	0.0	0.0	0.3
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 83.3"	"Cell type enriched"	"Detected in many"	5	"Sertoli cells: 148.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	29	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	21.5	17.8	34.8	6.7	43.0	1.7	7.8	4.4	52.2	9.3	6.4	83.3	8.0	7.6	7.5	8.5	28.3	8.9	5.9	6.1	40.4	25.2	5.9	4.0	8.4	2.8	42.8	24.8	7.3	5.2	3.5	2.1	9.4	41.3	8.7	7.1	5.1	4.3	17.6	23.8	4.4	8.9	13.7	48.8	15.5	7.0	8.7	51.9	0.0	5.0	2.1	2.2	4.6	4.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.7	0.1	0.1	4.4	5.9	1.0	0.5	0.4	0.0	0.0	0.2	6.6	2.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	4.1	0.0	0.0	25.8	0.0	0.1	0.0	7.2	0.0	13.8	0.0	0.0	25.3	0.0	0.6	0.0	0.7	1.3	0.0	0.0	4.6	3.5	0.0	0.0	0.9	1.0	0.0	0.3	31.3	5.6	0.0	0.0	0.2	9.6	2.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	34.8	43.0	4.4	28.9	40.4	25.2	42.8	24.8	41.3	51.9	8.9	9.8	0.0	0.8	1.5	1.7	2.1	0.0	2.7	6.8	0.0	0.0	0.4	0.0	0.4	3.6	2.0	0.0	0.0	3.0	0.4	11.3	0.8	0.0	1.0	0.2	0.0	0.0	3.1	15.2	4.2	21.9	3.1	8.5	0.0	0.0	8.2	0.4	0.0	20.8	0.0	1.5	148.8	28.3	0.7	1.1	1.0	0.2	0.0	0.0	1.0
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 23.5;Hepatocytes: 33.6;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.6;JURKAT: 30.1"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.2	4.4	7.1	12.1	4.6	9.0	4.9	8.9	7.0	6.4	23.6	0.1	0.0	5.1	4.8	4.5	0.3	5.3	5.9	5.4	0.0	4.9	0.0	0.0	7.5	7.7	0.0	1.9	8.1	2.2	4.9	2.6	4.3	6.0	30.1	4.8	0.4	7.1	3.0	9.2	0.0	4.1	0.0	2.6	0.0	3.4	0.7	4.3	4.6	3.6	4.7	0.0	2.9	4.1	3.7	3.1	0.8	9.3	7.0	6.1	4.6	2.5	0.0	0.9	0.0	0.8	0.0	2.5	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6	6.0	1.0	0.0	0.5	0.6	0.8	10.1	7.6	0.0	0.0	8.7	11.8	23.5	5.0	3.4	0.6	2.8	6.4	0.0	3.7	1.2	2.9	0.2	1.1	33.6	2.5	3.2	0.0	2.5	2.8	0.6	3.4	0.0	1.7	0.0	2.9	4.2	1.1	4.8	2.8	12.2	2.2	77.6	15.6	1.4	1.5	1.0	5.1	0.0	4.1	0.3
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391586-40587465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 21.7"	"Cell type enriched"	"Detected in some"	5	"Cone photoreceptor cells: 58.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.8;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;T-cells: 1.8"	"Group enriched"	"Detected in some"	5	"REH: 3.5;SH-SY5Y: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076660	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.5	1.4	5.9	0.5	7.6	1.3	0.6	4.5	21.7	0.5	0.8	0.0	0.0	0.5	0.6	0.4	1.8	0.6	0.6	0.4	5.0	5.2	0.5	0.4	0.4	0.5	2.3	7.4	2.1	0.7	0.4	0.6	0.5	0.9	0.5	0.7	2.7	0.4	0.4	0.4	0.5	0.5	0.5	0.8	3.1	0.7	2.5	0.5	0.0	0.7	0.0	0.6	0.5	0.2	0.0	1.3	0.0	0.0	0.3	1.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	3.5	0.0	0.0	0.0	0.3	1.4	10.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	1.3	0.0	0.2	5.9	7.6	4.5	21.7	5.0	5.2	2.3	7.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	11.6	0.6	0.0	0.0	0.0	0.0	58.9	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026911-41039217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 52.2;kidney: 60.9;liver: 29.9"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 40.8;Collecting duct cells: 21.0;Exocrine glandular cells: 59.0;Hepatocytes: 25.2;Pancreatic endocrine cells: 25.3;Proximal tubular cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"OE19: 31.1;RPTEC TERT1: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	0.4	0.2	0.4	0.6	0.4	0.3	0.5	0.4	0.4	0.4	9.9	0.5	0.4	23.7	0.8	0.8	0.5	0.7	10.2	0.4	0.4	0.1	60.9	29.9	0.9	0.4	0.4	0.4	0.5	17.7	0.1	0.6	0.8	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.6	52.2	0.4	0.4	1.2	15.9	0.6	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.3	1.0	0.7	0.3	0.0	2.4	0.2	0.3	0.1	0.4	0.6	0.1	0.1	0.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	1.8	0.0	0.0	0.1	0.1	0.2	0.0	0.7	0.9	0.4	0.0	2.6	0.1	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.0	2.0	0.3	0.3	0.0	0.1	0.6	1.5	0.2	31.1	0.1	0.6	0.0	0.3	9.5	0.0	0.4	0.4	0.0	0.0	0.9	0.5	0.1	0.1	0.1	0.0	0.3	0.2	0.0	3.1	1.5	0.4	0.0	1.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.2	0.7	0.2	0.1	0.3	0.4	0.0	0.0	0.0	0.3	1.0	2.4	0.2	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	3.0	1.4	0.9	0.6	0.7	0.2	0.6	40.8	0.0	0.0	21.0	3.9	0.4	3.3	14.5	1.7	0.2	5.9	0.0	59.0	0.7	0.4	0.5	0.0	25.2	0.3	1.6	1.2	1.3	0.6	0.0	0.3	1.0	1.7	1.0	2.7	0.3	25.3	1.5	0.7	29.6	0.3	0.0	0.3	0.4	0.7	0.1	0.7	0.5	4.1	0.3
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 72.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	14.6	19.1	19.1	15.8	19.3	15.3	19.3	13.2	20.2	13.6	17.4	18.8	30.3	19.1	12.6	26.6	15.8	20.1	15.9	13.5	19.1	18.6	27.8	35.4	16.2	24.8	21.4	19.6	22.5	25.3	21.6	22.4	13.8	20.9	16.8	20.4	17.6	15.9	24.2	16.7	14.9	17.9	15.8	21.4	16.2	22.7	44.7	20.9	21.4	24.6	14.2	20.7	16.0	14.1	27.6	16.5	23.4	16.2	27.4	24.4	13.2	11.4	7.4	16.0	10.8	9.2	10.6	9.5	7.0	10.1	8.4	9.4	11.1	8.4	15.8	7.8	4.3	9.2	8.5	9.9	9.5	12.5	13.9	5.4	19.2	7.8	20.8	8.7	13.2	12.6	8.3	14.0	8.1	27.9	7.6	5.8	20.5	24.4	13.6	9.0	17.1	21.4	15.5	15.1	72.4	4.9	10.0	14.0	15.4	16.6	6.3	16.8	11.3	6.6	6.7	23.0	12.8	11.8	12.2	6.0	8.7	10.3	5.6	12.1	18.0	17.9	35.3	7.2	13.4	7.4	20.4	13.8	23.4	17.2	14.2	21.6	27.6	19.7	17.0	16.5	25.8	24.4	23.2	13.4	27.4	16.2	16.0	21.8	13.2	19.1	19.3	13.2	20.2	19.1	18.6	21.4	19.6	20.9	20.9	14.9	40.0	42.2	37.8	25.3	59.8	37.9	43.3	57.6	34.2	57.6	43.2	77.5	72.9	37.0	142.4	30.6	31.5	0.0	42.0	52.6	25.1	27.9	47.3	57.2	39.6	39.7	21.2	19.6	46.1	120.0	26.2	34.7	33.7	36.9	47.2	59.6	29.7	43.8	24.4	76.7	60.3	25.8	35.0	186.5	159.6	25.6	38.1	48.9	57.7	23.1
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042554-41044337	"Predicted intracellular proteins, Predicted membrane proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 32.4"	"Cell type enriched"	"Detected in some"	84	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060691, HPA066996"			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.1	0.0	0.1	0.1	0.1	32.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	1.3	2.5	0.4	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	1.3	0.1	3.3	4.5	1.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.3	0.2	0.5	0.0	15.8	0.0	0.4	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.2	0.8	0.2	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.3	210.2	0.8	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053304-41064511	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 89.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 9.0;HSkMC: 3.1;SuSa: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014252, HPA017957"	Enhanced					NA	NA					"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	1.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	6.1	2.8	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	1.6	0.0	0.1	3.2	0.0	163.0	0.2	0.2	0.4	0.0	0.0	2.2	0.5	0.0	1.3	0.5	53.9	4.2	0.1	0.0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0.0	0.5	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.6	0.0	1.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	1.4	0.5	0.4	0.0	0.0	0.2	1.0	0.1	1.3	0.1	0.5	0.5	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.1	2.4	0.2	0.1	0.0	0.0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0.0	1.3	2.0	3.6	4.4	1.3	3.5	4.3	4.0	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	2.3	89.6	0.0	0.0	0.0	0.0	2.0	1.4	0.0	2.5	9.7	0.0	0.0	0.0	18.9	5.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	19.0	0.3	0.0	1.7	0.0	0.0	1.0	3.5	0.0	0.0	1.1	2.6	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.0	0.0
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009250: AB_2152107, HPA050779: AB_2681234"	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	14.0	10.8	20.5	16.2	27.1	34.0	14.7	20.9	19.7	11.6	11.0	15.2	8.5	9.2	14.2	14.4	12.7	11.3	11.8	10.5	17.7	10.3	9.8	13.1	13.4	16.6	24.7	13.0	18.3	12.8	15.8	15.2	12.6	17.8	13.3	13.9	9.3	11.2	14.0	10.7	10.6	11.1	12.9	17.7	13.4	11.4	34.0	19.9	32.4	18.2	9.7	18.3	11.6	25.9	6.2	5.9	10.8	5.0	8.6	11.1	4.1	12.9	10.7	20.4	34.1	8.4	8.3	8.7	9.8	9.2	15.5	13.2	13.9	9.5	15.8	8.2	6.4	8.2	8.6	12.4	11.8	17.2	11.2	15.6	20.6	9.0	19.7	6.0	21.7	18.1	5.2	10.2	12.4	16.8	7.6	13.4	26.4	20.1	19.2	15.2	12.9	24.5	8.7	9.1	38.4	10.6	20.0	11.2	11.8	11.4	17.7	20.8	14.3	8.6	7.8	15.1	13.6	7.3	22.1	13.0	27.7	15.1	5.4	18.7	7.6	7.6	26.3	5.4	18.6	10.9	3.7	4.0	6.3	8.6	5.0	11.1	5.2	8.0	9.2	4.5	6.2	8.6	9.2	10.8	8.6	4.5	5.9	8.8	4.1	20.5	27.1	20.9	19.7	17.7	10.3	24.7	13.0	17.8	19.9	8.9	3.8	9.4	9.6	12.9	4.4	4.1	7.6	6.7	4.5	10.4	3.9	6.5	1.7	8.7	34.4	5.4	6.9	0.0	6.5	8.9	6.6	9.5	2.3	6.4	8.7	0.0	4.6	8.0	5.3	25.1	3.4	5.2	6.8	5.4	3.9	3.1	7.5	7.2	2.8	2.1	5.2	0.0	7.2	21.4	7.9	13.9	9.0	10.2	5.8	19.3
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell type enriched"	"Detected in some"	11	"monocytes: 44.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Cell line enriched"	"Detected in single"	167	"HEL: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		94000000	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.6;brain: 34.8;lung: 24.6"	"Cell type enriched"	"Detected in some"	12	"Hofbauer cells: 939.0"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 1.3"	"Group enriched"	"Detected in some"	4	"hTCEpi: 37.4;THP-1: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Intracellular and membrane"	NA	NA		19000			"HPA010917: AB_1080365, HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	35.6	11.8	10.1	3.0	13.4	0.3	8.6	1.6	21.7	5.9	2.9	24.1	0.0	0.9	1.5	2.1	0.6	6.5	8.4	1.7	10.4	9.5	1.0	2.1	24.6	1.7	21.7	5.2	2.7	2.5	2.7	2.9	8.8	13.4	1.8	3.9	2.1	4.4	3.0	0.8	0.4	1.2	3.8	34.8	0.5	2.2	0.8	12.9	0.0	1.6	0.8	0.5	4.2	0.5	0.5	4.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	37.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	10.1	13.4	1.6	8.3	10.4	9.5	21.7	5.2	13.4	12.9	6.0	9.8	0.0	0.0	0.7	0.1	0.2	2.5	2.7	12.5	0.0	0.0	4.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.8	0.4	0.0	2.3	0.0	939.0	0.0	0.0	3.1	28.7	0.4	0.6	78.3	0.0	13.6	0.0	0.4	0.0	0.0	0.0	0.0	0.6	6.5	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41190277-41201194	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.8;bone marrow: 13.6;placenta: 54.3"	"Group enriched"	"Detected in some"	12	"Early spermatids: 19.0;Late spermatids: 25.1;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.1;neutrophil: 20.8"	"Group enriched"	"Detected in many"	15	"B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8"	"Cell line enhanced"	"Detected in some"		"HEL: 24.6;HL-60: 5.7;JURKAT: 7.0;SuSa: 4.3;U-698: 7.0;U-937: 4.5"					"Not detected"	"Not detected"									NA	NA		2300000				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.2	0.2	6.3	0.2	13.6	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.9	0.3	0.5	0.2	0.2	0.3	0.4	1.5	9.2	0.2	0.1	0.2	0.2	0.0	0.2	54.3	0.3	0.2	0.0	0.1	1.5	0.1	0.2	0.2	1.9	0.1	0.3	12.3	0.4	5.9	0.2	4.9	0.3	0.1	7.5	0.8	0.2	16.1	5.5	20.8	0.8	0.4	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.3	0.0	0.0	1.3	1.8	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	4.5	0.0	1.4	0.3	7.7	0.2	0.7	0.3	3.6	0.6	0.1	1.3	16.1	0.9	0.2	20.8	0.4	0.8	5.5	0.4	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	1.4	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	25.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.3	0.0	0.0	0.0
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 4.6"									HPA065044	Uncertain				"Secreted - unknown location"	NA	NA					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"	"Group enriched"	"Detected in some"	5	"SuSa: 6.5;U-87 MG: 23.8"									"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6	6.0	31.6	2.7	0.1	0.3	0.0	0.3	2.5	13.4	19.4	0.0	0.0	0.3	0.0	0.3	10.6	0.5	0.0	0.0	0.2	0.9	0.7	0.1	5.8	0.2	25.6	0.0	0.0	1.3	32.3	13.1	0.0	79.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	12.2	0.0	0.0	0.0
NCR2	"CD336, LY95, NK-p44"	ENSG00000096264	"Natural cytotoxicity triggering receptor 2"	O95944	6	41335655-41350887	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.5;intestine: 3.3;lymphoid tissue: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"NK-cell: 2.5;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 8.5;NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.6;JURKAT: 1.7;MOLT-4: 1.9"									HPA067249	Uncertain					NA	NA					"HPA067249: AB_2685811"		"unprognostic (5.81e-2)"				"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"		"unprognostic (2.12e-2)"				"unprognostic (1.65e-1)"				0.1	0.1	0.1	1.9	0.1	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.2	0.0	0.1	2.5	0.1	0.0	0.6	0.1	0.3	0.0	1.2	0.1	1.7	3.7	0.0	0.1	0.0	8.5	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	8.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546426-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 38.6;Mucus-secreting cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 39.3;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	12.1	7.8	6.3	13.7	12.6	4.4	15.5	12.3	10.0	28.2	15.8	14.0	16.4	18.7	20.7	8.4	10.5	10.1	29.5	12.9	6.6	7.3	16.4	18.9	14.4	9.1	12.9	4.9	17.1	24.8	5.9	12.6	5.5	9.4	21.7	7.2	21.2	30.1	13.0	7.9	7.1	19.3	11.7	7.9	5.8	37.0	15.4	10.9	12.0	23.9	6.3	14.0	11.7	27.6	2.0	1.0	0.3	0.9	0.6	1.5	0.4	9.1	12.6	15.9	17.0	3.0	1.0	16.3	5.0	2.7	4.5	3.1	39.3	2.9	10.6	9.5	3.0	13.5	7.0	4.6	4.8	1.9	8.4	7.3	8.4	7.0	26.3	5.8	5.3	6.9	2.5	5.9	4.0	2.4	6.6	4.4	6.6	10.4	4.3	2.1	24.8	6.2	9.2	4.0	48.5	4.4	6.8	5.1	7.1	3.9	7.6	4.5	6.4	5.4	12.9	9.0	5.1	7.3	13.0	6.1	5.7	14.2	8.9	8.5	3.4	2.1	14.7	4.7	9.0	5.3	0.3	0.7	0.3	0.7	0.9	1.2	1.0	0.6	1.5	0.6	2.0	0.1	0.3	0.3	0.6	0.3	1.0	1.1	0.4	6.3	12.6	12.3	9.2	6.6	7.3	12.9	4.9	9.4	10.9	0.0	9.4	0.5	4.9	8.1	4.7	14.6	10.2	1.4	3.4	5.2	2.0	2.1	0.0	6.9	22.9	2.8	18.6	0.0	14.0	2.7	5.7	13.8	3.5	15.5	3.6	0.0	38.6	7.4	3.2	16.3	3.7	2.6	1.7	7.2	37.4	0.8	16.6	20.1	8.1	6.9	2.6	12.9	8.9	2.1	7.2	6.8	3.7	3.2	15.0	8.4
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654246	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 196.5;Extravillous trophoblasts: 103.1;Pancreatic endocrine cells: 86.6;Syncytiotrophoblasts: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.6;HBEC3-KT: 29.3;OE19: 24.7;REH: 77.3"	"Region enriched"	"Detected in single"	8	"cerebellum: 19.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	29.5	2.1	2.9	5.3	3.1	0.4	10.5	0.9	10.8	14.0	3.2	2.5	3.5	1.9	4.8	4.6	20.5	4.1	12.3	4.0	2.3	2.1	2.5	2.3	10.1	4.5	2.4	1.3	15.7	1.6	0.9	4.2	17.8	3.4	13.3	0.6	6.3	10.1	4.7	1.0	6.7	1.3	2.9	2.0	0.7	3.2	4.6	1.3	0.8	7.0	31.0	19.6	8.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	12.9	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	7.1	0.0	5.4	0.0	0.0	13.6	3.5	29.3	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.9	13.6	0.1	6.4	0.0	9.7	4.0	0.0	0.0	0.0	0.0	10.1	0.1	8.8	24.7	0.5	77.3	7.4	0.1	0.8	2.2	2.4	5.9	0.1	11.0	0.0	9.3	0.0	0.9	10.7	0.0	12.6	0.1	0.4	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.9	2.0	2.3	2.1	2.4	1.3	3.4	1.3	0.0	0.0	0.0	26.4	21.8	0.0	0.8	0.0	0.0	0.0	5.2	0.0	196.5	0.0	24.1	0.5	3.0	0.0	0.0	44.9	103.1	11.5	36.3	0.0	0.0	16.7	0.0	0.0	3.7	0.0	0.0	36.2	0.5	0.0	1.0	0.0	0.0	86.6	0.0	5.6	0.0	0.0	0.0	1.9	0.1	1.5	8.0	116.0	0.0	0.0	51.1
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.2;Daudi: 19.1;OE19: 25.5;U-698: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049532			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049532: AB_2680807"	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	8.6	6.4	10.2	16.8	20.7	8.9	6.8	8.6	15.0	6.4	10.5	34.4	8.2	6.8	7.1	4.3	9.3	7.2	9.1	19.3	14.6	8.2	12.2	5.0	8.3	24.1	30.0	6.8	6.7	11.4	26.1	14.9	18.5	16.2	10.7	5.3	6.9	18.0	8.6	45.2	7.9	15.5	8.4	27.4	27.3	7.9	2.5	24.0	2.8	11.1	10.9	18.3	10.8	11.1	22.2	8.5	29.0	9.6	0.8	2.6	4.4	1.7	1.8	0.4	7.0	2.4	1.4	30.2	2.7	5.5	2.4	1.8	4.0	2.0	19.1	3.7	2.9	1.8	4.8	1.1	2.8	0.6	17.5	1.9	0.0	6.9	7.3	4.7	0.5	2.6	0.5	5.4	2.8	1.8	5.8	1.8	2.1	2.3	4.7	0.9	1.2	1.1	1.4	0.1	25.5	0.9	12.6	0.2	2.6	4.3	1.4	7.9	2.3	2.3	4.9	0.6	1.8	1.4	9.5	3.8	0.9	1.9	0.1	1.9	12.3	1.9	28.2	1.4	8.1	0.9	0.1	9.6	8.8	2.6	9.3	0.4	22.2	0.7	1.0	8.5	15.1	0.2	0.9	29.0	0.8	6.5	1.7	0.4	4.4	10.2	20.7	8.6	15.0	14.6	8.2	30.0	6.8	16.2	24.0	8.9	9.4	20.8	7.5	12.6	5.8	16.4	12.7	4.0	1.2	12.2	11.8	37.8	18.3	3.0	0.7	7.7	14.0	0.0	6.2	3.4	5.2	6.4	1.1	3.9	25.2	25.4	12.7	8.6	22.7	4.0	3.1	12.9	0.0	4.6	8.4	16.7	6.9	17.3	10.3	2.4	4.7	6.5	6.2	0.5	0.9	12.7	100.7	5.4	7.9	6.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Group enriched"	"Detected in some"	11	"Hep G2: 69.6;OE19: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.6	42.3	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	23.8	270.0	0.0	3.1	0.3	0.0	0.2	150.3	5.3	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	117.5	1.0	0.1	95.4	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	843.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.0	2.6
FRS3	"FRS2B, FRS2beta, SNT-2"	ENSG00000137218	"Fibroblast growth factor receptor substrate 3"	O43559	6	41770176-41786542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 12.7;Spermatocytes: 8.6;Spermatogonia: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030162, HPA030174"	Enhanced		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030162: AB_10599976, HPA030174: AB_10602093"	"unprognostic (2.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (4.23e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.29e-3)"	6.4	7.0	12.1	4.5	13.6	4.2	3.7	20.4	22.2	4.4	5.1	9.1	2.7	5.4	7.1	3.6	5.4	6.9	5.1	8.2	12.3	15.2	4.0	3.1	5.6	6.0	12.2	12.9	7.5	5.9	4.9	4.9	5.2	13.1	5.5	3.4	5.3	8.1	9.3	13.3	2.5	5.3	5.0	8.0	6.4	5.3	18.5	7.0	3.4	7.4	1.7	3.5	4.7	5.0	1.0	1.7	2.3	1.7	1.4	1.4	0.3	3.1	2.7	4.5	6.3	3.7	4.0	9.5	3.4	4.9	4.0	4.1	3.6	1.9	5.4	3.8	2.9	5.3	2.1	2.9	3.6	3.4	5.5	2.8	3.3	5.0	5.7	4.6	2.7	4.9	3.9	4.3	3.9	3.6	5.3	4.2	13.1	3.6	4.5	3.5	5.1	7.9	6.0	2.3	6.9	2.7	7.5	4.1	3.8	3.5	6.0	6.6	9.9	2.4	3.4	6.9	3.5	4.2	5.4	3.6	7.1	7.5	4.6	3.4	8.0	6.5	8.8	1.9	4.6	2.1	0.0	1.7	2.3	0.9	0.5	0.9	0.3	1.4	0.6	1.1	1.0	0.7	0.3	0.3	1.4	0.4	1.7	0.6	0.3	12.1	13.6	20.4	22.2	12.3	15.2	12.2	12.9	13.1	7.0	0.0	3.0	0.9	1.0	0.9	5.8	2.4	12.7	1.4	1.2	0.0	0.0	1.5	0.0	1.5	0.5	2.8	0.4	0.0	1.2	0.8	1.9	0.9	0.0	0.8	1.7	4.8	1.7	1.3	1.3	0.0	2.3	1.3	3.3	0.0	1.6	2.7	1.0	1.5	4.2	0.5	4.0	0.0	1.2	8.6	10.1	0.5	0.5	0.0	1.4	1.3
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780762-41787372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 2.6;Intestinal endocrine cells: 3.4;Rod photoreceptor cells: 3.4;Undifferentiated cells: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 5.3;HeLa: 6.0;hTERT-RPE1: 15.2"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	4.5	2.2	0.5	3.9	1.2	0.0	8.9	0.0	2.1	6.8	3.0	0.4	5.4	1.8	10.8	4.7	4.1	4.8	5.5	2.1	0.9		2.1	1.6	12.2	0.6	0.6	0.2	2.6	1.0	3.7	1.6	2.5	1.9	5.6	2.6	2.0	2.3	8.4	2.7	1.9	0.4	4.4	0.5	8.8	5.0	1.3	0.2	0.0	5.8	4.4	4.2	3.6	13.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	1.1	3.3	1.7	0.3	2.3	5.3	0.2	0.3	0.0	0.1	1.3	1.2	0.6	2.1	1.4	0.1	2.9	0.0	0.2	0.0	0.4	0.5	0.2	6.0	1.3	0.0	0.0	0.1	2.0	0.3	0.1	0.0	15.2	0.1	0.9	1.8	0.7	0.7	0.9	0.1	0.9	0.4	3.8	0.3	1.9	0.9	0.0	2.1	3.2	0.4	0.7	0.0	3.8	0.3	4.5	0.9	0.9	2.5	1.2	1.3	0.6	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	1.4	1.3	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.6	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	1.7	0.0	0.0	2.5	0.0	3.4	0.0	0.3	1.0	1.4	1.8	0.0	0.0	2.7	1.1
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 16.0;Ciliated cells: 30.8;Club cells: 19.4;granulocytes: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 201.9"	"Low region specificity"	"Detected in all"							HPA004801	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA004801: AB_1859553"																		44.1	68.7	54.2	47.4	51.9	55.4	66.4	26.0	52.6	44.0	44.7	43.6	37.1	29.1	38.9	83.4	62.1	49.0	32.1	64.6	45.3	43.8	80.9	92.6	37.7	60.4	45.1	36.3	56.9	84.5	31.6	39.7	49.9	42.3	47.1	53.1	48.4	83.1	43.8	80.2	47.2	48.7	39.4	41.5	58.7	42.0	53.1	37.2	56.7	65.9	78.3	71.9	44.7	38.7	66.2	75.2	39.0	70.5	33.8	56.9	89.2	56.8	28.4	34.4	34.8	32.4	39.2	36.6	28.6	30.3	37.0	35.7	49.3	26.6	26.1	35.0	34.1	41.8	18.2	54.8	47.4	47.7	36.6	57.8	46.8	36.4	80.1	25.6	62.3	30.5	35.1	49.8	40.5	34.8	26.4	44.4	36.9	116.5	32.0	45.3	67.2	44.7	98.9	30.2	201.9	29.0	32.8	21.6	76.7	49.7	29.3	30.5	42.5	19.5	33.8	47.5	38.2	41.1	126.6	31.0	25.4	31.5	25.2	42.6	29.7	63.3	114.8	14.4	53.0	32.7	15.1	69.1	39.0	49.1	68.7	47.7	66.2	50.2	48.7	72.0	61.8	56.9	55.4	9.0	33.8	70.5	75.2	46.5	89.2	54.2	51.9	26.0	52.6	45.3	43.8	45.1	36.3	42.3	37.2	3.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 21.6;Cone photoreceptor cells: 41.2;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"REH: 23.7;U-698: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA					"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.4	2.4	7.6	3.5	6.0	7.3	2.7	12.7	9.3	2.3	1.9	2.0	4.3	2.2	4.0	2.3	1.8	2.2	2.1	3.5	7.6	4.2	1.6	1.7	2.4	3.7	3.0	5.8	4.0	3.2	2.6	4.8	1.8	4.2	2.4	2.1	3.7	2.7	2.4	3.8	4.1	2.2	3.2	3.2	3.5	2.2	7.4	3.2	7.3	7.7	0.6	3.4	2.8	2.0	1.2	0.7	8.5	1.8	0.8	0.9	0.4	3.0	0.9	12.5	6.1	1.5	1.7	5.1	1.2	1.1	1.8	2.3	3.9	0.7	12.5	1.3	1.5	2.6	1.3	7.7	1.2	2.8	3.1	5.7	4.5	4.7	1.3	1.1	3.5	2.7	1.7	0.9	2.6	1.7	1.7	1.1	13.0	9.3	3.5	1.4	1.8	13.3	5.3	3.4	3.2	1.2	23.7	6.0	2.7	0.7	2.1	8.4	3.4	1.6	0.6	0.7	3.1	1.9	3.2	3.2	4.3	4.3	1.4	1.6	6.5	5.6	33.7	0.5	3.6	0.8	8.5	1.3	1.4	0.8	1.5	0.4	1.2	0.4	0.8	0.5	0.9	0.9	0.7	2.4	0.8	1.8	0.7	0.4	0.4	7.6	6.0	12.7	9.3	7.6	4.2	3.0	5.8	4.2	3.2	0.0	11.9	1.5	2.8	4.4	21.6	3.4	5.1	1.4	6.8	5.2	41.2	2.3	1.7	1.5	6.4	2.4	1.6	23.3	1.7	1.3	3.6	3.3	1.1	1.5	1.8	14.3	0.0	1.3	4.1	6.3	3.4	3.6	3.3	1.0	1.4	3.1	1.8	1.7	5.6	1.0	11.9	6.5	2.5	8.9	15.8	5.5	4.8	2.2	1.7	3.9
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	11.8	22.1	12.4	12.1	14.2	7.0	14.2	17.0	15.4	15.3	14.0	16.4	17.4	13.1	16.1	17.8	17.0	13.2	9.9	15.3	12.7	9.5	17.5	14.7	10.4	11.4	14.8	9.3	12.8	17.6	14.5	23.5	17.4	13.8	16.3	15.4	13.2	15.3	14.0	23.0	12.1	15.4	15.3	9.6	13.3	12.9	14.6	11.5	20.9	15.5	13.1	16.4	16.0	12.9	15.0	20.0	13.6	22.1	11.6	10.8	11.5	13.5	11.5	12.4	14.8	11.7	13.0	15.3	8.6	8.3	12.3	9.9	14.6	9.3	18.4	17.1	10.1	7.0	10.3	21.1	11.6	15.6	10.6	6.7	16.5	8.9	12.8	11.2	14.0	10.4	10.1	18.2	11.7	17.6	9.8	15.2	17.8	22.3	8.9	14.7	12.1	15.6	10.0	16.1	43.1	9.3	21.7	14.9	6.6	17.6	8.7	11.5	9.1	12.3	5.8	11.6	15.4	11.7	14.7	14.8	8.7	19.0	5.3	10.6	9.2	12.3	38.9	4.8	15.6	12.3	13.0	19.6	13.6	8.7	22.1	10.8	14.2	5.8	9.8	20.0	15.0	7.9	9.3	7.3	11.6	14.8	17.8	10.2	11.5	12.4	14.2	17.0	15.4	12.7	9.5	14.8	9.3	13.8	11.5	8.9	3.8	7.7	3.5	3.3	2.1	4.0	0.0	4.0	5.7	7.0	0.0	19.8	6.6	5.5	0.4	2.8	5.1	0.0	2.9	15.6	5.3	4.1	6.9	7.3	7.2	1.6	9.2	8.6	6.0	0.0	3.1	3.0	1.7	1.8	6.4	4.0	4.1	3.5	6.3	8.0	3.7	0.0	3.4	4.1	13.4	5.0	20.8	2.5	6.6	4.7
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921188-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	11.5	13.4	6.0	11.5	7.2	6.0	17.5	5.0	8.9	7.8	7.9	4.6	5.3	4.0	11.0	5.4	11.7	9.3	10.0	17.6	5.9	6.8	8.0	18.6	7.1	7.4	5.8	6.5	11.8	15.9	10.6	5.4	11.3	7.4	8.0	6.8	4.8	9.6	7.9	31.7	9.2	5.0	12.6	6.3	9.9	7.3	8.9	4.6	20.1	7.1	11.9	12.9	7.3	10.1	4.0	9.3	0.9	3.4	4.5	5.5	2.2	11.9	14.8	8.2	11.6	6.1	6.9	16.8	12.2	6.4	19.3	14.1	20.4	3.1	22.0	11.1	9.1	13.2	7.9	24.9	17.8	15.2	7.9	27.1	20.5	10.4	22.9	10.6	14.6	9.0	8.9	11.6	18.0	16.4	4.2	13.2	12.9	26.0	4.9	12.7	20.4	15.3	14.7	6.4	37.3	15.6	18.3	11.2	14.0	10.7	10.2	16.5	10.0	8.1	7.4	14.2	6.6	8.6	12.9	10.2	11.2	13.3	7.6	17.7	5.7	7.4	47.6	3.8	14.8	11.7	0.0	3.4	0.9	3.9	3.4	5.5	3.8	2.5	3.1	5.4	4.0	1.3	3.0	0.3	4.5	3.1	9.3	3.1	2.2	6.0	7.2	5.0	8.9	5.9	6.8	5.8	6.5	7.4	4.6	0.0	3.8	8.9	21.5	27.5	2.5	2.5	5.1	4.0	5.7	1.8	3.9	19.5	3.3	20.9	6.2	7.1	1.4	0.0	14.8	19.5	10.6	9.6	2.3	6.6	10.6	0.0	5.2	4.3	1.0	3.4	7.5	5.3	8.5	7.2	5.5	3.4	18.6	0.0	6.7	8.4	2.8	6.5	17.3	6.5	26.9	22.1	24.4	5.0	9.9	23.5
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934933-42050357	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 129.2;lymphoid tissue: 142.5"	"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 94.2;REH: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	20.2	39.8	16.1	28.9	17.5	74.7	36.0	13.3	19.8	13.3	17.3	11.3	14.1	16.0	10.8	10.4	13.5	13.4	19.0	16.3	15.4	14.5	13.7	8.0	32.1	83.8	14.1	15.5	11.1	10.9	5.0	10.1	21.9	9.3	14.2	11.4	10.2	18.1	14.4	6.5	14.6	22.0	11.7	11.5	51.2	18.0	7.4	10.0	142.5	26.8	9.3	32.8	13.0	16.6	24.1	42.4	129.2	45.8	39.0	52.8	66.2	9.2	33.7	3.5	7.8	6.4	13.2	40.9	10.8	6.2	11.2	8.2	6.3	4.2	39.7	18.4	7.2	10.0	5.7	9.4	13.2	5.8	6.7	6.1	62.9	15.0	5.1	14.1	10.2	55.6	12.5	8.7	10.8	4.1	3.4	13.7	26.7	31.7	3.9	16.0	12.5	94.2	49.4	1.5	28.4	7.2	89.5	13.7	4.4	25.9	6.2	12.0	3.1	9.2	11.8	5.3	4.7	7.3	40.2	22.9	12.5	6.9	10.7	12.1	2.5	2.0	62.1	7.3	21.7	7.5	129.2	30.5	87.7	52.8	35.1	37.0	16.4	36.4	42.5	42.4	24.1	42.8	45.0	42.8	39.0	45.8	27.8	23.2	66.2	16.1	17.5	13.3	19.8	15.4	14.5	14.1	15.5	9.3	10.0	56.6	64.8	78.2	82.2	24.0	9.3	21.8	56.0	16.0	18.2	19.2	5.9	150.0	24.9	17.1	12.1	47.0	34.6	93.5	21.5	66.5	22.6	44.0	25.5	3.9	39.8	11.1	9.2	55.9	111.4	7.4	38.3	68.6	35.4	7.2	16.9	35.9	21.6	28.8	48.8	13.2	14.6	45.3	26.8	1.7	5.7	19.7	197.8	130.7	19.5	56.2
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	24.7	17.4	11.9	17.1	13.2	25.5	17.4	9.6	15.1	15.6	19.0	15.2	21.4	14.9	16.1	17.6	15.6	11.4	12.1	22.8	11.5	9.9	18.7	14.1	16.2	19.9	15.0	13.2	13.8	14.0	22.3	12.3	19.1	12.4	15.6	13.3	16.4	16.4	19.6	25.5	12.8	14.1	14.7	12.2	20.6	17.2	18.9	12.2	36.0	24.3	11.2	20.1	16.7	15.6	15.4	19.8	19.7	24.6	8.4	13.2	7.3	9.5	10.5	8.7	9.7	9.8	9.1	8.0	4.5	7.8	11.9	12.4	17.9	5.8	14.7	9.7	6.5	12.2	7.2	14.1	9.5	9.3	12.7	13.6	18.5	12.6	8.8	12.1	10.7	13.6	12.4	7.6	8.5	10.8	6.0	13.2	18.3	22.8	15.5	6.6	12.7	9.8	16.3	5.4	25.5	4.9	20.2	10.3	11.2	10.5	7.9	9.0	8.0	8.2	6.4	9.1	7.5	9.7	13.2	12.3	10.7	11.2	4.9	9.1	13.5	13.1	31.1	4.9	11.9	6.0	13.4	12.1	19.7	13.2	12.8	9.3	14.1	12.0	10.3	13.0	15.4	12.5	12.1	15.2	8.4	24.6	19.8	10.1	7.3	11.9	13.2	9.6	15.1	11.5	9.9	15.0	13.2	12.4	12.2	17.9	22.6	10.4	11.0	6.3	15.6	24.5	15.3	9.4	19.4	10.4	29.5	19.6	26.6	8.9	8.2	15.8	9.2	0.0	8.4	6.8	10.4	12.4	18.5	7.4	11.5	20.6	8.6	7.4	14.2	13.8	13.8	10.9	6.8	12.6	11.1	11.7	7.4	7.0	11.0	12.9	23.1	12.9	10.8	7.9	14.5	7.3	18.0	12.8	9.0	11.5
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 118.2;Glandular cells: 119.1;Pancreatic endocrine cells: 145.1;Urothelial cells: 193.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.6;CACO-2: 18.8;CAPAN-2: 15.6;OE19: 61.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	20.6	0.2	0.0	0.0	0.1	2.4	10.2	1.2	1.5	2.9	3.0	18.8	15.6	0.0	2.2	2.0	0.0	13.9	0.0	6.2	1.9	1.7	2.9	1.0	1.8	4.2	0.7	0.0	0.0	1.4	11.7	2.2	3.3	1.1	0.0	0.1	0.5	0.2	0.6	7.2	0.2	0.1	1.4	61.4	0.5	0.0	0.0	0.1	2.2	9.3	1.1	0.0	1.8	12.6	0.0	1.5	9.2	0.1	0.3	0.1	1.3	5.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2	41.7	17.6	0.0	50.1	46.6	0.8	3.6	40.8	61.6	53.4	48.8	19.6	10.6	0.0	41.6	12.9	0.5	80.5	0.0	118.2	0.5	8.4	119.1	1.1	0.0	0.7	4.8	7.0	1.8	1.6	91.9	0.6	1.2	11.8	5.4	33.6	0.5	145.1	43.5	1.4	5.6	7.4	0.0	2.1	4.3	8.3	71.6	3.4	2.2	37.9	193.5
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42180056	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 91.2;testis: 62.2"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Cell type enriched"	"Detected in single"	84	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in single"	84	"dendritic cells: 8.4"	"Group enriched"	"Detected in some"	8	"NTERA-2: 7.2;SH-SY5Y: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.2	0.2	2.7	0.3	10.0	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	1.5	5.4	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	91.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.1	62.2	0.1	0.1	0.1	0.1	0.5	0.3	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	10.0	0.1	0.8	1.5	5.4	1.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	118.0	0.3	0.0	0.0	0.0	0.0	628.3	0.4	0.0	0.0	108.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	62.0	0.0	0.0	0.0	331.5	1.7	0.0	0.0	9.0	0.0	125.6	0.0	0.0	1.8	0.0	949.8	0.0	0.0	2.8	1.9	0.0	0.2	0.0	0.0	0.0
AL096814.1		ENSG00000214732			6	42155426-42163439	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	183	"testis: 78.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.4;HL-60: 1.4;hTCEpi: 2.1;OE19: 1.3"					"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.1	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42184401-42194916	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"retina: 88.4"	"Group enriched"	"Detected in some"	10	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 52.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.6;U-698: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055479	Enhanced					NA	NA					"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.8	0.9	1.9	1.4	2.5	2.7	2.9	6.6	2.5	1.8	1.4	1.4	1.4	0.7	2.8	2.8	1.4	2.6	1.4	1.4	1.8	1.6	1.4	1.9	1.4	1.4	2.0	1.4	3.5	1.4	0.7	1.4	1.4	1.4	1.4	1.1	88.4	1.4	1.7	6.0	7.0	1.4	2.8	1.9	2.3	0.6	2.7	1.4	1.4	1.4	1.4	2.2	1.4	1.4	0.7	0.7	0.5	0.1	0.0	1.2	0.0	0.2	1.6	3.5	1.0	2.4	2.4	0.8	1.4	1.9	2.3	1.7	3.6	1.0	3.7	1.8	0.3	0.2	1.1	3.6	0.8	2.2	3.0	1.2	0.8	0.0	0.5	0.7	2.8	1.1	0.9	8.6	1.7	2.9	0.9	0.2	2.8	2.2	2.7	0.3	2.1	1.4	2.0	0.1	0.5	0.7	0.3	1.5	0.0	1.0	1.2	1.3	2.4	0.0	0.4	0.2	0.6	0.3	2.4	0.0	0.5	3.5	0.8	1.2	5.4	2.3	8.4	0.6	1.1	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.6	0.2	0.0	0.0	0.7	0.0	1.2	0.5	0.0	0.0	0.7	0.1	0.0	1.9	2.5	6.6	1.7	1.8	1.6	2.0	1.4	1.4	1.4	0.0	0.0	0.0	0.1	0.2	3.8	0.2	0.0	0.0	0.0	0.0	78.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	4.5	0.1	0.0	0.0	0.0	52.8	0.0	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.1
MRPS10	FLJ10567	ENSG00000048544	"Mitochondrial ribosomal protein S10"	P82664	6	42206801-42217865	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029133, HPA029134"	Supported		Approved	"Actin filaments,Mitochondria"		NA	NA			Mitochondria	"Actin filaments"	"HPA029133: AB_10600084, HPA029134: AB_10600058"	"unprognostic (1.06e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.50e-3)"	"unprognostic (5.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.04e-2)"	17.3	21.0	16.6	14.2	23.3	15.3	16.3	16.4	22.9	15.5	15.0	17.2	8.6	13.9	16.2	14.0	34.3	12.0	11.9	33.4	15.2	16.8	21.7	30.5	11.7	16.2	16.8	14.7	13.7	14.1	13.0	20.3	18.8	22.1	14.1	17.9	17.1	16.9	13.5	47.7	14.7	14.9	18.1	16.2	14.7	14.2	13.3	16.5	19.3	18.7	25.6	21.4	15.6	18.4	22.5	28.4	14.4	22.7	21.2	25.7	20.1	26.3	9.5	10.0	17.0	14.0	13.6	9.0	17.5	17.4	17.0	15.0	10.8	10.5	18.8	11.7	16.3	19.1	9.7	16.5	23.8	23.0	17.1	13.5	16.7	9.3	18.0	14.7	24.6	10.9	11.8	18.4	15.9	34.1	11.6	17.2	20.1	29.0	14.8	20.5	16.9	16.0	17.9	8.5	79.3	15.7	13.8	15.1	17.8	29.2	12.0	15.4	11.3	10.0	13.8	32.2	9.8	22.9	33.6	11.0	14.6	14.4	14.0	26.0	11.1	16.7	40.1	9.9	24.6	14.5	13.4	19.6	14.4	19.3	22.7	22.4	22.5	23.7	22.8	22.0	20.5	24.4	23.7	10.1	21.2	20.4	28.4	25.7	20.1	16.6	23.3	16.4	22.9	15.2	16.8	16.8	14.7	22.1	16.5	20.8	16.3	43.8	41.8	35.9	25.1	113.8	17.8	58.9	15.9	36.6	29.5	90.5	77.9	52.6	6.7	35.8	23.6	23.3	40.9	53.7	40.1	48.9	31.3	52.1	47.5	30.2	14.3	25.8	22.9	4.7	26.7	35.2	28.7	161.5	23.3	46.4	50.7	26.6	34.3	69.7	55.4	19.4	33.3	60.2	77.9	35.5	63.0	30.5	27.3	62.1
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 20.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.1"					"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	4.9	8.7	9.3	7.7	8.7	16.7	4.0	18.1	10.8	12.0	5.1	2.9	9.7	4.2	10.0	4.0	12.6	7.2	6.9	2.8	4.5	3.9	5.2	1.4	4.0	9.2	2.5	4.7	10.2	2.5	7.5	9.3	3.4	3.5	8.8	4.7	7.3	3.7	5.2	1.3	8.4	6.6	8.6	4.9	9.0	5.6	11.2	4.8	23.4	3.3	3.6	12.7	13.3	11.0	0.4	1.4	8.1	1.1	2.7	3.0	1.1	5.2	3.6	4.1	5.2	1.9	4.3	5.8	4.0	6.4	4.6	3.8	0.0	2.8	4.9	0.8	6.0	6.3	6.3	5.2	4.9	3.7	55.1	0.4	5.2	3.0	0.0	1.3	9.6	16.9	1.7	6.9	4.1	1.6	4.1	0.0	3.3	0.0	1.6	2.0	1.1	2.4	16.4	4.5	3.8	3.8	4.5	0.3	1.8	2.7	6.5	3.3	1.7	2.4	0.0	0.4	2.3	2.3	13.1	1.7	2.6	3.0	4.2	1.1	0.6	3.5	5.3	1.7	8.8	0.0	2.1	1.1	8.1	3.0	0.4	2.9	0.4	2.2	2.7	1.4	0.0	1.9	2.0	3.8	2.7	0.2	1.2	2.1	1.1	9.3	8.7	18.1	10.8	4.5	3.9	2.5	4.7	3.5	4.8	3.0	2.2	0.8	2.6	7.3	10.8	1.6	2.5	4.0	5.7	5.2	0.0	2.7	0.0	1.3	2.3	3.8	2.3	0.0	0.9	0.7	7.0	1.7	11.5	0.0	2.7	7.9	2.9	8.0	4.4	2.0	13.0	5.8	3.3	1.8	1.9	4.9	0.9	2.9	20.8	0.2	0.5	25.8	4.4	2.4	6.1	6.5	1.0	7.0	2.8	3.4
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	14.4	7.3	8.5	13.3	17.5	16.9	11.5	11.1	12.0	9.9	10.3	10.5	6.0	9.9	8.9	12.0	11.5	14.6	12.2	9.5	12.6	13.3	8.6	15.7	10.8	13.6	14.2	15.1	10.8	11.9	10.4	9.8	10.8	12.2	11.1	14.4	18.3	12.6	9.4	11.6	11.8	13.4	7.7	28.5	7.1	10.6	12.7	14.8	11.3	12.6	10.1	8.0	11.2	10.8	10.9	13.5	10.6	14.7	16.0	9.0	7.1	11.0	8.0	11.7	10.3	15.3	4.7	11.4	5.4	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2	14.9	21.1	12.8	17.4	14.7	41.6	32.9	22.9	25.4	22.7	19.2	56.9	14.8	14.9	14.7	4.6	21.1	31.4	93.5	13.2	11.0	18.8	19.9	19.7	28.1	12.0	60.4	12.1	18.4	28.9	3.9	23.6	24.6	18.6	17.2	19.6	23.5	14.1	22.9	22.6	9.6	50.0	38.8	23.4	9.2	8.1	14.2	14.4	32.0	18.0	18.7
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696600-42722574	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 117.8"	"Group enriched"	"Detected in some"	13	"Cone photoreceptor cells: 245.4;Rod photoreceptor cells: 471.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.3;ASC TERT1: 4.9;fHDF/TERT166: 7.1;HHSteC: 11.0;HSkMC: 8.5;LHCN-M2: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA					"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.0	0.8	1.5	1.0	1.0	0.0	1.0	1.0	4.8	1.7	2.0	1.0	1.0	0.3	2.3	2.3	1.0	0.9	1.2	1.4	1.1	3.0	1.0	1.0	1.2	1.0	1.1	1.0	3.4	2.0	6.9	2.7	1.0	1.0	1.4	0.8	117.8	1.0	1.3	14.4	0.0	1.1	2.3	1.0	1.0	1.0	3.5	1.0	1.0	5.2	1.0	1.0	1.0	1.0	0.6	0.3	3.4	0.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	4.3	4.9	1.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	11.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.4	0.2	0.8	0.2	0.3	0.0	0.3	0.6	0.4	0.2	2.5	0.2	0.6	0.0	0.3	0.0	1.5	1.0	1.0	3.0	1.1	3.0	1.1	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	23.7	0.6	0.0	0.0	0.0	0.0	245.4	0.0	3.3	0.1	0.0	0.2	0.0	0.0	0.2	0.0	1.4	0.2	0.0	0.0	0.0	11.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	28.3	0.7	0.0	1.8	0.0	471.5	0.0	1.5	2.5	0.1	0.3	0.1	0.0	0.0	0.0
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744481-42746096	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	5.8	6.1	8.6	9.4	8.0	19.0	6.2	10.9	15.7	7.6	7.6	7.9	6.9	7.4	8.7	7.1	6.4	8.5	8.5	8.0	6.6	7.1	7.0	5.6	5.9	14.1	7.7	8.4	8.0	7.8	3.0	7.3	7.2	10.9	6.9	5.0	6.0	7.4	6.8	13.5	8.7	7.9	5.5	6.6	8.5	7.4	8.4	6.6	9.4	7.8	4.1	10.0	7.7	6.6	31.6	46.3	54.8	30.2	52.1	48.8	49.5	15.4	5.1	7.9	14.7	11.5	7.7	10.4	10.7	12.1	11.9	13.0	7.9	6.1	14.0	8.6	10.3	9.9	13.6	10.6	10.6	6.7	7.6	11.6	7.3	7.6	13.3	13.1	7.9	12.0	12.6	13.0	9.2	7.6	10.7	9.3	7.9	16.7	12.8	10.6	19.0	6.5	15.3	7.4	42.3	14.1	6.6	9.5	9.1	11.3	8.5	30.5	13.2	6.9	12.0	18.3	7.6	13.2	27.1	10.0	11.4	10.2	9.2	14.6	17.0	19.1	23.6	5.6	10.9	10.9	37.6	30.2	54.8	37.2	25.3	37.7	31.6	39.4	40.3	27.3	30.7	46.1	42.6	53.4	52.1	22.6	46.3	48.8	49.5	8.6	8.0	10.9	15.7	6.6	7.1	7.7	8.4	10.9	6.6	3.0	29.5	40.3	21.8	22.2	53.4	5.9	25.5	9.4	4.5	10.4	39.3	18.0	28.2	33.2	18.6	16.2	21.8	0.0	27.2	20.1	17.5	13.9	30.1	8.3	16.4	17.5	43.4	19.6	10.0	7.0	16.4	15.1	27.0	33.3	15.6	48.9	25.4	25.9	19.4	19.2	46.6	19.4	22.1	30.9	24.0	21.8	17.6	63.3	16.6	22.1
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.5;Ciliated cells: 5.3;Club cells: 7.9;Hofbauer cells: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	12.7	7.1	9.8	11.0	10.9	8.3	12.1	39.6	14.4	12.6	10.6	16.3	10.0	7.2	14.6	9.8	8.0	13.0	8.8	8.4	8.5	9.2	7.7	6.8	9.3	17.5	9.1	12.0	20.9	9.8	17.5	16.2	6.2	10.7	11.8	11.9	17.1	10.6	10.7	9.8	12.8	10.1	12.1	9.6	12.2	9.0	10.5	10.3	17.1	14.0	6.3	14.6	13.4	11.4	2.8	1.4	7.5	1.6	2.9	4.5	1.1	5.0	4.0	3.6	5.8	7.5	8.8	3.2	4.5	4.6	4.0	3.1	1.8	3.6	11.7	4.1	7.5	6.2	4.0	3.5	4.6	6.6	8.7	2.2	8.2	4.0	5.1	4.0	6.9	7.5	5.3	9.0	3.9	7.2	7.6	4.1	7.0	7.8	10.5	4.7	6.0	1.1	4.0	4.0	19.8	2.5	7.2	2.1	11.6	4.0	3.3	12.4	6.6	5.0	7.3	5.1	3.7	6.4	8.2	4.7	5.6	5.6	3.6	4.4	9.6	5.5	18.0	3.3	8.9	3.9	3.9	1.1	5.1	4.5	0.8	4.0	2.5	2.8	4.4	0.9	2.8	2.7	3.3	7.5	2.9	1.6	1.4	3.1	1.1	9.8	10.9	39.6	14.4	8.5	9.2	9.1	12.0	10.7	10.3	8.9	6.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.9	3.5	0.0	1.5	0.0	3.3	0.0	0.0	0.0	0.0	3.3	1.6	0.0	0.0	1.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.8	0.0	0.0	3.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879618-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: AB_2681138"	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	17.5	22.1	19.9	14.4	27.5	9.0	19.9	20.5	35.9	14.8	14.2	16.9	16.4	11.9	15.7	17.4	18.9	17.2	10.2	14.4	17.6	16.5	18.8	23.5	11.9	16.5	14.9	20.4	17.4	16.9	22.9	22.4	15.1	17.9	17.0	17.0	13.2	17.4	14.4	19.9	16.3	12.8	16.5	13.9	15.4	13.7	33.0	14.5	25.1	17.8	15.6	20.3	13.7	13.3	15.4	12.5	10.2	13.6	16.4	18.6	10.6	31.3	10.0	17.8	28.5	16.8	21.7	12.1	25.1	18.3	24.4	20.2	24.8	12.0	47.2	22.8	21.1	19.9	15.1	40.4	30.6	40.6	24.7	30.4	25.1	14.1	22.4	18.5	38.7	19.5	22.2	23.5	32.0	31.0	16.6	23.9	20.9	48.5	16.3	22.2	23.1	22.0	25.2	17.9	96.5	14.8	25.3	20.0	29.9	19.0	19.9	34.1	20.8	21.5	16.5	26.4	14.7	22.1	37.5	22.8	23.7	19.8	18.7	43.3	20.6	32.1	71.8	13.2	36.8	24.6	5.6	11.4	10.2	14.9	13.6	18.6	13.3	14.6	15.5	10.8	15.4	15.5	14.9	2.6	16.4	11.9	12.5	12.0	10.6	19.9	27.5	20.5	35.9	17.6	16.5	14.9	20.4	17.9	14.5	71.5	90.2	79.6	70.6	50.7	62.2	36.8	43.3	96.4	85.3	40.1	31.4	75.2	72.9	77.0	9.5	60.8	22.6	93.5	57.9	63.9	52.5	52.0	48.7	57.8	46.3	68.3	90.5	48.5	37.5	8.6	73.4	44.1	28.7	74.9	39.6	69.6	70.8	31.6	67.1	57.2	58.0	51.8	56.9	40.4	84.8	52.7	66.9	64.5	43.4	52.0
C6orf226	LOC441150	ENSG00000221821	"Chromosome 6 open reading frame 226"	Q5I0X4	6	42890265-42890816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA045350	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA045350: AB_10964640"	"prognostic favorable (1.93e-5)"	"unprognostic (2.21e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.17e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.13e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (4.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.82e-3)"	16.5	21.7	14.4	11.5	15.2	22.6	23.3	11.0	17.0	9.0	11.1	8.2	11.3	16.3	11.7	21.9	11.1	9.6	9.9	15.1	13.3	15.5	12.4	16.2	11.0	25.8	13.1	11.7	10.5	15.5	8.7	16.4	5.8	14.5	13.1	4.1	12.2	11.9	16.4	22.1	17.5	12.3	16.3	13.8	13.8	12.1	12.9	8.2	14.0	9.4	12.6	7.4	11.4	7.2	13.6	20.9	17.3	18.8	18.7	19.5	12.2	6.5	5.1	4.6	9.4	5.1	4.5	5.6	4.1	2.2	5.0	6.5	1.9	2.3	1.4	8.6	1.9	3.2	5.3	1.2	2.6	1.5	6.2	9.6	5.2	4.7	13.0	5.3	1.4	3.8	5.1	3.5	2.5	1.1	1.4	3.9	5.6	0.3	7.7	3.1	13.2	10.5	8.9	1.7	6.5	4.3	4.7	3.3	6.8	2.7	5.2	9.2	11.1	7.8	3.4	10.1	1.7	8.3	4.1	5.1	4.0	11.9	7.4	3.8	18.7	14.1	21.6	2.5	2.8	2.7	6.1	18.7	17.3	15.6	14.2	11.6	13.3	19.5	15.8	20.9	13.6	15.4	18.8	8.3	18.7	18.8	19.7	15.7	12.2	14.4	15.2	11.0	14.4	13.3	15.5	13.1	11.7	14.5	8.2	11.9	7.2	11.5	17.4	12.8	27.5	13.9	20.4	26.8	9.1	21.0	5.9	20.1	56.3	17.3	1.0	15.3	8.8	0.0	28.6	7.4	14.0	14.0	6.9	16.3	19.3	28.6	9.4	8.0	23.1	1.3	13.6	18.6	28.7	16.2	9.8	38.9	17.4	11.9	12.7	30.5	22.4	0.0	13.7	1.4	3.6	14.9	14.0	22.5	8.8	17.3
PTCRA	"PT-ALPHA, PTA"	ENSG00000171611	"Pre T cell antigen receptor alpha"	Q6ISU1	6	42915989-42925835	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	20	"blood: 74.1;lymphoid tissue: 129.5"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 18.2;Kupffer cells: 8.0;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	39	"plasmacytoid DC: 74.1"	"Lineage enriched"	"Detected in many"	39	"dendritic cells: 74.1"	"Group enriched"	"Detected in some"	9	"MOLT-4: 29.5;SK-MEL-30: 10.0"															NA	NA						"unprognostic (5.50e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.83e-2)"	"unprognostic (6.57e-4)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.45e-1)"	0.5	0.2	0.1	0.5	0.1	2.9	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.4	5.0	5.2	0.5	0.1	0.1	0.1	0.0	0.1	1.1	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.0	0.3	0.1	0.8	9.7	0.0	0.1	0.1	129.5	0.1	0.1	4.4	0.1	0.1	0.0	74.1	1.8	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	74.1	0.0	6.6	0.1	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	18.2	0.0	0.0	0.6	8.0	0.0	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CNPY3	"CAG4A, TNRC5"	ENSG00000137161	"Canopy FGF signaling regulator 3"	Q9BT09	6	42929192-42939287	"Predicted intracellular proteins"	"Immunity, Innate immunity"	Chaperone	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.6"	"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 217.2;Kupffer cells: 210.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016560	Uncertain				"Intracellular and membrane"	NA	NA		530000			"HPA016560: AB_1858173"	"unprognostic (5.26e-3)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (8.15e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.70e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (9.85e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.98e-3)"	14.6	13.5	16.3	24.8	17.8	51.4	20.4	12.1	21.8	17.5	12.8	21.6	14.3	12.6	17.4	14.0	10.8	21.1	18.0	12.8	16.3	18.3	14.8	27.2	19.7	31.5	23.4	14.7	21.2	60.5	9.6	19.3	19.3	14.6	19.3	12.5	17.8	14.3	15.1	6.4	9.2	20.9	17.5	25.8	48.5	15.0	19.3	15.1	45.2	23.8	6.9	27.5	17.0	13.6	30.3	77.8	96.6	54.3	14.1	15.1	38.3	14.6	14.7	14.7	31.1	24.3	9.2	14.4	11.7	15.6	15.9	18.4	16.3	11.2	15.7	18.2	20.0	34.8	12.3	10.7	13.4	9.8	15.4	11.5	17.1	12.9	25.3	14.3	29.6	35.2	11.1	8.2	12.3	13.6	23.1	14.2	15.3	13.6	31.4	10.2	27.7	26.8	35.9	11.6	70.8	8.1	18.6	10.0	22.9	15.8	11.3	15.3	13.6	7.3	7.6	25.3	19.7	9.7	64.8	10.5	16.6	16.9	6.1	12.5	21.6	14.5	22.1	6.8	34.5	13.9	18.6	54.3	26.9	13.8	36.7	13.2	30.3	12.2	15.1	46.2	27.5	13.8	14.1	96.6	14.1	33.9	77.8	11.1	38.3	16.3	17.8	12.1	21.8	16.3	18.3	23.4	14.7	14.6	15.1	11.9	12.0	91.0	29.7	20.3	42.9	14.4	28.1	30.8	15.9	22.7	13.7	52.2	6.6	39.5	40.4	26.8	23.4	0.0	29.7	135.2	27.2	40.7	45.1	48.2	217.2	1.6	53.2	39.3	210.8	51.6	31.1	105.5	28.7	83.8	26.6	20.0	32.7	29.1	28.3	15.7	9.5	19.4	21.7	26.5	29.2	14.9	30.2	65.5	30.8	31.1
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell type enriched"	"Detected in many"	34	"Hepatocytes: 729.0"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Not detected"	"Not detected"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		150000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.1	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.7	0.2	0.4	0.9	0.6	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.5	0.0	1.1	2.4	0.4	0.0	0.4	0.2	1.2	0.0	3.8	1.5	1.9	0.3	2.3	2.0	3.7	0.2	0.5	0.5	1.7	1.6	1.0	0.9	0.2	12.4	1.7	0.1	1.7	0.6	0.5	7.9	3.6	0.4	0.9	0.9	0.5	1.0	1.3	1.2	1.5	0.2	2.1	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1	0.0	2.1	3.4	4.2	0.2	1.2	4.5	15.3	5.3	0.0	1.8	0.0	0.1	3.3	0.4	0.2	0.1	0.0	0.0	0.7	0.1	0.2	16.1	0.0	729.0	0.5	1.6	0.0	16.5	21.5	0.0	0.9	0.3	0.0	0.0	0.0	0.3	0.9	0.0	2.5	2.2	0.3	0.0	0.7	0.5	0.6	0.1	0.1	0.0	0.0	1.6
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	15.9	7.7	3.9	14.5	14.5	14.0	4.0	2.8	4.4	2.3	4.8	4.8	4.7	6.5	3.9	6.7	9.8	15.1	13.5	14.6	2.4	12.6	7.2	2.1	10.9	2.8	9.8	2.2	4.5	17.4	16.9	9.5	2.6	18.8	11.7	8.9	11.3	6.7	5.0	1.8	5.7	7.2	4.8	36.3	6.7	12.3	6.8	2.6	5.9	4.6	12.2	5.3	2.6	10.4	14.7	6.6	20.5	9.8	6.5	7.4	1.4	3.6	6.4	10.1	8.8	8.9	2.5	11.3	5.9	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2	6.0	1.6	2.7	8.8	4.4	14.5	4.5	5.1	5.3	3.4	7.0	2.0	7.7	11.6	2.4	2.2	4.0	12.4	0.0	1.3	5.7	6.4	6.2	0.0	10.5	4.9	20.6	5.2	9.8	6.7	2.2	13.6	2.8	8.5	1.0	7.4	10.6	1.7	7.0	8.9	9.8	6.4	0.0	5.2	7.7	2.8	4.8	6.2	4.4	8.0	5.5
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984499-43012342	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	17.9	14.4	19.7	17.0	31.5	15.1	14.2	28.3	41.0	20.2	24.5	13.7	15.9	31.1	20.7	11.4	18.1	19.0	14.3	22.0	17.7	18.4	15.7	15.8	15.0	16.2	16.6	25.1	20.7	16.5	17.4	11.2	16.6	26.3	18.4	18.6	16.5	13.7	19.2	41.0	17.9	36.4	20.8	11.2	14.4	14.9	27.1	13.1	35.5	13.4	11.1	14.7	19.1	18.5	9.2	12.5	17.9	11.3	11.8	19.7	15.3	24.4	12.9	19.8	25.8	12.3	16.9	11.1	13.6	9.7	27.2	24.1	20.9	6.7	18.3	13.2	16.5	18.8	13.9	26.6	15.6	24.4	15.6	23.1	21.9	16.0	19.6	8.5	15.1	16.1	9.3	10.3	21.7	9.9	15.5	20.7	23.1	22.9	14.2	15.7	10.4	38.8	13.8	8.8	55.4	12.3	27.2	24.5	12.0	8.3	11.6	25.1	16.5	18.4	12.3	14.7	17.1	17.2	14.1	19.6	19.6	18.2	20.5	21.6	14.7	18.5	37.6	7.7	14.1	16.9	14.8	11.3	17.9	16.8	9.8	17.6	9.2	15.3	19.0	11.6	9.0	11.8	14.1	6.9	11.8	7.4	12.5	19.7	15.3	19.7	31.5	28.3	41.0	17.7	18.4	16.6	25.1	26.3	13.1	8.9	7.0	5.2	2.5	7.4	11.6	4.0	5.1	4.0	7.9	7.0	9.8	6.2	5.0	5.8	4.2	6.2	21.7	0.0	6.8	8.7	8.5	2.9	8.1	10.9	8.0	3.2	8.6	8.0	5.9	5.3	8.9	4.2	10.1	6.4	7.6	7.3	7.9	8.4	13.8	3.8	7.5	6.5	8.0	7.5	9.4	8.3	3.8	7.4	9.5	1.7
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 109.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 615.5;Late spermatids: 1508.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	16.8	17.4	26.6	13.9	23.4	11.8	17.4	13.1	29.9	16.2	14.3	17.2	14.0	12.7	20.1	25.2	16.8	20.5	17.2	12.5	20.9	25.4	16.5	18.7	15.2	14.2	21.9	20.8	22.7	26.7	13.2	17.7	17.3	17.5	20.9	17.0	19.6	16.6	20.3	14.6	15.2	13.1	19.5	15.7	12.8	13.0	109.4	8.7	19.1	15.8	13.4	21.2	21.5	14.1	61.2	40.9	70.6	51.0	46.6	51.7	59.9	38.7	22.4	33.6	26.6	30.8	20.6	13.4	26.0	27.7	32.5	35.7	33.3	10.2	20.3	27.3	31.7	47.5	19.7	25.9	35.3	30.6	23.2	35.1	37.7	24.5	35.9	15.9	27.4	19.8	16.4	17.6	43.1	28.2	33.1	19.5	33.3	25.4	22.8	35.5	74.3	36.7	31.8	15.8	110.3	19.8	18.0	20.0	20.2	22.4	36.8	32.5	22.8	20.0	17.2	29.5	28.3	26.2	30.0	14.4	35.9	28.9	23.2	44.8	26.0	21.5	33.9	18.0	20.6	29.1	64.5	39.2	70.6	46.7	44.5	42.9	61.2	42.9	45.6	40.9	56.8	43.2	45.8	35.9	46.6	51.0	40.0	51.7	59.9	26.6	23.4	13.1	29.9	20.9	25.4	21.9	20.8	17.5	8.7	23.8	11.8	43.2	62.1	58.8	20.2	24.9	43.3	58.9	39.8	52.4	3.9	94.6	142.6	74.9	615.5	56.2	55.4	0.0	80.2	87.3	55.2	61.8	46.1	39.4	95.1	15.9	28.7	41.7	31.9	1508.8	58.7	50.6	64.1	93.8	42.8	52.2	71.4	49.1	56.3	121.5	14.8	116.4	68.9	194.8	94.1	60.9	71.1	58.2	45.3	74.3
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.7"	"Group enriched"	"Detected in all"	9	"Early spermatids: 436.9;Late spermatids: 1305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	16.1	19.0	37.2	11.6	41.6	14.7	17.6	38.0	68.2	15.2	16.7	14.6	15.4	14.4	12.8	21.2	16.1	19.9	13.6	34.0	34.2	25.7	14.8	20.2	14.4	14.4	26.7	41.6	20.3	15.2	15.6	17.6	20.9	29.6	16.3	15.0	13.5	21.3	18.5	122.7	15.1	14.7	15.9	14.6	14.1	15.4	47.0	15.3	17.4	19.3	17.6	15.6	13.7	11.2	19.5	39.4	41.6	36.3	21.6	31.5	29.8	26.4	8.2	27.3	45.6	18.8	14.2	19.6	12.0	15.5	23.5	25.8	23.5	13.9	26.3	13.7	17.5	8.8	14.1	29.0	15.5	16.1	14.0	39.5	32.7	23.6	24.4	18.5	19.2	23.4	22.8	15.6	18.1	10.6	18.3	22.7	30.1	39.7	18.8	8.8	32.9	31.4	33.1	35.5	66.8	8.8	30.6	20.0	31.5	14.4	15.4	50.6	39.5	12.7	14.6	20.4	18.5	25.4	55.7	13.4	10.7	20.0	11.8	11.8	20.6	25.8	38.2	4.7	27.6	9.0	14.9	36.3	41.6	28.5	33.8	24.0	19.2	23.8	25.8	39.4	19.5	31.5	24.5	17.7	21.6	25.8	21.8	25.1	29.8	37.2	41.6	38.0	68.2	34.2	25.7	26.7	41.6	29.6	15.3	11.9	17.1	31.9	30.7	16.7	29.1	32.5	30.6	5.3	6.8	17.4	13.7	84.7	72.9	52.9	436.9	20.2	33.8	23.3	48.1	97.9	40.2	39.5	13.8	24.5	56.1	30.2	50.3	24.5	35.6	1305.6	41.4	26.0	32.1	61.3	43.7	33.2	40.4	43.6	55.5	45.1	21.9	51.8	26.8	102.4	30.2	18.1	89.5	30.2	50.7	28.0
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	39.4	22.3	22.2	32.4	24.0	22.5	18.7	31.3	28.4	40.2	39.5	40.5	17.3	18.3	25.6	32.6	29.5	21.2	37.1	38.0	44.5	23.1	37.8	29.4	24.8	43.2	27.9	24.4	22.9	22.7	23.3	48.0	20.6	14.4	32.6	16.6	35.5	20.0	37.2	41.6	29.3	26.7	24.6	70.7	23.2	27.7	21.9	21.1	24.6	37.4	28.5	25.0	23.1	21.2	35.8	21.8	29.2	30.1	26.2	37.2	28.3	24.4	49.1	18.8	28.2	48.9	16.2	30.9	34.5	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8	0.0	14.1	20.6	9.5	11.8	15.3	13.7	28.1	8.1	12.5	19.2	15.7	25.9	11.6	31.6	8.6	11.3	10.5	0.0	38.9	36.9	13.2	13.1	5.8	34.3	25.3	17.5	13.4	22.1	14.3	18.5	10.9	13.4	13.5	28.9	11.3	25.1	32.5	7.0	17.7	16.1	17.2	6.5	12.0	7.6	10.2	16.3	28.1	10.0	12.8	12.1
CUL7	"dJ20C7.5, KIAA0076"	ENSG00000044090	"Cullin 7"	Q14999	6	43037617-43053945	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015449, HPA030095, HPA030096"	Approved					NA	NA					"CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997"	"unprognostic (2.32e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (8.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.35e-1)"	8.2	15.1	8.2	11.2	11.6	4.7	9.7	18.3	13.6	14.6	8.7	5.0	10.0	9.1	14.1	14.7	9.4	16.4	12.0	6.5	6.1	6.5	14.4	10.2	8.2	7.4	3.9	6.9	19.4	23.3	14.6	34.6	17.9	5.8	12.9	6.7	15.1	9.2	19.1	13.5	9.4	10.1	10.6	4.1	10.1	9.0	7.7	4.2	10.5	14.9	9.1	12.4	10.7	10.6	3.3	4.7	3.6	3.0	3.7	3.7	2.2	6.0	5.1	17.0	19.4	16.3	23.7	1.7	9.5	11.8	10.7	10.9	11.3	4.8	3.0	19.7	15.1	11.6	2.7	5.8	7.9	5.4	7.0	6.4	7.8	6.3	16.3	13.8	2.6	9.1	25.0	7.5	9.5	10.6	20.7	10.2	3.7	6.3	8.5	13.6	13.0	3.4	7.0	3.0	18.1	3.9	5.1	4.2	7.0	10.0	8.5	9.9	10.9	7.1	7.1	7.0	8.6	10.4	5.7	10.5	18.0	8.0	5.7	4.2	17.6	4.6	7.5	6.6	3.1	9.8	3.6	3.0	2.0	3.7	2.6	2.6	2.2	2.4	1.6	3.2	3.3	1.8	2.0	1.4	3.7	2.0	4.7	2.5	2.2	8.2	11.6	18.3	13.6	6.1	6.5	3.9	6.9	5.8	4.2	6.0	8.0	4.2	1.4	2.3	4.9	3.9	2.5	14.7	2.3	3.5	5.9	4.1	0.0	5.4	0.5	3.3	4.5	0.0	4.1	3.1	2.9	1.7	4.6	2.0	4.4	1.6	6.9	5.5	3.0	0.0	8.6	2.7	1.7	1.0	7.1	3.8	4.1	3.5	7.1	3.4	7.5	0.0	1.9	0.6	2.3	1.5	3.7	1.3	4.4	0.7
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075099	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 103.2;Paneth cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	6.1	9.7	13.1	8.5	11.5	5.3	6.9	25.0	15.2	7.6	35.0	10.2	8.1	35.1	8.5	12.3	5.6	9.3	15.2	12.2	13.8	10.8	13.6	47.2	8.2	5.8	12.2	13.7	11.2	9.1	17.6	13.3	5.9	12.1	8.6	17.4	9.0	11.4	8.4	9.9	8.7	55.7	7.4	9.2	6.6	16.0	22.6	13.2	6.7	10.9	4.5	5.4	10.2	9.9	5.6	12.2	9.0	3.7	6.1	7.0	3.3	3.5	3.2	8.7	10.4	8.6	8.5	7.7	2.9	4.8	5.3	8.2	5.3	6.3	5.3	10.7	7.0	7.0	6.3	8.7	8.2	4.3	5.3	10.6	6.2	9.2	23.4	8.3	3.0	4.9	11.1	10.3	6.4	6.3	16.8	6.7	11.0	4.2	7.1	4.4	7.2	7.9	6.5	3.4	35.5	4.4	6.4	4.9	10.2	8.1	3.6	14.3	7.0	5.7	5.0	11.1	8.3	9.1	7.6	4.8	6.1	7.2	3.0	3.0	14.1	5.0	12.9	3.3	4.5	2.1	2.6	3.7	4.4	4.0	3.6	5.1	5.6	5.5	3.9	4.2	4.3	7.0	4.8	9.0	6.1	3.6	12.2	6.4	3.3	13.1	11.5	25.0	15.2	13.8	10.8	12.2	13.7	12.1	13.2	14.9	11.8	3.9	8.3	3.3	20.8	10.2	22.9	21.4	5.7	14.0	27.5	9.4	16.6	6.6	6.1	4.4	103.2	0.0	8.7	4.1	5.1	5.1	6.9	51.3	5.8	11.1	21.5	5.5	3.7	6.8	9.5	2.5	3.3	6.4	36.2	15.8	6.6	59.6	6.3	20.0	25.7	12.9	4.4	20.9	15.5	4.0	11.3	4.9	35.1	5.0
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059806	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	16.9	19.9	17.4	13.1	22.5	16.0	14.2	13.6	21.8	13.0	15.6	13.3	16.4	20.3	14.1	16.9	13.6	16.2	15.5	31.7	16.0	16.8	20.9	55.0	12.9	16.2	18.8	20.3	15.7	17.4	25.8	17.8	11.7	15.3	12.9	15.0	12.6	21.1	19.6	53.2	13.8	15.2	13.4	12.4	11.5	13.4	21.0	13.2	17.5	15.7	25.5	12.3	12.4	11.9	21.0	26.9	14.3	18.5	17.5	16.9	13.6	10.9	12.6	6.3	11.0	7.7	6.2	9.8	4.9	7.0	12.8	11.5	24.1	3.8	15.5	12.3	6.8	9.5	11.6	13.6	13.1	8.0	9.0	28.2	12.5	10.2	29.1	15.2	10.4	6.1	8.1	13.9	14.8	20.1	6.7	9.0	19.8	20.9	10.4	6.8	21.3	13.4	37.0	5.7	42.2	14.9	15.6	6.3	19.8	9.6	6.9	15.2	7.9	4.8	8.5	15.0	5.6	9.6	18.7	8.1	7.5	10.1	9.9	13.6	12.1	11.0	32.0	5.5	16.8	7.3	6.8	18.5	14.3	13.5	17.2	16.9	20.4	15.6	16.0	25.2	21.0	15.9	16.1	5.5	17.5	13.4	26.9	16.6	13.6	17.4	22.5	13.6	21.8	16.0	16.8	18.8	20.3	15.3	13.2	20.8	15.2	33.7	27.7	21.6	18.7	34.1	35.7	29.4	27.3	57.6	25.5	66.2	157.5	45.9	72.1	31.5	50.7	46.7	46.7	41.8	35.6	25.5	27.7	68.6	44.0	4.8	29.4	30.1	23.0	24.4	50.9	27.0	50.6	45.1	37.0	29.6	38.4	49.5	48.4	109.4	17.2	25.8	39.1	33.4	34.3	23.7	53.1	27.7	57.2	21.0
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 314.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 13.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		10000000			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9.0	9.0	20.9	4.2	18.2	3.3	13.9	15.0	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0.0	13.8	0.3	0.0	0.7	1.5	0.8	2.1	0.6	21.1	35.0	22.7	23.3	30.0	22.6	36.5	19.8	25.4	19.0	7.6	0.0	17.9	26.3	14.4	24.5	9.4	21.5	12.6	0.1	11.7	2.0	4.3	25.5	34.5	0.0	0.1	33.3	19.5	26.1	8.3	34.6	2.5	8.5	1.3	0.0	9.0	1.6	7.6	3.0	9.8	0.2	1.7	7.7	30.0	0.0	15.3	10.5	12.1	23.0	3.6	0.3	11.7	23.2	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0.0	3.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	1.5	0.2	0.7	0.0	13.8	0.0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4	14.9	12.5	0.0	16.8	15.3	1.4	1.6	2.5	2.7	6.8	12.2	53.0	18.9	1.7	19.2	314.6	1.0	0.2	0.0	6.2	1.9	31.6	10.9	1.1	0.0	3.1	0.0	20.7	1.8	0.0	38.8	17.0	1.1	15.1	1.0	1.2	19.8	8.6	3.5	17.3	0.5	1.7	12.9	9.5	2.4	18.5	9.2	6.9	0.7	2.6	9.7
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171299-43181507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	17.7	8.1	10.7	15.6	12.3	14.1	12.9	11.6	14.5	24.9	38.1	10.6	17.9	8.1	35.3	14.9	28.2	24.8	23.7	30.6	9.4	6.5	10.5	11.3	13.9	11.8	7.8	6.2	25.6	13.1	13.8	10.1	14.1	7.5	26.9	9.4	15.4	8.7	29.9	29.7	10.2	16.8	47.9	5.4	18.2	20.8	10.0	8.1	16.1	14.9	14.6	13.2	36.0	17.7	1.9	3.7	4.7	2.9	1.1	3.1	1.0	16.6	6.7	15.5	10.2	9.2	7.6	22.9	15.3	12.6	13.3	8.3	17.8	5.0	21.1	14.0	16.3	16.8	13.5	15.8	13.4	11.7	23.2	15.5	19.1	13.1	17.5	17.6	17.8	23.3	13.0	14.7	20.4	15.1	12.6	11.0	18.4	13.5	16.6	10.0	17.9	22.0	15.6	10.8	37.6	8.2	16.9	15.9	7.5	9.7	10.8	9.1	8.3	12.5	9.6	15.1	12.5	9.8	33.2	13.3	15.8	12.1	15.1	26.1	11.6	9.5	35.5	9.8	12.8	10.6	1.7	1.7	2.9	3.1	2.9	2.5	1.9	1.8	2.3	1.8	1.9	1.4	2.4	4.7	1.1	2.3	3.7	2.1	1.0	10.7	12.3	11.6	14.5	9.4	6.5	7.8	6.2	7.5	8.1	35.7	22.7	0.8	54.0	69.3	5.9	70.5	17.8	14.7	22.7	10.4	19.6	7.6	0.0	11.9	2.0	17.6	20.9	23.3	17.1	18.5	16.9	16.7	7.0	42.9	11.0	9.5	98.0	16.5	14.3	1.1	11.5	7.2	23.6	4.6	25.7	8.7	18.4	17.5	27.3	2.8	7.3	12.9	18.4	3.0	3.2	58.5	10.2	6.9	18.3	29.6
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182175-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	68	"Early spermatids: 532.1;Late spermatids: 1222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	6.2	9.2	11.7	9.5	13.9	12.8	6.9	12.5	13.8	7.4	8.5	12.9	7.3	8.2	11.2	6.5	11.5	10.7	8.5	5.5	10.0	6.4	7.7	5.6	7.5	11.7	10.0	9.8	9.5	8.6	13.2	15.9	5.0	9.2	8.3	5.1	11.2	8.7	9.3	6.0	16.1	10.2	7.7	6.9	10.1	8.7	12.5	10.4	10.8	10.9	4.9	10.8	12.0	7.0	1.1	1.1	0.5	0.9	0.3	2.6	1.0	7.5	5.6	3.1	7.4	8.8	5.2	4.2	3.0	5.4	4.9	4.6	1.8	3.2	6.3	5.9	4.8	4.4	5.5	2.6	6.4	2.3	7.6	2.4	6.9	6.0	2.8	5.7	4.3	11.4	7.1	13.5	4.0	3.6	4.3	7.1	11.1	3.6	8.4	4.3	7.0	8.7	6.3	0.5	14.7	3.6	12.9	2.1	6.2	3.7	7.9	5.3	7.6	4.0	4.9	6.8	2.8	8.3	9.8	6.5	12.3	8.5	3.6	5.7	8.0	7.5	5.1	3.1	7.7	5.5	0.0	0.9	0.3	1.2	0.5	1.3	1.1	0.7	2.6	1.1	0.8	0.6	1.4	0.5	0.3	0.4	0.9	2.5	1.0	11.7	13.9	12.5	13.8	10.0	6.4	10.0	9.8	9.2	10.4	0.0	8.0	4.4	2.2	5.7	9.5	4.4	12.7	4.0	4.5	3.5	11.8	2.7	3.3	3.1	532.1	5.8	7.4	0.0	5.4	1.5	2.8	1.9	2.3	5.5	10.6	11.1	5.8	9.2	5.7	1222.3	10.3	4.6	3.3	4.6	6.5	9.5	4.8	0.0	7.8	4.6	10.0	12.9	3.9	9.3	9.7	4.8	2.2	4.9	6.2	2.4
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229484	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 381.3;Proximal tubular cells: 791.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		370000	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	17.4	25.5	24.1	16.2	27.5	10.1	8.4	7.0	18.7	11.9	39.3	15.0	10.2	53.1	12.3	13.2	19.3	19.5	18.5	12.0	17.3	16.7	48.7	34.7	10.0	14.8	17.2	14.0	13.7	38.8	17.2	9.3	7.3	13.4	13.1	9.7	16.9	22.4	11.8	40.8	10.7	51.0	10.4	10.4	18.8	22.2	5.4	10.8	14.6	14.2	19.2	19.3	12.2	8.9	44.1	36.2	0.9	46.7	7.5	52.6	19.5	32.0	23.5	3.6	15.2	2.6	8.1	11.4	7.8	2.8	5.3	7.0	9.6	11.7	23.1	12.4	2.6	0.2	16.4	2.8	6.2	1.5	12.3	55.9	10.8	21.5	27.2	6.2	9.1	7.1	5.1	7.9	1.6	4.8	2.1	6.9	16.9	24.6	41.0	4.2	53.1	8.7	22.9	7.3	93.7	14.3	14.8	4.9	58.5	9.1	11.0	14.2	17.1	7.2	19.1	15.7	1.2	26.3	30.5	8.6	4.0	7.0	9.1	15.3	28.7	13.1	18.0	2.5	12.3	6.3	0.1	23.3	0.9	9.2	46.7	16.7	44.1	30.4	16.2	36.2	38.2	27.2	18.3	0.8	7.5	33.2	27.4	52.6	19.5	24.1	27.5	7.0	18.7	17.3	16.7	17.2	14.0	13.4	10.8	26.8	33.9	82.4	72.2	54.5	10.6	78.7	186.0	178.0	37.5	109.9	2.0	50.2	381.3	174.9	0.5	25.1	264.9	0.0	92.9	48.7	52.6	77.9	34.5	174.5	265.7	6.4	62.2	33.2	57.1	2.2	62.2	60.3	104.6	40.5	164.0	37.3	143.5	157.8	56.3	791.8	15.3	0.0	47.4	5.4	42.8	64.4	27.0	27.7	262.6	70.6
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243680-43288259	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"SCLC-21H: 21.3;SH-SY5Y: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	1.1	3.9	12.4	1.3	12.9	0.9	1.0	14.9	28.9	1.0	1.4	8.2	0.0	4.6	1.0	1.0	1.0	1.1	1.4	1.3	10.3	7.5	1.7	3.5	1.1	1.2	7.1	12.5	1.0	1.4	1.6	7.7	1.0	9.0	1.3	1.3	0.7	1.0	1.2	1.0	1.0	6.8	1.1	6.2	1.2	1.3	2.3	8.3	0.0	1.0	0.0	1.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	21.3	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.4	12.9	14.9	21.7	10.3	7.5	7.1	12.5	9.0	8.3	0.0	0.0	0.0	0.0	0.0	6.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	4.8	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 88.9"	"Group enriched"	"Detected in some"	16	"Hepatocytes: 185.6;Proximal tubular cells: 86.1"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enriched"	"Detected in single"	19	"Hep G2: 14.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA					"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	88.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.3	2.5	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.6	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;heart muscle: 24.8;liver: 29.0"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Distal tubular cells: 8.3;Late spermatids: 6.8;Spermatocytes: 5.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	14	"myeloid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;HEK 293: 4.9;HeLa: 5.1;Hep G2: 9.2;NTERA-2: 8.4;RPMI-8226: 6.8;THP-1: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.4	0.5	4.2	5.6	5.8	2.5	2.1	9.4	3.0	0.8	0.8	0.6	3.1	2.2	0.8	2.7	0.9	1.0	4.6	24.8	3.5	3.5	10.4	29.0	0.6	5.3	2.3	2.2	1.0	2.4	0.8	1.1	0.7	2.1	4.1	0.5	1.0	0.7	9.5	0.5	1.8	4.5	1.0	1.7	4.4	0.3	13.5	0.4	0.6	1.1	0.4	6.1	1.8	0.5	1.7	25.5	0.5	1.5	0.2	0.0	0.9	0.0	1.2	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.4	0.0	0.2	0.9	4.1	0.1	0.0	0.0	4.9	0.0	5.1	9.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	6.8	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.9	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	1.5	0.5	0.0	1.0	0.0	1.4	0.0	0.0	25.5	1.7	0.0	0.0	0.4	0.2	1.3	0.2	0.0	0.9	4.2	5.8	9.4	3.0	3.5	3.5	2.3	2.2	2.1	0.4	0.0	0.0	2.2	0.2	0.6	0.4	1.8	5.1	0.0	0.0	0.0	0.0	0.0	8.3	0.8	3.1	0.0	0.3	0.0	0.2	0.0	0.2	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.8	6.8	1.1	0.0	0.0	1.0	0.0	0.3	0.4	0.0	0.0	2.4	0.7	0.0	0.0	5.9	0.9	0.0	0.0	0.0	0.1	0.1
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369478	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 78.2;Spermatogonia: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 6.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.3	7.1	14.2	15.3	13.7	9.9	12.2	24.7	17.7	12.5	8.9	10.4	9.2	7.1	12.7	11.1	7.0	9.0	7.1	7.6	12.8	6.3	7.3	8.3	9.2	23.6	15.4	9.4	13.2	8.6	14.6	8.0	7.9	11.4	10.2	8.2	7.9	7.9	8.6	8.6	11.7	10.0	9.2	9.0	14.6	6.8	39.2	16.8	10.0	13.7	4.7	23.6	9.8	10.9	6.3	0.9	0.4	0.7	0.7	1.4	0.5	15.4	3.9	11.3	18.8	10.0	9.0	5.6	6.7	8.9	8.2	7.1	4.1	2.0	24.6	3.8	8.9	9.6	7.0	12.6	5.9	10.7	6.4	6.4	6.8	5.0	6.5	5.0	12.1	5.5	5.7	6.3	6.9	6.1	6.9	6.3	7.0	9.1	12.3	8.6	5.5	3.6	7.7	5.1	26.2	3.7	4.5	11.0	3.9	4.5	3.7	10.4	6.4	5.2	4.6	5.5	9.2	5.7	16.9	6.3	11.5	5.7	7.7	6.6	7.3	5.9	17.6	3.6	9.3	6.4	0.0	0.7	0.0	1.4	0.5	0.4	1.4	1.2	0.9	0.9	6.3	0.9	1.0	0.4	0.7	0.4	0.7	1.2	0.5	14.2	13.7	24.7	17.7	12.8	6.3	15.4	9.4	11.4	16.8	8.9	12.6	7.3	4.2	8.7	15.4	7.7	12.7	6.7	7.9	8.7	7.9	4.9	3.3	4.1	21.1	4.7	5.7	0.0	4.0	3.8	6.4	3.2	5.8	16.8	5.5	23.8	5.2	14.1	10.8	12.9	5.8	6.6	3.3	4.6	4.9	10.2	4.2	9.1	9.2	3.4	12.1	25.8	3.9	78.2	41.7	4.4	1.5	5.0	8.5	1.3
ABCC10	"EST182763, MRP7, SIMRP7"	ENSG00000124574	"ATP binding cassette subfamily C member 10"	Q5T3U5	6	43427366-43450430	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041607, HPA045464"	Approved					NA	NA					"HPA041607: AB_2677579, HPA045464: AB_2679336"	"unprognostic (2.41e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.80e-2)"	9.2	15.0	13.5	14.4	11.0	11.5	12.6	23.1	15.5	10.3	12.7	12.3	17.1	16.0	15.8	15.1	14.0	12.1	15.6	8.6	12.0	12.8	12.0	11.0	15.9	13.7	10.7	11.7	17.8	30.2	11.0	19.2	15.0	11.2	14.8	13.4	11.6	16.1	14.2	7.8	16.9	17.6	14.9	9.9	13.8	14.3	8.5	9.7	16.2	11.7	6.5	16.7	13.0	11.9	2.1	2.2	7.3	3.5	2.2	6.1	2.8	9.2	4.8	6.3	14.3	13.9	9.0	6.6	9.8	6.9	7.3	6.3	10.5	4.0	1.9	11.6	11.8	5.8	11.7	4.2	7.6	5.3	11.9	8.4	6.7	5.3	20.7	8.6	9.1	10.0	15.5	10.1	9.8	5.4	7.4	9.9	6.4	7.7	10.7	8.6	9.1	5.3	14.1	4.1	22.5	5.8	2.7	1.6	6.7	8.5	15.3	8.8	7.1	5.8	8.3	7.0	5.8	8.1	9.0	10.2	9.1	3.1	8.4	11.6	9.7	4.2	4.8	4.3	6.6	4.2	7.3	3.5	4.2	6.1	1.4	2.6	2.1	4.6	5.4	2.2	1.9	2.7	3.8	1.3	2.2	3.0	1.6	5.2	2.8	13.5	11.0	23.1	15.5	12.0	12.8	10.7	11.7	11.2	9.7	3.0	6.4	0.5	6.4	1.0	8.7	1.9	2.5	10.7	2.3	0.0	9.8	6.1	1.7	3.9	0.7	3.9	4.2	0.0	2.8	4.9	3.9	1.8	5.8	1.5	6.0	11.1	7.5	6.7	3.4	0.4	6.9	4.6	3.3	2.8	4.6	2.8	4.6	4.5	5.6	2.4	4.6	0.0	2.8	1.7	4.4	1.6	3.7	6.9	4.0	2.4
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 19.3"	"Cell type enriched"	"Detected in some"	7	"Basal glandular cells: 79.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	1.0	1.1	4.5	1.4	7.9	1.7	4.3	12.2	8.2	2.2	0.7	0.9	6.4	1.1	1.4	3.8	10.5	1.1	0.9	1.8	4.1	4.6	0.7	0.7	1.1	1.7	1.5	4.8	1.7	1.5	0.4	0.5	1.3	0.9	10.4	0.5	0.3	12.4	13.0	0.7	19.3	1.0	0.6	1.5	1.5	1.1	1.1	1.2	1.3	0.8	4.7	3.9	2.2	5.3	0.8	1.8	1.0	0.5	2.5	3.2	0.3	5.2	1.9	0.5	7.9	0.0	0.4	1.8	1.9	2.1	2.2	1.0	1.8	0.2	1.0	1.2	0.4	2.7	16.5	5.6	9.0	0.5	1.0	2.1	0.4	0.9	2.8	0.6	0.3	1.1	0.9	27.2	0.6	5.1	0.7	0.0	3.1	0.4	0.8	0.8	2.0	0.4	0.4	0.7	2.0	2.0	1.1	1.0	0.5	0.3	1.8	5.9	0.6	0.6	0.2	0.3	0.4	0.5	1.6	0.5	0.8	2.5	0.6	3.8	1.2	0.3	1.7	0.1	0.7	0.5	0.9	0.4	0.4	0.7	0.3	3.2	0.6	2.2	2.2	0.1	0.8	0.9	0.4	1.0	2.5	0.5	1.8	0.3	0.3	4.5	7.9	12.2	8.2	4.1	4.6	1.5	4.8	0.9	1.2	0.0	0.3	0.0	79.5	9.0	0.6	0.5	0.0	0.0	7.9	0.0	0.0	0.8	0.0	0.1	0.2	0.3	0.0	0.0	0.0	2.1	0.2	4.3	0.0	0.0	0.1	11.1	1.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	0.0	0.3	1.2	5.5	2.3	0.2	0.0	0.0	3.9
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	15.9	21.1	24.1	17.9	42.4	18.0	16.6	17.4	32.4	17.4	18.4	59.9	14.1	22.3	23.1	12.4	13.2	18.7	14.9	18.5	22.4	11.2	14.8	16.3	15.9	20.8	45.2	18.3	31.4	22.6	17.4	17.0	16.4	25.2	21.2	10.6	17.6	21.1	19.9	28.4	15.5	19.3	17.2	25.3	22.2	17.0	18.7	46.7	14.4	21.2	9.0	16.0	18.0	15.8	10.2	7.6	15.2	10.7	6.6	12.9	8.7	21.1	8.4	14.8	22.1	12.0	11.3	16.4	13.5	14.5	14.4	15.7	12.6	9.3	11.8	10.3	12.4	13.8	18.8	12.3	16.1	9.3	20.2	19.1	15.0	14.7	13.7	14.5	15.2	21.8	12.9	21.8	17.9	15.8	11.4	9.4	15.4	12.8	22.4	12.7	11.8	14.8	25.3	12.9	36.4	12.9	17.9	9.7	12.6	8.8	11.7	9.8	13.6	11.5	7.1	17.7	9.6	12.6	30.0	8.2	19.4	15.0	16.0	19.9	16.5	13.5	21.1	8.4	17.5	16.3	15.2	9.6	7.2	10.4	10.7	12.9	9.1	8.4	8.8	7.2	10.2	9.6	10.3	5.3	6.6	9.1	7.6	4.8	8.7	24.1	42.4	17.4	32.4	22.4	11.2	45.2	18.3	25.2	46.7	11.9	10.1	7.5	13.4	6.6	9.5	6.7	10.2	5.3	4.5	12.2	27.5	17.0	3.3	7.2	0.9	9.0	6.7	0.0	7.1	14.3	9.9	11.3	14.9	6.7	8.6	7.9	10.9	4.9	5.3	1.1	9.8	8.2	5.0	8.2	7.4	8.2	8.0	6.8	12.0	4.5	14.4	6.5	9.2	11.7	11.9	3.1	15.7	7.1	6.2	7.4
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5;testis: 31.6"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 299.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	1.2	6.1	10.4	0.9	19.4	0.8	1.1	2.3	23.5	1.4	1.3	2.3	0.9	2.1	1.4	1.5	1.0	11.3	1.8	1.8	8.9	5.2	3.0	1.2	1.6	0.9	3.1	12.1	2.0	2.8	7.5	4.1	1.2	6.2	1.9	1.1	0.6	1.4	2.1	1.0	1.1	1.2	1.5	1.1	1.2	1.8	31.6	1.8	0.0	1.6	0.0	0.9	1.4	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.8	5.7	0.9	2.9	0.2	0.2	1.6	0.5	0.3	0.0	0.3	0.2	0.1	1.0	0.8	2.2	0.7	0.7	0.0	0.1	0.9	0.0	0.4	0.2	0.9	0.0	0.1	0.5	1.1	1.8	0.3	2.8	0.1	0.3	0.3	0.5	1.0	5.7	0.0	0.0	0.1	8.0	0.7	0.0	0.0	0.1	1.5	0.0	2.1	2.5	0.5	0.4	0.2	0.0	5.8	0.0	0.2	0.4	0.6	2.1	0.2	0.5	0.3	0.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	19.4	2.3	23.5	8.9	5.2	3.1	12.1	6.2	1.8	0.0	0.0	0.0	2.4	0.3	4.9	0.8	0.0	8.1	2.3	3.5	0.0	0.1	6.6	0.6	299.6	0.1	1.3	0.0	0.7	0.1	0.6	2.3	0.0	0.4	0.1	27.0	5.2	0.0	0.0	27.3	4.0	0.0	1.7	0.0	2.0	8.3	0.2	0.0	3.9	5.1	6.6	6.5	1.1	41.7	9.7	0.0	0.2	0.0	0.6	0.6
POLR1C	"RPA39, RPA40, RPA5, RPAC1"	ENSG00000171453	"RNA polymerase I subunit C"	O15160	6	43509702-43562419	"Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	16.2	20.8	11.8	15.6	18.6	7.4	22.1	11.8	19.2	19.1	19.1	16.4	14.1	14.0	22.5	18.0	24.0	23.3	14.5	12.7	11.7	13.3	26.9	26.6	12.4	13.5	12.4	10.3	22.9	30.7	14.2	20.5	18.5	13.4	19.3	17.4	19.1	24.1	15.4	17.5	21.9	12.8	16.2	9.9	21.3	16.1	20.9	11.4	17.4	35.2	18.3	27.9	16.3	16.8	23.0	18.6	2.1	13.4	17.5	26.2	14.7	19.8	16.6	7.3	19.7	11.2	12.2	11.5	12.1	9.0	13.7	11.7	21.9	6.7	22.5	13.3	11.8	11.7	12.1	17.5	15.5	16.0	11.9	18.3	15.3	16.7	30.3	14.1	23.4	10.8	10.8	15.0	18.7	23.7	8.1	10.7	9.5	35.3	6.6	11.9	28.0	12.2	17.0	13.4	80.8	14.4	8.4	11.4	15.1	16.4	27.8	13.5	9.0	10.6	9.2	16.0	5.6	10.0	20.7	12.7	9.8	13.2	10.5	19.1	9.6	21.2	37.6	6.6	16.1	10.8	2.1	13.4	1.9	16.0	10.3	21.7	21.6	19.0	15.8	18.6	23.0	26.2	23.5	1.3	17.5	8.3	16.9	13.6	14.7	11.8	18.6	11.8	19.2	11.7	13.3	12.4	10.3	13.4	11.4	11.9	15.3	11.0	39.5	55.0	7.2	4.5	17.8	44.2	26.1	5.2	5.9	25.7	13.3	23.9	7.2	21.5	4.9	0.0	21.0	14.4	16.4	14.9	13.9	11.1	11.7	4.8	12.5	15.4	7.0	5.6	10.6	9.4	20.3	6.4	11.2	8.1	16.9	14.0	11.0	20.8	14.5	6.5	25.3	27.7	39.0	35.8	11.3	14.1	15.2	34.1
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511827-43516990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	26.8	51.0	26.1	20.3	36.8	19.3	28.1	24.2	48.9	33.5	30.4	38.1	40.3	31.9	31.2	50.5	31.9	34.4	39.9	30.9	26.2	25.5	44.2	62.0	30.0	21.1	26.1	21.4	34.0	73.7	47.0	38.9	59.3	29.7	36.0	29.9	36.8	75.4	31.8	30.6	26.9	38.4	27.4	28.1	28.0	38.8	27.8	22.6	27.9	51.2	31.3	32.9	32.8	26.5	11.7	18.5	74.3	19.7	14.6	18.3	16.0	19.0	13.4	19.8	38.3	44.6	36.1	11.9	23.0	35.7	19.1	24.2	16.0	13.9	7.8	18.4	42.2	16.5	19.2	14.5	22.4	12.1	14.3	20.8	12.2	19.8	30.4	34.6	12.9	18.4	36.0	29.3	16.2	16.1	32.5	28.7	13.3	13.2	18.1	22.7	29.2	9.8	16.5	10.2	99.8	14.9	8.7	9.1	20.6	34.0	20.3	16.0	22.9	10.4	13.9	24.3	15.7	22.9	27.2	27.3	21.7	11.4	11.9	15.8	21.3	17.1	15.5	15.4	11.2	14.6	26.2	19.7	28.3	15.3	18.5	13.3	11.7	13.8	13.5	18.5	11.7	11.3	12.6	74.3	14.6	18.4	17.0	18.3	16.0	26.1	36.8	24.2	48.9	26.2	25.5	26.1	21.4	29.7	22.6	32.8	25.2	38.7	57.7	36.1	56.4	26.7	56.0	32.1	39.8	52.4	35.3	167.5	41.4	124.0	24.9	56.8	99.6	23.3	88.8	180.7	66.2	64.5	40.3	62.3	87.8	55.6	102.8	65.7	41.3	59.8	64.7	40.3	62.4	92.8	108.3	110.5	105.8	94.7	62.9	58.6	49.3	32.3	47.5	38.7	38.1	31.0	220.8	42.4	69.7	72.1
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522330-43576075	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.2;Spermatogonia: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	11.5	12.2	9.5	10.8	14.0	9.0	10.8	14.6	15.4	9.6	8.8	11.5	8.3	7.8	12.0	12.0	16.7	9.8	7.5	8.9	8.0	7.3	10.0	13.1	9.4	10.0	9.5	8.0	11.9	19.7	17.7	16.1	9.5	9.4	10.5	11.5	9.7	12.9	10.6	14.9	15.3	8.6	12.3	8.0	9.9	11.2	42.3	9.7	18.3	16.7	8.5	13.7	10.5	10.4	3.7	5.9	3.6	11.7	8.4	6.8	4.4	15.6	9.4	15.7	31.6	8.2	6.9	14.6	8.2	5.8	16.2	11.8	25.8	5.5	21.3	10.7	7.8	15.3	13.5	26.1	11.9	18.3	15.4	20.7	20.6	11.3	18.7	11.8	22.7	11.0	5.0	12.4	17.0	26.6	5.8	11.5	15.3	44.1	16.8	10.9	19.2	17.1	11.3	16.8	43.1	9.6	18.7	16.7	15.9	9.3	12.3	32.5	13.4	11.4	10.5	14.6	14.4	12.1	18.3	9.6	12.0	14.3	11.4	17.2	10.7	11.7	41.9	4.3	19.9	12.8	0.0	5.0	3.6	6.3	6.4	5.8	3.7	5.6	6.8	5.9	3.4	4.5	5.9	0.5	8.4	11.7	1.8	5.5	4.4	9.5	14.0	14.6	15.4	8.0	7.3	9.5	8.0	9.4	9.7	6.0	3.5	3.0	4.4	7.9	10.8	5.4	2.5	5.3	1.2	10.4	7.9	4.2	1.7	6.5	9.2	4.5	3.3	0.0	6.6	5.6	6.4	6.0	11.5	4.0	5.5	20.6	13.8	1.8	6.5	10.2	3.7	4.0	1.7	2.8	6.6	4.1	6.4	0.0	7.8	4.2	13.7	0.0	4.4	27.2	26.3	6.1	3.7	3.2	6.4	5.2
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.5	4.7	6.4	9.3	9.1	15.1	15.2	22.0	6.9	12.9	14.8	5.4	3.6	22.8	5.5	8.9	3.7	5.2	6.4	13.8	16.1	11.5	4.9	6.7	13.3	15.6	6.8	11.4	9.0	10.1	17.0	10.5	5.7	5.2	12.1	7.0	10.5	13.7	16.2	6.8	10.3	3.0	1.9	15.7	3.6	11.3	6.6	5.7	4.9	15.4	7.2	2.5	7.0	5.8	3.5	7.4	8.3	5.1	16.4	11.9	11.6	5.6	11.1	12.9	8.9	41.2	5.7	6.7	12.9	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8	11.9	5.1	4.9	2.6	4.1	6.3	2.4	2.5	5.3	7.9	3.5	9.8	1.7	5.0	2.0	7.6	2.1	2.6	23.3	0.7	2.4	2.6	2.1	0.0	2.1	1.5	0.0	5.2	0.6	1.5	6.0	3.1	1.7	1.7	2.8	2.2	2.3	1.6	2.9	2.8	1.4	8.5	0.0	3.1	17.9	5.9	2.6	1.6	2.9	3.1	2.5
GTPBP2		ENSG00000172432	"GTP binding protein 2"	Q9BX10	6	43605316-43629162	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031418, HPA031419"	Approved		Approved	Vesicles		NA	Yes			Vesicles		"HPA031418: AB_2673872, HPA031419: AB_10600709"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (1.44e-15)"	"unprognostic (1.13e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	26.8	19.8	21.4	28.0	19.7	27.9	23.5	27.5	26.1	20.1	22.4	19.9	29.6	22.7	19.0	20.5	38.2	14.5	18.6	20.5	19.1	10.8	20.5	22.5	29.1	21.4	15.0	17.4	20.4	26.2	30.9	26.8	24.1	17.9	20.7	20.7	19.9	29.0	25.3	19.2	19.8	21.9	21.0	17.0	28.8	23.8	17.2	20.1	28.2	30.0	13.3	29.6	25.7	25.2	3.0	2.8	7.0	2.5	1.2	3.4	4.4	17.8	4.7	12.6	8.5	9.7	10.5	14.4	17.0	18.4	20.0	22.9	5.4	7.6	6.5	7.3	9.1	16.9	9.7	4.7	6.9	13.8	17.6	10.2	16.0	12.0	4.8	38.8	10.3	17.8	12.3	48.4	22.1	56.8	13.2	10.3	9.1	22.2	33.2	9.9	6.2	7.6	14.9	3.8	19.3	5.5	6.6	9.1	7.2	9.3	10.9	10.8	11.2	5.8	5.3	21.7	7.8	10.2	16.0	11.4	10.1	11.3	6.4	11.3	22.6	10.7	8.7	14.5	9.5	10.5	7.0	2.5	5.0	3.4	1.4	2.0	1.7	0.9	3.0	1.3	3.0	2.4	2.8	3.7	1.2	2.0	2.8	1.5	4.4	21.4	19.7	27.5	26.1	19.1	10.8	15.0	17.4	17.9	20.1	3.0	5.6	5.1	1.9	4.6	6.1	9.2	7.6	0.0	2.3	1.8	7.9	2.1	0.0	8.2	14.5	6.7	9.2	0.0	8.7	9.0	4.9	4.4	1.1	4.0	7.0	1.6	1.2	8.0	13.6	36.8	4.9	5.7	6.8	8.2	7.0	2.2	17.0	6.2	3.9	1.1	8.1	12.9	3.8	7.7	9.1	4.5	2.1	2.1	5.0	9.5
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	12.1	16.6	11.0	13.3	14.4	35.7	13.8	16.5	24.4	12.2	21.3	10.1	6.3	18.1	12.9	14.1	17.0	13.4	13.2	19.2	11.9	12.1	18.3	18.9	11.4	18.2	11.0	12.6	11.3	18.5	11.5	12.8	12.6	14.0	12.6	22.0	13.6	24.2	11.3	25.1	11.9	22.0	12.4	9.8	17.5	16.8	17.6	7.9	29.0	18.9	13.9	19.9	14.3	13.2	27.9	27.6	39.7	22.2	26.8	39.8	21.4	15.9	7.4	11.7	13.0	10.2	11.1	7.1	9.6	15.6	21.4	20.1	15.1	6.5	12.5	5.5	11.3	19.5	10.5	18.2	13.4	16.5	11.4	14.1	15.4	8.2	13.0	11.0	9.0	9.3	11.2	16.5	15.9	9.7	10.8	16.0	10.1	19.7	6.7	14.8	15.0	8.0	16.8	7.2	66.4	9.6	9.3	9.1	11.8	15.2	12.8	14.0	14.2	6.9	10.7	45.4	9.3	12.5	24.2	8.7	11.5	9.6	7.5	15.3	8.7	7.4	29.3	10.4	15.3	12.6	39.7	22.2	25.0	25.7	22.1	25.8	27.9	30.8	28.4	27.6	25.6	32.3	29.0	18.6	26.8	19.9	18.3	39.8	21.4	11.0	14.4	16.5	24.4	11.9	12.1	11.0	12.6	14.0	7.9	23.8	10.1	16.1	16.9	12.8	12.1	10.4	10.2	21.4	21.6	3.5	11.8	18.1	23.2	24.8	36.4	11.3	26.9	23.3	18.5	17.9	15.3	9.1	30.1	11.3	15.5	9.5	16.7	14.7	10.8	27.8	11.2	13.0	27.0	20.8	15.1	12.4	20.4	25.9	11.3	16.5	12.0	25.8	12.2	18.4	18.8	8.4	5.1	15.4	19.2	21.6
RSPH9	"C6orf206, CILD12, FLJ30845, MRPS18AL1"	ENSG00000172426	"Radial spoke head 9 homolog"	Q9H1X1	6	43645046-43672599	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.9;testis: 48.4"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 240.9;Early spermatids: 153.2;Spermatocytes: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 5.4;U-87 MG: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031703	Enhanced					NA	NA					"HPA031703: AB_10602126"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.73e-2)"	0.6	1.1	3.6	0.7	2.9	1.3	0.6	1.3	3.8	1.4	0.6	2.7	2.4	0.8	2.6	4.1	0.7	15.9	1.0	1.0	2.0	3.0	0.8	0.5	8.7	0.7	0.5	1.4	3.3	0.7	1.2	3.8	1.1	7.0	1.5	0.5	1.8	1.1	0.9	0.6	0.8	0.6	1.1	0.6	0.8	1.3	48.4	0.4	0.0	0.7	0.4	0.5	0.8	0.9	4.9	2.4	3.7	2.3	2.4	2.8	3.1	0.7	0.4	1.5	1.4	0.3	4.4	1.4	1.8	0.5	0.0	0.0	2.8	0.4	0.3	0.6	0.8	1.1	0.9	0.2	0.2	0.0	0.6	1.4	1.0	0.8	0.9	3.4	1.4	0.7	1.3	0.0	1.4	0.2	0.6	0.2	1.0	1.5	1.5	0.0	2.0	0.9	2.0	0.9	5.4	1.4	0.8	1.2	1.2	0.0	1.5	2.0	2.1	0.0	1.3	1.4	1.6	0.7	1.6	0.5	1.1	0.9	1.0	0.6	1.8	2.7	1.5	5.5	1.1	1.8	2.0	2.3	1.5	2.8	1.2	2.3	3.1	2.1	1.8	2.4	4.9	2.3	2.1	3.7	2.4	0.8	1.4	2.0	3.1	3.6	2.9	1.3	3.8	2.0	3.0	0.5	1.4	7.0	0.4	0.0	4.5	0.5	0.6	0.5	0.2	0.6	0.0	240.9	28.4	0.0	2.0	0.3	0.0	0.5	153.2	1.0	0.2	0.0	0.0	2.4	4.7	0.3	3.5	0.0	0.5	1.6	1.2	0.0	0.0	16.3	2.6	0.6	6.8	1.8	0.3	5.7	0.5	0.0	1.4	0.1	1.9	0.0	3.1	76.9	2.2	0.3	0.5	0.0	0.2	0.0
MRPS18A	"FLJ10548, MRPS18-3"	ENSG00000096080	"Mitochondrial ribosomal protein S18A"	Q9NVS2	6	43671303-43687791	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 95.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035450, HPA035451"	Approved					NA	NA					"HPA035450: AB_10670701, HPA035451: AB_10602029"	"unprognostic (9.85e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.03e-5)"	"unprognostic (9.35e-2)"	16.4	20.9	17.5	14.5	19.1	10.7	16.3	12.1	22.9	15.1	24.6	14.6	12.4	21.8	16.1	13.7	25.8	19.4	17.9	28.1	15.6	14.0	22.8	34.8	12.1	15.1	16.4	15.4	17.1	21.8	14.7	9.7	22.4	14.7	20.8	28.7	17.4	20.7	18.7	90.1	18.6	20.4	17.0	13.4	19.5	24.9	13.6	11.7	20.4	21.0	27.3	20.2	18.2	15.4	55.1	37.7	35.2	30.1	35.3	35.0	32.3	17.6	15.2	11.7	16.6	12.2	8.5	13.6	8.4	13.4	21.2	21.1	30.6	7.5	7.6	14.4	12.0	17.0	14.7	17.0	24.5	11.1	11.5	20.2	14.1	11.8	26.8	21.7	19.5	8.6	11.4	19.9	17.7	27.6	10.8	16.1	19.3	24.6	16.3	12.6	29.6	14.4	16.0	8.5	95.9	12.2	12.1	9.2	24.6	16.0	20.7	19.1	10.1	8.6	17.0	30.1	8.9	17.2	27.4	8.2	13.2	15.0	10.4	15.3	17.7	14.5	27.6	17.8	13.6	34.8	35.2	30.1	30.6	34.9	25.0	32.9	55.1	32.7	32.9	34.1	38.8	32.9	30.5	13.7	35.3	17.2	37.7	35.0	32.3	17.5	19.1	12.1	22.9	15.6	14.0	16.4	15.4	14.7	11.7	29.8	23.2	46.9	35.5	29.8	13.5	1.2	22.9	21.4	19.4	31.4	2.0	61.5	84.6	68.4	12.6	21.8	67.9	23.3	58.9	52.1	21.3	38.8	26.5	43.9	44.0	7.9	31.0	25.2	14.2	29.2	21.0	22.1	38.8	72.1	48.5	19.2	59.0	84.2	19.8	91.3	12.1	32.3	26.4	20.1	34.8	23.8	56.3	24.5	66.0	69.2
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 324.6;Muller glia cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;eosinophil: 1.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.9;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 65.7;U-87 MG: 103.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000				"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	35.0	17.5	16.6	11.4	20.1	12.8	39.5	6.5	32.3	11.8	25.9	8.7	15.0	16.0	54.1	9.4	19.4	10.4	27.5	57.0	13.4	5.4	25.8	58.6	30.0	2.9	15.8	3.7	16.4	25.1	20.6	7.3	16.7	19.8	40.5	7.2	24.4	15.1	23.8	52.9	11.9	26.3	19.2	35.1	19.0	20.5	4.5	15.4	0.3	87.9	19.6	13.6	47.5	15.7	0.0	0.1	1.9	1.2	0.0	0.0	0.0	11.8	2.1	2.0	11.6	3.5	5.5	13.7	7.3	13.0	4.8	9.6	6.8	1.6	3.9	5.9	4.4	50.2	4.9	5.4	14.7	8.6	4.2	1.7	2.9	2.8	4.5	36.9	3.2	6.6	9.7	29.3	47.4	47.2	65.7	1.2	3.3	5.5	19.7	17.6	4.9	0.3	4.4	1.2	34.8	3.3	0.3	1.9	9.3	18.7	10.0	3.6	7.6	10.5	7.2	25.2	2.7	2.8	11.9	1.7	20.2	5.4	29.1	11.9	11.2	6.6	7.6	103.7	7.5	7.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.6	20.1	6.5	32.3	13.4	5.4	15.8	3.7	19.8	15.4	324.6	89.9	11.2	34.6	62.6	31.5	146.9	81.5	4.0	93.3	21.0	29.5	1.1	1.7	39.1	0.0	22.8	60.6	23.3	35.0	3.1	45.9	128.0	107.6	99.1	13.4	170.0	26.2	18.4	22.8	0.0	1.7	44.4	27.0	11.8	42.9	340.3	70.3	34.8	3.2	15.2	37.5	0.0	52.8	0.9	0.9	68.4	6.6	6.9	40.0	115.1
C6orf223	MGC45491	ENSG00000181577	"Chromosome 6 open reading frame 223"	Q8N319	6	44000580-44005958	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 23.6;lung: 9.4"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.9;JURKAT: 18.7;RPTEC TERT1: 22.6;THP-1: 9.4"									"HPA035765, HPA046117"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA035765: AB_2797225, HPA046117: AB_10964082"	"unprognostic (2.94e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.06e-3)"	"unprognostic (2.34e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.31e-1)"	0.1	0.4	1.1	1.3	0.9	0.5	23.6	0.2	3.0	0.7	1.4	0.0	0.0	1.8	0.8	4.7	0.1	0.2	6.9	2.9	1.1	0.8	4.9	1.4	9.4	2.8	0.1	1.2	0.1	2.4	0.1	0.8	0.2	0.9	0.2	0.7	3.4	3.1	0.1	0.3	0.5	3.1	0.2	0.0	0.7	0.2	0.3	0.0	1.0	2.1	1.1	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	0.3	0.0	18.7	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.2	0.3	0.0	0.1	1.9	3.4	1.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.2	3.0	1.1	0.8	0.1	1.2	0.9	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.6	0.5	1.4	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113454-44127457	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 116.6"	"Low region specificity"	"Detected in all"							"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	10.1	16.1	12.5	9.6	12.8	7.9	11.7	10.5	12.7	10.5	16.4	9.6	8.4	16.2	12.1	12.3	15.7	10.4	14.8	18.5	10.0	8.4	12.4	35.5	25.9	10.4	10.9	11.5	7.1	17.5	4.9	9.6	11.8	10.6	9.7	16.3	13.7	14.0	9.4	61.4	16.0	14.0	12.7	7.9	10.2	12.7	19.0	10.4	13.1	26.3	27.8	12.4	12.3	10.0	33.2	36.4	9.0	36.1	46.7	32.5	30.3	39.8	17.1	12.1	16.7	10.5	10.3	15.5	14.9	14.9	19.9	20.0	35.6	14.1	17.4	16.9	12.7	19.2	16.3	13.6	24.3	15.9	20.6	37.1	17.9	15.1	43.5	13.0	17.0	12.6	9.5	13.2	18.8	11.2	15.4	16.4	15.0	37.6	11.2	17.6	40.3	20.3	26.8	10.6	116.6	16.4	14.6	13.6	23.6	32.8	19.8	27.1	10.5	9.6	18.8	18.5	11.0	17.2	17.5	13.1	17.8	26.6	12.7	25.8	14.0	12.3	40.8	20.1	16.9	12.9	9.0	36.1	7.5	25.4	32.7	29.9	33.2	32.5	28.6	32.4	30.2	25.8	26.5	2.0	46.7	21.9	36.4	21.9	30.3	12.5	12.8	10.5	12.7	10.0	8.4	10.9	11.5	10.6	10.4	348.4	202.5	87.1	148.9	205.3	26.8	126.7	117.2	72.3	125.1	54.1	29.5	154.6	172.5	198.2	197.3	76.8	185.2	23.3	191.9	163.1	85.4	198.8	43.8	284.0	228.8	31.8	89.7	48.5	40.9	90.3	69.0	86.6	65.8	216.4	126.1	48.1	252.2	194.7	50.2	212.2	55.1	45.3	85.8	91.7	125.6	245.9	133.9	72.7	153.8	317.1
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	9.7	13.2	24.4	8.7	21.4	14.0	9.4	33.2	34.3	9.1	19.7	14.8	7.5	17.1	8.2	11.7	21.1	8.6	13.2	16.6	21.6	15.2	10.7	28.6	35.0	5.2	13.1	18.2	8.0	10.6	19.6	10.2	12.8	22.8	12.9	18.4	18.6	13.9	8.8	29.4	29.6	17.0	9.7	13.8	6.3	24.5	22.7	16.0	4.7	11.4	14.8	8.9	14.4	13.4	1.3	1.3	1.7	2.1	0.3	2.6	1.2	15.4	8.2	7.8	13.2	12.3	7.3	13.2	6.3	8.6	7.8	7.4	5.8	5.7	2.6	10.5	9.4	11.6	15.3	9.1	23.6	4.5	7.2	7.9	7.6	6.0	17.0	8.7	1.5	8.0	10.0	20.5	10.0	6.3	14.1	7.1	6.0	24.6	4.6	7.8	15.3	1.6	3.7	4.0	58.7	4.1	2.0	4.8	4.9	19.1	14.7	8.5	6.9	5.9	13.6	14.1	9.9	16.0	4.0	8.4	9.3	11.1	7.1	7.7	5.5	4.0	3.0	14.5	2.6	11.5	1.1	2.1	1.3	1.4	1.1	2.5	1.3	0.7	0.7	0.9	0.8	1.0	1.1	1.7	0.3	1.4	1.3	2.6	1.2	24.4	21.4	33.2	34.3	21.6	15.2	13.1	18.2	22.8	16.0	14.9	29.0	1.4	12.3	12.0	16.3	2.8	10.2	0.0	7.9	10.4	15.7	12.5	1.7	13.4	56.9	6.8	47.1	0.0	13.3	14.8	10.8	15.8	0.0	31.6	21.1	15.9	17.9	12.9	8.3	71.4	10.9	7.0	6.8	7.2	26.3	11.1	25.1	40.4	8.5	10.2	26.6	6.5	9.2	1.6	5.8	15.9	16.7	4.3	18.0	22.6
CAPN11		ENSG00000137225	"Calpain 11"	Q9UMQ6	6	44158811-44184402	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 63.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 16.7;Late spermatids: 7.9;Spermatocytes: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NTERA-2: 4.4;TIME: 11.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB018070, HPA030955"	Enhanced					NA	NA					"CAB018070: AB_2069481, HPA030955: AB_2673672"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.62e-6)"	"unprognostic (2.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.89e-2)"	1.1	0.3	0.1	0.2	0.1	0.2	1.9	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.6	0.3	0.2	0.1	0.1	0.0	63.7	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.4	1.2	1.3	0.1	0.1	0.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.4	0.4	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.2	11.1	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.1	0.2	1.3	0.1	0.0	1.2	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	24.2	0.9	0.0	0.0	0.0	0.0	0.0
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216939-44218236	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"adipose tissue: 27.4;blood: 12.2;pancreas: 9.0"	"Cell type enhanced"	"Detected in some"	24	"Distal tubular cells: 3.3;Exocrine glandular cells: 2.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"					"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	121	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in some"	31	"RH-30: 56.5"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	27.4	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.8	0.0		1.1	0.0	0.5	1.4	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.7	0.0	2.2	0.0	0.1	0.0	0.0	1.8	3.2	0.6	0.0	2.8	0.4	0.0	0.4	0.5	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	56.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219505-44234151	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.2"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 192.2;Extravillous trophoblasts: 188.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	25	"eosinophil: 117.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 117.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA					"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	42.9	40.9	5.8	9.4	9.6	17.9	57.2	10.4	15.2	21.2	35.8	5.9	6.9	5.2	19.8	11.7	22.8	14.9	24.4	46.8	5.4	6.4	14.7	23.2	15.3	14.4	5.5	8.4	12.5	35.8	8.7	15.2	23.2	9.8	21.4	7.4	18.0	15.7	8.4	53.0	23.8	12.4	39.0	5.3	11.4	33.0	8.8	4.8	53.9	18.8	17.2	11.1	28.7	20.7	0.5	4.7	117.2	4.5	0.3	0.9	0.7	16.5	16.5	11.8	19.0	18.2	1.7	70.5	12.2	4.8	17.1	11.7	18.0	6.8	33.7	12.3	3.6	10.6	20.6	21.1	14.7	10.4	19.1	19.4	29.1	11.4	23.3	2.9	32.7	28.1	2.2	3.8	25.1	8.8	34.8	42.9	27.6	39.3	19.9	9.3	18.2	26.9	21.9	17.9	42.9	11.1	18.0	23.8	40.8	10.0	9.7	15.2	19.6	3.5	11.9	8.6	12.7	16.1	20.7	64.9	9.4	15.4	12.7	23.1	13.6	17.7	43.0	5.7	26.7	11.3	1.8	1.4	117.2	0.6	4.5	0.4	0.5	0.3	0.4	0.8	0.3	0.1	0.3	0.2	0.3	3.6	4.7	0.9	0.7	5.8	9.6	10.4	15.2	5.4	6.4	5.5	8.4	9.8	4.8	0.0	10.9	0.8	7.7	9.5	9.0	38.3	20.4	8.1	6.8	7.0	13.7	192.2	3.3	21.3	0.4	24.6	0.5	0.0	50.3	188.6	38.1	6.0	8.1	12.1	53.2	4.8	30.0	19.6	23.3	1.5	30.5	11.7	33.7	11.8	2.4	4.7	45.0	3.1	50.5	0.9	10.8	90.5	16.5	0.3	10.0	13.7	35.1	3.5	5.3	6.8
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 3438.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		62000000	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	79.9	116.1	88.0	65.9	105.0	74.6	107.8	92.1	118.2	92.3	60.4	61.7	80.9	40.6	113.3	107.6	71.6	138.4	63.8	115.0	89.0	110.5	72.0	70.7	76.2	73.8	109.7	94.4	238.4	113.9	151.6	95.3	83.6	133.7	93.5	76.4	52.7	64.8	100.3	197.1	67.9	49.0	102.1	93.9	57.5	77.3	45.9	100.2	58.3	133.8	89.8	102.5	86.2	223.4	75.9	50.5	7.2	45.7	55.7	82.5	74.9	135.6	87.0	77.3	95.0	53.1	55.6	81.0	61.3	60.1	113.6	80.0	130.1	41.6	173.8	66.5	63.8	115.6	79.1	188.1	91.3	140.6	57.5	76.1	135.2	49.3	170.0	38.5	135.0	93.7	51.4	61.8	89.2	77.1	99.7	108.6	89.9	180.5	64.9	77.2	137.0	112.4	81.4	90.2	251.8	66.7	108.5	79.1	95.4	76.8	82.5	113.3	69.2	47.6	69.1	86.0	109.7	89.8	67.6	68.1	67.8	113.5	55.4	140.0	75.2	117.8	313.9	73.7	99.3	77.2	7.2	30.2	6.8	49.3	45.7	82.5	75.9	55.2	56.4	50.5	63.2	75.2	71.3	3.7	55.7	43.3	31.4	42.6	74.9	88.0	105.0	92.1	118.2	89.0	110.5	109.7	94.4	133.7	100.2	833.7	606.4	539.1	3438.1	940.9	289.3	1217.7	456.0	1493.6	1074.9	347.2	214.0	960.1	618.4	836.0	145.7	761.3	375.2	163.5	596.7	897.4	930.6	1319.6	967.8	307.7	711.8	321.0	544.1	275.6	256.9	156.5	635.1	727.9	698.5	738.6	374.5	296.6	721.4	313.4	574.6	560.9	223.5	342.8	894.3	197.9	740.6	807.2	939.3	460.3	567.6	2341.3
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	18.0	28.2	14.8	12.6	15.0	10.7	17.7	16.2	24.8	18.3	18.9	35.8	19.0	13.0	22.6	23.4	14.3	18.6	27.1	17.7	15.2	10.9	32.3	35.5	16.1	12.9	17.1	14.6	16.7	38.1	27.4	11.1	26.1	19.8	19.0	20.2	23.8	49.6	20.4	17.5	15.6	16.4	20.5	24.7	18.4	20.6	16.3	18.7	12.2	19.3	17.8	17.6	19.6	14.3	12.9	14.4	21.8	8.6	10.8	21.1	10.2	23.1	13.3	16.7	32.0	27.5	29.1	12.2	25.4	42.1	25.0	30.8	11.7	21.6	5.2	22.9	31.4	26.9	22.1	11.4	28.6	17.6	15.3	14.7	10.4	10.5	13.9	25.7	22.2	17.0	29.8	30.1	23.0	11.3	34.6	18.3	11.9	14.9	22.4	29.9	27.2	8.2	18.6	7.4	69.9	15.5	8.2	10.8	26.4	27.0	17.2	20.8	20.0	12.5	13.9	28.6	10.9	25.8	20.4	18.1	19.7	13.1	19.6	22.1	17.3	19.7	12.1	26.3	17.7	40.0	21.8	8.6	13.2	21.1	6.5	17.8	12.9	11.9	16.1	7.7	7.7	11.0	14.2	0.7	10.8	2.3	14.4	9.6	10.2	14.8	15.0	16.2	24.8	15.2	10.9	17.1	14.6	19.8	18.7	6.0	11.5	22.3	25.5	11.9	9.7	6.7	43.3	5.3	11.4	26.2	2.0	50.8	11.6	69.2	0.4	9.8	13.7	0.0	64.7	44.1	30.6	27.0	34.6	15.3	32.9	9.5	18.9	16.0	9.9	1.2	21.6	10.0	50.6	32.5	20.3	42.2	56.9	27.4	18.7	11.5	12.5	0.0	16.7	15.2	67.3	12.2	29.4	13.1	29.9	18.4
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	5.8	5.2	7.6	24.6	5.4	24.0	5.2	9.4	7.8	3.7	8.0	4.2	3.2	6.7	4.7	5.5	6.9	3.0	9.8	4.6	7.9	5.5	11.5	8.7	15.9	17.1	6.0	4.1	6.1	7.1	3.5	4.1	6.0	4.8	7.1	5.9	3.6	7.7	4.1	3.7	7.4	9.5	3.6	5.0	29.6	6.3	7.9	3.7	14.5	5.5	4.6	22.7	6.7	6.7	8.1	8.2	7.1	10.2	0.8	3.5	1.6	13.9	3.5	4.9	7.7	1.9	1.4	2.6	2.5	12.2	7.7	8.1	7.5	6.6	7.5	8.9	2.5	20.7	3.0	5.2	7.8	8.7	12.9	2.9	3.9	1.5	8.4	6.0	12.8	11.8	3.7	3.4	7.1	4.4	6.5	5.2	3.6	3.6	20.2	1.9	7.1	2.5	26.1	2.6	22.0	1.9	4.7	4.4	6.9	17.7	15.2	3.1	4.0	1.7	6.4	10.1	4.3	4.4	15.0	9.1	4.4	5.1	2.7	7.7	12.9	5.4	13.9	3.9	14.2	8.2	7.1	8.1	3.8	1.8	9.4	3.5	8.1	2.4	1.6	6.8	7.3	1.1	1.7	3.2	0.8	10.2	8.2	3.0	1.6	7.6	5.4	9.4	7.8	7.9	5.5	6.0	4.1	4.8	3.7	0.0	11.9	25.1	19.3	34.0	3.3	3.4	15.3	0.0	3.4	3.5	2.0	4.3	14.9	42.8	13.7	8.7	11.0	0.0	18.4	6.2	6.8	25.5	33.3	1.6	52.3	3.2	14.3	4.9	17.8	25.0	1.7	66.3	45.5	85.6	7.0	2.6	39.6	24.6	2.5	10.3	4.0	6.5	16.9	21.4	8.7	34.4	4.5	9.6	6.6	32.1
TMEM151B	"bA444E17.5, C6orf137, TMEM193"	ENSG00000178233	"Transmembrane protein 151B"	Q8IW70	6	44270466-44307506	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 4.5;Cardiomyocytes: 2.2;Horizontal cells: 4.8;Rod photoreceptor cells: 1.2"	"Cancer enhanced"	"Detected in single"		"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 25.3"	"Low region specificity"	"Detected in all"							HPA055167	Uncertain					NA	NA					"HPA055167: AB_2682723"	"unprognostic (1.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.02e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.66e-1)"	1.0	5.7	16.9	1.6	8.4	1.2	1.0	52.2	39.5	0.9	1.7	1.2	0.0	1.7	1.3	1.0	1.2	1.0	1.0	1.1	21.6	8.9	1.0	0.9	1.0	1.2	7.9	18.1	1.0	1.1	0.9	1.4	1.0	10.0	1.1	1.5	0.0	1.2	0.9	1.2	1.2	2.0	1.1	2.3	1.0	1.4	1.6	3.7	0.0	0.9	0.0	1.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	5.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.1	0.5	4.3	0.1	0.2	0.4	0.0	0.1	0.0	0.1	25.3	5.2	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	16.9	8.4	52.2	28.1	21.6	8.9	7.9	18.1	10.0	3.7	0.0	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278743-44297688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 17.3;testis: 48.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 137.7;Late spermatids: 222.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.2;U-266/70: 1.8;U-266/84: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031739			Uncertain	Vesicles		NA	NA			Vesicles		"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	2.2	0.2	2.2	1.1	0.2	5.8	1.8	0.7	0.2	1.1	0.0	0.2	0.6	3.0	0.2	17.3	0.3	0.2	2.8	2.0	0.2	0.2	2.1	0.2	0.8	1.0	2.2	0.3	0.2	0.2	0.2	3.2	0.4	0.2	0.0	0.4	0.4	0.2	0.6	0.3	0.3	0.6	0.3	0.2	48.6	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.4	0.3	0.1	0.2	0.1	0.6	0.3	0.0	0.0	2.6	0.3	0.0	0.4	0.1	3.8	0.0	0.3	0.2	0.5	0.2	0.2	0.0	0.9	0.4	0.0	0.0	0.1	3.2	1.1	0.0	0.2	1.2	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	1.8	3.2	0.3	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.1	0.2	0.0	2.2	2.2	5.8	1.8	2.8	2.0	0.8	1.0	3.2	0.3	0.0	0.0	0.0	0.1	0.1	0.6	0.3	0.0	16.0	2.3	0.0	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	10.7	1.9	0.0	0.1	0.0	0.0	0.0
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	9.7	7.3	9.6	17.6	5.7	5.2	12.7	8.0	4.1	8.5	8.2	7.9	5.3	10.7	12.8	3.5	9.0	7.3	10.6	11.5	3.3	7.5	16.9	12.4	7.1	9.3	3.7	11.5	11.1	4.4	7.3	6.8	7.3	5.2	7.2	15.0	14.6	10.5	4.5	10.9	9.6	9.9	7.1	28.1	7.1	11.5	5.8	7.3	4.4	8.8	22.8	8.2	6.9	7.8	10.7	6.7	7.2	15.0	6.1	9.2	9.3	5.7	10.0	6.2	5.7	11.0	5.2	10.2	15.9	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1	6.0	3.5	2.4	1.9	0.6	6.3	2.8	7.6	4.0	3.4	0.0	11.8	4.4	0.0	2.1	2.2	2.9	4.4	0.0	0.3	4.4	1.4	1.2	0.0	2.4	2.7	0.0	0.0	3.7	2.8	0.4	4.4	1.6	0.0	5.4	1.4	1.5	1.1	0.0	4.2	0.8	6.7	0.0	1.4	3.3	7.0	0.4	4.5	2.2	3.3	1.4
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342660-44377167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 9.0;testis: 33.5"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-MEL-30: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	1.5	0.0	0.0	0.1	4.8	0.1	9.0	0.0	0.0	0.7	0.7	0.0	0.0	1.5	0.0	0.4	0.0	1.6	0.0	0.2	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	1.0	0.0	0.4	0.7	0.7	0.4	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387525-44450426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 293.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	21.3	18.6	17.1	17.4	17.6	24.5	18.3	30.3	22.1	19.4	16.1	12.2	13.9	12.6	18.2	20.5	20.4	15.1	12.0	18.0	17.4	15.3	16.4	24.7	12.8	16.3	16.6	15.0	21.8	15.0	32.4	26.1	20.8	19.2	19.6	15.6	8.6	16.8	13.6	30.8	14.8	15.9	23.2	18.1	17.6	14.3	16.9	19.1	28.4	16.0	17.4	18.1	26.0	16.6	11.5	13.6	21.1	17.6	14.8	14.8	8.2	18.3	7.2	17.8	14.4	7.3	9.6	10.1	13.4	10.5	17.0	18.8	9.4	6.3	17.6	11.2	10.7	13.9	11.7	18.5	10.6	25.6	14.8	16.6	23.4	7.2	12.1	6.7	17.5	12.7	7.3	9.4	16.6	14.4	9.8	11.0	9.1	17.9	10.4	15.4	12.4	16.2	12.0	12.5	44.8	6.7	12.7	20.5	11.3	9.6	11.0	19.8	17.2	10.8	7.3	14.3	11.9	10.3	17.1	10.1	14.7	15.0	11.4	18.9	9.0	10.8	32.3	9.4	15.3	14.7	16.7	13.9	17.4	11.7	16.6	13.3	10.7	11.4	12.9	13.6	11.5	12.2	11.8	21.1	14.8	17.6	11.8	14.8	8.2	17.1	17.6	30.3	22.1	17.4	15.3	16.6	15.0	19.2	19.1	68.5	39.9	34.7	52.2	39.3	32.7	74.2	25.5	104.4	97.8	22.7	29.5	47.5	33.2	43.0	293.7	44.7	17.1	0.0	47.7	42.8	39.4	39.6	69.3	34.7	39.6	30.2	34.7	27.6	35.5	192.5	57.0	42.2	18.6	66.7	34.2	61.8	43.6	34.0	51.9	22.6	35.1	64.7	52.1	39.1	88.8	33.5	60.0	32.0	35.9	49.8
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 115.4;Late spermatids: 129.6;T-cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	6.0	11.2	7.4	6.7	7.1	2.8	6.1	20.3	9.2	9.4	9.6	7.9	11.5	5.1	10.0	11.4	4.7	11.7	6.6	4.4	6.1	4.6	8.5	4.2	6.9	3.9	6.3	7.7	11.7	10.2	11.4	15.4	7.1	8.3	10.4	5.4	7.7	7.6	8.1	3.0	3.8	4.3	7.1	10.1	3.7	5.3	14.8	8.8	6.0	9.5	2.6	4.7	6.6	6.5	1.2	3.3	0.3	0.4	5.0	17.1	5.4	3.7	3.6	11.8	3.2	2.2	8.5	2.1	1.8	2.7	8.7	7.6	5.0	2.1	2.2	2.7	1.8	3.1	0.6	9.4	8.1	9.5	2.2	4.2	1.7	2.2	13.1	5.5	2.2	1.0	5.9	7.2	6.7	10.0	16.0	3.6	5.4	3.6	3.2	6.2	1.9	4.3	6.8	4.4	10.6	1.8	5.4	2.7	1.1	11.9	4.6	4.4	2.8	0.6	0.3	5.3	10.3	2.4	3.1	1.8	2.4	0.1	2.7	4.9	4.3	1.1	9.6	4.3	6.3	2.0	0.3	0.4	0.0	8.5	0.4	13.9	1.1	12.4	10.9	1.3	1.2	17.1	13.4	0.3	5.0	0.4	3.3	5.4	5.4	7.4	7.1	20.3	9.2	6.1	4.6	6.3	7.7	8.3	8.8	3.0	4.5	5.6	13.2	1.5	7.1	2.8	2.5	9.4	6.8	7.0	5.9	9.3	10.0	6.5	115.4	5.8	0.8	0.0	2.8	10.3	4.2	6.5	3.5	2.6	8.1	3.2	8.1	7.4	1.6	129.6	7.2	3.5	5.0	14.4	2.8	2.2	4.1	2.8	4.9	7.7	14.2	12.9	7.2	21.3	17.9	1.1	6.9	33.1	3.3	8.8
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"Runt related transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 67.7;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 16.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	3.7	2.1	4.9	13.7	7.0	15.5	5.7	1.0	7.2	13.5	6.0	5.6	7.4	4.1	3.5	2.3	3.4	2.4	6.8	1.8	7.4	3.5	3.9	1.8	5.3	8.6	6.3	3.4	5.0	1.9	1.3	3.8	3.3	7.2	9.5	7.8	5.4	19.8	14.9	2.2	4.9	10.8	3.4	10.5	6.6	6.0	2.1	7.3	6.5	4.2	4.5	11.7	7.3	8.9	0.1	11.4	5.3	0.6	16.0	10.2	0.7	1.6	0.5	0.3	0.0	1.5	4.0	0.0	1.5	3.6	5.1	7.2	0.0	0.9	0.0	1.8	2.1	2.3	2.0	0.0	1.4	9.4	6.1	0.7	0.0	1.1	0.0	8.0	6.3	0.0	10.8	1.1	4.5	5.1	18.6	0.0	2.5	0.0	29.1	9.1	0.4	0.2	11.0	0.3	1.4	0.2	0.0	24.3	0.0	5.0	3.2	0.0	0.0	1.1	0.0	1.8	4.5	1.7	0.5	0.2	5.2	4.2	8.0	5.5	9.2	0.0	25.4	5.9	2.4	2.3	5.3	0.6	3.2	1.2	0.1	10.2	0.1	2.8	3.2	1.8	0.1	0.5	1.5	4.8	16.0	0.1	11.4	2.3	0.7	4.9	7.0	1.0	7.2	7.4	3.5	6.3	3.4	7.2	7.3	0.0	2.4	3.7	14.8	2.5	0.0	1.7	0.0	4.0	4.5	3.5	0.0	0.0	0.0	0.6	67.7	0.3	0.0	0.0	0.2	0.0	2.7	15.7	2.3	0.5	3.8	0.0	0.0	1.8	4.5	13.2	1.1	7.9	6.8	20.8	0.7	0.0	0.4	0.0	2.1	2.2	0.0	6.5	2.5	0.9	0.4	1.4	0.1	17.3	0.0	18.2
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Cell type enhanced"	"Detected in many"	20	"Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		1000000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.6	0.0	9.6	0.0	0.0	0.3	0.0	0.1	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.3	1.5	0.0	11.7	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0	473.4	23.0	0.5	0.0	0.1	0.1	276.0	0.0	20.1	48.9	14.0	0.0	0.1	0.0	1.4	38.1	3.8	100.0	0.0	0.2	0.0	0.2	1.5	1.1	0.0	0.0	0.0	12.5	0.6	0.0	75.0	0.9	0.0	0.0	1.0	16.3	47.6	1.9	24.6	0.7	2.1	1.1	0.0	2.1	0.6	0.1	0.1	1.8	2.9	9.8	0.8
ENPP4	"AP3Aase, KIAA0879, NPP4"	ENSG00000001561	"Ectonucleotide pyrophosphatase/phosphodiesterase 4"	Q9Y6X5	6	46129993-46146699	"Enzymes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Ciliated cells: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 15.0;U-266/84: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016594	Approved					NA	NA					"HPA016594: AB_1848171"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (6.95e-7)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.56e-1)"	12.7	12.5	14.8	6.2	21.9	30.2	14.3	10.1	20.6	9.8	10.5	19.3	31.9	9.5	3.8	10.9	4.8	9.9	7.3	12.9	19.8	15.7	16.8	9.0	17.9	6.9	30.8	15.6	3.4	10.4	22.2	14.1	3.2	23.9	15.0	11.6	7.1	17.5	30.8	20.9	3.6	8.7	8.6	43.2	11.5	12.3	7.1	22.2	4.8	11.3	7.3	5.6	8.0	5.9	3.1	1.8	0.9	2.7	4.6	11.0	3.1	0.0	0.7	0.5	1.0	0.0	0.0	0.0	1.1	1.1	2.7	0.2	1.2	9.0	10.0	8.8	1.4	6.8	0.1	2.8	0.4	0.5	12.0	7.5	5.5	0.0	0.0	0.4	6.8	10.2	1.4	0.0	0.0	0.0	0.7	0.9	7.1	0.0	0.0	1.0	1.1	5.0	0.6	1.8	11.1	0.3	3.8	1.8	3.7	5.7	1.1	12.3	0.0	0.0	1.9	0.0	2.9	5.1	2.8	0.0	0.0	4.7	0.2	7.4	15.0	17.1	3.4	7.1	0.0	0.9	0.0	0.4	0.9	11.0	1.3	6.4	3.1	4.1	7.9	1.7	1.5	4.0	7.0	0.3	4.6	2.7	1.8	1.4	3.1	14.8	21.9	10.1	20.6	19.8	15.7	30.8	15.6	23.9	22.2	71.5	24.8	5.1	2.8	0.8	8.7	16.9	10.2	57.6	38.7	27.9	13.7	0.3	0.0	13.0	12.6	6.7	16.0	0.0	10.7	0.2	3.5	18.9	15.1	7.3	5.4	25.4	15.1	1.8	15.8	21.4	1.1	10.5	3.3	22.6	14.4	23.1	8.0	16.5	10.6	11.4	6.1	0.0	4.2	8.6	8.7	0.5	0.2	13.8	8.9	6.8
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)"	Q9UJA9	6	46159187-46170971	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 116.5"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 68.3;Muller glia cells: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 13.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		300000	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.5	4.8	6.5	1.3	10.3	0.8	7.1	9.2	16.1	6.9	2.0	3.3	28.7	1.5	1.6	116.5	1.6	7.9	3.9	3.9	6.6	9.4	12.1	1.0	4.7	1.2	14.2	10.5	5.4	6.2	21.8	23.3	1.5	14.4	14.6	2.3	11.8	6.9	27.5	6.9	1.3	1.6	5.1	5.5	3.2	3.5	16.2	3.5	1.0	24.3	0.9	1.4	5.7	1.7	0.4	0.0	1.0	0.1	2.2	13.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.6	0.1	0.3	11.7	1.9	3.9	0.2	4.0	0.0	0.6	1.6	0.1	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	1.9	0.0	0.5	2.5	5.5	0.0	0.0	0.3	0.2	4.9	0.6	5.1	0.2	0.0	4.9	0.0	6.9	9.2	0.0	0.0	0.0	1.3	0.0	0.1	5.8	7.9	0.0	3.1	0.0	0.1	0.0	0.0	0.0	13.4	0.1	7.2	0.4	2.7	8.6	0.0	0.4	0.8	8.2	1.0	2.2	0.0	0.0	0.0	2.6	6.5	10.3	9.2	16.1	6.6	9.4	14.2	10.5	14.4	3.5	11.9	9.8	0.0	4.7	0.8	11.0	8.1	7.6	68.3	9.1	22.7	3.9	4.2	1.7	6.9	0.8	0.1	1.4	0.0	6.5	2.4	3.3	16.0	4.6	0.0	0.3	9.5	7.9	0.6	0.0	1.5	2.6	0.7	0.0	1.0	3.4	94.1	2.7	2.9	11.3	16.2	2.9	6.5	0.7	0.2	2.3	0.5	0.2	3.8	2.5	2.6
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 25.3;HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	6.1	0.4	0.0	0.0	0.0	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	50.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.2	0.1	5.6	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0	6.0	4.3	0.8	3.8	5.6	19.4	229.0	2.5	0.0	0.0	3.5	3.9	0.0	59.7	5.8	22.0	10.8	0.0	0.0	2.1	0.0	5.6	1.7	0.0	0.2	0.1	28.6	24.1	0.0	0.3	11.0	27.0	1.8	30.4	0.0	0.3	167.3	4.3	0.0	47.4	1.4	8.0	97.0	159.7	0.7	0.9	6.5	0.0	0.0	0.1	1.1
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.2"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 58.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.9;hTCEpi: 15.5;OE19: 6.7;SiHa: 9.3;U-698: 10.9"	"Region enhanced"	"Detected in many"		"olfactory region: 24.1"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	2.6	2.0	1.7	2.9	1.9	0.0	2.9	19.3	1.9	3.6	1.9	1.5	6.4	0.4	1.9	12.0	4.9	2.3	3.4	4.8	1.6	1.1	3.3	52.2	2.6	0.2	2.3	0.9	6.5	8.7	8.6	8.3	0.2	2.3	8.2	1.9	8.0	21.0	1.8	0.5	8.5	1.4	1.7	2.2	0.6	2.7	3.3	0.9	0.0	9.4	2.3	2.1	2.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	2.0	0.3	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.6	6.9	5.0	0.0	1.0	1.9	0.9	1.6	0.0	0.0	3.0	0.0	1.8	2.0	4.7	0.0	0.0	0.5	15.5	0.0	1.8	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.7	1.7	0.5	1.3	0.1	3.3	4.4	0.8	0.0	9.3	0.0	0.2	0.5	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	19.3	1.9	1.6	1.1	2.3	0.9	2.3	0.9	14.9	1.0	0.0	7.1	3.5	0.2	4.6	10.2	8.1	4.5	3.5	2.0	0.0	5.0	1.6	11.8	2.3	0.5	0.0	0.3	0.9	1.7	12.3	0.0	58.9	0.2	0.0	0.0	0.0	1.9	15.3	5.8	0.2	3.3	0.0	3.1	8.0	0.9	2.9	8.9	4.1	1.5	0.0	2.1	0.7	0.1	13.4	0.0	0.0	2.3	6.0
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA			Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.4	2.4	8.0	9.1	6.3	0.1	1.1	3.7	1.1	0.2	0.0	2.9	0.8	5.5	2.0	2.6	4.1	1.1	3.5	0.7	0.0	11.8	0.0	26.3	2.9	4.8	0.1	0.3	9.8	14.8	0.0	9.4	5.8	0.2	8.0	0.1	0.0	0.9	0.8	0.0	0.1	1.2	2.0	3.1	0.0	3.1	0.1	6.0	7.5	7.3	0.8	5.5	0.3	2.9	3.6	5.9	0.0	0.8	5.0	3.3	0.5	1.0	3.2	0.0	16.2	0.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9	3.0	2.9	0.0	3.6	0.8	20.5	7.0	0.0	6.7	2.3	5.2	27.5	0.0	0.0	0.6	23.2	3.1	0.3	0.0	0.6	0.0	2.5	5.8	1.1	1.7	0.2	19.1	5.8	2.5	0.3	16.0	2.8	0.1	1.7	0.0	1.3	8.3	0.3	0.0	4.9	0.5	38.2	0.0	2.3	0.5	0.7	2.0	0.0	0.0	1.5	2.1
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 37.9"	"Cell type enhanced"	"Detected in many"	23	"Early spermatids: 172.1;Spermatocytes: 66.0;Spermatogonia: 30.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 8.2"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 1.4"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;HeLa: 4.0;hTCEpi: 2.3;PC-3: 3.4;SCLC-21H: 1.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.4	0.7	2.6	1.3	0.0	0.7	8.2	1.3	0.7	0.7	0.7	0.7	0.3	0.7	2.9	0.7	0.3	1.7	0.7	1.0	0.8	0.7	1.3	0.7	3.0	1.1	0.7	0.7	0.7	0.4	1.8	1.1	0.7	1.6	0.0	0.9	0.9	0.7	1.5	2.9	0.7	0.7	0.9	1.9	0.3	37.9	0.7	0.7	5.2	0.7	0.7	1.6	0.7	0.0	0.7	0.1	2.4	0.0	0.0	0.4	0.0	0.0	0.2	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	3.4	0.0	0.0	0.0	0.9	0.7	1.7	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.7	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	1.3	8.2	0.9	1.0	0.8	1.1	0.7	0.7	0.7	8.9	0.3	0.0	0.4	0.5	8.3	2.9	0.0	0.0	6.8	7.0	5.9	0.0	1.7	0.1	172.1	0.6	0.0	0.0	0.2	0.0	0.5	0.5	0.0	1.6	0.1	4.8	4.1	0.0	0.3	17.5	3.7	0.0	3.3	0.0	0.0	1.4	0.1	0.0	4.2	0.0	6.2	12.9	0.5	66.0	30.6	1.4	0.0	0.0	0.5	0.1
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell type enriched"	"Detected in some"	13	"Hofbauer cells: 332.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;NTERA-2: 3.9;PC-3: 7.9;RT4: 3.6;U-2 OS: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	2.2	1.6	0.0	0.1	0.0	0.2	2.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.9	0.0	7.9	0.0	0.0	0.1	0.0	3.6	0.1	0.5	0.0	0.0	0.0	1.1	1.0	1.0	0.0	0.0	3.7	0.1	0.9	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0	0.0	2.2	0.0	3.6	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.9	8.7	0.0	0.0	332.5	1.6	3.4	0.0	19.0	0.0	0.0	25.7	10.1	22.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	3.3
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 210.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	6	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.1	0.2	2.0	0.2	4.3	0.1	0.2	0.0	0.6	1.7	0.1	5.9	0.0	0.1	0.9	12.1	0.1	36.0	0.1	0.1	3.0	3.0	0.1	0.1	7.1	0.2	0.0	0.0	11.1	0.1	0.1	0.5	0.2	15.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0.0	0.2	0.1	0.2	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.3	0.0	0.6	3.0	3.0	0.0	0.0	15.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	210.1	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793390-46839782	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"intestine: 243.0"	"Group enriched"	"Detected in some"	4	"Enterocytes: 391.5;Paneth cells: 129.6"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CACO-2: 7.1;Hep G2: 1.9;NB-4: 3.1;RPMI-8226: 3.5;SH-SY5Y: 2.2;U-2197: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025163, HPA029416"	Enhanced					NA	NA		990000			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.1	0.1	0.1	4.7	0.1	0.0	0.1	0.1	0.1	0.1	100.5	0.1	0.1	51.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	19.8	0.1	0.2	0.1	0.1	0.1	243.0	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	391.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.9	0.0	0.0	4.7	0.0	0.0	0.0	0.0	61.3	0.0	0.0	129.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.3	0.0
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852512-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 54.6"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 271.0;Alveolar cells type 2: 421.7;Club cells: 164.9;Endothelial cells: 125.4;Ito cells: 281.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 13.5;TIME: 40.3"	"Low region specificity"	"Detected in all"													NA	NA		23000000				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	32.6	11.9	5.0	3.4	7.1	0.2	27.5	2.1	5.8	6.6	5.3	4.2	7.0	2.9	10.4	8.9	5.9	6.7	8.5	34.3	6.4	4.9	33.6	8.7	54.6	6.1	7.3	4.7	6.5	3.3	7.0	5.2	25.1	5.9	5.5	3.1	7.5	3.5	5.0	19.4	3.8	4.0	11.1	6.1	26.2	3.8	3.1	3.0	0.1	16.1	8.8	1.7	8.1	13.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	7.1	2.1	5.8	6.4	4.9	7.3	4.7	5.9	3.0	271.0	421.7	5.7	0.3	0.0	0.0	8.4	12.7	88.3	164.9	1.8	0.0	0.2	10.0	0.2	8.1	125.4	0.0	0.0	0.0	1.0	0.0	0.4	11.6	1.5	0.2	0.0	0.0	281.1	20.0	3.0	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	97.0	1.5	0.1	0.4	0.0	0.2	0.0	0.0	0.5
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997703-47042363	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.4"	"Cell type enhanced"	"Detected in some"	24	"Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038438	Approved				"Secreted - unknown location"	NA	NA					"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	6.5	6.1	0.0	3.7	0.1	1.3	4.2	15.7	0.8	10.0	0.0	0.0	0.0	27.4	0.1	5.4	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.6	0.0	7.5	0.2	0.0	3.2	1.9	0.1	0.1	5.5	2.1	0.1	0.1	1.5	1.3	0.0	0.0	11.3	5.6	12.3	16.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.7	0.0	0.0	8.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	13.0	0.0	0.0	0.0	18.3	45.7	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.9	0.0	12.6	0.0	0.0	0.4	15.3	26.8	25.0	102.9	0.0	0.0	19.9	25.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	30.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.4	305.8
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Cell line enhanced"	"Detected in many"		"OE19: 39.2;RT4: 99.8;SuSa: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.2	9.5	9.3	2.9	25.5	7.5	10.5	3.4	6.7	1.0	0.4	16.4	20.7	2.1	13.8	2.4	20.0	17.7	1.3	12.6	0.6	0.0	2.9	0.0	1.2	16.5	14.9	0.4	0.1	13.4	15.1	0.6	11.5	0.8	4.9	1.9	0.7	0.0	0.3	5.7	2.5	0.2	7.3	39.2	9.8	5.4	2.8	3.1	17.7	99.8	6.7	1.4	2.9	2.8	2.4	43.8	2.1	2.0	1.0	2.8	2.5	0.1	3.1	0.0	0.0	3.0	4.5	2.1	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1	0.0	12.7	0.0	142.4	21.1	0.6	7.6	35.7	10.7	25.0	1.8	0.0	24.6	13.3	69.3	45.6	5.6	30.3	0.0	25.8	16.8	14.1	135.6	19.6	0.0	20.6	0.0	11.5	1.8	36.8	29.9	2.6	5.8	11.8	0.0	40.2	4.4	63.5	46.7	1.1	48.5	1.3	77.6	16.2	0.6	1.4	8.7	149.4	1.3	14.0	360.8
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		160000	"Plasma membrane"	"Centriolar satellite, Cytosol"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	15.2	9.9	5.3	18.0	7.6	6.6	11.9	13.6	6.1	13.2	23.5	6.2	19.0	31.0	13.2	12.9	20.1	8.0	14.7	7.3	4.9	5.3	31.3	19.2	17.3	8.0	5.8	4.0	9.9	19.3	24.0	14.4	17.2	7.3	15.0	20.9	6.6	17.5	19.4	8.7	13.0	31.9	9.5	7.7	17.0	22.3	8.7	6.4	55.1	13.3	13.3	13.8	16.9	15.5	1.3	12.2	3.7	0.7	3.8	2.4	0.7	20.6	8.2	2.6	5.3	3.6	5.2	20.5	5.1	6.2	6.9	8.8	13.5	14.7	26.8	21.4	6.6	9.0	7.8	8.5	12.7	11.3	10.7	13.7	14.8	6.9	12.0	4.8	8.2	5.7	3.7	12.0	6.6	9.6	13.4	11.1	9.0	25.9	8.6	6.2	6.5	15.7	3.1	7.6	25.1	3.0	8.4	6.6	12.2	43.5	37.0	7.8	3.0	10.2	13.7	9.9	12.2	13.0	5.3	13.2	13.9	11.7	4.4	14.3	6.5	10.9	19.2	14.9	4.5	7.1	1.9	0.7	3.7	1.5	0.5	2.4	1.2	1.4	1.5	1.5	1.3	1.3	2.0	0.1	3.8	0.4	12.2	1.1	0.7	5.3	7.6	13.6	6.1	4.9	5.3	5.8	4.0	7.3	6.4	89.3	52.6	27.4	48.2	28.6	9.7	13.7	22.9	75.0	93.3	68.0	15.7	42.2	18.3	68.4	7.7	43.2	159.3	23.3	85.1	12.7	11.4	76.4	23.1	21.5	15.6	14.3	53.6	31.3	20.7	8.4	15.5	17.8	13.5	11.8	79.7	12.1	114.0	81.8	10.3	48.5	13.3	25.8	18.6	22.2	31.1	35.9	34.2	20.0	51.8	104.3
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell type enhanced"	"Detected in single"	21	"Ciliated cells: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;U-87 MG: 3.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain					NA	NA					"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell type enhanced"	"Detected in some"	14	"Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	8.7	0.0	13.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	3.3	0.2	0.0	0.0	0.0	3.0	9.6	0.1	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	16.0
OPN5	"dJ402H5.1, neuropsin, TMEM13"	ENSG00000124818	"Opsin 5"	Q6U736	6	47781982-47832780	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	12	"testis: 7.3"	"Group enriched"	"Detected in some"	42	"Early spermatids: 22.0;Late spermatids: 19.1;Spermatocytes: 8.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;Karpas-707: 1.0;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hypothalamus: 1.3"	HPA026084	Supported					NA	NA					"HPA026084: AB_2671807"					"unprognostic (1.95e-1)"								"unprognostic (6.18e-2)"		"unprognostic (4.84e-1)"	"unprognostic (1.07e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.0	0.0
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47878028-48068689	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3"	"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 1.4;Collecting duct cells: 1.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	2.1	0.7	4.6	0.1	7.4	0.2	1.3	2.7	11.3	3.8	1.2	0.3	0.0	0.6	1.7	3.7	1.9	3.2	1.4	1.4	2.2	1.3	2.2	2.1	3.1	0.2	1.4	5.5	1.1	1.1	0.4	3.9	1.9	1.8	2.3	1.2	1.6	2.1	6.4	0.6	0.3	0.4	1.9	1.3	0.2	0.5	0.9	0.8	0.0	3.6	0.0	0.3	2.8	1.3	0.4	0.4	0.8	0.2	0.1	0.2	0.0	0.0	0.0	10.1	0.0	1.7	5.0	13.5	1.5	3.2	0.1	0.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	22.5	0.5	0.0	0.0	7.4	7.2	0.0	0.1	5.4	1.5	2.3	0.0	0.0	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.5	0.0	0.0	0.0	22.9	0.0	0.0	11.4	2.5	1.6	0.0	0.2	0.0	0.0	0.0	3.4	0.0	9.9	0.8	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.2	0.4	0.0	0.0	4.6	7.4	2.7	11.3	2.2	1.3	1.4	5.5	1.8	0.8	0.0	0.6	0.0	0.0	0.1	0.4	0.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.4	4.8	14.5	16.9	28.9	27.5	8.0	12.1	16.0	12.8	19.0	5.5	7.0	12.5	9.7	12.9	19.4	7.7	16.1	8.6	18.1	10.6	11.7	6.6	11.0	14.4	21.1	8.5	6.4	16.6	12.8	13.0	15.2	11.5	12.3	13.6	12.0	15.0	15.0	8.4	9.9	8.4	6.2	14.2	3.5	8.9	18.2	17.2	14.8	12.9	13.5	9.4	13.3	9.6	20.0	15.9	8.3	13.6	8.8	11.9	8.8	16.1	16.3	5.9	6.7	10.7	16.8	10.0	10.4	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9	17.9	17.4	10.4	16.2	17.7	16.5	60.2	22.9	18.7	21.6	31.4	2.0	21.2	24.9	14.4	5.7	10.0	27.4	0.0	12.8	11.2	13.8	13.3	10.4	117.7	10.8	19.1	50.0	14.1	10.0	2.1	22.2	9.4	8.5	2.8	23.1	28.2	10.5	23.0	26.2	34.2	15.2	32.3	12.2	18.6	14.3	17.6	27.9	7.9	21.2	11.5
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463378-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	7.2	7.6	10.4	11.2	15.4	6.4	8.7	10.9	11.4	6.6	5.8	6.4	5.8	4.2	7.5	7.1	12.1	6.4	5.4	10.0	11.5	9.3	7.6	6.8	5.8	10.0	19.8	7.7	10.4	4.8	4.6	8.9	9.1	15.3	7.4	7.5	2.7	5.5	5.4	6.9	6.1	5.1	7.0	18.7	8.8	5.6	8.8	18.3	15.1	6.0	9.1	12.7	9.5	6.4	7.8	5.0	7.2	3.1	4.4	5.6	2.3	16.4	4.6	14.7	9.1	4.0	6.3	13.0	21.4	12.3	20.6	29.0	5.6	6.7	11.2	10.7	6.0	16.1	6.0	7.6	7.7	30.5	12.1	10.7	8.2	7.4	9.0	1.7	17.4	10.4	2.8	4.3	25.2	8.8	5.3	7.5	9.8	12.6	11.2	15.2	4.7	12.2	8.2	9.1	14.4	4.2	8.8	17.4	12.1	6.0	6.8	7.9	7.9	10.0	6.0	11.2	15.2	7.7	16.0	4.4	16.0	12.4	12.5	19.0	5.1	13.2	10.0	10.8	13.1	15.4	4.1	2.2	7.2	4.0	2.7	4.2	7.6	4.3	4.6	2.5	7.8	4.7	4.5	1.6	4.4	3.1	5.0	5.6	2.3	10.4	15.4	10.9	11.4	11.5	9.3	19.8	7.7	15.3	18.3	0.0	2.4	6.7	8.9	7.7	5.4	5.1	7.6	10.7	3.4	7.0	2.0	12.0	6.6	7.0	1.0	6.3	1.6	0.0	6.9	23.5	8.4	4.8	4.6	2.8	8.8	6.4	2.4	13.5	10.8	1.9	8.1	5.5	3.3	7.2	2.7	12.4	6.0	3.6	10.3	3.1	5.0	6.5	5.1	16.8	28.6	6.0	10.4	6.4	4.5	5.4
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499958-49527047	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 2.0;liver: 5.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	73	"T-47d: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain					NA	NA					"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6;gallbladder: 18.9"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"basal ganglia: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5"									HPA036199	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA036199: AB_2675002"	"prognostic favorable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.7	0.2	1.0	3.0	30.6	0.0	4.9	3.1	1.8	3.7	2.1	0.3	4.4	10.5	4.4	3.6	2.9	1.9	18.9	0.4	0.3	0.4	0.3	1.1	0.6	0.6	0.5	0.1	0.5	3.3	0.0	2.0	0.2	2.8	1.1	1.4	0.0	2.2	0.9	1.2	4.6	1.4	1.4	0.3	0.1	9.1	3.1	2.9	0.0	1.1	0.4	0.8	1.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.1	0.0	0.0	0.0	0.0	1.6	0.8	0.9	0.0	0.0	0.2	3.3	0.0	0.5	1.5	8.0	8.8	1.0	2.3	0.0	0.0	5.6	0.0	7.0	0.0	0.3	0.0	0.0	0.3	6.9	0.0	5.0	2.7	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.3	1.2	12.0	0.0	0.0	0.0	1.6	5.2	0.2	0.0	2.2	0.0	0.0	0.4	7.5	0.0	2.7	0.4	0.0	0.0	5.7	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	30.6	3.1	1.3	0.3	0.4	0.5	0.1	2.8	2.9	0.0	1.9	0.0	22.6	36.7	0.0	2.0	7.6	5.3	12.5	0.0	0.0	2.9	0.0	32.6	0.2	8.8	2.0	0.0	8.1	15.4	0.9	2.7	0.0	0.0	0.8	0.0	102.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	7.8	7.0	0.4	0.0	0.0	0.0	0.9	0.5	0.5	31.5	1.7	0.0	1.7	13.2
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Cell type enriched"	"Detected in some"	50	"Erythroid cells: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"HEL: 87.8;K-562: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	116.8	0.2	0.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CRISP2	"CRISP-2, CT36, GAPDL5, TPX1"	ENSG00000124490	"Cysteine rich secretory protein 2"	P16562	6	49692358-49713590	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 135.5"	"Group enriched"	"Detected in some"	81	"Early spermatids: 4897.0;Late spermatids: 16112.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.9;U-2 OS: 1.8"					"Not detected"	"Not detected"			HPA031248	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA031248: AB_10602211"	"unprognostic (1.10e-1)"							"unprognostic (1.51e-1)"		"unprognostic (1.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.35e-2)"		"unprognostic (9.23e-3)"	"unprognostic (4.05e-2)"			0.0	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.1	0.3	0.0	0.1	3.2	0.0	0.0	7.0	0.7	4.4	1.7	0.0	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.1	0.0	0.1	3.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	135.5	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	38.8	7.9	0.0	0.0	0.0	0.0	0.1	4897.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16112.2	124.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	78.8	0.0	0.0	64.7	0.0	130.2	60.3	0.0	0.0	0.0	0.0	0.4
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 38.2;Club cells: 23.9;Melanocytes: 21.9"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"	"Group enriched"	"Detected in some"	20	"HEL: 14.5;RT4: 4.9;SK-BR-3: 11.0;T-47d: 5.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		390000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	11.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	38.2	2.7	23.9	3.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785651-49787307	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"testis: 70.2"	"Group enriched"	"Detected in some"	48	"Early spermatids: 906.2;Late spermatids: 2050.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.0;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported					NA	NA					"HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	906.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2050.3	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	6.5	0.0	30.9	8.6	0.0	0.0	0.0	0.0	0.0
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 203.0"	"Group enriched"	"Detected in some"	45	"Early spermatids: 33.8;Late spermatids: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NB-4: 7.3;RPMI-8226: 2.1;SH-SY5Y: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA028445: AB_10670428, HPA030534: AB_2732459"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	48.8	0.0	0.2	203.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.4	8.8	0.2	0.2	0.6	0.0	0.2	0.2	0.2	7.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
DEFB133		ENSG00000214643	"Defensin beta 133"	Q30KQ1	6	49946021-49950265	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	30	"epididymis: 18.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"K-562: 4.2"														"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB114	DEFB-14	ENSG00000177684	"Defensin beta 114"	Q30KQ6	6	49960249-49964105	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	67	"epididymis: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	39.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB113	DEFB-13	ENSG00000214642	"Defensin beta 113"	Q30KQ7	6	49968677-49969625	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	139	"epididymis: 34.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1			0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB110	"DEFB-10, DEFB-11, DEFB111"	ENSG00000203970	"Defensin beta 110"	Q30KQ9	6	50009138-50021981	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	158	"epididymis: 149.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NB-4: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.9	0.0	0.1	149.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB112	DEFB-12	ENSG00000180872	"Defensin beta 112"	Q30KQ8	6	50043575-50048651	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	54	"epididymis: 58.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"NB-4: 2.9"														"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713828-50772988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"brain: 4.4"	"Cell type enhanced"	"Detected in single"	24	"Horizontal cells: 1.6"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 5.2;U-2197: 1.6"	"Region enriched"	"Detected in many"	4	"midbrain: 14.1"	"Region enriched"	"Detected in many"	7	"midbrain: 16.3"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847613	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 65.5"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 413.2"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in some"	41	"cerebellum: 4.7;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 32.4;SH-SY5Y: 60.4"	"Region enhanced"	"Detected in some"		"cerebellum: 11.2"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.2	3.0	0.0	0.0	0.0	0.0	9.4	4.7	0.0	0.2	0.2	0.0	8.8	0.0	0.0	65.5	5.8	0.0	0.0	0.1	0.0	0.1	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	6.3	0.1	0.0	12.2	7.0	0.6	0.0	6.3	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	60.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	10.4	6.9	0.6	0.0	0.0	0.0	48.8	7.9	10.5	46.4	0.0	11.5	0.3	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	1.0	413.2	0.0	0.0	0.0	0.5	0.0	0.0	101.3	0.0	0.0	2.3	0.0	0.0	0.4	0.7	9.7	0.0	0.0	0.5	0.0	3.8	4.1	0.0	0.0	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1, fibrocystin/polyductin"	P08F94	6	51615300-52087625	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 19.8;kidney: 49.4;pancreas: 32.9"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 56.0;Collecting duct cells: 43.6;Early spermatids: 167.1;Late spermatids: 63.8"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced					NA	NA					"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favorable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	5.6	0.0	0.1	19.8	0.1	0.1	6.3	0.1	0.1	0.1	49.4	2.5	0.1	0.0	0.1	0.0	0.1	32.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.1	0.5	1.4	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.5	15.8	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	56.0	0.0	0.0	43.6	0.0	0.1	1.7	11.7	167.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	2.6	0.1	0.0	0.0	0.0	0.0	63.8	2.0	0.0	5.0	0.0	0.0	1.9	2.9	0.0	0.4	17.7	0.0	0.0	0.0	1.4	1.8	0.0	0.0	0.0	0.0	0.1
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	37	"Karpas-707: 7.3;U-266/84: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	NA	NA	9920				"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244537	"Disease related genes, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	30000						"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.6	0.2	0.1	0.0			0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2			0.0		6.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264009-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 82.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		29000	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	17.3	10.9	8.5	29.7	10.5	22.3	15.3	10.7	9.7	15.9	17.2	9.5	20.2	9.0	21.2	13.0	21.7	15.5	15.8	15.4	7.4	6.6	16.1	12.6	13.7	30.1	8.9	5.8	20.0	13.8	16.0	7.4	24.7	10.0	15.9	19.2	12.7	12.6	23.4	12.1	15.0	17.8	17.7	9.5	23.2	15.3	16.1	10.5	82.5	12.9	20.1	35.7	19.1	15.3	21.1	12.9	11.4	13.3	22.2	29.4	18.6	30.2	20.1	35.1	33.0	7.6	6.8	23.0	22.5	17.3	38.4	39.4	41.1	16.5	33.0	22.6	13.1	25.1	24.1	46.2	27.5	38.8	37.1	43.7	62.4	40.4	57.9	2.0	61.2	25.6	4.1	6.4	28.2	7.9	9.4	19.5	40.0	50.7	76.2	19.7	19.9	61.6	47.3	29.1	60.3	14.2	54.7	53.7	44.1	17.0	32.2	35.6	27.3	23.6	13.6	20.4	51.4	26.8	43.4	10.0	26.2	28.2	27.1	33.5	22.6	25.8	58.8	22.5	53.1	30.7	11.1	8.0	11.4	22.9	13.3	19.7	21.1	23.3	23.0	12.9	19.2	22.6	24.0	1.1	22.2	7.4	8.3	29.4	18.6	8.5	10.5	10.7	9.7	7.4	6.6	8.9	5.8	10.0	10.5	20.8	10.5	30.5	14.0	17.1	13.8	13.9	12.7	22.7	20.5	21.0	3.9	85.3	11.6	21.3	0.6	24.8	4.9	23.3	17.7	53.2	16.0	7.5	36.9	9.3	30.8	0.0	7.0	14.7	8.9	2.3	25.0	13.8	6.8	10.8	16.7	19.0	13.0	10.5	19.8	6.5	11.2	6.5	24.7	21.7	59.4	8.8	22.9	27.7	31.0	11.2
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 19.4;OE19: 41.1;SuSa: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.4	3.5	25.6	6.6	32.4	1.3	2.2	14.9	31.0	4.2	28.9	35.5	14.2	14.5	4.4	6.7	13.7	5.4	4.9	2.9	27.3	17.5	5.3	1.5	5.8	7.2	48.5	15.8	19.5	2.5	3.7	1.8	5.5	28.2	3.8	28.1	1.9	1.9	28.5	1.1	2.7	25.1	5.2	69.2	4.8	24.1	3.1	36.5	3.1	2.6	0.4	6.0	7.3	3.3	1.0	6.0	2.0	2.6	7.0	16.3	3.2	0.4	0.4	5.2	2.2	3.1	5.1	3.5	1.5	5.8	1.0	2.1	1.9	1.8	0.5	0.5	1.0	2.3	0.2	0.6	2.5	1.6	6.9	0.8	3.1	0.4	19.4	0.8	0.8	0.4	1.4	0.3	0.6	3.7	3.6	5.5	6.1	0.7	3.1	4.0	0.7	2.0	2.8	2.6	41.1	0.2	5.3	0.8	1.2	6.0	1.4	1.9	4.2	0.4	0.1	5.8	17.5	0.1	6.9	2.3	2.0	0.8	0.5	0.9	0.9	1.2	0.7	1.8	8.0	10.3	2.0	2.6	1.3	2.5	0.5	3.8	0.9	7.6	5.2	6.0	1.0	16.3	7.6	0.5	7.0	0.5	3.0	4.7	3.2	25.6	32.4	14.9	22.8	27.3	17.5	48.5	15.8	28.2	36.5	3.0	8.8	0.0	3.2	1.8	1.6	4.6	15.3	0.0	1.2	3.5	7.9	1.4	0.0	3.2	0.4	3.8	94.7	0.0	1.0	2.6	4.7	6.0	4.6	0.0	7.9	0.0	22.1	3.7	16.7	1.0	5.2	3.9	13.5	5.4	40.0	4.5	3.0	55.1	9.6	0.0	3.0	0.0	1.9	11.4	2.9	0.9	0.7	5.9	24.1	7.8
EFHC1	"EJM, EJM1, FLJ10466"	ENSG00000096093	"EF-hand domain containing 1"	Q5JVL4	6	52362123-52529886	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 49.3"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 243.6;Early spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035307	Approved					NA	NA					"HPA035307: AB_2674561"	"unprognostic (2.11e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.60e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.33e-4)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.27e-1)"	4.1	5.2	12.5	4.1	25.5	5.2	8.7	12.6	18.3	10.1	10.2	29.4	12.5	4.0	10.6	10.9	4.1	49.3	6.1	4.3	16.7	9.7	6.8	2.9	8.5	4.1	37.8	13.4	10.9	6.0	8.1	18.8	6.1	23.0	6.5	5.9	3.5	5.5	22.4	3.7	8.9	14.9	6.2	21.3	4.9	5.9	23.1	29.3	2.9	13.3	0.8	3.7	5.2	6.0	5.6	8.6	2.8	0.8	1.9	1.2	0.6	2.7	3.0	7.3	5.1	7.1	12.4	1.4	3.1	8.2	4.3	6.9	1.9	3.1	1.1	7.4	5.2	8.2	2.7	2.1	5.8	5.6	0.6	2.6	1.0	7.5	2.4	5.0	1.0	1.3	5.8	3.3	6.1	5.7	20.6	9.0	1.3	2.3	1.9	6.5	2.2	1.1	1.8	2.2	2.0	1.3	1.6	3.9	1.3	5.9	1.0	15.1	4.1	0.8	1.4	6.3	9.6	5.2	1.3	2.9	3.1	4.3	1.2	2.3	1.6	2.2	1.9	8.6	0.4	5.6	0.8	0.8	2.0	1.2	0.3	0.6	5.2	0.5	1.0	1.9	5.6	0.6	1.0	2.8	1.9	0.5	8.6	0.4	0.6	12.5	25.5	12.6	18.3	16.7	9.7	37.8	13.4	23.0	29.3	6.0	12.2	17.9	27.6	16.1	22.9	3.1	5.1	243.6	38.7	40.1	56.9	10.3	0.0	14.7	178.6	12.1	12.3	0.0	7.1	14.4	23.0	22.5	8.1	4.9	7.0	12.7	24.0	11.6	9.2	47.8	26.2	11.0	15.1	8.2	9.6	15.2	9.0	16.9	20.8	3.1	40.4	32.3	18.9	79.6	24.7	10.7	3.8	12.8	10.0	20.5
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497402-52576915	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 54.4;ASC TERT1: 58.3;fHDF/TERT166: 52.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035092, HPA057925"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA035092: AB_10610562, HPA057925: AB_2683557"	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	17.3	4.9	2.0	11.8	3.7	2.7	29.4	2.0	3.3	13.3	12.5	4.3	4.4	9.2	12.7	9.0	8.3	11.5	11.8	10.5	3.3	2.2	7.7	23.7	12.6	13.1	4.0	2.2	15.6	6.8	1.9	4.0	46.7	6.0	9.9	10.2	12.0	6.2	4.0	6.3	7.6	15.9	17.6	5.3	20.0	8.4	11.6	2.7	4.9	11.7	6.0	12.1	14.0	19.6	3.6	3.1	2.8	5.4	2.0	2.8	1.8	9.1	4.1	4.8	4.7	54.4	58.3	8.4	27.0	27.4	22.7	21.1	8.8	1.9	2.2	4.5	52.3	16.2	2.0	3.1	16.9	28.7	5.0	1.6	4.9	4.1	11.1	15.5	1.2	2.7	21.1	1.7	19.8	8.8	33.2	26.0	1.9	3.0	16.5	32.4	3.3	1.7	3.6	2.2	3.6	1.8	2.2	12.6	18.5	5.4	1.5	1.1	1.8	6.2	2.8	6.5	10.6	4.3	2.6	41.1	38.2	8.3	13.7	14.7	11.3	19.2	6.4	13.9	3.3	23.2	0.2	2.8	2.8	2.8	3.4	1.5	3.6	2.2	1.7	3.1	2.0	1.2	2.0	0.8	2.0	5.4	1.5	0.8	1.8	2.0	3.7	2.0	3.3	3.3	2.2	4.0	2.2	6.0	2.7	6.0	2.7	11.5	2.5	7.2	3.0	7.1	5.1	5.3	4.5	7.0	23.6	31.3	3.3	3.4	31.2	13.7	4.1	23.3	2.7	25.0	27.7	2.3	2.3	25.6	13.0	4.8	8.6	23.4	12.1	84.2	19.2	4.2	25.3	0.0	15.0	1.7	5.6	0.0	21.9	2.9	13.7	12.9	12.0	22.4	4.9	3.6	17.3	6.4	4.7	1.4
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671109-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	8.7	24.4	26.7	6.2	32.0	4.3	12.9	25.7	40.0	13.9	12.5	13.5	5.8	18.9	14.3	19.3	18.0	16.3	12.6	8.1	25.5	40.7	25.8	52.7	9.0	8.8	28.3	22.6	21.0	23.8	9.2	12.9	7.9	31.7	19.0	13.3	25.7	9.6	11.7	2.0	6.8	17.4	13.4	29.1	6.5	20.3	8.4	10.7	5.8	14.6	11.1	11.6	14.1	11.6	22.3	14.3	6.4	0.2	4.0	25.7	11.9	67.3	10.2	7.6	21.5	20.8	16.1	6.4	13.6	18.7	12.6	19.6	15.6	17.5	8.3	15.2	17.1	26.6	25.8	16.8	22.8	21.3	33.3	13.8	12.2	16.7	25.5	6.8	6.2	15.3	14.4	16.1	13.8	3.1	16.7	17.0	10.6	2.5	23.7	14.9	13.7	12.1	7.1	4.5	44.7	17.9	9.6	10.8	6.5	24.4	13.0	39.6	19.2	15.2	12.2	25.4	9.9	18.8	12.0	12.5	17.5	23.6	6.8	21.9	11.4	9.6	12.5	24.6	3.9	13.9	6.4	0.2	6.4	16.4	0.0	10.6	22.3	21.2	17.2	7.8	13.2	16.4	17.5	0.9	4.0	0.0	14.3	25.7	11.9	26.7	32.0	25.7	40.0	25.5	40.7	28.3	22.6	31.7	10.7	23.8	14.5	18.0	51.6	42.9	20.8	12.5	50.9	61.6	33.0	48.8	7.9	51.8	54.7	95.2	1.1	42.1	22.0	0.0	122.4	120.9	88.8	80.6	25.3	119.7	38.4	4.8	32.1	33.7	7.3	2.0	40.3	16.9	84.4	6.4	47.0	24.6	77.7	28.8	47.0	136.7	10.1	6.5	75.2	4.4	24.5	33.4	12.9	22.7	47.2	49.8
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Cell type enhanced"	"Detected in many"	15	"Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 20.7;Hep G2: 15.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.3	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	5.9	0.5	0.1	0.0	0.0	0.0	338.8	780.3	46.6	15.7	0.0	0.0	180.8	6.3	4.5	0.0	0.0	0.0	201.6	0.1	0.0	5.3	0.0	50.4	0.1	0.0	0.0	1.3	1.6	6.5	1.1	1.3	0.0	9.0	0.4	0.0	549.6	0.0	0.4	368.8	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	1.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 89.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000		Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	89.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6	6.0	7.7	0.0	2.8	0.0	0.0	0.0	614.0	837.9	106.9	69.8	0.0	0.1	454.3	72.7	8.0	0.0	11.8	46.7	1419.6	0.0	0.0	51.4	2.3	628.5	0.1	0.0	2.9	23.4	22.6	21.8	60.7	4.4	0.0	22.6	33.3	0.0	1010.1	6.0	4.2	2005.4	0.0	0.0	0.0	5.6	3.4	0.0	0.5	4.3	29.3	42.0
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52846095	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Cell type enriched"	"Detected in single"	5	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	33.5	10.3	0.0	0.0	121.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.4	0.2	0.0	1.1	0.2	13.5	0.0	0.0	0.0	0.0	1.3	1.4	0.0	23.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	8.5	430.9	0.0	0.0	0.0
GSTA4		ENSG00000170899	"Glutathione S-transferase alpha 4"	O15217	6	52977948-52995378	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 105.4"	"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 233.2;Syncytiotrophoblasts: 376.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 17.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 17.4"	"Cell line enhanced"	"Detected in many"		"AF22: 32.5;ASC TERT1: 32.2"					"Low region specificity"	"Detected in all"			HPA048934	Approved					NA	NA					"HPA048934: AB_2680563"	"unprognostic (5.13e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	6.3	105.4	15.0	3.4	27.0	0.8	12.2	23.8	29.6	11.2	6.7	13.2	4.3	7.2	12.2	21.0	18.6	8.8	7.8	6.7	16.7	17.8	10.7	11.3	15.1	2.8	11.7	19.2	18.4	10.2	29.1	27.3	16.2	21.6	14.0	8.5	15.5	13.9	10.1	10.6	45.2	6.6	8.9	11.3	5.1	12.1	12.7	6.8	0.9	8.5	18.4	9.4	5.9	13.6	2.8	1.9	0.0	17.4	3.1	3.1	0.9	0.4	3.4	32.5	26.5	18.7	32.2	2.9	4.8	11.2	3.1	5.2	4.9	0.1	0.3	3.2	8.7	3.5	1.4	22.9	4.4	4.0	0.8	10.4	1.1	2.8	17.3	13.8	0.0	0.7	27.4	6.7	4.1	3.3	10.0	19.0	5.7	4.1	5.1	10.4	0.0	0.4	0.1	12.2	19.4	5.9	0.9	13.7	5.8	11.1	0.5	14.5	21.0	0.1	3.4	8.3	17.0	0.8	1.0	10.0	3.4	8.0	3.3	3.6	7.1	0.8	0.1	5.2	0.6	3.6	0.0	0.0	0.0	3.1	1.0	2.0	0.9	0.8	1.5	0.8	2.8	0.6	0.9	0.0	3.1	17.4	1.9	0.9	0.9	15.0	27.0	23.8	29.6	16.7	17.8	11.7	19.2	21.6	6.8	47.6	58.1	0.0	20.6	40.0	37.9	8.4	12.7	20.1	23.9	26.2	0.0	233.2	46.4	9.4	1.1	16.8	6.3	23.3	7.7	97.4	41.6	38.0	5.7	19.0	55.1	35.0	23.0	25.8	2.7	6.5	38.6	3.5	91.1	3.6	29.1	70.2	16.8	7.0	36.7	36.1	10.2	19.4	25.4	5.4	9.1	118.4	376.6	5.0	17.0	11.1
ICK	"KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Intestinal cell kinase"	Q9UPZ9	6	53001279-53061802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	9.8	28.2	10.1	6.5	10.7	2.8	13.4	14.3	12.7	11.5	12.3	20.1	6.6	11.3	10.6	6.8	10.4	9.2	8.3	9.6	10.8	7.7	5.4	9.6	8.2	5.5	13.3	8.1	11.8	8.2	9.0	5.3	44.3	12.3	12.2	13.0	9.7	20.7	12.7	5.9	10.1	14.2	13.7	16.8	6.2	15.0	5.6	12.6	14.8	7.6	7.0	7.9	10.6	9.1	4.5	4.1	6.2	3.1	3.2	5.0	2.1	5.1	1.9	10.1	6.9	6.3	10.0	11.7	4.6	8.5	7.5	8.6	2.7	1.6	3.7	2.8	14.1	2.4	3.4	12.0	4.8	9.9	13.0	4.7	2.8	2.3	14.8	3.2	3.4	3.7	8.8	5.3	3.2	3.7	5.4	6.9	8.2	5.3	15.5	17.0	4.4	3.6	4.2	3.8	18.0	4.2	5.8	4.5	5.0	3.1	3.7	16.3	7.3	4.5	11.2	6.4	10.3	6.5	7.3	5.7	12.0	5.6	4.4	11.4	4.3	3.1	1.5	2.4	3.3	5.8	6.2	3.1	5.6	5.0	2.3	4.8	3.7	3.6	4.1	2.9	4.5	4.2	3.6	1.7	3.2	2.5	4.1	4.8	2.1	10.1	10.7	14.3	12.7	10.8	7.7	13.3	8.1	12.3	12.6	17.9	16.8	7.1	4.3	6.9	30.5	8.7	7.6	17.4	26.1	3.5	35.3	17.7	11.6	8.9	1.8	8.7	9.5	0.0	21.0	27.3	8.2	14.5	19.7	12.3	5.2	25.4	8.6	8.0	10.4	1.1	13.3	6.0	3.3	5.4	25.7	20.1	16.6	2.9	26.9	3.8	41.7	6.5	14.4	6.4	2.7	7.3	48.6	7.5	12.3	8.0
FBXO9	"FBX9, NY-REN-57"	ENSG00000112146	"F-box protein 9"	Q9UK97	6	53051991-53100873	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064246			Approved	Centrosome		NA	NA			Centrosome		"HPA064246: AB_2685225"	"unprognostic (6.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.89e-3)"	"prognostic favorable (1.51e-4)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.64e-3)"	22.6	77.8	19.0	25.2	22.3	47.2	22.8	33.5	42.6	19.4	22.3	15.2	37.2	17.4	21.3	26.6	25.1	20.6	22.6	28.7	20.0	23.8	27.3	38.0	40.5	28.9	22.7	30.5	20.6	32.9	32.7	22.5	28.9	30.4	21.3	18.0	21.8	35.3	43.7	32.0	20.9	19.9	26.9	13.8	22.2	27.0	18.2	17.1	13.8	24.8	29.9	18.3	20.7	18.6	16.0	15.6	14.6	24.2	14.8	14.6	8.4	28.0	11.5	10.8	32.0	22.2	18.0	24.9	27.2	27.7	25.1	25.1	22.3	12.2	14.4	18.6	26.8	15.8	17.2	23.3	21.7	32.3	17.8	23.3	34.4	21.2	31.6	18.6	32.6	21.8	23.3	24.0	17.3	17.9	25.4	21.2	14.9	34.0	22.5	26.3	18.5	14.1	21.4	9.5	27.1	16.7	16.4	29.0	17.4	27.5	21.1	38.8	14.8	27.3	20.0	35.8	22.7	30.8	31.9	17.2	36.1	24.8	39.3	30.8	23.8	29.9	22.2	17.4	22.6	19.8	14.6	24.2	13.4	12.8	12.6	14.4	14.4	13.1	12.6	15.6	16.0	14.6	11.1	14.4	14.8	12.2	12.3	13.5	8.4	19.0	22.3	33.5	42.6	20.0	23.8	22.7	30.5	30.4	17.1	71.5	78.7	19.3	17.6	12.6	77.5	35.4	38.2	46.8	60.3	19.2	62.8	34.4	33.2	58.3	113.4	26.9	23.7	116.8	66.7	35.9	19.3	26.9	30.2	57.2	22.4	73.1	28.7	25.2	35.1	96.7	35.6	31.6	18.6	22.6	22.4	61.2	54.3	17.8	30.4	47.7	75.8	19.4	25.5	24.7	22.2	14.2	63.0	28.0	21.1	14.8
GCM1	"GCMA, hGCMa"	ENSG00000137270	"Glial cells missing homolog 1"	Q9NP62	6	53126964-53148829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"placenta: 102.4"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.5"	"Group enriched"	"Detected in many"	8	"B-cells: 1.8;granulocytes: 4.5"	"Cell line enriched"	"Detected in some"	5	"BEWO: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011343, HPA073469"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA011343: AB_2668489, HPA073469: "	"unprognostic (2.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.42e-2)"		"unprognostic (2.96e-2)"	0.3	0.3	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	1.5	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.2	102.4	0.1	0.2	0.0	0.1	0.1	0.1	3.1	0.0	0.4	0.1	0.1	2.2	0.0	2.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.8	0.2	4.5	0.3	0.4	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.0	30.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.0	6.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.6	0.3	2.2	0.2	0.1	0.2	0.7	0.1	0.1	0.2	1.8	0.2	0.2	4.5	0.4	0.3	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.3	1.9	0.0	0.0	0.0	0.2	166.4	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	222.5	0.0	0.0	0.0
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 102.4;Intestinal endocrine cells: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	7.3	49.2	4.0	9.5	4.8	2.2	5.4	3.7	6.0	2.8	3.3	7.2	17.1	14.0	7.1	3.3	21.5	10.5	12.3	27.1	3.8	11.0	7.6	9.3	9.5	42.0	5.5	12.3	5.8	3.4	11.5	3.1	14.1	3.7	4.2	12.3	5.1	4.4	1.3	7.7	10.5	4.9	7.5	68.1	4.6	3.5	2.5	12.3	9.1	45.4	11.7	5.7	6.2	10.0	6.5	6.1	6.8	5.8	5.9	2.5	8.8	6.4	5.5	5.9	9.1	8.1	6.3	8.8	4.2	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5	0.0	3.7	7.8	42.9	30.9	12.8	17.8	25.5	48.2	47.8	0.0	23.6	5.2	10.0	12.8	1.4	13.5	19.9	46.7	11.0	6.5	8.7	44.8	2.3	102.4	19.8	7.9	212.1	9.2	60.1	1.0	6.1	16.4	8.5	6.4	16.3	13.8	17.1	8.5	8.9	19.8	4.0	12.9	10.3	3.3	8.1	21.8	6.5	10.7	13.8	89.1
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647901-53665708	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9"	"Cell type enriched"	"Detected in single"	284	"Cardiomyocytes: 217.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 2.8;SCLC-21H: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	13.1	0.5	0.1	0.3	0.3	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	1.2	1.3	0.6	0.1	77.7	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.6	0.1	0.0	1.6	0.0	57.7	0.6	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	40.9	2.2	0.3	0.2	0.7	0.0	0.0	0.1	0.9	0.6	0.0	1.0	0.7	0.2	0.2	0.0	0.0	0.5	0.0	0.2	0.2	0.1	1.2	2.5	0.0	0.2	0.0	0.7	1.9	0.8	0.4	0.1	0.1	1.3	0.4	1.7	1.6	0.1	0.6	0.0	2.1	2.6	0.0	0.5	0.5	0.0	1.4	0.0	0.2	0.0	0.8	0.9	0.0	0.3	1.3	0.8	0.1	2.8	0.1	0.8	0.9	3.7	0.4	0.2	0.6	0.0	0.3	1.2	0.0	0.0	0.1	0.5	0.0	0.2	0.5	0.1	0.0	0.3	2.1	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.6	0.3	217.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.4
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 81.7;Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	13.1	2.3	8.6	7.6	17.0	2.5	12.4	4.0	13.4	12.1	22.6	17.5	7.3	15.3	5.3	8.9	17.2	7.9	12.0	3.8	9.4	6.1	7.3	1.1	7.0	2.4	21.8	6.1	5.7	8.3	24.8	8.0	26.1	11.2	8.3	23.2	7.8	14.9	7.0	1.9	20.2	20.7	6.1	11.9	1.8	13.2	12.3	20.6	8.3	16.3	8.4	9.3	12.3	16.1	1.8	1.4	0.4	0.2	3.3	1.1	0.1	20.1	2.6	2.8	5.0	0.7	0.4	20.1	2.8	5.7	2.4	3.3	22.4	10.0	2.9	2.3	1.7	4.5	10.0	22.1	8.9	3.1	3.5	6.4	1.7	2.0	15.0	7.3	2.2	1.3	0.7	7.4	0.2	5.4	3.8	4.3	10.6	0.4	2.7	1.3	8.8	14.7	0.3	2.2	15.1	2.0	3.0	4.7	1.5	6.5	26.1	7.4	0.7	3.3	14.7	4.3	7.4	9.6	2.2	2.0	1.8	6.0	0.1	2.5	2.7	2.1	2.0	2.1	3.0	2.2	0.0	0.2	0.4	1.0	0.0	0.4	0.3	0.9	1.1	1.4	1.8	0.8	0.6	0.0	3.3	0.0	1.2	0.1	0.1	8.6	17.0	4.0	13.4	9.4	6.1	21.8	6.1	11.2	20.6	38.7	3.8	2.7	22.4	46.8	33.1	3.3	5.1	9.4	20.5	15.7	3.9	42.9	6.6	17.3	75.0	17.5	33.2	0.0	13.8	43.0	5.2	14.6	5.7	0.0	4.5	7.9	17.2	7.4	0.3	81.7	8.6	1.5	10.1	3.6	22.1	38.2	21.5	36.6	9.6	10.1	2.7	6.5	2.5	6.1	6.9	46.0	89.7	3.8	18.4	26.7
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 190.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 18.1;SK-MEL-30: 17.4"					"Low region specificity"	"Detected in many"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0.0	0.0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0.0	0.0	2.7	31.6	2.2	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	18.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.2	0.0	0.1	0.6	1.3	0.0	0.0	0.5	17.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	190.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	11.7	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	18.3	0.0	12.7	0.0	0.6	1.5	8.2	0.3	0.0	6.8	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.2	0.1	1.8	0.0	0.0	0.0	0.1
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390152	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 27.2;kidney: 53.0"	"Group enriched"	"Detected in some"	6	"Enterocytes: 52.3;Proximal tubular cells: 176.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	34	"RPTEC TERT1: 46.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		26000			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	53.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.0	0.0	0.0	19.9	0.0	0.7	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	1.3	10.5	0.0	176.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54942022	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.7;intestine: 24.6;tongue: 30.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 29.9;Basal keratinocytes: 30.0;Suprabasal keratinocytes: 35.9;Urothelial cells: 28.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 12.6;HaCaT: 14.1;HBEC3-KT: 7.7;hTCEpi: 14.2;hTERT-HME1: 18.7;RT4: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031464, HPA031465"	Enhanced					NA	NA					"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavorable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.86e-5)"	0.4	0.4	0.4	6.9	0.4	0.0	1.6	0.4	0.4	8.8	16.4	0.0	1.9	6.5	0.4	2.9	32.7	1.4	7.0	1.6	0.4	0.4	6.3	0.5	0.5	0.0	0.4	0.0	0.5	3.7	0.0	0.4	15.6	0.0	5.5	8.2	0.0	5.5	1.7	3.5	22.3	24.6	1.3	0.4	0.4	3.6	0.9	0.0	4.3	11.0	30.1	8.5	4.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	0.0	5.4	2.9	0.0	0.0	0.0	0.0	14.1	0.0	7.7	0.0	0.0	1.8	0.0	2.4	0.0	0.0	0.0	0.0	0.0	14.2	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.0	5.8	16.1	0.2	0.0	2.4	0.4	0.0	2.6	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	29.9	30.0	0.0	2.4	5.1	0.0	7.9	7.0	0.0	8.0	0.0	5.5	4.5	0.0	9.3	0.0	2.9	9.4	0.7	7.2	0.0	0.0	0.5	0.0	1.2	0.6	0.0	1.8	0.0	0.0	0.0	0.0	5.5	0.0	3.6	10.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	35.9	15.7	0.0	7.1	28.6
HCRTR2	OX2R	ENSG00000137252	"Hypocretin receptor 2"	O43614	6	55106460-55282620	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 17.4"	"Cell type enhanced"	"Detected in some"	24	"Distal tubular cells: 1.7;Peritubular cells: 3.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"pons and medulla: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"AF22: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054516	Enhanced					NA	NA					"HPA054516: AB_2682513"						"unprognostic (4.86e-1)"		"unprognostic (2.69e-2)"		"unprognostic (1.86e-2)"	"unprognostic (2.32e-1)"			"unprognostic (7.45e-2)"	"unprognostic (7.39e-2)"			0.1	0.2	1.7	0.0	1.3	0.0	0.1	0.6	2.2	0.1	0.1	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.1	1.1	0.9	4.2	3.7	0.1	0.4	0.1	2.6	1.7	1.7	0.0	0.0	0.3	2.2	17.4	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	1.3	0.6	2.2	0.9	4.2	2.6	1.7	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.9;blood: 2.2;liver: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;Karpas-707: 1.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 0.3"	"Low region specificity"	"Detected in many"			HPA047372	Uncertain					NA	NA					"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			1.9	0.0	0.1	0.3	0.1	0.4	0.6	0.2	0.2	0.0	0.0			0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.1		0.1	0.0	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.9			0.0		0.1	0.0	0.0	1.2	0.7	2.2	0.6	0.6	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.1	0.8	0.6	0.2	0.2	0.1	0.1	0.8	0.2	0.1	0.0	1.2	0.3	0.3	2.2	0.6	0.2	0.7	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434369-55579214	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;pituitary gland: 14.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 14.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	2.2	7.7	7.7	0.9	14.5	0.5	3.4	10.1	18.4	2.2	1.7	3.1	0.3	0.8	0.8	0.6	2.5	1.5	1.8	4.1	8.7	12.6	2.2	1.8	5.7	1.1	9.1	10.0	1.3	3.6	0.8	14.8	12.5	14.6	7.0	2.2	4.8	2.1	2.9	2.4	0.6	2.4	1.6	10.1	0.6	2.9	5.5	3.3	0.0	0.9	0.0	1.0	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	14.5	10.1	12.6	8.7	12.6	9.1	10.0	14.6	3.3	0.0	2.2	0.0	0.0	0.0	14.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	1.4	0.0	3.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 22.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0	0.0	4.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.4	12.4	0.0	0.0	0.0	2.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3"									HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"	NA	NA		180000	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	3.9	1.6	6.6	2.1	2.3	0.3	3.0	5.1	3.6	25.8	11.3	5.2	7.9	0.8	20.0	7.0	3.3	7.6	3.9	4.5	8.5	2.5	1.4	1.5	7.4	0.7	3.6	4.6	3.9	2.1	0.8	3.6	26.4	6.9	5.4	2.2	5.9	4.4	10.9	2.3	6.3	2.6	24.2	5.3	0.7	5.7	3.8	5.8	0.0	2.1	4.1	0.8	10.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.1	0.0	1.0	18.9	6.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.1	0.0	19.2	0.7	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	2.3	5.1	3.6	8.5	2.5	3.6	4.6	6.9	5.8	0.0	1.0	0.0	2.3	5.3	0.0	36.4	0.0	58.9	12.5	0.0	0.0	17.6	0.0	0.0	3.5	3.4	0.0	0.0	0.0	52.2	33.7	0.1	0.0	0.0	5.4	0.0	0.0	4.3	0.8	1.1	14.1	1.0	5.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	6.6	0.2	0.6	3.6	19.5	0.0	0.0	1.5
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954628	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Basal glandular cells: 1024.4;Basal keratinocytes: 2104.0;Cone photoreceptor cells: 1319.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.5;hTERT-HME1: 70.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	26.5	29.2	43.4	11.7	57.1	2.5	59.2	43.6	52.4	53.8	31.5	32.1	11.5	15.1	53.6	21.7	37.1	19.4	16.8	28.1	41.2	36.2	18.0	26.6	29.4	5.4	56.5	28.9	30.3	14.0	32.1	28.2	15.1	53.9	22.6	17.4	8.4	23.6	25.3	57.5	81.8	16.9	53.6	54.9	12.8	14.8	11.7	66.5	6.1	7.6	33.6	7.7	19.7	23.7	0.6	5.3	0.3	1.7	2.1	0.4	0.3	12.2	5.9	7.9	4.4	13.1	20.7	4.5	16.5	15.8	6.8	7.6	3.4	3.2	1.9	6.8	37.2	6.8	8.6	6.7	29.0	13.5	11.6	9.9	3.4	10.6	6.2	11.8	3.3	0.0	9.1	94.5	16.6	70.1	11.9	12.9	1.9	2.8	8.1	17.7	3.4	1.0	1.3	6.0	6.8	4.3	0.0	6.1	2.8	20.6	15.8	10.5	7.9	7.0	2.4	11.2	14.1	3.7	5.3	34.5	15.1	12.7	7.2	13.6	9.1	6.4	1.0	10.7	1.8	7.2	0.3	1.7	0.0	0.3	1.3	0.1	0.2	0.4	0.0	3.2	0.6	0.1	0.2	0.1	2.1	1.0	5.3	0.0	0.3	43.4	57.1	43.6	52.4	41.2	36.2	56.5	28.9	53.9	66.5	312.7	10.2	2.2	1024.4	2104.0	540.0	729.3	79.0	49.5	257.0	52.4	1319.4	36.7	6.6	171.1	26.9	93.9	163.1	23.3	56.2	11.1	132.5	139.6	16.2	67.6	21.5	290.8	43.1	50.3	48.7	7.9	123.4	67.7	204.1	62.3	71.1	216.1	150.7	84.2	143.2	6.7	103.8	64.7	142.4	7.1	9.1	749.3	22.2	6.1	19.2	121.2
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955126-57027342	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.2;Horizontal cells: 39.7"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 11.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.2;fHDF/TERT166: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.5	3.1	12.0	2.0	10.7	1.0	1.1	29.2	29.7	5.8	1.7	2.5	0.6	0.8	3.2	1.3	1.8	1.1	5.2	3.1	11.2	10.0	1.0	0.5	1.0	1.2	11.3	8.6	2.9	0.8	2.8	1.1	2.7	33.0	3.4	2.2	0.2	1.0	3.4	4.3	1.5	1.2	4.8	7.2	1.2	1.3	1.5	4.1	0.0	1.3	0.0	1.3	3.9	1.6	0.0	11.1	0.0	0.0	2.1	0.0	0.1	3.4	1.5	0.8	0.4	12.1	20.2	3.3	10.4	10.1	4.7	5.4	0.1	1.6	0.0	3.4	18.4	6.5	0.4	1.2	0.5	5.9	1.5	0.6	2.2	4.9	0.2	3.2	6.3	0.1	8.7	2.9	6.4	2.9	8.0	3.1	8.7	2.8	6.0	9.4	3.5	3.8	1.6	2.9	0.1	0.8	0.0	0.1	1.6	1.7	3.4	4.1	4.1	6.9	0.9	0.8	4.2	0.2	3.8	3.9	14.2	0.4	9.6	2.2	8.3	9.1	2.7	8.3	4.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.1	0.0	11.1	0.0	0.1	12.0	10.7	29.2	20.8	11.2	10.0	11.3	8.6	33.0	4.1	0.0	0.0	0.0	0.2	0.8	68.2	3.6	0.0	0.0	1.2	0.0	3.9	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.2	6.9	0.6	0.0	0.0	0.1	39.7	0.0	1.8	0.0	0.6	1.7	2.1	3.3	0.0	0.0	3.7	0.3	0.0	2.8	0.3	4.1	0.0	1.9	0.5	4.1	0.9	0.0	0.0	0.0	0.0
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	7.2	8.7	11.9	5.7	19.7	11.7	9.0	33.8	15.7	9.1	6.8	2.9	6.5	3.6	10.4	6.5	5.7	6.1	7.8	6.0	10.4	8.7	6.1	8.0	5.9	6.9	10.9	9.3	13.3	5.4	9.8	19.7	15.3	12.4	9.1	4.5	2.6	5.0	6.5	4.1	4.3	5.3	7.5	8.4	7.4	4.7	12.5	10.4	6.2	9.6	3.6	6.4	9.0	6.6	5.5	6.3	3.1	4.2	8.2	7.1	3.2	4.9	2.1	13.1	14.9	5.3	8.6	7.3	8.3	6.9	7.3	8.7	3.4	1.6	1.9	6.9	6.1	6.4	2.5	10.0	4.9	10.0	6.2	7.6	20.6	4.8	7.8	6.9	16.5	7.7	6.2	3.6	6.4	7.1	5.2	6.8	5.4	28.3	1.6	8.5	3.9	7.9	10.1	8.5	1.7	3.1	7.3	9.6	4.7	4.8	10.3	11.1	10.3	5.4	1.8	6.2	9.4	4.3	15.0	5.5	11.2	4.7	10.7	5.9	6.6	8.7	9.7	6.9	12.2	4.5	0.3	4.2	3.1	3.9	3.0	4.3	5.5	5.7	4.9	5.9	4.4	7.1	6.0	0.3	8.2	2.8	6.3	6.5	3.2	11.9	19.7	33.8	15.7	10.4	8.7	10.9	9.3	12.4	10.4	8.9	4.6	9.0	4.2	9.3	14.8	20.8	2.5	12.0	7.9	7.0	2.0	36.3	10.0	5.7	45.2	7.1	0.7	0.0	4.7	25.6	16.5	1.6	12.7	3.9	10.7	9.5	5.2	8.0	7.3	18.2	11.8	5.6	3.3	7.2	2.3	8.9	3.2	0.0	13.8	12.4	7.8	19.4	10.3	18.1	18.9	3.9	8.9	7.4	3.3	1.6
ZNF451	"COASTER, dJ417I1.1, KIAA0576, KIAA1702"	ENSG00000112200	"Zinc finger protein 451"	Q9Y4E5	6	57086844-57170307	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 214.0;Late spermatids: 315.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028838			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028838: AB_10603330"	"unprognostic (5.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.17e-2)"	13.2	17.8	14.2	10.8	30.9	61.8	14.4	23.3	21.2	13.8	12.8	15.5	11.6	8.8	14.9	16.1	11.7	12.0	11.2	11.2	15.4	13.0	11.9	13.3	13.5	15.2	20.5	13.9	14.3	11.9	14.5	27.6	18.0	20.3	14.9	10.8	8.8	11.3	11.8	11.2	12.3	12.0	18.9	21.1	15.5	12.9	27.5	21.0	16.5	16.6	7.8	14.1	14.9	12.9	14.2	14.2	19.3	10.0	7.7	12.3	6.8	9.3	5.1	12.9	7.9	12.3	15.9	12.4	10.4	13.1	12.7	13.8	11.7	4.7	10.3	6.9	11.5	15.1	8.9	12.6	11.6	20.6	8.3	8.9	26.7	9.3	10.8	9.4	14.8	11.6	11.2	11.8	14.0	17.7	9.4	12.4	14.8	35.6	10.0	10.8	6.8	18.5	12.8	7.0	7.2	5.7	12.7	16.5	9.6	8.4	16.1	15.3	10.3	11.3	7.5	12.3	15.9	9.0	14.3	8.1	12.8	13.2	16.4	12.1	9.7	16.2	21.0	11.2	18.4	6.3	19.3	10.0	9.7	10.8	8.3	10.6	9.6	9.3	6.4	10.6	14.2	12.3	9.4	5.0	7.7	8.5	14.2	7.2	6.8	14.2	30.9	23.3	21.2	15.4	13.0	20.5	13.9	20.3	21.0	23.8	28.0	21.7	12.6	50.0	55.6	22.7	28.1	36.1	25.0	29.6	70.7	34.1	8.3	12.4	214.0	28.6	18.6	116.8	11.9	26.4	47.4	21.6	40.6	25.6	15.7	46.1	35.3	49.7	29.7	315.8	34.8	30.7	32.1	10.0	21.2	32.3	15.3	11.5	38.9	11.0	66.7	6.5	38.5	46.0	30.2	37.4	11.0	24.9	21.0	14.7
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 76.8;Early spermatids: 102.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.5	5.3	2.2	7.9	5.6	16.1	6.3	15.4	14.7	11.1	10.7	6.8	4.9	3.2	14.8	24.3	9.1	1.7	12.8	1.3	10.7	10.1	9.4	9.3	8.0	15.3	8.6	8.1	2.1	7.8	0.7	9.1	8.6	6.7	8.6	7.4	18.6	4.5	10.9	0.7	5.7	6.8	8.5	0.2	5.5	5.3	6.3	6.3	13.3	1.5	2.9	2.6	6.9	0.5	5.5	10.8	1.2	7.1	11.7	6.4	10.4	13.4	15.2	3.1	2.9	7.0	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6	3.0	3.0	20.8	4.4	2.2	6.0	33.9	0.0	6.7	2.3	3.5	11.8	76.8	1.7	8.4	102.4	3.6	0.3	0.0	3.0	11.5	50.7	7.0	4.6	13.2	13.1	9.5	1.7	1.8	3.1	24.6	28.7	4.0	6.8	14.4	0.2	6.1	6.8	0.6	36.4	22.7	15.5	6.5	35.4	43.2	6.8	3.3	15.8	8.4	0.6	1.8
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222314	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 62.4;urinary bladder: 48.9"	"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 23.8;Leydig cells: 18.4;Peritubular cells: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.6;U-2197: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	6.0	3.0	6.7	5.7	5.1	0.2	4.0	7.3	4.8	23.1	32.9	5.1	9.6	3.0	34.1	8.0	9.7	8.1	12.4	7.0	7.4	4.5	3.3	1.8	4.9	1.7	6.4	5.4	8.2	1.6	2.9	3.5	12.3	6.7	24.9	7.5	3.6	2.8	26.9	4.7	3.1	7.0	62.4	6.6	1.1	8.7	4.3	7.2	1.4	15.1	3.9	1.7	48.9	11.2	0.3	1.5	1.3	0.6	0.9	2.0	0.3	4.8	1.9	7.0	4.9	10.7	32.6	6.4	14.3	24.8	12.6	13.1	4.2	2.3	0.9	4.4	22.9	6.3	1.7	7.2	5.2	15.0	3.6	3.4	3.5	3.2	3.3	6.6	1.8	0.5	12.1	6.0	15.6	14.7	6.1	6.5	2.1	5.4	3.0	13.9	4.0	1.6	1.9	2.6	3.2	2.6	1.7	10.3	1.4	8.7	3.4	3.6	2.5	7.1	3.4	3.6	9.1	3.1	2.1	8.7	19.6	6.1	57.6	8.3	2.6	2.8	2.4	11.0	3.9	9.6	0.3	0.4	1.3	0.3	0.4	0.0	0.3	1.1	0.5	0.3	0.3	2.0	0.8	0.0	0.9	0.6	1.5	0.0	0.3	6.7	5.1	7.3	4.8	7.4	4.5	6.4	5.4	6.7	7.2	11.9	5.3	0.0	1.6	3.7	2.9	3.1	2.5	6.7	1.2	0.0	2.0	10.0	0.0	2.8	2.1	1.4	1.3	0.0	2.5	8.4	23.8	3.6	0.0	3.0	3.7	1.6	1.2	4.9	0.6	1.3	18.4	1.3	5.0	12.6	1.2	3.2	2.8	0.0	28.7	4.4	0.7	0.0	9.0	6.7	7.1	4.4	11.4	0.0	1.2	1.4
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.4	6.3	12.6	14.6	7.2	12.8	10.5	19.1	18.7	21.3	28.6	10.0	7.4	14.1	10.6	23.8	14.5	10.5	11.3	10.9	26.4	15.4	9.2	16.7	8.6	16.7	2.9	16.1	10.6	4.8	4.1	23.5	8.2	5.2	9.6	15.2	15.8	37.6	17.7	9.7	16.9	12.8	8.0	13.2	6.3	12.9	17.5	11.3	7.7	8.0	9.3	7.1	12.4	5.9	7.7	14.6	12.6	13.9	6.6	21.7	21.4	39.7	16.1	5.1	9.8	16.4	9.9	17.0	11.6	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7											0.0	2.4	5.1	5.5	3.5	5.0	0.9	2.5	2.7	3.4	3.5	11.8	13.3	3.3	3.7	7.2	2.9	3.5	23.3	4.5	19.3	5.2	5.5	11.5	3.8	7.9	6.4	1.2	4.9	4.8	2.8	6.1	5.1	0.0	5.4	6.1	4.9	3.9	5.3	6.3	1.4	4.5	19.4	5.2	10.6	12.1	2.6	4.8	12.8	7.5	5.0
KHDRBS2	"MGC26664, SLM-1, SLM1"	ENSG00000112232	"KH RNA binding domain containing, signal transduction associated 2"	Q5VWX1	6	61679960-62286227	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;thyroid gland: 16.9"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 35.7;Bipolar cells: 30.6;Club cells: 11.4;Horizontal cells: 33.4;Muller glia cells: 34.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"memory B-cell: 6.8;naive B-cell: 10.4;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	13	"B-cells: 10.4;dendritic cells: 2.6"	"Cell line enhanced"	"Detected in some"		"AF22: 12.8;NTERA-2: 3.3;SCLC-21H: 1.3;THP-1: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000500, HPA029392"	Supported					NA	NA					"HPA000500: AB_1079184, HPA029392: AB_10600816"	"unprognostic (6.98e-2)"			"unprognostic (1.21e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-5)"	"unprognostic (5.52e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.15e-1)"	1.1	3.0	6.4	4.7	18.4	1.6	0.8	0.9	16.9	0.9	1.6	1.2	0.0	1.0	3.2	0.8	0.9	0.9	1.0	0.9	6.7	8.1	1.9	0.8	9.7	2.4	4.0	14.6	1.2	0.8	0.7	7.3	2.4	3.9	1.0	1.4	1.3	1.2	1.3	1.2	0.7	2.2	1.3	2.2	3.8	1.0	1.0	1.6	0.0	16.9	0.0	2.9	0.9	0.5	10.4	2.6	0.0	0.5	0.1	0.0	0.3	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.1	10.4	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.3	6.4	18.4	0.9	16.9	6.7	8.1	4.0	14.6	3.9	1.6	35.7	3.5	4.5	0.0	0.0	30.6	0.3	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	33.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	1.4	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0
FKBP1C	bA184C23.2	ENSG00000198225	"FK506 binding protein 1C"		6	63211446-63213024	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 8.9;Cardiomyocytes: 9.4;Melanocytes: 8.5;Suprabasal keratinocytes: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.3;granulocytes: 6.2;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.1;SK-MEL-30: 3.1"									HPA051798	Uncertain					NA	NA					"HPA051798: AB_2681615"	"unprognostic (6.64e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.91e-5)"	"unprognostic (4.78e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.79e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.95e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	9.1	3.0	4.2	5.9	8.6	1.9	7.0	1.1	4.2	2.1	2.5	0.8	1.3	2.1	4.4	2.1	3.2	1.7	1.6	5.0	8.0	1.9	2.6	3.0	4.6	8.9	1.8	3.2	2.9	4.2	1.6	1.3	4.8	1.4	2.7	2.3	0.2	2.3	2.6	5.2	2.1	2.8	2.2	1.5	4.8	2.1	2.2	0.8	3.2	3.4	3.0	2.0	2.3	2.0	0.8	4.3	6.2	7.1	1.0	1.4	4.9	2.0	0.0	0.0	0.2	0.0	0.4	0.6	1.1	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.1	1.4	1.0	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.5	0.0	0.1	0.6	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.1	1.1	3.1	0.5	1.5	0.2	1.0	0.1	0.2	0.6	0.8	1.0	1.3	0.2	1.0	3.1	0.3	0.4	0.6	1.8	2.0	0.5	0.7	1.6	0.8	0.5	0.7	0.3	0.6	0.5	1.4	4.6	6.2	0.6	7.1	0.6	0.8	0.9	0.7	4.3	0.8	0.9	1.0	4.0	1.0	6.3	1.8	1.4	4.9	4.2	8.6	1.1	3.3	8.0	1.9	1.8	3.2	1.4	0.8	0.0	0.3	0.0	1.6	8.9	0.0	9.4	0.0	4.0	0.0	1.8	0.0	1.5	0.0	0.0	0.9	4.8	0.2	0.0	0.0	2.2	4.1	1.7	1.1	0.8	3.5	0.0	0.0	3.1	3.5	1.6	0.9	2.1	8.5	0.0	0.0	0.0	0.2	3.2	0.4	0.1	0.0	0.0	5.2	3.0	1.7	13.9	0.7	0.0	0.4	1.4
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.6	0.1	0.1	0.0	0.0	5.7	0.1	0.1	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.9	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	1.9	0.1	0.4	0.1	0.1	0.4	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	4.0	3.4	0.0	0.0	1.7	1.7	0.0	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.3	2.2	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.5	0.0
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase type IVA, member 1"	Q93096	6	63521748-63583587	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 135.1;skeletal muscle: 111.2"	"Cell type enhanced"	"Detected in many"	14	"Late spermatids: 2420.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA					"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	13.9	42.3	11.3	10.5	14.0	54.3	10.8	7.1	17.0	17.5	30.2	18.9	8.0	17.9	13.1	13.5	16.1	12.3	16.7	10.0	12.0	14.8	14.2	135.1	25.0	9.0	16.1	13.8	24.1	87.4	5.0	12.8	19.8	16.3	17.7	31.2	13.6	20.1	10.0	111.2	17.2	18.3	35.7	24.2	7.1	15.5	19.8	13.3	6.4	11.4	19.9	9.3	31.0	12.6	14.6	18.2	46.9	20.6	15.8	20.1	14.4	19.3	24.0	30.3	29.2	20.7	19.2	60.6	34.1	22.8	12.4	17.4	20.2	11.4	16.5	14.8	20.1	25.8	9.6	20.6	42.8	20.0	17.8	13.9	10.3	67.2	91.7	41.0	31.6	16.9	23.4	83.1	26.9	71.9	15.2	19.2	15.7	23.5	32.1	34.5	26.2	15.1	14.2	12.5	21.7	13.1	20.2	12.6	13.1	27.7	23.0	11.4	21.1	74.4	16.3	33.6	36.3	15.7	28.1	19.1	31.3	34.4	24.7	33.5	26.9	23.0	30.5	16.7	16.9	36.7	34.6	19.8	15.2	13.7	20.6	20.1	14.6	15.0	14.6	18.2	12.4	14.8	14.2	46.9	15.8	14.2	9.1	18.1	14.4	11.3	14.0	7.1	17.0	12.0	14.8	16.1	13.8	16.3	13.3	20.8	83.0	74.7	257.9	605.1	22.1	73.9	163.1	38.8	51.2	71.5	15.7	216.2	68.0	128.0	616.2	31.2	259.4	0.0	168.0	175.7	85.2	143.0	64.4	416.3	88.4	11.1	124.3	41.1	65.9	2420.5	26.4	64.7	161.9	36.1	129.4	17.8	159.8	140.8	22.6	85.2	23.2	6.5	110.2	32.8	21.3	560.3	384.3	37.0	97.1	110.7
PHF3		ENSG00000118482	"PHD finger protein 3"	Q92576	6	63635820-63779336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024676, HPA025763"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024676: AB_10599736, HPA025763: AB_10600987"	"unprognostic (4.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.37e-1)"	23.7	19.6	17.1	22.9	20.0	33.0	23.5	44.4	19.4	32.6	23.5	9.4	21.9	14.9	22.7	23.4	18.8	16.9	15.9	16.2	19.1	13.3	19.5	26.7	21.0	21.5	20.0	18.5	34.1	17.4	30.3	43.5	23.0	18.7	25.6	17.5	8.5	19.1	21.5	24.5	19.4	19.2	18.1	26.8	21.9	17.1	16.8	24.9	36.3	26.0	12.9	16.9	30.5	26.6	10.3	7.5	16.2	11.5	5.5	12.2	4.5	19.4	9.4	16.3	9.5	16.5	17.5	16.0	12.8	18.4	9.6	13.0	13.0	9.1	23.8	11.1	11.4	14.0	8.6	15.6	13.5	16.2	18.9	12.7	28.5	12.1	20.6	14.7	24.3	11.6	12.6	12.1	13.7	19.7	17.2	11.2	12.8	31.0	22.5	9.8	11.5	10.3	13.0	9.2	12.7	5.8	18.2	14.6	11.3	11.6	11.6	17.5	13.0	15.4	6.9	11.4	18.6	11.9	22.5	15.7	14.9	17.7	11.3	15.2	19.0	19.8	22.8	6.8	19.5	11.4	14.4	6.8	7.3	9.0	8.9	8.9	8.4	8.5	7.0	6.0	10.3	12.2	8.9	16.2	5.5	11.5	7.5	5.9	4.5	17.1	20.0	44.4	19.4	19.1	13.3	20.0	18.5	18.7	24.9	145.9	104.5	56.7	61.6	48.8	64.2	90.4	33.1	103.1	129.7	43.6	45.2	38.2	13.3	36.1	24.3	50.4	43.4	23.3	32.7	26.7	39.3	56.1	97.4	41.4	24.8	47.7	41.3	30.7	43.8	20.2	75.1	40.6	21.9	35.1	41.1	50.4	28.8	39.5	53.4	29.6	63.6	58.2	33.0	87.4	63.1	37.5	26.1	46.8	42.8	35.3
EYS	"bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM"	ENSG00000188107	"Eyes shut homolog (Drosophila)"	Q5T1H1	6	63719980-65707225	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 40.7"	"Cell type enhanced"	"Detected in some"	26	"Cone photoreceptor cells: 298.4;Early spermatids: 59.0;Rod photoreceptor cells: 144.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;SCLC-21H: 3.9"														"Secreted in other tissues"	NA	NA						"unprognostic (2.92e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.11e-1)"	2.8	0.4	0.4	0.6	0.2	1.1	1.1	1.2	0.8	0.2	0.7	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.4	0.4	0.4	0.2	0.2	1.7	0.3	0.6	0.2	0.5	0.4	0.6	0.0	2.2	0.3	0.5	0.6	2.6	40.7	0.5	0.2	0.6	1.3	0.6	0.2	0.3	0.3	0.3	2.9	0.2	0.6	0.5	0.2	0.2	0.4	0.3	0.3	0.3	3.7	0.8	0.3	0.4	0.9	0.5	0.3	0.7	0.5	0.0	0.6	0.2	0.4	0.3	0.0	0.0	0.4	0.3	0.8	0.5	0.1	0.2	0.2	0.9	0.4	0.0	0.5	0.7	0.5	1.3	1.1	0.1	0.8	0.3	0.3	0.9	0.3	0.1	1.0	0.0	0.4	0.6	5.5	0.5	0.0	0.3	0.3	0.2	1.2	0.6	0.3	0.1	0.4	1.2	0.2	3.9	0.3	0.2	0.1	0.2	0.8	0.0	0.8	0.3	0.5	0.6	0.3	0.5	1.6	0.8	0.4	0.6	1.1	0.2	3.7	0.8	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.3	0.3	0.4	3.2	0.3	0.3	0.2	0.1	0.9	0.4	0.2	1.2	0.7	0.4	0.2	0.2	0.5	0.5	0.2	0.0	2.6	0.0	0.5	0.2	7.4	1.5	0.0	0.0	1.2	1.8	298.4	0.6	0.0	0.2	59.0	0.3	0.0	0.0	0.4	0.2	0.2	0.2	2.3	0.0	0.1	9.5	19.4	0.0	0.0	34.1	0.9	0.2	0.0	0.0	0.1	4.0	0.4	0.0	0.7	0.1	144.8	0.0	0.3	1.8	0.7	0.1	0.9	0.0	0.2	0.1
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635367-69389511	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.0;pituitary gland: 17.1"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 43.5;Early spermatids: 14.7;Peritubular cells: 8.1"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.3;SH-SY5Y: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		9200				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	2.7	8.0	20.0	2.8	22.5	1.5	2.1	46.9	55.0	3.1	3.4	6.2	0.0	2.2	5.2	3.1	2.7	2.4	3.0	3.2	17.6	15.2	2.4	2.4	3.6	1.6	9.0	22.7	4.3	1.9	1.8	17.1	1.8	9.6	2.6	3.6	1.2	3.2	3.9	1.9	1.9	3.2	6.7	10.1	2.4	1.9	4.4	11.1	0.0	2.1	0.0	1.6	2.9	1.8	0.0	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	1.2	1.0	0.0	0.0	9.3	20.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	20.0	22.5	46.9	25.1	17.6	15.2	9.0	22.7	9.6	11.1	0.0	0.0	0.0	0.1	0.0	43.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.0	4.6	0.0	0.0	1.8	0.0	0.8	0.1	0.0	8.1	0.0	2.6	0.0	0.0	4.6	2.1	0.0	0.0	0.0	0.0	0.0
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69675802-69797111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	21.3	44.1	34.1	14.2	32.5	5.4	29.1	32.9	34.1	23.7	20.9	38.1	20.0	23.1	18.4	32.1	20.6	25.5	23.9	19.8	35.8	32.7	53.1	38.9	24.7	21.9	37.9	22.8	29.0	36.8	58.9	23.6	25.0	32.5	19.0	21.8	26.5	22.4	24.6	17.9	18.6	30.2	17.2	57.8	19.9	19.9	11.9	30.6	17.8	41.8	13.2	18.7	22.7	19.4	24.4	9.9	37.8	18.5	7.8	14.4	11.5	6.7	3.2	7.6	10.3	22.9	24.5	11.4	5.4	19.8	4.5	9.5	5.3	14.0	9.0	15.4	14.2	7.0	10.8	8.4	8.0	8.1	17.6	10.8	8.7	6.3	7.7	14.0	5.3	11.8	17.3	17.0	5.2	7.3	21.7	8.0	7.3	15.9	13.5	14.4	4.6	3.6	5.6	3.9	12.7	3.4	4.1	18.7	25.3	31.0	11.2	4.9	8.1	6.8	9.3	9.9	6.1	9.9	19.0	12.2	6.3	4.0	5.9	5.4	8.1	7.0	3.4	7.8	8.6	11.9	25.2	10.6	19.0	8.4	13.2	8.6	24.4	11.2	9.5	9.9	21.7	12.8	9.0	37.8	7.8	18.5	9.6	14.4	11.5	34.1	32.5	32.9	34.1	35.8	32.7	37.9	22.8	32.5	30.6	59.6	34.7	34.6	36.9	25.8	68.6	35.2	45.9	52.2	50.0	55.8	104.1	65.0	16.6	37.2	15.4	36.2	60.6	23.3	43.3	52.5	48.2	25.5	39.3	51.4	37.9	52.4	18.0	36.8	63.3	3.2	32.8	46.1	30.4	39.7	38.1	48.7	36.8	42.1	31.8	49.4	81.3	25.8	22.8	17.0	15.9	33.2	64.8	31.0	27.5	33.1
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell type enriched"	"Detected in some"	5	"B-cells: 16.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;RH-30: 14.5;SCLC-21H: 4.1;SK-MEL-30: 12.2;WM-115: 10.2"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.5	0.0	0.0	0.0	4.1	3.0	0.0	0.0	12.2	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0	0.0	0.0	16.7	0.2	0.1	2.8	2.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.9	1.7	0.9	0.0	0.0	0.0	0.0	0.1
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70215061-70303083	"Disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.6;retina: 52.6"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 18.1;Horizontal cells: 33.4;Muller glia cells: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 23.7;NTERA-2: 8.0"	"Not detected"	"Not detected"							HPA074749	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.7	0.6	8.5	0.7	7.5	0.5	0.6	3.6	4.7	0.6	1.1	7.2	0.0	1.8	1.1	0.8	0.8	0.7	1.1	5.6	8.4	9.4	1.1	0.5	0.6	0.6	10.3	1.7	0.6	0.5	0.9	3.3	0.6	5.6	29.6	1.4	52.6	3.0	1.1	0.6	0.6	2.0	0.9	5.3	0.6	2.6	4.1	6.9	0.0	1.0	0.2	0.7	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	7.5	3.6	4.7	8.4	9.4	10.3	1.7	5.6	6.9	0.0	0.0	0.0	0.1	0.0	0.2	3.5	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	18.1	0.0	0.2	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.1	33.4	1.2	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.4	88.9	0.0	0.0	0.4	0.0	1.8	0.0	1.4	0.6	0.7	0.0	0.0	0.0	1.1	0.1
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	5.8	4.3	6.4	9.2	6.8	1.7	5.3	14.0	10.7	9.6	13.3	4.0	5.3	14.9	7.7	4.9	33.8	5.4	8.8	5.2	5.4	5.2	9.6	5.5	5.5	4.1	6.1	7.1	8.0	6.9	16.4	13.8	22.7	8.5	18.9	13.0	4.2	10.4	6.7	5.7	14.2	27.9	4.8	8.9	4.5	12.3	11.0	6.0	4.1	4.8	13.1	10.6	7.6	14.4	3.9	6.3	3.3	5.3	5.4	2.2	1.5	5.9	3.4	7.7	4.8	3.6	2.6	6.9	1.9	3.8	2.1	3.5	6.7	4.8	10.6	13.9	1.4	10.1	5.8	7.6	4.8	3.6	5.1	6.3	4.8	3.7	5.9	4.4	8.9	5.0	2.3	11.1	4.0	11.1	2.6	5.5	3.4	7.6	5.5	2.4	0.7	1.6	4.2	5.0	7.1	2.8	5.2	24.2	5.0	7.9	3.2	8.1	2.4	2.3	2.1	2.3	5.1	1.4	4.0	2.7	1.8	4.6	1.7	4.4	6.6	7.5	4.3	1.3	8.1	3.2	3.3	4.3	0.2	1.5	3.5	1.9	3.0	1.4	0.6	6.3	3.9	2.2	1.3	1.2	5.4	5.3	1.0	1.7	1.5	6.4	6.8	14.0	10.7	5.4	5.2	6.1	7.1	8.5	6.0	26.8	12.2	1.4	9.5	14.2	18.2	9.4	15.3	8.1	5.7	19.2	27.5	2.2	5.0	5.8	24.9	10.0	28.4	0.0	10.7	1.2	5.9	32.9	8.1	5.7	5.1	225.6	22.4	9.2	14.2	17.3	14.4	13.1	5.0	9.0	26.1	12.8	13.3	30.0	12.4	6.8	27.5	6.5	6.6	25.1	8.2	29.4	6.9	3.9	19.4	11.2
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	13.4	14.5	18.1	6.5	20.1	6.1	14.3	15.7	25.7	8.3	9.5	7.9	10.3	7.9	9.0	14.6	9.8	16.0	8.5	17.6	18.0	21.2	14.9	10.7	8.4	10.6	14.7	17.4	9.7	14.2	10.5	18.3	10.2	15.5	10.6	10.6	11.1	9.7	8.9	30.5	9.7	7.9	8.8	13.0	6.9	8.8	7.3	9.7	7.4	11.5	10.2	7.8	8.1	6.9	10.5	13.4	9.1	10.5	9.6	9.3	6.2	10.0	3.3	14.3	8.8	7.3	10.9	2.8	5.4	4.2	2.6	4.0	2.9	8.5	6.9	10.4	2.8	6.4	1.8	4.9	4.8	3.9	14.4	3.3	4.8	1.4	2.9	12.4	4.7	3.8	7.8	15.4	2.0	11.8	9.2	6.5	11.6	3.2	10.7	8.6	6.9	4.2	11.7	6.8	5.1	3.3	4.7	9.7	8.0	11.4	3.3	13.2	9.6	3.2	1.6	6.8	6.4	7.3	12.2	4.8	2.7	2.1	2.2	5.8	5.0	3.4	2.2	3.0	11.2	6.4	6.0	10.5	9.1	7.7	9.2	8.0	8.7	8.5	9.0	11.3	10.5	9.3	8.5	7.1	9.6	9.5	13.4	9.1	6.2	18.1	20.1	15.7	25.7	18.0	21.2	14.7	17.4	15.5	9.7	11.9	15.2	2.2	7.2	0.0	7.5	17.6	7.6	25.4	10.3	7.0	7.9	8.8	19.9	8.0	4.0	5.2	3.3	0.0	10.1	7.4	5.1	7.1	4.7	11.3	9.1	17.5	3.5	3.7	4.1	2.2	11.5	8.5	0.0	12.6	6.6	9.9	9.8	3.5	6.3	11.8	5.8	12.9	3.1	10.7	5.3	0.0	4.2	4.4	6.4	6.9
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862015	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 261.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	18.7	14.8	19.9	17.8	25.1	15.1	15.3	20.7	30.2	14.4	25.2	14.5	18.5	24.5	16.2	17.7	29.3	10.5	16.3	20.5	20.5	18.6	14.1	17.2	14.4	18.3	19.2	18.1	15.2	33.9	27.1	11.5	14.8	25.0	17.2	27.0	13.0	18.6	15.2	32.6	21.0	29.6	18.7	15.7	14.8	20.7	29.6	13.0	26.6	20.0	17.5	20.1	18.9	16.6	12.5	11.7	24.0	15.5	20.2	21.9	16.3	26.7	8.5	13.5	16.4	12.5	16.5	21.8	12.0	13.8	10.1	9.9	12.6	8.0	14.0	13.1	14.7	14.6	8.5	12.7	12.8	17.2	16.1	17.7	15.5	8.0	10.6	8.4	11.3	13.2	10.8	14.9	11.3	13.8	19.0	15.8	7.4	14.7	17.2	15.8	15.7	8.4	13.8	9.9	14.2	9.9	16.0	50.1	23.1	18.2	16.5	18.9	13.5	7.7	11.0	7.6	12.0	14.5	17.1	15.1	8.2	14.1	5.3	10.6	16.0	14.3	7.2	6.2	13.3	11.2	24.0	13.7	14.6	16.3	15.0	18.5	12.5	21.9	18.6	11.7	11.1	11.2	14.4	19.3	20.2	15.5	11.5	20.5	16.3	19.9	25.1	20.7	30.2	20.5	18.6	19.2	18.1	25.0	13.0	35.7	32.5	47.6	31.8	59.4	49.5	34.1	66.2	16.0	30.7	36.6	35.3	22.2	46.4	68.3	261.7	39.6	88.7	0.0	131.9	35.0	39.4	71.6	48.4	36.8	51.8	52.4	40.2	63.3	52.2	208.7	46.9	47.5	30.4	54.1	58.5	64.5	87.9	63.4	62.9	42.1	36.2	64.7	46.2	64.2	85.5	67.5	26.5	51.7	60.3	38.6
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957038	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 27.2"	"Cell type enriched"	"Detected in many"	9	"Horizontal cells: 301.9"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	20	"SCLC-21H: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA					"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.8	1.5	9.5	1.9	7.8	1.6	1.1	3.2	27.2	0.8	1.1	26.2	0.0	2.3	1.4	1.1	1.4	1.1	1.4	1.5	19.2	11.5	1.0	1.3	1.2	2.0	9.7	13.6	1.1	2.2	0.8	0.5	1.2	21.0	1.3	0.9	0.4	1.5	0.9	1.5	1.9	2.4	1.1	17.3	2.0	1.5	2.9	16.3	0.0	1.5	0.0	0.9	1.3	0.9	1.2	1.0	2.0	1.2	1.1	2.2	0.2	0.3	0.0	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.2	0.3	0.2	0.0	0.2	22.7	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	1.3	1.2	1.2	1.0	1.0	0.9	1.0	1.5	2.1	0.4	1.2	1.7	1.8	2.0	1.1	1.1	1.0	2.2	0.2	9.5	7.8	3.2	11.2	19.2	11.5	9.7	13.6	21.0	16.3	0.0	2.1	16.6	7.9	22.7	12.4	0.8	7.6	0.0	0.0	15.7	21.6	5.1	0.0	5.0	6.6	7.5	11.0	0.0	3.3	2.8	10.3	14.9	0.0	7.7	7.0	301.9	0.0	3.7	5.3	4.0	18.4	11.1	13.5	11.8	4.1	17.1	7.1	7.0	12.7	0.5	21.5	12.9	8.2	17.4	32.2	17.3	5.9	13.1	3.8	9.9
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288803-71308950	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	16.9	8.7	20.2	11.3	26.8	16.9	36.0	22.3	33.3	6.7	7.2	29.1	2.8	2.9	8.3	10.7	24.5	5.2	8.3	5.8	30.2	17.6	5.7	4.8	8.5	9.6	27.7	18.3	5.4	6.0	5.8	10.0	9.9	37.8	6.7	4.3	3.3	31.8	10.3	4.1	14.6	5.7	24.1	52.2	11.7	5.4	2.4	29.1	3.2	4.8	4.3	17.8	5.4	9.4	0.7	2.4	12.8	3.0	0.5	0.5	0.6	3.8	1.1	4.1	0.0	11.2	10.3	1.5	17.4	10.8	7.0	7.2	1.4	0.7	23.7	24.0	7.5	6.5	1.9	3.1	12.0	25.0	5.0	2.5	5.2	4.2	0.6	9.1	2.4	1.8	10.3	10.3	5.2	16.4	5.9	5.6	0.0	0.3	1.9	24.1	3.2	0.0	3.8	1.7	1.5	1.0	1.6	12.6	5.4	16.3	0.3	14.1	6.4	5.1	3.2	1.1	6.2	5.5	19.2	8.6	17.3	8.7	1.8	5.7	2.5	0.1	3.1	5.8	16.5	3.0	3.1	3.0	0.1	0.5	2.0	0.5	0.4	0.4	0.5	2.4	0.7	0.1	0.3	12.8	0.5	1.4	0.9	0.2	0.6	20.2	26.8	22.3	27.4	30.2	17.6	27.7	18.3	37.8	29.1	6.0	21.8	14.3	18.0	34.6	15.3	7.8	5.1	1.4	11.4	10.4	23.6	19.2	1.7	12.9	0.4	21.0	0.0	0.0	27.8	10.1	31.4	13.9	5.8	4.0	53.5	36.5	13.8	8.6	79.5	1.1	15.3	93.2	30.4	27.9	2.4	83.6	18.3	0.0	31.1	3.1	5.0	25.8	18.6	0.4	1.1	40.7	15.9	12.1	4.3	14.9
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 83.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 58.2;Horizontal cells: 58.8;Muller glia cells: 101.2"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;EFO-21: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 15.1;SH-SY5Y: 10.7;TIME: 5.2;U-138 MG: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076565	Enhanced					NA	NA					"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.5	2.3	10.5	1.5	9.8	0.4	1.2	83.1	27.7	0.9	0.6	0.5	0.0	1.5	0.8	0.5	3.7	0.5	6.2	0.6	9.3	3.6	0.5	0.4	0.7	0.5	2.8	11.7	0.5	0.8	5.0	4.6	0.4	7.2	4.9	0.6	0.2	1.9	0.9	0.6	0.4	0.8	1.4	1.5	0.4	1.4	5.9	2.7	0.0	0.5	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.2	1.3	0.0	0.2	0.0	0.0	4.9	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	1.6	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.4	15.1	0.0	0.4	10.7	0.0	0.0	0.0	0.3	0.6	0.0	5.2	5.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	9.8	83.1	12.9	9.3	3.6	2.8	11.7	7.2	2.7	0.0	0.3	0.0	0.1	0.0	58.2	1.5	0.0	5.3	9.1	0.0	0.0	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.7	0.0	0.2	1.0	1.1	0.0	0.0	58.8	0.0	0.6	0.0	6.5	0.3	0.0	3.3	0.0	0.0	101.2	0.8	0.0	1.4	0.0	7.1	0.0	0.2	16.3	13.0	0.1	0.0	0.0	0.0	0.4
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 3.2;Cardiomyocytes: 2.0;Horizontal cells: 1.6;Melanocytes: 1.7;Smooth muscle cells: 1.4;T-cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HEL: 13.3;HL-60: 17.9;U-251 MG: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.4	3.0	3.0	2.6	0.0	0.0	12.2	0.0	6.9	0.3	0.4	0.1	1.2	3.6	0.1	4.3	13.3	0.0	0.0	0.5	17.9	0.0	0.2	0.5	8.7	9.1	2.0	0.0	0.0	0.7	8.4	6.0	0.1	0.0	7.7	0.8	0.0	4.3	0.0	0.7	8.4	1.2	0.0	3.4	1.6	0.0	0.0	8.3	0.1	2.5	1.3	0.0	12.7	5.6	0.1	13.5	8.8	0.2	5.6	0.1	8.6	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7	0.0	0.0	0.8	3.2	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	0.3	0.2	2.2	0.0	0.3
KHDC1L	RP11-257K9.7	ENSG00000256980	"KH domain containing 1 like"	Q5JSQ8	6	73223544-73225770	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 8.9;lymphoid tissue: 4.1;testis: 7.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 32.2;Late spermatids: 64.6"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 33.6"	"Region enriched"	"Detected in some"	5	"basal ganglia: 8.9"	"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"BEWO: 33.8"															NA	NA						"unprognostic (1.18e-1)"	"unprognostic (6.11e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-2)"		"unprognostic (9.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.01e-2)"		"unprognostic (1.31e-2)"	"unprognostic (4.13e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.17e-3)"	0.3	0.2	1.1	0.3	8.9	0.5	0.3	1.6	1.4	0.3	0.3	0.3	0.3	0.2	0.5	0.3	0.3	0.0	0.3	0.3	0.5	0.4	0.3	0.3	2.1	0.3	0.7	0.3	0.4	0.3	0.0	1.4	2.0	0.3	0.4	0.0	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	7.7	0.3	4.1	0.3	0.3	1.5	0.3	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.3	0.0	0.0	33.8	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	8.9	1.6	0.7	0.5	0.4	0.7	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	32.2	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.3	0.0	0.0	1.0	0.0	0.2	0.2	0.0	0.7	0.0	0.5	0.0	0.0	2.2	5.7	0.0	0.1	0.0	0.0	0.0
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 19.4;Spermatocytes: 29.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	2.9	2.9	10.3	2.0	12.9	0.9	2.2	8.8	14.6	4.7	1.3	2.6	1.2	0.6	3.9	3.3	2.7	6.2	2.6	3.4	8.5	8.4	1.3	0.4	1.8	3.1	8.6	5.7	7.4	4.4	5.0	9.6	1.5	4.7	4.4	1.4	2.9	1.3	3.6	2.7	1.0	1.1	2.4	6.2	0.9	2.9	8.2	4.1	5.4	5.9	1.7	3.4	2.2	2.1	2.7	2.6	3.8	0.2	2.5	5.2	2.0	2.9	4.2	0.8	2.3	4.0	4.6	2.0	5.7	5.5	8.8	13.1	4.0	2.3	6.2	2.2	2.5	4.5	2.8	5.9	1.2	6.7	5.9	4.2	4.1	3.4	0.0	5.2	2.0	0.1	5.9	2.5	8.7	2.4	3.7	1.9	6.5	3.0	7.5	3.5	6.9	0.4	1.9	3.9	0.5	8.4	0.9	0.0	5.0	1.4	0.1	10.5	2.2	3.2	0.1	0.2	2.9	0.1	6.2	0.1	1.9	4.0	1.1	6.0	12.7	7.6	4.5	0.1	1.7	0.7	3.8	0.2	0.0	4.4	0.0	2.6	2.7	2.8	4.9	0.7	1.9	2.2	3.4	0.0	2.5	0.0	2.6	5.2	2.0	10.3	12.9	8.8	12.4	8.5	8.4	8.6	5.7	4.7	4.1	0.0	1.0	3.0	3.2	0.7	7.8	1.8	0.0	0.0	2.3	3.5	2.0	1.5	1.7	0.8	9.3	0.3	0.0	0.0	3.3	0.3	3.1	1.7	0.0	0.0	0.4	12.7	0.0	0.0	0.0	12.1	2.0	0.0	3.3	1.0	0.5	11.5	2.3	0.0	3.2	0.0	6.8	19.4	1.9	29.8	12.9	0.5	0.1	4.3	0.9	0.4
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353062-73354295	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lung: 2.0;testis: 6.8"	"Cell type enhanced"	"Detected in single"	35	"Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SuSa: 12.7"					"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362677-73364171	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	3155	"testis cancer: 254.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;NTERA-2: 2.1;SuSa: 1.1"									HPA043699	Uncertain					NA	NA					"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.2	0.5	1.2	0.2	2.1	0.0	0.2	4.1	0.9	0.2	0.2	0.2	0.2	0.1	0.2	1.5	0.3	0.1	0.2	0.2	2.1	0.6	0.2	0.2	3.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.6	0.3	4.9	0.2	4.4	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.2	2.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.8	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	4.1	0.9	2.1	0.6	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
OOEP	"C6orf156, Em:AC019205.2, KHDC2"	ENSG00000203907	"Oocyte expressed protein"	A6NGQ2	6	73368555-73395133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 8.7;testis: 18.5"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 55.7;Spermatogonia: 46.4"	"Cancer enriched"	"Detected in single"	26	"testis cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.0;granulocytes: 1.6;T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;CAPAN-2: 13.0;MCF7: 4.2;U-2 OS: 2.9"									HPA055165	Approved					NA	NA					"HPA055165: AB_2682722"	"unprognostic (7.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.98e-2)"	0.4	0.3	0.1	0.2	0.6	0.1	0.5	0.2	0.2	0.2	0.4	0.2	0.0	0.3	0.3	0.0	0.4	0.2	2.6	0.8	0.1	0.2	0.3	0.5	1.1	0.8	0.4	0.0	0.9	1.6	0.0	0.3	5.2	0.6	0.5	0.1	0.6	8.7	1.5	0.1	1.7	0.6	1.3	0.3	0.4	0.8	18.5	0.0	0.2	2.0	0.3	1.6	0.8	0.2	2.0	0.2	1.6	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.3	0.0	0.2	0.3	0.0	13.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.9	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.7	0.0	1.4	2.0	1.1	0.8	0.0	0.7	0.0	1.6	0.3	0.0	0.3	0.2	0.8	0.1	0.1	0.6	0.2	0.2	0.1	0.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	8.5	0.5	0.0	0.0	0.5	2.4	0.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.8	0.1	0.0	0.1	55.7	46.4	0.9	3.8	0.0	0.0	0.3
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394748-73417569	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 35.2"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 50.6;Spermatogonia: 31.3"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.0;CAPAN-2: 15.1;HHSteC: 4.2;MCF7: 2.8;U-2 OS: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031381	Enhanced					NA	NA					"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.3	0.7	0.6	1.0	0.7	0.7	1.9	0.4	0.8	0.8	2.6	1.2	2.1	1.4	1.0	0.4	1.1	0.7	6.1	1.2	0.7	0.6	0.8	1.0	1.6	0.9	1.0	0.0	2.9	1.9	0.1	0.7	5.7	3.3	1.8	0.7	1.5	4.3	2.2	0.4	1.4	1.7	3.0	1.9	1.2	2.4	35.2	0.7	0.4	1.8	1.3	1.9	1.7	0.7	2.3	0.8	2.9	0.9	1.6	3.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.5	0.0	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.9	3.3	0.9	2.6	2.3	2.5	2.8	0.8	2.3	1.3	0.4	0.6	1.6	0.8	0.2	1.4	0.7	0.6	0.7	0.4	0.8	0.7	0.6	1.0	0.0	3.3	0.7	3.0	4.8	0.5	1.1	2.4	0.3	0.4	0.0	1.4	3.4	0.0	0.0	6.5	0.0	0.4	2.2	2.2	0.0	0.0	0.8	2.9	1.1	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.3	2.0	1.8	3.3	1.0	0.0	0.4	1.3	0.0	1.1	1.4	0.9	0.0	0.4	50.6	31.3	1.3	5.0	2.5	0.0	0.7
CGAS	"C6orf150, cGAS, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452276	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 32.0"	"Cell type enriched"	"Detected in some"	4	"monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.6;RH-30: 21.5;RPMI-8226: 22.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	6.5	2.0	2.9	10.5	4.5	18.5	8.1	1.2	3.9	4.7	3.7	3.4	2.1	4.1	5.5	2.8	5.3	3.9	4.3	3.2	2.8	2.9	2.5	1.9	9.6	11.8	7.2	0.6	3.4	3.8	2.3	1.8	4.8	4.4	6.6	3.1	2.2	4.2	2.9	1.9	1.8	5.2	3.6	4.7	12.8	3.5	1.7	4.3	6.2	3.9	4.2	15.5	6.6	32.0	6.3	12.5	13.3	12.9	3.0	6.0	3.9	8.9	3.0	0.1	0.1	0.6	1.3	0.0	4.5	1.9	5.9	6.5	9.9	6.8	0.1	9.8	2.1	3.2	4.6	5.0	0.0	6.3	14.9	0.0	7.8	3.8	0.0	2.1	6.0	5.5	0.9	1.6	5.8	0.0	0.0	1.8	0.0	0.0	18.6	4.3	3.7	0.0	13.6	2.9	1.1	5.5	11.6	21.5	22.6	0.0	3.7	0.1	0.0	7.9	0.2	4.7	0.1	0.0	16.2	2.1	0.0	4.3	3.9	0.1	4.0	8.8	0.1	0.0	8.6	5.9	13.3	9.2	13.2	4.6	12.9	3.6	6.3	6.0	4.6	5.4	4.8	1.4	2.6	5.8	3.0	7.8	12.5	5.8	3.9	2.9	4.5	1.2	3.9	2.8	2.9	7.2	0.6	4.4	4.3	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	3.5	0.6	0.0	0.0	4.7	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	47.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	10.4	11.0	11.1	13.5	13.7	14.7	11.5	21.8	13.6	14.0	14.0	11.3	12.4	12.7	12.6	11.2	12.1	10.0	8.1	13.3	10.0	10.9	19.7	28.4	9.8	15.8	19.3	10.0	14.5	12.1	24.6	15.6	8.7	13.9	12.2	12.7	10.1	10.7	12.3	15.8	9.8	13.6	11.9	12.1	18.6	11.9	20.5	15.0	13.0	14.0	11.0	16.6	12.1	15.0	10.4	7.4	5.3	7.8	10.5	14.0	8.7	5.1	4.7	6.5	5.3	9.4	11.0	5.9	10.7	9.8	10.5	12.8	9.7	3.9	13.5	8.4	10.0	8.2	8.8	11.9	8.6	16.1	7.8	7.8	10.3	11.4	10.5	12.4	18.5	7.0	9.5	13.6	11.3	12.7	7.4	7.9	12.0	17.6	13.0	10.9	8.9	5.1	16.0	4.8	7.7	4.8	8.5	18.7	22.4	8.4	8.1	5.5	3.3	5.5	9.3	9.6	6.2	6.1	19.6	5.0	6.2	6.1	3.5	10.1	8.5	13.1	5.4	3.2	13.8	8.2	1.7	6.4	5.3	9.7	7.2	11.9	10.4	11.7	9.8	7.4	7.9	12.9	10.5	1.8	10.5	7.8	5.5	14.0	8.7	11.1	13.7	21.8	13.6	10.0	10.9	19.3	10.0	13.9	15.0	14.9	17.0	14.3	13.5	6.9	0.0	12.9	7.6	6.7	11.4	10.4	0.0	10.2	18.3	6.5	108.3	9.0	9.0	0.0	6.4	6.5	6.9	10.3	5.8	18.4	7.8	0.0	8.1	9.2	5.9	11.0	10.3	10.8	0.0	8.2	8.1	0.0	6.1	7.0	9.2	12.6	0.0	6.5	10.2	21.7	10.2	8.8	8.6	24.2	9.8	9.7
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73515750-73523797	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	134.1	124.1	80.2	136.0	75.6	140.9	182.0	103.3	106.2	149.6	133.3	94.9	93.7	81.7	152.0	127.3	136.4	143.1	102.4	88.2	71.5	58.0	130.9	123.1	169.6	135.6	74.3	93.2	240.8	227.6	106.3	111.2	89.1	79.7	115.0	114.7	105.0	133.3	123.6	51.3	139.8	101.6	121.6	108.6	111.3	121.5	129.9	71.6	125.1	132.4	143.1	169.7	151.1	134.8	258.9	209.7	54.6	187.6	184.6	366.8	517.5	112.5	142.8	202.7	276.8	415.8	687.9	161.3	168.6	435.4	216.3	207.7	221.5	155.8	459.7	225.6	285.0	151.5	119.5	247.5	322.3	208.6	80.2	154.9	171.6	116.4	246.7	361.0	318.9	187.4	594.2	548.2	159.2	537.5	445.1	292.9	213.7	317.1	145.4	261.3	150.1	136.5	334.3	216.8	150.1	99.2	272.1	341.5	515.3	277.9	238.6	166.4	184.6	84.5	198.8	333.7	240.5	135.1	515.5	243.4	92.4	131.6	68.4	191.4	163.4	145.2	108.0	95.9	264.6	145.2	54.6	187.6	20.8	198.7	165.4	366.8	258.9	288.8	250.9	209.7	199.5	323.8	277.8	17.0	184.6	169.0	161.7	202.9	517.5	80.2	75.6	103.3	106.2	71.5	58.0	74.3	93.2	79.7	71.6	2945.0	5104.7	7686.4	9440.3	8731.8	946.3	163.3	4537.5	2577.7	4487.2	2501.9	514.4	8108.2	8765.4	4837.4	1096.2	6221.3	1773.7	1425.0	9007.6	10117.9	6235.0	8187.7	3506.7	2998.1	5660.8	467.2	3719.4	4654.6	6431.4	1730.5	8270.0	6531.1	4848.6	19235.8	6485.3	1457.9	7817.3	5029.0	6780.9	10371.8	951.6	3479.5	5699.9	1275.5	709.3	8789.4	9271.7	8651.4	9249.6	10618.3
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.7;ASC TERT1: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.8	3.8	3.9	6.2	41.7	31.1	5.2	9.3	23.5	2.5	8.9	2.5	6.9	2.6	4.5	13.1	5.9	5.0	5.4	2.3	4.5	1.8	6.3	1.1	2.1	5.9	8.4	2.1	4.4	14.2	3.5	5.7	4.0	10.7	6.4	3.5	2.7	2.9	8.8	1.9	0.8	1.2	2.8	11.9	2.3	1.9	4.8	11.1	6.6	7.9	1.5	2.7	1.9	5.6	5.4	6.0	2.5	13.2	9.3	1.2	1.1	5.0	2.2	8.2	11.4	0.7	4.2	4.6	3.7	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7	20.8	20.2	7.8	12.1	8.5	7.8	5.3	15.3	14.7	9.1	48.8	27.5	14.4	3.3	12.2	27.9	15.0	21.9	0.0	11.9	12.0	22.1	30.0	13.9	31.0	53.7	0.0	11.6	25.8	26.5	32.1	6.9	22.4	10.1	7.2	42.3	7.3	16.7	17.5	10.6	30.8	24.7	0.0	8.0	11.1	2.3	9.8	19.1	7.9	15.0	18.6
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"parathyroid gland: 203.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 36.9;Endothelial cells: 28.0;Hofbauer cells: 36.5;Suprabasal keratinocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;BJ hTERT+: 38.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	27.4	1.5	1.6	1.9	2.2	1.9	6.5	0.4	1.9	15.0	7.1	3.4	2.0	1.5	22.5	8.5	22.4	3.4	2.4	8.2	1.8	1.4	3.5	1.4	14.5	1.4	1.7	1.4	2.8	1.2	203.4	0.6	5.0	3.0	7.1	2.1	0.6	4.2	2.2	4.1	12.4	2.4	12.6	4.5	1.7	1.5	3.3	2.8	6.3	1.7	16.8	4.7	8.7	8.0	0.3	2.6	1.4	0.4	0.6	0.4	0.3	9.4	8.5	0.5	0.0	12.9	62.8	0.0	8.6	38.5	2.8	6.2	0.0	5.5	0.0	5.3	17.7	6.2	26.6	0.9	17.2	3.8	2.6	1.5	3.3	6.9	1.4	2.7	0.0	0.0	17.3	13.7	5.3	21.5	9.9	20.3	1.0	0.0	0.0	12.9	0.2	0.2	0.0	0.6	0.0	5.5	0.7	2.4	11.6	1.2	1.1	0.0	0.0	19.5	0.1	8.4	0.4	0.2	1.5	18.8	26.9	3.7	4.8	7.4	0.1	5.3	0.0	10.8	0.0	23.8	0.6	0.4	0.3	0.2	0.2	0.1	0.2	0.3	0.2	2.6	0.3	0.4	0.2	1.4	0.6	0.2	1.4	0.1	0.3	1.6	2.2	0.4	1.9	1.8	1.4	1.7	1.4	3.0	2.8	3.0	1.7	0.8	6.2	36.9	0.3	11.1	0.0	2.7	12.5	0.0	0.0	0.3	1.7	0.1	18.2	28.0	0.0	0.0	0.0	0.4	7.8	5.8	2.3	0.4	36.5	0.0	0.0	19.0	2.8	17.2	0.6	15.3	21.9	4.6	0.0	0.0	0.3	0.0	0.0	15.9	0.1	0.0	14.6	0.7	3.2	38.1	1.1	2.2	0.0	6.4
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206051	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 136.8"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 71.5;Leydig cells: 55.8;Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.5;SiHa: 97.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		4300000	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	53.1	5.6	0.9	33.1	1.3	0.0	136.8	0.4	2.0	65.0	23.0	0.5	14.8	4.2	64.6	18.1	29.2	14.9	16.3	17.1	1.1	1.1	7.6	1.5	22.2	23.5	2.0	1.5	52.0	4.1	1.5	1.9	2.6	1.6	12.3	8.7	2.4	5.9	21.4	21.6	16.8	14.1	32.4	1.4	5.0	6.9	10.6	0.4	1.0	8.2	15.0	4.4	24.8	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	35.2	19.7	3.3	32.0	26.7	22.0	30.7	3.2	0.0	0.0	3.3	164.5	0.4	7.0	0.0	3.3	20.8	0.0	0.1	0.0	11.9	0.0	13.1	0.0	0.0	29.6	0.6	4.9	6.0	21.3	3.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.8	0.0	1.8	0.0	2.7	0.0	1.1	1.6	0.0	0.0	97.7	2.5	0.0	1.9	15.5	0.0	0.0	9.5	11.8	5.0	10.6	0.0	0.0	0.0	3.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.4	2.0	1.1	1.1	2.0	1.5	1.6	0.4	71.5	6.1	0.0	0.6	18.3	0.2	2.8	0.0	2.7	7.9	3.5	0.0	0.4	0.0	0.8	19.1	3.6	0.0	0.0	3.8	0.6	25.9	1.3	1.1	0.0	0.7	0.0	0.0	5.5	0.0	9.7	55.8	1.7	20.3	0.0	0.0	0.0	4.6	0.0	12.4	0.8	0.0	45.3	24.5	0.2	0.6	11.4	0.6	0.0	0.0	0.3
COX7A2	"COX7AL, COXVIIa-L"	ENSG00000112695	"Cytochrome c oxidase subunit 7A2"		6	75237675-75250323	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"blood: 157.6"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 3729.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (8.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.73e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	26.9	25.3	49.7	18.8	55.3	26.5	30.2	27.0	54.9	19.5	55.9	12.3	37.0	35.3	16.9	41.5	29.7	20.3	23.4	76.3	38.0	32.9	44.8	51.7	17.8	23.9	48.9	34.6	12.6	46.9	19.4	27.2	18.3	36.8	24.0	61.5	18.3	35.7	27.1	38.2	19.1	35.6	29.0	39.4	18.1	36.4	62.8	27.5	17.4	22.4	47.1	27.1	23.4	16.7	109.1	130.5	94.1	108.8	76.9	110.3	157.6	15.3	35.2	46.2	37.9	27.6	31.4	33.5	37.5	34.5	37.5	40.7	63.3	23.5	25.1	33.3	33.8	50.5	33.4	32.1	40.5	47.0	45.8	65.9	37.6	110.1	83.1	28.4	40.0	44.4	33.9	54.3	34.6	22.7	39.5	43.4	57.2	33.2	36.5	50.6	71.4	17.0	43.6	29.0	75.8	64.5	27.8	23.3	66.0	59.7	100.2	31.6	38.3	23.3	42.8	37.6	39.6	26.1	113.0	21.1	16.6	30.3	13.2	42.5	51.7	56.3	27.8	18.9	45.8	32.3	92.9	100.0	94.1	78.3	107.7	83.0	109.1	102.4	93.5	103.6	90.2	101.1	93.4	74.7	76.9	108.8	130.5	110.3	157.6	49.7	55.3	27.0	54.9	38.0	32.9	48.9	34.6	36.8	27.5	282.9	318.7	403.4	476.4	491.8	218.2	2259.4	751.6	480.5	353.8	478.1	113.9	585.5	2205.0	700.7	3729.3	440.0	1510.8	210.2	878.7	682.4	432.2	710.6	290.2	1241.2	769.2	146.2	637.2	364.0	458.4	2761.1	329.4	416.4	803.1	743.0	1103.4	253.8	951.9	1195.4	318.9	1303.8	241.1	401.0	739.2	2380.3	194.6	547.7	684.3	381.3	1038.8	776.7
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284968	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA					"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	29.9	29.6	42.7	28.3	63.3	23.8	27.2	40.3	55.1	33.4	31.3	36.8	22.3	21.2	31.9	25.7	30.1	24.6	30.6	22.9	45.6	48.2	39.6	48.1	45.0	23.9	43.8	41.0	25.2	41.0	57.0	45.5	29.4	50.5	33.6	36.8	20.5	31.9	31.7	18.6	19.4	22.5	39.8	45.3	28.9	28.0	14.1	40.3	21.1	43.1	17.0	29.3	32.8	22.8	9.1	24.3	42.7	26.8	13.1	16.3	16.7	10.5	10.2	18.9	15.8	47.7	44.9	15.6	43.1	33.9	16.8	25.7	10.9	24.8	12.3	29.8	37.9	15.3	12.4	8.4	24.0	44.9	15.8	12.5	11.9	11.2	11.2	27.2	14.2	20.8	41.5	23.9	23.3	13.1	36.2	53.4	11.2	11.6	21.9	32.7	7.0	5.0	10.4	6.7	8.9	8.8	8.3	13.4	15.5	65.1	26.0	13.3	13.0	21.9	10.8	14.5	22.7	11.9	44.6	46.3	21.3	23.8	13.3	30.4	18.0	24.5	5.3	16.9	27.5	33.3	12.3	26.8	17.7	12.7	26.6	15.3	9.1	13.0	12.2	24.3	7.5	12.5	12.6	42.7	13.1	25.6	10.6	16.3	16.7	42.7	63.3	40.3	52.7	45.6	48.2	43.8	41.0	50.5	40.3	151.8	109.2	38.2	28.7	63.3	24.2	34.7	33.1	68.3	76.2	62.8	43.2	31.3	10.0	43.7	7.5	65.2	34.1	0.0	96.0	46.0	58.6	62.3	37.1	70.2	48.7	19.1	34.9	69.3	81.5	5.9	42.0	50.3	45.5	23.4	43.5	37.2	78.7	37.4	58.7	29.3	20.0	32.3	70.7	36.2	18.8	68.4	78.9	28.9	26.2	42.3
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.6;smooth muscle: 44.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 542.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA			"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	11.0	1.3	2.0	6.3	3.0	0.2	2.5	0.6	2.5	8.2	10.9	0.0	4.1	1.3	8.8	4.1	10.5	4.5	5.9	37.6	3.7	1.2	2.7	2.4	7.5	1.2	1.1	0.7	4.4	1.4	5.4	5.1	3.7	0.8	14.9	2.6	4.3	1.5	2.8	29.4	0.9	4.1	44.7	1.4	0.6	3.9	2.8	0.0	0.0	2.3	10.8	0.7	30.7	6.0	1.4	0.9	1.8	0.8	0.6	0.9	0.0	0.1	1.9	0.3	0.1	0.1	0.3	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	10.7	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.2	0.1	0.0	0.3	0.2	1.4	0.1	0.2	0.1	0.1	2.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	3.0	0.6	0.2	0.2	0.0	0.1	0.1	2.5	0.1	0.4	0.0	0.1	0.0	0.1	0.1	10.7	1.0	0.1	0.1	0.5	0.1	1.2	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.4	0.2	1.4	0.9	0.6	1.8	0.6	0.8	0.9	0.3	0.0	2.0	3.0	0.6	1.9	3.7	1.2	1.1	0.7	0.8	0.0	119.1	78.3	0.0	0.6	0.6	3.3	542.5	0.0	83.0	14.8	0.0	0.0	0.7	1.7	0.0	36.1	36.8	0.0	0.0	0.3	0.3	26.7	0.6	1.1	0.6	1.2	0.0	0.0	58.3	1.9	16.2	2.3	2.0	1.7	0.0	0.0	4.5	0.0	0.0	4.2	0.0	3.8	90.5	88.2	4.5	6.4	0.6	0.7	0.0	0.0	0.4
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO1/sentrin specific peptidase 6"	Q9GZR1	6	75601509-75718278	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.9	20.0	24.3	21.8	24.5	27.1	25.9	35.0	24.3	32.5	27.7	23.5	24.9	16.8	37.7	21.2	21.0	27.4	21.5	20.0	22.8	19.8	24.1	22.5	22.5	21.1	29.6	20.3	38.7	21.8	40.1	44.2	26.8	27.0	27.7	21.8	23.0	20.4	25.7	27.8	22.0	24.1	43.0	27.2	24.7	21.3	26.1	28.6	28.5	34.8	15.8	23.9	27.1	34.0	9.9	10.9	19.4	13.1	9.8	11.2	5.5	10.9	11.5	26.2	18.7	20.4	27.2	19.5	19.8	22.1	16.8	21.0	15.8	10.6	18.6	18.8	22.8	19.8	14.1	24.6	13.2	26.0	27.4	21.3	28.2	13.9	14.7	28.4	24.5	20.8	21.0	22.1	15.7	35.1	20.4	27.7	15.6	34.1	20.7	20.5	13.4	9.7	13.2	15.9	14.8	9.8	18.3	13.8	27.2	17.9	16.4	22.9	23.7	16.9	15.0	17.2	22.0	13.5	23.4	23.1	15.0	16.4	7.7	20.4	23.8	23.6	14.9	7.5	23.4	15.8	5.2	7.4	19.4	7.7	7.9	11.2	9.3	7.8	10.2	8.7	9.9	11.2	9.9	14.7	9.8	13.1	10.9	6.5	5.5	24.3	24.5	35.0	24.3	22.8	19.8	29.6	20.3	27.0	28.6	62.5	112.5	47.7	47.5	41.3	58.8	66.9	35.7	56.2	105.8	27.9	86.4	28.4	14.9	28.8	30.6	40.8	33.0	0.0	28.8	23.6	46.3	54.5	61.4	29.8	25.4	57.2	26.5	36.8	38.9	28.6	65.6	37.8	33.7	39.7	33.3	61.0	28.0	24.6	59.4	24.5	62.7	25.8	62.7	116.1	58.3	42.3	34.4	34.8	39.8	53.1
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 333.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3"	"Group enriched"	"Detected in many"	20	"NK-cells: 3.3;T-cells: 8.6"	"Cell line enhanced"	"Detected in many"		"RT4: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	8.4	9.1	18.2	9.0	27.0	0.9	26.9	17.1	24.1	16.2	18.9	26.8	28.7	30.0	7.5	25.9	28.1	10.0	23.1	4.9	19.1	12.2	44.0	13.8	20.5	4.5	24.0	17.9	4.6	18.5	42.2	24.2	7.1	19.0	16.0	17.3	11.9	23.3	33.7	4.2	14.1	27.7	8.0	21.2	6.7	23.9	14.3	28.2	0.9	13.4	9.1	10.9	16.1	13.1	0.2	0.0	0.1	0.1	3.3	8.6	1.2	22.7	6.1	4.9	3.5	11.9	9.6	19.6	8.1	8.6	6.0	7.8	9.2	20.5	0.0	7.9	9.1	6.9	18.0	5.8	11.6	6.9	9.6	11.9	6.5	2.0	5.6	10.2	0.0	9.5	6.8	8.4	8.1	6.4	10.0	16.6	3.3	8.5	3.3	6.1	21.9	0.0	0.2	3.3	17.1	1.6	0.4	11.8	0.4	22.3	43.4	10.2	6.7	2.0	20.4	3.5	11.6	8.7	13.3	24.3	6.6	5.7	0.3	7.3	6.9	7.0	0.0	4.1	0.0	2.3	0.1	0.0	0.0	8.6	0.0	4.0	0.2	2.7	4.9	0.0	0.0	0.6	4.8	0.1	3.3	0.1	0.0	0.1	1.2	18.2	27.0	17.1	24.1	19.1	12.2	24.0	17.9	19.0	28.2	131.0	218.3	7.6	88.9	26.8	74.9	7.3	35.7	75.0	79.6	143.1	113.9	27.1	46.4	104.1	3.9	45.8	95.7	0.0	104.0	18.4	24.2	142.1	25.4	28.2	5.5	90.6	81.6	42.4	3.8	5.6	27.9	6.0	28.7	4.6	66.2	333.7	145.6	80.7	40.7	83.4	184.9	12.9	16.9	10.9	13.8	29.7	65.6	12.1	54.2	164.0
IMPG1	"GP147, IPM150, SPACR"	ENSG00000112706	"Interphotoreceptor matrix proteoglycan 1"	Q17R60	6	75921115-76072678	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 110.5"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 634.2;Rod photoreceptor cells: 409.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;AF22: 3.0;HaCaT: 4.1;TIME: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027142, HPA030332, HPA030333"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433"	"unprognostic (6.65e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-2)"	0.6	0.0	0.4	0.4	10.3	0.0	0.4	1.0	2.8	0.4	0.4	0.4	0.4	2.8	0.4	0.4	0.4	0.1	1.1	0.5	0.5	0.4	0.8	0.4	0.5	0.4	0.5	0.4	0.4	5.4	0.0	0.4	0.6	0.4	0.7	0.0	110.5	0.6	0.4	0.6	4.0	2.3	0.4	0.4	0.5	0.7	0.9	0.4	0.4	0.8	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	3.0	0.0	0.0	0.6	1.6	0.8	0.0	0.0	0.0	1.8	0.6	0.0	0.3	0.0	0.1	4.1	0.0	0.0	0.0	0.1	1.5	0.7	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.2	0.6	0.1	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.7	0.7	1.2	0.0	1.8	0.4	0.6	0.0	0.3	2.4	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.3	1.0	1.9	0.5	0.4	0.5	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	44.9	0.2	0.0	0.0	0.0	0.0	634.2	0.1	3.3	0.0	1.5	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.2	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	409.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 41.8;TIME: 18.4"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.1	0.8	41.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77690658-77926974	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 59.5;Late spermatids: 15.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.5;NTERA-2: 1.5;TIME: 2.6;U-266/70: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.0	1.3	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.3	1.0	0.2	0.9	8.5	1.7	0.0	0.0	0.8		0.0	4.1	0.0	2.6	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	4.7			4.6		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.6	0.4	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.5	0.0	0.0	0.0	4.3	2.5	0.0	0.0	0.0	0.0	0.0
IRAK1BP1	"AIP70, SIMPL"	ENSG00000146243	"Interleukin 1 receptor associated kinase 1 binding protein 1"	Q5VVH5	6	78867472-78946440	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 79.6"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 31.4;Early spermatids: 52.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035742, HPA035743"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035742: AB_10670119, HPA035743: AB_2674764"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.58e-1)"	2.8	4.0	6.9	3.4	12.4	79.6	3.9	8.8	8.1	6.4	4.1	3.4	6.2	3.5	7.2	7.7	3.2	7.3	5.3	3.6	5.6	4.1	7.0	2.6	4.4	6.0	3.0	6.5	7.0	8.1	4.2	17.9	2.8	4.3	5.2	2.7	5.1	4.2	6.5	2.3	5.7	4.7	4.1	3.6	4.7	5.5	15.4	5.7	8.8	7.6	1.9	2.3	4.5	4.0	1.4	1.6	3.9	1.4	1.3	2.0	0.4	1.6	3.2	5.2	4.7	2.2	4.8	4.5	1.1	2.7	1.1	1.9	3.8	3.0	3.2	1.4	2.5	2.7	3.0	9.4	4.4	1.9	4.8	3.8	4.0	4.7	2.0	2.8	9.7	3.7	4.2	4.5	2.0	2.5	3.6	3.5	6.6	5.1	7.8	1.7	0.8	2.9	6.5	2.4	0.7	2.7	1.1	3.0	2.3	4.8	6.5	6.9	8.3	1.5	1.7	1.2	3.4	3.8	6.5	3.2	2.8	2.6	1.5	4.0	7.8	4.6	4.8	0.8	0.7	3.1	3.9	0.3	0.4	1.5	0.2	1.1	1.4	1.4	0.8	0.6	0.9	1.9	2.0	2.5	1.3	1.4	1.6	1.6	0.4	6.9	12.4	8.8	8.1	5.6	4.1	3.0	6.5	4.3	5.7	17.9	5.6	0.5	4.8	2.3	7.8	13.2	7.6	28.1	14.8	3.5	31.4	3.0	8.3	4.4	52.1	5.8	0.4	0.0	5.2	0.6	2.4	1.2	0.0	2.1	1.4	4.8	6.3	2.5	1.8	27.4	9.8	1.2	0.0	1.0	2.6	12.8	3.7	0.0	7.8	10.2	17.4	12.9	2.1	25.8	14.7	2.3	0.7	1.0	3.5	1.7
PHIP	"BRWD2, DCAF14, FLJ20705, ndrp, WDR11"	ENSG00000146247	"Pleckstrin homology domain interacting protein"	Q8WWQ0	6	78935867-79078236	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019140, HPA019838"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019140: AB_2670073, HPA019838: AB_2670287"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-2)"	14.7	9.6	13.3	14.9	16.9	40.2	19.4	30.1	14.6	19.1	13.9	11.8	15.0	9.4	18.1	14.1	11.6	16.1	12.3	12.2	11.0	9.7	10.4	7.9	15.4	16.8	15.8	11.0	19.8	15.5	20.6	28.4	14.2	12.8	14.7	12.8	11.0	15.6	18.3	16.6	14.1	13.8	17.1	13.7	14.9	12.9	10.2	17.9	27.8	13.4	8.8	14.4	17.1	22.6	8.3	6.2	17.3	6.1	5.1	7.3	2.2	9.0	7.4	17.8	17.2	6.8	9.9	10.3	9.8	7.8	8.4	10.8	9.1	5.7	15.1	7.8	6.1	7.1	8.4	13.2	6.2	14.3	21.7	9.6	16.9	13.9	6.7	3.1	18.8	10.8	6.0	5.6	10.1	10.2	7.1	8.8	9.6	16.9	14.7	8.1	6.1	7.2	13.5	11.1	4.7	8.1	12.7	22.7	6.5	9.0	12.4	17.4	11.1	13.1	10.0	6.1	11.8	7.8	25.2	10.4	9.8	7.0	4.7	16.1	10.0	9.8	8.6	4.1	12.2	14.6	10.2	5.0	8.4	5.6	3.3	6.0	6.8	6.6	6.1	3.3	8.3	7.3	5.8	17.3	5.1	6.1	6.2	5.4	2.2	13.3	16.9	30.1	14.6	11.0	9.7	15.8	11.0	12.8	17.9	65.5	95.2	80.9	77.1	56.1	179.4	47.2	53.5	178.0	106.9	52.4	143.3	72.7	1.7	63.5	24.5	73.6	39.6	0.0	40.8	78.5	66.7	73.6	111.0	16.3	44.0	171.6	69.9	57.1	82.9	10.5	93.7	72.3	47.2	116.4	56.3	84.3	48.2	48.9	82.4	15.3	178.7	51.8	78.3	100.9	50.8	49.3	85.4	74.6	53.5	73.7
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	26.6	57.2	53.6	22.9	52.7	18.8	37.2	73.1	84.6	26.1	28.3	22.6	28.4	27.7	29.9	55.4	29.0	66.8	26.4	68.6	53.3	33.4	52.5	44.6	34.4	35.5	70.8	36.1	34.9	27.8	38.7	66.8	35.4	53.0	27.4	23.5	28.0	47.4	30.6	41.8	24.8	22.3	33.0	53.2	27.7	31.0	24.8	63.5	21.9	36.1	37.9	32.8	26.1	25.6	28.0	52.3	7.7	38.3	32.8	29.4	36.4	14.3	13.1	45.9	19.8	18.5	15.2	10.4	10.0	10.8	11.2	16.5	73.2	12.2	0.1	18.6	8.1	15.0	9.2	29.8	11.3	11.1	42.3	25.0	50.7	41.0	38.1	11.8	41.4	7.7	18.4	12.7	7.4	4.1	10.9	25.0	10.8	29.6	40.6	18.1	13.1	19.0	80.1	33.6	12.5	32.9	32.6	70.1	14.7	77.1	21.0	18.7	25.1	19.1	22.0	14.1	42.2	12.5	70.0	10.9	3.1	13.7	10.8	22.1	35.0	51.6	0.2	1.7	0.1	15.0	7.7	38.3	3.2	29.4	36.2	25.5	28.0	20.6	24.6	44.8	23.2	24.3	29.2	1.8	32.8	33.3	52.3	21.9	36.4	53.6	52.7	73.1	84.6	53.3	33.4	70.8	36.1	53.0	63.5	89.3	143.6	96.0	158.6	151.9	231.2	376.3	186.0	619.7	254.8	230.3	70.7	769.9	510.6	171.3	36.2	149.3	30.7	0.0	172.6	615.0	191.6	116.6	106.3	217.9	268.2	184.3	262.2	186.6	174.4	27.1	173.2	154.2	244.6	542.8	88.7	204.1	113.5	63.1	157.0	607.4	113.5	142.3	169.0	21.1	50.0	131.0	464.4	124.6	105.7	145.7
LCA5	C6orf152	ENSG00000135338	"LCA5, lebercilin"	Q86VQ0	6	79484991-79537458	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 42.4"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 121.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029053, HPA029055"	Supported					NA	NA					"HPA029053: AB_10602020, HPA029055: AB_2672889"	"unprognostic (8.96e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.09e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.21e-2)"	5.2	3.4	8.8	2.9	9.9	4.7	7.4	16.4	9.7	7.6	4.3	5.7	9.1	2.2	8.2	6.0	4.9	13.9	4.9	3.9	9.1	7.8	4.8	2.4	6.2	2.6	7.4	7.7	11.0	4.3	42.4	11.4	5.1	17.2	7.5	3.0	4.4	7.6	9.3	2.7	2.0	2.5	6.6	13.6	2.9	2.9	9.5	8.0	0.1	13.4	2.1	2.2	7.6	8.8	0.3	0.1	0.0	0.6	0.0	1.0	0.2	1.8	1.4	4.3	2.4	5.3	6.0	1.9	3.1	3.8	2.0	4.0	10.4	2.0	0.5	4.3	2.5	3.7	2.0	3.2	1.9	3.6	0.0	2.4	15.3	2.1	1.4	5.6	0.3	1.3	5.6	2.2	3.4	4.4	7.7	5.9	0.1	2.3	0.9	3.2	0.0	0.0	0.0	1.2	1.1	1.6	0.0	7.4	0.7	4.2	0.6	3.2	3.8	2.9	0.5	2.0	5.5	0.3	0.9	4.1	2.1	2.5	0.6	2.7	4.0	1.4	0.0	1.0	0.0	1.6	0.0	0.2	0.0	0.5	0.6	0.0	0.0	0.2	0.0	0.1	0.3	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	9.9	16.4	9.7	9.1	7.8	7.4	7.7	17.2	8.0	14.9	7.8	0.5	10.9	0.9	11.4	4.6	7.6	121.8	26.1	10.4	21.6	6.6	0.0	12.2	7.7	12.2	0.0	0.0	4.3	3.1	6.9	4.6	1.1	0.0	0.9	9.5	2.4	8.6	1.3	3.6	16.7	0.9	3.3	0.0	0.0	12.8	6.3	0.0	14.9	2.2	28.0	6.5	9.2	14.0	2.9	0.9	10.3	0.0	0.0	9.0
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631283-79703659	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 104.4"	"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 75.8;Paneth cells: 69.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.4;neutrophil: 2.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 33.0;HEL: 16.8;OE19: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		4700000	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	21.0	3.9	11.6	6.5	10.7	1.1	29.3	9.7	18.3	14.6	24.7	2.6	7.9	17.3	9.1	13.0	29.8	9.3	14.2	7.4	12.3	13.8	8.2	27.6	8.0	4.1	14.6	7.8	3.5	11.6	17.9	12.6	14.4	22.4	13.8	24.1	9.6	104.4	6.4	8.3	7.1	17.3	8.2	13.9	3.8	34.1	3.7	2.4	0.4	38.3	11.1	15.0	8.7	12.6	0.0	0.2	7.4	0.3	0.0	1.2	10.8	3.4	0.6	3.2	0.6	2.8	2.4	7.6	0.2	2.3	0.8	1.7	33.0	6.7	0.0	4.8	0.2	0.6	1.6	2.9	3.7	2.8	0.0	4.2	16.8	0.7	6.3	1.2	0.6	0.4	1.3	3.0	2.4	1.4	1.1	9.8	0.0	6.6	0.0	0.2	0.5	0.0	0.0	2.7	40.3	1.1	0.0	0.9	0.0	0.8	11.1	8.5	9.4	0.2	1.0	0.2	4.5	0.1	1.4	5.5	2.2	1.4	0.0	1.9	5.0	2.3	0.0	0.3	0.0	0.7	7.4	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.2	2.7	0.0	0.0	0.2	0.0	10.8	11.6	10.7	9.7	18.3	12.3	13.8	14.6	7.8	22.4	2.4	6.0	19.0	0.9	3.7	1.9	12.6	5.2	66.2	25.4	27.3	21.0	7.9	33.0	0.0	15.1	10.8	29.8	58.0	0.0	11.3	1.9	3.6	27.2	0.0	61.0	3.7	12.7	12.1	35.0	4.1	14.7	0.6	1.1	15.1	1.8	75.8	8.3	14.8	69.1	4.2	8.4	11.7	0.0	5.3	1.7	0.9	0.6	44.1	0.0	59.5	25.7
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 278.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Cell line enhanced"	"Detected in many"		"JURKAT: 25.2;MOLT-4: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.5	6.7	7.4	5.6	5.4	1.0	3.4	3.8	2.9	6.4	0.9	0.0	0.0	0.6	4.7	12.1	0.7	8.6	4.8	2.2	0.0	11.2	0.2	1.4	0.0	5.2	2.6	1.0	4.4	1.8	3.0	3.1	4.2	4.8	25.2	0.0	0.0	6.1	1.1	19.2	0.0	6.4	0.0	3.5	0.0	9.6	0.0	0.1	0.0	8.9	2.6	3.7	5.9	1.0	4.8	2.3	0.2	0.4	1.3	2.6	2.0	2.6	4.5	8.9	0.0	3.1	0.0	2.0	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3	0.0	0.0	0.0	2.3	10.1	47.3	0.4	0.0	0.0	4.5	0.0	139.4	0.8	0.0	0.1	4.5	0.8	0.0	0.0	0.0	1.6	3.2	2.0	0.0	0.0	0.2	39.7	8.5	0.0	0.0	1.8	1.1	0.0	3.3	0.0	0.0	35.8	0.0	0.0	3.2	2.3	278.2	0.0	5.3	13.5	7.8	33.1	0.8	0.5	0.0	0.7
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 56.4;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	7.0	2.6	10.0	13.4	10.2	8.9	8.0	5.0	10.4	8.3	11.4	4.3	9.7	20.0	5.4	12.0	9.7	7.1	5.5	6.6	11.6	24.8	8.2	9.9	6.9	5.8	11.3	14.0	4.5	8.5	6.8	5.7	7.1	7.4	9.8	15.6	8.3	17.9	18.5	3.9	5.1	8.2	7.4	15.4	3.4	13.0	31.1	17.1	22.9	10.8	6.7	9.5	8.5	7.1	5.0	11.5	9.1	10.8	4.2	5.0	3.4	4.5	6.7	12.8	12.5	6.6	6.1	10.5	7.4	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4	8.9	15.2	6.7	10.1	7.6	7.0	26.0	10.2	16.0	14.8	5.2	2.0	15.7	23.2	6.8	56.4	9.0	12.4	0.0	9.0	6.6	13.0	8.6	16.1	55.0	10.2	3.2	11.5	11.1	9.8	4.1	8.1	6.1	15.1	10.0	28.8	14.6	4.5	11.5	8.1	25.2	8.2	6.5	8.9	7.7	4.8	10.8	8.7	8.9	15.3	9.8
FAM46A	"C6orf37, FLJ20037"	ENSG00000112773	"Family with sequence similarity 46 member A"	Q96IP4	6	81491439-81752774	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 106.4"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 311.3;Horizontal cells: 276.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	10.0	7.1	1.4	4.9	1.4	64.7	5.6	2.8	0.9	14.4	17.7	1.3	24.2	5.1	12.8	20.0	4.2	8.8	17.1	19.4	1.2	4.4	3.2	11.8	5.8	2.3	1.4	0.9	20.1	3.5	6.5	20.4	106.4	3.5	16.2	5.6	4.9	49.8	45.6	4.5	7.0	32.6	15.3	2.5	5.8	13.2	6.8	1.4	1.2	7.7	6.7	3.7	13.4	31.1	12.0	12.4	22.4	22.2	8.3	6.2	6.1	1.0	1.5	1.0	0.0	22.1	9.8	1.9	8.4	6.0	5.0	7.6	15.7	0.8	0.1	0.3	25.4	3.2	0.9	0.7	1.3	3.7	0.0	1.9	0.0	25.1	2.4	6.9	28.8	2.2	4.3	0.7	3.9	0.7	16.4	0.6	0.2	0.4	0.0	3.3	4.4	0.0	20.4	0.2	8.9	1.2	0.0	9.1	0.0	0.6	1.9	1.0	1.4	3.7	1.6	2.5	3.3	0.3	49.6	1.4	5.7	1.2	2.4	2.3	0.1	0.1	0.1	8.1	22.3	2.4	16.1	14.9	22.4	6.2	15.1	3.7	8.0	2.4	3.0	12.4	12.0	4.7	4.4	7.3	8.3	22.2	4.3	2.7	6.1	1.4	1.4	2.8	0.9	1.2	4.4	1.4	0.9	3.5	1.4	59.6	92.4	0.9	134.5	49.9	25.9	0.0	45.9	21.4	102.4	0.0	70.7	30.7	0.0	0.0	0.4	20.4	311.3	23.3	0.0	89.3	98.1	34.0	210.9	34.5	26.7	276.5	183.7	6.7	35.9	0.5	95.3	46.7	62.4	0.0	64.6	75.7	0.0	105.2	37.1	0.0	45.1	25.8	43.8	0.9	5.4	31.7	135.5	20.3	33.3	105.6
IBTK	"BTBD26, BTKI, DKFZP564B116"	ENSG00000005700	"Inhibitor of Bruton tyrosine kinase"	Q9P2D0	6	82169983-82247754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023826, HPA048438"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023826: AB_1851378, HPA048438: AB_2680392"	"unprognostic (3.13e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.27e-2)"	"unprognostic (9.78e-2)"	12.8	26.4	8.7	11.0	13.3	4.8	13.2	15.9	16.0	13.9	12.0	14.9	16.7	11.7	14.3	10.9	14.7	12.9	8.9	13.9	8.8	8.7	16.3	39.1	12.1	15.5	11.8	7.7	13.9	20.4	19.9	22.2	9.0	14.5	11.5	15.1	11.2	14.6	17.6	30.9	7.2	16.5	15.1	12.9	12.7	15.8	6.2	10.8	13.6	14.9	14.5	10.0	13.5	10.1	3.9	4.3	3.0	4.6	2.2	6.0	1.9	5.6	11.8	8.6	7.2	10.5	14.4	3.8	13.3	14.7	11.1	12.0	6.2	6.7	11.2	8.5	15.7	14.5	6.1	6.9	7.4	13.3	15.0	5.1	12.0	6.3	9.6	14.6	13.8	7.3	12.4	12.5	10.5	26.1	10.2	10.8	7.8	11.0	7.0	11.6	8.7	4.8	4.5	3.8	8.8	6.3	7.0	18.2	4.4	16.7	13.1	5.8	6.4	9.0	11.3	7.0	7.9	10.6	8.5	8.7	6.4	4.8	8.0	10.6	7.3	11.3	5.2	7.1	9.2	8.2	3.0	2.7	2.1	4.4	2.5	6.0	3.9	4.3	3.9	4.3	2.6	4.4	4.0	0.0	2.2	4.6	3.2	5.9	1.9	8.7	13.3	15.9	16.0	8.8	8.7	11.8	7.7	14.5	10.8	38.7	33.8	23.8	28.4	12.0	54.8	60.8	53.5	34.8	47.8	36.6	51.1	20.9	13.3	28.0	2.7	24.4	34.5	46.7	44.8	13.7	23.6	45.7	35.8	65.2	23.9	49.3	37.3	24.5	29.4	1.3	23.9	31.7	21.9	38.7	34.6	33.5	42.5	29.1	19.8	27.2	36.7	25.8	20.6	19.7	24.7	10.2	7.9	21.8	28.8	63.3
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82370828	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 67.5;Urothelial cells: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.2"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.9;hTCEpi: 30.5;hTEC/SVTERT24-B: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		330000	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	10.2	2.9	0.4	4.8	15.7	1.2	10.2	0.0	8.8	22.0	4.6	1.9	12.1	4.2	12.6	4.6	35.2	8.4	9.3	5.3	0.7	2.0	6.6	1.7	4.1	3.0	4.3	1.4	5.8	4.8	4.1	11.2	16.9	17.6	14.1	4.6	5.1	11.5	9.4	2.6	12.6	4.9	16.2	4.5	5.7	6.2	3.3	7.9	4.2	13.0	6.8	4.5	22.9	25.5	0.0	0.0	0.0	0.1	0.0	3.2	0.0	4.5	6.8	2.5	5.0	9.1	13.1	4.3	21.4	24.9	4.3	5.9	0.8	6.4	0.0	2.3	11.7	12.1	8.9	2.8	11.7	4.6	0.0	3.6	2.6	3.3	0.2	7.4	0.2	2.2	8.3	30.5	27.9	10.4	3.9	1.0	0.2	0.4	0.0	1.1	9.3	0.0	0.0	2.9	2.0	5.4	0.0	4.8	0.0	6.3	6.4	1.2	3.9	4.7	6.8	0.0	4.9	11.3	0.9	3.1	3.7	3.7	7.9	4.6	0.0	0.0	0.0	18.2	0.3	3.9	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.7	0.0	8.8	0.7	2.0	4.3	1.4	17.6	7.9	11.9	6.2	0.0	63.5	60.3	0.1	2.0	12.7	5.3	18.2	52.4	0.0	36.6	0.0	30.7	6.2	17.9	2.6	0.0	40.7	67.5	22.6	45.6	0.0	0.0	3.2	1.6	1.2	6.7	1.2	4.1	11.8	4.0	16.9	0.0	16.1	1.7	26.7	16.4	5.6	0.4	0.2	32.3	19.1	1.9	5.3	27.4	55.2	2.9	9.7	71.2
UBE3D	"C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W"	ENSG00000118420	"Ubiquitin protein ligase E3D"	Q7Z6J8	6	82892398-83065841	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 40.2;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027231	Uncertain		Approved	"Rods & Rings"		NA	NA			"Rods & Rings"		"HPA027231: AB_2256689"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.91e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.39e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.18e-1)"	4.6	9.0	6.3	6.2	9.5	3.0	8.7	13.1	10.6	6.7	5.5	6.0	4.9	7.5	6.9	5.0	6.7	14.0	5.1	5.4	6.1	9.1	7.9	4.9	4.1	7.6	7.4	7.2	8.0	10.1	8.9	11.0	4.2	5.9	4.1	6.8	6.4	6.5	5.6	8.8	4.1	4.2	8.7	5.8	8.2	6.3	3.7	7.7	4.5	10.0	5.2	7.8	8.6	6.0	6.6	3.1	0.3	2.7	1.3	8.2	3.2	2.7	3.8	3.8	3.5	3.1	5.0	3.0	3.0	3.7	3.8	6.5	5.5	1.5	12.6	4.6	1.8	6.6	2.9	7.3	3.6	6.0	5.3	16.6	7.3	2.1	6.0	4.2	6.2	3.6	3.9	5.1	4.1	5.0	2.8	4.9	6.9	10.4	5.8	3.2	3.1	3.8	7.9	4.7	10.0	6.2	5.8	8.6	5.0	7.2	3.7	6.8	4.2	1.7	4.3	2.6	5.3	2.7	4.5	1.5	1.7	4.5	3.6	7.2	6.4	12.8	4.3	2.8	11.5	3.4	0.0	1.0	0.3	4.7	2.7	6.1	6.6	5.2	3.7	3.1	4.4	5.6	8.2	0.0	1.3	1.2	2.3	5.2	3.2	6.3	9.5	13.1	10.6	6.1	9.1	7.4	7.2	5.9	7.7	6.0	5.4	9.3	4.8	5.6	11.1	2.4	2.5	40.2	4.5	7.0	33.4	5.9	1.7	4.6	1.5	5.2	2.0	0.0	4.0	4.1	6.2	2.7	1.1	2.4	4.4	6.4	7.5	4.3	3.2	0.8	6.4	3.6	6.8	0.0	5.2	5.1	3.7	6.2	3.9	4.2	15.7	6.5	3.6	5.9	15.9	5.9	2.5	4.4	6.6	3.4
DOPEY1	"dJ202D23.2, KIAA1117"	ENSG00000083097	"Dopey family member 1"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	9.7	8.7	15.7	11.3	19.5	5.5	13.3	25.2	21.2	11.9	9.5	10.1	10.1	9.5	13.9	9.5	9.5	12.0	8.9	10.6	15.2	7.0	8.9	7.5	9.1	8.3	10.9	12.9	17.7	12.1	20.3	21.7	7.3	17.3	12.4	11.0	9.0	13.8	14.9	12.7	16.6	11.7	9.5	13.1	9.5	9.5	14.9	12.8	10.7	16.9	8.5	8.9	12.2	10.7	2.3	2.8	1.4	1.4	1.2	4.1	1.3	3.7	2.7	9.1	8.2	8.2	8.7	4.3	6.4	5.3	4.4	6.4	5.8	0.9	7.3	4.6	6.9	5.5	5.0	9.1	6.9	5.5	6.3	10.3	6.1	3.7	2.1	4.5	8.9	6.4	6.9	9.7	6.1	15.9	5.8	6.4	11.4	12.6	5.4	4.7	3.5	2.6	4.0	1.9	2.7	5.5	7.3	6.9	2.6	5.8	10.5	16.4	3.0	4.8	3.0	1.2	6.8	4.8	5.1	10.7	5.5	2.0	5.6	4.9	6.8	4.8	4.2	3.0	4.1	4.3	0.1	1.3	1.4	1.9	1.4	1.6	2.3	1.6	4.1	2.8	1.9	3.0	1.4	0.2	1.2	1.2	1.2	1.5	1.3	15.7	19.5	25.2	21.2	15.2	7.0	10.9	12.9	17.3	12.8	17.9	7.8	3.2	6.1	10.2	24.8	8.1	2.5	14.7	15.9	3.5	37.3	3.7	1.7	5.4	4.0	6.2	10.2	0.0	7.6	0.9	3.7	2.9	15.1	4.3	3.5	11.1	9.8	8.6	6.9	2.7	9.8	6.4	1.7	1.0	8.3	6.3	4.5	11.8	8.9	4.1	42.6	6.5	4.2	23.8	16.0	8.5	2.9	6.9	8.1	5.9
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.1	6.8	13.1	15.6	21.3	22.8	15.2	34.8	25.3	16.9	26.6	17.5	4.8	5.4	7.4	34.8	17.2	6.5	11.9	14.6	32.4	4.0	11.6	6.9	13.3	29.2	24.2	6.7	3.4	14.4	12.1	29.7	37.7	17.1	19.9	3.7	22.5	5.9	18.2	10.6	1.1	4.4	5.8	9.1	9.3	4.7	29.3	3.1	13.1	10.1	5.2	8.2	10.0	9.0	7.0	20.5	7.8	7.5	28.9	11.6	6.4	23.3	18.7	11.5	4.4	3.8	9.1	5.4	18.2	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3	26.8	20.1	3.7	21.9	14.1	16.1	5.2	20.4	12.0	28.4	10.4	9.8	27.6	6.6	29.3	40.4	10.8	14.0	23.3	43.3	56.1	40.5	76.0	4.7	30.5	15.6	7.9	15.4	16.5	4.7	15.6	31.1	8.3	10.1	12.6	25.8	25.2	36.6	17.5	17.3	18.1	20.4	6.5	18.6	54.3	31.1	13.7	53.9	7.5	15.5	17.9
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193379-83198932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	5.0	10.1	8.5	3.4	10.4	1.0	5.4	11.8	14.6	5.6	4.0	5.9	11.6	4.2	5.7	15.9	3.1	6.5	7.6	7.2	9.4	11.0	7.5	8.1	4.8	3.9	6.5	11.7	7.0	13.4	7.4	9.8	4.2	11.6	19.2	4.3	3.7	16.4	11.3	4.1	3.4	4.0	5.5	4.8	4.1	5.3	14.5	3.9	1.7	10.4	3.1	4.4	5.2	2.8	3.7	6.8	0.7	3.9	0.8	4.6	2.1	2.2	2.0	4.7	8.9	5.7	4.2	3.3	5.0	10.7	3.8	4.6	2.9	1.2	1.7	4.1	6.1	8.7	2.2	3.9	3.0	5.9	2.0	4.0	2.0	3.0	6.4	8.8	0.5	1.6	5.4	5.0	4.8	10.0	12.5	7.0	4.8	3.1	3.0	4.6	3.1	0.7	1.5	1.6	2.0	2.0	2.5	9.7	1.0	7.9	2.5	1.7	5.8	3.0	4.9	4.5	7.1	3.0	3.0	7.4	2.7	1.7	3.7	2.2	6.7	2.7	1.0	3.1	0.8	3.1	0.5	1.8	0.0	2.4	1.6	3.9	3.7	3.6	3.6	2.0	2.2	4.6	4.5	0.7	0.8	3.9	6.8	4.0	2.1	8.5	10.4	11.8	14.6	9.4	11.0	6.5	11.7	11.6	3.9	0.0	7.9	5.2	3.2	3.3	5.6	5.0	5.1	4.0	0.0	1.8	0.0	6.8	5.0	7.7	27.1	2.9	2.6	0.0	8.0	2.7	5.8	7.9	0.0	4.4	4.3	1.6	5.2	4.3	1.3	11.7	8.3	2.3	8.5	3.6	4.7	8.4	6.2	3.4	5.6	9.3	4.1	6.5	5.0	20.7	7.2	2.0	4.8	2.5	2.6	2.1
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210389-83431071	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 57.7;Muller glia cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 15.6"	"Lineage enriched"	"Detected in many"	11	"T-cells: 15.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.9;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	30.7	35.3	16.3	4.6	17.7	0.8	27.1	5.5	13.1	5.9	6.7	5.4	39.2	18.1	3.8	7.4	24.5	4.2	13.5	21.3	10.5	14.0	3.6	12.4	7.7	6.0	16.8	11.8	10.0	3.3	30.0	11.1	2.9	16.3	7.9	10.1	9.3	7.8	30.2	25.7	10.1	8.7	18.7	17.2	6.3	20.0	13.4	7.2	1.4	6.3	20.9	4.5	13.7	14.9	0.0	0.0	0.0	1.4	0.0	15.6	0.5	8.8	18.3	0.4	0.0	15.6	14.6	0.0	5.7	14.7	6.1	11.9	42.9	7.8	0.0	15.0	13.4	12.2	9.3	13.6	5.1	6.7	0.0	7.6	0.0	11.7	0.0	20.0	4.3	16.1	15.9	10.3	12.3	8.4	10.3	9.5	0.0	6.1	0.0	8.3	9.9	0.0	4.9	0.0	48.5	7.2	0.0	15.4	8.5	18.1	4.2	1.8	4.7	9.7	14.4	0.3	8.3	0.0	10.6	10.0	3.8	4.6	1.2	0.0	3.4	3.9	0.0	0.0	0.0	11.2	0.0	1.4	0.0	0.8	0.3	15.6	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.3	17.7	5.5	13.1	10.5	14.0	16.8	11.8	16.3	7.2	17.9	8.9	0.0	4.2	1.6	16.7	35.8	5.1	1.4	6.8	5.2	2.0	0.5	1.7	10.0	4.4	1.9	8.0	0.0	8.4	0.6	7.1	5.6	0.0	12.4	6.8	12.7	0.0	4.9	57.7	4.2	23.9	9.5	0.0	5.4	4.0	93.9	12.7	5.8	35.0	2.6	6.4	0.0	3.3	4.9	1.5	3.0	0.7	0.9	5.5	1.8
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Cell type enriched"	"Detected in some"	55	"Muller glia cells: 458.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.2	5.2	0.5	1.0	42.7	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	4.1	0.0	0.0	0.0	12.6	0.0	0.0	0.5	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3	3.0	0.3	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.1	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	6.4	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	458.8	0.0	0.0	8.1	0.0	7.1	6.5	1.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Group enriched"	"Detected in some"	11	"GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.9	0.0	0.0	0.3	1.3	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.1	0.2	21.5	13.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9	0.0	0.0	0.0	0.0	0.0	46.7	0.8	0.0	0.0	0.0	0.0	58.9	1.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	30.2	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	8.9	0.5	0.0	1.1	0.0	59.2	0.0	0.0	25.0	2.4	0.0	3.7	0.0	0.0	0.0
RIPPLY2	"C6orf159, dJ237I15.1"	ENSG00000203877	"Ripply transcriptional repressor 2"	Q5TAB7	6	83853266-83857515	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 10.5;Cone photoreceptor cells: 3.9;Horizontal cells: 11.1;Rod photoreceptor cells: 8.0;Spermatogonia: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 15.2;HEL: 4.7;SCLC-21H: 20.8;SH-SY5Y: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047454	Uncertain					NA	NA					"HPA047454: AB_2680053"		"unprognostic (2.09e-1)"			"unprognostic (7.43e-2)"	"unprognostic (2.51e-1)"		"unprognostic (1.20e-3)"			"unprognostic (2.69e-3)"	"unprognostic (3.66e-1)"		"unprognostic (6.94e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	1.5	4.3	11.6	1.3	14.7	0.8	1.1	20.9	23.4	1.6	1.5	2.1	0.0	1.3	2.6	0.8	1.3	1.5	1.5	1.4	11.2	9.8	0.9	0.8	0.9	0.8	8.8	6.9	1.9	3.5	0.8	6.2	0.9	5.3	2.3	1.3	0.4	1.2	1.9	1.5	1.0	1.5	1.5	6.3	0.9	2.5	2.4	6.9	0.0	1.3	0.0	0.8	2.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	15.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.8	20.8	14.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	14.7	20.9	17.0	11.2	9.8	8.8	6.9	5.3	6.9	0.0	0.0	0.0	0.2	0.0	10.5	2.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	11.1	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	8.0	0.0	0.9	0.2	4.3	0.0	0.0	0.0	0.0	0.0
CYB5R4	"b5+b5R, dJ676J13.1, NCB5OR"	ENSG00000065615	"Cytochrome b5 reductase 4"	Q7L1T6	6	83859643-83967424	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 49.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.1;Late spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 49.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018992	Approved					NA	NA					"HPA018992: AB_1847371"	"unprognostic (4.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.77e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.44e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.15e-2)"	9.3	8.2	4.5	17.9	9.1	23.1	9.6	11.5	8.4	6.3	10.5	8.0	6.2	10.0	7.2	7.6	11.1	6.1	5.3	10.8	4.9	5.0	8.7	8.6	12.3	23.4	10.2	3.4	6.0	8.5	3.6	10.5	12.6	7.3	6.5	8.2	4.3	9.3	4.3	11.9	6.6	11.0	8.8	12.2	18.8	10.8	21.6	9.7	14.2	5.6	6.6	11.9	10.9	7.6	6.9	11.4	49.6	14.6	3.3	5.6	6.3	5.1	4.5	3.2	4.1	1.8	2.4	6.0	3.5	5.2	5.2	7.6	5.8	3.5	9.4	5.5	2.1	14.3	4.3	2.9	4.8	4.0	36.1	6.5	22.7	2.7	3.2	3.4	13.5	20.5	3.0	1.3	3.5	3.7	2.1	2.6	8.5	8.1	7.2	3.7	2.0	3.6	3.8	1.8	4.1	4.2	6.0	11.8	3.4	2.3	5.4	8.5	4.7	4.2	4.2	4.8	2.1	2.4	8.1	3.4	5.3	4.4	10.8	11.0	8.3	12.7	5.2	6.1	9.4	5.8	20.8	14.6	42.2	4.4	12.1	3.5	6.9	3.8	3.9	11.4	6.6	2.5	3.9	49.6	3.3	13.1	4.8	5.6	6.3	4.5	9.1	11.5	8.4	4.9	5.0	10.2	3.4	7.3	9.7	6.0	15.2	26.7	12.4	9.8	12.6	13.4	10.2	13.4	10.3	7.0	15.7	4.8	10.0	22.8	150.1	8.3	13.5	0.0	22.1	16.9	8.2	11.7	24.3	10.5	42.4	12.7	15.5	4.3	52.6	277.8	7.8	46.0	15.1	45.9	13.5	5.7	21.9	14.0	7.1	16.1	19.3	6.5	11.4	23.0	27.4	12.9	9.6	25.4	14.0	17.7
MRAP2	"bA51G5.2, C6orf117"	ENSG00000135324	"Melanocortin 2 receptor accessory protein 2"	Q96G30	6	84033756-84090881	"Disease related genes, Predicted membrane proteins"			Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 12.2;Mucus-secreting cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.3"	"Group enriched"	"Detected in some"	6	"K-562: 43.5;SCLC-21H: 15.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.82e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (8.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (9.85e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.47e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.50e-3)"	"unprognostic (9.12e-2)"	1.4	9.6	7.8	1.5	11.6	0.2	2.1	14.5	19.0	3.6	6.8	3.5	4.2	4.7	3.5	1.5	2.0	10.8	3.5	1.2	5.2	16.3	4.6	0.4	1.2	0.6	5.8	14.5	6.4	5.4	0.2	3.7	0.3	8.4	8.2	6.6	4.7	7.4	10.3	1.5	2.5	5.0	1.5	3.0	8.0	10.0	3.2	1.9	0.1	0.8	2.0	2.1	1.2	2.1	2.3	0.1	0.6	0.0	0.0	0.1	0.1	0.0	1.2	0.4	0.0	0.1	0.7	0.0	0.4	0.0	0.7	0.1	0.5	0.0	0.1	0.0	4.7	1.6	0.0	0.8	0.1	0.0	0.4	0.4	1.5	0.1	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	0.0	2.8	0.0	43.5	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.2	0.0	2.5	0.0	2.6	0.7	15.2	5.1	0.1	0.0	0.7	0.6	0.1	1.3	0.2	0.2	0.2	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	2.3	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.1	7.8	11.6	14.5	19.0	5.2	16.3	5.8	14.5	8.4	1.9	0.0	0.3	0.0	6.7	1.5	0.6	0.3	0.0	2.7	2.3	12.2	0.0	0.0	1.7	2.7	2.2	0.7	2.8	0.0	4.8	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.2	3.7	0.0	0.0	0.0	12.4	0.0	0.6	7.0	4.9	0.0	0.2	0.0	1.4	0.2	2.7	0.9	0.0	0.0	3.7	2.4
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227635	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 72.3;Early spermatids: 103.7;Spermatocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	5.9	4.3	4.2	5.3	6.0	3.8	5.4	9.4	7.8	6.4	6.3	4.8	6.6	2.1	9.1	4.4	4.1	7.2	5.2	4.0	4.5	2.6	7.7	2.6	5.3	4.6	4.8	3.2	7.9	4.1	9.6	19.1	4.5	5.8	4.7	4.9	2.7	5.5	4.6	4.1	4.1	4.2	6.4	7.6	5.8	4.9	14.4	6.4	11.6	7.7	2.1	4.2	7.3	5.4	2.5	1.8	2.2	1.3	0.1	2.6	0.8	2.9	1.3	8.8	9.5	5.2	7.8	5.5	3.3	3.2	4.7	5.8	3.8	4.0	3.2	3.2	2.6	8.4	4.6	5.1	3.1	7.5	8.1	3.6	5.8	5.9	2.8	2.9	6.3	5.6	3.6	2.3	4.8	1.8	6.3	5.2	4.8	11.8	3.7	3.4	1.5	1.6	4.1	5.8	2.1	2.1	9.0	11.3	1.7	3.5	2.7	6.0	7.5	2.4	1.4	2.5	6.6	3.1	4.6	4.2	4.7	4.2	4.1	3.7	2.9	3.9	1.9	2.9	3.5	5.8	0.0	1.3	1.5	1.9	1.2	2.6	2.5	1.5	1.7	0.7	1.6	1.2	2.0	2.2	0.1	1.0	1.8	0.3	0.8	4.2	6.0	9.4	7.8	4.5	2.6	4.8	3.2	5.8	6.4	29.8	14.5	5.0	6.4	0.0	5.2	7.6	0.0	72.3	12.5	8.7	11.8	5.8	5.0	10.5	103.7	6.3	5.1	23.3	6.2	4.6	5.0	3.5	17.4	2.6	4.7	27.0	10.9	8.6	5.6	39.3	10.9	6.1	0.0	1.8	4.5	11.2	5.3	14.0	11.3	5.0	13.8	12.9	3.6	62.7	22.4	0.0	3.2	7.5	5.2	3.3
TBX18		ENSG00000112837	"T-box 18"	O95935	6	84687351-84764519	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 23.3"	"Cell type enhanced"	"Detected in some"	16	"Basal keratinocytes: 4.8;Fibroblasts: 5.3;Melanocytes: 8.5;Smooth muscle cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 26.5;ASC diff: 19.3;ASC TERT1: 20.2;RH-30: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	14.5	4.9	1.7	2.1	4.0	0.3	16.1	1.8	3.6	4.4	1.9	4.1	0.5	0.5	2.4	2.1	7.3	2.7	3.6	9.9	3.4	1.8	1.0	0.8	0.7	3.9	6.3	5.5	5.0	1.4	1.3	2.6	4.1	5.0	4.9	1.3	8.9	3.9	2.9	2.5	8.0	2.7	11.1	4.0	0.3	1.0	2.5	1.8	0.0	2.8	2.0	3.0	7.6	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	19.3	20.2	0.0	10.9	5.4	8.3	8.0	0.1	0.0	0.0	0.0	4.5	0.0	1.4	0.0	6.4	6.8	0.0	10.8	0.0	0.0	0.0	2.5	0.0	11.0	8.3	0.6	5.7	12.3	0.0	9.5	0.0	13.7	0.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.1	0.0	0.1	0.5	0.0	0.4	4.2	0.7	0.0	14.3	8.4	0.0	2.3	8.4	0.0	0.1	0.0	0.0	5.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.0	1.8	3.6	3.4	1.8	6.3	5.5	5.0	1.8	0.0	0.0	0.0	0.0	4.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	2.6	1.1	0.0	8.5	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	16.7	0.3	1.9	3.9	0.1	0.0	0.0	0.0
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	23.4	25.9	19.9	16.0	21.9	16.6	26.7	25.2	30.1	20.1	23.3	16.1	17.8	17.7	23.8	37.0	17.1	17.8	17.4	17.4	19.5	24.2	33.2	41.0	23.8	17.7	21.6	18.0	17.9	27.7	27.2	35.5	29.6	30.8	21.1	22.2	19.9	17.7	20.2	9.6	17.1	31.0	15.8	20.7	24.6	26.8	49.1	17.1	16.1	26.1	11.2	18.2	22.6	15.1	8.9	16.4	20.0	24.1	13.4	13.3	8.9	15.0	9.2	15.1	22.1	34.5	25.4	15.8	19.3	26.7	15.2	23.5	16.6	25.5	19.8	23.9	24.8	29.7	20.4	10.3	19.9	24.1	17.5	6.1	21.6	12.8	24.8	28.5	20.2	22.5	22.1	15.1	17.7	18.0	28.2	27.0	7.8	21.9	17.2	32.9	17.5	1.2	38.7	6.1	23.6	10.4	8.1	30.8	9.4	37.0	27.9	6.6	15.1	11.8	26.1	17.9	20.9	16.2	36.3	24.0	12.0	7.5	15.0	20.0	17.3	27.4	7.3	24.7	23.9	24.2	18.1	13.6	20.0	13.3	20.3	10.0	8.9	9.0	11.9	16.4	8.8	8.2	10.3	6.3	13.4	24.1	4.8	10.2	8.9	19.9	21.9	25.2	30.1	19.5	24.2	21.6	18.0	30.8	17.1	86.4	38.0	17.1	16.6	13.1	35.5	12.3	17.8	32.1	28.4	21.0	53.0	44.7	5.0	28.9	45.3	24.0	24.4	0.0	36.5	25.9	25.0	15.8	30.1	26.6	31.1	14.3	30.6	27.6	34.8	10.7	18.1	25.4	27.0	39.7	28.0	32.8	30.0	24.6	27.6	23.7	39.0	19.4	21.6	165.5	8.4	12.9	47.3	25.3	25.3	15.2
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		77000	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	32.2	24.2	40.4	23.5	26.6	31.7	25.6	47.9	39.5	43.5	43.2	39.6	21.3	76.3	34.9	46.1	34.6	31.3	59.1	47.5	76.3	26.2	27.1	68.0	29.2	27.2	22.5	83.0	29.3	25.9	27.4	49.7	51.2	23.5	45.8	22.9	68.1	36.0	50.2	35.5	38.8	35.4	38.7	31.2	25.8	58.3	64.6	32.4	35.6	51.8	38.1	30.9	33.3	28.2	19.6	25.2	24.4	51.7	42.0	29.5	24.1	30.9	57.2	22.5	44.4	50.3	27.0	50.2	41.0	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1	107.2	97.5	44.7	111.8	131.7	43.4	77.5	48.4	87.0	134.2	43.6	15.7	88.7	46.4	116.0	77.9	92.0	42.3	0.0	85.9	107.5	80.8	88.9	59.0	74.1	86.4	58.8	54.4	52.8	60.2	17.6	68.1	69.2	50.6	61.3	65.0	37.9	106.5	45.6	60.5	62.1	40.3	19.4	102.9	77.7	58.0	123.8	98.7	52.5	77.4	123.7
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937306-87016683	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;ovary: 13.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"PC-3: 2.9;SH-SY5Y: 11.6"					"Low region specificity"	"Detected in many"			HPA004931	Approved					NA	NA					"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.5	0.6	8.9	0.6	13.3	0.5	0.5	5.4	16.4	1.6	0.5	0.0	0.0	0.5	5.1	1.1	0.6	0.5	0.8	0.5	4.1	2.8	0.5	0.5	0.5	0.5	1.8	11.4	13.3	0.8	0.5	0.3	0.5	2.2	1.1	0.5	0.0	0.5	1.2	0.5	0.5	0.5	2.9	0.6	0.5	3.6	1.4	1.5	0.0	2.7	0.0	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.3	11.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	13.3	5.4	16.4	4.1	2.8	1.8	11.4	2.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell type enriched"	"Detected in some"	30	"Syncytiotrophoblasts: 71349.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"BEWO: 73.5;SuSa: 141.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	1223.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2346.5	0.1	1.5	0.0	0.0	567.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	71349.9	0.0	0.0	0.3
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87264196	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	11.8	10.2	15.2	16.7	16.8	31.1	14.5	31.1	19.7	15.0	13.9	10.3	11.4	11.2	16.4	15.1	11.1	11.1	9.8	11.6	13.6	9.0	9.8	10.8	9.7	14.8	18.2	9.8	20.6	12.5	14.6	20.7	12.3	15.3	14.0	10.2	12.0	15.0	11.2	9.3	14.0	15.7	12.3	18.6	12.2	11.6	8.7	19.6	25.6	14.1	5.7	16.5	22.6	22.9	16.7	10.4	35.8	7.6	4.3	8.3	3.0	6.3	3.8	12.8	11.2	7.3	6.7	13.3	4.9	6.4	5.9	8.2	6.4	4.5	9.8	7.3	6.5	8.4	6.6	7.9	7.5	12.9	22.2	6.0	13.2	4.9	5.1	5.5	10.6	6.0	6.6	7.4	5.8	7.6	9.5	5.4	10.6	9.6	15.1	6.4	3.5	6.1	9.5	6.4	2.2	3.5	12.9	12.7	3.7	5.2	13.8	9.6	13.5	6.3	4.2	4.8	7.7	4.2	12.8	6.1	7.9	5.5	5.8	7.8	14.0	9.1	6.7	8.7	9.2	5.7	18.0	7.6	7.9	6.9	2.2	6.5	16.6	7.4	7.5	3.2	16.7	8.3	7.1	35.8	4.3	2.3	10.4	7.1	3.0	15.2	16.8	31.1	19.7	13.6	9.0	18.2	9.8	15.3	19.6	56.6	56.6	44.4	25.9	58.7	160.5	61.0	40.8	32.1	48.9	24.4	115.8	19.3	8.3	84.7	16.4	40.7	47.6	0.0	33.2	25.7	35.7	37.4	27.8	15.3	23.3	176.4	45.4	36.2	26.5	6.4	55.5	39.5	30.4	44.1	44.3	74.5	51.7	42.1	62.2	11.6	93.9	32.3	37.3	48.7	29.8	44.9	177.1	57.3	40.7	34.6
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282978-87329278	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6"					"Low region specificity"	"Detected in many"			HPA014392			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014392: "	"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0			0.0	0.1	0.0	0.0	12.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	10.0	4.5		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3			0.0		0.1	0.5	0.0	0.7	0.1	1.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	5.8	0.0	0.1	1.8	6.7	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	1.2	0.0	0.0	3.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.6	1.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	29.4	0.0	0.0	0.0	7.7	0.0	0.0	0.6	0.0	0.0	0.0	0.2	4.4	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	6.1	0.0	0.2	0.1
SMIM8	"C6orf162, dJ102H19.2, DKFZP586E1923"	ENSG00000111850	"Small integral membrane protein 8"	Q96KF7	6	87322583-87399749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007401, HPA067453"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA007401: AB_1078357, HPA067453: AB_2685844"	"unprognostic (2.54e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.86e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.01e-1)"	7.8	9.0	13.3	6.3	14.6	9.0	9.1	15.6	15.6	7.4	8.3	7.6	8.5	8.8	11.4	12.2	6.5	7.1	4.7	10.3	17.9	12.5	10.4	12.0	5.6	9.1	12.0	10.8	10.5	8.0	6.1	19.2	5.8	11.9	7.9	8.1	7.8	7.2	7.3	16.2	5.4	7.9	11.3	10.2	6.5	6.3	7.4	8.0	11.0	7.5	4.7	6.5	6.5	8.7	16.0	8.9	13.4	8.4	7.7	18.7	8.5	4.3	3.9	8.0	13.8	4.7	5.3	3.5	4.9	3.8	4.2	8.0	2.7	4.1	9.0	5.9	4.9	7.2	5.5	6.3	3.7	8.0	8.0	6.9	13.1	4.4	5.3	4.4	13.6	4.8	5.0	5.1	4.2	4.5	4.7	5.9	11.6	14.7	15.2	4.6	3.3	8.2	10.9	4.9	6.5	6.0	13.2	11.9	5.1	5.3	4.3	13.7	5.7	7.2	4.3	7.8	7.7	3.9	13.8	5.7	2.2	6.3	9.3	4.7	6.8	11.0	5.9	7.1	6.6	6.5	5.2	8.1	13.1	10.7	7.7	10.6	16.0	12.6	12.8	8.9	10.4	18.7	16.2	13.4	7.7	8.4	7.5	15.5	8.5	13.3	14.6	15.6	15.6	17.9	12.5	12.0	10.8	11.9	8.0	11.9	4.3	15.9	17.9	12.2	25.0	38.9	12.7	13.4	12.5	22.7	35.3	14.8	38.1	8.8	15.3	13.4	7.7	0.0	9.1	10.5	15.1	10.1	4.7	12.1	12.7	35.0	8.2	19.0	14.6	12.1	14.7	12.8	8.5	10.8	9.5	23.3	6.9	14.0	19.4	18.3	23.0	25.8	12.5	18.9	21.6	12.9	12.5	13.1	17.6	10.7
C6orf163		ENSG00000203872	"Chromosome 6 open reading frame 163"	Q5TEZ5	6	87344849-87365463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 20.2"	"Group enriched"	"Detected in some"	26	"Early spermatids: 164.9;Late spermatids: 171.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 1.4"	"Low region specificity"	"Detected in all"			"HPA044797, HPA052927"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044797: AB_10962365, HPA052927: AB_2681990"	"unprognostic (4.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.96e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	0.7	0.8	0.5	0.5	4.3	3.2	1.3	0.7	1.0	0.8	0.8	1.5	0.5	0.0	1.4	3.0	0.5	2.3	0.5	1.0	0.9	0.4	0.6	0.9	1.7	0.9	0.5	0.5	3.3	1.1	1.7	1.8	0.5	4.6	1.2	1.2	0.5	1.2	0.5	1.5	2.4	1.1	0.5	0.5	1.7	0.8	20.2	1.2	0.5	1.1	0.5	0.8	0.6	0.6	1.4	0.7	3.4	0.9	1.2	1.8	0.4	0.2	0.6	3.0	4.5	0.5	3.3	3.6	0.0	0.0	0.6	1.0	1.3	0.9	1.8	0.5	0.4	1.9	0.8	1.2	2.6	0.0	1.6	1.8	2.3	1.0	1.0	0.0	1.1	0.6	1.6	1.5	0.8	0.8	1.3	0.5	1.9	3.5	1.6	0.4	0.7	0.3	1.5	0.7	0.1	0.2	4.0	1.0	0.1	1.9	2.9	2.3	1.2	0.3	0.5	1.2	3.2	0.6	1.3	1.0	1.8	1.4	0.9	1.4	0.5	0.8	0.3	0.2	2.1	1.1	0.5	0.7	0.3	1.8	0.4	0.9	1.3	1.8	1.2	0.7	1.4	1.7	1.8	3.4	1.2	0.9	0.4	1.0	0.4	0.5	4.3	0.7	1.0	0.9	0.4	0.5	0.5	4.6	1.2	0.0	0.3	0.0	0.3	0.3	0.6	1.7	2.5	1.4	0.0	0.0	0.0	0.4	0.0	0.1	164.9	0.0	0.2	0.0	0.0	0.3	0.4	0.4	0.0	0.2	0.2	0.0	0.0	0.0	1.2	171.0	2.3	0.0	1.7	0.0	0.3	0.0	0.1	0.0	1.8	0.4	0.5	6.5	0.4	2.1	1.6	0.1	0.7	0.0	0.2	0.3
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407983-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.7;testis: 60.5"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 80.3;Early spermatids: 214.5;Spermatocytes: 42.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.5;RPTEC TERT1: 5.4;T-47d: 9.1"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.2	0.5	1.3	0.3	3.0	0.2	0.5	0.3	2.2	0.9	0.3	3.0	0.2	0.3	0.7	3.4	0.2	17.7	0.4	0.3	2.1	2.0	1.5	0.3	2.4	0.2	0.7	1.4	2.7	0.3	0.8	2.6	0.4	8.1	0.5	0.2	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.2	60.5	0.6	0.0	1.4	0.0	0.2	0.4	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	2.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.2	1.0	0.0	0.0	0.0	2.1	1.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.4	1.2	1.1	0.6	0.4	0.5	0.3	0.1	9.1	0.2	0.0	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	3.0	0.3	2.2	2.1	2.0	0.7	1.4	8.1	0.6	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	80.3	13.6	0.0	0.0	0.1	1.7	0.1	214.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.1	0.7	0.4	0.0	0.0	42.3	2.0	0.0	0.0	0.0	0.0	0.0
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	11.0	18.0	14.0	9.2	19.8	6.3	20.5	24.1	22.9	19.2	25.3	10.0	8.0	12.0	20.1	15.1	10.0	13.6	12.7	10.6	15.2	13.8	15.7	20.8	24.2	10.3	16.3	11.6	15.8	11.6	13.0	24.4	12.6	21.4	24.9	31.6	13.1	19.4	11.4	9.1	15.9	14.5	18.9	12.2	14.0	18.8	8.1	14.5	18.6	14.2	8.2	11.8	17.4	12.0	9.4	24.6	21.6	28.4	8.7	15.1	17.2	2.0	5.0	9.1	10.7	24.9	22.8	7.3	6.1	5.4	5.1	7.1	4.3	37.8	7.6	7.5	7.5	14.2	8.1	10.9	4.9	6.6	10.8	8.1	8.6	6.8	7.6	16.4	11.1	6.0	11.6	12.0	6.0	11.8	12.1	12.2	11.2	11.0	12.6	7.5	19.0	3.0	16.9	4.9	26.0	8.2	9.6	8.9	8.1	15.8	8.8	6.0	6.6	11.2	21.1	9.7	10.9	18.7	22.9	11.3	7.4	5.0	8.1	4.9	9.4	13.6	2.8	6.2	19.9	10.5	21.6	28.4	11.6	9.8	22.1	15.1	9.4	10.6	11.9	24.6	8.7	13.6	12.6	7.0	8.7	21.5	9.1	13.6	17.2	14.0	19.8	24.1	22.9	15.2	13.8	16.3	11.6	21.4	14.5	41.7	25.2	6.9	15.8	13.2	6.9	5.2	17.8	16.0	10.3	15.7	11.8	20.9	6.6	8.2	5.8	14.3	15.8	0.0	7.9	15.9	17.7	17.6	21.8	17.4	14.5	11.1	14.5	47.3	30.6	4.9	15.3	13.6	20.3	10.8	73.6	18.1	8.5	14.0	18.0	9.3	6.4	19.4	16.5	7.5	9.7	12.9	23.0	13.8	25.5	7.4
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87514378-87590003	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	27.0	44.1	13.3	21.1	15.9	16.0	22.9	24.0	17.3	25.1	21.4	18.6	25.2	17.5	35.5	25.5	20.4	21.1	19.2	21.5	14.4	12.8	23.7	32.1	20.5	24.4	17.3	14.2	22.2	30.1	20.5	36.9	28.3	17.2	20.7	23.1	24.0	23.5	27.7	23.0	20.4	30.5	24.7	16.8	21.1	20.5	23.9	13.6	28.0	21.2	20.5	27.3	24.3	20.2	16.7	18.9	22.8	20.2	18.1	28.8	16.2	10.1	10.1	24.3	26.4	24.7	27.0	17.3	24.4	29.2	16.9	21.5	19.4	11.4	12.9	14.5	25.0	17.1	14.2	20.4	14.0	24.0	9.5	19.3	13.3	12.8	30.8	31.1	15.7	11.5	26.9	13.6	14.2	18.1	23.7	22.2	13.6	30.7	12.8	24.9	18.7	5.1	16.7	15.8	21.8	10.9	10.3	24.5	11.3	20.8	21.4	22.0	29.7	12.8	6.4	17.1	21.4	11.9	24.0	15.1	11.2	9.0	12.3	20.1	13.6	22.8	10.7	17.6	16.6	19.4	15.9	19.1	22.8	18.1	19.3	21.3	16.7	23.4	17.0	16.7	16.2	23.0	19.1	11.6	18.1	20.2	18.9	28.8	16.2	13.3	15.9	24.0	17.3	14.4	12.8	17.3	14.2	17.2	13.6	17.9	14.1	14.5	30.7	15.3	13.2	19.7	7.6	20.1	26.1	10.4	19.6	27.0	38.1	25.7	69.3	24.2	16.2	0.0	41.3	37.9	29.7	24.9	17.4	13.2	18.2	6.4	8.6	22.7	14.8	27.7	23.6	14.2	18.6	22.6	23.2	12.1	29.9	21.8	22.6	23.7	15.6	25.8	24.7	38.7	31.1	15.7	33.1	21.8	24.1	29.1
ORC3	"IMAGE50150, LATHEO, ORC3L"	ENSG00000135336	"Origin recognition complex subunit 3"	Q9UBD5	6	87590067-87667453	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039553, HPA053748"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039553: AB_2676566, HPA053748: AB_2682247"	"unprognostic (9.38e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (8.63e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.09e-1)"	16.9	22.6	17.6	11.4	23.1	8.9	18.7	33.9	24.4	18.1	10.7	12.1	12.4	8.1	16.5	19.6	11.0	18.1	11.2	21.7	17.8	19.6	16.7	17.3	12.4	15.2	17.6	19.4	24.8	11.8	27.8	30.0	17.6	28.5	16.4	12.9	11.5	11.0	14.2	23.6	12.2	11.4	13.8	19.8	15.4	10.0	26.8	19.4	29.0	18.6	15.3	15.3	17.0	11.1	15.1	9.7	14.9	17.1	15.1	20.6	11.1	8.5	11.4	21.4	16.1	16.5	17.5	15.9	17.4	15.5	20.4	28.8	15.8	10.7	17.1	23.4	11.7	17.2	15.6	23.9	13.8	28.2	20.8	16.3	15.7	17.1	16.2	8.9	17.6	5.4	15.5	11.1	23.1	20.2	11.7	12.4	17.8	35.4	18.1	19.2	10.8	7.4	9.3	15.0	12.0	12.9	17.2	28.8	10.3	15.7	12.3	15.4	11.2	13.6	8.2	13.1	23.2	11.3	15.3	10.1	10.4	10.0	21.1	20.4	8.8	19.0	11.7	13.7	18.0	15.6	14.9	8.8	9.5	11.4	14.2	16.8	15.1	16.3	14.2	7.2	12.9	20.6	17.2	5.9	15.1	17.1	9.7	15.4	11.1	17.6	23.1	33.9	24.4	17.8	19.6	17.6	19.4	28.5	19.4	11.9	11.2	14.1	9.3	4.4	18.3	27.8	12.7	24.1	13.6	7.0	11.8	19.8	18.3	9.5	43.1	9.0	17.6	23.3	9.0	20.3	13.2	8.4	11.5	8.5	16.9	6.4	9.9	12.3	7.1	19.9	17.3	9.7	8.5	7.2	13.7	18.1	8.4	9.9	14.5	20.3	29.1	12.9	7.8	43.9	30.9	3.9	12.2	13.8	10.4	6.3
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87675072-87702209	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064239			Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA064239: AB_2685222"	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	27.9	24.1	23.7	19.9	27.0	53.4	22.0	19.3	27.8	13.7	14.1	17.5	10.3	11.4	16.3	22.5	20.5	16.2	14.4	20.1	22.1	21.1	14.8	27.8	21.9	34.5	19.3	18.6	20.7	8.5	12.0	15.5	16.7	17.3	13.4	11.9	21.3	15.5	11.6	54.2	12.9	13.6	15.9	20.2	35.7	12.1	20.7	14.7	45.0	14.1	14.8	26.1	21.4	14.9	15.4	27.0	51.9	25.6	12.5	13.6	11.1	10.4	11.4	32.7	18.5	20.8	14.4	19.2	18.7	12.0	15.7	15.5	18.0	8.2	27.8	20.3	19.3	25.8	16.2	18.2	13.6	18.1	35.3	22.6	16.1	10.3	40.2	22.7	13.7	13.9	16.6	14.1	19.2	19.2	15.2	17.1	11.2	31.2	19.4	20.2	13.8	4.3	28.3	23.2	9.1	17.8	17.2	23.3	11.3	19.4	9.4	24.6	23.4	11.4	6.7	18.2	19.6	8.2	32.8	21.7	12.9	8.7	10.8	24.2	18.8	20.9	17.6	14.1	18.1	20.5	23.1	20.6	21.7	10.7	25.6	11.0	15.4	10.5	10.3	19.5	12.6	8.3	8.7	51.9	12.5	24.6	27.0	13.6	11.1	23.7	27.0	19.3	24.5	22.1	21.1	19.3	18.6	17.3	14.7	23.8	16.6	44.6	173.9	85.7	12.9	18.5	28.1	4.0	19.4	17.4	7.9	40.7	38.1	26.5	41.2	28.6	13.7	23.3	12.9	57.9	48.3	99.6	32.4	25.8	69.7	11.1	11.6	38.6	81.5	82.9	33.1	86.1	70.9	25.2	8.3	53.7	23.7	10.5	26.5	40.8	14.2	6.5	48.6	61.8	46.9	81.2	114.2	55.8	10.9	178.8
SPACA1	SAMP32	ENSG00000118434	"Sperm acrosome associated 1"	Q9HBV2	6	88047789-88066832	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	99	"testis: 49.2"	"Cell type enriched"	"Detected in some"	26	"Early spermatids: 646.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026744, HPA043297"	Enhanced					NA	NA					"HPA026744: AB_2194642, HPA043297: AB_2678413"															"unprognostic (4.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	646.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	22.2	4.4	0.0	0.0	0.0	0.0	0.0
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell type enriched"	"Detected in some"	14	"Sertoli cells: 97.0"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.9"	"Group enriched"	"Detected in some"	7	"ASC diff: 40.3;HSkMC: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	19.4	6.4	18.0	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0.0	4.3	4.0	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0.0	2.6	0.0	9.9	2.7	3.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	40.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.9	1.4	0.0	2.6	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	18.0	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8	0.0	7.2	2.7	0.4	0.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	97.0	2.3	0.0	0.1	0.1	0.1	0.0	0.0	0.7
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88610272-88963721	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	9.1	12.1	10.2	19.6	12.2	14.2	9.9	18.5	13.1	10.0	8.1	8.7	7.0	7.4	11.1	7.2	12.5	8.7	7.2	9.6	10.5	16.0	9.4	11.8	9.4	26.3	9.8	6.4	10.4	6.6	12.1	23.1	11.6	11.1	9.8	9.8	9.4	8.4	11.6	10.5	9.0	10.7	10.7	10.7	14.3	7.5	15.0	10.4	28.0	10.0	7.8	28.2	10.9	13.8	18.6	4.4	5.7	4.6	8.0	8.4	4.3	5.7	8.8	13.7	17.5	8.1	8.5	8.2	13.2	8.6	10.7	13.6	10.0	4.4	14.9	10.8	9.4	14.2	7.2	16.0	10.6	19.7	20.2	12.5	19.3	7.9	8.0	6.6	20.7	11.0	5.4	9.3	11.1	10.8	9.2	9.4	8.2	19.1	12.0	15.8	7.6	9.1	14.8	8.2	9.5	7.7	18.0	21.2	8.4	9.6	8.9	8.1	11.6	10.9	6.6	7.2	13.6	7.1	20.8	7.5	8.7	8.0	9.8	17.7	10.9	19.0	8.4	12.8	15.5	15.8	3.5	3.0	5.7	6.4	4.6	6.4	18.6	7.2	7.9	4.4	16.8	8.2	8.4	2.5	8.0	3.9	3.1	6.7	4.3	10.2	12.2	18.5	13.1	10.5	16.0	9.8	6.4	11.1	10.4	0.0	18.1	34.7	7.8	7.3	19.8	9.2	2.5	13.4	18.2	12.2	37.3	8.7	0.0	5.7	4.9	4.7	5.9	0.0	4.3	8.0	7.1	6.8	8.1	8.6	6.7	14.3	8.7	6.2	7.5	3.6	5.5	9.8	3.3	6.4	5.7	8.7	5.6	3.5	7.4	5.8	43.3	6.5	7.5	19.9	21.7	7.5	9.8	13.8	6.3	5.8
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 1093.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 54.1;hTCEpi: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	70.5	58.1	21.3	46.1	28.3	105.4	48.1	30.8	31.8	55.9	51.5	30.3	27.0	23.6	60.3	30.9	45.4	73.6	45.0	48.5	20.8	17.9	32.9	97.9	59.5	87.1	23.1	22.3	83.4	41.3	31.3	29.5	38.8	20.4	56.6	26.0	46.5	35.5	40.8	154.1	49.0	32.4	63.6	31.1	46.9	38.2	35.5	20.8	91.2	38.4	30.8	45.4	113.2	41.0	9.6	7.3	37.5	7.1	6.9	10.4	3.8	2.9	2.8	6.1	10.3	24.8	41.8	4.2	3.8	26.8	7.2	16.9	2.4	8.2	6.4	18.7	4.6	29.6	10.1	3.2	5.8	11.0	8.0	10.0	1.1	16.5	7.7	54.1	5.9	14.8	30.0	57.5	4.8	22.2	27.2	11.8	7.6	0.9	19.7	7.9	2.9	1.5	31.3	1.7	3.3	6.1	7.0	7.4	5.1	16.9	5.2	3.9	11.0	9.9	13.6	10.0	19.0	6.7	29.9	11.2	5.7	3.4	4.0	1.4	31.0	15.1	2.1	11.5	5.1	3.5	10.3	6.6	36.7	7.5	7.1	7.8	8.3	8.9	7.8	4.2	9.6	10.4	10.4	37.5	6.9	6.3	7.3	7.1	3.8	21.3	28.3	30.8	31.8	20.8	17.9	23.1	22.3	20.4	20.8	131.0	125.0	333.4	716.3	860.7	129.0	174.7	124.9	45.5	52.4	85.5	47.1	189.8	198.9	158.1	59.9	195.6	165.4	23.3	206.9	57.7	278.7	681.2	165.7	181.5	204.0	68.3	237.9	148.0	328.8	20.9	446.1	557.5	416.7	926.1	131.7	222.1	145.2	115.8	354.7	216.2	99.3	413.9	840.5	47.0	44.3	1093.4	229.5	380.5	99.7	411.4
SRSF12	"SFRS13B, SFRS19, SRrp35"	ENSG00000154548	"Serine and arginine rich splicing factor 12"	Q8WXF0	6	89095959-89118081	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.4"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 130.7;Late spermatids: 165.7;Spermatogonia: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;AN3-CA: 9.9;HAP1: 7.8;HEK 293: 7.9;REH: 7.7;SCLC-21H: 8.6;SH-SY5Y: 8.4;SuSa: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049782	Approved					NA	NA					"HPA049782: AB_2680880"	"unprognostic (6.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.58e-4)"	"unprognostic (4.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.83e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.96e-3)"	1.5	1.5	6.2	1.7	8.8	1.2	1.5	5.5	9.0	2.0	0.9	1.0	1.1	0.7	2.2	1.8	1.0	1.7	2.3	0.9	7.5	6.3	1.5	0.8	0.8	1.0	3.1	4.5	3.2	1.8	3.2	4.5	1.1	5.7	2.6	0.8	1.6	1.0	2.0	0.7	1.2	0.7	2.3	2.2	0.8	1.4	21.4	2.5	0.0	3.0	0.0	0.9	1.2	0.8	1.4	0.8	1.6	0.6	2.9	1.1	0.2	0.0	0.9	9.7	9.9	0.0	0.0	0.1	0.1	0.1	0.5	1.0	0.3	0.1	0.0	0.9	0.0	0.3	0.0	7.8	0.2	1.0	0.1	7.9	0.0	0.1	0.6	1.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	0.0	0.7	0.1	0.2	0.2	0.1	0.0	0.3	2.2	0.0	0.2	7.7	0.5	0.1	4.9	0.0	8.6	8.4	0.2	0.1	1.4	6.1	0.1	2.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	1.1	0.6	0.4	1.1	0.4	0.8	0.6	0.8	0.6	0.2	1.4	1.1	0.7	1.6	2.9	0.3	0.8	0.5	0.2	6.2	8.8	5.5	8.9	7.5	6.3	3.1	4.5	5.7	2.5	0.0	0.6	0.0	3.1	0.9	9.0	2.0	0.0	0.0	0.0	0.0	7.9	0.7	1.7	4.5	130.7	0.7	0.0	0.0	2.7	0.4	2.1	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	165.7	3.1	0.2	3.3	10.8	0.0	4.5	4.1	0.0	2.5	2.7	1.1	6.5	1.9	33.2	47.5	0.5	0.2	0.0	0.0	1.6
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146050-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	6.8	5.0	4.8	11.4	6.9	6.5	7.6	11.2	4.9	11.9	13.4	4.4	9.3	7.0	11.3	7.1	14.2	11.0	9.1	16.9	5.1	5.5	9.6	9.7	6.2	8.3	3.7	3.1	21.0	11.3	12.5	23.8	6.9	8.6	23.5	8.5	17.6	8.6	8.7	38.5	10.2	8.0	27.7	4.8	5.2	7.6	4.0	2.9	16.6	23.0	10.6	12.1	19.5	8.5	4.1	2.4	3.0	1.0	4.8	4.0	1.5	11.9	5.3	4.8	7.4	1.6	1.0	0.3	6.0	6.0	9.0	11.6	6.2	5.9	34.9	7.4	1.3	7.7	4.6	9.8	4.8	20.6	10.8	12.5	7.0	3.2	5.8	1.8	20.2	5.7	1.6	3.6	3.4	7.3	7.4	2.1	10.5	2.7	18.7	2.8	1.8	12.7	16.0	1.9	10.4	5.3	21.2	23.8	25.3	10.1	2.3	13.5	9.4	3.6	5.8	5.9	6.5	0.0	17.9	3.5	0.2	5.5	1.9	12.6	10.0	14.6	7.4	2.5	17.5	0.8	1.9	1.0	2.9	2.2	0.6	3.5	4.1	2.7	3.7	1.6	3.1	4.0	3.5	3.0	4.8	0.6	2.4	0.5	1.5	4.8	6.9	11.2	3.9	5.1	5.5	3.7	3.1	8.6	2.9	8.9	9.3	11.5	19.6	26.9	19.1	18.2	28.1	10.7	14.8	15.7	29.5	2.0	5.0	11.3	4.3	10.5	4.9	0.0	9.0	1.9	14.7	40.0	5.8	7.3	3.0	7.9	10.4	7.4	8.2	7.0	22.7	3.2	16.9	19.8	16.1	10.3	16.0	3.5	18.0	13.2	21.1	6.5	17.6	4.5	6.1	27.7	1.0	10.0	24.9	14.4
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor rho1 subunit"	P24046	6	89177501-89231278	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"retina: 12.3;testis: 4.6"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 53.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"amygdala: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.4	0.0	2.2	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	1.0	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	6.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	53.4	0.3	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	3.8	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1
GABRR2		ENSG00000111886	"Gamma-aminobutyric acid type A receptor rho2 subunit"	P28476	6	89257208-89315299	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"retina: 18.8"	"Cell type enriched"	"Detected in some"	13	"Bipolar cells: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in some"		"U-266/70: 4.4;U-266/84: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.05e-2)"	"unprognostic (1.47e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.19e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.69e-2)"	"unprognostic (7.81e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.15e-3)"	0.2	0.6	0.2	0.5	0.4	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.7	0.5	0.2	0.1	0.4	0.2	0.3	0.2	0.3	0.4	0.1	0.9	0.3	0.1	0.1	0.8	0.0	0.2	0.1	0.1	0.3	0.0	18.8	0.6	0.2	1.5	0.5	0.1	0.1	0.2	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.3	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.6	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.0	0.0	4.4	1.6	0.0	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.4	0.3	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	19.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352848	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 501.0;Late spermatids: 1092.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 63.8;Karpas-707: 55.2;U-266/70: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced					NA	NA					"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favorable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	18.7	17.3	14.6	47.1	15.4	52.7	28.2	19.1	13.6	18.8	25.9	11.3	24.4	28.0	19.5	18.4	19.2	18.0	19.9	17.1	14.4	14.7	18.7	33.5	20.4	52.0	17.0	9.5	17.2	46.1	11.5	13.6	27.5	13.0	22.9	26.3	10.7	42.1	33.2	12.5	11.3	36.3	17.9	18.9	45.8	24.4	17.7	14.4	42.5	17.6	16.4	47.7	21.7	21.4	20.7	23.7	15.9	17.8	6.4	6.4	6.1	8.3	2.9	8.1	10.3	8.5	11.1	0.0	13.3	11.8	8.2	9.1	4.7	5.2	63.8	7.4	13.7	6.9	3.4	5.3	7.7	13.5	8.9	8.2	11.6	3.8	7.7	22.6	14.5	7.6	8.4	7.7	6.9	11.8	11.1	18.4	7.6	9.3	55.2	9.6	5.1	6.0	11.2	2.8	5.9	4.2	23.9	10.5	30.5	10.3	5.9	4.1	8.3	5.6	12.4	12.3	12.3	4.9	32.3	12.3	4.6	4.4	8.1	10.2	62.1	30.8	17.5	9.1	10.5	7.6	10.3	6.6	12.3	3.4	11.1	4.0	20.7	4.6	4.2	6.5	13.4	4.3	3.9	15.9	6.4	17.8	23.7	6.4	6.1	14.6	15.4	19.1	13.6	14.4	14.7	17.0	9.5	13.0	14.4	14.9	33.4	95.3	52.5	22.0	31.9	8.1	30.6	22.7	18.2	19.2	27.5	69.3	43.1	55.4	501.0	59.9	55.1	0.0	88.1	72.0	50.7	96.3	24.3	37.6	70.2	22.3	74.2	98.8	102.2	1092.2	50.6	55.8	69.2	46.9	54.1	14.7	86.7	70.2	44.9	36.1	13.7	32.3	55.6	20.7	19.6	30.4	108.2	36.2	57.4	100.2
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364636-89412270	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 118.0;Distal tubular cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	8.1	8.4	9.2	2.6	12.8	8.9	8.8	22.4	16.3	8.7	3.3	7.9	3.1	2.2	2.1	6.6	12.8	11.9	3.7	29.9	8.6	7.4	21.8	5.0	6.4	2.8	8.5	7.9	2.2	6.4	16.0	11.5	3.4	10.7	5.9	2.4	12.8	38.7	4.2	60.0	5.5	2.1	7.5	12.6	4.4	2.3	6.1	9.2	4.1	23.3	13.9	5.2	9.2	9.3	0.1	0.7	6.3	3.9	0.1	0.6	0.3	0.0	0.7	1.9	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	10.0	0.0	10.7	0.0	0.0	0.0	5.3	2.4	0.0	0.0	0.8	7.1	8.5	0.2	0.6	0.0	0.0	0.0	0.0	7.4	0.2	28.2	0.0	0.7	3.4	3.5	1.6	0.0	0.7	7.1	10.3	0.1	2.6	0.2	14.8	0.8	0.2	1.0	12.0	0.6	0.3	5.6	0.0	0.8	1.2	5.1	1.3	35.7	16.5	0.0	2.7	5.4	0.8	3.9	1.2	2.6	0.0	1.1	0.1	0.1	0.4	0.0	0.7	0.0	0.3	0.6	6.3	0.1	3.9	0.6	0.0	0.3	9.2	12.8	22.4	9.1	8.6	7.4	8.5	7.9	10.7	9.2	8.9	11.8	7.5	12.1	14.3	18.0	118.0	15.3	13.4	5.7	14.0	29.5	0.4	99.5	14.2	15.2	3.6	0.0	0.0	14.9	1.2	6.0	29.7	4.6	8.6	46.1	44.5	1.2	3.1	19.9	10.4	2.8	8.5	37.1	5.4	0.3	18.0	12.3	0.0	3.9	15.6	14.2	0.0	6.6	8.4	25.7	19.7	0.6	1.5	0.0	25.7
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433170-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;intermediate monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.2;BEWO: 31.2;HAP1: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310"	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.9	2.2	11.7	3.0	7.8	1.6	3.9	47.8	17.8	5.7	2.9	2.8	1.1	1.0	6.1	4.4	4.9	11.7	5.7	8.9	7.8	9.1	5.4	4.5	5.7	2.5	4.2	12.0	15.6	4.3	9.3	4.2	4.3	7.3	3.6	1.1	6.6	7.7	2.3	4.0	1.9	1.8	5.4	5.0	2.0	2.6	6.1	3.7	2.0	5.6	3.3	2.5	4.4	4.0	0.3	0.1	3.0	2.9	0.6	1.0	0.3	0.0	1.3	10.2	4.3	0.1	0.4	31.2	0.1	0.1	0.0	0.6	0.3	0.8	0.0	1.0	0.0	4.7	0.0	9.3	5.2	0.4	0.0	6.9	3.7	0.0	0.3	0.1	0.0	1.4	0.6	1.4	0.0	0.0	0.0	1.0	0.9	0.3	2.3	0.0	1.1	0.1	0.3	2.9	0.4	1.0	3.6	0.0	0.0	1.5	5.2	6.7	2.4	0.8	6.9	3.4	6.5	2.0	2.2	0.0	1.7	0.6	0.1	0.8	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.4	3.0	1.0	2.9	0.0	0.0	0.7	0.0	0.1	0.3	0.3	0.4	0.7	0.6	0.0	0.0	0.2	0.3	11.7	7.8	47.8	11.6	7.8	9.1	4.2	12.0	7.3	3.7	14.9	14.2	0.0	4.6	0.8	0.6	3.9	10.2	10.7	7.9	1.8	11.8	2.5	10.0	4.8	2.5	4.1	0.0	0.0	10.0	6.5	4.7	1.8	10.4	2.5	2.3	0.0	1.7	4.9	2.7	4.3	8.9	1.1	3.3	3.6	0.0	5.7	4.2	0.0	26.2	3.4	1.6	6.5	3.3	5.4	4.9	1.0	1.6	1.3	0.0	4.3
LYRM2	DJ122O8.2	ENSG00000083099	"LYR motif containing 2"	Q9NU23	6	89568144-89638753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063932	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA063932: AB_2685155"	"unprognostic (3.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.27e-2)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.64e-2)"	11.2	17.5	21.6	9.8	22.0	12.5	14.5	11.9	22.5	10.3	13.6	15.2	15.1	8.6	13.4	15.4	12.8	14.1	10.7	17.3	19.2	19.6	18.2	13.8	10.2	11.8	22.2	23.0	11.3	10.3	24.9	34.0	16.1	19.0	14.1	16.8	9.0	10.9	10.2	20.9	7.0	10.0	12.5	19.8	9.4	12.9	11.0	22.2	9.8	26.2	13.2	10.8	12.0	8.9	21.9	17.5	9.2	21.0	16.6	20.2	9.6	9.5	5.1	17.5	10.4	8.9	13.5	7.2	16.7	11.9	13.0	13.2	4.5	5.1	13.2	16.1	15.7	19.5	8.8	11.1	15.7	17.0	16.6	19.3	20.7	5.5	3.8	13.3	22.0	16.2	16.5	15.4	14.8	20.0	10.7	10.1	14.4	21.2	17.1	15.0	8.6	5.0	7.8	4.0	7.8	6.4	10.5	21.7	9.8	14.7	9.5	19.5	13.2	9.6	6.1	16.7	8.5	8.5	22.6	16.0	8.2	7.3	14.9	23.0	12.3	17.7	6.8	17.3	15.9	15.5	8.7	14.4	9.2	15.3	16.2	16.3	21.9	17.4	20.2	13.1	20.3	19.8	18.2	4.1	16.6	21.0	17.5	15.7	9.6	21.6	22.0	11.9	22.5	19.2	19.6	22.2	23.0	19.0	22.2	38.7	39.9	36.7	24.6	10.5	26.7	79.5	28.1	89.7	54.6	26.2	15.7	71.6	79.6	33.6	48.2	24.8	26.1	23.3	42.9	26.6	24.6	23.5	31.3	25.1	48.9	23.8	39.0	19.6	27.2	11.4	28.4	37.5	28.7	34.3	38.2	89.1	34.2	35.1	25.5	53.0	48.0	51.8	25.8	46.4	37.1	14.2	60.5	28.7	37.7	23.5
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.1;NTERA-2: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.6	4.6	4.8	4.5	7.9	7.5	4.8	3.2	2.4	3.6	4.5	10.6	1.7	14.0	3.7	3.3	3.9	4.1	12.4	4.3	6.5	5.5	8.2	15.2	5.9	6.9	3.0	19.6	3.8	4.6	3.7	9.7	9.0	2.2	6.4	6.4	27.1	3.4	3.5	5.6	3.0	7.4	26.4	3.9	4.0	6.1	9.1	3.5	3.2	6.6	8.7	3.9	4.5	2.7	2.9	6.6	1.9	8.7	8.2	2.4	4.5	3.2	7.4	3.9	4.3	6.9	3.3	11.2	4.2	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7	26.8	15.5	8.5	5.2	26.1	24.4	30.7	7.6	13.4	25.0	14.0	23.6	4.9	0.0	5.9	6.0	13.3	4.6	23.3	6.9	5.7	10.0	7.3	5.8	41.4	5.9	17.5	7.5	9.2	3.3	2.5	6.6	6.6	11.8	2.8	6.9	7.8	5.6	3.5	8.1	1.8	19.5	0.0	9.5	21.7	50.0	26.3	2.9	9.6	9.3	8.7
CASP8AP2	"CED-4, FLASH, FLJ11208, KIAA1315, RIP25"	ENSG00000118412	"Caspase 8 associated protein 2"		6	89829894-89874436	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 89.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053573			Approved	"Nucleoli,Nuclear bodies"		NA	NA			"Nucleoli, Nuclear bodies"		"HPA053573: AB_2682194"	"unprognostic (7.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.75e-4)"	"unprognostic (4.58e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.53e-1)"	3.8	3.1	5.4	8.0	7.3	4.8	6.0	9.7	7.8	7.4	4.7	3.3	3.8	3.5	5.0	3.4	4.5	3.7	3.5	3.9	6.5		3.1	3.4	3.9	8.8	6.1	5.0	6.6	3.8	5.7	7.0	5.9	6.6	7.2	4.3	3.5	4.0	5.2	3.2	2.6	4.7	5.3	5.7	5.4	4.0	5.0	5.9	9.1	4.5	2.1	5.9	6.5	3.2	9.9	7.8	17.7	4.1	17.8	12.3	3.6	4.2	4.3	13.8	9.5	4.7	4.7	5.5	10.6	4.0	7.6	9.9	5.0	3.4	12.6	5.6	5.4	5.8	6.4	12.4	5.3	8.8	12.9	10.5	15.7	10.2	1.7	2.0	14.7	8.3	2.3	2.5	9.9	4.6	3.1	5.5	12.5	16.9	7.6	5.1	3.8	8.3	2.7	4.0	4.0	4.0	16.4	17.2	4.9	1.4	9.3	9.1	6.3	8.8	1.9	3.8	6.5	4.2	7.5	7.4	4.9	4.2	8.4	9.6	4.6	11.2	7.5	5.0	8.4	7.7	17.7	2.5	8.2	10.7	4.1	10.3	8.3	12.3	11.2	3.1	9.9	9.9	9.5	4.4	17.8	3.5	7.8	10.2	3.6											29.8	16.4	13.9	8.5	0.0	18.7	39.9	5.1	25.4	21.6	7.0	5.9	14.1	3.3	13.0	4.6	12.8	9.6	0.0	11.0	13.0	12.4	10.8	15.1	6.6	10.6	33.4	2.4	8.6	9.7	3.5	21.3	11.3	0.0	28.9	10.0	16.6	8.2	10.1	24.4	6.9	23.8	19.4	13.7	29.1	89.7	0.0	9.2	13.8	13.3	7.3
GJA10	CX62	ENSG00000135355	"Gap junction protein alpha 10"	Q969M2	6	89894469-89921760	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	12	"testis: 2.3"	"Cell type enriched"	"Detected in single"	148	"Horizontal cells: 17.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 2.8;NTERA-2: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA021145	Uncertain					NA	NA					"HPA021145: AB_2670600"															"unprognostic (1.09e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 187.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Group enriched"	"Detected in some"	6	"Daudi: 52.7;U-698: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	52.7	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.2	0.0	0.0	3.4	2.1	4.6	0.0	0.1	1.0	0.0	0.5	0.0	0.4	7.2	1.3	0.9	0.0	0.1	1.7	4.9	0.1	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.5	0.1	30.9	0.2	0.5	0.4	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9	0.0	0.3	43.2	8.5	6.6	5.6	2.0	0.0	0.0	3.4	3.5	39.3	0.1	0.0	4.4	17.2	1.1	0.0	0.0	2.4	0.2	5.3	14.0	0.0	2.4	0.5	187.5	0.0	2.5	0.3	5.3	5.5	0.9	3.3	0.0	0.1	0.6	3.8	0.0	4.2	0.0	1.9	0.0	1.7	0.0	1.5	6.8	0.0	5.1	0.0	3.1
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.9	7.0	20.5	17.6	15.0	20.1	14.5	16.0	18.5	14.4	18.2	9.0	7.6	17.7	10.2	17.2	12.8	8.5	12.9	12.4	24.6	9.0	13.7	15.8	9.7	11.9	15.8	17.5	12.2	16.6	15.3	14.0	17.2	16.6	13.5	15.6	31.5	14.5	20.6	9.7	8.1	14.8	16.8	12.4	8.9	14.0	36.9	8.6	12.1	8.9	10.4	14.8	11.1	7.7	12.0	16.8	7.7	31.1	12.9	11.7	7.4	10.7	14.8	12.9	11.5	7.7	18.0	19.2	17.2	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7	14.9	24.0	20.7	17.4	32.3	22.8	28.8	12.7	16.0	10.3	15.7	25.5	27.6	6.6	16.6	2.6	20.3	9.3	0.0	18.3	26.6	23.5	24.4	12.8	17.9	21.1	27.0	11.6	30.7	26.3	2.2	24.7	25.3	20.3	27.9	15.6	18.9	15.5	7.0	38.5	13.1	21.1	19.4	19.1	24.6	24.0	32.5	40.5	25.5	15.1	23.0
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419547	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 110.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.1;Cardiomyocytes: 10.8;Early spermatids: 3.7;Horizontal cells: 11.1;Proximal tubular cells: 11.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.9;HEK 293: 25.5;RH-30: 24.4;THP-1: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		340000			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	1.3	1.3	6.0	1.7	24.6	1.2	2.2	21.6	8.6	2.4	24.6	0.0	0.1	2.5	2.0	7.5	14.7	1.7	3.1	4.2	13.8	2.9	6.9	1.3	1.5	1.3	2.4	5.8	3.0	1.3	110.4	5.6	1.6	6.7	17.9	3.6	0.4	8.2	1.9	1.3	1.4	6.5	20.2	4.8	4.7	14.9	2.1	4.4	0.0	1.3	0.0	1.3	9.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	25.5	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.5	0.0	0.6	4.5	24.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	20.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	24.6	21.6	8.6	13.8	2.9	2.4	5.8	6.7	4.4	0.0	0.0	0.0	0.4	0.3	14.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.7	0.7	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.1	11.1	0.0	0.0	0.0	2.1	0.9	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	11.5	0.9	0.0	0.8	0.2	0.7	0.9	0.0	0.0	0.0	0.0
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577543-95609457	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 53.1;Ito cells: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		87000	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	18.0	8.1	6.0	6.7	6.9	2.4	14.4	8.3	6.0	9.6	9.5	5.0	5.8	7.7	7.5	8.2	11.5	7.2	7.1	9.3	6.5	6.2	14.6	44.9	9.8	12.3	8.9	6.7	10.4	8.0	10.9	13.5	7.4	7.8	9.2	8.0	4.5	8.1	7.6	3.8	5.9	9.5	6.0	11.6	13.2	10.7	7.1	6.9	17.9	11.7	5.9	9.7	11.2	7.5	6.6	3.4	8.5	5.7	3.8	10.4	3.3	3.8	3.3	12.5	10.1	20.8	24.5	4.8	10.8	9.9	6.3	9.5	3.7	9.7	7.4	13.5	7.0	9.5	6.4	8.6	7.2	14.5	12.7	7.7	10.0	3.1	6.0	7.2	13.1	8.9	24.2	8.4	7.5	5.3	9.1	14.7	7.7	15.4	17.2	13.4	2.7	7.6	5.6	1.8	10.2	3.3	9.2	12.5	11.0	9.6	6.7	10.1	5.4	6.1	4.4	3.8	9.3	7.0	12.3	13.3	6.3	4.5	11.3	10.6	12.9	7.5	9.2	11.3	11.5	14.3	8.5	3.3	1.9	4.8	5.7	6.8	6.6	5.9	5.5	3.4	3.3	6.9	4.6	0.7	3.8	4.9	1.3	10.4	3.3	6.0	6.9	8.3	6.0	6.5	6.2	8.9	6.7	7.8	6.9	11.9	6.7	4.5	4.6	6.5	8.3	3.2	7.6	10.7	7.9	12.2	3.9	4.5	5.0	3.3	12.0	6.3	2.5	0.0	6.2	4.6	5.2	3.2	2.3	53.1	9.2	11.1	1.7	36.8	9.1	10.0	5.5	6.9	8.5	2.8	4.7	9.1	3.3	3.5	14.9	8.6	4.8	12.9	5.3	6.8	12.5	6.0	1.1	6.4	5.2	3.0
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 2.9;Exocrine glandular cells: 1.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.1	4.1	0.0	0.0	0.0	0.0	0.0	9.5	9.7	0.2	0.0	5.5	0.0	0.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5	0.0	0.0	0.0	0.6	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		6900	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	20.2	26.3	19.8	21.9	24.0	14.6	20.9	16.4	23.6	22.1	17.9	19.4	32.1	21.5	20.5	28.5	23.6	18.6	20.2	22.1	21.6	17.8	21.6	32.7	15.8	21.5	31.1	20.0	24.8	35.7	28.8	32.4	25.6	28.0	24.6	19.2	14.2	23.9	30.7	33.0	19.3	28.4	18.5	33.0	18.8	20.6	13.4	27.3	29.2	27.6	23.1	20.1	24.0	18.8	11.2	12.6	10.1	11.7	14.7	14.7	7.9	8.9	4.7	10.1	16.9	14.6	22.4	15.1	12.6	12.9	8.1	7.6	5.9	10.5	21.7	16.1	12.6	9.0	17.5	8.2	11.9	11.9	11.6	7.4	9.5	7.5	10.8	19.5	17.8	14.2	16.0	11.2	9.6	26.8	15.1	13.2	14.0	12.6	24.1	15.3	8.6	6.5	11.1	3.6	7.7	5.4	8.3	11.9	17.1	14.6	16.4	7.1	7.0	10.4	12.3	11.7	9.4	29.9	15.3	12.9	11.4	6.2	11.5	13.2	14.3	7.3	16.7	17.5	12.0	10.4	7.8	9.2	10.1	10.9	11.7	12.5	11.2	11.5	11.6	11.8	11.0	14.7	11.5	2.0	14.7	11.2	12.6	12.7	7.9	19.8	24.0	16.4	23.6	21.6	17.8	31.1	20.0	28.0	27.3	53.6	39.1	26.8	27.8	17.3	47.7	56.2	30.6	76.3	54.6	43.6	43.2	53.5	16.6	35.6	46.2	28.1	32.8	0.0	44.3	29.6	25.7	28.2	29.0	62.7	31.5	41.3	19.0	33.7	30.2	36.5	46.3	26.2	13.5	31.5	45.7	31.7	33.7	37.9	47.4	28.0	67.4	19.4	28.6	88.5	29.6	16.8	76.1	30.9	32.0	23.0
FHL5	"ACT, dJ393D12.2, FLJ33049"	ENSG00000112214	"Four and a half LIM domains 5"	Q5TD97	6	96562548-96616636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 95.7"	"Group enriched"	"Detected in some"	23	"Early spermatids: 1073.4;Late spermatids: 1344.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"ASC diff: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (4.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.48e-3)"	14.6	4.0	1.7	1.7	2.0	0.0	5.5	1.7	1.9	12.6	1.7	1.7	1.7	0.4	6.1	7.4	3.6	6.3	4.9	1.8	1.7	0.7	2.4	1.7	5.4	1.7	1.7	1.7	4.6	1.7	1.0	1.7	1.7	1.9	1.7	1.6	1.7	1.7	4.4	3.0	1.7	1.7	3.5	1.7	1.7	1.4	95.7	1.7	1.7	3.4	1.7	1.7	2.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	1.7	1.9	1.7	0.7	1.7	1.7	1.9	1.7	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1073.4	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1344.3	48.6	0.0	5.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	51.8	51.5	6.2	3.4	0.3	0.0	0.0	0.0	0.0
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794126-96837463	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	1.8	3.4	3.8	3.1	11.0	0.8	1.6	7.5	10.7	3.3	3.9	1.6	1.0	5.1	1.9	1.5	2.0	2.8	2.7	1.9	3.2	2.2	1.4	0.5	1.4	0.9	2.2	6.4	4.0	5.0	3.9	4.3	2.5	10.1	3.3	6.2	2.5	1.7	2.2	1.0	1.7	3.6	3.6	1.4	1.3	4.1	8.0	5.2	2.5	2.3	0.0	0.9	2.2	4.8	0.8	0.9	2.6	0.6	1.4	1.1	0.1	0.0	0.1	1.5	0.3	2.2	0.8	0.4	0.9	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.1	1.2	1.1	4.9	2.3	0.0	7.8	3.8	4.7	0.4	0.0	12.8	2.9	0.5	2.4	0.4	0.0	3.5	0.3	0.0	7.0	3.4	19.2	0.4	0.4	2.2	0.0	5.0	0.0	0.7	0.0	1.8	3.8	0.3	0.2	2.3	1.4	0.3	3.1	0.5	1.7	1.2	0.6	0.0	1.3	2.0	0.2	1.8	1.5	0.8	0.1	0.8	1.8	1.0	0.8	0.6	0.2	0.6	0.2	0.3	0.7	1.1	0.6	0.1	0.8	1.0	0.9	2.6	1.4	0.2	0.9	0.3	0.1	3.8	11.0	7.5	10.7	3.2	2.2	2.2	6.4	10.1	5.2	0.0	0.0	0.0	0.8	1.6	1.1	0.5	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.4	21.8	0.1	0.0	0.0	0.8	0.6	0.9	1.0	0.0	0.0	0.2	0.0	2.9	1.8	0.0	26.5	3.1	0.0	1.7	0.0	0.4	0.3	0.5	0.0	4.6	0.0	0.2	0.0	1.1	22.8	9.3	0.3	0.1	0.0	0.5	0.3
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889313-96897881	"Disease related genes, Predicted intracellular proteins"		Calmodulin-binding	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	7.9	10.1	16.1	5.4	19.0	2.7	9.0	20.4	27.4	8.9	9.1	5.0	5.7	6.2	7.3	6.4	7.1	6.0	6.0	30.2	18.7	17.3	17.3	18.1	4.3	5.4	18.1	12.3	10.4	7.2	7.3	6.5	6.1	28.5	9.5	9.7	4.5	7.7	12.8	25.0	6.2	6.5	7.3	9.6	7.6	6.4	5.7	8.4	4.9	9.5	11.2	5.8	8.2	5.1	6.4	4.5	0.6	4.3	3.3	10.0	4.1	1.5	4.3	7.5	10.1	7.5	4.4	4.0	4.2	4.0	6.3	4.8	5.8	2.6	14.1	7.7	3.8	6.0	3.1	17.4	6.5	6.1	9.9	13.7	15.7	2.3	5.0	8.2	16.4	6.6	4.1	10.1	5.4	5.5	3.2	4.9	10.0	14.1	9.6	9.8	4.8	10.5	8.9	14.2	7.8	7.1	5.0	4.2	7.3	10.4	4.2	12.8	6.0	2.1	7.6	11.9	7.7	2.3	11.0	4.0	3.3	2.5	11.5	6.8	2.2	3.6	13.9	4.5	12.4	4.8	0.2	2.2	0.6	5.1	4.3	6.6	6.4	6.7	6.7	3.8	6.3	10.0	8.8	0.4	3.3	2.6	4.5	6.8	4.1	16.1	19.0	20.4	27.4	18.7	17.3	18.1	12.3	28.5	8.4	8.9	16.6	43.3	52.1	96.7	15.5	108.1	25.5	17.4	27.3	22.7	0.0	40.6	142.6	37.3	2.3	31.6	17.5	23.3	23.9	34.6	34.7	26.3	19.7	43.9	47.0	25.4	37.6	25.8	18.0	4.4	24.2	27.4	52.3	15.4	38.0	14.0	21.1	10.5	23.3	99.4	12.4	25.8	69.8	36.9	55.8	84.6	27.5	27.9	48.2	38.3
KLHL32	"BKLHD5, KIAA1900"	ENSG00000186231	"Kelch like family member 32"	Q96NJ5	6	96924620-97140754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 47.1;fallopian tube: 12.8"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 24.1;Horizontal cells: 17.5;Intestinal endocrine cells: 10.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.2;T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.0;HDLM-2: 8.2;JURKAT: 3.1;RPMI-8226: 3.7;SCLC-21H: 3.5;U-266/70: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039150	Enhanced					NA	NA					"HPA039150: AB_2676367"	"unprognostic (1.75e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-5)"	"unprognostic (5.82e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.49e-4)"	1.0	2.6	14.2	1.5	47.1	1.1	1.5	8.8	36.9	1.5	2.0	19.4	0.0	2.3	1.3	1.8	1.0	12.8	1.5	2.1	16.2	11.1	4.3	2.0	2.2	1.6	31.0	14.7	2.7	3.2	2.6	3.0	1.0	22.0	1.2	2.5	0.1	1.8	1.3	2.9	1.1	2.9	1.2	30.6	1.4	1.7	3.7	32.2	0.0	2.3	0.0	1.6	1.1	0.5	2.2	0.1	0.1	0.0	0.7	5.5	1.5	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.5	6.0	0.2	0.0	0.0	0.2	0.6	0.2	0.0	8.2	1.3	0.4	0.1	0.2	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	3.0	0.0	0.0	1.5	0.4	0.4	0.3	0.3	0.2	0.0	3.7	0.0	0.0	3.5	1.2	0.0	0.0	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.0	0.0	4.4	0.7	2.4	0.2	0.3	0.4	0.0	0.0	0.0	0.9	0.0	2.1	2.2	3.6	1.3	0.1	1.5	4.2	5.5	0.1	0.7	0.0	0.0	2.5	1.5	14.2	47.1	8.8	36.9	16.2	11.1	31.0	14.7	22.0	32.2	3.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	24.1	0.0	5.2	0.0	0.0	3.3	0.1	4.6	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	17.5	10.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.4	0.0
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 39.3;Early spermatids: 45.4;Spermatocytes: 34.8;Spermatogonia: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067042			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	3.1	3.3	3.0	8.0	4.6	12.7	7.1	2.0	3.2	4.2	3.4	5.5	3.6	2.7	5.2	2.8	4.9	3.1	3.0	3.7	3.6	3.3	2.7	2.1	6.0	11.0	5.1	1.8	3.7	3.2	5.0	4.3	4.1	4.0	4.6	5.0	4.6	3.9	3.5	1.6	5.9	5.1	3.9	8.1	4.5	2.8	13.1	3.1	21.4	2.5	4.0	6.8	3.5	4.0	3.0	4.1	3.1	4.8	2.1	3.9	1.4	4.9	5.6	9.4	10.2	1.5	2.9	7.4	10.2	4.7	9.7	14.2	7.7	5.9	11.0	6.3	3.8	11.2	9.1	11.8	5.6	19.3	9.4	8.8	11.1	8.1	4.8	0.9	17.0	7.9	1.5	3.0	13.6	6.3	2.0	4.1	10.4	15.1	17.7	9.0	5.9	6.2	6.9	3.6	8.1	4.2	10.5	8.9	3.9	4.1	6.6	5.3	4.6	6.7	3.4	2.8	5.5	5.2	10.5	3.1	9.8	9.4	8.1	13.9	2.2	6.6	12.4	5.6	10.8	10.8	1.6	1.5	3.1	2.4	2.4	3.6	1.8	3.2	3.5	3.6	3.0	3.0	3.9	1.5	2.1	4.8	4.1	2.8	1.4	3.0	4.6	2.0	3.2	3.6	3.3	5.1	1.8	4.0	3.1	3.0	7.5	10.7	4.6	8.1	10.7	3.6	5.1	4.0	9.1	3.5	39.3	7.5	1.7	2.3	45.4	5.3	2.6	0.0	3.6	9.4	6.4	2.3	7.0	2.6	5.3	3.2	1.2	11.1	8.7	11.8	9.2	5.2	6.8	1.8	7.5	6.9	2.1	0.0	5.3	0.3	29.7	6.5	3.1	34.8	44.9	7.2	3.0	12.1	7.0	1.8
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834592-98839470	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"brain: 28.0"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 12.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 52.2;SK-MEL-30: 7.1;U-251 MG: 15.9;WM-115: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047081: , HPA056261: AB_2683081"	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.9	1.0	9.0	0.9	10.8	0.9	0.9	3.4	28.0	0.9	0.9	10.3	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.9	9.8	7.1	0.9	0.9	0.9	0.9	10.7	6.8	0.9	0.9	0.9	0.0	0.9	9.7	0.9	0.9	0.0	0.9	0.9	0.9	1.0	0.9	0.9	8.4	0.9	0.9	1.2	9.0	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.0	0.4	0.0	0.2	0.0	2.2	1.7	0.4	0.0	0.0	0.0	2.9	1.5	0.0	0.0	7.1	0.0	0.4	0.0	0.0	0.3	0.0	0.1	15.9	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.0	10.8	3.4	12.5	9.8	7.1	10.7	6.8	9.7	9.0	0.0	0.0	0.0	0.2	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.1	0.0	0.0	0.0	0.2
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868538-98948006	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	13.7	18.9	9.2	11.2	13.1	7.9	18.4	10.7	14.2	12.7	10.9	14.2	14.4	9.9	12.9	19.2	11.9	13.2	11.6	13.5	10.1	11.1	22.3	24.9	13.2	16.4	15.2	8.4	14.4	21.7	26.8	17.4	11.3	13.8	13.9	11.8	11.5	14.9	14.8	21.2	11.9	12.2	15.2	20.1	10.5	12.5	6.9	13.2	19.9	20.3	7.5	12.2	12.6	12.6	6.8	3.9	16.5	5.7	4.1	6.7	3.9	4.6	7.4	6.3	8.5	10.7	19.7	6.8	10.4	8.8	6.1	8.7	3.3	8.8	10.5	9.7	8.6	10.8	6.7	7.3	7.5	9.3	17.1	6.0	7.4	5.2	7.5	8.3	9.1	7.5	11.2	13.7	5.5	15.5	17.2	7.8	8.4	9.9	8.4	11.0	4.5	3.3	4.4	3.3	6.0	4.6	11.7	4.3	8.5	11.7	6.6	8.0	6.4	5.5	7.4	9.7	8.0	5.4	6.6	10.8	7.1	3.1	9.9	7.4	2.8	2.6	4.4	8.8	8.4	8.4	16.5	4.8	12.6	5.1	4.5	6.7	6.8	5.1	5.0	3.9	6.7	6.6	6.0	6.1	4.1	5.7	2.5	6.1	3.9	9.2	13.1	10.7	14.2	10.1	11.1	15.2	8.4	13.8	13.2	17.9	11.0	6.9	6.8	8.7	12.9	14.3	7.6	10.7	7.9	34.9	21.6	8.5	16.6	8.5	3.5	10.8	8.4	0.0	9.6	9.1	9.3	12.8	9.2	18.7	7.6	9.5	6.9	11.1	14.6	1.5	17.5	6.2	5.0	12.6	12.5	10.2	7.1	8.6	12.0	10.3	13.4	12.9	7.1	3.0	5.8	7.4	8.2	4.9	9.3	7.1
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog"	Q5TGI0	6	99271169-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 17.5;Bipolar cells: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.2;HAP1: 14.5;SCLC-21H: 21.3;SH-SY5Y: 14.8;SK-MEL-30: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	3.3	9.4	2.1	12.2	0.4	4.6	11.0	19.7	1.8	13.3	1.8	5.1	2.3	4.5	15.3	8.6	2.4	3.5	1.3	7.7	10.3	2.5	0.3	2.3	0.4	9.1	9.9	3.4	2.2	9.3	10.4	1.4	7.5	10.1	4.3	1.4	5.8	15.1	0.9	0.4	2.1	19.1	4.8	0.8	5.2	2.8	1.6	0.0	2.0	0.2	0.5	13.6	1.7	1.2	0.6	1.4	0.6	0.8	0.4	0.0	2.3	1.9	6.4	8.8	0.0	0.0	2.3	3.0	1.9	5.0	4.4	1.1	0.7	0.0	0.3	0.6	16.2	0.1	14.5	2.8	4.4	0.0	7.2	0.0	1.2	0.4	0.4	0.0	0.0	0.3	4.6	0.1	2.3	3.7	0.0	1.2	0.3	0.0	1.6	4.1	0.0	0.0	7.5	0.0	2.9	0.0	0.6	0.0	2.7	0.1	21.3	14.8	2.7	2.0	13.0	2.7	6.1	0.0	0.6	1.6	2.9	0.0	9.2	0.0	0.0	0.0	0.1	0.0	11.9	0.8	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.2	1.2	0.3	0.4	1.4	0.8	0.3	0.6	0.2	0.0	9.4	12.2	11.0	17.4	7.7	10.3	9.1	9.9	7.5	1.6	23.8	17.5	0.0	3.4	0.3	12.6	0.8	0.0	2.7	10.3	1.8	9.8	0.8	8.3	1.7	2.1	0.6	0.0	0.0	0.6	0.1	0.4	4.1	3.5	0.0	0.2	3.2	0.0	1.3	0.8	3.6	0.0	0.4	1.7	0.0	0.2	3.1	1.3	0.0	1.8	0.8	11.6	0.0	0.7	0.9	9.0	0.3	0.2	0.0	0.2	1.0
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369400-99394204	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 37.1;Distal tubular cells: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	5.2	7.8	8.6	4.2	10.8	3.2	7.5	13.6	16.3	4.5	8.9	4.5	4.3	6.9	4.3	6.8	8.2	4.5	3.0	21.7	8.2	7.5	10.2	12.4	2.9	7.1	6.9	12.0	6.0	5.7	11.6	7.4	2.5	9.8	6.8	11.0	7.3	11.7	7.6	28.0	5.8	6.3	6.6	4.6	4.8	5.2	2.3	6.0	4.1	4.3	16.8	7.0	7.5	4.6	6.6	8.0	9.4	7.4	9.7	12.5	5.3	12.0	6.9	8.4	11.9	5.5	6.2	11.6	10.4	6.5	15.8	18.3	9.6	5.2	11.8	7.0	7.8	10.2	11.2	14.0	16.3	19.3	12.5	17.9	14.4	9.5	10.3	7.2	20.8	5.7	3.9	10.0	9.3	9.4	3.5	9.6	14.6	21.9	9.0	8.4	11.9	9.1	17.4	10.2	11.9	13.4	4.5	8.6	15.7	12.4	10.5	13.2	7.0	7.2	11.2	13.6	5.9	13.7	13.7	3.4	6.9	10.1	10.6	15.8	3.2	5.9	18.6	8.8	20.2	10.1	9.4	3.3	2.4	6.0	7.4	6.8	6.6	7.6	9.5	8.0	3.1	12.5	9.5	0.5	9.7	6.3	5.2	5.5	5.3	8.6	10.8	13.6	16.3	8.2	7.5	6.9	12.0	9.8	6.0	3.0	3.0	6.1	8.0	3.9	7.1	37.1	7.6	0.0	5.7	3.5	0.0	13.0	28.2	10.0	0.4	4.5	3.2	0.0	9.3	11.0	4.1	2.0	1.1	7.8	5.7	6.4	0.0	3.7	0.6	0.0	7.5	3.3	5.0	1.8	6.5	10.4	7.0	6.0	5.6	8.8	7.8	6.5	8.2	3.4	12.4	3.8	5.3	4.4	9.0	3.1
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.1	7.5	40.3	27.6	14.4	21.4	18.7	17.6	9.7	10.5	13.1	13.5	20.2	34.1	11.8	9.9	12.3	17.0	20.2	15.4	21.4	28.0	22.6	19.8	37.4	13.5	10.9	27.4	28.0	21.0	21.9	11.7	15.3	38.3	15.4	18.1	23.0	22.4	13.9	11.1	13.0	31.5	22.5	10.2	7.0	26.3	11.4	12.2	20.7	19.3	16.3	21.6	8.8	11.4	15.1	33.0	15.3	24.2	16.9	10.6	12.6	10.3	15.0	15.6	10.7	31.3	16.0	28.2	12.3	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1	172.7	197.8	329.9	282.6	173.4	521.3	112.2	109.5	187.4	202.4	169.3	420.2	132.4	63.0	108.9	13.5	170.1	148.0	70.0	90.8	86.5	187.1	270.2	182.8	89.8	87.1	470.4	237.9	98.8	88.1	13.3	549.4	181.7	158.6	221.0	84.6	269.4	105.3	147.3	414.8	35.6	432.5	245.8	215.3	310.7	171.1	151.8	151.3	236.8	126.4	254.3
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432379-99521728	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	9.8	9.1	8.5	10.2	12.2	7.2	9.0	28.4	11.6	9.0	9.7	8.6	8.9	13.7	15.7	9.6	10.0	8.1	11.9	11.5	7.7	8.5	12.2	9.0	7.1	12.7	9.8	8.0	10.7	9.6	10.2	21.7	9.6	15.0	9.9	13.1	7.9	9.8	8.4	14.6	11.8	12.4	10.8	10.6	9.9	8.9	5.7	9.4	7.1	10.7	10.4	9.5	8.8	15.0	8.6	5.1	3.7	2.5	2.6	6.2	1.4	4.2	3.0	6.0	8.5	11.2	10.6	6.4	7.4	8.3	7.7	11.1	6.3	4.8	11.3	5.5	7.4	9.1	5.8	9.2	7.3	10.7	8.9	8.8	11.0	6.0	4.9	8.6	10.2	6.3	11.3	5.9	6.9	11.9	8.2	11.4	10.3	26.5	11.3	7.3	3.9	3.2	9.8	9.7	6.6	6.5	4.8	4.5	6.3	10.8	5.0	8.5	7.0	5.3	6.9	5.4	7.9	3.7	5.0	11.5	4.2	5.4	6.2	11.2	4.8	4.4	20.7	7.3	9.7	7.5	3.7	2.0	0.6	4.9	1.3	6.2	7.4	4.2	5.6	3.5	8.6	3.0	2.9	0.5	2.6	2.5	5.1	3.5	1.4	8.5	12.2	28.4	11.6	7.7	8.5	9.8	8.0	15.0	9.4	3.0	4.3	4.4	6.8	2.1	7.9	7.1	7.6	12.0	3.4	3.5	17.7	5.3	5.0	3.9	10.8	5.3	5.8	0.0	2.3	5.9	3.8	5.6	2.3	3.8	3.5	9.5	2.4	8.0	4.1	5.9	12.0	3.9	3.3	13.6	2.3	5.6	4.3	2.9	8.1	13.4	7.6	0.0	6.2	1.8	5.5	2.5	6.2	5.1	6.0	6.5
TSTD3		ENSG00000228439	"Thiosulfate sulfurtransferase (rhodanese)-like domain containing 3"	H0UI37	6	99520693-99531918	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 19.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (4.57e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.32e-4)"	"unprognostic (8.43e-5)"	"unprognostic (1.35e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.42e-2)"	7.2	4.5	4.1	4.2	5.1	2.7	4.8	11.7	5.0	4.1	3.2	4.4	6.5	4.4	4.2	4.5	2.4	4.5	5.0	4.5	4.2		4.5	2.4	3.6	2.6	4.4	5.2	3.1	3.5	7.4	10.7	1.9	5.3	6.9	3.4	4.2	3.1	6.0	6.7	2.0	3.1	6.2	4.0	2.4	4.2	1.4	4.4	0.3	6.4	3.7	1.4	4.5	3.4	5.3	2.5	2.3	2.0	4.8	5.8	1.2	1.7	3.4	4.1	5.0	10.9	8.1	3.0	5.2	3.4	3.3	3.6	1.8	4.5	0.6	5.2	6.4	7.5	2.9	2.3	2.5	3.7	7.3	4.2	3.8	6.6	4.1	5.7	3.6	7.5	5.2	6.2	2.2	5.1	8.5	6.5	4.8	5.5	10.3	4.5	6.5	1.0	1.7	2.4	6.2	3.1	0.0	1.9	3.5	11.1	2.0	2.6	3.9	5.1	2.7	3.1	7.7	3.4	3.3	5.6	2.4	3.5	3.2	5.2	2.3	2.7	4.3	7.2	4.8	4.6	0.3	2.0	2.3	2.4	0.4	5.8	5.3	3.1	4.5	2.5	2.7	1.7	2.2	0.3	4.8	0.4	1.9	2.4	1.2											3.0	4.8	3.7	3.4	1.6	1.3	8.7	12.7	8.1	5.7	12.2	0.0	5.1	19.9	3.7	0.3	4.5	3.9	0.0	6.9	5.3	3.7	6.4	1.1	2.6	5.1	0.0	3.5	6.2	4.0	0.5	6.1	1.0	5.0	2.8	5.3	4.3	6.2	3.5	9.2	11.9	2.6	12.9	6.2	0.2	1.8	1.8	3.0	2.2	5.3	3.1
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542380-99568973	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	18.0	21.1	14.5	16.8	20.4	13.7	23.8	23.2	24.3	15.6	17.3	8.7	21.8	19.8	13.5	28.1	26.5	11.7	24.7	12.0	14.9	16.9	31.5	47.4	16.2	23.4	13.6	12.6	13.5	35.6	20.8	31.8	24.4	17.6	18.2	15.9	12.4	37.0	20.9	13.1	15.4	22.6	17.3	12.1	21.1	20.2	8.6	10.0	27.3	30.7	16.8	21.9	17.5	15.5	20.1	15.0	21.5	13.9	17.7	26.6	18.8	27.3	8.1	15.7	30.6	11.8	16.1	39.4	19.9	23.9	24.1	30.9	31.3	16.1	53.6	21.4	16.4	23.9	17.9	24.0	26.9	38.2	13.5	25.8	33.2	13.6	27.3	21.2	37.1	10.9	15.9	16.4	17.0	21.4	16.7	23.9	29.8	45.0	20.0	21.1	13.9	13.5	27.4	21.0	16.7	13.5	23.3	26.4	21.3	31.2	30.9	23.6	14.4	10.0	22.6	23.2	24.4	13.2	35.5	19.1	13.3	17.7	13.9	29.2	14.2	21.8	46.0	22.4	26.5	16.3	21.5	12.9	10.7	14.2	13.9	26.6	20.1	17.9	14.5	15.0	16.0	20.1	15.7	2.5	17.7	10.4	15.0	18.0	18.8	14.5	20.4	23.2	24.3	14.9	16.9	13.6	12.6	17.6	10.0	41.7	32.8	32.0	84.7	66.6	40.4	13.7	50.9	26.8	37.5	22.7	21.6	96.3	71.3	107.0	19.5	44.4	29.0	0.0	162.8	75.7	39.3	116.5	32.3	46.4	37.2	23.8	41.9	33.7	29.7	33.8	20.8	32.2	55.6	39.7	33.7	45.2	119.1	24.6	23.7	103.7	40.3	19.4	43.4	58.1	15.7	59.0	147.5	37.4	38.8	113.6
PRDM13		ENSG00000112238	"PR/SET domain 13"	Q9H4Q3	6	99606730-99615578	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.1"	"Cell type enhanced"	"Detected in single"	19	"Horizontal cells: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070592	Uncertain					NA	NA					"HPA070592: AB_2686283"		"unprognostic (4.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"		"unprognostic (3.16e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.93e-1)"				"unprognostic (1.86e-2)"	"unprognostic (7.54e-2)"		"unprognostic (1.29e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
MCHR2	"GPR145, MCH2, MCH2R, SLT"	ENSG00000152034	"Melanin concentrating hormone receptor 2"	Q969V1	6	99919910-99994247	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	15	"brain: 14.9;testis: 5.5"	"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.3;cerebral cortex: 14.9;olfactory region: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HMC-1: 1.9;U-266/70: 1.8"					"Region enhanced"	"Detected in single"		"cerebral cortex: 0.9"							NA	NA										"unprognostic (5.76e-2)"													0.2	0.2	1.9	0.3	6.3	0.3	0.2	0.2	14.9	0.2	0.5	0.0	0.0	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.7	0.6	0.2	0.2	0.2	0.3	0.5	4.4	0.3	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.3	0.5	0.2	0.2	0.2	0.3	5.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.3	0.2	0.6	0.2	0.5	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.5	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.2	0.0	0.4	0.1	0.1	0.2	0.2	1.8	0.9	0.3	0.0	0.1	0.0	0.6	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.3	0.1	0.1	0.3	0.5	0.0	0.2	0.2	0.1	1.9	6.3	0.2	14.9	0.7	0.6	0.5	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 19.2;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7"	"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	8.0	0.0	12.8	18.7	5.8	5.4	0.0	0.0	0.0	0.0	4.0	1.2	0.0	0.0	0.0	4.9	5.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	6.6	3.0	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	1.6	0.0	0.4	0.0	0.0	0.0	0.0
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	15.9	15.4	10.9	15.5	14.5	13.6	13.4	16.1	11.7	16.7	13.2	7.7	10.1	11.4	16.4	12.9	18.4	11.3	11.1	14.9	9.7	8.4	10.4	28.3	12.6	13.1	13.1	7.6	13.8	15.1	25.0	38.6	26.1	10.4	16.4	17.1	6.4	15.4	14.0	13.6	15.3	16.1	12.2	15.5	17.7	11.5	11.7	12.4	25.0	10.6	11.6	15.2	16.0	17.9	8.5	9.4	5.9	6.4	6.0	7.8	1.8	7.1	8.9	13.4	8.2	15.0	19.2	20.8	31.2	20.1	10.8	12.5	18.1	5.7	21.9	6.1	20.9	8.6	16.0	11.5	27.7	17.5	13.8	9.8	16.6	16.6	11.8	13.8	17.5	12.8	17.4	14.2	15.7	20.0	10.2	19.8	9.1	19.5	10.0	29.7	6.9	8.7	5.3	7.0	13.7	6.8	10.5	10.2	8.1	10.6	20.2	8.8	6.6	12.9	11.8	5.4	24.9	6.5	10.0	27.1	12.0	9.1	10.4	13.1	4.3	4.0	19.5	8.7	13.2	12.5	5.9	3.9	2.4	6.7	6.4	7.8	5.8	5.6	6.0	4.1	8.5	6.5	6.2	0.3	6.0	5.2	9.4	4.3	1.8	10.9	14.5	16.1	11.7	9.7	8.4	13.1	7.6	10.4	12.4	29.8	19.8	36.0	39.8	22.7	25.2	28.6	20.4	33.5	39.8	3.5	21.6	20.4	10.0	20.1	6.1	18.0	14.6	23.3	21.5	57.6	23.6	58.3	20.9	28.8	15.8	27.0	13.3	8.6	19.6	1.5	21.3	20.7	5.0	15.4	16.4	16.4	22.7	11.0	16.3	9.7	30.3	6.5	26.4	47.4	20.0	24.0	31.8	23.5	17.1	49.7
GRIK2	"GluK2, GLUR6, MRT6"	ENSG00000164418	"Glutamate ionotropic receptor kainate type subunit 2"	Q13002	6	101398788-102070083	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 4.6;Cardiomyocytes: 2.8;Ciliated cells: 2.7;Early spermatids: 3.3;Late spermatids: 5.6"	"Cancer enhanced"	"Detected in some"		"glioma: 3.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 11.7;BJ hTERT+: 19.4;fHDF/TERT166: 14.5;HAP1: 7.5;SiHa: 7.8;WM-115: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014395, HPA014623, CAB022463"	Approved				"Intracellular and membrane"	NA	NA					"CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305"	"unprognostic (1.43e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-4)"	0.8	3.9	16.1	1.1	22.5	1.0	0.8	40.6	22.8	3.1	1.2	1.6	0.0	1.4	1.2	2.5	1.2	0.9	1.5	7.6	9.1	11.4	1.9	0.6	0.7	0.6	4.1	17.0	1.1	5.2	0.5	13.0	4.3	8.5	2.1	1.2	0.4	2.0	2.6	1.8	3.8	1.5	0.9	2.7	1.1	0.8	1.8	5.3	0.0	6.3	0.0	0.4	1.1	0.9	1.4	1.2	2.7	0.7	1.2	0.9	0.4	0.0	0.1	2.5	0.2	2.6	0.1	0.0	11.7	19.4	0.7	0.4	0.0	0.2	0.1	0.0	14.5	0.0	3.9	7.5	0.0	0.2	0.0	0.0	1.3	6.7	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	4.3	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	2.6	5.1	7.8	0.0	0.4	0.4	0.0	0.7	0.0	1.6	0.3	0.1	0.9	0.0	0.0	0.0	1.1	0.0	17.7	2.5	0.7	0.7	0.6	0.7	0.4	0.7	0.6	0.4	0.2	1.4	0.8	0.9	2.7	1.2	0.7	1.2	0.3	0.4	16.1	22.5	40.6	21.9	9.1	11.4	4.1	17.0	8.5	5.3	0.0	0.3	0.0	0.9	0.6	4.6	2.8	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.5	0.0	0.6	0.7	0.0	0.0	0.1	0.0	1.7	0.0	0.0	5.6	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.9	0.0	0.5	0.0	0.3	0.5	0.0	0.0	0.0	0.9
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.6	2.5	10.9	13.6	6.5	8.7	12.9	7.3	11.3	4.6	7.0	2.3	2.1	2.1	3.3	5.5	7.9	2.5	2.7	5.0	9.8	8.4	6.9	7.2	2.3	3.1	6.5	6.2	2.4	5.8	4.6	6.0	5.1	6.1	7.6	8.7	6.9	2.3	9.1	2.6	4.6	3.7	4.7	2.7	2.5	7.3	12.4	0.8	3.7	6.2	5.8	8.8	3.9	4.1	2.1	7.3	2.6	8.5	8.0	3.7	3.1	10.0	6.9	3.3	3.7	7.0	3.9	5.9	6.8	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9	3.0	0.6	0.0	1.6	4.1	11.4	6.3	2.5	0.0	4.5	5.2	43.2	7.5	1.7	1.7	3.1	6.7	1.3	0.0	1.3	4.6	4.8	2.2	1.1	2.5	4.6	15.9	1.7	4.3	2.2	3.3	5.8	2.4	1.7	4.6	1.4	5.8	1.1	2.9	3.5	4.1	30.6	6.5	6.6	12.5	2.7	4.1	5.3	2.2	2.1	1.8
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 51.9"	"Cell type enhanced"	"Detected in some"	13	"Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	1.2	0.0	0.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.0	0.0	1.0	51.9	1.2	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	5.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.7	2.1	0.4	0.2	0.5	0.3	0.0	0.9	14.1	2.8	0.0	0.0	73.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.8	0.0	8.8	0.0	0.0	0.0	6.8	10.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.3	0.0	0.0	1.5	1.7	12.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	1.1	13.5	0.0	2.9	0.3	0.0	1.5	0.0	0.0	4.3	6.0	0.0	0.0	0.0	0.0	1.6	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.7	0.1	0.2	2.1	0.2	0.4	0.7	0.2	0.3	1.2	0.8	0.1	1.3	0.9	1.3	0.5	0.8	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	5.9	66.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	67.8	0.0	0.0	0.0	0.0	8.0	1.6	0.0	0.0	0.0	17.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	6.5	0.0	5.8	9.2	0.0	46.7	0.0	0.0	0.0
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.7;WM-115: 18.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.8	0.8	7.0	9.7	2.1	3.6	2.5	5.6	7.4	0.3	0.0	0.0	0.0	6.7	9.3	0.0	2.0	1.2	5.2	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.4	5.6	4.3	8.6	0.7	4.2	2.4	2.0	0.1	12.1	12.2	0.1	0.1	0.6	1.0	0.0	0.0	3.4	18.7	0.0	0.0	0.0	6.2	10.8	2.3	0.0	4.8	3.6	0.0	12.2	5.5	8.9	0.0	0.0	9.3	1.1	0.5	0.0	5.3	0.0	18.8	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3	0.0	0.0	0.0	0.2	0.2	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.9	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	1.7	0.0	0.0	2.5	0.0	42.6	1.1	0.5	0.0	1.8	0.0	0.0	0.2	0.0	3.2	0.0	0.0	12.9	3.9	12.5	5.1	0.6	0.1	0.0	0.0	0.1
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell type enhanced"	"Detected in some"	27	"Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.4	0.1	2.4	6.3	0.5	2.4	2.6	4.3	5.2	0.0	1.4	0.0	1.0	4.9	25.2	0.0	1.2	1.1	3.6	0.0	2.6	0.0	0.9	0.0	0.1	0.0	0.0	2.5	0.2	6.9	0.9	1.2	0.3	0.0	2.6	7.3	11.9	0.0	0.0	0.9	2.8	0.0	4.1	0.4	13.4	0.0	0.0	0.0	6.1	11.0	0.0	0.0	8.6	1.5	0.0	4.7	5.4	2.6	0.0	1.7	9.0	0.0	0.0	0.0	12.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	75.0	0.0	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.6	0.6	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.1	0.0	0.0	0.0
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105277565-105403084	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1400000	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	13.0	14.2	10.1	22.2	10.1	10.4	36.2	10.9	24.9	11.9	27.2	5.2	11.2	20.2	13.2	10.9	16.4	10.5	15.0	19.0	8.8	7.1	8.9	14.6	23.9	31.4	8.3	15.4	13.6	18.8	16.1	11.1	15.4	9.7	9.4	33.0	8.9	14.9	11.5	58.0	24.2	19.0	15.3	8.5	11.9	14.0	20.1	8.8	17.4	10.2	18.5	13.3	18.2	21.0	8.3	15.3	7.1	18.7	16.6	16.3	11.2	11.0	13.5	14.5	16.2	34.3	20.3	14.3	14.9	14.0	19.7	20.9	17.2	7.0	14.2	14.7	17.5	18.2	17.2	21.3	43.6	22.4	21.4	20.8	19.0	11.4	19.6	13.2	19.2	13.9	18.8	26.6	14.1	36.5	14.9	18.3	25.1	32.4	25.4	23.8	18.0	12.8	19.5	14.0	21.4	13.6	19.8	24.9	9.2	14.7	26.4	19.0	27.1	13.1	21.9	10.4	19.2	9.4	30.8	18.4	9.0	12.6	11.3	18.3	7.4	4.9	18.6	16.0	20.9	28.1	4.8	13.6	7.1	16.0	15.4	15.6	8.3	13.7	16.3	15.3	6.8	12.9	15.2	0.7	16.6	18.7	6.5	12.0	11.2	10.1	10.1	10.9	24.9	8.8	7.1	8.3	15.4	9.7	8.8	3.0	7.0	6.1	5.7	9.6	5.3	13.2	5.1	1.4	7.9	7.0	13.7	16.0	5.0	9.1	0.9	9.0	15.7	0.0	10.2	27.4	9.0	4.3	13.8	13.9	13.4	12.7	18.6	9.2	15.8	2.4	10.0	10.0	5.0	18.0	33.1	3.3	12.9	17.3	8.5	6.7	9.5	0.0	12.3	2.1	17.9	7.4	56.8	11.3	34.9	7.6
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	18.0	28.5	16.1	15.6	17.2	9.4	21.4	16.0	21.4	23.0	20.9	10.5	14.1	16.9	21.5	23.2	16.7	20.6	12.8	14.0	15.1	15.4	20.5	23.6	15.4	18.1	14.7	15.8	21.0	16.7	12.8	23.3	26.9	17.0	22.9	20.6	11.0	16.5	21.7	20.4	10.9	28.6	19.7	14.9	20.3	16.4	13.0	10.2	23.3	24.9	14.7	18.0	20.7	21.0	7.3	6.8	11.6	10.5	6.5	12.9	4.9	8.2	3.6	6.0	8.1	14.0	15.0	6.3	8.8	14.1	13.0	16.0	3.5	5.0	5.8	7.1	13.4	14.7	5.9	8.7	12.9	23.0	2.5	4.9	6.8	4.5	4.4	14.9	8.0	3.5	11.6	14.4	9.3	11.8	17.6	13.7	5.4	9.8	5.8	14.7	3.8	3.3	9.7	6.9	10.8	4.9	3.4	14.2	4.5	14.1	5.9	4.6	4.3	5.4	10.2	8.0	11.3	5.0	15.5	11.3	5.1	2.9	5.9	15.0	2.4	2.3	5.4	18.9	11.0	9.3	5.1	6.5	11.6	4.8	7.7	12.9	7.3	8.5	6.6	6.8	5.2	9.3	7.9	5.5	6.5	10.5	2.6	9.0	4.9	16.1	17.2	16.0	21.4	15.1	15.4	14.7	15.8	17.0	10.2	20.8	17.6	31.9	25.7	23.4	13.5	16.2	22.9	24.1	34.2	24.4	15.7	40.8	24.9	34.0	26.6	23.2	39.5	0.0	39.3	52.7	23.5	33.0	19.7	18.7	34.1	19.1	18.5	21.5	27.2	9.5	19.0	26.9	21.9	53.3	36.4	17.1	32.5	59.6	17.0	30.7	17.2	25.8	29.7	25.0	38.2	23.7	55.6	34.1	30.0	39.1
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.7	0.0	2.3	7.2	0.7	1.3	0.4	2.8	0.6	0.1	4.6	0.1	0.1	0.0	1.1	0.8	6.4	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.6	1.0	3.0	0.2	0.9	0.3	0.4	68.5	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	12.8	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.5	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.7	16.6	1.5	1.6	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5	0.0	9.0	19.7	8.0	17.3	0.8	1.4	0.0	2.7	7.9	3.5	49.1	0.4	0.0	0.3	0.8	20.4	7.3	23.3	0.2	0.5	5.1	3.1	3.5	1.5	19.3	0.0	1.7	8.0	24.7	0.0	0.0	38.5	35.4	47.7	3.1	0.5	4.8	4.3	1.1	0.1	0.4	0.0	16.4	0.3	1.3	36.3	0.6	100.2	2.5	77.0
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Low region specificity"	"Detected in single"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.6	0.0	0.0	0.0	9.0	32.1	3.3	1.5	11.8	3.4	3.2	0.7	3.8	16.7	0.7	7.3	4.8	17.2	0.1	40.2	1.7	22.7	0.7	0.0	0.5	5.2	4.2	10.1	0.0	16.0	23.5	6.5	31.1	0.0	14.7	13.2	0.5	2.4	9.2	1.2	2.9	4.0	0.1	0.0	7.1	5.0	0.1	0.1	5.4	25.3	0.7	0.0	6.5	11.1	0.1	1.0	5.5	7.7	4.2	3.9	0.5	0.0	10.6	1.8	1.4	18.2	18.4	12.8	8.3	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5	11.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	23.9	31.4	0.0	184.0	3.3	8.8	0.0	0.0	0.0	0.0	10.8	7.2	0.0	0.0	1.1	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	16.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	501.8	0.0	0.0	0.0
RTN4IP1	NIMP	ENSG00000130347	"Reticulon 4 interacting protein 1"	Q8WWV3	6	106571971-106629487	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036357	Approved					NA	NA					"HPA036357: AB_10673128"	"prognostic unfavorable (9.18e-6)"	"unprognostic (5.87e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.62e-1)"	"unprognostic (9.82e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.76e-2)"	3.6	10.2	7.8	6.6	8.3	2.9	6.1	8.5	11.2	4.7	10.0	7.7	7.9	7.9	4.1	11.1	6.9	5.1	4.9	15.9	9.1	7.8	11.5	10.0	3.5	12.8	7.3	8.0	4.0	6.7	9.2	8.4	3.8	8.9	4.6	10.1	7.8	6.5	6.4	21.5	4.1	6.0	5.4	6.5	6.2	7.2	6.9	5.1	7.7	7.7	9.7	9.7	4.4	4.0	14.7	10.9	2.4	5.5	7.3	8.1	3.5	6.4	11.5	5.6	12.8	5.0	4.5	8.9	5.0	6.2	8.1	7.0	18.4	4.2	12.5	6.5	5.0	12.8	10.4	11.6	11.1	12.2	6.8	9.0	11.9	8.6	15.5	6.6	11.4	7.8	5.6	7.6	9.3	6.8	4.2	7.0	14.1	21.7	4.7	8.8	10.7	3.8	13.0	9.8	8.8	9.6	15.0	11.9	7.8	12.7	7.2	7.1	4.4	5.6	11.9	9.4	7.0	13.2	9.5	4.4	4.6	5.6	8.8	8.7	3.1	5.0	20.1	12.3	17.7	8.7	0.0	5.0	2.4	3.4	5.5	3.8	11.1	5.0	4.0	10.9	14.7	4.7	4.5	0.9	7.3	3.9	5.7	8.1	3.5	7.8	8.3	8.5	11.2	9.1	7.8	7.3	8.0	8.9	5.1	0.0	3.2	6.4	1.0	0.7	5.6	16.3	5.1	5.3	0.0	1.8	7.9	10.9	23.2	5.7	6.1	1.6	3.3	0.0	7.4	12.3	2.1	0.8	2.3	5.0	6.3	0.0	4.1	2.5	5.7	2.6	0.6	4.1	0.0	0.0	3.0	3.6	5.0	2.9	1.8	11.0	5.6	12.9	1.9	7.1	15.7	0.9	4.7	2.5	6.6	1.4
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.2	6.5	9.0	13.0	5.8	7.3	12.7	7.1	7.4	9.6	9.6	7.5	5.2	20.9	6.6	7.9	9.9	11.1	13.3	8.6	12.1	9.9	10.2	10.1	6.9	7.8	9.1	22.9	9.1	7.2	13.5	10.2	15.1	7.3	6.8	13.2	18.4	6.8	7.9	7.0	7.3	11.2	9.3	10.9	7.6	20.1	11.5	5.3	10.4	7.2	7.8	8.0	5.7	13.4	10.5	8.2	8.7	17.8	6.6	6.8	5.6	7.2	11.0	4.0	5.6	12.2	9.3	15.6	10.0	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7	17.9	8.4	62.4	6.4	3.5	14.2	24.6	10.2	26.8	7.9	10.4	15.7	18.2	14.9	13.3	10.4	10.4	10.5	0.0	15.9	19.4	7.2	6.4	17.4	13.0	11.3	3.2	16.7	8.0	13.2	4.5	7.8	9.0	8.5	14.4	10.5	9.4	12.8	7.0	8.5	14.6	18.7	0.0	6.6	20.7	12.0	4.6	10.3	11.4	19.0	8.4
CD24	CD24A	ENSG00000272398	"CD24 molecule"		6	106969831-106975627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	6	"kidney: 383.7"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	26	"eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0"	"Group enriched"	"Detected in many"	202	"B-cells: 23.4;granulocytes: 30.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	0.5	0.5	12.8	2.4	9.9	17.9	25.5	0.5	2.9	69.5	30.6	0.7	1.6	1.2	34.5	5.9	38.1	6.0	25.1	4.2	22.7		383.7	0.8	0.7	0.9	4.8	7.2	15.6	40.0	0.0	5.7	48.2	13.0	3.2	21.2	0.7	15.9	16.6	0.4	0.5	0.8	2.2	4.9	0.7	16.4	0.5	6.5	0.4	48.8	1.2	11.3	4.0	8.1	23.4	0.0	30.4	0.1	0.0	0.0	0.6	23.4	14.5	0.2	1.9	0.0	0.0	27.5	0.0	0.1	0.1	0.0	0.2	0.1	2.3	7.2	0.0	1.0	48.5	8.2	18.3	0.1	0.0	0.1	0.0	17.9	1.0	0.0	0.3	0.1	0.1	21.1	0.2	1.2	1.1	0.1	0.0	0.5	0.0	0.4	29.4	0.1	0.1	66.4	52.2	5.6	54.8	0.0	0.2	313.7	60.5	41.1	30.3	16.6	91.2	0.0	31.1	42.1	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.1	31.0	0.3	0.1	0.1	0.1	0.0	30.4	0.0	0.0	0.0	23.4	0.0	0.0	0.0	15.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6											145.9	106.6	139.4	57.2	0.0	6.5	1.1	1003.8	691.9	180.9	1235.3	2.0	679.9	1347.9	1087.4	21.0	2.3	819.9	0.0	3019.5	709.4	9.3	444.2	10.4	3.8	61.3	0.0	552.5	53.4	8.9	32.3	9.5	11.8	0.0	55.9	391.5	1.1	1516.5	703.5	2.1	408.2	0.5	6.5	0.4	0.5	4.9	0.0	466.9	12.5	734.9	281.9
C6orf203	"HSPC230, PRED31"	ENSG00000130349	"Chromosome 6 open reading frame 203"	Q9P0P8	6	107028213-107051342	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049535	Approved					NA	NA					"HPA049535: AB_2680808"	"unprognostic (1.34e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.09e-5)"	"unprognostic (2.64e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.19e-2)"	"prognostic favorable (2.11e-5)"	12.5	26.4	18.6	11.4	21.9	4.3	11.9	19.4	18.1	9.8	16.6	11.5	14.2	14.9	9.2	19.4	11.0	10.3	7.7	26.4	17.0	15.3	22.8	20.8	7.6	9.5	16.3	17.0	11.0	18.8	9.8	15.2	8.0	13.5	10.8	16.7	11.1	14.5	11.6	33.1	10.4	12.4	15.6	13.2	9.9	10.9	6.9	12.4	14.1	15.1	11.9	11.0	10.4	9.1	15.9	17.0	10.4	12.6	15.5	21.1	11.0	6.7	4.5	13.7	18.5	26.6	23.0	4.9	14.9	12.1	10.1	13.3	2.5	4.8	19.2	11.2	11.1	10.2	9.2	9.1	13.0	14.2	15.2	6.9	11.5	3.9	4.7	17.6	13.9	6.4	16.4	18.5	8.2	12.8	13.8	14.7	15.3	12.6	13.8	22.0	9.6	5.7	21.2	6.0	22.3	7.6	10.8	11.2	8.3	25.9	10.0	8.0	8.9	7.3	9.3	12.4	10.5	7.2	25.2	10.9	6.8	6.2	8.5	7.6	2.5	3.9	9.6	12.0	21.8	14.0	1.1	12.2	10.4	13.4	12.6	13.7	15.9	15.6	14.5	16.8	14.4	21.1	18.6	1.6	15.5	10.4	17.0	19.5	11.0	18.6	21.9	19.4	18.1	17.0	15.3	16.3	17.0	13.5	12.4	6.0	10.9	9.3	8.0	6.5	12.7	41.2	15.3	25.4	12.5	21.0	7.9	27.4	86.2	18.7	2.6	8.7	20.7	0.0	15.1	12.3	8.4	7.6	19.7	21.3	21.2	12.7	7.5	9.2	5.9	3.0	19.5	10.5	6.8	10.8	17.1	30.3	14.5	17.5	23.7	52.2	15.0	12.9	10.3	22.6	29.9	4.4	15.2	6.9	27.0	6.3
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 12.6"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 5.9;Late spermatids: 5.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	1.8	1.9	1.4	1.8	2.5	1.8	5.6	4.0	2.2	1.6	3.6	1.3	0.8	3.0	2.4	4.2	2.5	2.3	3.6	3.8	1.1	1.3	3.1	4.4	2.0	1.5	1.8	0.8	1.9	12.6	1.8	2.3	1.5	3.3	2.6	3.9	1.3	3.4	1.0	5.0	1.4	4.1	2.5	1.8	2.8	5.0	4.6	1.5	2.4	1.9	3.9	3.6	2.2	1.2	1.5	1.3	2.0	1.0	0.8	1.7	0.4	2.8	4.1	11.3	6.4	1.3	1.0	9.3	1.1	1.5	1.5	1.8	4.6	2.1	8.4	2.9	2.9	2.6	2.8	12.2	6.3	2.5	3.3	6.1	2.3	3.0	5.1	1.1	6.0	3.0	2.5	2.6	2.2	3.2	1.2	1.9	4.0	6.3	3.5	1.9	5.7	5.1	4.6	15.8	7.1	2.6	7.0	3.3	5.5	2.4	8.4	11.5	5.6	3.6	6.1	2.3	6.0	3.6	4.8	2.2	4.1	3.9	1.9	5.4	2.4	3.2	8.6	1.4	4.7	3.2	2.0	0.8	1.5	1.2	1.0	0.9	1.5	1.1	1.1	0.5	1.1	0.8	1.7	1.6	0.8	1.0	1.3	1.2	0.4	1.4	2.5	4.0	1.8	1.1	1.3	1.8	0.8	3.3	1.5	3.0	2.4	0.0	0.8	2.6	1.4	2.8	0.0	1.4	2.3	0.0	5.9	0.8	0.0	0.8	4.2	0.8	0.4	0.0	1.5	1.2	0.6	1.0	0.0	0.6	0.6	0.0	1.2	0.0	1.0	5.2	0.9	0.5	0.0	0.0	2.2	0.2	0.9	0.0	0.0	0.8	1.4	0.0	2.1	0.6	2.5	2.6	0.7	0.0	3.0	0.7
PDSS2	"bA59I9.3, C6orf210"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152557-107459564	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	10.6	27.3	7.2	17.0	8.3	8.3	19.6	9.0	10.3	10.4	12.7	9.0	13.7	9.6	13.1	11.4	11.5	9.2	11.2	16.0	7.0	6.8	22.1	27.4	18.2	18.3	9.2	5.3	10.8	14.0	11.4	19.4	7.0	9.6	15.6	13.9	12.0	19.9	19.9	13.1	9.0	10.1	11.0	8.1	9.1	10.5	12.8	10.1	11.3	14.1	11.1	10.6	10.9	12.9	8.5	9.4	4.1	12.1	4.6	8.3	4.3	5.7	7.7	6.7	10.3	11.5	14.7	15.2	10.2	12.9	9.8	9.5	7.6	8.4	11.0	9.3	11.3	10.5	7.9	16.0	12.7	13.4	7.0	7.8	10.9	9.2	12.7	12.2	14.0	8.8	10.9	15.1	15.5	12.3	8.6	10.3	12.9	15.5	15.0	9.5	7.1	4.0	14.9	4.2	13.3	10.0	7.3	5.9	8.8	12.1	7.9	6.6	5.7	7.0	12.2	14.5	7.5	9.9	17.0	6.4	7.0	4.2	9.8	8.7	4.2	5.1	8.5	13.0	20.9	12.9	4.1	6.6	3.5	5.3	7.6	8.3	6.6	5.6	6.8	9.4	8.5	7.3	6.9	0.9	4.6	12.1	4.5	7.1	4.3	7.2	8.3	9.0	10.3	7.0	6.8	9.2	5.3	9.6	10.1	14.9	15.5	8.3	11.4	3.8	8.1	15.1	10.2	20.1	11.4	14.0	2.0	22.3	29.9	10.8	31.9	6.8	11.2	0.0	12.7	14.4	6.2	15.1	13.9	24.1	10.3	6.4	9.9	5.5	14.1	4.4	4.9	10.4	6.8	6.4	16.1	10.9	11.0	11.5	8.9	33.4	10.1	25.8	5.9	18.1	12.5	5.1	10.0	6.2	17.4	10.7
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107489958-107660167	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 68.3;Horizontal cells: 87.4;Late spermatids: 46.7;Peritubular cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 3.0;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"B-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 11.0;AN3-CA: 14.2;ASC diff: 13.5;HDLM-2: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	7.6	12.0	19.3	4.4	15.6	1.3	3.6	15.1	30.2	12.7	12.8	11.0	2.5	3.7	9.0	5.5	5.6	6.2	7.6	17.0	18.0	12.4	5.8	3.6	5.0	2.9	12.5	14.9	21.6	3.9	10.9	12.0	6.1	9.6	13.0	4.2	7.4	21.1	7.0	22.1	1.5	3.4	14.3	9.6	4.7	5.6	9.1	11.1	1.0	6.1	4.1	3.3	14.8	8.0	4.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	11.0	14.2	13.5	5.2	1.3	0.1	0.0	0.3	0.6	0.0	0.0	5.8	0.4	0.0	1.0	0.0	7.3	0.2	0.2	9.3	6.9	0.7	0.0	6.8	1.8	3.0	0.6	5.4	0.0	5.3	0.0	1.1	4.4	2.7	0.0	0.3	0.0	2.9	1.4	0.3	2.6	0.2	0.9	3.3	1.4	0.0	0.0	0.2	3.6	5.9	1.3	0.0	0.1	0.5	0.5	2.1	0.1	3.5	1.2	6.0	0.5	2.8	0.5	3.8	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.2	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	19.3	15.6	15.1	20.6	18.0	12.4	12.5	14.9	9.6	11.1	3.0	9.8	8.5	8.9	0.5	36.8	20.2	28.1	16.0	5.7	22.7	0.0	0.1	0.0	1.9	68.3	2.8	0.0	0.0	0.2	0.6	7.3	8.4	0.0	0.6	2.3	87.4	10.4	3.7	7.4	46.7	41.7	1.6	3.3	0.0	0.0	6.9	0.5	0.0	46.0	9.8	9.8	25.8	16.1	3.0	2.2	0.6	0.1	0.0	0.0	0.7
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107704104-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.3;lymphoid tissue: 24.6"	"Group enriched"	"Detected in many"	21	"Early spermatids: 71.9;Late spermatids: 104.1;T-cells: 35.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6"	"Group enriched"	"Detected in many"	5	"NK-cells: 17.6;T-cells: 27.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 37.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	1.3	0.6	0.5	13.9	0.6	2.7	1.4	0.3	0.5	1.2	5.4	0.3	0.3	10.1	0.9	4.9	1.3	1.2	2.4	0.6	1.7	0.9	1.7	2.7	3.2	24.6	0.4	0.0	0.7	1.4	0.0	3.9	0.3	0.5	1.2	2.1	1.6	5.7	0.0	0.3	0.9	12.4	0.4	0.9	11.5	2.4	10.4	0.2	23.9	1.5	1.3	24.5	2.3	1.3	4.5	0.3	3.6	0.1	17.6	27.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	2.1	19.5	0.0	18.0	4.5	27.3	24.3	0.0	3.5	26.9	23.9	3.6	17.6	0.1	0.3	2.6	9.4	0.5	0.6	0.3	0.5	1.7	0.9	0.4	0.0	0.5	0.2	0.0	0.0	0.9	0.0	1.3	0.0	0.8	0.0	1.4	0.0	0.0	0.0	1.0	0.0	0.6	71.9	0.3	1.0	0.0	0.0	0.0	0.6	0.0	1.1	1.7	0.2	1.6	0.0	1.3	0.0	104.1	0.9	0.8	3.3	1.0	1.6	0.0	0.1	0.3	0.7	0.0	0.0	0.0	1.0	1.1	0.5	0.1	0.1	35.9	2.9	0.0
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	19.9	26.0	22.2	14.4	20.0	20.2	17.4	17.3	19.2	22.8	17.6	13.9	21.9	11.5	22.4	21.5	16.3	18.6	15.4	19.5	18.4	14.5	14.2	35.2	17.6	10.6	19.2	17.9	30.5	45.8	24.9	32.3	27.9	16.8	20.0	13.3	14.0	46.6	27.2	15.3	14.6	12.6	20.2	20.0	13.7	18.5	21.6	21.5	16.7	36.2	9.3	11.7	24.2	21.4	6.1	9.6	6.3	12.0	9.2	11.1	4.9	11.3	6.9	19.2	23.8	20.1	23.8	17.3	24.3	26.9	11.6	16.6	12.4	14.2	21.2	20.8	21.8	14.4	16.7	13.3	15.6	17.9	25.4	14.7	22.9	11.0	12.7	31.4	26.1	13.6	18.6	25.9	18.6	41.2	21.1	16.2	13.0	19.1	34.3	23.8	9.0	8.1	11.8	15.1	12.1	7.5	26.0	22.7	17.3	14.1	15.1	16.9	19.2	13.4	20.3	24.3	13.7	14.4	38.7	17.4	17.6	10.9	17.5	18.8	13.1	9.6	21.2	19.4	22.9	20.0	6.3	7.3	6.3	7.0	6.3	11.1	6.1	5.9	5.7	7.4	6.1	6.6	5.1	2.5	9.2	12.0	9.6	3.1	4.9	22.2	20.0	17.3	19.2	18.4	14.5	19.2	17.9	16.8	21.5	110.2	115.9	47.7	57.1	75.6	58.2	69.4	73.9	135.1	136.5	50.6	37.3	67.2	10.0	69.3	20.3	58.5	30.2	0.0	109.1	79.1	85.4	76.0	66.0	118.1	56.0	44.5	51.5	63.3	51.7	13.6	98.4	64.0	75.9	27.1	61.3	52.4	75.9	58.8	111.7	36.6	44.0	45.3	91.8	139.3	53.4	69.9	76.1	46.5	54.2	62.9
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Melanocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.1	6.4	7.6	11.1	23.0	7.5	10.9	16.0	16.1	11.7	19.5	3.8	3.6	5.0	13.2	11.1	31.6	4.1	7.5	5.4	18.1	11.5	5.9	10.6	4.1	4.7	17.8	11.6	24.7	10.9	13.6	14.4	11.5	10.8	5.9	5.7	8.3	18.5	18.9	3.0	2.5	2.6	3.0	2.6	4.9	4.1	11.1	2.7	8.4	5.8	0.8	4.5	12.9	3.3	28.5	10.6	3.7	16.9	7.2	10.3	3.8	22.7	22.6	7.1	12.1	4.4	30.4	7.9	22.6	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7	8.9	21.3	25.4	14.7	41.4	29.2	18.5	12.7	5.3	6.8	12.2	9.8	18.7	1.7	10.8	3.4	18.0	10.3	0.0	19.8	29.3	16.9	16.3	24.2	12.4	46.3	27.0	4.1	28.8	46.6	2.7	13.3	33.0	143.4	10.8	4.2	24.0	15.6	12.9	26.9	21.0	15.7	25.8	33.9	19.8	19.5	27.1	51.1	27.7	2.9	14.0
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166058-108188809	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 19.0"	"Cell type enriched"	"Detected in single"	50	"Muller glia cells: 39.7"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.4;GAMG: 3.0;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: AB_2682871"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.6	1.1	14.5	0.6	16.0	0.8	0.8	0.0	19.0	0.6	0.6	2.8	0.0	0.7	0.6	0.6	0.6	0.6	0.6	0.7	10.8	4.3	0.9	0.6	0.6	0.7	3.5	7.5	0.7	0.7	0.8	0.1	0.7	0.0	0.6	0.6	3.3	1.0	0.6	0.7	0.9	0.6	0.6	0.0	0.7	0.7	0.8	4.1	0.0	0.7	0.0	0.6	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	2.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	14.5	16.0	0.0	10.0	10.8	4.3	3.5	7.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261260	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		730000				"prognostic unfavorable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	63.4	66.9	67.1	36.1	59.2	73.4	125.2	34.4	63.8	40.7	45.5	32.5	29.9	34.3	38.8	47.2	60.2	37.4	39.1	81.1	62.3	53.5	49.3	77.7	42.1	53.6	57.7	41.2	55.8	41.1	27.7	27.8	57.2	34.1	49.7	34.0	25.3	37.9	37.6	82.7	32.4	38.1	52.1	53.7	52.3	32.4	34.3	35.1	35.7	69.7	46.7	45.9	52.6	179.0	52.3	34.3	42.0	20.0	16.3	13.5	16.6	26.3	16.1	15.9	52.1	86.9	65.6	24.8	40.6	39.8	31.6	39.3	25.3	19.6	22.5	40.2	51.5	55.7	21.1	35.2	34.2	43.4	27.8	26.0	43.9	20.2	29.3	47.0	29.5	29.6	55.7	47.1	30.2	34.4	50.4	51.9	21.7	42.0	26.8	43.6	25.2	11.1	64.6	13.3	32.3	28.5	12.1	38.7	23.2	50.0	37.1	18.6	26.1	25.7	32.9	40.7	37.5	16.5	101.1	39.0	27.3	18.6	36.6	51.6	11.0	14.5	24.0	48.2	54.1	32.5	24.6	20.0	42.0	10.5	17.8	13.5	52.3	12.4	11.0	28.7	40.9	12.7	10.4	12.9	16.3	16.9	34.3	12.3	16.6	67.1	59.2	34.4	63.8	62.3	53.5	57.7	41.2	34.1	35.1	98.3	59.5	318.1	274.6	336.6	46.4	376.8	132.5	84.3	63.7	181.5	15.7	567.2	545.5	271.5	306.4	229.2	200.3	163.5	222.6	454.3	369.8	200.3	168.0	224.1	807.9	41.3	122.8	235.7	416.7	366.9	267.2	452.1	349.2	395.0	120.2	203.2	234.3	181.8	250.7	585.2	42.0	252.2	337.7	188.4	150.5	385.3	517.1	156.6	154.3	287.9
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294894-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 10.7;Club cells: 9.1;Distal tubular cells: 8.3;Proximal tubular cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	4.9	7.3	7.6	6.5	6.6	4.3	5.7	6.2	7.3	4.1	5.7	7.3	6.9	8.9	3.7	4.9	5.5	5.1	4.8	9.4	6.3	4.9	11.0	7.6	9.1	4.8	7.3	7.4	4.1	5.2	11.6	6.9	4.7	6.1	3.9	7.0	5.5	4.7	5.4	9.0	4.2	6.3	4.0	5.6	4.4	6.0	25.4	6.5	5.6	6.6	4.1	4.5	4.8	4.3	5.7	3.0	5.1	7.2	4.2	4.4	1.7	3.5	1.9	4.7	8.2	4.8	7.1	4.6	3.9	5.9	6.6	6.5	7.4	4.4	6.3	5.3	6.1	7.8	2.0	5.9	5.9	7.4	3.6	3.5	7.5	2.4	8.6	4.8	6.6	3.7	6.6	4.9	4.9	8.0	4.2	3.5	4.8	7.5	3.0	6.1	3.3	1.2	6.2	3.0	6.0	3.7	4.4	6.3	3.6	8.2	3.9	5.1	4.5	3.3	4.7	8.7	6.5	3.8	13.0	4.3	4.0	1.0	3.5	4.5	2.1	3.2	4.9	5.0	7.9	6.1	0.0	3.1	5.1	2.0	2.2	2.6	4.8	3.2	3.8	2.7	5.7	4.4	2.9	0.8	4.2	7.2	3.0	4.1	1.7	7.6	6.6	6.2	7.3	6.3	4.9	7.3	7.4	6.1	6.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	9.1	3.5	0.0	5.1	8.3	2.7	0.0	0.0	0.0	0.0	3.3	4.1	0.0	0.0	2.3	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.9	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	29.6	7.7	11.5	12.2	12.6	36.7	35.4	28.0	18.1	19.9	16.1	12.6	9.8	7.8	17.4	16.1	22.3	16.5	18.0	12.9	9.7	7.7	10.7	14.0	21.1	16.8	12.4	14.0	28.8	52.3	14.3	8.8	13.1	10.3	13.8	11.0	14.3	21.2	10.5	54.7	20.3	11.3	13.9	7.9	14.2	14.8	13.1	13.2	11.6	13.1	12.7	10.2	17.1	20.3	1.8	2.7	15.7	4.6	3.4	4.0	1.0	9.1	3.3	6.0	9.7	18.6	22.3	7.5	7.6	8.0	6.7	9.2	5.9	8.3	5.9	6.5	8.9	9.8	6.7	6.2	9.3	10.0	5.3	9.0	14.7	2.9	4.4	21.7	3.5	10.8	25.4	18.8	13.7	18.8	9.3	5.0	5.4	9.8	40.1	12.1	5.2	4.9	5.4	3.9	4.4	5.0	5.7	17.1	19.7	13.3	7.0	10.6	27.6	6.5	5.3	7.6	11.0	5.8	11.7	8.0	11.4	6.4	7.0	9.8	0.7	6.9	5.6	6.2	7.1	7.8	6.7	2.9	5.7	3.6	1.5	4.0	1.0	1.9	3.0	1.7	1.8	1.7	2.3	15.7	3.4	4.6	2.7	1.8	1.0	11.5	12.6	28.0	18.1	9.7	7.7	12.4	14.0	10.3	13.2	41.7	39.5	22.4	61.6	60.1	55.0	28.2	73.9	44.2	46.6	24.4	66.8	19.2	14.9	43.0	12.5	63.2	36.2	210.2	26.5	31.0	67.9	115.8	15.0	60.6	39.1	49.3	64.2	66.9	66.3	12.1	98.7	35.8	54.0	43.3	49.3	89.6	53.0	33.6	94.4	15.9	67.1	32.3	89.8	7.2	18.1	40.7	34.4	35.5	29.9	108.9
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974472	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.8"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 88.3;Early spermatids: 89.1;Late spermatids: 112.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025809: AB_1845032, HPA053696: AB_2682233"	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	6.0	5.2	13.3	5.6	19.6	7.8	7.3	9.6	14.7	7.4	4.2	7.9	2.1	2.0	8.2	11.9	3.7	21.5	5.4	9.4	12.2	7.0	4.6	2.8	8.8	4.0	4.0	11.8	6.1	3.3	9.9	20.0	7.0	16.7	4.4	4.9	5.7	3.8	5.2	3.7	5.3	3.5	4.4	6.3	5.8	4.9	31.8	7.1	2.4	11.0	2.8	4.3	4.0	5.0	2.7	4.6	9.5	4.7	4.8	7.0	1.6	3.4	2.1	10.3	6.5	5.1	6.4	2.3	2.1	2.9	5.4	7.2	3.1	3.1	5.4	2.7	3.4	8.3	3.0	5.6	4.2	9.4	1.5	4.8	5.1	4.7	3.2	2.8	7.8	2.3	7.3	5.9	6.2	1.8	7.2	5.0	16.6	2.1	8.4	5.5	2.6	6.7	7.1	3.2	3.3	2.6	7.7	8.5	4.4	4.9	4.1	14.4	5.3	7.3	1.9	5.1	6.0	3.7	4.0	2.5	4.6	2.4	3.8	2.8	3.9	5.2	4.6	7.8	5.5	5.7	4.3	3.5	0.9	3.4	4.7	3.2	1.4	2.7	3.7	2.8	2.7	1.6	3.9	9.5	4.8	3.7	4.6	7.0	1.6	13.3	19.6	9.6	14.7	12.2	7.0	4.0	11.8	16.7	7.1	8.9	3.0	0.0	1.1	0.9	1.5	4.3	2.5	88.3	18.2	0.0	0.0	1.3	0.0	0.8	89.1	1.2	0.0	0.0	0.8	1.7	1.3	0.8	0.0	0.2	3.2	1.6	1.7	0.6	3.7	112.4	6.4	1.3	5.0	0.0	0.3	1.8	0.7	0.0	9.6	1.2	5.2	0.0	2.3	27.6	5.5	1.3	0.5	2.9	0.5	0.7
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"B-cells: 21.0;NK-cells: 21.8;T-cells: 30.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	23.5	14.2	14.5	11.0	23.7	22.7	39.3	21.2	18.9	13.2	16.9	10.2	17.3	10.3	17.1	14.4	11.9	15.2	10.0	32.4	13.0	11.3	8.8	14.1	17.5	54.1	12.2	14.6	33.0	16.1	18.1	25.6	26.8	13.0	15.2	12.8	9.5	10.0	17.2	69.2	19.7	18.6	17.9	13.7	19.3	14.9	20.8	13.6	9.6	18.2	15.4	16.4	16.1	15.3	21.0	2.1	3.9	3.0	21.8	30.6	7.8	1.5	2.5	11.6	5.4	14.8	19.0	36.5	6.1	7.0	2.1	4.1	4.7	1.6	12.8	5.2	4.5	1.6	1.8	3.1	12.2	2.6	1.1	15.5	5.6	3.2	17.7	9.1	2.2	5.8	20.4	19.5	3.8	6.2	9.3	11.0	3.7	4.1	9.2	10.4	3.0	4.8	7.0	4.7	2.4	1.6	3.9	3.3	5.8	4.6	7.7	2.8	5.8	3.3	2.1	2.4	19.6	2.0	14.6	6.7	1.6	3.2	1.5	1.9	9.3	5.3	5.2	3.6	5.6	3.5	3.9	1.0	1.2	14.2	2.3	30.6	4.4	13.3	11.1	1.0	21.0	16.6	8.8	3.9	21.8	3.0	2.1	5.6	7.8	14.5	23.7	21.2	18.9	13.0	11.3	12.2	14.6	13.0	13.6	59.6	15.3	22.2	3.5	5.8	21.5	24.9	17.8	34.8	22.7	14.0	43.2	39.6	8.3	3.4	108.0	6.3	7.9	0.0	4.7	11.8	13.0	7.1	3.5	11.6	35.8	25.4	14.9	11.1	30.9	78.2	31.9	10.8	15.1	9.0	9.7	36.4	2.9	8.6	33.2	5.8	42.4	25.8	13.3	13.2	15.7	7.3	37.3	34.6	11.5	2.3
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109163932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	11.9	9.3	10.6	7.3	13.5	8.9	11.4	13.9	16.1	11.3	8.8	8.1	8.6	8.4	9.6	10.9	8.0	7.1	9.3	10.4	8.9	6.9	8.1	11.8	8.4	8.1	10.2	10.5	9.3	7.5	18.5	13.5	9.7	13.5	7.1	11.1	7.0	7.4	7.3	7.8	6.8	7.6	10.7	12.8	7.2	7.8	24.6	11.8	6.3	8.7	6.1	6.9	7.6	9.1	7.4	6.9	14.6	10.3	13.4	8.2	5.2	8.3	3.6	11.0	11.2	10.5	17.4	8.9	19.3	10.5	17.1	19.6	5.5	7.3	7.4	8.9	9.8	15.0	4.4	7.6	7.1	27.1	9.4	7.4	15.9	8.7	5.7	9.7	13.0	7.0	10.0	5.5	14.6	14.6	9.5	14.9	25.1	28.8	25.8	15.7	5.6	14.5	11.3	3.6	6.8	7.1	12.0	8.3	7.4	8.1	3.5	8.5	6.9	9.4	7.1	6.3	7.6	8.9	20.8	7.2	11.3	6.8	11.9	20.1	7.5	8.5	11.8	10.7	20.1	9.1	14.6	6.3	7.4	6.1	7.1	6.2	4.0	6.0	8.2	6.7	7.4	5.8	8.2	3.6	13.4	10.3	6.9	8.0	5.2	10.6	13.5	13.9	16.1	8.9	6.9	10.2	10.5	13.5	11.8	6.0	4.0	2.2	6.5	3.0	6.0	8.1	2.5	12.0	7.9	5.2	19.6	7.0	6.6	6.5	36.0	8.7	4.2	23.3	4.7	11.0	11.8	3.3	4.7	4.9	8.4	4.8	5.2	6.7	4.4	26.1	16.1	5.9	8.5	8.2	2.6	9.4	5.0	5.5	11.7	10.4	12.0	12.9	12.8	72.6	5.0	3.9	7.1	6.9	4.5	3.0
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382812	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010636: AB_1078447"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.51e-1)"	85.0	37.6	17.1	37.2	28.5	38.0	72.9	11.2	19.2	34.2	55.2	31.1	57.4	50.5	35.6	44.4	29.6	31.7	58.1	32.0	18.6	22.6	67.4	66.1	52.5	60.9	45.2	16.7	38.0	49.2	30.4	55.0	106.6	28.2	33.4	57.4	44.1	75.1	49.6	38.5	30.6	100.2	41.5	42.8	43.2	55.8	38.1	30.2	50.7	73.3	25.0	34.7	40.3	37.2	32.6	54.2	66.1	48.9	61.1	46.7	83.2	20.5	11.5	6.1	38.6	88.3	85.3	37.4	38.6	48.7	34.7	50.1	23.0	31.4	16.6	37.4	41.8	34.9	20.3	22.9	24.7	53.7	34.0	22.9	28.2	12.3	27.7	52.4	33.2	67.3	66.8	49.0	34.3	31.4	48.7	32.1	14.7	26.9	44.3	47.9	21.5	31.3	41.5	9.1	46.7	18.8	20.6	18.0	20.9	51.2	27.7	6.5	13.2	23.5	31.5	56.3	31.1	27.5	44.1	32.4	22.7	16.6	32.5	30.5	16.8	23.6	19.1	40.9	39.0	23.3	66.1	47.6	39.9	44.7	48.9	46.4	32.6	36.5	40.9	47.1	28.8	38.3	40.7	32.7	61.1	45.5	54.2	46.7	83.2	17.1	28.5	11.2	19.2	18.6	22.6	45.2	16.7	28.2	30.2	151.8	62.8	154.7	162.8	177.7	29.5	60.1	211.5	374.8	95.5	266.9	23.6	193.9	79.6	146.9	73.7	93.1	381.3	23.3	120.3	352.8	194.4	248.6	124.8	160.3	277.6	31.8	159.9	106.2	314.8	72.5	147.0	269.8	234.5	92.8	363.1	107.0	148.8	273.5	171.1	307.5	42.7	122.9	177.2	153.3	160.8	202.0	564.1	162.5	216.7	229.5
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 187.4;Early spermatids: 262.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.0	1.2	6.5	10.4	12.9	1.1	0.0	2.3	0.5	0.2	0.1	1.8	0.0	0.5	0.6	0.9	1.2	1.0	0.0	0.3	0.5	0.9	0.5	0.1	0.0	5.2	0.6	0.3	2.7	6.2	0.2	3.9	9.3	0.8	1.4	0.9	0.3	0.4	0.6	0.1	0.6	0.2	4.2	1.3	0.8	0.0	0.6	5.0	0.1	1.5	2.5	0.2	0.3	4.3	0.3	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.1	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3	6.0	5.8	0.0	3.5	1.9	2.1	3.3	5.1	187.4	22.7	3.5	2.0	0.5	21.6	1.6	262.5	1.5	0.7	0.0	1.0	0.7	1.7	2.9	0.0	0.0	0.3	1.6	2.9	0.6	0.0	40.8	4.9	0.5	3.3	1.0	1.8	4.9	0.7	0.0	4.9	8.0	11.5	0.0	1.2	52.6	22.0	2.6	0.6	0.5	1.7	1.1
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 151.6;Late spermatids: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.7	5.3	18.3	3.0	11.2	7.6	7.2	9.8	7.3	4.9	6.4	6.4	16.0	11.5	5.5	13.2	4.6	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	8.5	6.9	8.7	11.0	8.7	3.7	12.9	10.0	13.5	1.5	11.9	5.0	7.1	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.9	13.5	4.6	5.7	12.0	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	6.0	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7	11.9	7.4	4.2	8.5	8.8	1.3	2.0	12.7	58.9	7.9	12.2	3.9	8.2	1.7	14.7	151.6	3.8	27.2	0.0	17.1	16.1	6.0	12.7	0.0	3.2	8.5	0.0	8.1	4.3	6.6	248.2	8.6	10.8	8.5	11.8	21.2	2.3	13.7	24.6	8.5	7.9	5.2	12.9	2.8	36.6	10.6	16.3	14.2	4.9	13.8	13.7
MICAL1	"DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL"	ENSG00000135596	"Microtubule associated monooxygenase, calponin and LIM domain containing 1"	Q8TDZ2	6	109444062-109465968	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030175, HPA030176, HPA030178"	Approved					NA	NA		32000			"HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.05e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	10.5	4.2	17.6	20.4	13.5	45.9	9.0	18.1	18.6	18.9	13.3	9.2	10.5	28.9	16.6	7.3	10.1	14.5	11.5	5.0	16.1	9.6	9.2	3.0	17.8	22.6	10.7	12.8	7.4	4.6	10.1	9.9	12.1	10.8	16.2	9.0	6.7	6.5	17.0	3.1	9.8	29.5	22.8	9.1	29.8	12.5	9.3	10.5	12.6	6.9	4.6	16.2	30.3	23.3	5.0	13.5	11.7	12.5	4.5	8.4	5.3	1.4	1.7	5.8	0.1	21.4	16.7	3.9	11.0	8.0	2.4	4.1	2.6	1.7	8.1	2.5	12.1	7.2	1.9	3.5	4.4	1.1	7.1	1.4	3.4	3.8	3.9	8.5	2.2	0.1	9.6	2.2	5.8	4.8	9.5	7.3	5.0	0.9	14.1	14.9	1.7	2.8	12.3	3.7	2.0	1.9	7.7	3.7	1.1	5.5	3.5	1.9	10.2	1.1	1.0	17.7	3.9	1.7	53.0	7.7	6.1	2.1	3.5	4.3	10.8	3.3	7.3	5.0	7.5	4.4	10.1	6.4	11.7	6.3	12.4	3.9	3.4	6.3	5.0	11.8	5.0	4.4	3.0	8.4	4.5	12.5	13.5	8.4	5.3	17.6	13.5	18.1	18.6	16.1	9.6	10.7	12.8	10.8	10.5	41.7	15.6	8.8	1.1	5.5	3.0	2.8	0.0	14.7	6.8	1.8	3.9	1.0	1.7	6.8	11.2	3.5	32.0	0.0	5.8	10.2	8.0	1.7	14.0	0.0	28.6	0.0	30.8	4.9	26.3	14.4	19.2	34.7	15.1	41.5	28.8	2.0	10.6	31.6	35.3	4.2	16.7	0.0	30.8	5.1	9.8	4.3	4.0	12.8	9.7	1.0
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483237	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	9.6	7.1	6.6	13.8	13.7	16.6	10.1	12.7	11.5	9.5	7.5	11.4	6.8	7.6	9.8	7.5	8.4	8.4	6.4	5.5	7.0	6.8	9.1	6.6	8.5	16.9	11.5	8.8	8.3	8.2	19.1	10.0	12.4	8.8	8.8	8.5	9.6	9.8	9.1	9.7	12.2	11.1	8.5	7.7	13.7	8.6	9.0	12.1	17.4	10.8	5.2	17.1	10.0	10.2	5.7	2.2	1.7	1.5	2.4	5.3	1.0	3.9	4.1	3.8	9.4	6.1	6.2	6.2	4.5	6.3	5.8	6.6	5.7	3.1	16.9	5.9	5.7	6.9	5.2	9.5	7.1	8.7	10.4	9.3	13.7	5.5	4.3	4.5	11.1	7.0	6.2	5.9	5.8	10.1	4.0	4.7	8.0	11.4	9.5	5.9	6.8	15.8	7.5	9.3	4.0	4.6	10.0	5.3	7.0	7.1	6.8	6.4	5.6	5.8	6.2	14.4	5.5	4.3	12.1	4.6	4.7	4.7	3.9	9.8	4.6	3.6	17.3	6.1	8.8	7.8	0.1	1.2	1.7	1.5	1.1	0.9	5.7	3.0	1.8	1.4	5.6	3.9	2.2	0.8	2.4	1.5	2.2	5.3	1.0	6.6	13.7	12.7	11.5	7.0	6.8	11.5	8.8	8.8	12.1	11.9	7.8	15.9	6.2	9.0	17.3	3.3	7.6	8.1	5.7	3.5	29.5	7.0	3.3	6.8	1.3	4.5	5.5	0.0	7.9	9.4	7.3	5.9	9.2	5.0	6.9	9.5	9.2	3.1	12.6	1.1	6.6	8.9	8.5	22.6	11.1	8.1	5.5	3.5	6.0	6.1	63.1	0.0	4.2	4.6	29.8	8.4	6.5	14.9	7.8	5.8
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 165.9;Spermatocytes: 116.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.5	1.8	7.6	13.5	7.1	4.5	5.7	4.0	5.0	4.2	5.7	2.9	5.3	5.5	2.1	3.7	9.2	4.5	2.2	4.3	8.9	11.7	4.7	4.2	4.4	2.9	5.8	5.3	2.6	3.6	8.4	7.7	10.1	10.3	5.5	8.4	3.9	4.6	3.1	5.2	4.6	3.5	1.7	5.8	2.9	6.1	4.2	5.1	6.1	5.0	9.2	7.9	4.8	4.6	6.6	4.5	6.0	6.4	5.8	4.0	2.7	5.8	2.6	2.4	2.1	3.2	8.1	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7	26.8	18.8	6.6	7.7	2.4	14.6	16.1	2.5	165.9	18.2	8.7	13.7	3.3	0.0	7.0	55.8	11.3	10.5	0.0	3.9	1.2	3.5	4.8	20.9	1.8	3.0	19.1	19.0	5.5	4.6	32.1	6.9	5.3	5.0	1.8	14.3	15.2	6.1	7.8	6.0	5.6	48.9	25.8	5.2	116.9	28.5	2.3	4.7	12.8	9.9	7.5
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109691312-109825428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	11.0	13.5	14.5	12.2	30.3	14.0	14.4	13.5	35.3	12.4	13.2	11.0	5.0	8.3	11.3	17.0	11.7	10.5	13.4	10.1	14.5	18.5	13.2	8.7	19.2	16.6	17.6	17.7	12.2	9.9	25.4	15.4	12.6	19.0	11.6	14.6	9.7	17.0	12.0	12.1	9.2	10.7	14.7	16.0	17.3	11.4	12.6	12.9	18.1	12.6	8.5	15.0	12.5	10.5	15.5	15.9	12.8	20.0	8.0	7.7	9.8	6.2	6.5	9.8	11.7	10.4	14.4	6.2	8.1	11.7	6.7	18.0	4.8	6.6	16.8	5.2	13.1	12.4	4.7	9.6	6.4	15.6	10.2	11.7	9.4	6.5	4.8	9.6	8.8	8.4	7.4	8.4	11.4	7.9	17.2	13.6	11.1	5.5	7.2	9.4	5.8	9.0	7.6	5.1	9.3	3.2	6.3	4.5	5.8	11.3	15.5	10.9	10.2	5.3	7.8	16.4	12.5	5.6	14.7	9.5	4.2	3.6	6.1	6.9	3.4	2.4	8.1	22.3	6.3	3.8	11.5	20.0	12.8	7.7	19.7	6.0	14.6	5.7	7.3	15.9	15.5	7.0	6.8	8.7	8.0	13.5	6.9	6.6	9.8	14.5	30.3	13.5	35.3	14.5	18.5	17.6	17.7	19.0	12.9	14.9	7.0	5.9	6.5	4.0	6.1	5.1	5.1	9.4	4.5	8.7	2.0	11.5	5.0	8.9	13.3	5.0	5.3	0.0	9.9	5.8	4.4	4.5	8.1	3.8	20.0	1.6	9.8	6.2	20.5	13.8	3.1	13.5	8.5	9.0	8.8	7.5	6.8	6.8	6.3	6.3	6.0	0.0	6.6	4.9	11.7	3.9	10.3	10.7	6.1	7.6
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	19	"brain: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"basal ganglia: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SCLC-21H: 4.6"	"Region enriched"	"Detected in some"	11	"basal ganglia: 81.5"											NA	NA										"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.4	0.5	3.5	0.4	42.5	0.5	0.4	0.0	6.5	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.8	0.4	0.4	0.4	0.4	0.1	0.8	0.4	0.4	0.4	2.2	0.4	0.0	0.4	0.4	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.5	4.6	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	42.5	0.0	4.0	1.3	1.8	0.1	0.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WASF1	"KIAA0269, SCAR1, WAVE, WAVE1"	ENSG00000112290	"WAS protein family member 1"	Q92558	6	110099819-110180004	"Predicted intracellular proteins"		Actin-binding	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.3;ovary: 17.7;testis: 55.4"	"Cell type enhanced"	"Detected in many"	23	"Early spermatids: 160.4;Late spermatids: 354.5;Spermatocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"memory B-cell: 3.9;naive B-cell: 5.9;plasmacytoid DC: 10.7"	"Group enriched"	"Detected in many"	10	"B-cells: 5.9;dendritic cells: 10.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 42.3"	"Low region specificity"	"Detected in all"							"HPA004105, CAB022161"	Approved	Supported				NA	NA					"CAB022161: , HPA004105: AB_1080583"	"unprognostic (8.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.82e-8)"	"unprognostic (9.20e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.38e-1)"	5.4	7.6	19.8	3.4	44.3	7.1	5.5	18.0	63.3	5.4	3.9	10.9	0.5	2.3	9.9	5.1	6.1	4.9	6.6	1.8	43.8	10.3	6.5	4.6	2.6	3.3	10.6	26.7	17.7	4.6	4.1	5.8	2.8	17.0	4.3	3.5	0.9	3.3	4.3	1.3	4.3	2.7	10.5	12.8	2.4	3.0	55.4	9.3	1.0	2.3	0.6	3.4	4.6	2.8	5.9	10.7	0.1	0.8	0.6	0.3	0.5	3.4	3.9	20.4	16.6	8.8	11.5	2.2	7.2	8.3	6.2	10.8	6.6	3.3	19.6	4.7	11.3	9.2	3.9	31.8	9.9	10.8	0.3	15.0	38.3	7.5	6.0	15.9	2.2	5.9	9.0	14.0	8.6	42.3	9.0	9.4	9.7	14.4	4.6	7.1	2.8	20.1	0.6	18.4	2.5	5.0	18.5	7.5	0.7	9.9	3.9	16.5	25.6	5.1	3.8	4.7	22.2	4.8	9.8	6.9	5.7	5.9	16.6	9.6	0.1	3.0	17.2	6.4	16.5	4.2	0.0	0.7	0.0	0.1	0.2	0.3	3.9	0.3	0.0	0.8	5.9	0.1	0.1	0.1	0.6	0.8	10.7	0.0	0.5	19.8	44.3	18.0	48.9	43.8	10.3	10.6	26.7	17.0	9.3	0.0	0.0	0.0	1.9	13.2	11.4	0.9	0.0	0.0	1.2	0.0	5.9	3.3	1.7	4.4	160.4	1.8	0.0	23.3	0.8	2.7	5.6	2.3	0.0	5.6	0.9	9.5	12.1	6.7	3.0	354.5	16.7	1.6	3.3	0.0	2.0	4.6	1.7	0.9	8.9	9.5	6.2	6.5	3.7	66.2	20.5	7.8	1.5	0.0	0.5	1.8
CDC40	"EHB3, FLJ10564, PRP17, PRPF17"	ENSG00000168438	"Cell division cycle 40"	O60508	6	110180141-110254275	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 179.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046620			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA046620: AB_2679722"	"unprognostic (4.19e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.09e-1)"	13.1	20.7	13.4	13.9	32.8	36.3	15.3	15.4	34.1	15.0	12.7	12.4	11.7	12.0	13.8	12.1	13.3	12.7	11.7	11.3	18.0	11.0	19.9	19.9	12.0	19.5	12.7	12.5	18.7	14.3	17.1	34.0	11.9	14.7	14.5	13.8	11.4	13.3	11.6	16.4	11.8	14.9	13.1	11.6	21.3	12.4	13.1	13.3	29.1	18.1	12.7	19.8	14.2	12.6	23.6	19.8	18.3	17.3	12.4	14.0	7.7	6.6	6.2	11.2	19.5	11.6	12.0	9.2	13.0	16.1	13.2	16.8	13.6	6.9	22.4	14.6	11.6	14.2	9.6	17.2	10.6	18.9	18.0	13.1	18.4	8.9	7.4	15.1	23.5	24.8	10.9	10.2	13.9	11.3	9.9	13.1	14.7	18.3	13.6	13.2	6.5	17.4	8.9	11.2	9.1	6.8	15.3	13.2	7.7	9.7	14.2	12.0	11.9	9.6	8.5	9.2	10.7	7.9	22.8	14.7	7.2	7.2	16.8	14.4	6.9	9.1	20.3	11.7	19.9	10.4	18.3	15.0	15.3	11.7	15.8	11.3	23.0	11.6	11.9	12.4	23.6	14.0	12.0	16.9	12.4	17.3	19.8	12.7	7.7	13.4	32.8	15.4	34.1	18.0	11.0	12.7	12.5	14.7	13.3	29.8	29.9	51.1	24.2	23.5	87.2	18.1	22.9	29.4	31.8	26.2	41.2	28.3	48.0	32.3	179.7	34.6	21.6	0.0	32.6	26.0	25.8	20.0	48.5	50.8	33.4	89.0	25.3	38.6	28.2	63.6	62.5	41.9	10.1	21.6	26.9	50.0	24.6	31.7	42.5	58.7	77.9	77.6	20.3	18.2	18.8	23.7	24.0	42.6	31.9	17.4
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 4.3;Horizontal cells: 1.6;Late spermatids: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	34	"T-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;fHDF/TERT166: 2.6;HHSteC: 3.1;SCLC-21H: 4.6;SH-SY5Y: 2.8;SuSa: 4.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	2.1	1.9	2.4	3.7	2.8	0.0	1.8	2.8	2.1	11.9	10.8	2.9	4.8	1.5	16.2	5.0	5.6	7.0	9.6	3.2	2.1	1.9	5.2	1.1	2.4	0.6	2.1	2.7	9.2	2.3	5.8	4.6	0.3	2.2	8.6	5.0	10.2	1.1	8.6	0.4	1.1	4.0	16.1	2.8	0.6	6.0	2.8	1.5	0.6	2.1	3.0	1.5	13.3	5.1	0.0	0.1	0.0	0.0	0.2	7.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.8	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.4	2.8	2.8	2.1	2.1	1.9	2.1	2.7	2.2	1.5	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.1	5.0	1.2	0.8	0.0	0.0	0.0	0.7	0.7	10.9	0.0	0.0	0.0	2.2	4.5	0.0	4.6	0.0	3.9	1.6	0.0	0.0	0.1	0.0	2.5	0.1	2.2	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.8	14.2	0.0	4.5	0.1	0.1	0.0	0.4	0.6	0.0	0.7	1.0	0.8	1.0	0.1	0.0	2.3	0.1	0.3	0.0	1.9	15.8	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2	0.0	0.0	0.0	0.8	0.0	0.0	14.1	0.0	1.4	0.0	0.0	2.0	0.1	3.3	2.8	0.0	0.3	2.7	0.0	1.9	0.1	0.3	0.3	0.0	4.4	1.8	0.0	4.1	2.5	4.0	0.0	0.3	1.1	0.0	1.0	5.9	9.1	1.2	6.0	0.0	9.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.3
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Predicted membrane proteins"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 9.5"	"Group enriched"	"Detected in many"	66	"dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5"	"Group enriched"	"Detected in some"	18	"NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4"					"Low region specificity"	"Detected in all"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	3.5	0.2	0.2	0.4	0.2	16.0	0.2	0.1	0.2	0.1	0.7	0.0	0.0	0.0	4.9	0.8	0.1	0.3	0.7	0.1	0.2	0.1	1.1	0.3	1.6	0.0	0.2	0.0	0.9	0.1	9.6	0.1	0.3	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.1	1.6	0.2	0.8	0.2	26.4	0.0	2.2	0.1	0.8	0.1	0.1	0.1	0.0	5.1	5.0	9.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.4	0.0	5.0	9.5	1.6	0.0	2.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	23.3	0.0	0.1	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.2	23.1	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	35.7	0.2	0.4	0.0	0.0	0.0	0.0
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 84.5;Late spermatids: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA007053: AB_1233803"	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	5.3	3.3	18.1	6.1	29.4	9.7	6.0	13.8	21.3	6.6	6.3	31.1	2.4	4.8	9.6	3.7	7.8	5.3	7.8	4.1	20.8	10.1	6.3	4.6	6.2	8.0	22.1	12.9	9.7	3.1	8.0	4.1	10.5	14.4	25.8	6.1	3.4	4.5	5.9	3.2	7.9	5.9	7.1	20.8	7.0	6.5	16.4	26.3	6.1	5.8	1.3	8.4	5.9	6.4	1.3	1.8	8.5	2.2	1.3	0.8	0.6	3.6	3.9	13.7	16.5	7.4	10.7	7.1	11.9	12.7	4.5	5.9	4.9	4.1	9.3	4.3	8.3	9.0	2.1	5.2	2.5	10.3	11.5	3.0	15.8	5.8	5.7	4.5	6.4	11.9	7.3	5.6	6.1	9.5	11.3	4.4	7.9	4.8	13.0	9.6	5.9	8.6	9.6	1.3	5.2	2.7	9.2	7.0	3.5	5.2	6.7	7.0	13.0	9.0	7.4	10.6	4.8	2.5	23.6	4.9	9.4	5.0	18.9	7.2	1.4	1.9	8.0	9.9	8.7	9.7	3.3	2.2	1.5	0.8	1.2	0.8	1.1	0.7	0.7	1.8	1.3	0.5	0.7	8.5	1.3	0.7	0.9	0.8	0.6	18.1	29.4	13.8	21.3	20.8	10.1	22.1	12.9	14.4	26.3	3.0	16.2	8.1	13.2	8.8	17.3	6.2	12.7	4.0	7.9	15.7	15.7	5.4	1.7	7.5	84.5	11.7	13.8	0.0	4.1	17.1	10.8	49.2	6.9	10.5	14.4	22.3	12.1	14.7	33.3	95.4	10.0	18.4	25.3	3.6	14.2	34.3	6.0	17.5	15.2	5.6	14.1	6.5	8.5	38.1	14.1	14.2	6.6	12.8	12.9	7.4
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110895713	"Enzymes, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 104.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	16.7	15.2	29.7	16.9	35.6	38.1	17.8	27.3	34.2	18.6	18.6	45.7	12.5	14.9	18.9	14.2	28.9	14.7	17.5	18.5	32.5	21.5	25.2	16.9	16.9	18.5	39.0	22.0	16.9	20.2	21.8	26.2	33.8	32.7	104.7	19.4	12.8	17.5	19.2	15.3	14.5	13.5	18.4	38.3	16.7	18.4	15.8	46.0	19.4	25.5	20.1	24.6	12.6	16.8	6.6	12.9	42.0	14.0	6.1	9.2	6.5	20.8	14.3	17.5	33.1	26.5	16.9	22.9	30.1	33.4	23.5	27.7	22.7	13.2	36.9	14.6	19.0	25.0	14.4	41.3	27.2	32.4	21.6	23.9	38.2	13.0	23.8	15.8	32.9	22.9	11.3	25.2	16.2	32.8	8.2	20.4	19.0	28.5	32.2	39.5	12.6	43.7	25.3	21.5	20.8	13.1	24.1	17.6	21.9	26.6	28.0	22.5	16.0	18.3	23.3	26.5	14.9	15.0	28.2	13.4	15.6	11.8	83.0	32.4	8.8	14.3	37.7	18.0	26.4	20.0	15.0	9.8	14.7	7.6	11.6	8.9	6.3	7.6	8.7	12.9	6.6	9.2	9.0	42.0	6.1	14.0	5.8	8.8	6.5	29.7	35.6	27.3	34.2	32.5	21.5	39.0	22.0	32.7	46.0	35.7	72.7	96.8	225.1	280.1	92.0	87.2	86.6	30.8	108.1	52.4	56.9	32.2	124.3	65.9	25.2	75.1	78.4	70.0	59.9	125.5	124.4	304.0	93.3	52.5	68.2	73.1	119.2	47.9	101.7	37.7	40.6	70.6	124.9	74.9	52.0	241.3	72.3	49.3	47.0	70.8	99.1	19.4	119.5	83.5	72.8	251.9	45.7	59.8	63.1	119.5
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958560-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	17.0	21.6	26.4	14.3	25.3	12.8	14.6	10.9	17.4	15.8	22.1	14.2	12.7	17.4	12.3	12.9	17.3	16.4	23.0	32.1	21.2	20.1	31.1	23.5	10.9	15.6	24.8	17.8	15.6	14.7	21.6	15.5	11.0	18.1	32.7	18.4	12.1	14.7	16.1	95.8	10.4	17.5	15.7	21.4	19.7	18.1	20.3	20.3	17.9	13.2	30.7	18.7	17.2	13.1	36.2	38.8	19.0	37.6	23.4	63.5	33.3	14.8	27.8	19.6	20.6	9.7	19.2	26.8	25.1	18.3	24.1	19.6	40.2	11.1	21.0	24.0	22.3	4.6	6.3	21.9	21.4	18.1	31.6	36.9	39.5	25.8	51.8	19.6	56.0	32.2	19.3	17.3	18.4	17.6	13.1	26.6	26.6	47.4	11.4	34.9	28.7	27.6	58.1	27.1	14.8	22.4	27.6	15.0	17.6	31.3	32.6	17.4	24.7	18.1	2.4	18.6	13.8	9.1	30.1	28.3	6.0	18.2	44.1	37.9	10.0	20.4	35.9	6.3	33.7	30.0	19.0	26.9	14.9	25.1	37.6	27.9	36.2	31.6	30.9	35.6	26.3	24.8	29.2	4.3	23.4	29.9	38.8	63.5	33.3	26.4	25.3	10.9	17.4	21.2	20.1	24.8	17.8	18.1	20.3	65.5	40.1	59.5	60.5	27.0	36.8	263.0	203.8	61.6	42.1	99.5	15.7	80.1	258.6	151.4	140.9	51.7	98.6	23.3	256.8	207.8	47.9	134.2	52.1	79.5	242.8	25.4	105.5	52.8	67.6	203.2	60.1	78.3	52.3	200.2	92.0	74.5	175.0	112.2	64.3	317.0	26.5	64.7	52.8	104.2	113.1	26.0	75.6	66.1	106.5	98.7
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 83.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	21.1	17.1	13.9	14.1	19.2	15.4	20.7	16.7	17.3	14.5	13.8	9.0	10.3	10.3	15.4	12.1	19.2	15.8	14.4	19.6	16.5	11.0	18.8	30.7	12.2	15.3	16.8	11.3	20.9	25.9	13.7	21.6	15.5	19.3	15.5	14.1	9.5	14.0	11.5	46.3	16.7	10.6	19.8	17.4	16.3	14.2	18.1	18.7	10.0	20.4	29.3	15.8	22.1	15.1	10.3	9.3	0.8	7.7	11.1	12.4	6.1	8.0	3.9	4.4	17.4	7.7	12.1	11.6	11.6	6.9	10.3	10.3	15.7	5.9	19.0	11.1	5.8	15.3	9.2	14.6	11.0	23.4	8.0	13.4	12.4	4.9	9.1	9.3	18.8	6.0	7.3	8.8	14.3	29.3	6.9	8.2	8.8	33.0	10.5	12.9	7.8	13.9	19.8	12.8	13.1	7.1	13.3	8.4	13.5	9.9	8.1	7.5	9.7	5.1	6.8	19.1	6.6	6.2	16.1	5.3	8.5	7.5	83.2	31.0	4.5	7.0	23.7	11.3	23.8	17.1	0.3	6.9	0.8	5.9	7.7	12.4	10.3	8.4	7.7	8.1	7.8	11.1	10.5	0.2	11.1	4.9	9.3	7.3	6.1	13.9	19.2	16.7	17.3	16.5	11.0	16.8	11.3	19.3	18.7	17.9	26.9	21.2	94.7	69.6	12.6	61.4	45.9	61.6	63.7	17.4	0.0	40.8	58.0	40.9	72.5	33.0	12.0	0.0	41.1	44.2	40.8	42.1	44.0	66.6	48.0	17.5	10.9	22.7	27.3	20.4	31.9	26.8	35.4	18.0	26.8	18.6	37.2	21.0	25.5	70.4	8.2	12.9	35.4	37.2	27.3	58.0	28.9	17.9	32.7	65.4
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 26.2;Melanocytes: 42.2"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.4	0.0	0.1	0.5	0.8	5.1	0.2	4.1	0.9	0.1	1.4	0.0	29.4	0.0	0.5	0.1	12.7	4.7	0.3	4.8	0.0	5.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.8	0.1	0.0	2.0	6.2	0.7	9.0	0.1	1.9	3.5	4.3	24.2	0.0	0.4	6.8	2.1	0.1	0.6	1.1	2.3	1.2	0.8	0.0	0.1	1.1	0.3	1.6	2.0	0.0	1.1	0.2	3.8	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8	8.9	26.2	0.9	10.0	8.7	6.2	7.7	0.0	1.4	5.7	5.2	2.0	1.1	1.7	0.1	7.2	0.7	3.9	0.0	11.1	1.7	2.5	2.8	1.1	19.7	20.5	1.6	6.3	5.5	13.5	5.2	0.0	14.3	42.2	1.0	2.8	1.7	3.1	0.0	0.0	15.2	0.6	0.0	1.0	9.8	9.8	12.9	1.0	0.5	5.0	0.9
MFSD4B	"KIAA1919, MGC33953"	ENSG00000173214	"Major facilitator superfamily domain containing 4B"	Q5TF39	6	111259348-111271167	"Predicted membrane proteins"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 40.3;Ciliated cells: 18.7;Club cells: 25.0;Cytotrophoblasts: 18.5;granulocytes: 18.6;Syncytiotrophoblasts: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 15.7"					"Low region specificity"	"Detected in all"			HPA031784	Approved					NA	NA					"HPA031784: AB_10603775"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.50e-5)"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.98e-4)"	4.7	5.8	5.3	7.2	8.7	4.6	6.4	5.5	6.6	6.4	8.3	4.1	7.8	9.1	6.8	10.1	5.4	5.9	3.9	5.5	3.4	3.5	13.3	8.4	5.4	5.0	3.2	2.6	5.7	6.2	6.0	12.3	26.1	3.3	5.2	5.3	6.9	7.8	8.0	6.1	8.3	14.6	4.0	3.6	5.9	5.3	9.1	3.0	8.1	6.5	2.7	7.6	5.0	5.3	6.0	4.0	3.6	3.3	2.4	3.7	1.8	1.5	2.6	3.0	6.9	2.3	1.4	5.3	2.0	2.4	2.7	3.5	5.5	2.9	3.9	3.1	1.7	2.6	3.8	5.1	1.9	3.6	3.0	2.2	5.4	4.3	4.4	3.3	4.9	8.7	1.3	4.0	3.3	2.1	3.9	2.1	5.8	6.0	4.9	2.9	2.5	3.4	3.1	2.1	2.4	1.0	3.7	2.1	1.8	4.5	3.2	2.5	2.4	2.3	2.6	1.4	2.9	2.0	4.4	3.1	3.3	2.1	15.7	3.2	3.5	2.7	3.9	4.0	3.1	3.3	3.0	3.3	3.6	3.7	3.1	3.6	6.0	2.1	2.9	2.5	3.9	3.1	3.5	3.5	2.4	2.3	4.0	1.5	1.8	5.3	8.7	5.5	6.6	3.4	3.5	3.2	2.6	3.3	3.0	8.9	40.3	0.0	0.0	0.0	0.0	0.0	0.0	18.7	25.0	5.2	0.0	18.5	1.7	4.8	0.0	0.0	0.0	0.0	3.1	10.5	0.0	0.0	18.6	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.6	0.0	0.0	3.9	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.2;ASC TERT1: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	21.0	7.1	7.8	8.8	7.3	7.3	15.1	26.0	7.6	31.7	11.0	5.8	14.1	5.4	34.5	18.5	7.6	12.2	7.4	7.1	6.5	6.1	6.5	6.4	10.8	6.3	5.4	5.8	11.3	8.1	7.8	15.1	10.2	6.8	11.4	7.4	8.3	6.9	16.3	17.1	8.2	7.0	18.0	6.9	7.1	8.6	10.3	6.7	10.2	9.2	7.2	5.5	18.3	16.2	5.1	2.8	6.0	2.9	1.7	4.6	1.0	4.7	3.0	5.8	8.8	40.2	30.6	6.4	6.7	11.1	3.7	6.1	5.3	2.9	10.4	4.9	9.7	5.8	4.9	8.5	3.7	6.3	6.1	4.7	6.9	7.6	7.1	5.6	7.2	4.2	19.5	3.4	6.8	10.7	6.4	6.8	5.4	8.8	6.6	7.1	4.4	8.5	1.5	2.0	2.4	5.0	5.5	6.4	3.4	2.8	5.9	7.7	6.1	8.4	3.1	7.2	4.7	3.8	7.8	7.8	5.6	5.2	26.0	7.6	7.0	8.1	9.3	5.4	5.6	7.3	1.9	1.7	3.3	3.3	1.3	4.6	2.8	2.5	3.0	1.7	5.1	1.6	2.8	6.0	1.7	2.9	2.8	1.9	1.0	7.8	7.3	26.0	7.2	6.5	6.1	5.4	5.8	6.8	6.7	44.7	73.8	34.3	19.1	27.1	106.3	31.0	12.7	56.2	45.5	19.2	53.0	18.3	3.3	13.5	30.3	42.0	13.4	0.0	9.9	10.9	62.7	15.8	45.1	12.5	10.9	33.4	57.4	19.0	18.3	11.9	46.6	44.7	20.3	15.4	14.8	74.6	10.1	13.5	36.7	9.2	58.5	38.8	60.6	40.2	68.7	23.5	27.6	22.4	17.7	6.7
TRAF3IP2	"ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522"	ENSG00000056972	"TRAF3 interacting protein 2"	O43734	6	111556454-111606278	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.8;hTERT-HME1: 36.2;U-2197: 37.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036352	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA036352: AB_10672085"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-1)"	"prognostic favorable (4.73e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (1.11e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.31e-1)"	16.0	13.3	11.9	12.4	12.0	13.4	18.2	3.5	12.5	15.7	16.4	6.0	27.1	16.4	22.4	16.1	24.3	22.5	13.4	7.9	10.2	5.0	9.2	5.6	11.7	8.3	6.1	4.8	8.9	15.5	9.1	11.7	17.9	18.8	11.9	15.8	11.2	19.1	32.6	10.6	30.4	13.6	13.7	13.8	6.3	16.6	3.9	7.7	12.9	16.2	21.0	18.5	11.9	15.9	5.4	2.0	8.0	1.4	2.9	11.8	2.0	7.2	2.5	0.6	3.3	9.6	10.3	4.2	7.3	19.3	3.5	4.5	1.5	4.2	1.1	2.9	9.4	10.4	16.0	2.8	28.8	4.0	9.1	1.9	1.3	3.3	3.2	3.2	1.8	5.6	15.0	20.8	8.4	36.2	7.3	6.5	1.9	3.5	0.4	3.4	6.3	5.5	4.6	2.2	8.4	2.7	9.5	3.4	0.7	9.1	11.8	5.6	0.4	3.5	19.2	12.4	3.0	8.9	5.0	1.7	5.0	1.9	37.9	8.0	0.2	2.0	3.7	10.5	3.0	11.2	8.0	1.4	3.5	2.9	0.3	10.0	4.6	5.6	3.8	2.0	5.4	5.9	5.5	1.5	2.9	0.1	0.2	11.8	2.0	11.9	12.0	3.5	12.5	10.2	5.0	6.1	4.8	18.8	7.7	3.0	14.4	4.7	52.7	26.8	6.7	4.5	7.6	22.7	15.9	3.5	11.8	14.5	5.0	30.6	0.1	17.9	20.6	0.0	27.9	23.8	11.2	36.1	18.6	4.5	5.6	6.4	12.7	1.3	1.8	0.4	6.6	8.5	11.8	9.0	14.6	12.4	18.7	19.2	7.1	4.9	4.5	0.0	13.3	0.6	2.4	21.5	17.5	5.0	20.8	42.3
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Proximal tubular cells: 145.7;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.3	34.9	5.8	26.7	16.4	0.6	5.5	17.5	4.7	8.5	0.2	0.3	3.9	3.6	10.7	4.1	0.2	4.9	7.6	9.2	0.1	12.8	10.7	2.6	0.5	15.8	3.6	3.7	15.8	11.6	17.7	15.2	12.4	19.2	19.2	0.9	27.3	16.8	0.2	17.1	3.3	5.0	0.6	3.5	5.4	4.7	0.2	0.0	1.7	24.5	9.9	1.0	0.4	23.3	8.1	0.2	10.8	12.2	14.3	2.6	105.3	3.5	3.9	3.5	6.0	26.9	8.4	24.8	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3	0.0	11.7	18.8	1.9	15.1	53.9	9.2	12.7	5.3	3.4	7.0	0.0	2.2	14.9	8.1	2.8	56.2	3.5	0.0	0.9	2.1	36.8	1.4	51.8	59.3	2.8	44.5	12.7	71.8	42.5	0.9	24.5	33.6	35.4	3.6	2.4	88.8	6.3	0.0	6.7	145.7	7.8	12.9	23.1	2.6	4.3	11.7	43.5	208.1	1.2	0.9
WISP3	CCN6	ENSG00000112761	"WNT1 inducible signaling pathway protein 3"	O95389	6	112054072-112070969	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 9.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.3;cerebellum: 5.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 11.2;THP-1: 3.6;U-2197: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA			Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.4	0.5	0.3	0.4	2.3	0.8	4.2	5.9	0.5	1.9	0.3	0.3	0.3	0.1	0.6	9.5	0.9	3.2	1.4	0.4	0.3	0.5	5.3	0.8	0.4	0.5	0.4	0.3	1.6	0.3	0.0	0.3	0.4	0.3	1.1	0.0	0.3	0.6	0.3	0.6	4.8	0.3	0.3	0.4	0.4	0.4	5.8	0.9	0.3	0.3	2.8	2.2	0.3	1.5	1.1	0.6	2.0	0.5	1.7	1.2	0.2	0.1	0.0	0.3	1.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.9	0.2	0.3	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.7	0.3	0.1	0.0	0.2	0.9	0.4	0.1	0.2	0.3	0.1	0.3	0.0	11.2	0.5	0.6	0.1	0.2	0.9	0.4	0.2	3.6	0.2	0.2	0.2	2.6	0.3	0.3	0.0	0.3	0.4	1.1	0.2	1.4	0.4	0.6	0.5	0.3	0.6	0.8	0.9	0.9	0.3	1.1	1.2	1.1	2.0	1.7	0.5	0.6	0.6	0.2	0.3	2.3	5.9	0.5	0.3	0.5	0.4	0.3	0.3	0.9	0.0	0.0	0.0	2.7	0.7	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	82.4	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	6.5	0.0	0.6	0.7	0.6	0.1	0.0	0.0	2.1
TUBE1	"dJ142L7.2, FLJ22589, TUBE"	ENSG00000074935	"Tubulin epsilon 1"	Q9UJT0	6	112070777-112087529	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 158.3;Spermatocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 29.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA032073, HPA032074"	Approved					NA	NA					"HPA032073: AB_10601773, HPA032074: AB_10601216"	"unprognostic (4.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-3)"	10.3	10.7	12.4	7.0	18.5	5.1	11.9	32.4	18.9	15.5	10.3	12.2	11.4	6.7	21.4	11.5	6.6	12.7	11.6	17.4	10.5	12.2	11.4	47.4	8.4	8.8	15.4	14.5	14.9	12.5	11.8	20.4	11.7	14.0	12.1	8.5	9.3	9.9	12.6	7.1	13.8	7.0	14.4	18.2	8.0	10.5	32.7	15.5	5.3	10.6	4.3	7.3	11.5	12.6	3.2	1.7	2.2	1.4	3.6	7.5	2.8	1.2	1.8	4.7	14.0	10.6	5.8	4.0	5.7	8.3	4.2	7.2	3.0	2.5	4.5	3.6	2.2	6.2	3.9	5.3	2.6	7.1	2.7	4.9	2.1	1.1	3.5	17.4	9.8	6.4	6.2	15.5	5.5	13.5	5.0	5.1	15.8	9.3	6.5	3.2	1.1	5.5	11.5	4.3	7.9	3.7	6.0	2.9	3.0	5.3	1.3	7.0	6.3	4.4	3.6	14.6	4.2	2.7	20.0	2.8	3.3	3.2	29.3	5.4	2.1	0.7	5.3	5.0	10.9	8.1	0.1	0.9	2.2	2.7	1.2	7.5	3.2	5.3	3.5	1.7	2.5	7.4	5.8	0.6	3.6	1.4	1.5	5.1	2.8	12.4	18.5	32.4	18.9	10.5	12.2	15.4	14.5	14.0	15.5	6.0	14.7	11.2	16.2	21.9	20.7	14.9	10.2	10.7	11.4	21.0	33.4	4.2	13.3	9.3	158.3	15.6	8.7	23.3	15.8	9.6	11.5	11.9	16.1	56.2	6.4	12.7	5.8	16.0	6.4	39.6	14.4	7.4	6.8	4.6	9.8	11.0	9.6	8.0	18.7	19.4	29.4	19.4	14.4	75.1	27.4	10.9	2.7	15.0	6.9	12.4
FAM229B	"C6orf225, DKFZp586F0922, LOC619208"	ENSG00000203778	"Family with sequence similarity 229 member B"	Q4G0N7	6	112087599-112102790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 118.9"	"Group enriched"	"Detected in many"	10	"Early spermatids: 2880.3;Late spermatids: 5153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036068			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA036068: AB_10673495"	"unprognostic (1.65e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (3.74e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	4.7	7.4	18.4	2.1	16.8	2.0	7.7	5.8	14.8	8.2	4.2	17.3	4.3	2.2	9.6	17.0	3.8	23.7	8.8	16.8	15.7	16.2	11.6	11.0	5.2	2.0	20.7	11.2	10.7	4.3	10.0	15.4	5.2	15.3	7.3	3.1	8.6	3.9	11.0	5.9	1.9	2.3	8.6	21.7	2.3	4.3	118.9	13.6	1.6	9.7	2.6	2.0	4.6	2.6	4.0	3.4	2.7	0.3	5.4	8.1	2.8	1.6	4.2	17.4	8.5	15.4	15.3	0.8	6.4	24.5	9.2	19.5	0.7	4.1	1.3	19.0	11.8	9.6	1.0	3.6	9.3	14.8	0.4	12.0	1.5	1.9	6.5	9.6	3.3	0.8	9.3	6.3	15.2	2.6	21.5	9.0	15.2	2.0	3.4	11.2	0.4	6.2	5.4	4.5	1.2	10.1	9.7	4.3	1.3	13.5	0.2	16.2	6.8	5.1	0.6	9.9	9.8	8.3	3.1	5.1	7.7	3.3	29.4	8.5	2.5	0.1	11.7	12.3	2.8	10.2	0.1	0.1	2.7	4.2	0.0	5.3	2.5	3.7	3.3	0.5	4.0	8.1	7.2	0.4	5.4	0.3	3.4	0.4	2.8	18.4	16.8	5.8	14.0	15.7	16.2	20.7	11.2	15.3	13.6	3.0	10.7	4.7	14.7	7.4	29.1	81.9	22.9	313.2	31.8	48.8	11.8	1.2	112.7	25.4	2880.3	27.2	0.0	0.0	9.2	4.2	30.9	16.9	1.1	39.9	2.7	15.9	2.9	34.4	1.9	5153.7	67.3	6.2	23.6	2.8	0.3	63.3	6.5	0.0	85.2	62.8	30.9	58.2	24.7	416.7	35.0	7.5	0.5	4.4	0.6	7.9
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		350000	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	51.9	79.0	0.0	13.0	7.8	1.3	0.2	0.0	4.9	0.0	8.6	22.4	3.0	0.0	0.5	0.0	0.2	0.0	6.7	0.0	6.5	0.0	10.6	0.0	0.0	61.5	0.0	9.4	0.0	38.0	64.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.2	0.3	0.0	0.3	2.0	0.0	10.0	0.2	0.0	0.0	59.2	21.4	1.1	23.8	4.3	0.0	0.0	0.0	5.3	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5	3.0	5.0	0.0	1.2	20.1	1.0	47.4	0.0	0.0	3.4	3.5	0.0	0.9	3.3	0.4	76.6	56.3	0.0	0.0	0.6	71.2	77.1	1.1	1.1	28.2	2.7	0.0	0.0	19.6	2.2	34.0	154.2	1.7	54.0	1.0	0.0	0.0	0.6	0.0	76.4	0.0	0.2	64.7	100.7	0.7	0.5	16.3	2.5	0.0	0.0	5.2
AL365214.3		ENSG00000281613			6	112236806-112350094	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	11	"testis: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"RPTEC TERT1: 9.2"									HPA059324	Uncertain					NA	NA					"HPA059324: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0			0.0	0.0	0.0		0.8		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	9.9			0.0		0.0	0.1		0.3	0.0	0.3	0.2	0.2	0.1	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.2	0.5	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	9.2	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351296	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 8.0"	"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 13.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;K-562: 3.1;RPTEC TERT1: 4.1;U-266/70: 1.7;U-266/84: 12.7"									"HPA059324, HPA066464"	Uncertain					NA	NA					"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.3	0.0	0.0	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 652.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 74.7;TIME: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.7	4.0	25.3	16.5	0.4	22.2	31.2	15.7	26.2	7.2	9.8	0.0	4.7	40.9	12.4	21.3	12.3	6.4	20.5	0.0	7.3	0.0	4.3	9.4	16.9	1.8	0.1	17.0	12.7	15.1	14.4	43.1	44.2	0.0	0.8	19.7	22.2	0.0	0.2	0.0	9.6	7.7	5.3	0.0	7.5	0.7	4.9	13.2	10.4	30.3	14.2	7.2	15.2	18.4	0.3	2.0	58.7	14.6	0.1	23.9	37.8	53.3	3.8	2.0	11.2	9.9	27.9	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4											8.9	19.9	84.3	477.4	447.8	131.4	10.5	56.0	99.0	62.6	36.6	27.5	5.0	31.5	120.8	46.4	214.9	254.5	0.0	195.2	5.5	224.2	281.9	2.3	4.3	324.8	79.4	322.8	234.5	223.1	24.8	111.7	249.4	259.8	652.8	331.8	330.7	220.9	241.8	62.9	3.4	33.7	38.8	128.7	20.0	15.6	558.1	24.6	7.5	259.9	481.3
HDAC2	"RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	25.8	33.8	25.8	30.1	31.3	34.9	58.7	32.8	36.5	32.1	30.7	25.6	32.2	22.0	38.7	36.7	36.3	32.7	23.3	27.6	26.5	26.9	31.6	22.2	29.9	41.5	29.6	26.5	39.2	31.5	31.7	45.1	38.1	27.9	32.1	36.1	17.5	29.3	39.0	33.9	30.8	26.1	36.1	31.1	30.7	29.9	47.4	27.4	64.0	35.1	31.3	32.5	33.1	47.3	27.0	35.7	28.2	32.6	26.3	32.6	24.3	24.6	17.0	79.6	45.7	20.5	23.5	33.3	29.5	24.1	34.8	41.7	45.1	18.2	20.4	24.6	26.5	35.8	19.4	54.0	29.8	58.7	29.0	37.3	49.1	22.1	26.0	27.4	49.8	22.2	18.9	20.1	37.0	34.8	34.1	40.5	36.1	63.1	20.7	57.6	20.7	44.6	45.1	45.0	26.4	23.5	30.3	39.7	18.7	35.9	29.8	53.3	45.2	23.3	22.0	24.5	50.0	16.0	58.1	32.7	22.2	25.5	23.2	48.8	16.5	21.7	48.8	18.8	48.0	37.6	23.1	27.6	28.2	21.1	26.6	28.1	27.0	25.9	22.7	35.7	22.3	32.6	29.7	16.3	26.3	32.6	30.9	24.5	24.3	25.8	31.3	32.8	36.5	26.5	26.9	29.6	26.5	27.9	27.4	53.6	49.8	31.2	71.8	170.6	26.7	56.1	33.1	81.7	79.6	50.6	3.9	139.9	36.5	140.8	72.3	70.5	33.4	140.2	91.3	114.1	97.6	61.7	53.2	30.8	91.5	14.3	96.4	47.9	63.7	84.2	76.8	67.2	79.2	128.0	68.7	30.1	115.2	49.1	63.3	52.8	23.5	38.8	84.5	123.0	166.8	168.8	173.7	50.7	90.3	79.6
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 5.0;Collecting duct cells: 10.4;Cone photoreceptor cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 5.0;RT4: 9.2;SCLC-21H: 17.8;U-266/70: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA					"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.5	1.9	3.3	0.9	13.1	1.3	0.5	0.6	11.9	0.8	1.0	9.1	3.5	0.7	0.8	0.5	0.6	0.6	0.7	0.5	4.2	3.5	0.9	0.5	1.1	0.5	6.1	2.7	0.6	1.3	0.5	0.3	0.6	7.8	0.7	0.9	0.6	0.7	9.4	10.1	1.3	1.2	0.9	7.5	0.5	1.2	0.9	8.0	0.0	0.6	0.0	0.5	2.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	2.5	5.0	0.0	1.0	0.0	0.0	9.2	17.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.1	4.5	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.3	13.1	0.6	5.7	4.2	3.5	6.1	2.7	7.8	8.0	0.0	0.0	0.0	0.0	1.1	5.0	0.7	0.0	0.0	0.0	10.4	17.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.2
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 19.0;RT4: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	2.5	4.2	0.7	1.0	0.3	0.3	0.8	0.6	0.2	0.0	0.1	3.3	4.1	1.1	3.9	0.6	0.6	6.1	0.3	1.2	0.1	3.5	0.4	1.4	3.6	2.8	0.2	1.0	0.9	0.3	1.7	0.4	0.4	0.5	0.2	0.7	0.7	2.6	1.0	1.4	0.8	0.6	1.1	19.0	0.7	1.2	3.7	1.3	5.2	8.0	0.9	1.0	0.9	5.4	0.5	1.1	1.6	0.8	1.0	1.2	1.2	0.9	0.6	4.0	2.8	1.8	1.2	0.7	0.8	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5	0.0	10.1	0.0	15.3	2.4	0.7	8.4	12.7	22.7	15.9	22.7	0.0	4.3	10.0	16.5	73.1	0.3	35.5	0.0	14.3	3.8	3.5	20.3	3.5	19.2	0.8	6.4	19.0	1.8	0.6	17.7	0.6	0.5	0.0	1.8	13.0	0.3	19.1	20.1	1.1	22.5	0.0	12.9	7.5	1.4	0.7	2.8	0.7	0.5	16.1	34.6
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100849-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030352	Uncertain					NA	NA		130000			"HPA030352: AB_2154066"	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	13.0	31.1	9.4	12.8	25.8	6.4	14.6	6.0	18.0	9.6	14.1	37.3	19.7	21.4	9.7	17.7	15.6	15.7	13.1	21.6	13.2	10.3	21.4	31.2	13.4	21.7	40.7	11.3	10.5	15.7	17.7	15.6	5.9	31.7	21.5	15.2	12.6	19.4	25.2	19.6	11.8	19.1	13.6	34.0	10.2	17.0	7.6	32.7	6.8	21.4	16.8	16.0	19.1	10.6	24.3	14.6	18.4	10.8	12.6	19.9	11.4	10.5	9.3	8.4	11.2	9.4	5.7	13.9	8.0	18.9	13.0	15.5	13.3	11.6	22.1	17.4	7.3	14.2	17.6	5.7	13.1	11.4	33.3	11.4	9.4	7.9	14.2	10.2	20.6	0.9	10.6	10.6	8.2	7.2	28.4	11.5	13.9	11.3	13.1	16.3	11.6	3.9	6.8	7.5	24.9	12.2	23.3	22.5	12.1	12.1	13.5	5.5	8.1	17.0	13.6	12.0	9.7	12.5	4.2	9.6	5.9	9.7	11.3	16.1	18.3	25.1	17.7	14.0	13.9	10.4	7.7	10.8	18.4	12.6	6.1	19.9	24.3	18.8	15.9	14.6	18.0	18.2	15.3	7.3	12.6	7.0	7.4	18.2	11.4	9.4	25.8	6.0	18.0	13.2	10.3	40.7	11.3	31.7	32.7	59.6	30.5	30.3	29.9	23.2	14.4	40.6	20.4	96.4	48.9	17.4	25.5	34.3	54.7	32.2	15.0	19.8	21.2	0.0	36.1	24.4	12.3	27.4	23.1	46.0	26.8	42.9	25.5	30.1	21.8	6.2	17.5	12.7	18.6	64.1	28.9	17.7	25.4	11.5	19.4	43.4	20.6	32.3	22.3	13.8	28.1	18.7	21.4	16.6	38.2	21.8
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 30.1"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in single"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.2	0.3	4.6	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	30.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.9	0.1	0.3	0.4	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3	0.0	1.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0
TSPYL4	"dJ486I3.2, KIAA0721"	ENSG00000187189	"TSPY like 4"	Q9UJ04	6	116249961-116254140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044863	Approved					NA	NA					"HPA044863: AB_10962578"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.41e-3)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (5.13e-7)"	"unprognostic (3.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.38e-2)"	5.3	24.5	24.2	4.8	43.6	6.0	9.6	42.2	51.2	10.3	4.9	12.0	5.4	4.0	14.5	12.6	6.9	14.5	7.2	13.5	23.6	35.5	10.4	4.9	6.9	6.3	18.3	28.7	17.7	8.2	25.6	16.9	7.2	29.2	15.6	5.7	6.3	5.0	13.2	3.0	6.9	4.3	10.7	13.3	7.0	9.4	9.5	14.0	5.8	9.8	1.5	6.0	5.7	8.1	6.5	5.7	5.4	4.9	6.9	8.4	5.8	2.9	1.6	23.6	19.5	9.7	8.4	4.4	11.8	8.0	15.2	9.1	4.6	2.9	2.4	4.5	18.1	8.0	6.6	10.1	10.5	23.0	9.8	3.4	4.8	8.2	10.8	7.7	9.0	3.2	8.1	4.9	11.8	6.0	11.9	10.3	13.7	7.3	8.1	12.6	9.1	17.2	5.5	5.7	1.0	3.9	9.9	1.3	2.3	4.6	4.3	27.8	18.8	10.5	4.4	2.0	8.8	8.0	5.0	11.8	12.7	10.7	7.2	6.7	3.2	3.8	0.4	5.9	6.0	7.9	0.9	3.6	4.3	6.3	3.5	7.5	4.7	7.6	6.3	3.4	6.5	8.4	5.9	5.4	6.9	4.9	5.7	6.6	5.8	24.2	43.6	42.2	48.7	23.6	35.5	18.3	28.7	29.2	14.0	3.0	4.8	7.3	8.9	4.2	19.9	31.9	7.6	37.5	10.3	10.4	19.6	2.7	16.6	4.0	15.8	8.2	0.9	0.0	6.5	1.5	8.0	9.4	10.5	3.0	3.0	38.1	30.4	12.9	4.0	5.3	9.5	4.3	5.0	2.8	5.5	19.7	5.3	2.9	10.3	4.5	27.1	0.0	9.2	15.4	2.9	4.5	2.9	7.0	3.7	8.1
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.2	13.0	16.8	30.6	29.8	19.7	14.1	21.3	21.3	19.6	22.5	16.8	9.7	28.4	26.8	24.6	17.6	23.5	13.2	36.4	21.0	11.5	34.4	11.4	19.3	30.4	18.9	18.7	6.9	23.0	28.5	20.1	19.6	20.4	18.6	12.6	20.1	22.1	27.2	29.1	12.4	11.0	8.3	12.7	12.2	11.5	14.5	15.5	33.8	25.9	14.8	14.6	17.7	23.8	10.2	19.9	31.3	23.3	22.4	13.2	11.8	10.6	23.0	12.1	13.1	15.6	21.8	12.2	8.5	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2	32.8	41.6	47.2	90.2	147.6	76.3	93.6	53.5	20.1	39.8	99.5	25.5	48.1	131.0	34.9	24.0	35.6	43.4	0.0	38.5	23.1	50.3	71.7	31.1	71.3	35.6	36.5	71.6	63.3	55.3	16.8	69.9	47.1	82.7	28.9	56.9	82.6	40.7	56.1	89.8	169.2	50.8	129.4	74.1	48.1	24.5	141.5	49.9	52.4	55.2	61.6
Z84488.2		ENSG00000285446			6	116399395-116463696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.5;lymphoid tissue: 3.0"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in single"	6	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"BJ: 3.4;GAMG: 2.9;HDLM-2: 3.6;hTEC/SVTERT24-B: 2.8;Karpas-707: 4.3;RPMI-8226: 3.2"															NA	NA																							0.5	0.0		0.0		0.4	0.0		0.1	0.1	0.0			0.0	0.0	0.0	0.2	0.8	1.5	0.0			0.0	0.4	0.2	0.1			0.2	0.0	0.0		0.1		0.0	0.1		0.7	0.0	0.0	0.0	0.4	0.0		3.0	1.1	0.0			0.0		0.5	0.0		0.5	0.1	3.5	0.3	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	1.2	0.0	0.0	0.0	0.8	0.0	2.9	1.4	0.2	1.8	0.9	3.6	0.0	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.3	0.0	3.2	0.0	0.6	0.0	0.0	2.4	0.2	0.7	1.7	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.5	0.0	0.1	0.2	0.8	0.0	3.5	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALHM6	"C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5"	ENSG00000188820	"Calcium homeostasis modulator family member 6"	Q5R3K3	6	116461370-116463779	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.3;lymphoid tissue: 58.7"	"Cell type enriched"	"Detected in some"	7	"Hofbauer cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 83.9;non-classical monocyte: 95.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 10.0;Karpas-707: 16.7;RPMI-8226: 56.6;U-937: 21.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-3)"	"unprognostic (9.53e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.31e-10)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.25e-3)"	3.0	2.7	2.8	19.6	5.2	12.9	3.1	1.1	2.1	1.5	3.4	1.5	1.7	3.9	1.1	1.3	2.0	1.5	3.9	4.3	3.1	3.2	2.9	8.1	4.2	30.6	2.6	1.8	2.8	1.0	0.4	2.5	4.6	3.4	3.1	2.2	2.7	4.2	0.7	1.0	0.9	8.1	3.7	5.1	58.7	2.2	3.3	1.7	7.3	2.1	1.9	7.5	3.5	1.4	39.6	23.3	13.8	95.3	3.1	3.8	17.8	2.3	0.0	0.2	0.1	0.2	0.7	4.3	0.0	0.4	0.7	0.5	0.0	0.3	0.0	1.3	0.5	0.0	0.0	0.1	0.0	1.6	0.2	0.1	10.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	16.7	2.0	0.0	0.9	1.7	1.3	0.0	0.0	0.8	0.0	56.6	0.8	0.1	1.0	0.0	5.4	0.0	4.0	0.6	0.1	2.6	0.0	0.0	0.0	0.0	0.3	4.3	0.0	0.0	0.1	21.5	1.4	1.8	24.7	5.5	2.1	83.9	2.1	27.0	2.9	1.9	23.3	39.6	3.8	1.9	13.8	3.1	95.3	10.2	0.3	17.8	2.8	5.2	1.1	2.1	3.1	3.2	2.6	1.8	3.4	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	9.1	4.9	0.0	0.0	0.0	0.0	118.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
TRAPPC3L	"bA259P20.2, BET3L, FLJ11180"	ENSG00000173626	"Trafficking protein particle complex 3 like"	Q5T215	6	116494989-116545610	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9;placenta: 9.7"	"Group enriched"	"Detected in some"	6	"Ito cells: 6.2;Kupffer cells: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA060912			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA060912: "	"unprognostic (1.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.09e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.47e-3)"	1.1	0.9	0.8	0.5	0.9	4.3	1.0	0.6	1.3	0.7	0.8	0.7	0.4	0.7	1.1	2.2	0.9	0.8	1.3	2.6	1.5	1.6	1.3	5.2	3.4	5.0	1.4	0.4	1.1	0.5	1.5	0.8	9.7	0.8	1.8	0.1	3.4	1.1	0.5	1.8	2.6	1.9	1.6	2.3	10.9	0.9	1.9	0.4	0.4	2.1	0.4	0.4	0.9	0.7	0.4	0.7	2.1	0.5	0.4	0.6	7.0	1.6	0.9	2.2	3.2	0.7	2.3	2.2	1.2	1.0	0.8	1.1	1.0	1.4	2.7	1.4	0.5	1.6	1.9	0.7	1.4	1.2	1.5	1.1	2.6	3.3	1.2	1.2	1.8	1.5	1.4	0.9	0.7	1.0	3.1	1.5	2.1	1.6	12.6	0.8	2.8	1.6	2.1	2.1	0.7	1.1	1.7	1.5	4.0	1.5	2.6	2.1	1.6	1.6	1.0	1.2	2.7	1.6	1.6	2.3	2.4	2.0	2.6	1.2	2.5	1.5	1.7	1.8	1.8	1.5	1.1	0.4	0.6	0.5	0.4	0.3	0.3	0.4	0.4	0.3	0.4	0.6	0.4	2.1	0.4	0.5	0.7	0.3	7.0	0.8	0.9	0.6	1.3	1.5	1.6	1.4	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	6.2	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CALHM5	"C6orf188, dJ493F7.3, FAM26E, MGC45451"	ENSG00000178033	"Calcium homeostasis modulator family member 5"	Q8N5C1	6	116511646-116524792	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	19	"Alveolar cells type 2: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 6.3;fHDF/TERT166: 6.6;HUVEC TERT2: 6.7;LHCN-M2: 7.1;TIME: 10.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034969, HPA034970"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA034969: AB_10670299, HPA034970: AB_2674390"	"unprognostic (2.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.24e-7)"	"unprognostic (1.16e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.65e-3)"	11.5	1.7	1.0	2.5	1.6	0.2	8.1	0.6	1.7	5.9	4.3	1.9	0.4	1.4	7.9	6.2	7.6	2.9	3.6	10.1	1.2	1.1	6.0	1.4	4.0	5.8	1.5	2.1	4.6	0.8	1.6	1.4	18.5	1.8	5.3	2.6	14.4	2.1	2.6	4.0	3.2	2.9	11.0	1.3	4.0	2.1	5.2	0.6	0.0	4.4	6.8	1.5	8.2	4.0	0.1	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.0	5.5	0.0	3.4	5.4	0.0	4.3	6.3	1.7	4.7	0.2	0.0	0.0	0.4	6.6	4.7	0.0	0.0	0.0	1.8	0.0	0.2	0.9	0.0	0.0	0.8	0.0	0.0	3.3	0.0	4.1	0.0	1.3	6.7	0.0	0.0	1.3	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	10.6	3.0	1.0	0.3	0.2	0.0	0.0	0.0	2.6	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	1.0	1.6	0.6	1.7	1.2	1.1	1.5	2.1	1.8	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"placenta: 29.7;skin 1: 9.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 45.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 2.8;SuSa: 6.2"														"Intracellular and membrane"	NA	NA															"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	29.7	1.4	0.0	0.0	0.2	0.0	0.0	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.1	0.0	2.8	0.0	0.3	0.2	0.2	0.3	0.0	0.3	0.6	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.2	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0
RWDD1	PTD013	ENSG00000111832	"RWD domain containing 1"	Q9H446	6	116571367-116597675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028712, HPA028713"	Approved					NA	NA					"HPA028712: AB_10602793, HPA028713: AB_10601485"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.58e-2)"	"unprognostic (9.60e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.63e-1)"	29.2	28.4	26.4	18.4	24.2	29.7	37.4	26.4	22.3	24.7	31.6	14.4	22.3	20.9	22.2	22.9	33.4	16.9	23.7	55.8	26.3	22.9	29.2	32.3	23.1	24.9	32.4	12.6	31.7	43.2	20.5	30.3	19.0	27.8	31.7	20.2	14.1	32.9	27.7	65.7	19.7	25.9	37.2	35.1	26.1	23.0	14.1	22.2	20.6	29.1	38.0	21.6	39.5	27.9	24.5	27.5	17.6	24.9	30.9	40.8	17.6	15.1	9.7	21.6	46.6	34.8	43.5	13.5	35.8	22.8	21.9	24.9	17.1	9.1	22.3	22.6	24.0	26.1	12.1	17.1	22.7	30.3	26.3	24.7	19.4	15.6	24.6	27.6	31.9	17.0	26.8	27.0	14.8	25.7	31.9	25.4	22.7	30.8	31.8	33.1	13.9	30.2	43.0	10.8	26.2	18.2	25.6	14.1	20.0	27.9	12.3	18.9	18.7	11.2	23.0	40.2	22.4	15.3	29.7	18.2	26.1	13.9	24.6	38.2	23.1	26.3	41.4	23.4	25.1	27.6	17.6	15.9	14.8	25.0	19.5	32.6	24.5	33.6	28.7	18.8	19.7	31.3	30.9	6.0	30.9	24.9	27.5	40.8	17.6	26.4	24.2	26.4	22.3	26.3	22.9	32.4	12.6	27.8	22.2	65.5	55.1	123.6	140.5	183.4	127.3	171.9	129.9	71.0	85.3	123.9	110.0	89.0	373.0	114.8	151.6	149.5	106.4	23.3	159.9	128.1	164.6	166.1	106.1	167.7	141.1	100.1	86.6	149.1	167.0	116.8	204.0	151.6	199.1	87.4	106.1	102.6	132.0	101.5	208.9	290.5	168.7	168.1	216.5	139.5	128.3	186.7	81.5	156.9	121.0	134.8
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head 4 homolog A"	Q5TD94	6	116616479-116632985	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7"	"Cell type enriched"	"Detected in many"	10	"Ciliated cells: 365.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.4;pons and medulla: 19.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 7.6;U-266/84: 5.5"	"Low region specificity"	"Detected in many"							"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3.0	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1.0	0.6	0.4	0.6	0.7	1.0	0.8	6.6	1.8	0.0	1.0	0.0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1.0	0.0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1.0	0.3	0.1	1.2	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0.0	0.8	1.1	0.4	0.2	1.0	0.2	0.1	0.0	0.9	0.2	0.1	0.6	0.2	0.7	0.1	0.6	0.1	0.1	0.8	1.6	7.6	3.2	0.4	2.8	1.2	0.2	0.2	0.5	0.3	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.5	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1.0	0.1	0.1	0.4	0.3	0.0	0.0	0.8	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	1.8	9.4	1.2	0.7	3.0	3.3	0.5	1.1	19.8	1.8	3.0	4.3	0.0	0.0	0.0	3.0	0.4	0.0	365.4	35.2	0.0	2.0	0.0	1.7	0.4	18.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	2.3	0.0	0.1	1.6	0.0	2.5	0.0	8.7	0.3	0.0	1.7	0.0	0.0	1.7	0.2	0.0	0.0	0.0	3.2	0.0	0.4	4.4	1.5	0.1	0.2	0.0	0.0	0.0
ZUFSP	"C6orf113, dJ412I7.3"	ENSG00000153975	"Zinc finger with UFM1 specific peptidase domain"	Q96AP4	6	116635618-116668794	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	8.0	8.4	8.8	9.7	14.1	19.0	9.7	18.8	14.4	7.2	10.3	7.3	5.1	16.5	7.3	7.3	11.0	6.7	9.0	5.4	10.5	8.7	9.3	11.9	10.2	12.8	14.3	8.0	5.6	9.7	6.0	18.1	8.5	11.3	8.6	9.8	5.2	8.2	7.3	6.2	10.3	13.5	6.8	10.5	12.3	8.4	9.5	11.5	15.4	7.6	7.5	13.9	8.9	8.2	11.1	11.1	17.3	11.5	9.2	12.6	7.1	4.5	4.4	10.6	19.0	6.1	8.1	7.7	10.2	9.7	10.2	12.1	7.5	5.3	16.5	8.5	6.3	11.7	7.6	12.0	7.0	13.6	9.6	12.3	12.6	6.4	13.8	9.4	14.9	15.5	7.1	11.9	8.0	14.2	7.8	8.9	12.8	22.3	8.6	13.3	7.1	7.5	11.4	7.6	7.3	4.9	9.9	8.9	6.9	11.1	4.8	8.8	10.0	7.0	6.2	6.2	9.5	3.8	11.6	7.0	6.4	4.3	3.7	8.9	7.9	10.1	16.7	5.8	9.0	9.4	17.3	8.5	8.4	8.4	9.9	9.7	11.1	9.3	9.5	11.1	10.3	10.7	7.8	3.3	9.2	11.5	7.9	12.6	7.1	8.8	14.1	18.8	14.4	10.5	8.7	14.3	8.0	11.3	11.5	6.0	3.4	2.4	12.4	11.0	8.7	0.0	5.1	8.1	7.9	0.0	7.9	9.2	0.0	0.0	1.6	5.8	6.0	0.0	0.0	7.3	6.5	10.1	10.3	5.9	6.6	11.1	5.8	3.1	6.0	0.8	2.0	10.5	1.7	0.0	5.8	9.4	0.0	6.5	1.8	0.0	7.8	0.0	7.1	15.0	18.3	12.0	7.8	10.2	5.5	11.6
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741866	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;Alveolar cells type 2: 181.5;Ciliated cells: 240.9;Club cells: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB026464: , HPA054037: AB_2682351"	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	5.7	6.5	11.9	5.9	12.8	7.5	7.6	24.1	21.2	8.6	6.0	4.3	3.4	4.0	11.2	5.3	6.1	9.8	6.5	5.8	11.0	8.1	6.6	3.6	7.2	10.7	9.0	13.5	22.3	4.4	9.5	19.7	5.6	14.1	8.4	4.5	5.7	4.7	7.1	14.0	4.7	5.6	8.5	12.0	7.4	4.8	46.6	8.2	10.9	12.2	3.9	7.3	6.4	7.4	18.0	10.5	11.9	4.0	6.3	16.6	2.9	2.5	1.5	11.0	6.8	4.2	7.9	4.5	3.8	10.6	6.7	9.5	7.1	2.6	9.2	5.0	4.1	7.6	4.2	5.8	3.4	8.7	5.8	15.8	8.8	4.6	4.0	5.2	6.8	5.5	7.0	2.1	8.2	4.8	7.9	7.6	9.3	12.9	4.0	7.4	3.4	10.5	4.7	4.9	1.7	4.1	8.7	3.6	2.6	5.1	5.0	11.5	11.0	2.9	2.3	3.6	7.5	4.6	6.7	6.0	2.8	5.7	2.9	6.6	10.4	11.3	10.7	3.1	4.8	5.8	11.9	3.1	3.7	8.8	3.2	10.9	14.9	10.0	10.3	1.6	18.0	16.6	12.1	0.8	6.3	4.0	10.5	7.3	2.9	11.9	12.8	24.1	21.2	11.0	8.1	9.0	13.5	14.1	8.2	211.4	181.5	19.3	7.0	12.0	45.3	13.6	10.2	240.9	211.5	8.7	27.5	3.3	8.3	5.3	34.2	15.8	1.4	0.0	4.7	1.5	10.8	7.1	119.7	4.2	3.8	44.5	32.4	16.0	5.4	5.9	16.4	10.4	10.1	4.6	6.8	34.6	4.2	0.0	15.6	4.2	36.7	12.9	7.2	60.3	9.8	7.9	2.7	12.5	3.5	2.6
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765723	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.6"	"Group enriched"	"Detected in some"	4	"Sertoli cells: 64.7;Smooth muscle cells: 58.7"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.0;BJ hTERT+: 19.0;BJ hTERT+ SV40 Large T+ RasG12V: 18.3;HHSteC: 5.3;HSkMC: 6.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 6.9"	"HPA036112, HPA060342"	Enhanced					NA	NA					"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	11.4	12.5	2.2	1.0	4.0	0.5	11.2	0.5	8.6	13.0	3.8	1.1	4.8	1.1	7.8	7.0	6.5	6.7	4.9	7.7	2.0	1.8	4.3	1.0	14.6	2.4	2.7	5.8	7.7	1.5	2.5	6.1	51.6	1.9	9.7	2.2	6.0	6.5	11.8	7.3	2.5	1.9	3.7	1.3	0.5	3.0	2.9	0.5	0.0	8.7	5.2	1.4	5.7	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	7.0	19.0	3.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.0	0.5	8.6	2.0	1.8	2.7	5.8	1.9	0.5	0.0	0.0	0.0	0.1	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.9	4.5	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.0	2.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.0	64.7	58.7	3.5	6.0	0.6	0.5	0.0	0.0	0.0
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829037	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6"	"Cell type enhanced"	"Detected in single"	35	"Intestinal endocrine cells: 1.7"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"U-266/70: 6.0;U-266/84: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA								"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932163	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8"	"Cell type enriched"	"Detected in some"	15	"Intestinal endocrine cells: 65.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.4;U-266/70: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA					"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.1	7.4	0.1	0.8	0.1	0.0	4.5	0.1	0.4	0.2	6.9	0.2	0.0	3.4	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.1	8.3	0.0	2.1	1.5	0.0	0.5	2.0	0.0	1.2	4.0	0.1	0.1	9.2	0.0	0.1	0.1	11.8	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	65.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0
VGLL2		ENSG00000170162	"Vestigial like family member 2"	Q8N8G2	6	117265558-117273565	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 75.9"	"Cell type enhanced"	"Detected in some"	27	"Cardiomyocytes: 1.7;Hofbauer cells: 1.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RH-30: 17.4;U-2 OS: 6.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.4"	"Not detected"	"Not detected"									NA	NA										"unprognostic (3.02e-2)"	"unprognostic (3.09e-2)"				"unprognostic (1.75e-1)"					"unprognostic (4.92e-1)"			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	9.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	1.7	0.3	75.9	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.0	7.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	2.1	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.7	18.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	2.2	1.4	0.1	1.7	0.0	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0	14.9	56.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
AL132671.2		ENSG00000282218			6	117318211-117573571	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"epididymis: 3.7;lung: 2.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	37	"U-138 MG: 14.5"									HPA019477	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019477: AB_1849890"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	3.7	0.0	0.0	0.0	0.0			0.0	0.0	2.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		11000000	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	15.5	5.2	6.6	7.9	5.6	0.7	12.2	5.1	8.9	12.9	10.6	4.2	10.4	9.0	7.9	6.2	7.9	3.9	12.8	8.2	4.8	3.7	6.1	13.2	15.6	6.3	4.7	3.2	3.2	13.1	12.2	12.6	12.1	7.0	7.6	8.7	4.5	7.1	9.6	17.8	4.3	12.7	7.1	10.2	5.8	10.5	7.6	3.2	1.2	8.8	7.0	5.1	10.5	12.2	0.0	1.2	0.0	0.7	1.0	3.5	1.2	3.1	7.3	2.6	2.9	4.6	5.8	7.4	18.2	24.0	15.5	11.8	15.3	6.9	0.0	9.1	7.8	19.3	7.3	5.0	8.1	16.4	1.4	3.8	2.7	7.6	24.9	20.0	3.9	2.3	6.6	19.0	14.0	13.3	17.9	21.5	2.7	5.8	2.8	20.2	2.5	0.0	2.6	1.9	8.6	3.0	0.0	0.5	1.8	3.4	3.8	7.9	0.1	13.4	1.5	2.1	3.9	1.9	5.2	15.9	0.0	18.8	5.2	7.9	7.8	2.1	2.1	7.8	3.9	6.8	0.0	0.5	0.0	1.7	0.7	0.3	0.0	2.4	3.5	0.6	0.0	3.0	3.5	0.0	1.0	0.3	1.2	2.2	1.2	6.6	5.6	5.1	8.9	4.8	3.7	4.7	3.2	7.0	3.2	14.9	13.1	5.2	2.9	4.6	5.6	3.2	12.7	5.3	15.9	5.2	5.9	23.0	1.7	5.2	22.6	7.8	9.7	0.0	4.2	4.8	5.1	3.1	1.1	7.9	5.0	4.8	4.1	13.5	5.1	7.0	0.9	6.3	8.5	1.0	7.1	1.2	7.9	7.8	0.4	2.1	3.0	12.9	17.6	1.5	13.6	5.3	15.2	6.1	9.3	5.3
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	18.4	15.6	17.2	21.1	22.2	6.5	21.5	30.0	27.8	26.9	19.3	17.0	25.7	12.7	25.3	20.1	15.1	20.3	17.3	22.8	18.9	17.8	15.6	19.2	14.1	19.0	18.6	21.8	28.3	16.9	32.6	34.2	21.2	21.2	18.0	21.8	10.7	17.5	24.6	17.6	19.5	17.3	20.7	18.7	18.5	15.5	17.6	18.3	32.1	25.3	13.2	17.4	18.7	26.4	9.9	11.0	9.8	5.5	10.6	11.9	4.9	5.7	6.3	8.2	10.9	18.0	21.4	13.0	24.1	17.8	13.2	13.7	9.6	6.5	17.5	10.5	13.5	26.2	13.1	15.8	11.6	18.6	8.7	8.8	16.0	16.4	15.4	18.8	21.3	10.7	25.3	32.5	9.8	28.7	26.7	11.2	12.3	14.9	7.2	26.6	5.3	8.8	16.6	7.1	9.9	6.8	13.6	15.9	12.6	10.1	5.4	11.7	9.1	24.2	8.4	6.4	16.4	6.1	20.7	13.3	0.9	12.1	12.2	25.9	12.9	11.6	14.9	16.5	18.1	10.1	9.8	5.0	3.8	8.4	4.5	11.9	9.7	9.1	8.9	6.6	9.9	10.7	10.8	3.7	10.6	5.5	11.0	8.9	4.9	17.2	22.2	30.0	27.8	18.9	17.8	18.6	21.8	21.2	18.3	20.8	17.7	13.7	21.2	41.4	55.8	35.1	33.1	33.5	22.7	19.2	21.6	65.0	23.2	23.3	25.7	32.0	27.1	0.0	22.3	50.4	51.1	21.8	31.1	35.0	32.7	69.9	32.2	39.3	19.9	10.2	39.1	21.9	27.0	17.2	57.0	39.5	17.6	37.4	39.6	20.7	34.1	32.3	30.3	106.6	43.2	52.2	43.7	28.7	34.0	22.1
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675502-117710640	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	8.4	10.2	14.7	9.3	14.7	7.0	10.0	8.8	13.4	29.6	9.2	6.8	2.0	7.1	9.6	13.5	9.5	8.8	7.1	8.2	12.7	9.9	13.1	17.4	9.5	8.4	16.4	15.7	8.8	28.9	15.0	20.0	10.6	16.2	9.6	9.3	7.1	13.8	14.9	7.9	6.1	14.4	8.5	7.3	9.1	10.6	5.6	12.2	7.2	16.5	3.1	8.7	9.1	18.0	2.4	8.1	3.3	4.9	4.1	4.5	2.3	10.3	7.6	16.4	18.3	16.6	21.8	40.4	18.9	19.7	15.8	18.2	17.2	11.6	24.4	20.6	17.4	20.1	9.4	24.4	18.5	29.5	18.2	22.5	27.9	12.8	30.7	25.6	35.1	16.5	19.0	21.0	17.3	35.4	16.2	16.2	18.3	33.3	21.8	23.6	11.6	16.5	22.4	19.1	14.2	13.9	15.9	11.8	17.5	31.4	10.3	19.5	15.4	11.4	14.8	13.8	19.1	9.4	36.9	14.2	9.8	12.1	15.6	27.1	30.3	22.6	26.0	23.2	27.1	19.5	3.3	3.0	1.8	3.1	3.0	4.5	2.4	3.7	4.1	3.2	2.1	3.1	4.0	0.2	4.1	4.9	8.1	3.4	2.3	14.7	14.7	8.8	13.4	12.7	9.9	16.4	15.7	16.2	12.2	0.0	21.1	21.6	29.1	53.8	14.3	6.1	15.3	10.7	14.8	24.4	9.8	21.6	23.2	19.8	11.9	17.5	19.7	0.0	26.2	41.6	19.7	52.1	31.1	35.9	32.9	14.3	12.6	27.0	29.1	11.8	16.7	32.9	30.4	22.6	26.8	7.5	29.9	21.0	19.1	29.2	8.2	6.5	37.6	21.8	28.8	49.1	48.4	14.1	21.0	80.5
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907526-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 41.9"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9"	"Group enriched"	"Detected in some"	16	"glioma: 15.1;melanoma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"AF22: 23.9;WM-115: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	2.8	2.7	13.8	2.1	14.5	0.9	1.2	3.6	41.9	1.7	3.5	4.3	0.0	1.6	2.7	5.5	1.8	1.5	1.8	5.3	10.4	10.2	1.7	1.0	1.1	1.0	9.3	15.3	1.4	1.4	1.0	0.6	1.0	5.6	2.3	2.3	2.6	1.7	2.9	1.2	1.6	1.8	2.6	4.1	1.6	1.4	1.8	5.6	0.0	1.8	0.0	1.0	1.4	2.6	0.2	0.6	1.0	0.1	0.3	0.9	0.1	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.2	0.0	2.9	3.4	0.0	0.0	0.1	0.0	40.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.3	0.0	0.6	0.0	0.1	13.8	14.5	3.6	17.4	10.4	10.2	9.3	15.3	5.6	5.6	0.0	0.0	0.0	0.0	0.3	11.0	4.3	0.0	0.0	2.3	0.0	2.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.1	15.9	0.0	0.0	0.0	17.4	0.6	0.0	13.5	0.0	0.0	27.9	0.0	0.0	1.1	0.0	1.8	0.0	0.7	0.9	1.2	0.0	0.0	0.0	0.0	0.0
CEP85L	"bA57K17.2, C6orf204, NY-BR-15"	ENSG00000111860	"Centrosomal protein 85 like"	Q5SZL2	6	118460772-118710075	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 409.4;Late spermatids: 601.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029137, HPA029138, HPA029139"	Uncertain					NA	NA					"HPA029137: AB_10600657, HPA029138: AB_10600874, HPA029139: AB_10601220"	"unprognostic (3.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.87e-5)"	"unprognostic (2.72e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-2)"	5.4	7.3	4.5	17.6	6.8	12.9	4.4	15.5	8.4	5.8	4.2	4.4	3.5	2.6	6.5	3.9	4.4	5.6	5.0	5.5	5.1	4.2	2.9	3.3	6.5	15.7	7.9	3.1	10.4	7.1	6.5	14.6	5.7	6.3	4.9	3.7	5.1	8.3	6.0	18.8	2.8	6.3	12.9	5.5	9.1	10.2	35.7	7.4	29.1	4.1	8.8	12.1	8.4	8.8	4.4	5.3	15.3	11.6	6.7	7.5	3.7	1.0	0.9	5.8	3.3	3.2	5.9	22.7	3.0	4.4	2.6	3.0	0.2	0.3	5.5	0.9	4.3	2.2	1.4	2.6	4.2	4.9	2.8	2.8	7.2	1.6	0.6	2.6	0.5	2.3	3.4	2.3	3.2	3.6	5.3	3.9	8.1	7.0	5.3	4.4	0.8	12.9	3.3	1.7	0.1	1.3	3.1	4.5	1.2	3.2	2.5	3.3	2.0	2.2	0.1	4.1	4.8	0.7	2.8	3.1	4.3	2.4	3.7	4.6	6.8	5.0	5.2	3.5	2.4	4.3	1.5	10.4	8.6	6.9	11.6	7.0	3.4	5.6	5.5	5.3	4.4	7.5	6.1	15.3	6.7	9.6	2.5	4.3	3.7	4.5	6.8	15.5	8.4	5.1	4.2	7.9	3.1	6.3	7.4	6.0	5.8	11.5	10.4	6.2	30.3	27.8	0.0	4.0	1.2	3.5	9.8	21.8	1.7	3.2	409.4	24.4	0.0	0.0	3.6	5.0	16.5	4.8	8.1	5.0	7.3	31.8	2.9	13.5	27.7	601.9	29.7	15.0	21.9	3.6	0.5	7.0	7.0	0.2	27.3	1.7	9.0	19.4	32.5	36.4	37.9	4.3	18.5	30.5	0.4	7.1
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 337.5"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2230.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.3;Karpas-707: 1.6;NB-4: 1.8;SuSa: 1.7;U-2197: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005597, HPA026900"	Enhanced					NA	NA					"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	9.0	1.8	0.4	2.7	0.5	0.0	5.4	0.4	0.6	22.3	22.2	0.0	9.8	2.0	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0.0	1.6	6.0	68.4	1.5	14.0	30.8	1.2	0.6	6.5	12.3	0.0	0.0	2.8	23.7	0.8	32.2	6.6	0.3	0.0	1.3	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.2	0.1	0.0	0.2	0.2	1.6	0.1	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.7	0.2	0.8	0.4	0.1	0.0	1.7	0.4	0.0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.4	0.0	1.0	0.1	0.0	0.4	1.3	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.3	1.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0.0	0.0	0.0	0.0	0.0	3.8	1.6	2230.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	71.2	0.4	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.7	0.9	0.3	3.3	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.2	271.7	280.1	1.1	0.4	1.4	0.0	0.0	0.0	0.4
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031137	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	8.6	7.2	5.9	11.9	8.4	14.5	17.7	5.2	6.9	9.4	11.2	8.2	9.8	7.3	9.0	16.0	10.2	8.6	8.2	6.6	5.9	4.0	9.3	7.6	15.6	12.1	11.5	4.7	8.7	12.2	11.9	11.2	13.8	6.3	10.5	8.4	7.0	11.8	8.7	4.2	9.8	12.6	10.9	5.7	10.2	7.3	7.9	8.1	27.0	13.1	7.1	9.9	9.6	10.5	3.1	5.2	8.0	5.3	10.2	6.4	3.9	4.6	7.4	11.9	12.8	5.4	5.3	9.1	4.4	7.9	6.5	8.3	6.1	8.4	14.1	5.5	7.6	4.3	14.0	8.3	4.8	9.2	8.3	11.4	11.2	8.8	5.9	3.2	12.0	7.6	5.8	5.7	6.7	7.7	4.1	6.2	8.8	13.5	6.5	4.3	9.8	10.6	9.7	5.8	7.7	3.4	8.4	7.5	3.7	6.6	9.3	10.3	7.4	7.8	5.7	4.1	3.2	8.5	17.0	6.3	5.2	4.6	3.7	6.5	8.7	7.2	16.7	6.6	9.8	6.0	7.2	4.5	8.0	4.9	5.3	3.8	3.1	3.0	5.0	5.2	3.0	3.6	3.5	5.4	10.2	3.2	3.7	6.4	3.9	5.9	8.4	5.2	6.9	5.9	4.0	11.5	4.7	6.3	8.1	6.0	4.1	4.4	3.1	2.6	3.5	3.9	2.5	12.0	4.5	7.0	9.8	9.1	3.3	2.3	1.5	4.4	5.1	0.0	2.5	2.9	2.8	3.4	6.9	2.4	3.0	1.6	6.9	3.7	5.3	1.9	3.4	4.5	0.0	2.8	5.9	2.1	2.1	5.8	3.9	2.9	5.4	0.0	2.1	4.8	2.7	1.8	6.1	5.3	4.1	4.1
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894220-118909167	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA030502: AB_2673504, HPA071495: AB_2686404"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.8	14.1	21.5	9.1	23.8	7.9	14.4	20.3	17.5	12.9	10.4	12.6	16.1	8.5	12.3	15.6	13.7	12.3	9.0	14.6	18.1	19.2	14.4	13.3	15.0	16.3	21.6	14.9	20.9	10.8	25.7	12.9	9.5	15.2	12.0	12.5	9.1	11.6	15.4	16.6	12.9	11.7	11.6	21.4	15.2	11.8	10.5	14.8	36.9	20.2	14.9	16.4	13.3	12.2	13.4	12.8	12.2	7.9	12.1	30.8	17.6	6.0	3.9	13.8	9.2	11.9	7.0	11.1	8.3	8.3	10.9	12.3	4.8	5.3	10.2	13.7	5.9	9.5	6.7	11.9	10.6	13.9	7.3	11.0	15.0	9.4	30.9	8.3	25.3	7.8	6.1	10.8	9.4	14.4	14.6	14.4	32.7	23.2	27.4	12.8	6.4	29.5	20.0	5.7	9.1	13.5	16.2	5.6	12.7	14.5	7.9	8.9	6.8	8.4	8.5	9.7	4.5	4.9	23.7	12.3	5.1	7.5	7.0	12.7	8.5	14.1	14.9	13.3	20.2	10.9	6.6	6.0	12.2	16.3	6.3	22.7	13.4	26.6	20.9	12.8	8.1	29.1	23.8	1.0	12.1	7.9	9.7	30.8	17.6	21.5	23.8	20.3	17.5	18.1	19.2	21.6	14.9	15.2	14.8	14.9	19.9	35.3	13.8	26.2	15.4	23.4	12.7	24.1	15.9	8.7	3.9	59.8	53.0	28.9	26.4	23.7	8.5	116.8	20.7	67.2	19.7	9.5	22.0	13.9	21.7	23.8	28.4	14.1	16.8	7.8	23.6	19.0	15.1	26.2	10.5	22.6	19.3	10.5	21.9	22.6	12.5	12.9	29.7	26.5	40.0	28.9	39.0	47.3	16.7	11.1
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.4"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	4.0	2.8	14.2	3.7	13.7	0.6	6.1	13.9	16.0	2.8	3.0	4.6	0.4	3.8	3.9	3.6	2.6	3.9	2.3	2.4	11.3	10.5	6.7	6.4	15.3	4.9	9.1	10.0	7.1	5.1	14.2	15.4	31.4	11.9	4.0	1.9	2.7	2.9	4.1	1.2	2.3	2.6	3.1	4.6	1.0	1.7	23.2	7.1	0.1	8.5	1.1	5.8	2.1	2.0	0.5	0.0	0.0	0.2	0.3	1.9	0.0	0.1	0.2	15.9	1.6	0.2	0.2	0.0	0.5	0.3	0.5	0.8	2.1	1.2	1.1	0.0	0.2	6.0	0.0	4.9	0.0	0.2	1.2	9.4	0.5	1.4	7.0	0.1	0.0	1.5	0.3	0.2	0.1	0.0	0.3	0.0	13.4	13.0	0.5	0.2	0.3	0.3	0.0	5.3	0.6	1.2	0.0	0.0	0.0	0.1	0.1	10.4	7.7	0.5	0.5	1.5	3.0	2.1	1.8	0.2	0.8	0.4	0.1	4.0	4.0	4.3	0.3	1.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.0	0.0	0.1	1.5	1.2	0.0	0.3	0.0	0.0	1.9	0.0	14.2	13.7	13.9	12.9	11.3	10.5	9.1	10.0	11.9	7.1	44.7	90.2	0.0	6.1	2.2	36.7	3.9	5.1	60.2	31.8	3.5	27.5	45.2	14.9	0.8	12.9	1.9	0.1	0.0	1.0	13.5	5.0	0.9	5.8	3.4	4.9	12.7	5.8	3.1	0.3	5.4	3.4	0.8	0.0	0.0	0.0	12.5	0.5	0.0	6.7	1.3	27.8	6.5	2.3	64.6	15.4	3.0	222.8	4.1	0.4	1.0
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177209-119349761	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 149.9;Hepatocytes: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.3;Hep G2: 42.3;Karpas-707: 47.2;U-266/70: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		390000000	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	41.8	19.8	5.8	10.5	17.4	8.1	32.2	1.5	7.9	12.3	23.3	3.2	3.6	17.4	11.3	12.0	10.6	9.5	22.0	10.4	5.0	3.3	23.4	74.2	16.4	16.8	2.8	5.7	10.3	22.0	3.4	6.4	26.1	3.7	14.7	9.9	10.5	41.0	5.3	7.1	9.6	36.3	19.7	3.5	20.9	10.0	8.7	3.7	8.8	15.2	10.3	9.1	21.2	36.4	1.4	5.5	6.0	1.1	1.9	4.7	0.6	0.0	0.0	0.7	0.0	60.3	26.7	1.4	1.4	8.8	1.1	2.7	4.1	0.5	9.0	0.0	5.5	14.2	0.1	1.6	0.0	1.4	13.3	4.1	7.5	0.8	42.3	6.0	0.0	3.8	18.2	1.1	9.0	5.5	4.8	0.7	2.6	26.0	47.2	8.5	1.2	0.3	0.0	0.5	4.1	2.1	2.5	0.9	13.6	2.9	7.4	3.0	4.5	0.0	0.1	0.0	1.9	2.2	1.0	5.2	3.7	3.4	6.9	3.3	63.8	9.0	17.8	10.9	0.1	2.2	6.0	0.6	2.0	2.4	1.1	4.7	1.4	1.3	1.3	0.6	0.9	0.8	1.9	3.8	1.9	0.9	5.5	1.4	0.6	5.8	17.4	1.5	7.9	5.0	3.3	2.8	5.7	3.7	3.7	8.9	36.6	18.6	5.7	28.2	18.6	3.9	45.9	8.1	11.4	101.2	0.0	4.7	5.0	5.1	149.9	42.5	42.8	23.3	32.8	8.0	90.1	5.0	3.5	232.5	81.6	0.0	46.1	103.7	76.4	24.4	24.5	57.9	27.0	6.4	55.5	1.3	20.9	14.4	3.9	32.2	4.7	6.5	18.1	2.1	3.9	24.3	5.1	26.1	11.5	7.6
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.4"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	3.2	7.3	7.3	5.5	8.8	2.4	5.0	3.9	11.1	5.7	3.5	4.8	3.8	4.5	5.1	4.1	4.1	4.8	5.6	3.5	7.0	4.1	4.5	1.8	3.2	3.0	8.1	7.8	6.5	4.0	9.7	25.4	8.2	8.0	5.0	2.4	4.2	4.6	3.2	1.7	5.5	4.6	2.4	7.0	3.1	3.8	9.2	7.9	8.1	7.0	2.1	3.2	3.7	5.1	6.4	10.7	5.8	1.3	3.4	3.7	0.4	1.6	2.0	3.2	4.2	2.9	4.4	1.6	1.8	2.7	3.1	4.6	0.1	1.1	2.9	3.1	2.0	4.7	1.5	1.5	1.6	3.8	22.0	2.1	3.7	0.6	0.7	1.3	1.8	1.5	1.7	1.1	2.9	2.0	3.7	0.6	3.7	2.1	0.0	2.4	1.0	2.1	1.1	1.9	1.0	0.7	1.8	1.6	0.3	1.7	0.8	6.6	3.3	2.3	1.3	1.0	1.8	2.0	1.5	0.4	2.1	2.1	0.5	2.1	1.5	0.0	1.3	2.8	1.0	3.2	5.8	1.3	1.7	2.6	0.7	1.9	3.4	1.9	1.8	0.8	6.4	3.7	2.8	1.1	3.4	1.1	10.7	2.1	0.4	7.3	8.8	3.9	11.1	7.0	4.1	8.1	7.8	8.0	7.9	3.0	5.9	1.5	3.2	5.5	27.8	2.9	5.1	24.1	13.6	7.0	41.2	3.8	0.0	2.2	3.4	3.2	4.2	0.0	1.9	1.3	6.1	2.8	3.5	1.0	1.2	12.7	5.2	3.7	1.3	2.1	2.3	3.3	1.7	1.0	5.2	5.8	0.9	3.5	1.8	1.0	111.1	0.0	3.1	12.6	7.9	4.4	1.9	3.2	2.8	1.8
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435692-121449727	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	19.7	65.2	78.6	5.5	69.7	0.4	14.2	32.4	44.4	64.5	4.0	23.8	6.1	4.2	23.5	5.5	17.3	7.8	23.0	36.0	87.3	25.5	3.6	2.5	15.2	4.4	42.9	39.9	10.5	4.5	94.7	5.7	63.8	53.7	20.0	4.8	26.3	7.1	35.7	3.4	86.3	4.4	25.6	38.7	1.1	6.4	8.3	64.3	0.5	38.9	9.9	7.6	14.8	32.2	0.5	0.5	0.4	0.5	0.0	0.4	0.0	0.0	6.6	29.3	0.0	16.0	9.9	0.0	21.9	44.6	7.4	18.1	0.1	0.0	0.0	2.4	8.5	6.3	2.8	0.7	13.4	24.1	0.0	8.0	0.3	2.7	0.0	20.0	0.0	0.0	26.4	14.5	27.1	9.8	73.4	56.2	0.0	0.0	0.6	1.4	1.2	0.0	11.7	57.2	0.0	7.3	0.0	0.0	0.5	29.6	3.2	0.0	0.4	0.0	0.0	0.0	74.9	2.3	0.0	41.3	22.8	6.3	19.2	14.1	0.0	0.0	0.0	55.7	0.0	3.2	0.4	0.5	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.5	0.4	0.4	0.0	0.0	0.1	0.5	0.1	0.0	78.6	69.7	32.4	42.8	87.3	25.5	42.9	39.9	53.7	64.3	232.3	73.8	0.0	121.0	208.6	0.2	174.1	0.0	5.3	14.8	1.8	2.0	46.7	0.0	69.9	0.3	111.0	0.0	0.0	3.5	8.1	139.5	19.9	8.1	0.0	7.5	0.0	0.0	22.7	0.3	1.1	2.3	2.8	42.2	1.0	0.0	0.1	17.0	0.0	3.9	0.0	0.2	0.0	27.8	0.3	0.1	330.6	16.7	0.0	0.0	45.0
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399546-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.6	13.7	9.0	6.7	14.7	20.6	11.4	17.8	19.4	12.7	9.3	9.9	9.2	6.3	14.4	9.8	8.7	11.1	6.9	20.3	9.2	11.3	6.4	4.9	7.7	11.5	9.7	15.5	14.3	5.9	13.5	18.5	7.3	18.0	10.4	6.5	9.7	7.7	12.1	37.9	10.2	7.8	12.6	9.2	8.5	8.5	31.7	9.3	14.3	8.3	15.9	10.7	13.1	8.6	6.6	3.8	4.0	4.2	7.0	21.3	7.7	4.3	4.5	23.6	19.2	10.6	8.5	6.6	7.8	18.6	14.3	22.5	6.7	3.7	16.6	6.8	9.7	16.6	5.5	15.7	7.5	20.2	16.7	19.1	16.2	4.4	13.8	10.8	11.9	8.3	10.7	11.5	11.8	13.6	13.4	8.6	15.2	17.3	8.3	13.5	5.8	19.5	15.6	7.2	6.4	6.5	18.1	9.6	5.3	10.8	4.9	25.2	16.9	8.1	6.6	7.5	18.2	5.7	13.1	5.1	7.8	9.0	8.6	11.7	12.1	11.5	21.2	8.4	7.9	10.1	3.4	2.7	4.0	8.5	3.2	9.1	6.6	8.1	7.4	3.8	5.4	21.3	16.0	0.4	7.0	4.2	2.6	8.8	7.7	9.0	14.7	17.8	19.4	9.2	11.3	9.7	15.5	18.0	9.3	17.9	9.3	5.2	10.6	28.2	20.9	21.0	5.1	22.7	12.5	0.0	25.5	13.0	10.0	6.1	46.7	10.5	2.4	0.0	3.7	6.2	14.4	6.6	8.1	4.3	6.7	20.6	6.3	6.2	4.5	14.0	9.5	7.3	18.6	1.8	5.7	13.8	4.2	4.3	9.2	6.1	32.6	25.8	13.7	42.8	81.2	22.5	2.6	11.4	4.6	5.8
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443354-122471822	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	49.0	62.0	72.0	21.6	74.5	31.4	39.6	67.3	96.4	40.4	25.1	61.5	17.0	23.9	36.7	27.8	23.8	27.0	31.6	39.1	75.5	78.4	48.7	58.1	38.9	20.6	91.6	57.7	42.7	24.4	56.4	32.9	47.0	109.2	36.0	25.2	29.7	22.5	37.8	37.4	20.5	27.2	35.4	120.6	28.4	23.1	15.6	57.5	12.9	50.8	13.0	18.7	33.2	22.8	10.0	12.6	44.1	20.4	17.7	20.7	17.4	7.4	9.2	23.3	21.3	88.4	48.6	12.4	39.2	49.2	21.5	33.4	10.7	20.2	5.0	30.9	44.1	24.7	14.9	13.7	16.9	32.3	15.9	16.3	14.1	15.7	19.5	39.6	14.1	28.2	50.4	33.3	26.7	37.0	49.6	18.5	13.2	14.0	28.5	44.4	8.5	6.3	9.4	7.5	11.7	11.7	7.8	11.5	12.0	46.2	13.1	12.2	22.1	17.3	19.3	26.5	21.6	13.3	19.9	37.7	25.9	11.3	21.2	20.3	21.6	24.1	6.6	34.3	11.5	30.2	44.1	15.0	31.4	16.8	18.8	18.1	10.0	17.6	16.2	12.6	8.7	20.7	17.9	38.9	17.7	20.4	9.9	18.6	17.4	72.0	74.5	67.3	86.9	75.5	78.4	91.6	57.7	109.2	57.5	140.0	86.4	39.7	67.4	58.7	103.2	138.9	89.2	52.2	54.6	73.3	66.8	48.9	8.3	55.1	2.4	116.4	66.3	46.7	42.2	46.7	95.4	88.7	119.2	115.6	64.9	130.3	81.1	105.6	142.0	5.6	117.3	84.8	89.4	25.2	36.8	98.4	63.7	38.6	123.4	38.5	56.5	58.2	75.4	17.9	19.6	65.5	100.1	71.3	29.3	78.2
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 91.6;placenta: 140.9"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 457.3;Enterocytes: 299.8;Extravillous trophoblasts: 381.2;Syncytiotrophoblasts: 802.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 91.6"	"Cell type enriched"	"Detected in some"	11	"myeloid DC: 22.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 22.3"	"Cell line enhanced"	"Detected in many"		"AF22: 20.0;MCF7: 22.6;OE19: 24.5;PC-3: 31.8;RPTEC TERT1: 52.0;SCLC-21H: 44.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 92.0;olfactory region: 58.4"	HPA030156	Approved					NA	NA					"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	0.8	2.0	3.3	7.3	3.7	0.0	8.8	91.6	2.3	1.8	33.0	1.0	1.0	5.4	0.9	1.2	1.6	1.8	2.3	0.5	2.8	4.5	0.9	2.6	2.0	0.9	6.1	2.2	0.5	2.3	18.9	22.3	140.9	17.7	2.0	23.6	5.6	2.8	1.2	0.5	3.1	12.0	1.2	2.8	0.8	12.2	1.2	0.7	1.6	1.0	1.3	2.5	1.8	0.7	0.1	22.3	0.0	1.9	1.4	0.5	0.5	0.0	0.7	20.0	0.1	0.1	0.0	17.5	0.0	0.2	0.0	0.3	0.1	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.2	0.1	1.0	0.3	1.1	0.4	0.0	0.0	3.4	0.1	0.3	0.3	4.3	9.6	0.1	0.1	5.8	0.1	0.0	22.6	0.0	0.1	8.2	24.5	31.8	0.1	3.0	0.1	52.0	2.8	44.3	0.0	0.0	4.7	0.5	11.5	3.3	0.4	1.7	0.0	13.5	0.0	1.6	0.0	0.0	0.0	13.2	0.4	0.1	0.0	0.4	0.0	0.0	1.9	0.5	0.0	0.0	0.0	22.3	0.1	0.3	0.1	0.0	1.4	0.1	0.3	0.2	0.5	3.3	3.7	91.6	2.3	2.8	4.5	6.1	2.2	17.7	0.7	3.0	3.8	2.7	2.1	17.5	14.0	0.3	5.1	97.7	13.6	1.8	3.9	457.3	16.6	18.6	103.5	1.5	299.8	0.0	30.1	381.2	7.1	14.7	38.1	3.8	46.4	6.4	94.2	1.8	40.2	208.8	1.1	124.0	42.2	40.5	65.2	9.4	67.0	45.5	0.4	3.3	47.6	6.5	4.0	2.7	5.4	14.9	802.7	3.2	47.0	4.7
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779475-122784074	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 62.7;breast: 26.8"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 827.1"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1"	"Group enriched"	"Detected in some"	8	"AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3"	"Region enriched"	"Detected in all"	6	"olfactory region: 1471.1"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13.0	0.0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32.0	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1.0	2.1	1.3	11.2	1.3	1.2	5.7	7.0	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0.0	1.1	0.0	1.1	1.4	0.0	0.4	0.2	3.1	0.3	1.1	0.4	0.0	0.0	0.0	38.7	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.4	0.0	23.3	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0.0	34.8	15.5	51.6	27.3	32.0	16.4	11.4	30.3	11.2	6.9	0.0	0.0	0.0	0.1	10.9	6.8	0.4	0.0	0.0	0.0	0.0	11.8	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	162.7	1.1	0.0	0.0	0.0	2.5	4.8	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	827.1	0.0	0.0	0.0	0.2	37.4	0.0	0.8	0.0	0.0	16.6	5.9	0.0	0.0	0.0
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 208.6;Proximal tubular cells: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		22000000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.8	15.9	4.0	8.3	5.4	8.1	24.9	9.7	9.9	35.3	46.7	3.8	8.0	19.2	10.0	9.8	9.6	5.1	8.5	11.9	4.5	4.1	20.1	36.9	13.0	29.1	4.7	5.6	6.2	24.6	16.1	7.0	23.2	6.5	19.6	28.5	7.6	9.5	13.7	56.1	32.1	63.6	10.9	4.9	37.7	13.1	3.8	3.2	3.3	7.2	18.0	7.6	18.7	24.3	0.1	0.4	31.2	3.2	0.0	0.0	0.5	0.1	1.2	3.0	1.4	22.3	10.1	9.6	5.0	13.5	1.5	3.3	1.6	1.3	0.0	0.7	3.1	4.1	2.4	0.8	2.5	1.3	0.0	2.6	1.1	5.1	4.2	14.3	0.0	0.0	12.3	18.3	1.4	2.7	6.0	2.7	0.0	1.8	0.0	6.2	4.4	0.0	0.1	0.5	28.0	3.9	0.0	5.3	0.1	7.4	2.0	2.2	0.0	0.7	9.1	12.7	2.0	1.5	0.7	5.2	3.0	1.7	0.3	3.2	0.0	0.0	0.0	4.3	2.3	6.7	31.2	1.7	0.4	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.5	4.0	5.4	9.7	9.9	4.5	4.1	4.7	5.6	6.5	3.2	3.0	16.2	2.2	20.4	47.7	2.8	3.6	22.9	5.3	3.4	5.2	3.9	117.9	48.0	19.1	0.1	5.8	208.6	0.0	22.5	35.4	27.9	13.5	9.3	67.1	54.3	3.2	46.8	24.5	86.5	1.1	14.4	9.9	33.7	1.0	51.3	11.4	17.1	87.7	13.4	122.4	5.9	12.9	8.3	0.9	3.9	66.5	96.2	4.3	33.0	12.8
CLVS2	"bA160A10.4, C6orf212, C6orf213, RLBP1L2"	ENSG00000146352	"Clavesin 2"	Q5SYC1	6	122995971-123072927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 71.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 14.7;SCLC-21H: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043764	Uncertain					NA	NA					"HPA043764: AB_10960281"	"unprognostic (1.35e-1)"		"unprognostic (3.28e-2)"		"unprognostic (4.68e-2)"				"unprognostic (3.60e-1)"		"unprognostic (2.38e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.72e-3)"	"unprognostic (9.60e-2)"		"unprognostic (8.71e-2)"	0.7	2.8	5.0	0.9	9.6	0.7	0.8	39.9	22.6	2.1	1.1	0.6	0.0	0.9	3.1	0.7	0.8	0.7	0.8	0.7	5.8	3.9	0.7	0.8	0.7	0.8	3.0	10.2	0.7	0.7	0.7	6.3	0.7	8.5	7.9	1.1	0.1	0.8	1.1	0.7	0.8	0.9	2.8	1.3	0.7	0.8	1.0	1.8	0.0	0.7	0.0	0.7	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	9.6	39.9	22.6	5.8	3.9	3.0	10.2	8.5	1.8	0.0	0.0	0.0	13.8	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	71.4	0.0	0.0	0.4	0.0	4.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.8
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 855.7;Muller glia cells: 805.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.1	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	5.8	855.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.9	12.0	0.0	1.7	0.0	0.0	805.6	0.0	0.0	10.6	0.0	13.4	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Group enriched"	"Detected in some"	16	"Horizontal cells: 44.5;Muller glia cells: 20.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.2	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.5	0.1	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1	0.0	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	44.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 63.3"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9;myeloid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain					NA	NA					"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.92e-4)"	9.6	3.5	3.3	4.2	4.7	10.5	14.6	3.8	3.5	8.0	7.7	5.7	6.4	2.3	5.9	5.6	6.2	7.5	12.1	6.5	3.8	1.7	2.5	6.3	7.3	3.7	4.3	2.9	11.5	3.8	63.3	4.0	12.0	3.4	6.4	2.3	6.0	6.0	6.9	10.1	10.9	3.1	13.0	2.3	2.6	4.5	7.4	5.7	0.1	7.4	3.6	1.6	8.7	13.6	0.0	1.2	0.6	1.9	0.3	0.2	0.3	4.1	4.3	1.5	0.5	5.4	2.1	8.6	5.7	7.7	3.9	5.1	0.0	3.9	0.0	8.0	5.4	8.9	6.0	0.9	5.1	5.5	0.0	4.8	2.3	6.4	1.3	5.2	0.0	0.2	5.9	4.8	2.9	8.6	4.6	4.4	0.0	11.6	0.0	6.8	0.0	0.0	0.0	1.3	0.0	1.1	0.1	6.0	0.0	4.0	1.9	0.7	0.0	2.5	0.6	2.2	4.4	4.2	0.7	6.9	3.2	10.4	0.0	12.2	0.0	0.0	0.0	2.4	0.0	3.8	0.6	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.3	3.3	4.7	3.8	3.5	3.8	1.7	4.3	2.9	3.4	5.7	20.8	16.0	0.0	12.7	42.7	6.2	12.5	2.5	5.3	10.3	5.2	15.7	15.2	0.0	6.8	92.0	15.0	1.7	0.0	8.3	23.6	21.6	10.4	1.1	24.6	8.5	20.6	2.9	14.1	12.9	49.9	23.9	13.3	18.6	2.8	3.0	4.0	10.7	0.0	19.8	1.9	5.0	6.5	12.3	1.4	2.6	41.0	15.0	0.5	2.7	9.7
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	7.0	8.0	0.0	52.5	0.4	0.1	12.5	1.2	1.1	0.0	0.1	12.8	9.0	0.0	27.0	5.9	1.7	16.2	1.6	11.2	0.0	0.1	11.2	0.1	11.3	0.1	1.1	0.0	0.0	1.4	46.2	0.0	6.1	16.4	0.0	0.0	5.6	0.1	0.9	68.6	0.0	0.1	0.8	6.9	4.4	0.0	0.0	0.0	53.2	1.8	1.7	0.0	13.5	37.1	0.8	2.0	31.6	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2	0.0	21.2	0.5	40.2	17.4	1.7	40.6	17.8	13.4	13.6	118.7	3.9	27.1	149.2	28.9	5.4	30.1	4.6	0.0	97.5	106.8	3.1	35.2	2.3	56.3	9.5	0.0	15.5	4.3	1.9	3.4	16.1	4.1	124.9	1.0	9.1	3.2	37.3	0.0	34.3	26.2	1.3	0.0	15.6	2.8	5.3	32.5	12.0	2.9	9.7	17.9
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		19000	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	17.5	29.8	50.5	12.0	36.1	11.3	21.1	26.4	31.7	14.8	15.2	11.1	31.6	12.4	12.9	25.2	19.6	17.2	12.4	34.7	41.1	37.0	31.3	8.9	13.4	18.8	45.0	18.9	18.3	22.9	16.3	15.6	11.5	23.4	15.7	16.9	19.3	54.8	42.0	42.8	13.5	16.1	19.0	25.8	12.2	14.4	25.7	16.8	12.9	24.3	35.4	18.2	17.7	11.2	27.3	15.4	4.4	14.2	23.6	33.9	17.7	8.6	24.1	15.0	61.5	12.2	16.8	20.9	11.6	17.7	12.6	13.1	37.9	10.4	40.0	25.2	22.1	29.1	8.6	21.0	17.0	16.1	15.7	49.3	18.5	13.4	37.2	27.8	23.9	13.7	23.5	26.2	17.9	41.3	19.8	9.0	22.2	69.9	17.3	27.2	48.0	18.5	25.2	17.6	25.8	19.6	27.9	11.9	8.4	29.4	11.0	29.4	14.3	14.2	27.7	25.4	14.7	16.2	40.6	5.5	12.7	14.0	19.5	23.4	20.6	14.2	33.1	18.3	43.3	25.9	4.4	14.2	2.5	22.9	12.2	18.7	27.3	25.3	31.0	14.7	22.0	31.4	33.9	3.2	23.6	11.1	15.4	21.5	17.7	50.5	36.1	26.4	31.7	41.1	37.0	45.0	18.9	23.4	16.8	23.8	38.7	42.4	51.6	39.6	51.4	109.7	33.1	34.8	30.7	59.3	13.7	75.6	286.8	71.8	43.7	26.4	42.4	23.3	86.1	127.4	62.7	54.8	36.9	18.1	98.5	65.2	61.9	11.6	46.6	33.2	84.3	41.0	75.9	12.6	64.1	45.8	55.3	45.6	107.8	202.1	18.2	38.8	76.2	115.5	66.8	37.6	38.2	62.3	78.2	45.1
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 28.5"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.9;Late spermatids: 59.0;Muller glia cells: 32.0;Sertoli cells: 51.8;Smooth muscle cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEK 293: 6.7;SK-MEL-30: 6.1;TIME: 13.9;U-266/70: 16.9"	"Region enriched"	"Detected in all"	4	"olfactory region: 34.5"	"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.0	1.8	7.4	1.8	9.2	0.7	5.5	5.7	11.8	10.4	2.9	13.1	0.7	2.2	11.3	24.0	2.8	19.3	7.6	28.5	8.2	6.2	3.6	7.8	3.7	1.2	8.2	11.4	10.7	4.1	7.1	5.4	5.4	12.8	2.3	2.4	10.4	3.0	4.5	19.1	2.1	2.2	2.9	11.3	2.9	2.0	6.5	7.2	0.0	3.6	4.9	1.4	3.5	4.9	0.0	0.0	0.0	0.1	0.0	2.6	0.4	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.4	6.7	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.5	0.0	0.4	0.0	0.0	3.0	0.0	0.3	0.5	0.6	0.8	0.0	0.1	2.2	0.0	0.0	0.0	6.1	3.2	1.8	0.0	13.9	0.3	0.0	0.1	0.7	16.9	0.3	0.1	0.6	0.0	1.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.4	0.0	0.0	0.1	0.0	0.0	0.4	7.4	9.2	5.7	5.9	8.2	6.2	8.2	11.4	12.8	7.2	3.0	0.6	0.5	0.3	3.4	0.4	17.9	0.0	6.7	1.2	0.0	7.9	0.0	8.3	0.0	37.9	3.7	0.0	23.3	1.6	0.1	3.0	0.3	0.0	7.3	0.1	1.6	0.0	1.3	0.3	59.0	6.1	0.6	3.3	0.0	0.0	32.0	1.8	0.0	21.9	4.2	5.0	51.8	35.0	10.8	7.0	1.8	0.0	0.5	0.0	0.4
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932030	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 348.4;Ciliated cells: 413.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	32.0	37.6	24.8	26.6	33.7	23.1	20.4	39.7	32.6	19.2	18.0	17.9	3.9	19.8	13.9	6.4	22.7	11.3	28.9	12.3	23.2	24.1	33.7	21.5	30.8	19.0	35.7	25.6	12.5	11.8	7.4	49.3	8.0	39.5	12.2	18.4	7.6	31.6	8.5	6.3	8.7	23.1	17.1	30.9	16.2	18.7	4.9	35.4	4.7	15.6	12.0	16.6	44.1	20.8	12.8	22.6	10.5	8.8	9.1	17.5	3.5	4.3	11.9	0.7	5.3	26.6	15.8	7.8	5.9	23.5	7.3	10.1	11.0	4.1	17.4	31.9	3.2	36.1	25.8	4.0	4.0	4.5	37.0	4.6	8.9	15.2	4.1	15.1	5.0	8.5	11.2	9.8	7.0	5.4	13.1	15.2	5.7	12.5	10.4	4.5	4.9	4.9	5.3	0.9	10.8	2.4	3.7	1.8	3.2	13.0	29.9	12.2	10.6	30.2	8.2	13.2	2.3	2.0	6.6	8.7	1.7	3.7	8.6	4.4	12.8	10.4	9.1	3.7	7.1	5.8	10.5	8.1	2.8	14.1	6.3	17.5	12.8	13.4	11.2	6.5	7.5	7.4	7.2	5.0	9.1	8.8	22.6	5.2	3.5	24.8	33.7	39.7	32.0	23.2	24.1	35.7	25.6	39.5	35.4	291.8	348.4	26.9	190.5	87.1	48.0	8.5	68.8	413.6	277.5	59.3	41.2	6.8	68.0	215.9	0.7	103.4	38.3	0.0	123.8	8.9	57.0	95.1	35.9	21.9	11.7	35.0	34.3	88.4	26.4	3.2	39.1	30.8	49.0	32.5	25.4	86.2	116.6	101.7	27.6	77.2	48.8	12.9	29.8	8.4	33.0	51.8	3.2	39.2	37.9	172.9
HINT3	FLJ33126	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956781-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.8"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 260.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	11.4	16.3	27.4	8.0	23.3	7.2	15.6	19.4	24.3	13.1	13.1	24.8	10.6	10.4	11.5	12.6	15.2	11.4	10.9	19.0	28.1	23.0	15.1	18.5	13.9	7.0	28.7	17.0	10.4	12.8	16.3	13.4	12.1	20.7	20.5	12.1	10.3	16.0	16.2	65.8	11.6	10.5	15.2	40.8	6.8	16.0	21.9	17.0	7.7	15.9	16.8	7.4	16.1	8.8	11.0	11.1	15.0	13.2	7.9	9.9	7.0	7.0	5.6	7.8	16.1	3.1	8.4	9.7	7.6	11.0	5.9	6.1	13.6	3.9	15.3	14.2	5.1	13.1	10.6	9.9	6.4	6.9	14.4	12.8	6.4	8.4	11.4	14.4	10.1	10.9	6.6	14.3	5.9	15.0	15.2	8.8	11.4	19.9	10.3	5.8	10.6	8.0	7.3	2.6	14.4	5.4	6.7	5.3	5.1	12.1	12.9	15.7	9.7	6.9	9.9	35.6	5.9	10.0	15.5	6.2	4.0	5.6	19.2	10.8	15.0	17.2	9.7	11.4	9.6	5.1	14.4	13.2	11.4	7.2	8.4	7.8	11.0	9.2	7.5	11.1	10.4	9.9	8.7	15.0	7.9	10.8	6.9	9.1	7.0	27.4	23.3	19.4	24.3	28.1	23.0	28.7	17.0	20.7	17.0	74.5	57.0	16.0	9.5	16.1	22.3	37.6	10.2	24.1	31.8	15.7	7.9	16.0	28.2	27.0	260.9	11.3	12.3	0.0	17.5	5.7	10.8	19.4	9.2	16.3	23.3	6.4	15.6	6.2	14.5	54.5	9.2	17.0	20.3	9.0	22.7	30.7	20.3	28.1	16.3	21.4	23.9	6.5	13.7	89.1	27.7	15.2	22.1	7.0	19.9	17.1
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986430-126039276	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	10.0	12.6	14.3	12.5	17.7	3.6	15.5	33.9	19.4	17.9	12.6	9.4	11.2	16.1	25.9	15.1	13.2	12.8	12.9	16.1	15.0	12.6	18.8	28.0	10.1	12.4	12.7	16.4	19.2	10.4	15.9	38.1	13.3	15.4	12.8	15.0	14.8	11.7	13.8	10.6	7.4	20.6	15.7	15.2	9.6	12.9	9.8	11.1	8.0	18.0	9.8	13.7	11.5	12.5	8.0	4.7	1.3	2.0	7.5	11.7	4.0	8.6	6.5	13.2	2.8	6.9	7.5	7.8	7.4	11.3	8.1	12.0	19.9	9.1	12.2	13.6	4.8	17.0	12.0	14.3	7.5	12.4	9.8	20.5	9.5	12.9	24.8	11.9	15.6	2.6	7.5	7.2	9.5	15.6	12.8	3.6	5.2	21.6	2.4	8.4	13.2	7.2	8.2	9.3	8.6	8.3	4.9	10.0	7.3	9.5	5.4	16.6	7.8	9.1	8.3	16.1	9.8	6.5	12.6	3.6	5.4	4.1	12.4	12.9	6.7	0.7	3.3	11.0	12.1	9.4	1.3	2.0	0.0	6.8	1.5	11.7	8.0	9.1	7.5	4.1	6.7	11.4	10.4	0.3	7.5	0.7	4.7	6.8	4.0	14.3	17.7	33.9	19.4	15.0	12.6	12.7	16.4	15.4	11.1	6.0	22.4	12.3	23.6	11.8	57.1	11.4	20.4	25.4	25.0	7.0	68.7	16.7	16.6	15.9	7.7	10.5	8.0	0.0	14.1	12.2	17.6	11.7	18.4	21.5	6.4	19.1	8.7	4.9	6.5	3.0	23.9	6.9	3.3	14.4	9.6	20.7	12.4	14.0	23.0	23.3	75.1	6.5	12.1	9.5	7.0	8.8	12.5	5.7	12.8	16.0
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340174-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.2"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 184.2;Extravillous trophoblasts: 133.8;Spermatocytes: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067285			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067285: AB_2685818"	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	5.5	3.3	3.3	14.8	2.6	27.1	5.2	1.4	4.9	9.9	9.6	1.3	7.7	5.3	17.4	12.4	16.8	5.9	3.5	2.2	5.3	1.5	2.9	2.7	4.0	9.1	1.3	4.5	4.8	1.7	0.0	2.0	4.8	1.6	4.7	11.7	1.8	6.5	2.9	2.1	5.8	7.0	10.5	1.8	5.5	5.0	43.2	0.8	28.6	2.0	21.4	17.0	4.6	7.9	5.2	14.6	2.6	15.2	5.6	8.9	5.0	20.6	14.1	26.6	23.6	3.0	3.2	23.2	16.5	11.9	23.1	28.1	42.5	13.9	24.5	15.0	10.4	36.6	25.5	21.8	26.3	32.2	28.1	40.4	23.7	36.3	44.7	0.9	34.2	17.5	1.8	3.0	19.1	14.2	6.5	24.4	33.3	39.2	15.6	19.0	33.5	27.9	56.4	16.3	17.8	21.4	29.7	18.2	17.0	10.2	9.2	28.8	12.9	14.0	12.6	18.7	22.5	12.5	33.4	13.6	21.2	23.3	29.5	45.3	11.0	21.0	43.6	12.7	43.7	25.2	2.6	13.2	1.8	1.7	15.2	0.6	5.2	3.7	3.4	12.3	2.3	2.9	2.4	2.5	5.6	10.1	14.6	8.9	5.0	3.3	2.6	1.4	4.9	5.3	1.5	1.3	4.5	1.6	0.8	0.0	1.6	16.4	7.3	33.8	1.4	0.3	10.2	0.0	4.5	1.8	2.0	26.4	5.0	14.3	184.2	5.6	11.8	70.0	15.8	133.8	19.2	8.6	13.8	5.7	55.0	3.2	7.5	11.6	18.0	15.9	17.8	25.1	8.5	12.6	13.0	2.2	12.7	11.5	8.5	0.9	1.1	0.0	9.2	97.1	73.0	25.3	17.7	4.5	21.3	31.8
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118604-127197765	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Fibroblasts: 10.4;Ito cells: 16.0;Leydig cells: 25.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.7;hippocampal formation: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.5;BJ hTERT+: 4.1;hTERT-RPE1: 7.8;U-138 MG: 5.2;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 32.5"	HPA029957	Uncertain				"Secreted to blood"	NA	NA					"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	18.5	10.5	2.8	12.1	0.8	0.0	40.7	5.7	2.3	12.9	8.5	0.0	23.8	1.2	50.3	32.5	23.7	14.9	7.6	4.2	20.5	1.7	3.3	4.2	3.8	10.2	0.8	2.4	13.2	1.5	0.0	2.6	24.1	0.8	10.2	4.7	8.6	3.9	15.3	19.7	2.2	6.7	34.1	0.6	1.4	10.8	12.4	0.0	0.2	2.9	2.1	0.9	9.3	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.2	0.5	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	7.8	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	5.2	2.0	0.7	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.8	5.7	2.2	20.5	1.7	0.8	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	10.8	2.8	0.0	0.0	0.0	1.0	10.4	0.6	0.0	0.0	1.3	0.0	0.0	16.0	0.3	1.1	25.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	2.7	0.0	0.1	0.1	1.4	0.0	0.0	0.1
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.8	24.9	9.7	18.9	30.3	10.1	14.6	9.1	8.4	10.0	13.4	15.4	15.9	7.1	7.9	8.9	14.8	11.5	6.9	12.7	8.4	12.7	24.6	7.5	9.1	21.7	18.7	11.4	22.8	23.4	17.7	10.0	13.7	9.9	22.3	10.6	7.4	13.6	9.7	3.4	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.2	7.4	10.5	11.6	16.5	7.1	26.1	20.8	17.9	5.9	18.5	13.3	14.3	8.8	6.6	13.7	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7	32.8	24.8	20.8	11.4	15.8	34.0	33.0	38.2	20.1	7.9	8.7	3.9	25.1	34.9	24.3	40.1	34.9	12.8	0.0	14.1	22.7	38.1	21.4	21.9	25.2	22.8	28.6	19.7	28.3	67.8	33.7	64.5	25.0	43.9	24.4	11.5	36.1	15.1	13.9	62.6	42.1	18.1	32.3	33.5	44.7	12.2	17.6	32.2	28.7	10.9	14.1
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288710-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	40.1	16.8	20.8	16.5	23.1	6.8	21.9	16.6	21.4	18.6	27.2	12.0	12.8	21.9	13.7	15.5	20.6	11.4	16.1	20.0	19.4	18.0	44.4	44.3	26.8	17.8	27.3	16.5	11.9	14.2	14.5	16.1	17.0	23.1	19.8	26.3	15.1	22.2	14.5	22.0	13.3	25.8	30.1	27.3	14.1	18.1	8.3	20.9	20.7	42.4	14.2	19.4	24.2	22.6	13.2	29.6	13.4	31.2	6.4	11.6	16.9	15.9	12.8	18.4	16.9	27.3	26.0	15.6	26.2	31.8	22.6	28.8	22.2	12.2	24.3	22.5	24.8	25.6	13.2	0.0	19.6	28.6	14.4	12.3	32.3	17.2	35.2	24.3	43.1	18.2	29.3	23.7	21.0	17.9	20.5	20.4	17.9	40.0	14.7	30.0	15.1	28.5	20.0	15.1	8.0	15.9	13.4	22.6	19.9	41.1	19.8	21.1	20.6	14.7	0.5	35.9	14.6	0.5	50.5	21.1	13.9	22.3	35.0	29.1	19.0	38.0	31.9	25.4	37.8	32.6	6.2	31.2	10.0	11.0	25.6	11.6	12.8	9.5	10.8	29.6	13.2	11.6	11.6	13.4	6.4	17.9	22.6	9.6	16.9	20.8	23.1	16.6	21.4	19.4	18.0	27.3	16.5	23.1	20.9	89.3	91.1	32.9	31.3	23.2	25.4	53.7	25.5	48.2	87.6	29.6	29.5	92.5	107.8	66.8	54.2	29.5	50.2	0.0	69.9	70.0	41.4	25.3	42.7	52.3	76.6	27.0	13.3	22.1	48.0	20.2	30.5	56.1	33.7	19.0	31.2	28.6	47.4	28.1	29.4	160.1	37.1	25.8	25.6	26.9	22.6	19.9	54.8	31.9	50.3	46.0
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6;smooth muscle: 37.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 86.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	22.9	3.1	9.1	3.4	6.9	0.0	2.8	12.4	21.0	7.4	12.0	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0.0	6.8	1.1	0.9	20.4	5.0	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2.0	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	2.9	12.5	0.0	1.1	3.0	0.0	0.3	2.2	1.9	4.5	0.0	0.0	0.0	0.0	0.4	10.9	0.0	1.2	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	8.1	0.0	1.4	0.0	1.2	0.0	0.3	2.3	0.0	4.3	0.0	4.2	0.0	0.1	0.0	2.1	0.0	0.7	0.0	31.5	15.6	0.0	0.0	0.3	0.0	0.0	0.9	0.0	8.6	1.4	0.0	2.0	0.0	0.0	0.0	5.0	0.2	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2	86.4	19.0	0.0	0.1	0.0	3.3	0.0	0.0	6.7	5.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	7.9	0.0	1.3	0.8	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.9	0.1	0.0	0.1	0.0	0.0	0.0
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;pituitary gland: 11.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.8	2.8	5.0	1.8	5.3	0.4	0.4	11.4	15.3	1.0	0.8	3.7	0.0	0.5	2.1	0.2	2.0	1.0	1.9	0.8	4.2	4.5	0.6	0.6	1.7	0.8	6.7	5.0	3.3	1.7	0.2	11.9	1.2	7.9	1.1	0.6	0.7	1.1	0.5	0.3	1.0	1.9	0.6	11.4	1.4	3.9	1.8	4.3	0.0	1.9	0.0	0.3	1.6	0.8	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.2	3.3	7.5	1.1	0.0	0.6	0.3	0.7	0.9	0.9	2.4	0.2	0.3	0.4	0.2	0.1	6.2	0.0	0.8	0.0	0.7	0.7	0.1	0.6	0.0	0.1	0.0	0.2	0.1	1.2	0.0	3.7	0.0	0.8	0.0	1.1	0.3	0.2	0.5	0.5	4.9	0.0	3.4	0.0	0.8	0.4	1.8	0.0	0.1	0.0	24.3	13.9	0.0	0.0	0.2	0.9	0.0	0.3	0.2	6.0	1.2	0.4	1.7	0.2	0.1	0.1	4.5	1.1	5.9	0.0	0.0	0.0	0.3	0.0	0.4	0.3	2.3	0.8	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.0	5.3	11.4	8.2	4.2	4.5	6.7	5.0	7.9	4.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591817	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6"	"Cell type enriched"	"Detected in single"	14	"Early spermatids: 8.7"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.1;RPMI-8226: 6.4;WM-115: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	NA	NA		41000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	98.4	0.1	0.0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	189.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	54.2	0.2	0.0	0.0	0.1	122.6	1.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.1	0.3	0.3	0.2	0.0	0.9	0.2	0.4	0.5	5.1	0.1	0.0	0.0	0.8	0.8	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.5	0.0	0.1	0.5	0.2	0.4	0.9	0.3	0.2	0.2	0.2	0.0	6.4	0.6	0.1	0.2	1.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.2
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Group enriched"	"Detected in some"	4	"HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4	0.0	4.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	40.2	0.0	0.1
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.5	4.9	2.9	0.2	6.2	8.3	3.0	12.3	23.8	5.1	4.6	8.1	3.8	0.0	3.7	11.3	14.8	12.9	3.1	9.7	7.2	13.6	4.9	0.1	7.5	11.2	7.6	0.0	0.4	6.1	9.0	10.6	14.5	13.3	13.8	4.4	0.0	0.2	12.4	9.1	6.9	0.0	3.1	8.3	6.3	24.8	6.3	0.8	12.6	9.3	15.5	0.0	12.7	14.2	0.7	3.5	3.9	0.3	23.4	8.0	5.6	15.5	11.1	0.1	1.6	0.0	10.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7	23.8	27.4	9.7	78.6	56.3	3.1	19.3	76.5	18.7	33.0	17.4	3.9	21.8	0.0	51.8	3.4	46.7	63.1	0.0	53.2	4.5	30.5	99.0	1.1	36.5	5.1	9.5	42.2	8.0	1.0	2.1	15.8	1.8	16.9	2.8	41.3	7.0	84.8	57.5	17.0	11.2	0.6	58.2	35.8	3.6	5.8	33.2	22.4	1.0	48.9	100.5
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883141-129516569	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.7;placenta: 71.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 76.7;Leydig cells: 170.6;Peritubular cells: 210.7;Sertoli cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 2.2;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 66.7;ASC TERT1: 48.6;HHSteC: 14.5;HSkMC: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"	NA	NA		38000000			"CAB040310: , CAB078182: AB_2665829"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (3.65e-5)"	35.3	7.4	1.7	3.5	8.1	0.9	38.9	6.4	3.8	22.0	10.4	1.7	6.3	2.0	13.3	12.8	17.1	17.7	13.6	65.7	2.1	1.5	3.6	3.8	17.1	8.8	4.7	3.3	33.0	5.4	2.1	7.0	71.2	6.2	8.2	4.2	3.5	9.4	7.5	26.1	8.2	7.2	26.8	6.9	7.3	10.2	16.7	5.4	0.0	9.6	9.2	1.4	18.5	22.1	0.1	0.1	0.0	0.0	2.2	2.2	0.1	0.0	0.0	0.7	0.0	66.7	48.6	0.0	6.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	40.8	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.2	11.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.7	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.2	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.0	2.2	0.0	0.0	0.5	0.1	1.7	8.1	6.4	3.8	2.1	1.5	4.7	3.3	6.2	5.4	0.0	0.3	0.0	2.3	3.3	0.8	76.7	0.0	5.3	1.2	0.0	0.0	1.9	0.0	1.4	6.0	5.7	0.0	0.0	0.2	1.5	36.3	0.1	0.0	0.0	2.7	0.0	0.0	5.5	0.0	4.7	170.6	1.3	1.7	0.0	0.0	14.2	0.6	0.0	210.7	0.4	1.0	116.4	8.2	1.4	0.7	2.5	3.2	1.3	0.0	0.7
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710225	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 362.7;granulocytes: 240.9;Syncytiotrophoblasts: 177.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 92.9;LHCN-M2: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		840000	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	23.8	32.2	4.1	14.1	4.0	1.7	19.7	2.5	2.4	9.6	19.5	2.9	12.0	13.3	7.8	25.8	5.8	15.7	11.8	16.9	4.4	6.8	33.2	4.5	38.8	15.5	4.1	1.4	8.0	38.2	10.6	22.0	16.7	12.2	9.6	8.2	10.4	16.7	24.2	12.1	5.4	40.6	6.5	9.0	15.8	15.1	10.9	3.8	5.1	12.7	12.1	6.4	10.3	5.8	2.9	11.8	13.0	5.9	2.5	5.8	6.0	1.9	4.3	0.4	0.6	4.2	6.0	3.5	14.6	11.2	6.5	4.3	2.2	3.2	1.6	7.2	9.8	2.0	2.5	3.1	4.8	12.1	1.5	1.3	10.4	3.4	12.8	6.0	1.5	92.9	3.8	0.7	11.7	10.5	13.6	18.4	0.0	5.5	4.0	26.1	0.5	0.0	1.5	0.4	3.6	1.0	0.0	2.0	3.0	19.8	1.1	0.0	0.0	1.2	2.0	7.2	2.2	2.2	1.8	14.0	6.8	0.9	0.5	11.7	1.8	1.3	1.0	2.3	2.8	9.4	8.9	5.2	13.0	5.3	5.9	3.3	2.9	2.8	5.8	4.8	1.7	0.5	2.9	4.0	2.5	3.1	11.8	2.7	6.0	4.1	4.0	2.5	2.4	4.4	6.8	4.1	1.4	12.2	3.8	53.6	36.1	12.9	16.2	11.6	0.0	3.1	15.3	362.7	50.0	36.6	2.0	73.2	127.6	38.7	17.9	35.4	23.6	0.0	105.3	16.5	19.2	20.3	240.9	4.4	101.2	0.0	12.6	11.6	45.7	13.8	3.4	131.1	6.8	18.0	19.9	14.3	82.5	24.6	1.1	20.3	0.6	25.8	11.9	3.4	1.2	11.3	177.5	25.4	28.3	15.9
TMEM244	"bA174C7.4, C6orf191"	ENSG00000203756	"Transmembrane protein 244"	Q5VVB8	6	129831244-129861547	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 12.2;retina: 22.7"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.9;T-reg: 4.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.3;LHCN-M2: 8.4;U-2 OS: 2.9;U-251 MG: 6.3;U-266/70: 6.1;WM-115: 4.1"					"Not detected"	"Not detected"									NA	NA						"unprognostic (4.65e-1)"	"unprognostic (3.65e-2)"				"unprognostic (1.10e-1)"		"unprognostic (1.54e-1)"			"unprognostic (1.15e-1)"			"unprognostic (2.15e-1)"	"unprognostic (9.57e-2)"			0.3	0.2	2.7	0.4	2.7	0.4	0.4	0.2	5.2	0.4	0.5	1.5	0.0	0.0	0.2	1.6	0.3	0.4	0.3	0.7	2.5	0.7	0.7	0.2	0.6	2.3	4.8	3.3	0.2	0.2	0.0	12.2	0.2	0.9	1.1	0.6	22.7	1.2	0.2	1.0	0.4	0.3	0.0	1.9	0.7	1.1	0.4	2.0	0.0	0.3	0.0	2.5	0.8	0.4	0.5	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.9	1.0	6.3	6.1	0.0	0.0	1.7	0.0	4.1	0.0	0.0	0.0	2.5	0.0	0.0	0.5	3.9	1.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	4.2	0.4	2.7	2.7	0.2	2.7	2.5	0.7	4.8	3.3	0.9	2.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL3, histone methyl-lysine binding protein"	Q96JM7	6	130013699-130141451	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		Yes	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044382: AB_2678920, HPA053035: AB_2682021"	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	8.8	16.7	5.2	16.4	8.2	7.5	7.5	2.4	7.7	17.1	5.6	3.6	9.3	3.1	17.5	14.1	5.7	7.4	6.0	4.1	5.4	5.8	6.1	6.4	7.4	11.4	5.2	5.9	12.1	3.8	8.1	17.0	6.5	5.7	10.3	5.7	4.8	5.8	7.5	5.3	4.3	7.6	9.9	5.4	18.5	4.6	7.5	3.9	25.5	10.2	4.3	12.8	10.4	11.6	10.7	10.8	3.9	14.1	1.7	4.2	0.6	0.8	3.2	7.4	1.1	5.1	6.9	1.5	3.7	7.7	1.5	2.7	3.8	4.0	1.3	5.4	4.8	4.6	3.2	4.2	6.6	2.3	2.9	4.3	8.6	1.6	1.0	2.6	5.1	31.5	4.3	4.8	1.7	5.1	7.6	30.6	4.1	6.2	3.5	3.8	0.3	10.8	0.9	3.5	0.7	1.6	4.0	2.1	0.0	4.9	1.2	0.2	1.0	1.4	0.3	3.0	9.5	7.8	4.5	20.9	2.5	3.5	0.4	2.4	0.6	0.0	2.3	1.2	2.1	2.5	3.9	3.5	3.5	2.7	4.0	2.7	7.6	2.7	3.8	1.3	10.7	2.4	3.0	3.7	1.7	14.1	10.8	4.2	0.6	5.2	8.2	2.4	7.7	5.4	5.8	5.2	5.9	5.7	3.9	3.0	9.2	7.5	4.8	4.5	2.9	2.9	2.5	5.3	3.4	8.7	2.0	10.2	1.7	4.3	18.5	5.6	0.7	0.0	4.9	6.0	6.7	4.2	38.3	4.9	3.3	0.0	3.5	7.4	8.2	1.6	8.9	3.6	1.7	4.6	7.2	5.6	7.5	3.5	5.6	4.3	0.7	6.5	5.1	5.4	6.1	3.9	5.1	10.0	4.1	5.2
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8"	"Cell type enriched"	"Detected in some"	7	"T-cells: 87.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	31	"gdT-cell: 32.8;MAIT T-cell: 25.7;memory CD4 T-cell: 11.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 8.4;naive CD8 T-cell: 20.4;NK-cell: 31.9;T-reg: 10.8"	"Group enriched"	"Detected in many"	47	"NK-cells: 31.9;T-cells: 32.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 4.0;HDLM-2: 7.1;hTEC/SVTERT24-B: 4.7;hTERT-RPE1: 4.3;NTERA-2: 3.7;PC-3: 2.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"HPA028992, HPA028993"	Uncertain					NA	NA					"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	3.3	4.1	3.2	11.4	0.9	4.6	2.1	1.8	1.0	2.8	1.4	0.6	0.5	0.6	11.7	3.6	1.2	2.4	4.1	1.4	4.4	3.1	2.0	3.0	9.8	12.0	1.2	0.7	3.3	1.4	0.0	8.0	3.0	1.6	4.1	3.0	4.8	5.3	1.2	0.9	0.6	2.2	2.3	1.4	13.9	2.0	4.4	0.4	16.4	1.5	2.7	12.6	3.8	1.5	0.6	0.1	0.6	0.1	31.9	32.8	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.3	0.8	0.9	0.1	0.0	0.1	0.7	0.4	0.0	0.0	0.0	4.0	7.1	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.5	0.0	4.7	0.3	4.3	0.2	0.9	0.3	0.0	0.2	0.0	0.2	0.0	3.7	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.8	0.1	25.7	0.6	11.7	28.9	0.1	0.0	8.4	20.4	0.6	31.9	0.1	0.1	10.8	10.0	3.2	0.9	1.8	1.0	4.4	3.1	1.2	0.7	1.6	0.4	0.0	2.9	0.0	0.0	0.3	2.3	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	3.5	2.5	3.4	5.6	0.6	0.6	5.0	0.0	0.1	0.0	0.0	1.1	1.8	0.5	0.1	0.0	0.4	0.5	0.6	0.4	0.0	87.3	0.7	0.0
TMEM200A	"KIAA1913, TTMC"	ENSG00000164484	"Transmembrane protein 200A"	Q86VY9	6	130365734-130443063	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 36.2"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 25.8;Erythroid cells: 23.3;Horizontal cells: 12.7;Intestinal endocrine cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	8	"NK-cells: 7.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 20.8;hTEC/SVTERT24-B: 33.6;hTERT-RPE1: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014396	Uncertain					NA	NA					"HPA014396: AB_2204904"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.19e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-3)"	6.0	17.0	4.6	7.6	2.7	0.0	5.6	0.6	6.2	12.1	7.1	1.5	0.0	4.7	36.2	8.1	1.9	10.6	4.2	4.3	3.1	2.2	14.4	1.2	7.0	3.9	1.1	2.5	26.0	3.9	0.4	11.6	2.1	1.4	4.3	15.1	6.8	2.0	0.8	2.6	2.3	5.3	13.5	0.9	1.2	3.9	7.8	0.2	7.4	3.6	0.3	2.1	8.7	4.0	0.5	0.0	0.0	0.0	7.1	1.8	0.4	0.0	0.0	0.1	0.0	6.0	7.6	0.0	5.2	6.4	5.6	9.9	8.1	0.0	0.0	0.0	10.9	1.2	1.2	0.5	0.0	20.8	7.4	0.0	0.0	0.0	0.3	2.7	0.1	0.0	8.5	0.0	33.6	6.7	16.9	0.2	0.1	0.0	0.7	2.6	0.0	0.0	0.0	4.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	6.4	2.0	0.5	0.9	4.1	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	0.5	1.8	1.0	0.0	0.1	0.3	0.1	0.0	7.1	0.0	0.0	0.0	0.4	4.6	2.7	0.6	6.2	3.1	2.2	1.1	2.5	1.4	0.2	0.0	0.3	0.0	0.0	1.8	25.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.2	6.4	23.3	0.0	1.3	4.1	0.0	0.0	0.0	0.2	12.7	23.6	0.0	0.0	1.3	5.5	0.0	1.7	0.0	1.4	0.5	0.2	7.2	9.9	9.2	1.9	0.0	2.3	0.5	1.5	1.3	0.5	1.5	3.3	0.0
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 33.8;liver: 67.3"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 193.4"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 42.5"					"Low region specificity"	"Detected in all"			HPA066060	Uncertain					NA	NA					"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	14.0	0.0	0.0	7.8	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.1	2.3	67.3	0.1	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.4	0.1	0.0	0.0	1.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	15.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
EPB41L2	4.1-G	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		170000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	50.2	16.5	29.6	17.3	42.8	3.9	21.1	6.5	40.1	20.5	23.1	32.3	7.2	12.3	23.0	13.7	13.2	25.6	18.0	22.8	33.4	24.6	11.5	12.1	24.4	15.4	50.5	33.1	44.4	9.1	8.2	8.4	26.2	34.8	11.2	23.2	52.0	10.1	15.8	16.0	7.1	21.4	20.6	59.5	25.3	11.7	32.2	51.9	6.8	15.2	14.6	11.6	15.2	16.6	10.5	8.6	0.5	8.8	1.0	2.5	1.3	8.3	8.8	20.0	27.4	13.9	22.3	6.1	14.2	18.0	14.5	20.3	16.8	11.9	10.2	26.7	19.5	11.8	4.3	7.6	13.1	29.0	43.3	17.7	18.3	10.5	9.6	8.2	0.0	22.3	10.9	0.2	25.6	9.9	23.5	22.3	15.6	49.5	29.3	9.2	2.1	14.3	3.1	18.5	35.8	9.6	22.3	24.0	0.9	24.4	8.0	2.1	0.0	5.9	0.1	11.5	21.4	3.0	19.1	27.0	17.1	32.3	28.9	42.7	24.3	0.4	9.5	11.7	0.1	26.0	0.1	3.1	0.5	1.0	8.8	0.9	2.9	1.0	1.2	8.6	10.5	1.7	0.7	0.0	1.0	3.3	2.3	2.5	1.3	29.6	42.8	6.5	39.6	33.4	24.6	50.5	33.1	34.8	51.9	6.0	11.8	15.4	12.1	13.7	52.8	12.6	22.9	20.1	28.4	1.8	212.1	2.8	0.0	28.2	273.7	47.2	31.6	0.0	14.3	5.1	74.8	3.3	42.8	3.4	29.8	27.0	9.8	39.3	104.6	245.3	67.6	61.1	10.1	17.2	36.8	499.6	37.8	21.0	43.5	9.8	1331.8	116.4	56.7	54.3	79.8	8.9	2.1	5.0	21.6	6.8
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135666-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 39.4;pancreas: 37.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.4;RPTEC TERT1: 17.0;RT4: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	5.7	39.4	16.1	6.2	11.2	6.3	4.7	16.6	15.4	6.0	12.9	4.9	4.1	19.9	4.5	4.1	3.0	4.9	6.8	4.4	12.0	9.9	5.6	15.7	6.2	11.6	8.1	11.7	7.2	37.5	3.1	3.5	2.8	7.2	10.0	13.3	2.9	3.4	4.8	9.8	2.3	12.4	5.2	6.2	6.2	3.7	5.8	6.4	18.9	4.2	2.1	5.5	8.6	4.3	4.4	1.8	9.5	3.4	3.2	14.9	5.0	0.8	1.5	5.6	2.7	3.1	6.7	3.9	2.3	3.8	4.0	5.3	1.9	1.5	0.1	4.4	4.0	3.0	0.0	1.6	2.5	2.9	0.0	2.3	5.6	1.8	8.3	4.5	0.2	1.8	5.7	1.8	2.5	3.3	3.7	4.1	3.3	0.9	8.1	3.8	1.5	2.4	1.4	19.4	0.5	2.1	5.0	3.7	0.1	17.0	18.8	0.1	2.0	3.2	0.3	7.6	3.4	1.3	11.7	1.4	1.9	2.6	5.3	5.8	7.6	0.0	1.3	4.5	5.7	4.2	9.5	1.5	0.2	6.8	2.9	10.5	2.6	9.4	9.1	1.8	4.4	14.9	9.3	0.4	3.2	3.4	0.1	3.2	5.0	16.1	11.2	16.6	15.4	12.0	9.9	8.1	11.7	7.2	6.4	17.9	7.8	10.9	7.0	5.6	20.9	9.0	124.9	1.4	2.3	5.2	15.7	6.4	16.6	21.9	3.9	4.8	14.7	23.3	3.6	8.3	5.9	6.7	10.4	34.7	7.7	7.9	1.2	8.0	11.0	1.3	7.8	9.3	1.7	0.0	14.4	37.6	2.7	31.5	5.3	15.2	11.5	0.0	6.9	3.5	9.1	3.6	3.9	17.5	16.6	3.7
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131573144-131584332	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 284.1"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 867.5"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 24.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;Hep G2: 1.7;HL-60: 4.0;RH-30: 1.6;SiHa: 1.8;U-698: 2.2"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Not detected"	"Not detected"			"HPA003595, CAB009434, HPA024006, CAB056159"	Enhanced					NA	NA		15000000			"CAB009434: AB_2058955, CAB056159: AB_2665582, HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	1.0	0.0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.1	3.0	0.2	0.0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0.0	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0.0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0.0	4.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.7	0.0	4.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	0.5	0.1	0.4	0.1	0.0	0.0	0.0	1.6	0.4	0.0	0.3	0.2	0.1	1.8	0.4	0.3	0.2	0.1	0.5	0.0	0.0	0.2	0.3	0.1	1.0	0.2	2.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	24.4	0.0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	867.5	0.0	0.0	0.0	25.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0
MED23	"CRSP130, CRSP3, DRIP130, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628229	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	14.0	17.1	12.1	19.7	12.7	21.8	16.3	23.0	17.6	14.7	12.3	12.1	17.8	12.7	21.6	13.3	14.9	14.6	10.2	10.2	11.7	8.3	12.2	9.6	13.1	15.4	15.9	12.3	20.5	18.7	23.9	16.1	12.3	11.3	13.9	14.4	12.3	19.8	16.8	14.8	15.0	15.4	14.3	11.0	13.7	14.9	13.1	13.3	22.7	18.0	7.4	16.7	16.2	20.7	6.0	6.8	8.8	5.7	15.0	10.9	4.6	5.2	5.9	14.0	17.6	17.4	13.3	12.9	13.3	15.0	12.3	17.9	6.1	7.4	11.7	9.7	13.6	11.8	9.5	7.5	8.6	19.2	13.3	10.5	12.3	10.7	10.3	12.6	20.2	20.9	11.7	10.3	13.6	13.9	14.4	15.2	12.8	15.7	12.3	12.9	8.1	15.3	12.8	6.6	9.1	5.9	13.9	8.7	7.0	9.5	7.8	10.5	9.5	9.4	13.3	8.6	16.9	3.6	14.3	15.3	9.2	10.4	14.6	12.0	13.1	8.8	16.9	11.3	9.3	12.2	4.5	5.3	8.8	7.3	5.7	10.9	6.0	7.2	8.0	6.8	5.2	7.4	6.7	4.5	15.0	3.9	3.6	7.8	4.6	12.1	12.7	23.0	17.6	11.7	8.3	15.9	12.3	11.3	13.3	17.9	8.1	15.2	5.3	8.1	21.1	5.7	5.1	5.3	12.5	22.7	15.7	7.2	3.3	6.7	1.4	9.8	12.5	0.0	6.6	5.7	9.0	11.5	13.9	10.6	7.1	11.1	13.8	12.3	15.4	0.9	13.3	9.1	5.0	6.4	17.6	8.9	7.4	17.3	9.6	7.3	20.5	12.9	6.9	13.0	4.8	7.5	6.5	15.4	13.2	6.3
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
OR2A4	OR2A10	ENSG00000180658	"Olfactory receptor family 2 subfamily A member 4"	O95047	6	131699644-131701401	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 10.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"renal cancer: 0.8"					"Group enriched"	"Detected in some"	48	"basophil: 10.6;NK-cell: 3.8"	"Group enriched"	"Detected in many"	48	"granulocytes: 10.6;NK-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;HMC-1: 1.1;MCF7: 1.7"									HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"													"unprognostic (1.22e-5)"	"unprognostic (3.60e-2)"				0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2			1.4	2.1	0.0	0.0	0.4	0.4	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.1		1.0	0.0		1.0	0.3	0.5	0.0	0.6	0.0	0.0	0.0	0.4	1.1			0.0		0.0	0.9	0.2	0.0	0.0	10.6	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.5	0.5	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.3	1.3	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.9	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE9		ENSG00000236761	"CTAGE family member 9"	A4FU28	6	131708684-131711017	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	29	"testis: 11.6"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 2.3;Early spermatids: 1.9;Suprabasal keratinocytes: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A-431: 1.3"									"HPA000387, HPA000922"	Uncertain					NA	NA					"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (3.92e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.48e-2)"			"unprognostic (1.92e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.36e-1)"		"unprognostic (5.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.74e-4)"	"unprognostic (3.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	11.6			0.2		0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.2	0.2	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.2											0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 425.8;Ito cells: 621.2;Peritubular cells: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 131.2;HUVEC TERT2: 110.3;TIME: 227.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.2	0.3	23.2	13.2	0.1	29.6	14.3	18.4	9.8	0.0	0.9	0.0	131.2	38.0	15.1	0.4	0.3	2.1	17.3	0.1	0.2	0.0	4.2	10.6	9.1	0.0	0.0	19.2	0.4	13.3	3.3	27.8	110.3	0.0	0.0	0.0	52.2	0.2	0.0	0.0	4.9	3.2	1.7	2.5	0.4	0.0	6.7	0.0	0.0	0.0	3.0	5.0	1.4	26.2	0.5	0.2	227.6	25.5	20.0	32.1	54.7	0.9	0.1	0.2	3.4	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3	425.8	55.6	2.9	247.2	86.5	0.0	34.4	73.9	103.1	38.7	12.2	0.0	11.5	0.0	245.6	0.9	205.6	11.7	0.0	212.2	18.8	248.5	11.6	13.9	23.6	12.0	0.0	13.3	621.2	7.2	2.7	46.6	12.6	62.4	27.1	7.9	2.8	177.6	6.6	453.3	0.7	0.2	103.5	206.0	1.2	4.4	52.6	13.6	1.8	7.5	6.5
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401545	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;smooth muscle: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 24.8;Early spermatids: 36.8;Muller glia cells: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	47	"memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	58	"B-cells: 4.9;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;ASC TERT1: 31.0;BJ: 23.4;fHDF/TERT166: 43.5;HBF TERT88: 28.1;U-2197: 69.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035740	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	1.9	19.5	13.4	3.8	12.5	0.2	1.4	0.3	16.0	17.2	7.7	6.7	7.3	2.7	57.2	7.8	17.4	1.9	15.1	3.2	9.8	1.1	21.4	1.2	15.3	2.9	1.0	6.4	2.4	1.7	0.1	4.3	3.3	0.2	17.6	4.9	0.9	10.6	21.5	0.4	7.4	4.5	41.1	0.8	3.2	3.1	3.1	4.6	0.8	1.5	7.7	7.7	9.4	8.6	4.9	7.8	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	38.5	31.0	0.0	23.4	15.9	8.6	15.1	0.0	0.2	0.1	0.0	43.5	7.1	0.0	0.3	0.1	28.1	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	7.3	0.0	17.3	0.5	10.7	0.0	0.0	0.0	1.7	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.1	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.5	2.3	0.0	1.3	0.1	3.9	3.7	69.7	12.2	0.9	0.0	0.0	10.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.3	13.4	12.5	0.3	16.0	9.8	1.1	1.0	6.4	0.2	4.6	0.0	2.2	3.4	0.4	24.8	0.2	0.6	0.0	0.0	4.5	1.8	0.0	0.6	0.0	0.4	36.8	0.0	0.0	0.0	0.0	1.0	9.6	0.2	3.5	0.0	0.4	0.0	0.0	0.0	0.0	6.8	0.3	0.6	6.8	0.0	0.0	14.0	0.4	0.0	0.4	0.0	0.8	0.0	0.4	0.5	0.4	5.9	0.0	0.0	0.0	0.0
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 13.0;classical monocyte: 16.5;eosinophil: 15.0;intermediate monocyte: 18.0;memory B-cell: 26.9;myeloid DC: 19.5;naive B-cell: 35.1;neutrophil: 26.4;non-classical monocyte: 18.2;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes		NA	NA		850000	Lysosomes		"CAB062564: AB_2665605, HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	28.9	14.3	27.8	26.4	24.3	13.0	21.1	27.2	29.4	17.3	21.8	25.0	11.8	25.1	22.2	14.1	23.8	16.0	23.2	23.8	24.9	23.6	35.0	12.6	22.6	47.8	28.3	22.2	22.7	13.0	12.5	13.4	31.9	31.2	18.6	20.5	16.3	20.2	19.3	16.3	17.8	26.7	20.6	42.1	29.0	19.2	8.2	27.7	9.0	21.9	15.2	46.5	21.2	19.9	35.1	23.5	26.4	18.2	2.9	3.9	8.5	7.2	7.3	12.4	8.8	24.9	22.2	9.7	14.3	14.8	14.9	21.6	12.7	12.1	36.0	14.1	17.3	22.2	9.5	10.9	13.2	20.2	12.4	12.9	13.7	6.5	13.4	19.9	9.2	10.4	12.7	12.5	15.2	13.9	20.5	16.2	8.3	14.6	13.0	16.9	10.1	4.2	7.5	4.7	10.6	8.6	10.0	9.6	10.3	24.9	8.4	10.1	3.1	6.4	10.7	38.5	19.2	7.2	8.9	27.9	8.7	8.9	18.9	15.1	12.5	7.2	15.5	12.2	7.5	9.7	13.0	16.5	15.0	3.7	18.0	1.5	26.9	2.7	2.5	19.5	35.1	2.0	2.4	26.4	2.9	18.2	23.5	3.9	8.5	27.8	24.3	27.2	29.4	24.9	23.6	28.3	22.2	31.2	27.7	65.5	32.2	127.2	20.7	37.4	23.0	41.3	66.2	38.8	27.3	40.1	2.0	74.5	54.7	45.9	0.8	40.6	58.7	23.3	27.0	45.9	35.0	20.8	40.3	16.8	146.3	35.0	12.7	36.2	77.1	1.3	28.4	81.6	126.5	65.9	37.5	24.1	46.1	52.0	43.5	107.8	14.7	38.8	38.1	3.0	16.8	36.0	46.3	18.7	25.9	22.4
TAAR9	"TA3, TAR3, TRAR3"	ENSG00000237110	"Trace amine associated receptor 9 (gene/pseudogene)"	Q96RI9	6	132538290-132539336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"NTERA-2: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.8	0.0	0.0	0.2			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR8	"GPR102, TA5, TAR5, TRAR5"	ENSG00000146385	"Trace amine associated receptor 8"	Q969N4	6	132552693-132553721	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.2"															NA	NA																							0.0	0.6	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.1		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR6	"TA4, TRAR4"	ENSG00000146383	"Trace amine associated receptor 6"	Q96RI8	6	132570322-132571359	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"kidney: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"REH: 1.0"	"Not detected"	"Not detected"													NA	NA																		"unprognostic (1.70e-1)"					0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.1	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0			0.0		0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR5	PNR	ENSG00000135569	"Trace amine associated receptor 5"	O14804	6	132588673-132589686	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051703	Uncertain					NA	NA					"HPA051703: AB_2681580"																		0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.6	0.2	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR2	GPR58	ENSG00000146378	"Trace amine associated receptor 2 (gene/pseudogene)"	Q9P1P5	6	132617022-132624275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.3"	"Cell type enhanced"	"Detected in single"	35	"Early spermatids: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR1	"TA1, TAR1, TRAR1"	ENSG00000146399	"Trace amine associated receptor 1"	Q96RJ0	6	132644984-132646003	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"stomach 1: 13.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;HBF TERT88: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055614	Approved					NA	NA					"HPA055614: AB_2682862"											"unprognostic (2.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.3	0.1	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	13.6	0.0			0.0		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132681590-132714049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 131.9;liver: 112.2"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 71.4;Ductal cells: 179.6;Hepatocytes: 68.4;Pancreatic endocrine cells: 77.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 13.4"	"Group enriched"	"Detected in many"	71	"dendritic cells: 4.9;granulocytes: 8.0;monocytes: 13.4"	"Cell line enhanced"	"Detected in some"		"A-431: 4.1;CAPAN-2: 4.3;EFO-21: 15.1;HBEC3-KT: 4.0;LHCN-M2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064145	Uncertain				"Intracellular and membrane"	NA	NA		1100000000			"HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	1.8	0.4	0.3	0.6	0.3	2.4	0.7	0.2	0.3	0.4	128.6	0.1	0.0	40.6	2.5	0.2	0.6	1.7	27.0	1.1	0.3	0.3	6.5	112.2	7.9	2.4	0.4	0.1	0.4	0.9	0.0	0.3	1.0	0.5	0.4	0.3	0.2	1.5	0.1	0.4	0.5	131.9	0.0	0.5	5.6	0.8	0.5	0.1	0.2	0.4	0.0	0.4	0.4	0.9	0.1	4.9	8.0	13.4	0.0	0.0	3.6	4.1	0.0	0.5	0.1	0.1	1.3	0.9	0.3	0.3	0.0	0.0	0.1	4.3	0.2	15.1	0.0	0.8	0.1	0.0	4.0	1.1	0.1	0.0	0.2	0.2	2.3	2.3	0.3	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	4.3	0.2	0.0	0.6	0.1	0.1	0.2	0.1	0.2	1.8	0.9	0.3	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.7	1.0	0.1	0.5	0.2	0.4	0.0	0.1	0.5	0.1	0.6	2.3	13.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	8.0	0.0	10.2	0.2	0.0	3.6	0.3	0.3	0.2	0.3	0.3	0.3	0.4	0.1	0.5	0.1	0.0	4.8	0.0	0.0	1.1	0.0	0.3	71.4	1.4	1.2	1.8	0.0	0.0	0.0	179.6	0.0	0.0	13.2	0.0	17.0	0.1	0.2	3.1	0.0	68.4	13.9	0.0	0.0	0.6	13.9	0.0	0.0	10.6	0.0	5.4	4.3	0.0	77.2	0.9	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	9.9
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 69.6;Club cells: 19.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3"														"Secreted to blood"	NA	NA	150000000					"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	69.6	19.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	9.7	0.1	0.0	0.0	0.6	9.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 17.4;Ductal cells: 36.1;Kupffer cells: 27.8;Macrophages: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	8	"Daudi: 35.7"					"Not detected"	"Not detected"									NA	NA		270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6	0.0	10.7	0.0	0.0	0.0	0.0	1.2	2.5	17.4	3.4	0.0	0.0	0.6	0.0	36.1	0.0	0.0	0.0	0.0	0.3	0.1	0.5	5.6	4.7	0.0	11.3	0.0	0.0	4.3	27.8	0.0	0.0	17.1	0.0	1.8	0.0	0.0	4.0	0.0	0.0	0.3	0.0	6.5	0.5	0.0	0.0	0.0	1.1	6.1	0.0	8.4
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132798553	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 48.4;Hofbauer cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029747, HPA049659"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA029747: AB_10600797, HPA049659: AB_2680843"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.3	7.3	26.2	6.0	21.9	4.5	11.0	13.1	20.6	9.4	9.5	18.8	3.1	14.4	7.0	7.8	10.7	10.1	11.5	4.2	21.6	15.8	11.8	6.0	5.7	7.2	19.5	10.8	7.4	7.8	13.0	6.9	15.5	17.0	5.0	11.4	7.4	11.7	4.9	4.8	10.5	10.4	5.8	21.7	7.0	14.9	2.3	16.3	8.3	10.1	5.9	8.6	10.6	5.5	7.5	15.6	0.6	11.3	2.8	9.4	6.5	4.0	3.8	6.5	0.0	0.8	2.4	4.0	1.4	4.5	2.9	9.3	8.4	8.3	0.1	5.8	0.9	5.1	11.3	8.8	9.9	2.3	5.9	16.6	2.1	7.0	10.2	5.0	1.9	0.2	6.5	9.5	4.6	10.0	5.9	9.3	13.2	23.7	1.6	2.4	5.7	6.1	0.2	8.6	9.0	5.4	9.8	7.1	6.6	24.1	7.1	13.1	0.0	7.8	15.5	12.4	3.9	5.3	0.0	4.3	1.3	3.4	1.3	3.8	5.1	0.4	0.2	7.1	0.2	1.0	0.0	11.3	0.5	3.7	2.5	6.7	5.5	5.7	5.2	15.6	7.5	8.2	5.6	0.6	2.8	0.2	12.1	9.4	6.5	26.2	21.9	13.1	20.6	21.6	15.8	19.5	10.8	17.0	16.3	0.0	6.2	5.9	8.2	9.0	4.1	2.6	48.4	12.0	10.3	26.2	2.0	41.0	8.3	26.3	0.1	5.1	3.9	0.0	13.2	16.4	5.1	7.2	0.0	11.9	51.1	0.0	15.6	22.1	19.4	0.0	6.4	7.8	13.5	2.8	11.9	8.5	15.1	3.5	4.2	5.0	3.3	0.0	3.3	0.2	0.4	9.5	23.8	4.9	16.6	11.5
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814441-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		280000	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: AB_2667570"	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	95.6	65.1	66.4	169.3	53.2	199.6	187.3	49.6	66.9	98.4	83.8	42.5	93.7	73.1	106.1	99.2	129.4	88.0	113.7	152.2	56.1	44.6	78.0	108.8	182.0	515.8	67.8	42.0	222.2	403.5	23.2	46.3	87.7	44.5	94.4	82.1	56.5	220.6	71.5	100.5	153.8	79.5	162.6	71.8	122.9	85.4	62.6	52.5	139.6	116.7	155.1	130.9	109.7	196.8	159.2	101.3	17.4	54.3	70.9	211.8	222.0	67.7	51.5	80.0	124.2	154.6	196.5	95.1	86.4	116.5	91.9	89.0	105.9	65.1	150.2	119.9	110.5	47.7	66.1	86.9	144.7	84.4	98.3	111.8	102.3	67.6	149.5	173.3	287.6	80.0	210.4	237.3	79.4	281.5	158.1	120.7	124.0	167.5	99.9	111.6	138.2	121.1	167.6	98.7	116.1	84.2	137.2	64.0	95.1	122.2	70.5	68.2	55.6	29.1	187.4	231.2	79.8	79.4	292.9	105.0	39.3	112.7	131.6	159.4	150.1	122.2	111.9	129.8	163.5	56.0	17.4	54.3	7.8	95.6	50.7	147.0	159.2	168.0	123.1	73.4	139.3	211.8	174.2	5.7	70.9	40.7	101.3	90.8	222.0	66.4	53.2	49.6	66.9	56.1	44.6	67.8	42.0	44.5	52.5	1542.4	2505.6	7624.6	6638.1	7352.8	495.9	774.7	3589.8	892.7	2634.3	1174.2	168.9	6440.4	3876.2	3101.2	589.5	3918.9	1905.6	3387.3	6989.0	7823.6	3608.9	7408.3	1688.4	3952.6	5017.5	200.2	2756.2	3903.9	5319.7	1401.7	5625.0	4474.4	3735.1	4011.8	6131.1	754.9	6107.0	3738.4	2810.9	3874.6	503.2	1591.0	3387.1	860.2	1688.1	9189.4	6602.5	5004.5	7735.2	7372.2
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	1.2	0.0	0.0	0.0	0.0	0.0	10.2	0.2	1.5	0.0	0.0	0.0	10.0	0.0	13.2	0.0	7.7	3.3	0.0	0.0	10.0	1.3	35.6	0.0	0.3	0.0	3.5	2.6	0.0	7.3	2.3	1.7	0.0	0.0	0.0	5.4	4.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	12.1	0.0	0.0	1.9	1.9	2.0	0.1	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	3.7	1.6	0.0	12.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4	11.9	2.6	0.0	0.1	0.1	0.0	13.7	0.0	0.0	3.4	43.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.7	0.6	1.3	2.0	0.6	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	6.6	0.0	0.0	0.0	0.0	0.1
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889138-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lung: 74.4;ovary: 61.6"	"Group enriched"	"Detected in some"	5	"Leydig cells: 94.6;Peritubular cells: 110.0;Sertoli cells: 116.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HHSteC: 19.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013189	Uncertain					NA	NA					"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	4.7	2.2	0.2	11.6	0.5	0.0	0.4	0.2	0.2	12.7	16.8	0.4	9.6	5.2	12.9	9.6	19.1	2.2	14.6	13.2	0.2	0.2	17.0	4.1	74.4	1.0	0.2	0.0	61.6	1.9	0.0	2.4	48.4	1.2	57.8	5.3	0.0	0.2	16.0	0.8	0.3	13.9	21.1	0.2	52.2	5.7	5.9	0.0	0.0	0.5	0.0	0.0	19.6	24.6	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.0	1.2	0.0	3.0	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	5.2	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	19.5	0.3	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	94.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.0	0.0	0.0	116.4	1.7	0.2	0.4	0.0	4.8	0.0	0.0	0.4
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.3	7.8	17.9	11.6	13.7	14.2	10.1	12.1	12.8	16.2	21.3	9.1	5.1	19.8	8.3	9.6	18.0	8.4	11.4	13.0	19.6	15.1	14.2	34.8	4.7	10.0	13.9	18.2	13.6	8.7	13.3	18.1	19.6	12.3	15.3	17.5	50.2	13.6	11.5	14.5	15.2	10.9	20.0	9.3	10.2	10.6	10.8	7.6	9.5	5.7	23.3	23.2	7.1	9.4	14.9	15.6	4.3	7.3	13.8	9.3	13.5	20.5	13.2	11.0	11.9	12.9	15.6	11.9	11.1	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0	6.0	12.6	23.3	25.8	62.8	20.7	9.2	20.4	12.0	7.9	7.0	17.7	36.2	24.9	25.0	221.6	33.3	12.0	0.0	22.1	57.3	32.7	32.8	40.3	8.9	21.4	14.3	68.1	17.2	16.7	29.8	19.5	20.0	30.4	19.0	22.4	12.3	24.3	21.0	17.3	18.9	9.4	19.4	34.0	178.1	63.9	57.5	204.8	47.3	23.6	36.7
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	2.1	0.7	1.8	0.0	1.4	0.7	0.1	1.3	5.4	0.7	3.0	0.0	7.4	0.2	1.1	0.1	5.5	5.6	0.0	0.5	1.0	0.0	4.7	0.0	0.6	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	13.5	0.4	0.3	0.4	0.6	0.1	0.6	0.1	0.1	1.6	0.0	0.5	0.0	0.9	2.0	1.6	0.7	0.2	0.5	0.0	1.7	0.0	22.1	0.0	0.0	0.0	0.2	8.0	0.2	0.7	2.8	2.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3	0.0	4.8	0.0	0.8	1.8	0.1	5.7	0.0	9.4	2.3	0.0	0.0	1.9	3.3	1.2	0.0	0.4	0.0	0.0	0.2	0.5	0.3	11.7	0.0	0.9	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.8	2.9	1.4	0.3	0.5	0.0	0.1	0.0	0.0	1.6	30.7	0.0	0.3	1.4
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 455.4;Syncytiotrophoblasts: 484.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.8	2.2	1.0	12.6	26.3	16.5	13.5	1.9	1.7	2.1	1.9	13.0	8.1	0.4	1.1	2.0	12.2	0.0	0.5	0.1	31.4	1.4	51.2	0.1	1.1	13.2	12.6	16.2	21.0	6.6	27.6	0.3	4.0	32.0	5.9	0.1	0.1	0.4	0.8	3.2	1.3	0.4	1.5	0.2	78.5	0.2	0.3	3.1	39.6	0.1	50.9	7.6	0.1	0.3	61.1	4.8	2.1	29.5	2.7	6.0	56.0	6.5	4.5	1.9	6.5	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1	35.7	233.2	40.3	98.2	162.8	10.8	19.4	96.8	24.1	99.0	64.6	33.4	39.9	18.3	60.3	7.2	107.9	230.9	0.0	151.5	27.8	58.7	45.7	257.3	17.5	283.4	0.0	10.2	455.4	148.5	5.6	14.1	322.4	254.8	6.4	46.9	4.3	52.7	129.6	14.9	92.1	28.6	12.9	39.1	48.4	7.5	101.6	484.9	9.6	6.4	68.4
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		24000	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.1	1.6	0.8	0.5	0.2	1.4	0.4	0.5	0.1	1.0	0.5	0.7	0.4	0.6	0.0	0.4	1.1	1.1	0.1	0.9	1.2	5.6	3.7	3.9	5.3	0.6	1.5	2.0	1.6	1.8	0.4	0.9	1.2	0.4	1.8	5.4	2.2	0.2	0.1	1.8	2.4	0.3	0.4	1.1	0.1	0.5	0.5	6.4	0.8	1.7	0.6	0.3	0.1	1.3	0.5	0.9	0.3	0.4	0.8	3.2	1.3	1.5	5.6	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3	3.0	1.1	2.2	0.2	0.0	1.8	0.3	2.5	0.0	1.2	29.6	0.0	0.2	16.6	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	0.0	129.5	0.1	3.2	0.0	3.1	1.3	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	0.0	94.1	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	16.9	18.6	17.5	13.0	27.3	31.8	18.0	23.2	34.7	16.7	14.9	18.2	9.2	10.1	15.6	10.8	20.0	13.8	12.0	22.3	18.4	18.8	17.4	28.4	11.7	16.3	21.1	16.0	15.6	20.4	19.5	25.4	18.7	33.6	14.2	13.5	11.0	17.1	14.1	66.4	14.7	15.3	18.6	25.0	14.4	14.2	14.0	17.1	42.5	17.5	19.9	18.5	16.3	13.6	25.2	28.4	38.4	24.6	32.9	38.4	28.3	15.1	10.2	21.3	30.9	19.6	17.5	16.3	30.7	26.5	29.3	36.3	17.1	11.5	26.3	13.9	27.1	21.2	11.4	29.8	22.6	45.8	26.7	20.4	80.4	28.9	22.9	23.5	49.6	22.0	17.2	17.2	27.7	34.1	22.0	24.2	31.5	42.9	22.2	30.9	14.4	30.5	12.6	13.7	18.2	11.2	28.7	23.8	17.9	18.1	14.5	21.1	14.4	21.0	22.0	21.8	17.6	18.3	30.0	22.8	20.8	21.7	25.7	32.4	50.7	36.5	44.7	31.7	25.8	25.8	38.4	24.6	25.4	23.4	22.1	26.3	25.2	28.1	23.8	28.4	22.6	38.4	31.6	11.2	32.9	21.1	22.6	32.9	28.3	17.5	27.3	23.2	34.7	18.4	18.8	21.1	16.0	33.6	17.1	23.8	21.7	26.8	23.0	24.3	42.7	51.6	22.9	28.1	36.4	10.4	13.7	27.2	21.6	20.9	27.5	18.0	9.8	93.5	17.8	26.9	19.6	19.2	56.8	33.1	12.0	20.6	15.6	17.2	22.1	11.0	17.3	14.9	28.7	27.1	11.4	26.1	16.4	13.9	20.8	19.2	26.4	38.8	24.0	25.9	25.7	16.3	33.9	20.3	14.5	22.5
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	25.2	0.1	0.0	0.0	39.5	20.0	0.0	0.0	0.1	0.0	0.0	0.0	24.8	20.4	3.8	0.2	2.0	72.0	37.5	0.2	3.5	0.3	44.5	1.0	6.1	0.0	0.2	1.9	1.2	0.0	2.0	0.0	0.1	1.5	62.8	0.0	0.0	0.3	1.5	0.4	4.8	1.2	12.2	0.0	34.2	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6	0.0	2.2	2.9	1.1	2.4	0.6	0.4	2.5	44.2	10.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	2.9	0.0	0.7	0.6	0.4	2.7	25.4	0.0	0.9	0.0	16.9	0.0	1.2	0.0	0.0	1.5	8.5	0.0	26.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	6.0	0.2	1.9	37.5	2.0
AHI1	"FLJ20069, JBTS3, ORF1"	ENSG00000135541	"Abelson helper integration site 1"	Q8N157	6	135283532-135497776	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"	"Developmental protein"	"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 54.2"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 1056.4;Rod photoreceptor cells: 1624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031698, HPA046684"	Approved		Uncertain	Centrosome		NA	NA			Centrosome		"HPA031698: AB_2673997, HPA046684: AB_2679752"	"unprognostic (4.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (7.51e-5)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.07e-9)"	"unprognostic (2.49e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.19e-3)"	6.7	16.2	16.8	6.4	16.5	5.9	12.5	35.3	26.5	11.7	8.7	4.2	13.2	4.9	14.4	32.1	7.8	9.0	9.0	7.6	15.9	19.9	8.4	6.8	8.1	6.0	11.4	19.6	13.9	11.6	11.5	54.2	8.3	18.2	16.3	13.1	10.0	8.2	15.9	6.7	6.1	5.7	11.1	18.5	4.3	10.7	29.2	13.1	3.3	11.6	5.0	6.3	8.9	12.0	10.6	16.6	4.8	1.7	3.8	4.2	0.5	5.2	7.2	8.5	10.9	13.9	15.1	3.8	9.7	12.2	9.8	15.1	2.8	5.6	8.2	4.8	9.3	9.8	4.0	6.3	3.0	14.6	6.5	8.5	3.0	20.3	5.3	5.9	15.2	3.3	7.0	5.0	15.2	8.3	15.2	8.0	10.2	13.5	0.5	13.2	5.6	14.4	3.4	5.1	4.0	4.4	7.3	3.4	2.7	4.9	5.3	14.8	7.9	12.9	4.8	5.8	6.6	3.8	6.9	7.6	8.5	10.5	14.5	7.6	10.7	9.8	3.8	12.0	2.2	10.1	4.8	1.7	0.6	4.2	0.5	2.6	8.2	4.0	4.2	2.6	10.6	3.2	4.1	0.1	3.8	0.5	16.6	2.4	0.5	16.8	16.5	35.3	26.5	15.9	19.9	11.4	19.6	18.2	13.1	35.7	87.4	13.4	33.8	25.4	293.7	22.6	7.6	89.7	51.2	55.8	1056.4	21.3	11.6	24.5	265.7	46.0	7.7	0.0	38.6	16.0	36.7	32.6	56.6	15.8	12.0	311.4	97.8	16.5	4.7	272.8	62.7	18.8	30.4	11.8	34.2	96.6	20.6	37.4	61.2	9.7	1624.0	51.8	41.2	126.9	110.1	19.7	23.9	12.8	31.5	21.8
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851696-136195574	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 112.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.8	4.3	7.3	4.0	21.9	0.8	3.6	1.6	12.8	6.2	4.0	2.3	25.2	3.6	14.2	4.9	2.8	4.2	6.1	7.9	5.1	7.4	9.6	6.4	3.3	2.8	6.4	4.2	22.7	1.6	3.7	8.7	2.2	5.9	6.8	5.0	5.4	5.0	28.5	7.2	1.5	3.7	13.5	5.3	2.3	5.2	2.9	7.1	7.7	8.3	6.1	1.9	10.6	5.1	4.3	2.6	0.6	0.9	0.7	1.8	0.3	0.0	4.5	0.1	0.0	7.3	8.6	0.0	0.4	2.3	1.7	0.9	0.0	0.0	0.0	13.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.8	0.0	3.1	0.1	0.0	18.7	0.0	3.4	0.0	0.7	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	0.5	3.2	3.0	0.1	0.1	0.0	0.0	1.5	0.0	1.9	0.0	9.3	0.0	0.1	0.0	0.0	0.5	0.0	0.7	0.2	0.9	0.6	0.2	0.2	0.1	1.5	0.4	0.2	2.6	4.3	1.8	1.0	0.3	0.7	0.1	0.2	0.2	0.3	7.3	21.9	1.6	12.8	5.1	7.4	6.4	4.2	5.9	7.1	0.0	0.3	3.0	0.2	0.3	2.3	8.5	2.5	0.0	0.0	21.0	0.0	0.1	0.0	0.1	0.4	18.2	0.0	0.0	1.5	0.0	3.3	0.3	10.3	4.7	0.3	6.4	7.0	35.0	1.5	0.0	11.2	0.5	0.0	0.0	0.0	13.8	0.1	0.0	7.4	1.2	0.7	12.9	3.1	0.1	0.2	1.3	0.0	0.0	0.0	0.1
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Extravillous trophoblasts: 18.8;Spermatocytes: 11.8;Spermatogonia: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles		NA	Yes			Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	1.7	0.9	0.6	5.1	1.5	15.2	0.9	0.9	1.1	0.8	2.9	0.8	0.4	2.8	0.7	0.9	4.5	0.5	1.7	1.0	0.6	0.6	2.5	0.7	1.5	6.4	0.8	0.4	0.9	0.7	0.0	0.7	3.2	1.2	0.7	4.1	0.6	1.3	0.4	1.4	1.9	3.2	0.9	1.1	3.8	1.9	13.5	0.4	16.8	0.4	3.2	5.8	1.1	1.4	1.6	3.0	0.1	2.9	0.0	2.6	1.1	7.2	5.6	4.8	9.0	0.8	1.4	8.6	9.6	6.7	11.4	15.9	9.9	5.9	18.8	5.9	3.8	15.1	11.3	10.9	7.1	17.0	10.5	8.4	14.8	4.1	9.0	0.5	27.1	14.0	1.1	1.5	12.6	8.1	1.3	6.1	16.5	15.9	14.6	8.5	9.6	15.2	22.7	4.8	9.7	6.9	14.0	7.7	9.4	4.9	5.6	3.8	3.8	6.0	10.6	5.5	6.2	4.5	18.7	3.3	5.7	5.9	19.9	14.6	5.6	13.1	12.4	3.3	18.5	8.6	0.0	0.6	0.0	1.2	2.9	0.4	1.6	1.6	2.6	3.0	1.3	0.2	1.3	0.1	0.0	2.3	2.2	2.2	1.1	0.6	1.5	0.9	1.1	0.6	0.6	0.8	0.4	1.2	0.4	0.0	0.6	6.2	0.3	0.9	0.0	0.3	0.0	1.4	1.2	0.0	0.0	4.9	0.0	0.8	6.5	0.3	0.9	23.3	2.2	18.8	0.4	0.8	1.1	0.5	5.6	0.0	0.0	1.3	4.3	4.2	0.3	1.8	0.0	2.8	1.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.3	11.8	9.9	0.3	2.5	1.5	1.4	0.9
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		190000	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	22.6	20.9	19.3	20.6	33.6	93.9	26.8	56.9	31.0	27.6	23.2	13.3	18.1	15.2	25.8	21.3	22.7	22.9	12.4	17.0	20.4	19.0	19.3	22.0	19.9	22.7	24.4	19.5	33.5	20.5	34.8	50.2	25.5	27.8	21.4	23.7	14.2	23.5	18.2	26.8	22.2	20.8	23.1	22.4	22.7	22.2	16.7	27.2	38.6	24.7	21.5	25.4	24.0	23.2	22.2	25.2	35.7	20.4	29.1	24.9	13.4	18.4	16.0	38.1	31.7	12.1	10.2	19.3	35.2	21.9	23.7	25.3	22.8	12.5	38.8	21.9	26.9	26.4	17.9	42.5	23.2	29.9	21.3	26.4	48.3	23.1	24.7	14.0	80.7	30.8	14.0	11.6	33.5	21.0	8.7	21.0	17.9	42.8	19.2	24.8	22.0	32.2	9.2	28.0	12.4	16.7	29.3	47.8	17.2	17.8	35.4	32.4	22.4	34.5	16.6	13.5	14.9	15.6	16.4	28.8	18.8	27.7	22.5	34.3	16.3	29.4	53.5	11.2	26.0	21.8	15.4	16.4	24.2	21.1	20.4	21.0	22.2	19.4	17.6	25.2	19.8	24.9	22.3	35.7	29.1	19.7	14.9	14.7	13.4	19.3	33.6	56.9	31.0	20.4	19.0	24.4	19.5	27.8	27.2	190.6	153.2	83.6	108.7	60.7	127.0	77.9	45.9	167.3	142.1	54.1	198.3	96.6	28.2	81.2	9.9	101.1	66.6	23.3	56.7	91.0	71.4	104.6	151.4	53.9	65.0	96.9	114.1	63.8	71.0	10.5	113.1	102.2	65.8	111.0	71.1	93.3	66.1	77.5	102.9	34.9	131.3	109.9	75.2	98.4	119.5	62.2	107.3	105.5	70.0	102.3
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.4"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 301.8;Early spermatids: 212.6;Horizontal cells: 287.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.8;HeLa: 26.0;MCF7: 32.0;OE19: 20.1;RT4: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.2	6.8	24.1	3.6	41.3	3.4	10.4	36.9	29.3	5.2	18.5	49.8	6.0	21.8	2.1	15.7	11.9	7.9	6.5	1.5	30.7	18.3	25.3	13.3	5.5	1.3	47.6	16.5	1.5	19.0	18.9	13.8	5.3	26.2	15.8	18.0	6.6	14.0	8.2	1.1	13.0	19.7	2.1	55.4	1.5	14.4	17.1	52.7	0.4	12.6	4.3	3.9	6.3	6.0	1.6	5.9	13.0	2.8	0.7	0.6	0.7	9.2	14.4	0.1	0.0	0.1	0.1	15.3	0.2	0.4	0.1	0.2	21.8	9.8	0.0	2.0	0.3	2.5	14.1	4.1	12.8	0.2	0.0	9.1	9.6	26.0	0.1	0.1	9.3	1.1	0.0	11.9	0.0	0.9	0.3	0.1	0.7	6.5	0.2	0.0	32.0	0.1	0.9	1.9	20.1	2.1	0.0	0.3	1.7	8.9	25.1	9.2	1.9	10.1	19.4	0.2	3.6	7.7	0.9	0.2	0.0	0.7	0.1	0.6	1.7	2.2	0.0	0.2	3.7	0.2	3.0	2.6	0.0	0.0	1.7	0.3	1.6	0.6	0.0	5.9	1.2	0.1	0.0	13.0	0.7	2.8	0.0	0.2	0.7	24.1	41.3	36.9	29.3	30.7	18.3	47.6	16.5	26.2	52.7	53.6	37.7	2.9	34.7	25.0	301.8	2.2	22.9	77.6	53.4	17.4	137.4	27.7	26.6	30.3	212.6	2.8	55.1	0.0	42.3	19.5	2.8	61.3	0.0	30.9	12.9	287.6	112.9	1.3	3.2	27.4	6.4	5.9	16.9	1.8	75.1	52.0	32.2	46.0	3.2	70.8	107.3	19.4	5.2	36.1	19.0	26.6	63.7	2.1	55.9	54.6
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.9	1.8	0.0	0.0	4.2	11.3	1.0	4.2	22.7	2.2	2.1	0.1	3.0	1.7	6.2	5.8	1.6	4.0	7.2	2.1	5.7	2.3	5.7	15.0	4.0	0.0	20.1	6.9	0.0	14.8	2.8	3.4	9.8	8.4	7.3	2.1	3.7	16.8	15.3	5.6	0.1	5.9	0.7	5.7	2.4	3.9	4.8	6.8	8.8	18.6	5.3	3.5	3.5	3.4	0.9	0.8	0.7	6.2	6.3	3.6	1.1	0.2	3.9	13.7	9.1	0.0	2.8	9.8	3.2	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6	6.0	22.4	10.4	17.9	4.4	17.5	21.8	2.5	16.0	34.2	10.4	5.9	0.7	3.3	2.1	4.9	3.8	7.7	0.0	19.7	0.9	5.1	22.3	5.7	9.6	7.1	0.0	33.5	9.8	22.1	2.3	21.9	18.4	0.0	1.0	12.1	42.4	18.9	5.8	13.4	6.8	2.5	12.9	8.0	1.4	15.0	8.8	2.3	6.9	10.0	19.3
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	8.6	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.1	5.1	10.2	8.1	5.3	11.7	11.9	5.1	9.7	11.3	3.5	9.9	4.7	12.6	7.9	4.7	4.7	5.0	15.4	6.4	8.8	12.6	6.1	8.8	8.5	5.4	5.7	10.1	4.0	4.7	2.2	7.3	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4	3.0	6.5	1.5	10.9	10.8	8.2	14.1	5.1	8.1	7.9	10.4	7.9	16.2	51.4	13.6	8.7	5.3	10.7	0.0	19.9	17.5	7.5	13.8	13.9	5.7	10.8	0.0	9.9	6.2	5.4	7.3	8.3	7.2	13.5	15.4	17.9	14.0	15.4	14.0	9.2	27.9	8.5	6.5	9.4	34.9	17.6	15.8	14.3	4.3	17.8	15.3
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922264-136925639	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 16.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Group enriched"	"Detected in some"	4	"basal ganglia: 9.9;hypothalamus: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 18.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 26.6;olfactory region: 10.4"	"Region enriched"	"Detected in many"	6	"basal ganglia: 24.4"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.1	4.9	0.0	0.4	9.9	1.2	0.1	0.0	0.4	2.0	0.4	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	0.4	0.0	4.8	4.0	0.0	2.1	0.0	1.7	0.0	0.8	1.2	0.0	0.0	0.1	0.5	4.3	0.6	16.4	0.2	0.1	0.0	0.2	1.3	0.3	0.0	0.2	3.2	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	18.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	9.9	0.0	0.4	0.0	4.8	1.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 28.9"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 33.5;Muller glia cells: 36.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.4;HaCaT: 6.8;OE19: 9.7;RT4: 11.3;SH-SY5Y: 10.9;T-47d: 10.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favorable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.6	7.0	2.0	1.6	5.9	0.1	21.2	4.4	2.8	13.9	3.5	4.3	0.6	2.4	5.5	3.7	6.4	13.6	7.9	5.9	3.6	3.0	0.4	0.8	4.7	0.1	3.7	2.3	5.4	16.3	0.2	1.8	0.4	4.6	7.3	3.7	3.5	11.8	7.8	0.5	28.9	1.3	2.9	5.5	0.0	4.9	2.9	3.3	1.0	2.2	3.7	5.6	5.6	9.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	9.4	0.0	0.1	1.4	0.1	6.8	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	9.7	1.4	0.0	0.4	0.0	0.0	11.3	0.7	10.9	0.5	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	4.4	2.8	3.6	3.0	3.7	2.3	4.6	3.3	3.0	18.4	0.0	11.2	19.5	1.7	3.9	25.5	33.5	14.8	3.5	0.0	2.4	0.0	11.1	0.2	0.6	5.2	0.0	0.6	6.6	2.4	18.3	2.3	0.0	0.4	0.0	7.0	0.6	0.0	0.5	8.1	1.7	13.5	0.0	18.4	36.8	8.0	2.9	14.2	0.6	0.7	0.0	1.2	0.2	3.4	15.7	6.9	0.0	13.3	17.1
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5"	"Cell type enriched"	"Detected in single"	6	"Syncytiotrophoblasts: 1.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HL-60: 2.8;U-937: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"	NA	NA	40500000				"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.1	0.0	0.1	2.5	0.1	0.0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197484-137219449	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 258.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 57.1"					"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.73e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.38e-3)"	69.5	22.2	17.4	36.9	23.5	37.7	65.3	8.4	18.5	23.6	27.1	27.8	13.8	28.0	19.2	21.2	23.0	20.3	25.9	53.7	20.6	17.4	19.3	66.4	58.7	86.9	33.8	13.2	19.2	17.5	9.2	12.8	47.0	29.9	20.1	22.8	11.6	24.5	18.0	25.3	24.0	46.7	22.5	45.7	69.1	20.3	14.1	26.3	14.5	22.8	19.7	38.2	25.0	22.3	12.2	39.4	92.3	65.4	5.4	29.7	52.3	4.8	4.7	6.2	8.0	40.8	21.5	5.2	13.9	20.7	9.1	12.3	30.5	9.5	4.8	22.3	8.0	13.2	30.3	5.4	14.1	12.7	10.4	7.5	7.6	5.8	45.1	23.1	23.7	11.4	47.5	57.1	7.6	12.3	8.4	11.4	7.0	6.4	8.3	6.8	5.5	3.8	10.9	5.1	44.4	3.8	11.7	6.5	7.3	15.8	23.0	6.2	9.6	17.2	10.1	12.6	12.3	3.6	15.7	15.8	8.9	6.5	11.5	7.3	6.1	5.7	5.4	4.6	15.8	8.6	16.5	65.4	43.3	14.1	63.0	29.7	10.9	8.0	11.8	39.4	12.2	5.2	5.8	92.3	5.4	44.1	10.1	5.6	52.3	17.4	23.5	8.4	18.5	20.6	17.4	33.8	13.2	29.9	26.3	74.5	64.2	57.6	146.1	113.3	14.2	38.0	33.1	83.0	77.3	26.2	11.8	63.2	6.6	61.6	3.2	106.4	70.3	0.0	88.3	59.0	70.9	89.3	61.2	50.3	132.8	9.5	12.6	63.8	258.9	4.3	40.9	249.4	47.2	88.4	19.2	19.7	74.0	28.1	46.3	15.1	20.6	12.9	65.2	8.4	20.4	99.0	175.5	67.8	27.9	144.7
OLIG3	"Bhlhb7, bHLHe20"	ENSG00000177468	"Oligodendrocyte transcription factor 3"	Q7RTU3	6	137492202-137494250	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.7;esophagus: 1.4;placenta: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;NTERA-2: 4.8;SuSa: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA018303, CAB024865"	Uncertain					NA	NA					"CAB024865: , HPA018303: AB_1854796"				"unprognostic (1.07e-3)"							"unprognostic (1.44e-1)"	"unprognostic (2.77e-1)"			"unprognostic (2.03e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	1.8	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.4	0.5	0.8	3.0	5.1	2.1	5.1	19.9	1.4	1.8	9.9	2.9	2.0	13.1	5.8	31.8	6.8	0.3	14.7	2.6	14.5	0.5	2.0	5.1	5.8	3.3	2.7	3.6	4.6	2.1	16.8	16.0	1.7	0.8	5.3	4.0	48.1	2.4	0.5	14.7	11.5	0.3	0.6	0.4	41.8	10.4	1.4	4.3	4.3	0.2	0.0	1.0	1.5	4.3	2.1	1.0	3.3	4.0	14.4	1.7	12.9	2.9	15.5	35.9	4.1	5.2	3.4	1.7	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1	35.7	83.1	25.1	141.6	688.4	1.0	4.2	30.6	41.5	26.1	0.0	27.5	5.5	1.7	50.3	2.3	27.0	39.0	0.0	23.4	88.6	55.5	117.9	248.4	10.2	45.4	0.0	11.3	45.4	74.2	2.4	6.4	241.1	123.2	82.0	12.5	1.7	27.9	8.2	5.6	2.2	13.3	6.5	87.3	0.9	2.3	651.8	19.3	101.2	8.5	60.3
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"PERP, TP53 apoptosis effector"	Q96FX8	6	138088505-138107511	"Predicted membrane proteins"	"Apoptosis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 250.2;skin 1: 157.9;tongue: 230.6"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 2942.7;Suprabasal keratinocytes: 5094.7;Urothelial cells: 1450.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 21.3;T-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.9;hTCEpi: 142.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022269	Enhanced					NA	NA					"HPA022269: AB_1855219"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	4.2	1.6	1.0	2.7	1.2	0.0	25.5	1.3	0.9	51.9	12.5	0.5	7.1	6.3	6.4	11.7	250.2	7.7	15.6	14.7	1.2	1.5	4.4	28.0	8.4	1.7	1.3	0.3	3.3	11.5	5.0	3.3	31.5	1.6	17.5	5.0	2.4	46.6	7.9	1.4	157.9	23.4	7.1	1.3	0.6	8.4	1.9	0.6	6.7	8.7	230.6	113.6	14.0	57.8	1.4	0.0	21.3	0.0	0.0	5.6	0.8	10.2	11.5	0.0	1.1	8.1	8.6	24.0	16.7	18.9	2.4	1.7	9.4	21.2	0.0	6.0	4.2	19.9	37.9	2.0	30.2	0.5	16.1	9.4	0.0	11.5	8.8	5.8	0.0	0.0	6.4	142.2	0.2	15.5	13.8	9.4	0.6	0.1	4.5	0.2	7.1	0.0	0.5	4.9	24.5	6.2	0.0	3.8	0.0	16.1	12.0	4.0	0.0	17.7	9.5	8.1	11.6	5.3	2.1	11.2	4.2	1.6	4.5	0.0	1.4	1.8	0.0	3.3	0.0	8.8	21.3	0.0	0.0	3.0	0.0	5.2	1.4	3.8	2.6	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.0	5.6	0.8	1.0	1.2	1.3	0.9	1.2	1.5	1.3	0.3	1.6	0.6	196.5	66.8	11.7	1261.9	2942.7	3.4	114.6	234.4	397.5	227.5	146.5	15.7	849.6	53.0	494.4	1.4	53.7	255.2	0.0	273.4	823.5	67.6	524.2	10.4	153.4	71.8	3.2	141.3	9.8	2.2	2.0	9.8	5.1	332.3	18.0	159.9	23.8	453.2	273.5	2.5	10.1	25.6	6.5	122.7	1.8	0.9	5094.7	689.2	31.2	162.2	1450.6
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161921-138344663	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2;parathyroid gland: 24.5;salivary gland: 26.6"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 92.2;Ciliated cells: 68.3;Club cells: 81.9;Glandular cells: 88.3;Intestinal endocrine cells: 64.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 11.4;RH-30: 10.8;RT4: 15.2;SK-BR-3: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain					NA	NA					"HPA036350: AB_10672084"	"prognostic unfavorable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.6	5.5	15.1	1.5	15.7	1.1	11.0	26.2	19.7	7.3	5.7	17.1	2.1	3.2	1.5	1.8	1.0	3.4	2.7	1.7	10.9	10.2	3.5	0.7	8.4	0.9	13.9	13.6	0.7	11.2	24.5	9.3	2.4	11.7	15.8	6.6	0.7	26.6	1.9	0.9	1.7	2.9	1.5	12.4	1.1	13.1	1.3	14.5	0.0	2.9	0.0	1.1	4.2	0.9	0.2	0.1	1.0	0.0	0.6	0.1	0.0	6.1	2.4	0.0	0.4	0.0	0.0	3.8	0.3	0.2	0.1	0.0	0.1	0.3	0.0	2.5	0.2	2.2	2.0	3.0	1.5	0.0	0.0	3.9	0.0	1.2	0.7	0.0	2.3	0.0	0.0	0.7	0.0	0.8	2.9	3.3	2.1	0.0	3.9	0.0	11.4	0.0	0.0	2.1	6.6	2.7	0.5	10.8	2.0	2.1	15.2	5.6	0.0	6.2	17.8	0.7	0.2	3.5	0.0	0.3	0.2	1.8	0.0	6.1	1.4	5.0	0.0	2.6	1.4	0.4	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	15.1	15.7	26.2	19.7	10.9	10.2	13.9	13.6	11.7	14.5	14.9	92.2	0.0	14.5	0.0	18.5	7.0	17.8	68.3	81.9	3.5	0.0	13.5	3.3	9.0	39.6	8.4	1.1	0.0	21.2	1.6	0.5	88.3	2.3	0.0	1.2	11.1	64.4	8.0	0.0	9.4	0.0	0.0	0.0	3.6	49.0	1.0	14.5	7.0	0.0	0.3	3.1	0.0	0.8	1.0	0.2	0.0	5.1	0.0	13.2	42.2
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;bone marrow: 1.9;brain: 1.9"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 1.0;Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.1"									HPA063021	Uncertain					NA	NA					"HPA063021: AB_2684923"	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.2	0.0	0.3	1.9	0.2	1.9	0.2	0.0	0.0			0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.2	1.1	0.1	0.1	0.0	0.1		0.0	0.8	0.7	0.3	0.0		0.5	0.0		0.5	0.0	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2			0.2		0.0	0.0	0.0	0.8	0.4	2.5	0.4	1.1	0.4	0.1	0.0	0.5	0.1	0.8	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.8	0.2	1.1	0.4	0.8	0.4	0.1	0.0	0.3	0.1	0.3	0.0	0.4	0.3	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.9	0.1	0.0	0.5	0.1	0.0	2.5	0.4	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.4	0.1	0.1											0.0	0.3	0.0	0.3	0.0	1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SMIM28		ENSG00000262543	"Small integral membrane protein 28"	A0A1B0GU29	6	138377905-138383075	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"intestine: 6.2;lymphoid tissue: 2.4;smooth muscle: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.1;SCLC-21H: 2.4"															NA	NA																	"unprognostic (2.50e-2)"		"unprognostic (5.48e-2)"				0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	6.2			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.0		0.3	3.1		0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.3	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HEBP2	"C6orf34, SOUL"	ENSG00000051620	"Heme binding protein 2"	Q9Y5Z4	6	138403531-138422197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Urothelial cells: 1163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 66.1"	"Low region specificity"	"Detected in all"							HPA016928	Approved					NA	NA		340000			"HPA016928: AB_1850572"	"unprognostic (8.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.76e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.07e-4)"	53.7	14.3	5.2	11.6	5.3	15.4	79.9	7.7	5.1	20.1	29.0	4.5	16.3	12.3	13.5	16.7	43.7	8.7	28.0	48.3	4.8	6.8	19.1	42.3	14.0	15.1	6.1	4.2	12.2	14.3	4.9	9.4	23.2	6.3	24.9	11.2	10.6	22.3	15.2	64.7	22.8	16.9	20.6	5.3	10.5	18.4	5.8	4.5	7.1	20.3	35.0	21.2	24.8	37.8	4.9	7.4	15.1	8.1	1.9	6.3	2.3	12.7	2.6	4.2	14.1	13.6	5.5	27.6	14.0	3.9	1.8	3.1	7.0	8.7	0.4	23.3	7.3	9.1	12.2	4.0	6.9	1.0	9.2	18.8	5.2	2.6	12.7	8.0	8.1	0.0	6.6	8.1	2.0	7.1	10.1	7.3	9.7	12.0	7.3	3.2	10.4	2.6	24.9	5.5	6.7	10.2	8.7	6.4	7.7	8.1	9.6	9.7	1.7	14.5	26.5	8.4	6.9	8.5	66.1	8.8	4.6	12.8	5.8	13.9	11.4	9.2	5.0	8.0	12.6	2.9	5.5	8.1	5.4	1.6	8.0	2.2	4.9	4.6	2.6	7.4	3.1	2.2	1.8	15.1	1.9	4.6	4.6	6.3	2.3	5.2	5.3	7.7	5.1	4.8	6.8	6.1	4.2	6.3	4.5	17.9	30.6	46.9	254.6	104.4	18.0	137.3	196.1	28.1	23.9	115.1	13.7	232.5	250.4	288.0	3.6	76.6	152.1	0.0	502.3	349.2	72.8	467.0	44.9	480.1	81.4	17.5	98.1	62.0	75.7	8.5	62.7	55.5	55.6	62.3	125.6	46.5	488.1	134.9	62.6	238.6	26.1	58.2	66.2	11.6	48.1	179.0	243.6	50.4	107.4	1163.3
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 93.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.4;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	7.4	1.1	6.0	5.4	5.7	0.2	2.4	3.7	8.6	2.2	46.3	4.3	3.4	13.4	3.0	11.2	10.0	0.9	7.2	18.4	4.8	3.4	17.4	19.5	15.0	2.0	4.2	1.3	1.2	4.6	2.8	1.7	3.5	6.3	1.7	10.0	7.9	3.4	0.4	2.3	10.5	93.0	3.0	2.8	2.0	6.8	1.6	1.6	0.2	1.2	3.6	1.7	2.4	3.9	0.1	1.2	1.0	3.8	0.1	0.1	0.7	2.6	2.3	16.6	6.9	4.8	6.0	6.2	2.4	1.1	0.9	0.8	3.0	1.5	0.0	3.1	2.0	1.6	6.1	10.0	6.2	0.4	0.2	6.7	1.6	1.1	22.4	7.2	5.9	1.2	8.6	3.5	0.4	7.2	0.9	11.7	0.9	0.0	0.9	3.6	5.2	0.6	0.4	6.6	1.5	4.4	6.8	1.7	0.5	5.7	6.8	6.3	0.0	2.5	5.2	16.7	11.5	1.6	1.9	31.9	2.3	2.3	2.3	6.5	0.6	1.2	0.0	0.2	2.4	12.8	1.0	3.4	0.5	0.1	3.8	0.1	0.1	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	3.8	0.7	0.0	0.7	6.0	5.7	3.7	3.5	4.8	3.4	4.2	1.3	6.3	1.6	56.6	50.9	0.8	2.4	38.0	0.7	20.3	5.1	25.4	12.5	27.9	27.5	12.0	8.3	3.0	0.8	8.3	65.2	0.0	3.1	3.0	11.6	3.5	8.1	32.7	3.9	35.0	19.4	29.4	6.7	0.0	0.6	3.8	20.3	0.0	29.8	14.7	3.5	45.6	0.0	12.9	0.9	6.5	4.6	0.0	0.7	43.0	36.3	0.9	40.2	7.4
GVQW2		ENSG00000279968	"GVQW motif containing 2"	A0A096LPI5	6	138725211-138773652	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;bone marrow: 3.7;gallbladder: 2.2"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 23.4;Late spermatids: 5.8;Spermatocytes: 8.1"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	4	"basophil: 5.4;eosinophil: 1.7;memory B-cell: 1.6;naive B-cell: 2.2;neutrophil: 2.3"	"Group enriched"	"Detected in many"	6	"B-cells: 2.2;granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.4;MCF7: 2.2;U-266/70: 1.8"															NA	NA						"unprognostic (2.47e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.65e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.42e-4)"	0.5	0.9		0.7		3.7	0.0		0.0	0.5	0.4			0.0	0.4	0.0	0.0	0.0	2.2	0.0			0.0	0.1	0.0	0.0			0.0	0.0	0.8		0.1		0.0	1.6		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0			0.1		0.3	0.0		2.2	0.4	5.4	0.4	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	1.2	0.0	0.3	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	5.4	0.4	1.7	0.0	0.3	0.2	1.6	0.6	0.1	0.2	2.2	0.3	0.3	2.3	0.3	0.4	0.4	0.1	0.5											0.0	0.0	0.0	0.8	0.0	0.1	0.0	2.5	2.7	0.0	1.8	0.0	1.8	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.5	0.0	0.0	1.8	0.0	5.8	0.0	0.3	0.0	1.0	0.1	0.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	8.1	2.5	0.0	0.7	0.0	0.4	0.8
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"	Q8IWP9	6	138773509-138793319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	12.9	30.8	25.4	19.8	28.7	20.9	17.9	22.6	27.9	15.6	17.4	13.3	18.7	18.5	11.5	24.8	12.4	22.6	16.8	11.0	31.4	32.2	36.5	40.5	17.4	19.2	22.2	21.7	14.2	22.2	25.5	19.2	19.3	28.3	16.1	15.4	16.4	31.6	20.8	17.4	11.0	21.3	13.9	16.1	18.3	16.5	15.0	13.4	18.2	33.9	9.3	19.8	19.3	12.5	30.0	29.3	73.5	27.3	30.6	44.5	24.5	3.4	6.2	4.7	8.6	8.9	12.5	9.6	5.7	10.0	7.5	12.4	5.3	6.8	14.8	11.1	5.6	10.7	6.0	7.7	7.9	12.3	17.1	17.2	12.0	7.7	10.6	14.1	20.8	12.7	8.0	10.1	5.4	16.2	15.6	12.3	21.1	12.1	20.8	8.5	7.6	17.0	27.4	4.3	13.9	6.5	10.3	4.7	13.7	9.0	5.1	5.9	9.1	7.5	6.9	16.4	9.8	3.3	23.0	9.4	5.9	6.8	11.0	8.6	27.9	24.6	10.9	6.4	12.9	5.2	33.2	27.3	33.7	26.0	27.0	23.2	30.0	27.6	28.3	29.3	29.7	32.1	29.5	73.5	30.6	22.9	25.8	44.5	24.5	25.4	28.7	22.6	27.9	31.4	32.2	22.2	21.7	28.3	13.4	29.8	34.4	36.3	23.6	11.8	15.2	9.4	15.3	60.2	20.5	34.9	17.7	69.7	104.5	12.9	140.9	19.6	31.3	0.0	27.6	36.9	20.0	38.9	41.6	41.9	35.0	9.5	23.7	28.3	38.3	64.6	15.5	34.4	30.4	35.1	32.2	20.5	17.7	32.0	14.2	100.3	12.5	12.9	12.2	40.2	30.3	13.0	91.1	37.6	22.2	27.7
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 133.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 2.8;SCLC-21H: 2.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain					NA	NA					"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.5	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.3	0.0	0.0	0.9	0.2	0.5	2.8	0.2	0.0	0.1	0.9	0.4	1.3	1.0	0.0	0.0	0.6	0.0	0.2	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.2	0.6	0.5	0.3	0.2	0.0	0.7	2.9	0.7	0.2	0.8	0.4	0.5	0.3	1.2	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.8	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8	0.0	0.6	0.0	0.5	0.5	2.2	1.2	0.0	133.8	21.6	0.0	2.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.3
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	9.5	9.4	18.9	11.5	22.0	15.5	18.4	25.9	25.5	12.9	12.9	14.8	15.3	11.7	17.5	32.5	20.9	14.6	14.0	17.7	17.7	17.6	12.1	23.1	11.5	13.3	15.1	19.4	17.0	13.9	32.8	28.3	14.0	20.0	13.6	13.7	13.6	21.6	13.4	12.1	22.6	12.2	16.3	10.8	15.8	12.4	27.7	11.7	30.7	13.9	13.5	18.4	14.7	14.3	4.6	6.2	8.0	7.5	5.2	6.9	2.0	12.8	10.1	19.4	24.2	11.0	19.7	21.2	12.5	13.8	14.7	17.8	24.0	11.2	15.5	10.6	17.4	17.5	15.1	22.0	18.9	19.6	16.5	19.0	13.1	6.1	14.5	16.6	41.2	21.2	16.0	15.5	26.9	32.7	14.0	15.1	23.1	17.4	16.0	18.8	21.7	23.3	22.6	18.5	16.5	9.7	27.4	11.9	8.8	12.1	19.5	17.4	17.2	11.5	17.7	16.5	29.9	8.4	28.5	14.7	8.2	13.7	22.2	17.1	15.8	14.3	21.8	9.8	17.0	12.0	8.0	2.3	3.2	4.2	6.5	6.9	4.6	5.4	5.8	3.4	3.4	5.5	6.5	1.5	5.2	7.5	6.2	5.4	2.0	18.9	22.0	25.9	25.5	17.7	17.6	15.1	19.4	20.0	11.7	17.9	6.1	13.7	10.2	11.8	11.3	25.0	12.7	17.4	13.6	5.2	15.7	22.4	6.6	7.0	9.2	9.3	8.3	0.0	6.1	24.3	8.0	9.3	16.1	34.5	11.5	12.7	5.8	17.2	21.9	5.1	6.6	11.5	5.0	3.6	14.7	32.3	7.5	10.5	8.1	6.9	14.7	19.4	7.6	35.6	32.8	13.0	23.9	20.0	14.5	15.4
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028682-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 308.6;Proximal tubular cells: 337.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 77.9;U-937: 75.7"	"Low region specificity"	"Detected in all"							HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		7400000	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	12.2	4.2	12.0	25.5	10.1	23.1	22.1	1.8	19.0	6.5	28.4	2.4	10.6	22.6	10.3	43.8	23.5	6.0	10.9	7.9	15.1	7.1	29.0	26.8	14.0	39.0	5.5	10.3	5.1	9.5	10.3	9.3	12.9	4.8	8.2	26.9	4.3	19.9	9.7	2.3	12.8	35.5	7.1	5.1	45.6	13.7	20.1	5.0	60.2	13.2	19.2	26.0	23.0	9.0	17.1	37.2	30.5	82.9	24.6	48.8	51.8	11.2	6.0	15.5	14.4	6.2	9.7	17.0	9.0	6.4	6.8	14.0	13.4	13.2	0.0	16.4	8.8	29.4	17.1	13.6	19.4	7.9	29.9	25.1	43.9	3.4	4.6	9.0	73.2	20.2	8.7	16.4	9.1	7.5	12.3	35.5	31.0	5.5	15.4	19.4	23.6	45.6	77.9	18.5	17.6	11.8	29.5	9.5	3.5	18.2	33.4	34.7	3.8	6.1	17.2	28.0	22.9	6.8	55.0	26.4	4.3	3.7	9.0	15.9	8.4	23.8	3.0	5.5	75.7	12.8	30.5	31.7	18.9	29.8	55.8	46.1	15.3	48.8	38.1	33.8	17.1	47.7	44.3	8.6	24.6	82.9	37.2	43.5	51.8	12.0	10.1	1.8	19.0	15.1	7.1	5.5	10.3	4.8	5.0	17.9	26.9	128.7	58.7	124.0	0.2	2.8	30.6	20.1	22.7	41.8	0.0	69.4	51.4	124.4	2.6	35.9	215.0	0.0	127.3	176.9	29.2	47.3	79.5	178.9	308.6	0.0	41.3	49.1	193.8	9.4	4.4	118.3	82.7	71.3	101.8	34.9	147.3	167.5	12.0	337.1	1.3	32.3	17.4	1.4	2.1	78.7	40.6	137.1	116.5	103.7
HECA	"dJ225E12.1, HDC, HDCL, hHDC"	ENSG00000112406	"Hdc homolog, cell cycle regulator"	Q9UBI9	6	139135112-139180802	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 111.7;Suprabasal keratinocytes: 124.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012581, HPA042313"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA012581: , HPA042313: AB_10796903"	"unprognostic (2.98e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-3)"	"unprognostic (5.77e-2)"	17.2	8.9	11.7	19.3	12.6	31.5	38.5	10.8	18.7	12.1	17.7	9.2	9.3	15.7	15.5	8.8	21.0	12.0	12.8	26.5	16.6	10.6	7.5	10.3	20.4	34.2	14.1	13.3	19.3	9.6	10.7	8.3	10.4	14.6	10.8	12.3	5.7	16.4	9.7	22.1	24.8	18.8	14.7	14.7	25.2	11.5	9.0	13.3	34.1	11.4	10.8	23.9	16.1	38.3	3.0	1.7	7.5	7.3	2.2	6.9	2.2	3.0	0.6	6.0	6.9	13.9	12.8	4.4	5.5	9.3	2.5	5.8	1.2	3.5	13.2	8.1	11.4	6.0	5.1	3.6	5.0	4.6	20.6	7.7	6.6	3.1	0.2	4.4	11.5	6.0	14.6	12.3	5.5	6.7	6.9	8.4	8.9	2.8	17.9	4.6	3.1	5.6	9.5	1.1	2.6	1.1	8.8	6.1	6.6	2.2	9.7	5.8	1.7	4.5	12.5	3.4	7.0	2.8	15.4	10.5	4.4	4.2	10.0	4.7	10.8	8.0	12.1	1.6	6.8	2.5	6.9	2.0	2.8	4.4	2.6	5.6	2.4	6.9	6.0	1.5	3.0	6.6	6.5	7.5	2.2	7.3	1.7	5.8	2.2	11.7	12.6	10.8	18.7	16.6	10.6	14.1	13.3	14.6	13.3	6.0	15.2	20.0	18.9	111.7	1.4	33.9	7.6	1.4	5.7	10.4	2.0	5.9	0.0	6.7	9.4	34.3	31.1	23.3	8.5	4.8	30.1	27.6	12.7	10.5	16.9	1.6	12.6	37.4	76.3	9.1	14.4	36.1	42.2	3.6	21.1	6.0	12.4	25.2	18.4	2.3	2.5	51.8	34.8	11.1	4.1	124.3	14.5	39.9	15.7	35.1
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139292139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 228.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	4	"B-cells: 5.3;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;HSkMC: 4.7;REH: 3.9;RPMI-8226: 5.4;U-698: 10.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA030401, HPA030402, HPA030403"	Enhanced					NA	NA					"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	4.5	0.9	0.4	1.1	0.6	0.1	0.7	0.2	0.5	1.0	0.7	0.6	0.0	0.2	1.3	5.1	3.4	0.6	0.7	37.9	0.5	0.5	0.3	0.3	0.6	0.9	0.5	0.4	3.8	0.2	2.3	0.7	0.2	0.8	0.9	0.3	0.1	2.1	0.1	131.5	0.3	0.8	1.1	1.5	1.0	0.4	1.2	0.1	3.4	0.9	49.7	2.7	1.0	0.5	5.3	0.3	2.1	0.3	0.3	0.8	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	7.3	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.1	0.8	1.0	0.1	0.0	0.0	2.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	2.2	0.4	0.3	0.7	0.8	0.2	0.0	0.5	3.9	1.7	5.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.9	2.2	1.4	0.1	0.1	0.0	0.1	1.2	2.1	10.2	0.3	2.0	0.0	0.0	0.2	0.0	0.4	0.2	0.6	5.3	0.4	0.8	0.1	1.9	0.4	0.2	2.1	0.3	0.3	0.3	0.3	0.3	0.4	0.6	0.2	0.5	0.5	0.5	0.5	0.4	0.8	0.1	0.0	0.0	5.2	0.1	0.5	0.0	228.7	0.0	21.4	2.3	1.8	0.0	0.1	0.0	0.0	30.5	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	1.3	5.8	49.6	0.6	2.2	5.0	0.0	0.0	7.5	0.0	0.0	2.1	0.0	0.0	0.0	0.4	4.7	0.5	0.4	0.0	1.3	0.0	0.0
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374620	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 592.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 78.3;fHDF/TERT166: 136.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	42.8	34.5	6.8	27.1	11.2	71.7	35.4	24.2	27.9	22.2	23.6	6.0	19.0	9.3	53.3	26.5	24.1	58.1	27.0	37.7	4.7	6.6	24.9	55.2	40.6	14.3	3.7	7.2	84.0	35.3	58.5	6.0	75.7	17.4	23.3	11.4	26.1	31.4	44.6	44.5	34.8	19.6	23.3	3.7	40.6	21.4	17.7	3.0	11.2	99.7	18.7	16.6	17.6	24.4	1.9	2.9	20.0	6.6	2.3	4.7	2.2	2.9	1.7	6.0	17.7	25.7	27.5	22.7	78.3	58.3	35.8	33.7	15.5	4.4	2.1	11.5	136.2	7.6	3.5	1.8	1.8	25.5	57.8	5.8	42.9	9.8	1.2	21.0	12.6	4.7	21.9	8.4	15.6	12.1	23.4	6.5	1.2	16.0	10.3	46.4	6.4	2.1	15.8	5.6	1.8	2.7	3.0	4.4	18.6	17.2	6.6	6.7	0.1	5.6	21.5	2.5	14.6	9.2	43.6	35.7	28.7	9.1	8.5	4.3	3.0	2.7	3.2	8.8	10.9	2.0	2.1	6.6	20.0	3.0	3.7	4.3	1.0	4.7	4.3	2.9	1.9	4.1	2.1	3.3	2.3	4.9	1.3	2.7	2.2	6.8	11.2	24.2	27.9	4.7	6.6	3.7	7.2	17.4	3.0	107.2	265.7	40.2	132.0	31.8	30.0	100.1	86.6	24.1	53.4	97.7	11.8	110.8	157.5	15.3	1.5	29.2	85.3	163.5	12.7	592.3	59.2	48.6	45.1	58.7	304.1	28.6	95.8	63.8	84.7	5.3	92.0	87.1	79.2	2.8	110.2	49.6	21.5	84.2	57.3	82.4	35.3	97.0	57.9	0.9	1.3	29.5	225.2	123.7	94.5	29.9
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 2.5;fallopian tube: 3.3;testis: 5.1"	"Cell type enhanced"	"Detected in some"	35	"Early spermatids: 5.9;Late spermatids: 1.6;Spermatocytes: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;RPTEC TERT1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026665			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.1	0.0	0.6	0.0	2.5	0.0	0.4	0.0	0.8	0.5	0.0			0.0	0.2	0.3	0.6	3.3	0.0	0.0	0.5	1.6	0.2	0.0	0.2	0.0	0.6		0.3	0.0	0.0	0.0	0.1		0.0	0.0		0.2	0.6	0.0	0.0	0.0	0.2	0.8	0.1	0.2	5.1			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.9	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.9	0.0	0.6	0.1	0.0	0.3	0.5	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0
GJE1	CX23	ENSG00000203733	"Gap junction protein epsilon 1"	A6NN92	6	142133090-142135151	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014916	Uncertain					NA	NA					"HPA014916: AB_1847134"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.7			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224689	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		22000	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	18.8	19.5	20.5	15.5	28.2	17.2	20.6	25.0	39.3	17.2	22.0	18.5	9.6	24.2	16.0	17.1	31.4	17.9	14.9	21.2	19.8	20.3	24.9	29.9	13.5	19.3	20.1	20.7	15.3	15.6	16.3	21.7	30.5	30.7	16.8	26.3	11.2	19.4	13.5	48.6	20.9	32.7	17.0	24.0	20.8	14.6	12.9	18.2	33.6	18.0	24.3	24.0	18.4	19.7	29.0	30.9	58.6	38.1	30.9	30.1	36.1	18.4	15.9	26.0	39.8	23.0	25.3	18.0	42.0	25.1	38.5	36.8	26.9	14.5	30.2	28.4	37.6	29.3	23.7	27.6	28.6	53.4	20.4	24.3	32.7	17.1	32.1	17.0	50.7	19.0	20.9	33.6	38.4	24.9	20.7	24.6	23.6	30.3	15.2	32.1	27.0	32.9	26.4	19.5	23.9	18.3	30.3	20.9	18.4	29.6	20.6	27.3	21.2	23.6	18.2	21.1	22.7	19.7	34.6	17.8	17.4	24.2	29.0	30.1	15.0	25.9	34.4	11.4	28.4	26.4	58.6	31.0	49.5	23.5	38.1	30.1	29.0	26.8	27.4	30.9	26.6	29.8	29.9	19.1	30.9	37.4	19.0	25.7	36.1	20.5	28.2	25.0	39.3	19.8	20.3	20.1	20.7	30.7	18.2	20.8	16.9	15.6	15.3	22.3	9.1	37.0	10.2	40.2	25.0	15.7	0.0	28.5	14.9	26.8	2.2	15.7	29.3	0.0	24.4	30.4	20.0	13.7	11.6	22.7	24.3	11.1	20.7	8.0	20.8	2.1	10.9	15.6	8.5	18.0	24.5	21.3	24.7	17.5	11.7	24.5	10.8	6.5	8.2	20.6	25.7	27.0	26.5	16.2	23.7	15.3
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 51.9;placenta: 104.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 118.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 3.5"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.5"	"Cell line enhanced"	"Detected in many"		"A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		70000000			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.6	1.4	1.1	4.1	1.0	0.0	6.1	0.5	1.1	4.1	14.0	1.0	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12.0	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5.0	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0.0	3.5	0.0	0.2	0.0	0.1	0.0	4.8	25.7	0.5	2.7	0.1	0.0	0.0	6.7	1.2	5.1	3.2	20.5	14.9	0.0	6.0	3.8	1.4	12.1	0.7	6.4	8.4	0.0	2.0	1.0	4.4	24.0	5.0	4.0	0.0	0.0	10.4	0.1	24.4	2.9	47.1	0.1	0.1	0.0	2.0	44.2	0.0	0.0	0.2	1.7	5.9	0.0	2.3	5.0	2.6	10.9	0.0	0.0	1.9	9.0	4.2	4.4	4.9	0.0	1.6	0.0	2.3	2.2	3.3	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9	6.0	5.1	0.5	15.4	0.0	0.0	1.4	15.3	5.3	14.8	8.7	0.0	4.8	0.0	11.5	0.0	4.4	0.8	0.0	4.7	24.6	0.6	11.8	0.0	118.8	2.0	0.0	0.0	16.5	24.7	0.2	0.6	0.6	0.0	1.0	0.9	0.0	22.8	3.6	0.4	10.3	0.0	6.5	0.5	1.6	5.1	0.0	11.3	0.0	1.8	21.0
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"Human immunodeficiency virus type I enhancer binding protein 2"	P31629	6	142751467-142956698	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 83.8;Suprabasal keratinocytes: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	11.3	9.7	13.9	13.6	17.4	4.2	9.2	29.8	30.1	6.3	7.2	5.9	3.8	6.1	8.6	7.3	11.7	15.9	13.5	10.5	15.7	10.4	8.5	7.7	10.6	14.9	9.3	12.8	18.5	13.4	19.0	8.7	9.6	12.7	7.3	6.3	7.1	10.9	8.6	24.3	10.6	8.0	10.1	13.5	10.4	6.5	2.7	8.5	18.6	11.2	9.6	15.5	12.5	12.0	2.1	1.1	2.3	0.6	1.7	3.9	1.2	3.7	0.7	0.9	3.3	7.3	8.2	2.6	5.4	13.8	3.4	4.1	0.3	3.1	5.9	3.4	23.7	6.4	2.4	1.5	11.0	8.3	2.2	1.7	1.6	2.4	1.4	5.5	5.1	0.0	7.5	11.0	13.8	15.9	7.8	1.8	4.7	0.1	5.4	5.7	4.2	6.7	2.2	0.8	0.9	5.4	8.9	6.0	0.5	3.1	6.5	9.0	3.8	7.1	5.9	4.0	1.6	1.0	3.0	1.9	11.4	2.8	9.5	4.7	11.3	1.8	12.7	3.2	4.0	5.3	0.0	0.3	0.0	1.6	0.6	3.6	2.1	3.9	3.2	1.1	1.3	3.9	3.0	2.3	1.7	0.5	0.5	2.9	1.2	13.9	17.4	29.8	30.1	15.7	10.4	9.3	12.8	12.7	8.5	20.8	27.5	3.2	41.6	83.8	14.1	18.3	10.2	30.8	39.8	7.0	23.6	1.9	0.0	10.2	1.5	14.3	3.8	0.0	12.9	1.0	34.3	37.8	3.5	4.3	2.3	28.6	3.4	6.7	3.4	0.9	10.9	11.1	23.6	5.4	4.5	2.3	17.1	7.0	14.9	2.3	2.3	0.0	30.9	0.5	0.9	82.7	3.9	12.8	2.9	53.2
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143340304	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.7"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 202.6;Proximal tubular cells: 212.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	18.4	14.9	20.1	5.6	18.7	13.0	16.8	15.6	22.3	8.1	15.1	26.6	7.9	22.3	7.7	18.8	14.7	16.7	14.2	21.9	21.7	26.0	51.4	115.7	8.6	5.7	23.3	15.7	17.1	14.2	9.7	19.2	6.3	25.7	12.5	9.7	21.1	11.5	12.8	10.1	8.2	25.6	8.9	28.6	9.4	8.7	10.0	14.7	1.7	23.0	11.2	11.3	14.5	10.5	6.4	19.0	8.2	18.7	6.3	10.0	5.7	9.4	7.1	6.7	18.8	9.6	8.5	2.3	8.2	18.3	8.2	20.1	10.5	27.9	6.3	11.8	18.9	12.1	13.5	8.1	27.1	20.4	18.5	17.9	1.5	11.0	43.5	14.3	13.5	0.9	10.1	27.8	10.4	44.5	29.8	3.2	8.7	1.1	22.2	21.0	12.6	4.1	3.4	12.6	10.7	8.2	6.0	18.2	10.5	32.9	21.6	23.7	13.2	10.7	10.1	4.8	12.0	10.6	31.5	1.0	7.9	8.5	7.8	10.1	29.6	23.5	0.5	19.4	3.2	8.1	5.8	3.9	5.9	4.4	16.8	10.0	6.4	8.2	6.7	19.0	4.2	8.8	6.8	8.2	6.3	18.7	1.9	5.7	5.7	20.1	18.7	15.6	22.3	21.7	26.0	23.3	15.7	25.7	14.7	14.9	23.0	21.7	44.8	22.1	63.0	65.1	76.5	57.6	35.2	48.8	23.6	56.8	44.7	47.3	9.7	28.1	17.9	23.3	27.4	6.9	41.9	39.0	36.8	202.6	29.0	50.9	37.9	31.3	26.1	5.6	29.7	27.8	52.3	23.4	25.0	69.0	25.6	26.6	36.0	212.5	31.0	32.3	36.0	3.6	12.3	40.0	90.4	20.4	28.1	43.8
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase, tRNA specific 2"	Q7Z6V5	6	143422832-143450673	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	7.3	9.5	6.6	15.1	9.4	17.1	8.6	7.7	8.8	6.6	9.5	4.9	4.7	9.9	8.3	5.3	12.0	7.9	7.6	4.2	5.2	3.8	7.5	13.2	11.3	17.6	4.9	8.0	7.5	13.3	7.1	9.6	4.0	7.3	8.6	13.3	6.0	10.1	6.2	13.3	17.1	10.0	6.5	6.7	13.1	10.8	4.1	5.3	8.6	10.8	10.1	13.5	6.6	8.7	2.8	3.2	0.4	1.4	1.9	6.6	2.3	2.9	2.5	3.1	10.6	2.6	8.5	4.7	4.2	1.9	2.9	4.1	6.7	7.5	10.5	4.6	2.8	3.3	8.6	5.8	5.9	5.7	5.5	13.0	14.8	10.5	13.5	3.3	20.8	7.4	2.9	8.7	5.7	9.1	2.5	6.2	9.7	16.1	9.1	4.4	4.2	8.0	11.7	4.0	4.0	4.8	9.8	9.2	8.5	4.5	3.3	6.9	4.7	3.5	9.5	2.8	1.7	4.0	7.6	4.8	4.3	3.6	8.8	8.0	9.4	6.6	7.9	4.0	17.5	4.9	0.0	0.9	0.0	3.2	1.4	4.7	2.8	3.0	2.9	3.2	2.0	3.4	5.1	0.4	1.9	0.2	3.0	6.6	2.3	6.6	9.4	7.7	8.8	5.2	3.8	4.9	8.0	7.3	5.3	6.0	11.7	0.8	3.4	6.0	3.6	2.7	0.0	2.7	4.5	1.8	0.0	2.0	3.3	3.4	1.0	4.7	1.8	23.3	3.4	2.1	4.4	2.9	7.0	4.0	4.1	1.6	4.1	4.3	5.1	1.1	6.4	2.8	5.0	0.0	5.6	2.0	4.8	0.0	3.2	0.7	3.1	0.0	4.9	1.8	5.4	8.2	0.7	6.9	7.8	3.8
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450807-143490010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	10.1	47.5	13.7	14.0	15.5	3.3	14.5	17.3	17.7	13.6	8.5	12.1	14.0	7.0	12.5	16.4	21.1	12.5	9.0	15.8	14.3	11.4	22.7	29.2	9.6	10.3	13.7	15.9	14.4	8.6	16.2	14.8	22.2	17.4	15.0	8.1	10.4	12.8	15.7	12.6	14.6	8.8	12.7	14.6	8.7	11.3	14.4	12.7	10.1	19.3	13.5	11.6	11.9	15.1	18.2	8.7	7.8	9.6	12.0	18.7	8.1	14.6	3.6	7.7	16.1	12.8	12.6	9.6	13.1	10.7	18.2	22.2	23.6	9.5	25.6	15.6	14.0	19.6	12.4	10.6	18.6	22.5	14.8	13.0	18.1	7.4	15.2	11.8	29.1	7.3	15.3	12.7	17.4	13.1	8.6	9.9	13.3	15.4	11.8	17.3	10.2	14.7	11.8	4.9	8.9	13.1	11.3	17.3	11.0	22.3	6.3	11.9	4.3	17.4	15.1	11.6	7.8	7.6	9.7	9.1	13.0	11.1	22.2	15.5	8.5	10.7	25.6	17.0	20.1	10.2	7.8	5.1	4.9	13.2	8.0	15.1	18.2	14.1	13.1	7.9	15.4	18.7	17.9	0.8	12.0	9.6	8.7	16.5	8.1	13.7	15.5	17.3	17.7	14.3	11.4	13.7	15.9	17.4	12.7	14.9	11.8	10.0	10.4	23.7	12.3	11.3	5.1	25.4	14.8	8.7	3.9	32.3	16.6	11.5	3.2	11.7	5.5	0.0	8.3	9.5	12.0	7.4	24.3	18.1	9.9	15.9	5.8	12.9	7.5	3.2	12.7	6.4	8.5	9.0	5.0	14.1	7.5	2.9	10.6	19.9	11.9	6.5	14.1	65.4	17.0	30.5	49.1	8.7	7.0	5.9
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494811-143511690	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		53000000			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	22.6	32.6	10.3	14.2	16.2	11.6	24.1	6.2	11.4	18.5	21.2	17.6	23.1	22.0	17.9	24.8	11.9	17.2	25.0	25.6	11.6	11.8	34.1	45.7	21.7	30.0	20.4	8.7	21.9	32.6	52.3	14.4	40.7	16.9	12.0	28.4	21.4	18.9	24.5	6.7	9.3	29.5	14.6	18.5	20.3	20.4	11.0	16.1	3.6	17.9	8.7	10.3	16.7	15.0	4.1	22.9	9.3	29.3	9.7	6.7	14.9	23.3	13.7	11.9	21.7	17.8	35.0	22.7	22.1	23.7	27.3	46.5	26.1	23.5	0.0	16.6	29.6	8.6	0.1	6.0	2.9	38.0	20.9	23.0	7.8	25.6	39.3	25.7	0.0	4.0	18.6	17.5	24.4	10.6	23.3	27.7	0.0	27.8	12.3	30.7	27.6	0.0	18.2	15.5	10.7	18.9	0.0	25.1	17.3	32.4	14.6	9.0	5.9	24.3	16.3	19.8	9.6	8.0	19.3	16.2	16.3	13.8	40.6	42.5	4.5	4.9	0.1	18.8	14.4	5.6	9.3	29.3	8.7	4.9	28.8	5.6	4.1	3.6	4.1	22.9	2.5	1.6	3.0	2.0	9.7	20.0	3.5	6.7	14.9	10.3	16.2	6.2	11.4	11.6	11.8	20.4	8.7	16.9	16.1	38.7	28.1	11.5	10.0	10.0	2.5	22.9	30.6	22.7	15.9	24.4	0.0	45.1	10.0	64.9	1.4	23.4	39.4	23.3	109.4	92.6	60.3	14.4	36.9	31.6	98.2	1.6	9.2	25.8	46.4	0.9	61.9	43.0	40.5	41.5	35.4	11.3	60.3	28.1	42.8	36.9	0.8	6.5	23.7	3.7	3.6	6.9	38.8	12.9	49.1	15.7
PHACTR2	"C6orf56, KIAA0680"	ENSG00000112419	"Phosphatase and actin regulator 2"	O75167	6	143536845-143831185	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 60.1"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 199.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031719, HPA031720, HPA031725"	Approved					NA	NA					"HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279"	"unprognostic (3.25e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.99e-4)"	"unprognostic (3.60e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	14.6	28.1	6.6	10.8	4.1	5.4	13.3	2.8	5.2	10.9	10.2	4.6	12.0	5.8	12.3	7.9	16.7	6.6	11.0	17.6	6.3	3.8	6.2	13.0	16.1	10.0	4.4	5.3	8.6	4.2	11.0	8.0	60.1	13.0	10.6	6.8	18.7	9.7	8.9	9.8	4.4	10.7	8.4	3.8	11.9	9.1	7.2	2.7	2.6	12.0	8.9	8.8	8.6	10.5	0.5	3.6	6.9	3.9	3.6	14.3	1.8	9.3	5.9	1.6	11.8	1.7	3.7	6.8	7.9	12.0	3.4	4.3	10.3	4.2	0.5	21.5	22.6	2.4	2.8	0.9	7.8	4.1	7.7	3.7	15.3	6.6	6.0	2.8	3.9	4.7	5.1	4.4	3.4	11.3	5.3	20.8	2.9	4.3	0.0	5.5	10.3	0.5	0.9	12.0	3.3	1.7	1.4	11.8	0.1	4.2	8.4	2.3	2.3	8.8	11.7	0.1	6.3	4.4	5.7	36.1	15.8	8.3	6.8	5.1	0.1	0.0	0.1	3.9	4.1	1.4	4.5	3.9	6.9	3.9	2.8	14.3	0.5	4.7	5.1	3.6	0.2	2.9	2.0	2.0	3.6	2.8	3.6	5.7	1.8	6.6	4.1	2.8	5.2	6.3	3.8	4.4	5.3	13.0	2.7	199.5	74.0	12.8	13.8	21.5	17.3	67.7	30.6	62.9	89.9	21.0	2.0	63.3	11.6	24.0	10.1	116.8	34.9	0.0	19.6	43.1	109.6	43.7	38.1	25.2	32.0	95.3	20.7	163.2	98.4	15.9	95.5	36.8	23.6	80.2	16.0	7.3	34.1	19.5	112.8	21.3	2.8	97.0	46.7	3.0	1.2	15.1	43.9	34.1	24.4	10.6
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843344-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	20.0	20.6	15.6	19.5	26.2	39.3	26.7	19.4	26.0	14.6	16.5	11.1	17.9	13.8	21.2	14.7	21.2	18.0	11.3	15.7	25.1	10.9	14.4	29.0	18.9	21.2	21.0	17.1	20.6	20.9	13.3	19.7	17.3	17.4	16.3	18.9	8.0	16.6	18.5	52.0	23.5	17.2	20.7	18.5	20.8	18.3	17.5	18.1	15.0	16.1	26.4	21.8	16.6	25.5	17.3	18.4	4.1	12.9	21.2	16.1	8.3	11.7	11.0	13.1	29.1	9.7	11.9	15.2	18.3	13.5	20.3	16.2	17.8	6.1	24.8	14.8	16.5	22.3	13.3	21.8	17.9	28.4	14.2	21.3	49.0	12.6	27.3	17.2	60.2	28.5	13.3	13.2	22.5	24.8	8.4	14.0	14.5	46.5	16.5	15.6	19.8	20.5	25.7	15.5	13.5	12.2	17.8	24.8	11.1	15.0	16.4	11.6	14.0	18.7	15.5	17.0	12.5	8.7	38.6	12.6	13.0	15.0	28.9	33.5	20.6	25.3	33.7	13.0	31.6	18.2	1.2	10.1	4.1	12.1	12.9	13.1	17.3	12.7	13.0	15.2	14.3	14.1	16.1	0.3	21.2	11.0	18.4	10.9	8.3	15.6	26.2	19.4	26.0	25.1	10.9	21.0	17.1	17.4	18.1	6.0	28.5	25.1	16.5	22.8	9.2	21.2	10.2	29.4	30.7	7.0	2.0	22.4	11.6	22.5	19.1	16.8	7.4	0.0	24.9	25.7	22.1	9.1	24.3	17.3	24.9	11.1	18.9	11.1	11.1	6.2	23.9	21.1	5.0	37.9	11.7	9.9	24.3	8.6	25.8	12.4	8.7	6.5	15.6	50.2	65.1	28.1	13.6	16.6	16.4	15.6
ZC2HC1B	"C6orf94, dJ468K18.5, FAM164B"	ENSG00000118491	"Zinc finger C2HC-type containing 1B"	Q5TFG8	6	143864436-143938356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 29.1"	"Cell type enhanced"	"Detected in some"	30	"Early spermatids: 8.8;Late spermatids: 3.6;Melanocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.3;U-266/70: 1.1;U-266/84: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	1.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 95.0"	"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 117.4;Leydig cells: 128.3;Peritubular cells: 91.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 35.7;ASC TERT1: 29.1;RH-30: 36.3"					"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	14.6	28.5	2.3	14.8	4.3	7.7	12.3	2.0	7.6	12.9	8.9	4.6	10.0	3.9	19.5	16.3	12.4	7.7	13.0	9.0	5.1	1.5	6.8	1.5	12.1	8.2	2.6	2.2	16.0	11.2	5.2	45.6	95.0	3.6	12.6	8.6	19.3	11.7	7.3	4.5	23.1	7.9	16.8	3.8	6.8	10.9	6.8	2.0	3.9	5.6	24.2	12.0	14.2	18.4	4.1	10.3	16.4	8.1	1.7	1.4	2.3	0.0	1.6	35.7	0.0	14.1	29.1	0.1	12.2	7.9	6.1	12.7	0.1	1.9	0.8	6.1	10.6	1.6	0.0	0.2	4.3	12.0	0.9	1.6	15.1	17.8	0.2	4.7	13.5	3.0	21.9	1.6	5.3	4.7	7.9	12.0	5.6	1.5	0.2	7.2	2.1	5.6	6.3	5.9	0.0	1.1	6.8	36.3	0.0	11.4	0.3	3.2	3.5	17.6	0.0	0.0	11.3	0.0	16.8	6.9	0.0	13.0	28.2	13.2	3.1	3.0	0.1	9.4	5.6	0.7	3.4	8.1	16.4	1.0	6.2	1.0	2.7	0.9	1.4	10.3	4.1	0.7	1.2	14.8	1.7	1.9	4.6	1.3	2.3	2.3	4.3	2.0	7.6	5.1	1.5	2.6	2.2	3.6	2.0	47.6	38.2	8.2	12.9	19.3	2.0	6.5	2.5	6.7	18.2	5.2	0.0	4.5	6.6	10.3	1.6	12.8	9.3	0.0	9.8	10.9	117.4	33.9	18.4	0.0	18.0	7.9	16.0	9.2	25.4	1.7	128.3	19.1	8.5	37.9	27.2	1.0	10.6	22.4	91.2	11.6	0.4	12.9	27.6	0.7	0.6	37.9	8.2	5.7	24.3	13.2
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094881-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	31.0	52.5	32.9	34.0	37.2	76.6	41.7	18.6	35.8	36.9	42.6	23.8	45.3	33.1	34.5	42.6	46.9	47.1	39.8	47.7	32.0	31.1	54.4	84.8	30.3	62.4	32.5	26.0	40.9	100.7	22.3	48.4	31.3	28.0	32.1	40.6	26.5	43.1	60.4	47.4	39.8	40.3	33.2	30.6	38.7	33.9	47.3	24.7	56.7	47.7	63.7	43.4	35.3	30.2	42.7	76.4	38.4	80.7	38.6	48.6	68.5	22.6	30.8	35.4	65.4	41.6	47.4	21.1	23.6	39.8	48.6	55.7	32.6	20.8	37.9	42.5	38.3	47.2	27.0	40.6	54.2	34.4	39.1	57.3	41.3	27.5	71.6	40.0	80.4	26.6	48.3	73.3	53.3	53.4	31.5	58.8	52.5	52.9	55.4	43.5	80.5	51.9	72.6	22.7	35.7	37.3	32.4	46.4	38.3	52.8	20.5	48.7	30.8	32.9	40.4	43.9	18.7	29.3	49.5	31.7	25.0	34.2	44.7	50.9	41.7	50.2	35.6	40.5	67.6	30.8	30.6	80.7	38.4	38.4	56.1	47.2	42.7	43.6	45.2	68.8	39.1	43.5	43.3	21.6	38.6	49.8	76.4	48.6	68.5	32.9	37.2	18.6	35.8	32.0	31.1	32.5	26.0	28.0	24.7	83.4	145.5	165.3	123.3	240.9	44.9	77.9	196.1	116.4	94.4	116.9	11.8	202.6	388.0	204.2	171.0	134.9	248.1	210.2	274.2	179.7	208.8	158.9	174.4	239.5	289.2	41.3	257.0	153.4	220.2	84.0	124.8	193.2	239.6	242.5	242.8	104.3	226.1	234.4	102.2	429.7	46.6	103.5	144.3	82.1	55.6	283.4	172.7	200.5	251.5	180.0
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150526-144188370	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 68.1;breast: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 75.6;granulocytes: 91.9;Kupffer cells: 68.7;monocytes: 71.3;Suprabasal keratinocytes: 135.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 13.4;granulocytes: 45.5;monocytes: 40.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.5;Karpas-707: 13.9;RH-30: 8.9;TIME: 11.2;U-266/70: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		19000000			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	20.0	3.6	0.7	7.0	1.2	68.1	41.9	0.3	0.8	1.4	3.1	0.6	0.0	1.1	1.1	2.2	4.4	2.0	2.4	8.8	1.8	0.9	2.0	5.4	26.3	14.5	1.2	0.0	2.5	0.9	0.6	2.4	15.5	1.8	1.9	1.0	1.6	1.6	0.6	5.3	5.6	2.5	1.9	2.0	20.6	1.4	0.9	1.0	2.8	8.2	4.0	6.8	2.6	6.1	0.8	13.4	45.5	40.8	1.5	4.1	18.9	0.5	0.2	0.0	5.9	0.2	0.2	0.9	0.6	0.5	0.6	1.1	0.2	0.5	0.0	0.6	0.9	1.1	0.9	0.1	0.2	0.2	25.5	0.9	3.7	0.7	0.0	1.6	0.9	0.4	0.0	0.0	0.3	0.1	0.3	6.3	1.1	0.1	13.9	0.8	0.3	0.5	1.1	0.0	0.0	0.6	0.0	8.9	1.0	0.0	2.8	0.2	0.0	1.7	0.1	2.7	0.4	0.0	4.6	11.2	0.1	1.7	0.4	0.4	16.4	6.3	0.0	0.2	2.8	0.5	9.2	35.0	21.6	3.1	40.2	1.9	0.7	1.4	2.6	13.4	0.8	0.5	1.6	45.5	1.5	40.8	1.4	4.1	18.9	0.7	1.2	0.3	0.8	1.8	0.9	1.2	0.0	1.8	1.0	50.6	12.5	8.8	9.6	75.6	0.0	4.0	5.1	2.7	4.5	1.8	0.0	0.6	0.0	5.5	0.3	11.7	0.0	0.0	2.3	3.1	14.8	11.2	91.9	0.9	31.3	0.0	3.4	4.9	68.7	1.0	0.6	60.3	42.2	71.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	22.6	2.6	3.4	135.1	23.5	22.4	0.0	30.1
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 381.2;Early spermatids: 418.2;Late spermatids: 250.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.4;HUVEC TERT2: 41.7;TIME: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6000000	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	34.5	14.1	11.6	34.5	23.5	22.9	25.4	3.1	11.3	32.6	15.3	6.8	21.9	7.7	28.8	21.5	17.7	21.4	15.8	13.8	9.2	12.8	15.5	11.8	35.2	30.9	12.7	8.8	22.7	23.8	53.1	13.0	21.1	16.0	23.4	15.2	17.3	18.4	24.8	11.7	16.7	14.8	19.8	16.6	45.8	13.3	45.0	8.5	27.4	32.4	20.0	25.7	20.7	23.4	11.7	15.0	10.6	48.0	10.3	12.6	3.7	6.9	5.9	10.5	13.6	18.3	16.8	6.3	10.3	10.1	8.4	12.3	22.5	2.6	2.2	9.1	23.1	9.9	4.1	58.4	8.7	12.1	23.3	6.7	8.3	6.4	13.3	7.2	9.2	0.1	9.7	1.8	12.4	6.5	7.9	41.7	6.6	0.5	6.1	11.8	4.6	7.3	4.0	4.2	4.3	6.3	6.6	19.0	0.2	9.7	0.2	13.4	0.2	16.1	2.2	6.4	16.8	8.9	12.5	53.6	8.1	10.1	4.1	9.8	4.7	6.3	0.3	4.9	5.6	13.2	9.8	12.3	6.6	12.6	36.3	9.0	7.4	8.0	10.2	5.1	11.7	7.0	7.3	10.6	10.3	48.0	15.0	6.4	3.7	11.6	23.5	3.1	11.3	9.2	12.8	12.7	8.8	16.0	8.5	381.2	100.6	59.6	24.2	26.2	6.0	51.2	35.7	125.8	185.4	29.6	0.0	73.5	0.0	20.7	418.2	142.7	5.3	0.0	27.6	3.8	38.2	40.0	27.8	12.1	19.7	57.2	30.0	68.2	90.1	250.3	22.2	56.1	37.1	8.2	14.2	29.3	24.9	10.5	31.5	4.9	3.4	142.3	109.3	5.7	4.6	39.6	108.1	64.0	20.4	18.4
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.3"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.3	6.3	8.2	2.5	1.4	3.0	3.5	2.8	3.4	1.5	1.7	20.3	2.5	3.5	3.4	1.8	1.2	1.3	2.5	7.9	1.7	3.3	2.4	2.5	5.0	11.3	2.0	2.1	6.8	1.7	0.6	3.7	2.0	4.8	1.4	5.2	3.5	2.6	7.5	2.4	3.4	3.0	1.7	4.3	3.0	5.9	2.5	1.7	6.1	6.1	5.3	3.2	7.0	3.1	1.8	6.5	4.3	2.8	1.4	2.6	2.3	3.8	3.8	8.2	2.4	2.7	4.4	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1	6.0	1.0	3.2	0.8	0.8	7.9	23.5	5.1	2.7	3.4	1.8	5.9	0.7	10.0	0.9	28.2	1.5	0.3	0.0	2.0	0.6	1.2	1.3	2.3	5.8	2.0	28.6	1.2	1.3	1.5	14.1	2.8	3.1	6.8	0.0	1.5	7.5	1.1	1.1	2.1	6.3	6.7	0.0	2.0	1.6	1.3	0.4	0.3	0.0	1.0	0.3
FBXO30	"Fbx30, MGC21674"	ENSG00000118496	"F-box protein 30"	Q8TB52	6	145793502-145814753	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 10.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012583			Approved	Microtubules		NA	NA			Microtubules		"HPA012583: AB_2668686"	"unprognostic (8.69e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.36e-2)"	"unprognostic (7.61e-7)"	"unprognostic (5.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.78e-1)"	6.9	6.9	7.4	5.9	11.2	8.8	6.0	7.3	9.0	7.6	17.9	5.6	6.4	5.8	10.8	4.8	14.7	7.0	8.5	11.5	10.6	6.3	6.1	4.9	6.1	5.6	10.8	6.3	9.1	9.7	7.6	5.7	6.9	11.3	10.8	7.1	5.1	7.0	10.9	22.9	4.7	8.5	20.9	7.8	5.6	8.6	9.0	10.8	4.8	15.4	4.5	5.8	19.7	8.9	1.4	2.4	10.5	1.9	0.7	1.2	0.8	3.1	5.9	8.5	11.5	8.9	8.0	8.7	8.9	8.3	6.1	6.1	7.4	2.9	14.4	6.9	10.1	11.2	4.9	7.3	6.5	9.3	8.3	5.0	9.1	7.7	7.4	16.1	11.8	9.5	13.1	7.3	7.5	10.1	8.0	8.8	3.6	10.5	10.4	11.8	2.4	5.2	6.3	9.8	2.0	4.4	6.9	19.0	4.9	6.3	3.2	3.8	6.1	10.9	5.7	5.2	8.9	2.6	11.7	11.5	6.3	5.3	8.0	8.8	7.7	5.9	5.8	10.1	5.1	6.7	10.5	1.9	2.3	0.7	1.6	0.5	0.9	0.7	1.2	2.4	1.4	1.0	1.0	1.8	0.7	1.3	0.7	0.5	0.8	7.4	11.2	7.3	9.0	10.6	6.3	10.8	6.3	11.3	10.8	3.0	5.1	1.4	5.0	12.7	9.3	19.1	12.7	1.4	4.5	3.5	3.9	4.5	10.0	4.6	7.8	13.5	3.5	70.0	2.8	2.8	14.7	5.6	11.5	6.7	6.6	25.4	5.8	9.2	13.5	3.1	10.3	8.1	6.8	5.4	5.5	9.5	4.4	3.5	9.6	6.5	7.6	0.0	14.4	18.5	8.9	15.2	4.7	7.9	5.0	4.3
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	10.9	7.3	8.3	11.0	10.0	5.5	10.4	38.0	11.5	10.6	8.0	4.5	10.8	6.0	14.1	9.2	8.5	9.8	6.7	7.2	7.2	4.2	8.4	6.5	7.1	9.0	7.6	5.9	18.8	8.7	11.4	19.7	6.6	8.5	8.3	7.4	7.3	10.2	13.7	11.4	13.9	8.2	11.0	10.3	8.8	8.5	10.7	8.7	8.4	12.5	7.2	8.0	10.7	11.5	6.7	4.8	4.4	2.4	3.4	4.3	1.2	3.0	2.3	11.7	6.8	5.4	5.8	5.6	3.6	2.9	4.5	5.8	5.3	2.1	10.6	4.5	2.7	3.5	5.2	7.1	5.1	5.9	4.7	8.1	10.7	5.3	4.4	4.0	22.4	6.7	4.0	5.9	4.2	6.2	4.4	4.8	7.6	14.8	6.0	3.8	2.7	14.4	8.3	7.8	5.0	4.1	10.4	18.1	3.6	6.1	3.0	9.6	6.7	6.4	5.9	4.0	8.4	3.1	10.8	5.3	2.9	5.4	5.6	4.2	4.9	7.0	12.7	3.0	9.6	4.4	1.6	2.3	4.4	4.3	2.4	3.7	3.9	3.6	2.9	2.7	6.7	4.1	3.3	0.1	3.4	2.4	4.8	3.3	1.2	8.3	10.0	38.0	11.5	7.2	4.2	7.6	5.9	8.5	8.7	26.8	18.9	20.8	15.3	18.8	113.2	15.9	17.8	12.0	23.9	21.0	198.3	12.7	6.6	15.4	8.3	19.7	10.0	0.0	11.1	5.8	14.4	13.4	12.7	14.8	10.2	89.0	18.5	14.1	21.8	5.1	46.9	15.5	13.5	15.4	14.3	57.4	13.0	10.5	32.2	4.5	175.4	71.1	21.7	76.9	67.5	17.2	5.5	20.3	15.0	9.6
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 113.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.1	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	1.8	15.7	0.0	1.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	113.7	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543693-146554965	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.5"	"Group enriched"	"Detected in many"	40	"dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA025731	Approved		Approved	Cytosol		NA	NA		330000	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	18.4	9.0	5.2	11.0	4.9	57.8	29.9	1.1	4.4	8.4	14.6	6.6	6.3	6.7	14.8	12.8	10.2	10.2	11.2	15.3	5.2	3.0	10.7	23.0	16.5	26.4	6.2	3.5	11.0	7.4	1.5	2.8	5.9	7.4	12.5	14.9	11.3	10.1	6.9	6.3	10.2	9.0	28.2	7.5	29.4	10.6	20.8	5.5	10.4	5.8	7.0	5.6	15.6	15.2	0.0	16.0	26.5	17.3	0.5	0.0	4.9	12.0	6.4	7.5	12.5	11.4	19.4	0.0	23.5	26.1	32.2	53.6	3.9	6.0	0.0	8.6	24.7	35.8	16.0	0.4	15.1	43.5	0.0	5.8	15.3	16.1	14.1	49.6	21.1	22.7	17.1	25.4	18.4	26.2	16.9	20.8	0.0	2.9	0.0	17.5	2.8	9.6	11.5	0.9	0.0	12.4	0.0	8.0	0.1	12.6	8.4	0.0	9.9	27.5	3.3	40.5	6.9	6.4	17.2	16.6	9.8	13.4	25.7	28.5	0.0	1.7	0.0	22.5	15.9	13.2	26.5	17.3	2.9	0.0	7.7	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	6.3	0.5	5.3	0.8	0.0	4.9	5.2	4.9	1.1	4.4	5.2	3.0	6.2	3.5	7.4	5.5	44.7	6.5	5.3	93.5	47.6	1.4	1.4	48.4	2.7	9.1	10.4	3.9	1.7	21.6	146.0	64.9	29.2	39.3	0.0	90.9	5.3	38.7	32.5	57.6	67.1	193.4	0.0	57.7	31.9	182.0	123.7	22.7	98.6	160.3	72.1	30.8	9.1	140.5	43.2	24.1	61.7	1.3	19.4	20.6	31.1	12.3	16.7	2.6	5.7	62.4	55.7
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.9"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2	3.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	121.8	14.8	0.0	3.9	0.0	0.0	0.0	236.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.2	2.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.2	3.0	0.0	0.0	0.0	0.0	0.0
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"HEL: 56.6;HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		11000	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	4.4	9.1	4.3	6.6	5.9	14.0	9.0	7.8	9.0	6.7	17.6	2.0	22.1	3.9	4.6	6.5	10.2	3.8	9.2	3.5	3.6	4.3	2.0	2.4	3.8	3.5	3.3	4.7	3.0	10.9	82.7	15.5	3.1	4.3	5.7	7.8	6.5	5.7	21.0	7.0	10.9	35.1	5.3	2.7	4.7	4.0	9.6	2.3	2.2	4.2	5.6	4.6	5.3	9.1	0.9	0.5	11.2	0.6	0.5	1.7	0.3	2.8	2.5	1.3	4.6	6.7	14.1	1.5	6.7	10.0	5.0	5.6	2.1	1.9	2.1	1.5	13.3	8.6	3.5	3.9	5.9	6.1	4.5	3.0	56.6	7.5	2.4	7.7	19.3	61.9	10.2	4.2	10.0	20.4	11.9	6.4	3.3	15.2	2.6	9.8	4.2	3.0	5.0	1.1	2.4	5.9	0.4	7.1	0.8	2.7	5.0	2.9	2.1	5.2	3.7	2.3	2.5	1.1	7.6	7.3	7.2	2.6	3.5	6.1	2.2	0.0	2.5	3.9	7.1	5.1	4.7	0.3	11.2	1.2	0.5	1.3	0.5	0.7	1.4	0.5	0.9	1.2	1.7	4.0	0.5	0.6	0.4	0.3	0.3	4.3	5.9	7.8	9.0	3.6	4.3	3.3	4.7	4.3	2.3	14.9	9.1	1.5	2.0	3.2	28.1	12.9	7.6	1.4	9.1	15.7	29.5	4.0	0.0	4.4	26.8	7.9	17.0	0.0	11.2	3.2	4.5	10.0	41.7	3.4	4.0	31.8	39.6	8.6	7.8	34.7	7.2	4.1	10.1	2.8	28.2	5.0	9.8	24.6	6.7	1.4	25.2	12.9	3.4	12.3	10.7	5.8	3.2	4.9	17.4	3.0
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508927-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 66.1;Hepatocytes: 23.7;Undifferentiated cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.7;Hep G2: 33.3;K-562: 22.4;RH-30: 15.7;WM-115: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067811	Uncertain		Supported	Vesicles		No	No			Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	1.6	2.2	1.6	3.4	5.7	0.2	4.9	1.4	4.7	3.9	7.1	0.7	1.9	3.6	10.9	2.2	15.9	1.7	6.6	2.4	2.7	3.4	26.5	12.8	8.0	0.5	1.9	2.2	1.4	2.4	17.3	13.9	14.6	14.1	3.0	10.1	9.8	4.9	3.3	0.8	3.6	5.4	4.0	1.3	1.7	5.5	10.9	2.6	0.0	3.0	6.3	6.5	2.6	3.9	0.7	0.5	1.8	0.4	0.6	0.5	0.1	5.7	0.7	0.8	1.1	0.0	0.0	0.0	1.9	0.7	0.1	0.1	8.7	0.0	0.3	1.9	0.0	0.3	0.0	0.1	1.3	0.2	0.0	1.0	0.4	0.8	33.3	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	3.7	0.0	22.4	0.3	2.6	0.0	0.0	0.0	0.1	4.4	1.5	0.0	15.7	3.3	0.0	1.2	0.3	0.0	0.5	0.1	1.5	0.1	0.0	0.0	2.6	0.2	0.8	0.2	0.7	0.0	0.5	0.0	0.0	0.0	11.0	1.8	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.7	0.5	0.4	1.1	0.6	0.4	0.5	0.2	0.1	1.6	5.7	1.4	4.7	2.7	3.4	1.9	2.2	14.1	2.6	3.0	5.1	0.5	4.1	1.5	66.1	2.4	0.0	0.0	0.0	17.4	2.0	0.1	8.3	1.5	0.3	2.8	4.4	0.0	0.2	0.2	6.6	1.3	0.0	23.7	0.7	0.0	16.3	4.9	1.0	0.5	0.3	0.6	0.0	0.0	9.3	12.1	0.3	0.0	3.2	15.9	2.4	0.0	0.9	0.5	0.1	1.4	0.2	0.0	22.8	3.5
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552050	"Predicted intracellular proteins"			"Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 97.4;Muller glia cells: 93.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	32	"monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.2;ASC TERT1: 22.8;HUVEC TERT2: 21.8;WM-115: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	41.4	5.4	19.6	5.3	21.7	0.7	25.7	9.9	28.1	16.8	9.2	22.2	4.4	5.6	11.2	9.3	35.6	10.0	15.6	13.2	21.9	14.2	13.5	7.7	16.7	4.7	26.3	11.4	5.3	7.7	15.0	3.5	23.5	22.8	9.8	8.3	9.2	12.2	8.1	10.6	17.5	6.7	13.2	28.6	10.3	6.0	4.8	22.3	0.2	30.9	10.4	8.2	13.2	17.9	0.0	0.0	0.1	5.5	0.0	0.1	0.6	1.3	0.8	6.9	2.3	60.2	22.8	1.1	7.9	19.1	6.0	9.2	1.7	1.6	0.0	4.2	21.1	3.0	1.6	2.1	1.9	5.0	0.0	1.5	0.0	3.9	1.6	1.8	0.0	0.4	10.6	1.9	9.0	2.4	2.4	21.8	0.0	0.1	0.0	5.6	1.5	0.0	0.0	2.0	0.7	1.1	0.0	5.0	0.0	4.4	4.3	0.2	0.0	2.4	8.9	6.2	1.8	0.7	3.9	18.9	5.9	1.2	18.6	1.7	0.0	0.0	0.0	9.4	0.0	27.8	0.1	2.9	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.6	19.6	21.7	9.9	17.9	21.9	14.2	26.3	11.4	22.8	22.3	14.9	20.8	0.8	6.3	36.5	12.5	18.3	7.6	14.7	21.6	43.6	5.9	16.4	6.6	2.2	0.5	97.4	2.5	0.0	2.1	55.4	26.8	6.2	2.3	6.6	8.1	3.2	4.6	63.8	31.8	1.1	17.0	12.1	40.5	0.0	4.5	93.7	1.2	2.9	26.5	12.2	3.9	77.6	64.3	0.3	4.5	28.9	27.3	0.0	6.4	5.7
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747328-149076990	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 17.0;Muller glia cells: 13.3;Peritubular cells: 10.6;Suprabasal keratinocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA					"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	8.6	16.0	4.8	7.1	9.3	0.8	8.5	20.9	10.8	12.8	8.6	6.0	6.6	2.6	10.8	8.1	8.2	10.4	12.2	4.5	6.3	12.6	5.2	2.2	8.6	4.9	14.1	4.5	15.6	19.0	0.7	2.3	6.1	13.0	9.8	4.0	10.7	4.3	6.9	3.7	8.6	5.6	11.5	9.1	8.0	5.7	12.1	6.5	3.1	37.5	5.7	4.9	10.6	21.0	1.5	1.3	0.1	0.9	6.2	1.7	0.4	0.0	2.1	12.0	9.2	14.6	12.2	0.1	5.1	13.4	2.5	6.5	0.0	0.8	4.2	1.1	7.9	6.3	3.7	8.5	4.3	5.1	5.6	6.4	0.1	6.8	0.1	5.4	0.2	1.8	6.2	9.7	6.5	12.1	5.1	0.1	7.1	0.0	0.0	2.0	5.3	0.0	0.0	7.0	20.7	2.7	2.0	1.6	4.9	0.1	9.6	6.2	0.0	17.0	4.2	3.1	9.0	3.1	0.2	0.2	7.3	0.8	1.6	4.5	0.0	0.0	0.0	8.1	3.4	4.1	0.0	0.2	0.0	1.7	0.7	1.4	0.8	1.3	1.5	1.1	1.5	0.1	0.7	0.1	6.2	0.9	1.3	0.4	0.4	4.8	9.3	20.9	7.4	6.3	12.6	14.1	4.5	13.0	6.5	3.0	2.7	0.5	4.2	8.4	0.0	1.2	0.0	1.4	1.2	1.8	0.0	1.4	0.0	0.1	0.6	0.1	0.0	0.0	1.7	0.2	8.1	4.2	0.0	0.0	1.4	0.0	0.0	2.5	1.3	2.6	17.0	1.1	5.0	1.0	1.4	13.3	1.5	0.0	10.6	0.4	0.4	0.0	2.2	1.7	3.2	10.2	1.1	1.5	0.6	6.8
TAB2	"KIAA0733, MAP3K7IP2"	ENSG00000055208	"TGF-beta activated kinase 1/MAP3K7 binding protein 2"	Q9NYJ8	6	149218641-149411613	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065436, HPA070137"	Approved					NA	NA					"HPA065436: AB_2732735, HPA070137: AB_2732148"	"unprognostic (1.08e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.49e-1)"	19.5	16.2	39.9	26.8	32.7	24.6	20.3	25.3	31.6	27.6	34.8	24.7	11.5	14.2	21.5	17.6	23.1	20.1	16.4	35.2	39.8	20.1	20.9	35.1	20.9	20.9	22.7	23.0	26.1	19.3	27.7	15.0	16.3	29.9	24.5	20.2	15.1	30.9	23.1	46.6	18.8	20.2	24.0	34.6	19.7	22.1	12.3	36.8	21.4	21.7	13.3	21.8	32.6	37.4	2.8	3.5	7.2	2.4	6.9	6.9	2.0	12.2	7.8	20.8	22.3	20.4	17.7	16.1	14.2	26.0	22.3	29.1	11.9	17.7	13.0	18.2	16.8	29.1	12.6	16.8	19.4	35.1	42.6	12.2	21.1	10.6	16.7	20.2	18.3	13.5	21.2	27.7	22.6	30.1	34.4	21.1	13.3	15.9	13.1	22.8	15.3	17.1	10.3	13.1	10.5	8.9	14.5	14.6	8.3	20.8	18.1	15.9	14.4	19.3	32.3	10.6	25.0	20.2	20.2	22.6	17.1	21.1	18.7	24.6	11.5	6.7	19.7	28.8	11.6	17.7	0.0	1.4	0.4	2.2	2.4	2.1	2.8	6.5	4.3	3.1	1.5	4.3	3.7	7.2	6.9	2.0	3.5	6.9	2.0	39.9	32.7	25.3	31.6	39.8	20.1	22.7	23.0	29.9	36.8	62.5	27.0	18.2	24.4	41.8	8.4	42.2	12.7	17.4	17.0	15.7	2.0	11.6	10.0	13.5	23.0	20.4	24.1	23.3	17.1	10.1	25.9	35.7	27.7	32.6	25.4	11.1	15.6	22.1	41.8	11.5	27.0	27.3	16.9	36.1	24.1	11.0	21.1	11.5	26.9	14.6	5.2	19.4	14.6	15.4	11.3	37.5	8.9	27.7	20.1	35.7
SUMO4	"dJ281H8.4, IDDM5, SMT3H4"	ENSG00000177688	"Small ubiquitin-like modifier 4"	Q6EEV6	6	149400227-149401292	"Predicted intracellular proteins"	"Ubl conjugation pathway"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;HeLa: 4.2"									"HPA042123, HPA048064"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.44e-11)"	"unprognostic (4.94e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	1.5	0.8	0.7	1.9	1.7	3.6	2.7	5.1	6.5	2.1	1.1	1.2	1.4	1.6	3.0	3.2	1.7	0.7	1.5	3.6	1.0	0.8	2.3	6.6	2.8	3.9	0.7	1.7	2.9	2.2	1.2	2.6	1.8	2.8	3.1	1.7	1.7	2.5	1.1	2.3	1.3	1.4	1.9	1.9	2.2	1.5	2.0	0.2	1.4	2.1	0.7	1.8	1.4	3.5	1.9	0.7	5.6	1.1	3.2	2.6	0.5	0.2	0.0	0.2	0.2	0.4	0.0	0.5	0.8	0.2	0.4	0.3	0.3	0.3	1.6	0.3	0.0	0.3	0.3	0.0	0.6	0.4	2.9	0.3	0.3	4.2	0.3	0.3	0.2	0.3	0.3	0.2	0.5	1.0	0.2	0.0	0.0	0.6	1.2	0.2	0.0	0.5	0.6	0.5	0.0	0.3	0.4	0.6	0.5	0.0	1.5	0.9	0.2	0.6	0.0	0.0	0.7	0.0	1.7	1.4	0.8	0.7	0.7	0.5	0.6	0.1	0.1	0.5	0.6	0.0	0.3	0.5	0.9	1.3	0.6	0.7	1.1	2.6	1.9	0.7	1.9	1.7	2.4	5.6	3.2	1.1	0.5	2.5	0.5	0.7	1.7	5.1	6.5	1.0	0.8	0.7	1.7	2.8	0.2	3.0	1.0	0.0	1.3	2.6	4.3	9.2	0.0	1.4	1.2	1.8	3.9	0.7	0.0	0.6	0.0	2.1	1.0	0.0	0.8	0.3	1.7	3.5	1.1	1.5	0.9	0.0	1.7	1.3	1.0	0.7	2.0	4.4	0.0	4.6	0.2	2.3	0.9	0.0	1.1	0.0	4.2	6.5	1.4	1.4	0.9	0.6	0.2	1.7	0.4	2.2
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485061	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 38.1"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 5.4;Kupffer cells: 10.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 27.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	3.3	0.8	0.5	33.4	1.0	3.4	1.2	0.7	0.6	0.8	3.0	0.1	1.0	3.0	0.6	1.2	0.8	0.8	0.9	0.6	0.5	0.7	1.3	0.8	2.0	10.6	0.5	0.0	0.4	0.7	0.0	0.6	0.8	0.5	0.7	1.5	0.9	2.0	0.2	0.4	1.1	7.7	0.4	0.7	9.5	0.7	0.7	0.4	4.8	0.9	1.6	38.1	1.7	0.6	3.2	1.7	1.3	2.7	0.7	7.2	1.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	6.4	0.1	0.0	0.2	0.2	0.0	0.0	0.1	27.0	0.2	0.2	0.8	2.2	0.0	2.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	2.0	0.0	0.0	0.0	5.6	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	3.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.3	2.1	0.1	1.3	1.8	0.4	0.3	1.0	0.5	3.1	3.2	1.5	1.7	3.2	2.0	0.5	1.3	0.7	2.7	1.0	7.2	1.5	0.5	1.0	0.7	0.6	0.5	0.7	0.5	0.0	0.5	0.4	3.0	3.8	3.2	0.5	0.3	0.6	1.1	2.5	0.0	1.2	0.0	3.9	0.0	1.7	0.0	0.3	1.1	5.4	0.0	0.3	0.0	0.6	0.3	0.0	0.0	3.2	0.0	0.0	2.5	10.8	0.2	0.0	3.6	1.7	0.0	1.5	0.8	0.2	0.0	0.0	1.4	0.6	0.0	0.3	0.1	0.4	1.3	0.0	5.7	2.1	0.3
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	11.1	6.0	21.0	17.3	12.5	16.4	19.6	22.0	21.0	24.1	25.7	12.6	11.4	11.8	15.2	16.9	14.4	10.1	16.0	8.4	38.3	17.1	15.1	13.0	13.2	21.6	19.7	23.6	11.1	12.8	14.4	24.6	20.6	13.5	13.1	8.6	28.3	7.1	18.7	11.9	13.4	20.3	16.6	11.2	9.5	18.2	19.4	5.9	18.3	8.5	12.4	9.5	26.2	11.5	15.0	15.2	13.5	17.2	15.3	16.0	12.5	28.3	20.9	9.4	4.8	18.5	13.5	19.0	23.0	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4	62.5	64.3	22.6	54.3	43.4	44.2	33.3	17.8	80.3	61.4	43.6	7.9	43.1	36.5	34.7	17.2	37.3	15.2	0.0	23.1	37.9	55.5	27.1	73.0	18.7	31.8	27.0	22.3	30.7	21.3	9.6	57.2	29.9	38.8	47.7	19.7	40.0	26.4	22.9	52.6	27.5	35.5	51.8	68.4	58.2	53.4	39.5	54.6	41.5	20.0	32.7
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 261.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		8700	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: AB_2677611"	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	32.1	26.3	21.3	17.8	34.7	20.0	51.5	26.1	27.6	28.8	25.7	22.4	29.0	14.2	29.3	36.9	21.5	24.1	24.3	48.2	20.3	18.3	51.3	29.6	28.4	32.9	43.6	21.4	31.7	28.3	27.1	17.5	34.0	23.0	23.6	19.8	21.7	20.7	40.1	29.2	20.9	17.3	36.7	31.3	18.6	22.8	31.0	30.2	11.5	41.5	21.6	13.1	28.6	22.6	16.8	12.6	23.7	16.0	8.0	8.1	7.7	7.9	5.7	9.3	12.5	50.2	30.1	15.2	27.2	31.9	20.7	26.0	7.4	10.7	5.9	15.0	25.7	19.1	16.4	6.0	13.6	27.1	9.8	13.4	5.6	5.5	8.8	19.2	11.0	5.4	33.4	11.8	17.5	12.1	22.7	22.2	8.1	7.2	9.8	19.4	10.2	6.9	8.3	3.2	11.7	6.1	7.4	16.7	4.4	29.4	7.0	5.9	5.7	27.1	16.1	5.6	10.7	10.1	11.2	15.5	11.2	11.8	28.5	17.9	9.7	11.2	7.3	20.8	9.9	10.3	11.9	13.7	17.1	6.8	13.2	7.9	16.8	8.1	7.4	10.0	11.7	7.9	6.4	23.7	8.0	16.0	12.6	7.5	7.7	21.3	34.7	26.1	27.6	20.3	18.3	43.6	21.4	23.0	30.2	74.5	47.2	33.3	50.3	41.6	20.9	44.8	30.6	33.5	43.3	62.8	27.5	69.7	33.2	80.6	144.2	73.7	38.6	0.0	70.5	63.5	82.2	48.5	27.8	35.6	40.9	15.9	25.7	88.4	45.9	261.3	120.0	45.3	40.5	82.0	22.0	80.5	55.4	29.4	106.1	117.9	21.9	97.0	65.6	141.4	88.4	41.0	102.6	28.7	25.1	50.0
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 312.3;Late spermatids: 142.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.5	7.8	9.3	11.9	9.8	14.2	11.7	13.0	9.5	13.8	12.1	15.0	6.0	7.6	15.3	10.3	12.5	10.9	10.1	11.3	9.1	6.7	13.7	8.4	10.8	11.8	10.4	7.9	18.7	9.6	5.7	12.1	11.0	15.0	12.7	9.5	17.5	10.1	10.5	21.2	12.0	10.8	12.4	8.9	12.2	10.4	36.7	12.0	22.5	13.9	10.3	14.0	15.1	12.7	19.6	19.4	23.5	20.8	12.7	24.2	14.9	11.5	4.1	9.5	20.7	11.5	18.4	14.7	14.5	12.3	15.3	20.3	9.9	6.1	16.1	8.4	14.4	11.1	9.1	18.6	9.5	20.0	14.7	15.7	21.4	8.9	13.7	15.9	29.9	8.1	11.6	11.3	17.5	13.9	14.2	14.0	21.7	22.1	11.8	13.5	16.0	20.5	19.5	9.3	12.9	7.0	14.1	17.3	7.8	10.9	6.5	7.7	10.9	26.4	7.6	10.1	13.9	7.8	29.2	12.0	8.0	12.2	21.0	16.7	11.0	10.1	22.1	10.5	21.3	13.0	23.5	15.2	21.0	19.9	20.8	17.5	19.6	20.2	20.0	19.4	14.2	17.2	17.3	7.0	12.7	18.0	16.7	24.2	14.9	9.3	9.8	13.0	9.5	9.1	6.7	10.4	7.9	15.0	12.0	14.9	9.9	13.7	31.3	26.1	8.6	15.9	10.2	24.1	13.6	14.0	27.5	18.4	14.9	16.5	312.3	15.5	9.7	23.3	10.9	15.9	23.8	16.3	19.7	6.6	15.3	12.7	5.8	10.4	11.8	142.0	19.5	18.0	10.1	22.6	8.4	10.9	12.0	10.5	15.6	16.6	34.9	6.5	18.9	100.5	54.7	25.1	21.4	17.5	8.9	15.2
LATS1	WARTS	ENSG00000131023	"Large tumor suppressor kinase 1"	O95835	6	149658153-149718256	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031804	Approved					NA	NA					"HPA031804: AB_10601688"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.65e-1)"	15.4	12.9	17.6	12.5	17.6	19.4	14.7	38.4	16.9	15.9	13.6	17.4	9.5	10.1	17.7	11.8	12.2	14.6	11.1	11.7	15.1	8.8	11.5	11.1	12.7	12.6	18.2	8.8	23.6	12.2	22.3	21.8	17.2	15.5	16.3	12.5	14.1	13.8	11.9	12.4	12.8	14.7	15.8	13.0	13.5	11.6	10.6	19.6	20.5	12.9	6.5	12.8	14.7	14.7	7.4	4.6	9.5	11.4	4.2	8.9	2.9	6.1	4.9	10.3	14.6	9.8	12.8	7.9	8.2	8.3	8.9	8.9	7.9	5.4	10.0	8.4	11.5	7.0	8.7	13.5	8.8	14.1	9.3	10.8	20.3	6.2	7.1	9.1	19.0	14.8	8.5	14.2	10.1	17.3	9.0	11.0	8.8	24.9	10.3	8.7	7.4	9.8	7.8	6.1	5.7	4.8	9.6	12.4	4.7	8.2	8.8	6.9	11.0	11.6	8.5	6.1	7.2	8.7	16.4	13.6	7.1	11.2	8.4	13.2	8.6	9.5	11.6	6.5	10.7	10.4	9.5	4.2	6.6	8.9	7.7	8.0	5.8	7.0	7.4	4.6	7.4	6.0	7.8	2.9	4.2	11.4	4.1	6.7	2.9	17.6	17.6	38.4	16.9	15.1	8.8	18.2	8.8	15.5	19.6	11.9	17.6	9.0	9.7	14.4	19.3	8.9	17.8	13.4	13.6	7.0	17.7	8.2	1.7	7.3	18.1	13.1	11.6	0.0	5.7	9.8	11.4	13.8	13.9	12.2	9.5	12.7	16.1	20.9	12.6	5.2	12.7	11.0	13.5	5.4	12.3	10.4	8.1	11.5	24.4	5.0	21.0	19.4	10.5	7.1	8.7	15.7	11.0	13.6	11.1	11.2
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	16.9	14.2	12.7	15.2	13.8	7.6	19.6	15.6	13.5	20.1	13.1	17.9	18.3	12.4	18.4	11.5	17.4	13.1	9.1	14.7	10.9	10.0	15.7	13.7	12.6	20.3	15.2	9.2	15.7	22.6	14.1	13.2	18.8	12.9	16.6	14.1	17.7	14.2	14.2	20.0	18.7	16.6	16.2	12.1	22.7	14.4	13.8	16.4	28.6	18.9	12.1	24.2	18.4	14.2	10.6	8.1	5.1	8.6	6.1	9.7	3.3	9.0	15.8	13.9	21.8	8.9	11.2	21.8	15.7	9.0	15.4	19.5	22.6	8.5	26.1	16.8	8.6	14.4	14.5	23.8	13.8	26.2	12.2	16.7	29.9	16.8	21.0	6.1	30.6	19.5	6.8	7.3	22.4	14.3	5.8	12.1	15.1	30.5	14.6	12.8	9.7	22.0	12.7	12.2	10.3	9.4	21.6	19.2	8.7	10.1	12.6	5.7	9.6	18.7	11.9	6.1	12.0	12.7	13.0	9.4	12.6	13.7	17.9	23.9	9.0	18.3	28.0	11.2	21.3	17.6	4.4	8.3	5.1	6.3	8.6	6.6	7.3	7.4	6.2	4.2	10.6	7.8	9.7	3.3	6.1	7.2	8.1	7.9	3.3	12.7	13.8	15.6	13.5	10.9	10.0	15.2	9.2	12.9	16.4	3.0	5.6	6.2	4.5	7.0	11.7	12.6	10.2	2.7	4.5	3.5	5.9	9.5	3.3	7.6	27.2	5.3	3.4	0.0	6.7	10.5	4.7	5.3	0.0	3.2	6.7	6.4	9.8	6.2	10.3	58.0	9.5	6.0	8.5	10.0	5.8	11.1	5.5	0.0	9.9	3.8	9.5	12.9	8.2	4.9	10.0	7.4	5.5	6.9	7.6	5.6
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Early spermatids: 968.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		8200000	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	19.1	18.4	35.7	13.0	43.0	28.5	19.3	33.5	58.3	20.2	16.9	19.2	12.4	14.7	16.0	22.2	17.9	15.8	11.0	43.9	35.0	38.8	21.3	29.5	15.1	14.6	35.1	46.0	16.2	14.6	16.4	15.5	17.2	57.4	22.1	18.1	11.6	17.2	21.4	69.5	14.7	13.6	19.6	28.6	12.0	12.7	29.1	19.2	18.1	19.3	15.9	17.9	14.4	13.7	31.6	53.0	51.2	58.0	30.0	37.4	51.6	21.8	17.3	17.7	22.1	38.1	31.5	19.7	35.9	20.5	28.5	36.1	50.2	16.7	27.6	30.5	30.3	33.9	27.2	30.4	35.8	41.2	19.2	44.0	42.2	32.5	49.0	25.5	50.2	51.9	15.7	26.5	32.5	35.2	20.6	26.9	23.4	60.3	27.1	34.0	65.0	24.3	38.3	14.4	21.5	19.4	20.2	23.0	19.9	27.7	16.1	33.8	13.0	27.2	43.5	23.3	22.7	26.3	35.8	20.0	16.8	21.4	31.9	38.9	17.1	26.6	28.2	26.5	33.6	33.4	40.0	58.0	51.2	30.2	53.6	30.1	31.6	30.6	32.7	53.0	24.2	28.5	32.5	30.8	30.0	52.2	23.9	37.4	51.6	35.7	43.0	33.5	58.3	35.0	38.8	35.1	46.0	57.4	19.2	50.6	33.8	61.0	64.4	155.6	73.9	150.1	58.6	62.9	33.0	75.0	35.3	145.0	66.3	107.5	968.1	68.2	50.9	46.7	96.6	180.3	97.5	60.4	104.1	112.2	107.3	62.0	53.0	50.3	78.3	318.9	66.4	94.5	131.6	139.7	62.0	111.0	87.2	56.9	69.3	69.4	50.7	109.9	107.2	205.7	85.4	137.8	124.0	71.9	52.4	51.7
LRP11	"bA350J20.3, MANSC3"	ENSG00000120256	"LDL receptor related protein 11"	Q86VZ4	6	149818798-149864026	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017267			Approved	"Vesicles,Plasma membrane"		NA	NA		640000	"Plasma membrane"	Vesicles	"HPA017267: "	"prognostic unfavorable (2.31e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.23e-2)"	12.0	16.5	17.8	4.4	26.9	1.6	11.2	17.9	25.6	14.0	11.5	15.1	9.4	10.5	10.6	14.8	20.2	20.2	10.5	8.0	19.7	19.3	18.2	9.0	12.1	2.2	15.0	16.9	15.3	17.2	46.2	15.2	14.7	20.6	23.3	11.4	10.8	14.2	12.3	8.1	20.2	8.7	10.9	13.3	3.6	14.4	7.2	15.6	0.8	20.8	13.8	6.4	17.3	14.2	3.5	1.0	0.0	1.7	0.0	0.7	0.1	9.5	8.4	6.4	5.6	14.3	26.2	1.2	10.0	19.6	7.0	8.5	2.5	20.0	0.1	13.7	15.7	30.9	25.6	7.2	18.2	5.0	15.4	7.2	4.5	30.9	11.0	8.8	4.6	0.1	16.3	35.5	9.0	17.8	19.9	10.8	4.4	9.3	4.3	8.3	16.5	0.1	0.1	3.8	19.0	8.4	5.0	9.6	2.2	12.6	19.6	8.5	5.7	31.6	17.7	6.0	3.3	14.5	9.6	8.4	8.8	2.0	18.3	7.6	0.0	3.0	2.2	15.9	4.7	5.1	0.0	0.1	0.0	0.2	0.4	0.0	3.5	0.7	0.6	1.0	0.6	0.2	0.3	0.0	0.0	1.7	0.0	0.0	0.1	17.8	26.9	17.9	25.6	19.7	19.3	15.0	16.9	20.6	15.6	6.0	3.2	0.8	10.9	10.1	10.5	7.6	20.4	24.1	5.7	19.2	2.0	1.4	5.0	5.6	26.8	6.8	3.9	0.0	19.4	2.2	12.9	21.0	0.0	8.3	2.9	7.9	28.3	11.1	1.8	24.2	15.3	1.1	13.5	0.0	3.7	6.3	16.2	2.9	13.8	5.4	5.4	0.0	5.6	6.1	5.9	12.5	4.7	0.0	11.3	20.6
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 1.9;Early spermatids: 5.0;Late spermatids: 4.2;Suprabasal keratinocytes: 5.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.9;HeLa: 21.8;hTCEpi: 15.8;SiHa: 7.5;U-87 MG: 6.8"									HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Focal adhesion sites"	Cytosol	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.2	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.1	2.0	1.7	0.0	15.9	0.2	0.4	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.3	15.8	0.9	3.3	0.5	0.1	0.0	0.0	1.3	0.9	0.1	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.5	2.0	0.0	0.0	1.1	0.0	3.0	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.8	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.9	1.9	0.6	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.8
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6"									HPA062673			Approved	Vesicles	"Secreted - unknown location"	NA	NA			Vesicles		"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.8	0.0	0.6	2.4	1.1	1.5	0.0	1.2	0.0	0.5	1.3	1.1	2.0	0.7	4.1	0.8	0.2	1.3	0.4	23.4	0.0	0.5	0.0	0.0	2.7	18.7	2.8	1.3	1.3	0.4	0.6	0.2	0.2	0.4	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	2.5	0.3	0.2	9.2	0.4	0.0	0.1	0.3	0.3	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2	0.0	0.0	0.0	4.2	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	9.5
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.0;U-2197: 23.1"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.6	5.6	10.1	8.3	3.5	5.3	0.0	14.7	10.9	14.5	6.6	3.6	8.8	5.8	4.2	1.9	0.5	1.4	0.0	3.6	0.0	0.7	1.3	6.8	8.9	3.9	8.2	5.7	8.0	1.1	0.0	7.4	6.4	0.8	0.0	0.0	1.7	4.9	1.4	2.2	0.0	14.3	2.7	0.3	0.0	32.0	0.7	0.9	1.6	0.9	4.0	8.9	6.6	8.3	23.1	11.0	0.0	0.0	0.4	9.5	5.1	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1	0.0	2.2	0.0	5.4	3.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.9	6.3	3.8	0.0	0.0	7.4	0.2	0.9	0.9	0.0	0.0	1.8	0.0	0.0	9.2	1.2	6.4	0.0	1.7	1.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	1.0	2.3	3.2	2.5	0.0	2.9	0.0	3.2
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 23.1;JURKAT: 17.8"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.6	1.4	2.6	7.7	2.7	3.6	1.1	1.6	2.8	1.8	3.1	2.7	2.9	12.4	6.6	2.6	23.1	4.5	4.3	12.0	3.8	0.2	0.9	0.0	13.6	0.1	1.0	8.4	5.6	11.4	3.0	1.3	2.3	17.8	2.2	0.0	4.0	3.2	2.8	0.0	0.9	1.7	4.2	1.2	2.4	0.3	4.9	2.0	0.9	0.3	5.3	3.3	0.8	1.6	2.6	5.3	1.9	1.3	2.3	5.1	3.2	0.4	0.4	2.5	7.9	4.0	3.3	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2	6.0	2.1	0.0	0.4	0.1	0.0	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	0.0	0.0	0.0	0.1
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1"	"Group enriched"	"Detected in some"	4	"Basal glandular cells: 5.9;Basal keratinocytes: 5.7;Glandular cells: 6.9;Suprabasal keratinocytes: 14.9;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 19.7"															NA	NA						"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavorable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0	0.3	0.0	31.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.5	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.1	15.3	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.8	0.0	1.1	19.7	0.5	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	3.8	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.3	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	6.4
ULBP3	RAET1N	ENSG00000131019	"UL16 binding protein 3"	Q9BZM4	6	150063150-150069095	"Predicted intracellular proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.7"	"Low cell line specificity"	"Detected in many"											"HPA056541, HPA063007"	Approved		Uncertain	"Vesicles,Centriolar satellite"	"Intracellular and membrane"	NA	NA			Vesicles	"Centriolar satellite"	"HPA056541: , HPA063007: AB_2684920"	"unprognostic (4.87e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.16e-2)"	8.0	3.6	1.0	0.4	1.2	0.2	8.2	0.3	2.0	1.9	2.8	0.4	1.1	1.4	1.1	2.1	3.6	3.6	4.4	1.2	1.3	2.3	5.5	2.6	3.1	0.3	0.7	0.6	2.0	1.1	1.9	0.7	1.4	0.8	1.3	1.1	1.7	1.2	0.4	0.7	1.0	1.0	0.8	0.5	0.5	2.9	24.3	0.3	0.3	8.2	5.3	2.1	1.8	3.1	0.3	0.0	0.0	0.0	0.0	2.7	0.5	3.9	1.6	4.6	5.1	1.5	8.8	1.4	4.2	1.9	5.4	6.0	8.4	3.7	0.0	9.4	6.9	8.4	6.5	13.8	15.2	5.4	3.4	7.0	0.1	2.4	0.4	2.1	0.0	0.6	7.8	2.9	11.5	6.0	5.0	7.0	0.0	0.2	0.0	4.8	5.7	0.0	0.0	2.1	1.7	12.4	4.4	4.7	0.2	10.7	9.0	0.8	0.1	9.8	6.1	2.1	2.2	1.8	1.0	3.8	0.9	7.1	14.0	9.8	0.0	0.0	2.8	7.5	2.0	3.8	0.0	0.0	0.0	1.5	0.0	2.0	0.3	2.0	1.1	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	2.7	0.5	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143076-150250357	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.0;skeletal muscle: 32.0;skin 1: 37.1;thyroid gland: 32.4"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 248.9;Suprabasal keratinocytes: 294.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 15.7;HBEC3-KT: 33.3;HEK 293: 14.1;hTCEpi: 40.7;hTERT-HME1: 16.4;RPTEC TERT1: 14.0;SK-BR-3: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.3	0.4	4.2	1.9	7.7	0.3	3.7	1.3	12.8	4.5	6.8	0.8	0.0	5.7	1.0	0.7	8.0	9.0	0.3	50.0	4.7	3.7	5.3	0.3	6.7	0.4	2.7	7.6	0.2	0.5	4.7	0.8	13.9	7.7	0.9	5.0	0.1	1.5	0.3	32.0	37.1	1.2	0.7	1.3	0.3	0.7	3.5	1.0	0.0	32.4	8.8	3.2	0.4	8.3	0.0	0.0	0.0	0.2	0.0	1.2	0.1	10.4	0.0	4.6	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.5	1.4	0.2	3.1	2.0	0.7	15.7	2.3	33.3	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	40.7	0.0	16.4	0.0	0.0	0.2	8.7	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	14.0	0.5	2.4	0.0	0.2	14.8	0.8	0.3	0.0	0.7	0.0	0.0	8.0	12.7	3.6	0.0	0.0	0.0	5.6	6.1	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.2	7.7	1.3	12.8	4.7	3.7	2.7	7.6	7.7	1.0	17.9	37.9	0.0	8.9	248.9	0.6	64.6	0.0	44.2	17.0	14.0	0.0	0.1	1.7	2.4	0.2	2.8	13.5	0.0	0.2	0.1	5.7	1.2	1.1	0.0	2.9	1.6	27.1	0.0	0.0	1.1	0.0	1.7	28.7	1.8	2.5	0.0	7.5	37.9	0.4	18.3	0.0	0.0	4.1	0.5	0.4	294.2	1.6	0.0	8.4	1.4
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"thyroid gland: 212.3"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 8.5;Cholangiocytes: 20.4;Club cells: 12.5;Enterocytes: 25.8;Hepatocytes: 18.3;Mucus-secreting cells: 15.4;Paneth cells: 17.3;Proximal tubular cells: 33.8;Undifferentiated cells: 10.3"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"CACO-2: 3.0;OE19: 6.8;SK-BR-3: 7.4"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 8.1;thalamus: 2.6"	"Low region specificity"	"Detected in many"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	8.2	0.1	0.1	3.6	0.1	0.3	0.1	0.1	6.7	0.1	0.1	0.1	5.4	6.8	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.3	0.0	0.1	0.2	13.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	212.3	0.0	0.1	0.1	0.1	1.4	1.0	5.9	1.3	2.3	0.7	2.3	0.1	0.0	0.2	0.3	0.1	0.8	0.4	0.0	0.0	0.0	0.0	3.0	0.5	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.2	0.4	0.8	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.6	0.0	0.4	0.0	0.3	0.3	6.8	0.2	0.3	0.2	0.2	0.0	0.7	0.3	0.2	0.0	7.4	0.0	0.1	0.7	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	1.3	0.7	0.7	1.1	0.5	0.6	0.6	0.5	0.1	1.4	0.6	0.7	5.9	2.3	0.5	1.0	0.5	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0	3.0	8.5	0.0	0.5	0.1	0.0	0.5	20.4	1.4	12.5	0.0	0.0	0.0	1.7	0.1	0.0	0.0	25.8	0.0	0.2	0.0	0.0	1.0	1.1	18.3	0.1	0.0	3.5	1.3	0.0	0.0	0.0	0.5	0.0	0.0	15.4	0.0	0.2	17.3	0.0	33.8	1.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	10.3	0.7
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 43.2;Ito cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 14.7;naive B-cell: 15.9"	"Lineage enriched"	"Detected in single"	29	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4"	"Region enriched"	"Detected in many"	5	"thalamus: 56.1"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	27.5	2.2	7.3	10.6	7.3	2.3	10.0	2.4	7.1	8.3	5.8	10.1	4.8	4.8	7.8	14.1	9.6	8.9	8.1	5.9	7.7	6.7	4.5	5.1	12.1	13.5	10.5	3.0	4.7	2.8	8.2	5.1	13.9	11.1	4.1	6.2	3.4	3.5	5.4	6.4	8.9	6.0	5.7	19.6	28.9	4.5	7.3	7.7	39.7	6.0	5.8	13.3	7.4	8.5	15.9	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	12.5	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	6.9	3.0	4.9	4.8	0.0	1.2	1.8	18.4	1.6	0.0	7.7	2.0	0.3	0.9	0.0	0.0	0.0	1.4	0.8	4.7	0.0	0.1	0.0	7.7	4.1	0.0	16.4	0.0	0.2	1.5	0.0	0.9	4.8	0.5	0.8	0.0	0.0	3.6	8.2	0.4	0.1	0.0	2.2	1.5	1.4	0.0	0.0	7.7	0.0	1.7	0.0	3.3	0.0	0.0	11.4	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.5	14.7	0.3	0.4	0.0	15.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	7.3	7.3	2.4	7.1	7.7	6.7	10.5	3.0	11.1	7.7	0.0	3.8	8.1	0.6	3.8	0.2	1.6	2.5	5.3	3.4	7.0	0.0	4.2	3.3	2.3	2.7	43.2	4.3	0.0	1.0	1.3	9.9	0.7	0.0	3.0	0.5	0.0	5.2	39.9	6.1	1.3	0.3	0.8	5.0	8.2	9.0	8.3	6.3	10.5	0.4	2.8	0.5	0.0	2.3	1.0	0.9	3.1	2.4	3.2	4.2	2.4
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865549-151101887	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 107.1;Syncytiotrophoblasts: 61.6;Urothelial cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	10.4	10.6	8.0	12.1	8.1	12.2	7.1	32.4	10.5	6.5	6.2	7.8	10.2	3.4	8.5	7.2	6.4	8.0	7.3	10.7	7.5	7.9	9.5	6.9	17.1	11.0	12.3	7.6	22.2	13.7	7.1	9.1	15.5	8.5	5.0	9.1	12.7	3.4	10.5	2.5	5.7	4.7	10.9	10.2	8.7	5.6	13.6	6.6	6.7	12.2	5.0	11.4	8.7	5.1	1.1	3.0	0.2	0.8	1.0	5.0	0.6	12.0	10.5	13.7	33.7	3.6	12.6	33.5	19.0	20.8	19.1	23.6	21.1	11.3	44.5	12.7	29.0	11.3	12.9	21.9	18.5	23.8	18.3	19.9	18.5	18.7	19.3	22.6	33.8	3.0	14.9	23.7	18.5	33.8	17.2	31.9	24.9	43.9	23.3	19.6	25.4	16.5	7.0	14.0	12.1	9.7	19.8	10.2	19.8	12.9	5.9	13.7	10.2	25.1	11.1	15.5	13.0	3.5	23.7	24.2	12.8	28.1	28.4	26.9	19.4	18.0	46.4	21.3	31.6	16.5	0.2	0.7	0.0	0.8	0.8	1.3	0.8	1.9	2.1	3.0	1.1	1.8	1.9	0.0	1.0	0.8	1.5	5.0	0.6	8.0	8.1	32.4	9.5	7.5	7.9	12.3	7.6	8.5	6.6	0.0	1.7	10.7	5.1	5.8	0.0	2.4	2.5	4.0	2.3	14.0	0.0	18.7	6.6	10.4	19.2	7.1	0.9	0.0	15.4	107.1	15.4	4.1	0.0	1.0	21.7	0.0	1.2	3.7	2.4	3.4	0.6	10.1	33.7	1.0	2.5	0.0	15.0	0.8	7.4	12.2	0.0	0.0	6.1	0.5	6.4	3.0	61.6	3.2	3.5	39.1
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239999-151358557	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 255.3;Muller glia cells: 521.2;Spermatocytes: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	184	"basophil: 20.4"	"Lineage enriched"	"Detected in single"	184	"granulocytes: 20.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 37.5;REH: 42.9;TIME: 42.7;U-251 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		6400000	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	52.5	11.2	11.5	11.0	18.1	2.0	38.5	31.3	21.2	11.5	23.4	1.9	5.9	6.1	20.5	13.6	12.8	15.6	32.3	22.8	9.8	17.4	14.9	20.6	18.2	6.9	11.4	9.9	49.0	7.6	2.0	11.1	24.1	28.7	13.5	9.4	26.6	3.3	14.7	11.3	4.1	10.6	27.9	14.1	8.1	12.4	62.0	6.6	0.3	11.4	6.6	2.8	34.5	24.7	0.0	0.0	20.4	0.0	0.0	0.1	0.0	1.7	8.5	12.3	0.0	23.3	35.0	4.3	10.0	5.4	4.5	4.5	0.2	32.4	0.0	4.0	7.5	37.5	0.2	23.4	7.4	4.0	11.1	8.6	0.1	9.5	7.9	2.6	0.0	2.2	24.7	0.0	19.0	1.0	5.9	29.3	0.1	2.1	0.2	16.2	0.1	0.0	0.0	7.7	0.0	10.1	42.9	0.5	0.0	26.0	1.4	8.8	5.1	3.2	0.1	5.6	18.2	0.6	0.1	42.7	0.6	8.0	25.5	45.7	0.0	0.0	0.0	14.8	0.0	8.5	20.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.1	31.3	19.1	9.8	17.4	11.4	9.9	28.7	6.6	11.9	21.0	12.7	21.4	17.4	9.5	7.8	7.6	8.1	23.9	48.8	2.0	1.6	1.7	120.3	57.8	105.1	0.0	0.0	5.7	5.5	80.8	45.7	64.5	3.9	20.4	0.0	1.7	255.3	23.1	93.7	36.8	11.7	55.6	1.0	0.0	521.2	193.7	0.0	104.0	64.3	24.1	97.0	171.6	222.6	34.3	9.9	8.4	7.2	0.0	129.4
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364117-151391548	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	11.1	7.7	10.3	10.6	8.6	14.4	13.3	11.7	10.7	9.3	10.3	8.2	9.2	7.9	11.1	8.1	8.5	10.7	11.5	8.4	8.4	6.6	7.7	9.9	13.1	14.4	11.0	6.8	17.4	14.4	8.6	5.3	9.2	10.3	8.7	9.9	6.9	11.1	12.3	14.0	8.6	10.6	14.6	9.6	12.0	9.4	7.7	11.1	27.7	32.2	8.0	13.0	11.2	13.9	5.7	6.6	15.1	10.7	7.8	14.1	6.3	8.8	6.4	9.9	7.4	10.6	11.2	10.6	14.1	20.3	17.8	17.0	12.4	7.3	22.8	7.9	14.1	18.0	10.6	15.8	17.1	22.3	10.3	11.8	10.2	7.7	18.7	15.8	27.6	12.7	11.8	10.3	16.3	20.0	10.2	10.4	10.8	18.6	13.4	12.5	19.8	14.9	12.9	12.0	11.0	9.8	14.3	9.3	9.1	13.5	13.5	11.0	7.7	11.1	14.6	11.0	10.4	9.8	16.6	8.5	15.1	16.4	6.9	18.6	17.9	18.6	25.5	6.2	15.1	10.7	13.6	6.0	15.1	11.3	6.6	14.1	5.7	10.3	13.4	6.6	4.4	8.7	10.5	6.9	7.8	10.7	2.7	8.3	6.3	10.3	8.6	11.7	10.7	8.4	6.6	11.0	6.8	10.3	11.1	8.9	5.8	5.9	7.3	14.0	2.9	7.6	5.1	8.1	11.4	0.0	0.0	5.2	11.6	4.2	7.2	8.7	4.6	0.0	2.5	16.2	8.2	12.0	9.2	2.4	6.6	1.6	8.6	4.3	7.6	8.9	8.1	9.4	10.1	1.0	6.6	2.9	3.9	0.0	3.9	4.1	1.8	6.5	14.2	3.2	6.8	15.9	10.4	14.9	6.4	8.2
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452181	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.9	15.7	9.0	6.8	12.1	4.0	17.0	14.5	15.6	10.5	12.8	7.7	6.4	13.2	10.9	11.7	8.3	12.2	8.0	11.4	9.9	11.7	34.0	29.1	7.8	8.2	10.1	13.5	15.7	9.9	6.9	11.2	14.4	14.0	8.0	11.5	10.5	7.3	8.0	10.9	7.9	14.9	11.2	8.9	6.9	8.0	8.6	7.0	11.2	18.9	6.0	9.5	10.6	11.9	11.3	7.2	6.8	12.2	13.2	11.3	5.0	8.2	3.8	8.5	17.6	11.5	26.1	11.6	12.9	12.6	10.1	13.9	10.8	6.2	7.9	9.3	8.2	12.4	7.1	15.5	8.1	17.5	9.0	12.4	12.4	6.1	22.2	23.4	27.7	4.0	18.2	10.4	14.3	21.9	12.1	13.0	11.8	13.5	6.4	15.2	26.9	9.4	8.9	6.3	9.3	7.6	10.7	10.5	9.7	14.2	3.7	14.2	13.7	9.2	11.7	15.4	10.7	19.5	17.9	7.4	7.9	10.3	16.3	10.1	6.5	8.6	9.0	19.7	21.7	9.1	2.1	5.9	6.8	7.1	8.2	11.2	11.3	8.5	9.9	7.2	9.0	11.2	10.2	2.9	13.2	12.2	3.3	11.3	5.0	9.0	12.1	14.5	15.6	9.9	11.7	10.1	13.5	14.0	7.0	0.0	12.8	7.3	6.0	3.4	8.7	9.8	2.5	13.4	14.8	12.2	11.8	23.3	14.9	13.6	7.0	4.5	7.3	0.0	9.2	18.4	4.8	2.6	9.2	13.5	12.0	4.8	2.9	8.6	8.6	3.3	6.4	11.6	3.3	13.6	9.9	6.4	9.4	13.9	6.0	30.5	6.7	0.0	9.5	10.4	15.6	2.4	14.1	5.0	12.6	3.1
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		3200000	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	15.5	15.8	10.7	11.5	16.2	3.9	20.5	17.5	18.2	13.7	12.8	7.5	9.9	14.7	13.0	13.4	11.5	10.6	9.0	13.4	11.4	13.0	34.7	33.2	15.4	15.0	10.9	8.6	15.3	7.7	7.7	13.8	26.7	18.6	11.6	14.2	9.2	8.8	10.6	14.9	7.0	16.2	11.8	10.6	16.2	10.9	10.8	9.4	13.2	26.5	11.9	14.0	14.1	10.6	9.6	12.3	26.9	18.6	10.8	13.2	10.8	8.2	6.3	13.3	11.9	10.9	17.2	21.5	15.5	13.5	13.0	17.3	16.4	6.8	12.3	10.4	10.9	11.9	8.4	39.3	11.6	22.0	13.6	12.3	8.9	7.5	19.0	13.6	16.6	11.2	13.8	8.2	17.4	10.3	10.8	18.4	9.3	12.7	15.9	16.2	34.3	10.4	16.0	22.7	8.1	5.3	13.8	11.5	9.7	39.8	10.5	5.5	3.6	12.9	12.2	7.9	24.9	34.6	13.1	15.2	6.4	8.9	23.5	12.3	7.4	9.3	14.7	11.3	20.6	7.4	22.8	14.7	26.9	7.8	18.6	10.3	9.6	10.2	8.3	12.3	7.1	9.5	8.7	12.2	10.8	16.6	4.6	13.2	10.8	10.7	16.2	17.5	18.2	11.4	13.0	10.9	8.6	18.6	9.4	23.8	36.8	8.9	7.0	0.0	8.9	16.5	7.6	20.1	11.4	22.7	7.9	26.6	38.1	17.4	0.9	7.7	12.9	23.3	15.6	32.5	8.4	5.6	3.5	43.3	30.5	7.9	4.7	17.2	35.4	2.3	17.8	24.7	0.0	31.5	10.6	14.5	16.3	7.0	13.8	56.4	19.8	0.0	13.7	18.9	17.0	0.0	30.1	12.8	13.8	8.4
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Cell type enriched"	"Detected in many"	8	"Ciliated cells: 481.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 14.2;T-47d: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.1	8.3	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5	3.0	1.0	0.5	0.2	0.6	0.3	0.8	0.0	481.8	62.6	0.0	21.6	0.1	0.0	0.2	38.6	0.3	0.4	0.0	1.0	0.1	1.7	1.0	3.5	1.1	9.6	0.0	0.0	1.3	14.3	64.1	6.6	18.9	0.0	1.8	0.0	2.5	1.7	2.9	0.0	3.5	0.7	0.0	1.2	2.4	1.0	0.9	0.0	0.0	0.0	0.4
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 68.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 36.0;Hepatocytes: 48.4;Horizontal cells: 58.8"	"Group enriched"	"Detected in many"	9	"breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MCF7: 24.9;T-47d: 32.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	3.0	0.9	0.5	1.6	0.5	0.2	16.2	0.8	0.4	64.5	1.5	0.2	2.2	0.1	68.9	27.7	1.1	26.7	1.9	1.1	0.5	0.8	1.5	6.6	3.6	1.6	0.4	0.1	14.2	0.4	0.0	9.3	0.9	0.6	3.6	0.1	2.6	1.6	4.1	2.0	0.6	0.5	20.8	0.4	1.6	0.3	1.9	0.4	1.9	1.3	2.2	2.5	3.8	23.7	0.6	1.0	0.0	0.8	0.3	2.5	1.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.0	0.0	0.6	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.1	32.2	0.0	0.0	0.1	0.1	0.3	0.0	3.0	0.5	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.3	0.2	1.0	0.6	1.3	0.4	1.0	0.4	2.5	0.9	0.0	0.3	0.0	0.0	0.3	1.0	0.5	0.5	0.8	0.4	0.5	0.8	0.4	0.1	0.6	0.4	0.0	0.6	0.0	1.4	0.9	3.8	4.5	0.0	1.4	1.2	0.0	7.9	0.1	1.7	0.0	36.0	0.6	0.0	0.0	0.2	0.1	4.7	0.6	2.3	48.4	0.9	58.8	1.7	6.7	4.7	6.9	3.7	2.4	1.7	0.0	0.0	2.7	0.2	0.0	2.1	3.3	4.0	0.0	1.4	1.6	1.2	1.5	0.1	0.0	0.0	8.4
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 182.4;Bipolar cells: 303.5;Ciliated cells: 222.1;Cone photoreceptor cells: 188.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 33.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.8"	"Cell line enhanced"	"Detected in many"		"U-266/70: 19.2"									HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	12.7	11.5	18.2	9.1	30.2	41.7	9.0	62.0	25.0	16.8	7.3	9.8	12.4	2.7	15.2	18.4	6.2	12.9	7.9	22.7	21.0	17.5	18.4	11.2	16.1	13.7	13.2	15.1	27.7	10.6	37.3	37.0	4.7	19.7	10.1	6.3	10.5	3.6	12.5	22.0	16.9	5.3	19.1	9.7	15.5	9.0	8.3	11.6	9.0	20.6	9.5	12.1	10.0	12.3	3.2	0.8	33.8	1.5	4.7	6.4	1.4	0.1	4.0	2.8	3.2	4.0	8.8	1.1	9.0	4.7	2.3	4.3	0.9	0.1	8.4	0.5	4.9	7.7	0.2	1.0	2.3	2.4	10.1	2.8	3.5	2.7	2.7	9.2	0.6	1.6	5.6	0.5	5.1	10.5	6.5	4.5	4.4	0.0	9.7	6.3	0.4	1.4	0.1	0.6	0.7	1.5	1.9	5.6	2.4	9.0	0.1	1.7	2.7	1.5	0.6	6.2	2.6	0.5	0.3	6.0	10.9	14.7	3.8	4.9	19.2	8.2	13.5	6.0	2.0	3.1	3.0	1.1	33.8	6.4	0.7	4.1	2.9	4.2	6.1	0.8	3.2	4.0	5.1	1.1	4.7	1.5	0.7	5.1	1.4	18.2	30.2	62.0	25.0	21.0	17.5	13.2	15.1	19.7	11.6	154.9	182.4	21.6	6.0	11.3	303.5	110.2	2.5	222.1	95.5	41.8	188.5	0.8	3.3	20.2	8.3	87.0	0.0	0.0	6.6	5.4	44.0	3.0	14.0	19.5	7.2	130.3	2.9	65.7	9.2	9.0	30.8	11.2	15.1	1.0	6.7	24.3	4.5	0.0	37.4	14.1	150.7	25.8	40.0	2.9	5.8	8.4	1.0	49.8	0.2	1.6
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 121.1;Ito cells: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 20.4"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 20.4"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 46.9;TIME: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		69000	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	37.3	3.1	4.1	4.4	6.3	1.1	27.5	3.0	7.7	16.2	8.4	1.5	5.2	3.1	14.5	9.4	14.4	6.8	9.1	17.2	5.1	4.2	6.9	11.1	24.1	4.9	5.8	1.9	8.2	2.5	3.4	2.7	17.4	6.6	8.8	5.3	8.3	4.0	3.7	14.2	4.8	5.5	10.8	5.4	39.4	4.6	7.7	5.2	0.6	12.5	11.0	2.8	17.0	12.3	0.1	0.0	20.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	38.8	0.2	0.3	0.5	0.0	0.4	0.0	5.8	0.0	0.0	0.0	0.4	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	4.1	6.3	3.0	7.7	5.1	4.2	5.8	1.9	6.6	5.2	0.0	6.9	0.0	0.1	6.4	0.0	2.8	5.1	29.4	1.2	0.0	0.0	0.0	0.0	0.1	6.0	121.1	0.0	0.0	0.2	0.0	2.4	0.4	1.1	1.0	0.1	0.0	0.0	178.6	9.1	2.9	0.3	0.8	13.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.1	4.8	0.0	0.0	0.0	0.2
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.7;Melanocytes: 27.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000		"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	2.0	0.2	0.2	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	4.2	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 29.3;lymphoid tissue: 69.0"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 70.0;Spermatogonia: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	4.2	2.9	2.7	13.7	3.1	29.3	3.5	6.6	3.3	5.3	6.1	1.8	1.8	3.5	5.8	3.7	6.1	4.4	3.0	2.4	2.8	2.3	3.0	4.1	3.8	10.8	4.4	1.6	5.1	3.1	2.0	3.4	8.2	3.5	3.9	4.1	1.6	6.9	2.4	1.6	3.3	5.0	3.9	2.4	10.6	3.5	4.2	3.9	69.0	5.6	4.8	11.2	3.5	4.5	6.8	5.3	0.0	3.5	8.8	7.9	3.2	11.1	5.8	24.6	16.5	1.9	3.9	7.8	27.2	12.2	20.5	23.1	11.9	6.7	27.4	8.4	7.2	13.8	10.7	19.4	9.1	24.7	14.6	17.3	27.4	8.6	12.9	3.6	24.5	17.0	2.7	1.7	13.8	10.9	5.0	9.3	14.4	28.9	25.8	18.6	8.5	27.9	15.8	14.3	8.6	8.6	23.6	19.7	17.7	7.2	6.1	16.1	16.7	19.3	10.4	5.1	9.0	7.5	23.0	7.0	15.4	20.1	17.7	31.7	8.6	9.5	40.5	11.2	18.2	18.6	0.0	2.4	0.0	3.8	3.0	5.4	6.8	6.3	6.9	4.6	6.0	6.2	6.4	0.0	8.8	3.5	5.3	7.9	3.2	2.7	3.1	6.6	3.3	2.8	2.3	4.4	1.6	3.5	3.9	0.0	0.6	13.7	3.5	8.9	2.8	1.4	2.5	2.7	5.7	1.8	5.9	6.7	3.3	2.7	0.5	4.5	1.0	70.0	1.4	24.6	7.2	2.7	2.3	1.7	6.5	1.6	4.6	6.2	1.0	0.0	4.0	4.8	1.7	2.8	2.7	4.0	1.3	0.0	5.6	2.9	3.0	12.9	6.6	8.8	32.4	4.5	4.9	7.0	4.3	1.7
MTRF1L	"HMRF1L, mtRF1a"	ENSG00000112031	"Mitochondrial translational release factor 1 like"	Q9UGC7	6	152987362-153002685	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036367	Uncertain					NA	NA					"HPA036367: AB_10670715"	"prognostic unfavorable (4.82e-4)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.56e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.80e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.84e-1)"	11.1	12.7	11.2	13.9	10.8	9.6	13.0	14.2	12.3	9.2	13.0	7.9	8.8	13.4	9.3	10.4	10.8	7.5	9.2	20.0	10.6	12.0	18.2	15.8	8.9	11.4	12.4	7.2	8.2	10.3	12.2	13.8	9.3	14.5	9.6	10.9	7.3	9.5	9.9	27.4	12.6	12.7	13.7	12.5	15.5	10.1	7.9	10.1	8.1	12.9	13.4	9.3	13.2	12.2	3.4	5.1	8.6	9.1	4.9	5.9	4.8	6.6	7.7	13.2	17.9	14.7	7.9	12.7	11.9	12.0	11.5	16.8	13.3	5.4	11.8	9.1	12.6	19.6	10.1	18.6	10.9	16.7	13.3	11.1	11.8	11.0	17.6	12.7	11.9	12.8	12.1	12.5	14.3	16.3	11.3	16.4	13.1	18.7	7.9	13.8	10.8	9.0	9.9	7.9	14.6	10.8	8.5	9.6	9.5	17.0	11.8	13.9	17.5	15.6	11.4	8.7	15.4	7.5	13.6	11.2	9.4	14.5	15.3	15.7	13.1	12.3	12.5	17.8	9.1	11.7	7.7	4.4	8.6	4.3	6.0	4.5	3.4	4.5	4.6	5.1	2.4	3.9	4.6	3.2	4.9	9.1	3.7	5.9	4.8	11.2	10.8	14.2	12.3	10.6	12.0	12.4	7.2	14.5	10.1	11.9	13.1	21.6	22.7	30.1	0.0	22.5	10.2	6.7	12.5	17.4	0.0	12.3	21.6	31.8	43.3	28.7	23.6	46.7	23.2	19.1	16.7	18.8	18.4	14.5	15.2	0.0	16.6	41.1	18.0	46.1	18.7	18.7	15.1	35.1	11.4	0.0	28.4	20.1	24.1	30.7	0.0	38.8	39.6	34.1	12.1	28.5	16.5	12.9	15.5	21.3
RGS17	"RGS-17, RGSZ2"	ENSG00000091844	"Regulator of G protein signaling 17"	Q9UGC6	6	153004459-153131249	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 17.3;Ductal cells: 11.7;Intestinal endocrine cells: 40.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.9;GAMG: 11.0;hTERT-HME1: 14.0;LHCN-M2: 13.9;RH-30: 10.0;U-87 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022276, HPA056493"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA022276: AB_10794628, HPA056493: AB_2683152"	"unprognostic (2.77e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.33e-2)"	"unprognostic (5.96e-12)"	"unprognostic (2.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	3.0	1.3	14.2	1.5	12.5	3.3	1.4	16.8	10.1	7.1	1.5	1.2	0.0	1.7	2.2	1.1	3.2	1.3	5.9	1.0	8.1	7.3	0.9	0.6	1.4	1.6	3.2	7.8	2.7	4.4	0.3	7.2	0.6	7.9	5.2	2.0	0.2	1.5	1.6	0.6	1.9	1.8	1.4	4.1	1.2	4.3	3.3	3.0	0.3	8.9	0.0	0.6	3.7	1.5	0.5	0.4	1.4	0.3	2.1	1.6	0.2	0.0	4.3	3.2	0.1	1.5	12.9	0.1	0.3	1.4	1.0	2.7	0.0	0.3	0.2	0.3	0.7	11.0	0.2	3.0	3.2	1.5	0.2	0.3	0.5	0.3	0.1	3.5	0.2	1.5	5.4	0.0	5.5	14.0	3.1	6.4	1.2	0.1	0.2	13.9	2.3	0.1	0.3	2.2	0.1	3.5	0.1	10.0	0.1	4.0	1.3	2.2	5.8	0.1	0.0	0.0	0.5	0.0	0.2	3.2	2.2	2.7	2.7	3.9	0.2	0.0	0.1	11.8	0.1	3.0	1.4	0.3	0.4	1.6	0.2	0.2	0.2	0.9	0.6	0.2	0.5	0.3	0.9	1.1	2.1	0.3	0.4	0.2	0.2	14.2	12.5	16.8	10.1	8.1	7.3	3.2	7.8	7.9	3.0	0.0	0.0	0.0	0.6	0.2	17.3	0.8	5.1	4.0	5.7	0.0	0.0	0.1	0.0	11.7	0.1	1.0	0.0	0.0	0.3	0.2	2.0	5.9	10.5	0.0	0.3	3.2	40.3	0.0	0.6	0.4	2.8	0.4	0.0	0.0	0.0	2.2	2.2	0.9	8.5	0.0	3.4	0.0	1.7	0.9	3.2	0.0	0.2	2.1	0.1	7.3
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.9"	"Group enriched"	"Detected in some"	33	"Early spermatids: 24.0;Late spermatids: 23.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 37.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	24	"SH-SY5Y: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported				NA	NA					"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.5	3.4	7.0	0.6	17.5	1.8	0.9	37.9	7.6	0.5	0.6	0.8	0.0	0.6	0.7	1.4	3.7	0.5	1.0	0.5	2.6	2.3	0.5	0.5	0.5	0.9	0.6	9.3	0.8	0.7	0.4	0.6	0.5	5.2	0.7	0.4	0.0	0.6	0.2	0.9	1.8	0.5	0.3	1.9	0.6	1.0	8.0	0.5	0.0	1.0	0.0	0.3	0.5	0.5	0.5	0.2	2.1	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.5	0.3	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.0	0.3	0.5	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	13.1	0.0	0.1	0.3	0.4	0.3	0.1	0.3	0.4	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.0	0.2	0.1	0.6	0.6	0.0	0.7	0.2	0.3	0.5	0.1	0.5	0.4	0.1	2.1	0.1	0.0	0.2	0.3	0.0	7.0	17.5	37.9	7.6	2.6	2.3	0.6	9.3	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.1
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Cell type enhanced"	"Detected in many"	17	"Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HMC-1: 19.7;THP-1: 10.0;U-937: 10.5"									"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.7	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	1.1	1.0	0.0	0.5	0.2	0.2	0.5	1.0	2.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9	0.0	1.7	0.5	0.4	0.6	0.0	0.9	0.0	1.4	2.3	1.8	0.0	1.4	6.6	0.9	0.7	1.4	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.8	2.2	3.2	0.0	2.5	14.6	0.0	0.3	9.5	0.0	0.0	0.3	0.3	0.0	0.0	0.4	1.2	0.1	0.0	0.4	0.2	0.1	0.5	2.3	30.5	0.2	1.2
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387504-154510659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 17.4"									"CAB037133, HPA049651"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	9.4	2.2	4.2	5.5	5.8	1.6	5.8	1.8	5.0	7.6	12.5	11.6	6.0	8.7	15.8	8.3	19.4	6.5	9.2	8.9	5.3	3.4	17.0	20.0	6.3	3.5	8.0	2.5	10.0	26.6	1.5	4.5	8.2	8.3	8.3	5.5	12.6	7.5	7.7	2.2	6.7	13.5	15.3	8.2	7.6	6.7	8.6	7.7	0.6	4.1	8.7	6.6	9.8	10.2	0.9	1.4	3.6	0.6	0.9	0.5	0.2	0.3	4.0	2.8	5.6	5.0	3.8	0.3	4.9	3.0	8.6	7.1	17.4	0.4	0.1	5.4	5.3	2.8	1.7	8.3	0.5	4.5	0.0	5.1	13.3	0.8	9.6	2.2	0.0	3.0	5.1	2.7	3.3	3.4	1.5	2.7	1.1	1.7	0.1	2.3	1.1	0.1	0.3	2.0	3.3	5.2	3.8	4.9	6.4	10.0	2.8	1.7	10.7	2.2	1.2	1.0	1.3	0.0	1.2	3.1	0.8	2.5	6.4	3.2	0.1	0.0	0.1	0.1	0.3	3.7	2.1	0.6	1.2	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.9	0.5	0.5	3.6	0.9	0.4	1.4	0.3	0.2	4.2	5.8	1.8	5.0	5.3	3.4	8.0	2.5	8.3	7.7	11.9	38.5	0.9	13.6	23.6	1.9	30.2	12.7	13.4	18.2	24.4	0.0	6.3	8.3	14.8	39.4	28.7	27.4	0.0	10.4	0.8	14.6	10.7	5.7	55.0	1.5	0.0	41.5	67.5	7.6	11.1	5.5	5.1	30.4	1.0	21.1	27.8	10.1	15.8	9.9	24.5	1.8	0.0	6.6	1.1	5.3	20.8	18.0	5.1	11.5	8.8
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733325-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	27.9	19.1	17.4	32.0	19.1	36.1	27.5	28.1	22.2	30.0	23.4	18.2	20.8	14.2	28.3	21.6	18.5	25.1	21.9	19.3	16.9	13.4	19.8	17.6	19.6	23.5	16.2	15.1	32.6	20.0	33.6	24.1	23.8	14.8	24.4	20.7	17.9	21.9	30.1	28.5	26.9	21.2	23.8	14.3	21.7	19.9	25.4	20.2	42.6	24.7	20.1	22.8	26.1	32.9	5.4	3.3	3.8	6.7	6.1	7.5	2.6	8.5	8.4	24.9	15.0	16.8	17.3	15.3	14.1	19.9	18.7	19.0	13.1	8.7	26.9	11.5	16.2	16.6	11.7	21.9	18.6	25.1	11.7	11.0	24.1	9.1	16.0	19.5	22.2	16.2	18.6	19.8	16.3	25.6	14.5	15.8	11.9	27.9	16.4	17.1	15.6	23.7	15.1	17.3	13.2	6.3	22.8	13.6	14.5	15.8	15.8	15.4	18.0	14.7	19.4	10.7	18.7	12.7	25.9	14.4	10.7	13.0	13.8	14.2	15.4	11.3	29.8	13.3	13.9	16.5	1.2	2.8	3.5	6.0	3.9	5.8	4.8	6.2	5.9	3.3	5.4	6.3	5.6	3.8	6.1	6.7	3.2	7.5	2.6	17.4	19.1	28.1	22.2	16.9	13.4	16.2	15.1	14.8	20.2	23.8	18.6	14.1	10.3	11.2	17.7	31.1	7.6	13.4	9.1	12.2	23.6	9.2	1.7	9.3	2.7	13.5	12.2	0.0	10.2	7.4	13.5	10.4	33.5	10.4	11.2	12.7	12.5	19.6	25.1	4.2	15.3	11.4	10.1	6.4	13.9	14.8	11.9	8.6	11.7	5.3	18.6	25.8	8.2	21.4	22.4	9.4	8.9	10.0	13.6	12.8
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in all"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	35.1	4.1	1.5	4.3	0.4	1.8	1.1	1.7	2.9	0.5	2.6	1.0	1.9	3.2	0.6	0.7	1.2	0.0	1.2	15.0	1.9	0.3	0.6	2.0	0.9	0.3	1.1	2.9	0.1	0.6	0.1	1.6	2.4	0.5	0.5	0.1	3.9	0.4	0.4	0.9	2.5	0.2	1.0	4.5	22.9	0.4	0.1	0.2	0.9	8.0	0.1	0.4	0.2	6.9	0.3	0.5	0.8	0.3	8.9	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9	3.0	1.6	8.1	16.3	2.7	13.8	7.3	7.6	2.7	1.2	1.8	76.6	1.2	0.0	4.7	131.1	3.0	2.9	0.0	2.7	2.1	4.7	7.7	19.6	0.9	1.7	22.3	0.0	7.4	2.1	220.7	9.2	4.7	11.8	14.4	4.2	6.9	4.2	2.0	7.4	0.7	25.2	0.0	3.8	5.2	5.5	2.3	0.3	4.8	2.6	7.4
TFB1M	"CGI-75, mtTFB"	ENSG00000029639	"Transcription factor B1, mitochondrial"	Q8WVM0	6	155257509-155314493	"Disease related genes, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029428	Approved					NA	NA					"HPA029428: AB_2673038"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.33e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.77e-2)"	6.6	24.2	9.2	10.5	11.7	3.2	10.7	15.2	13.2	7.0	10.1	12.1	7.9	8.6	12.0	10.4	12.6	9.3	6.7	16.2	8.6	8.0	10.2	19.8	6.8	13.3	8.6	7.2	10.6	11.6	11.5	26.3	5.9	12.2	8.4	13.9	12.8	12.9	8.5	21.5	10.8	8.5	10.1	10.4	11.7	9.1	13.8	10.4	16.4	11.7	6.9	17.7	9.7	8.9	18.4	15.1	9.8	9.4	16.7	20.0	8.3	6.3	4.7	4.8	11.8	6.0	14.1	7.5	9.7	9.0	9.8	13.8	6.2	5.2	13.3	5.4	4.3	8.3	13.6	5.1	10.2	17.3	6.7	7.6	5.7	4.9	38.6	20.4	10.6	4.2	14.6	4.4	15.4	13.8	12.4	12.1	11.4	14.3	4.2	12.2	4.7	5.7	10.4	8.5	9.0	10.3	5.6	2.9	13.2	10.1	6.0	5.6	11.4	2.8	9.5	9.9	9.7	6.0	10.3	5.3	3.8	5.2	11.2	11.3	7.2	8.2	9.5	17.4	13.5	8.2	9.8	7.0	8.4	11.4	9.4	16.3	17.1	16.3	14.9	15.1	18.4	20.0	16.6	3.0	16.7	7.2	12.8	18.3	8.3	9.2	11.7	15.2	13.2	8.6	8.0	8.6	7.2	12.2	10.4	20.8	11.8	9.0	11.9	5.6	13.1	19.3	2.5	9.4	9.1	12.2	21.6	16.9	26.6	17.7	196.9	5.0	4.5	0.0	15.5	16.0	7.8	6.2	26.6	21.7	13.5	28.6	5.8	3.7	7.3	7.6	4.6	8.6	3.3	17.2	7.6	12.8	11.8	7.0	8.1	15.1	21.4	12.9	12.3	24.6	14.1	9.9	6.1	14.1	14.2	7.3
CLDN20		ENSG00000171217	"Claudin 20"	P56880	6	155264013-155276548	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	24	"Bipolar cells: 1.4"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.5;WM-115: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.26e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.05e-1)"	0.2	1.0	0.1	0.5	0.2	3.1	0.4	0.8	1.3	0.1	0.3			0.5	1.6	0.0	0.7	0.1	1.2	0.4	0.8	0.2	1.2	0.5	0.4	1.3	0.8		0.6	0.7	0.0	0.4	0.1		0.3	0.0		1.2	0.0	0.7	3.6	1.0	2.4	2.1	1.2	0.6	1.3			1.6		0.0	0.4	0.9	0.9	0.1	0.8	0.3	0.0	0.6	0.0	0.4	1.5	0.6	1.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.9	0.6	2.9	0.4	0.0	0.3	1.6	0.0	0.0	0.0	0.3	1.0	1.0	2.1	3.5	0.3	1.7	0.6	1.4	0.0	0.0	0.0	0.2	0.0	0.4	1.3	1.5	0.0	2.5	0.1	1.6	0.1	0.3	0.2	0.9	0.4	0.2	0.0	3.3	0.3	1.1	0.5	0.3	0.5	0.2	0.9	0.2	1.8	1.3	0.7	0.9	1.9	0.7	0.4	2.1	0.8	1.1	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOX3	GP91-3	ENSG00000074771	"NADPH oxidase 3"	Q9HBY0	6	155395370-155455903	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"adrenal gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MCF7: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073837			Uncertain	Vesicles		NA	NA			Vesicles		"HPA073837: "					"unprognostic (3.42e-1)"													0.0	1.8	0.4	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156777374-157210779	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	18.3	15.0	20.2	18.8	20.9	25.8	19.3	42.1	32.8	20.0	17.4	26.3	21.7	15.3	23.0	14.2	18.6	20.7	15.9	16.8	20.4	11.3	14.2	10.6	17.0	18.3	19.4	16.7	30.2	18.5	47.4	29.2	12.2	17.7	17.7	13.3	24.0	20.0	20.2	30.6	27.3	17.8	21.7	14.9	21.1	15.0	10.7	24.6	24.0	23.8	13.3	26.3	23.5	21.0	9.5	11.9	5.6	3.0	2.7	5.6	1.6	7.2	11.1	16.4	22.3	13.5	12.4	11.2	7.7	10.1	10.0	10.0	9.8	10.5	22.8	4.8	13.0	12.3	9.2	14.0	12.5	9.9	22.9	9.8	16.5	11.2	11.6	9.5	13.7	12.1	14.0	10.1	15.2	13.6	10.9	13.8	14.9	19.4	17.8	7.1	8.5	15.9	15.5	8.3	9.6	5.9	36.3	7.0	12.3	6.9	13.4	15.0	19.2	15.4	16.2	9.0	9.0	10.9	21.6	14.2	12.6	13.4	11.6	15.0	12.3	11.0	29.2	11.0	16.5	16.9	5.6	3.0	2.5	5.4	2.4	5.0	6.8	4.7	3.8	2.3	9.5	4.0	5.6	5.5	2.7	2.6	11.9	4.6	1.6	20.2	20.9	42.1	32.8	20.4	11.3	19.4	16.7	17.7	24.6	44.7	46.7	59.6	18.3	42.2	35.6	27.8	28.1	28.1	36.4	120.4	27.5	10.8	6.6	33.6	12.1	27.8	19.2	0.0	29.8	6.4	27.7	23.2	38.1	23.3	12.3	44.5	39.2	37.4	29.2	13.0	52.6	28.8	28.7	72.1	38.0	23.8	39.9	21.0	59.1	12.2	30.1	45.3	28.2	6.3	14.9	48.7	14.6	23.2	34.9	20.2
TMEM242	"BM033, C6orf35"	ENSG00000215712	"Transmembrane protein 242"	Q9NWH2	6	157289386-157323601	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025764	Approved					NA	NA					"HPA025764: AB_1845742"	"unprognostic (5.42e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	10.6	16.8	16.1	8.3	21.0	16.4	10.8	24.6	20.0	11.7	10.6	12.1	9.7	10.3	13.2	15.1	10.0	9.6	8.9	22.4	15.0	14.9	14.9	17.7	8.6	8.7	14.3	15.5	12.2	9.3	15.1	16.3	11.7	21.7	11.8	11.4	7.9	11.7	9.9	18.3	9.5	9.2	13.7	14.3	8.5	10.0	8.0	13.8	8.4	13.3	11.4	9.9	10.5	10.8	13.8	23.7	10.1	16.0	12.8	12.7	9.2	4.6	3.8	7.7	8.4	15.2	9.7	5.8	8.8	8.5	8.7	10.2	4.8	4.6	7.0	11.2	8.8	12.3	8.4	8.1	8.0	9.7	9.8	13.2	10.0	8.4	9.9	15.2	10.0	7.7	9.6	9.2	6.4	13.0	12.3	10.4	8.4	15.2	9.6	8.0	4.5	5.9	13.7	5.5	2.9	7.0	3.6	5.0	10.2	13.3	4.1	10.0	5.5	8.0	5.5	10.3	7.7	5.2	10.4	9.5	6.3	7.3	13.7	11.8	9.0	9.1	6.7	12.8	11.9	9.4	10.1	16.0	9.3	11.7	12.9	11.3	13.8	12.0	11.6	14.7	12.6	10.4	12.0	2.6	12.8	8.8	23.7	12.7	9.2	16.1	21.0	24.6	20.0	15.0	14.9	14.3	15.5	21.7	13.8	11.9	7.7	24.1	17.3	24.5	23.1	44.0	20.4	26.8	9.1	21.0	3.9	44.3	28.2	46.0	8.2	28.4	18.8	23.3	34.1	43.1	30.0	13.7	15.1	26.2	32.4	36.5	9.2	21.5	14.3	4.9	19.5	24.3	40.5	23.4	17.9	25.7	33.1	27.7	25.1	30.0	29.9	58.2	35.5	29.7	33.2	21.2	34.8	23.5	20.3	14.8
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.9;GAMG: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	44.7	18.9	13.0	16.5	14.7	17.2	35.4	6.7	16.2	27.4	24.6	19.8	43.5	18.1	32.1	19.5	31.4	17.2	26.4	20.4	12.2	10.8	17.8	25.4	14.6	22.5	19.7	11.4	19.8	22.5	17.7	10.8	45.0	13.3	25.0	17.7	11.1	25.2	41.7	16.5	21.2	28.0	44.6	16.4	19.8	21.5	10.9	18.4	5.0	18.4	17.9	20.3	34.0	40.2	4.1	11.2	1.3	7.3	0.5	6.7	1.0	7.5	5.0	5.3	6.2	26.5	23.6	11.2	15.2	42.9	10.4	13.9	4.3	7.7	0.0	7.6	23.5	41.6	5.0	6.2	10.2	8.7	6.2	7.2	4.8	7.6	6.6	13.3	2.5	9.7	14.0	9.1	10.7	10.5	18.8	14.4	7.4	24.1	0.0	5.1	4.3	0.0	3.8	4.2	5.1	6.4	0.0	5.3	8.6	16.7	4.5	3.4	6.2	9.7	4.5	23.2	5.5	2.1	5.5	11.7	11.5	5.2	36.8	8.0	0.0	0.0	0.0	23.0	1.9	6.7	0.0	1.0	1.3	0.6	3.2	2.4	4.1	1.7	1.3	2.0	3.4	6.7	2.1	0.1	0.5	7.3	11.2	2.8	1.0	13.0	14.7	6.7	16.2	12.2	10.8	19.7	11.4	13.3	18.4	0.0	0.6	20.4	84.5	38.5	12.7	24.6	17.8	12.0	18.2	8.7	0.0	31.7	18.3	44.5	37.1	48.9	55.8	46.7	48.8	32.8	55.0	114.0	11.5	28.7	37.1	3.2	15.1	32.5	39.6	18.9	41.4	29.1	20.3	62.3	31.0	12.4	78.9	45.0	43.9	32.7	1.5	38.8	46.7	17.9	13.8	26.1	91.9	10.2	26.0	107.8
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981887-158099176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 62.0"	"Cell type enhanced"	"Detected in many"	8	"Pancreatic endocrine cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 46.3;TIME: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	2.8	3.9	12.2	4.9	25.1	15.3	6.7	3.0	18.7	3.9	8.7	50.5	3.7	5.8	5.2	9.4	6.0	4.6	8.0	8.5	17.8	10.9	3.2	4.0	2.8	4.4	46.8	8.8	2.9	6.6	1.1	2.9	2.6	33.0	5.3	8.9	1.4	13.5	5.1	4.3	3.1	5.6	6.6	62.0	3.3	7.0	6.5	24.4	3.0	4.4	1.4	5.3	5.9	3.0	3.2	1.1	9.3	1.3	2.4	3.8	0.8	5.4	19.2	1.6	2.5	1.2	4.0	8.5	10.1	20.5	12.1	14.3	9.8	4.6	0.1	6.9	19.4	46.3	5.2	3.4	6.3	14.1	7.6	3.2	10.6	10.0	10.3	2.3	3.7	11.6	2.0	3.4	18.4	4.3	16.4	21.0	5.6	8.1	2.4	5.5	2.5	4.6	4.1	1.8	17.1	10.7	2.0	6.6	4.9	4.0	6.3	12.2	0.7	7.8	4.9	1.9	6.3	3.8	2.3	37.1	9.2	9.4	21.2	12.2	1.0	2.6	0.2	17.2	5.9	6.3	4.5	1.3	1.1	1.9	0.6	3.8	1.9	2.6	1.7	1.1	3.2	2.2	1.7	9.3	2.4	0.8	1.1	2.1	0.8	12.2	25.1	3.0	18.7	17.8	10.9	46.8	8.8	33.0	24.4	3.0	3.5	2.7	16.6	19.3	0.0	10.4	10.2	10.7	6.8	17.4	0.0	5.3	3.3	36.4	22.7	10.5	15.3	0.0	30.7	4.2	14.6	30.3	4.7	4.5	1.9	0.0	16.7	7.4	3.4	37.2	1.1	4.6	10.1	10.8	14.5	1.5	88.4	3.5	6.0	1.4	0.4	0.0	6.6	0.7	1.1	15.1	13.3	5.3	14.5	32.4
SERAC1	FLJ14917	ENSG00000122335	"Serine active site containing 1"	Q96JX3	6	158109515-158168280	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 65.4;Late spermatids: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025715, HPA025716"	Enhanced					NA	NA					"HPA025715: AB_1856697, HPA025716: AB_2185128"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.03e-2)"	4.8	12.8	10.4	2.9	10.7	1.1	5.9	12.3	11.7	5.6	5.8	11.9	3.2	5.5	8.0	6.9	10.6	4.3	7.0	5.6	8.0	7.8	8.7	5.3	5.0	3.4	9.1	11.8	4.5	17.5	4.4	7.2	4.4	8.9	7.7	6.0	3.8	7.4	7.5	9.2	7.7	5.5	10.9	9.4	4.3	6.3	10.7	7.7	3.4	9.9	2.5	4.8	6.7	5.9	0.9	5.4	2.7	5.9	2.4	2.7	2.4	3.8	5.6	9.3	11.3	6.8	4.9	4.4	4.8	5.1	8.6	11.3	3.0	1.6	1.9	3.6	9.9	6.3	3.4	9.0	3.5	7.4	2.1	5.2	5.9	2.4	5.2	6.9	2.8	2.8	3.4	6.9	6.7	6.9	13.3	5.6	4.3	5.1	1.4	7.6	1.6	2.4	3.0	4.0	5.9	3.0	1.7	6.7	2.3	9.4	3.4	6.7	5.0	5.2	6.3	4.5	8.0	3.1	4.2	6.4	5.9	4.5	13.5	10.4	1.5	2.7	1.6	4.1	3.2	5.7	2.0	5.0	1.3	2.3	5.9	2.7	0.7	1.7	2.2	5.4	0.9	1.7	2.1	2.7	2.4	3.8	1.5	1.8	2.4	10.4	10.7	12.3	11.7	8.0	7.8	9.1	11.8	8.9	7.7	3.0	19.7	2.0	4.4	6.2	6.8	5.5	5.1	8.1	12.5	1.8	3.9	2.3	1.7	10.0	65.4	3.7	6.3	0.0	5.1	0.9	5.3	9.2	11.5	2.9	4.3	4.8	5.2	4.3	6.3	72.4	4.6	9.0	10.1	2.8	3.6	4.3	4.9	7.0	6.0	4.2	9.5	0.0	4.2	14.4	7.7	10.0	4.8	4.4	4.3	6.7
GTF2H5	"bA120J8.2, C6orf175, FLJ30544, TFB5, TFIIH, TTD, TTD-A, TTDA"	ENSG00000272047	"General transcription factor IIH subunit 5"	Q6ZYL4	6	158168352-158199344	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.04e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.56e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (6.11e-4)"	"unprognostic (3.13e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.58e-3)"	"unprognostic (1.33e-2)"	11.1	15.4	17.4	6.3	19.8	5.3	11.9	11.7	16.5	9.0	8.3	7.0	10.0	5.5	9.1	17.7	12.1	9.8	11.7	11.5	15.9	13.1	12.2	13.9	9.0	10.5	13.9	11.7	10.2	13.2	7.2	8.4	7.4	9.8	11.3	6.7	6.9	11.8	11.3	21.9	9.0	6.3	14.4	14.5	7.8	6.8	9.5	8.5	11.8	11.3	15.4	6.8	9.7	6.7	8.9	11.6	4.7	8.6	8.7	10.2	6.4	4.6	5.1	6.1	7.9	9.7	14.3	5.8	8.6	7.7	7.0	8.2	3.3	4.9	7.3	12.0	8.5	9.2	3.3	3.8	8.5	8.4	7.6	8.7	9.2	4.7	10.0	8.4	4.8	3.6	12.1	8.5	7.1	8.4	12.1	5.6	7.3	10.1	4.3	14.4	4.2	5.8	9.6	6.5	4.9	4.4	4.5	4.8	8.7	13.2	4.1	5.5	4.3	8.8	7.3	5.5	7.7	5.5	9.8	10.1	5.2	5.6	7.6	9.9	3.7	4.5	7.4	10.3	4.5	9.5	4.7	7.2	4.7	7.7	8.3	6.8	8.9	8.5	7.8	8.5	8.1	10.2	9.4	2.4	8.7	8.6	11.6	9.6	6.4	17.4	19.8	11.7	14.4	15.9	13.1	13.9	11.7	9.8	8.5	41.7	56.6	41.5	99.3	40.4	45.1	75.9	89.2	136.5	56.9	134.3	15.7	156.2	354.8	106.5	272.9	45.8	46.4	0.0	107.6	149.6	76.5	85.4	63.6	151.5	141.9	44.5	44.7	95.2	77.9	74.1	104.2	71.5	75.9	120.0	60.4	86.6	88.8	42.1	103.6	345.7	44.5	71.1	69.5	214.7	110.2	55.2	111.1	44.6	70.2	112.3
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"Tubby like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 161.0;Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA					"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.2	2.8	8.1	2.0	13.7	0.7	4.4	8.1	16.1	2.9	2.4	2.7	3.0	4.5	3.8	3.2	3.0	2.3	2.3	7.2	8.6	6.9	3.5	1.6	2.7	3.0	8.5	8.3	2.7	9.2	8.8	3.7	2.7	9.0	2.7	2.1	1.2	3.2	6.9	6.3	7.1	4.7	2.5	9.4	2.9	3.3	4.3	3.0	1.2	5.5	2.2	3.2	2.6	2.1	4.2	6.1	0.6	3.7	2.5	5.4	2.8	2.8	6.0	4.4	9.7	7.8	5.0	9.2	2.7	3.9	2.6	3.2	8.7	1.8	7.6	2.7	5.5	7.5	4.9	5.2	6.7	4.7	4.9	2.9	3.8	4.1	8.9	5.7	3.5	4.2	3.8	7.8	4.2	8.9	9.4	6.6	7.3	5.8	12.0	7.2	4.2	3.5	4.0	2.9	3.3	2.7	7.5	10.5	4.8	4.2	4.5	8.4	10.5	7.8	11.9	8.3	4.3	6.9	4.6	10.4	6.7	8.1	9.8	10.4	8.3	10.0	6.6	6.4	2.7	8.2	0.6	2.7	0.0	3.8	3.0	5.1	3.8	4.4	5.0	1.7	4.2	3.2	3.7	0.2	2.5	3.7	6.1	5.4	2.8	8.1	13.7	8.1	16.1	8.6	6.9	8.5	8.3	9.0	3.0	3.0	23.1	18.2	13.0	19.1	47.1	40.6	10.2	17.4	22.7	24.4	161.0	21.7	13.3	16.4	3.3	21.0	17.7	0.0	13.9	7.3	13.7	16.6	4.7	12.8	11.6	149.4	19.5	14.1	17.2	5.1	26.2	10.1	15.1	9.0	11.4	15.8	18.5	15.2	39.3	21.4	77.3	12.9	14.4	17.0	30.9	34.4	15.8	15.2	12.8	18.7
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040189, HPA040228"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA040189: AB_10793959, HPA040228: "	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	7.1	5.6	32.4	4.8	49.2	3.1	8.6	5.3	36.6	13.4	10.1	4.2	6.5	10.9	8.4	3.9	6.3	5.8	7.3	5.3	18.5	8.7	3.3	6.4	6.7	3.4	5.5	23.3	5.6	18.5	8.1	21.5	6.5	11.2	9.4	11.5	4.3	22.4	10.0	4.9	7.0	12.6	7.8	7.3	7.6	16.3	16.0	8.5	2.3	9.7	2.1	3.2	9.9	7.0	1.0	2.1	7.7	3.4	3.9	4.7	1.4	10.2	5.9	8.4	12.9	22.3	20.5	16.1	23.2	13.6	12.1	13.9	10.0	12.6	4.3	12.0	19.2	26.0	15.2	12.4	15.3	19.3	6.3	8.9	8.0	8.8	21.1	18.2	10.0	7.7	16.9	15.1	13.5	18.3	18.3	19.4	6.2	15.2	5.4	19.8	6.2	4.4	12.5	6.5	20.4	7.6	4.3	9.7	4.9	11.6	8.0	24.9	17.1	17.0	16.0	11.1	12.1	6.1	14.1	18.4	12.6	8.5	20.8	20.0	3.2	2.2	4.8	15.2	12.6	11.9	7.7	2.2	5.7	4.7	2.3	3.6	0.9	2.7	3.7	1.6	1.0	2.4	3.2	1.6	3.9	3.4	2.1	2.6	1.4	32.4	49.2	5.3	36.6	18.5	8.7	5.5	23.3	11.2	8.5	11.9	31.5	2.4	11.3	18.1	13.4	14.8	20.4	5.3	7.9	15.7	17.7	7.7	3.3	22.0	3.2	24.0	29.3	0.0	28.2	10.9	15.0	29.8	10.5	18.6	8.9	19.1	42.6	20.3	14.2	4.0	12.0	13.6	13.5	4.6	34.5	6.0	36.3	28.1	16.6	4.8	14.4	6.5	17.1	14.2	22.6	18.3	4.3	20.1	24.4	29.1
DYNLT1	TCTEL1	ENSG00000146425	"Dynein light chain Tctex-type 1"	P63172	6	158636474-158644739	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046559			Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA046559: AB_2679698"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	20.2	34.2	20.2	16.6	23.6	8.2	29.6	16.0	22.0	29.3	33.5	17.4	31.1	27.0	30.8	38.5	44.2	42.7	28.7	36.0	18.4	15.1	45.6	25.5	32.3	23.9	26.5	16.9	24.7	19.5	14.2	27.6	25.6	32.5	28.8	33.6	16.0	37.8	31.0	44.9	14.1	55.5	42.4	29.3	27.2	26.7	52.5	22.8	15.7	32.8	30.8	28.9	32.1	27.7	10.8	27.7	99.5	56.5	12.0	20.3	30.9	31.9	22.8	37.7	36.8	39.1	39.9	15.6	33.3	26.9	41.2	48.8	27.0	29.0	7.7	13.9	69.1	31.0	29.5	23.6	35.9	50.1	11.0	32.9	12.2	22.3	31.0	41.3	5.6	8.6	34.3	38.9	33.9	34.1	35.8	52.0	10.9	23.3	9.3	60.4	28.5	2.5	14.7	20.6	57.8	18.7	5.0	20.3	7.0	57.3	22.0	75.6	37.8	46.9	38.4	13.5	33.5	26.1	12.7	45.1	20.5	25.8	21.9	29.8	5.6	7.0	12.9	29.1	23.6	22.1	17.9	56.5	5.4	16.4	52.5	18.1	10.8	17.6	18.5	27.7	6.6	14.6	15.2	99.5	12.0	38.9	13.6	20.3	30.9	20.2	23.6	16.0	22.0	18.4	15.1	26.5	16.9	32.5	22.8	89.3	87.3	54.4	206.4	48.0	16.8	146.9	173.3	546.0	134.2	200.7	11.8	189.7	353.1	366.9	70.1	71.6	286.6	0.0	241.4	159.7	112.4	234.5	58.9	73.1	140.1	22.3	165.8	125.2	101.8	42.1	99.8	99.9	108.0	154.1	199.8	78.6	342.5	284.0	120.2	447.2	40.3	135.8	134.9	320.2	181.7	53.3	179.9	79.1	152.2	375.2
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 58.9;granulocytes: 129.6;T-cells: 171.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"basophil: 55.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 55.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8;SCLC-21H: 11.2;U-138 MG: 12.8;U-2 OS: 13.9;U-266/70: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	Yes			"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favorable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	8.3	1.5	2.3	9.0	3.7	9.4	3.8	0.8	2.4	5.1	7.4	7.1	0.6	2.9	4.6	5.5	3.6	11.6	7.3	5.3	3.4	2.0	4.7	2.2	20.2	26.7	3.5	1.3	2.5	2.3	0.9	2.1	1.3	5.5	5.3	1.8	4.8	12.4	4.8	11.4	3.0	12.0	3.5	10.4	21.9	5.8	3.2	3.9	2.3	21.7	1.2	24.5	18.8	3.6	0.2	1.3	55.6	4.5	10.9	10.2	4.4	4.9	0.7	0.0	0.3	0.7	0.7	0.2	2.0	1.3	0.5	1.4	0.4	3.9	0.0	0.4	3.4	1.8	0.5	0.1	0.6	2.0	9.7	0.3	3.8	0.1	0.0	1.2	1.0	16.8	2.2	1.5	4.2	0.7	1.8	1.0	0.7	0.2	3.8	5.0	0.2	0.1	1.3	0.1	0.9	0.7	0.0	4.1	0.5	1.9	0.2	11.2	0.8	0.7	7.1	0.5	0.2	1.3	0.2	5.8	12.8	13.9	0.3	0.4	19.6	4.4	0.4	8.2	5.4	0.4	55.6	4.5	0.2	10.2	0.8	6.0	0.2	4.1	6.8	1.3	0.0	4.5	5.5	9.2	10.9	0.3	0.3	4.1	4.4	2.3	3.7	0.8	2.4	3.4	2.0	3.5	1.3	5.5	3.9	14.9	12.5	12.8	3.1	4.0	0.0	4.0	2.5	58.9	20.5	14.0	2.0	1.1	5.0	0.6	6.2	2.4	1.4	0.0	0.5	0.4	2.4	2.4	129.6	0.9	4.2	0.0	0.0	4.3	8.9	9.9	0.0	9.1	10.1	14.4	1.3	0.1	0.4	0.0	0.7	1.4	0.4	0.0	2.5	2.2	6.6	3.9	1.6	171.2	0.4	2.6
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819412	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 1685.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		75000000	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	22.8	56.4	30.9	31.2	31.4	24.7	13.3	4.0	21.5	18.0	45.5	28.2	35.2	33.8	9.8	25.8	71.8	25.1	30.2	34.3	37.6	13.9	53.5	16.2	44.3	36.7	14.8	19.0	20.7	33.0	77.1	14.6	125.1	23.5	21.7	22.8	37.0	27.4	32.0	13.6	47.5	87.9	22.8	12.8	26.0	55.4	21.4	22.2	41.6	37.1	34.4	75.6	38.2	25.3	81.7	30.0	24.3	31.2	20.7	61.7	41.1	88.1	48.2	11.9	17.1	1.3	1.4	69.7	27.7	9.1	31.3	26.4	56.4	48.9	88.8	27.5	31.6	15.0	67.6	23.5	30.9	36.4	31.0	15.2	1.8	29.2	24.9	31.8	21.9	13.7	2.3	24.0	29.4	28.6	26.8	20.5	12.3	17.5	43.5	18.1	23.2	31.1	26.5	19.9	24.1	16.1	23.4	5.6	20.2	64.3	26.8	21.7	17.7	48.5	69.9	5.2	57.0	17.0	29.0	26.4	10.1	32.5	13.9	42.6	30.0	27.3	76.1	6.3	11.3	12.0	24.3	14.0	16.4	34.8	31.2	41.0	81.7	36.7	42.9	30.0	67.5	19.9	26.5	6.1	20.7	30.6	14.0	61.7	41.1	30.9	31.4	4.0	21.5	37.6	13.9	14.8	19.0	23.5	22.2	884.4	543.1	187.4	615.4	546.1	5.3	247.6	119.8	1685.0	977.1	148.3	0.0	366.9	82.9	222.1	7.9	84.3	679.2	46.7	221.5	488.7	135.0	354.7	114.5	30.6	98.9	0.0	153.2	31.3	77.1	21.1	125.4	213.0	305.4	115.4	206.3	31.3	408.3	238.4	276.5	168.7	4.0	245.8	120.5	46.2	56.6	635.1	1039.8	112.2	143.1	1039.6
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3 homolog"	Q86UC2	6	158972871-159000187	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 113.8;Early spermatids: 110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039109, HPA040230"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"HPA039109: AB_10794423, HPA040230: AB_10796119"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	4.9	9.0	7.1	3.8	9.8	3.1	6.2	6.3	12.7	6.8	8.2	7.0	14.3	11.3	7.4	12.8	15.5	10.7	6.0	6.6	8.0	6.8	10.7	5.4	8.5	2.6	4.8	10.6	7.3	8.6	25.9	14.4	5.5	10.4	8.9	6.5	5.5	10.3	14.9	3.8	7.6	12.2	6.6	6.0	3.9	7.5	24.3	7.0	2.1	12.8	5.1	3.9	9.1	8.4	2.3	5.8	13.0	7.7	1.8	1.8	1.6	9.8	5.1	2.3	5.4	5.4	6.9	2.9	7.0	8.2	2.8	3.7	2.0	6.0	2.1	6.5	7.5	7.6	7.5	1.5	6.6	3.1	4.8	4.4	2.7	5.0	3.4	5.2	2.5	1.9	8.5	11.8	4.5	8.9	10.7	2.7	2.7	3.1	3.4	4.6	5.6	1.5	3.1	1.5	4.3	3.4	2.4	0.4	2.1	8.8	3.2	3.5	4.4	13.2	4.4	2.5	2.9	5.4	6.2	6.4	2.9	7.4	5.6	3.8	3.6	6.9	1.8	12.4	3.3	4.6	0.7	5.2	0.6	0.8	3.6	1.8	1.3	1.2	1.6	5.4	2.3	1.0	1.4	13.0	1.8	7.7	5.8	1.4	1.6	7.1	9.8	6.3	12.7	8.0	6.8	4.8	10.6	10.4	7.0	23.8	13.2	0.5	14.8	6.5	12.2	15.9	15.3	113.8	25.0	21.0	33.4	9.0	11.6	12.7	110.2	5.8	27.3	0.0	9.0	8.8	8.9	17.9	2.3	7.5	9.2	3.2	12.6	6.7	10.3	47.9	13.0	11.6	6.8	1.0	18.0	13.4	10.9	14.4	16.6	16.5	29.6	6.5	6.1	45.3	8.7	7.8	4.9	8.7	10.0	19.7
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 68.1;Macrophages: 53.7;T-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;HMC-1: 21.0;Karpas-707: 21.9;U-266/84: 9.8;U-698: 20.2;U-937: 16.1"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	4.4	2.3	1.5	16.9	2.1	55.6	2.5	0.9	2.0	1.9	2.5	7.9	1.3	1.7	9.7	1.8	2.7	2.1	4.1	2.0	1.9	3.7	2.2	2.4	8.4	32.7	5.0	1.1	1.9	1.0	0.4	1.4	2.8	3.9	1.9	3.6	3.2	3.2	1.8	0.8	1.4	11.8	12.2	9.2	22.1	2.7	1.7	3.0	32.6	2.2	4.0	32.1	6.8	1.9	14.9	7.8	47.9	7.7	12.0	22.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.0	0.0	0.0	7.4	21.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	21.9	0.0	0.0	1.9	3.9	5.9	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	3.4	0.1	0.0	0.0	0.0	0.0	2.4	9.8	20.2	0.0	16.1	0.0	38.7	7.7	23.6	16.4	5.5	18.5	13.9	22.0	19.0	7.8	14.9	17.4	12.1	47.9	12.0	7.0	2.6	15.5	14.4	1.5	2.1	0.9	2.0	1.9	3.7	5.0	1.1	3.9	3.0	3.0	10.0	68.1	0.2	2.5	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	3.7	0.4	18.5	0.8	23.7	0.0	0.0	1.8	19.5	0.9	1.1	53.7	27.0	0.0	0.0	0.3	0.0	0.0	21.2	0.2	0.1	0.0	0.3	0.0	0.1	2.4	0.7	89.6	0.0	0.3
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169397-159272109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell type enriched"	"Detected in some"	5	"Fibroblasts: 15.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Region enriched"	"Detected in single"	6	"hippocampal formation: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.2	0.6	0.5	7.6	0.7	0.0	2.5	0.3	0.7	9.7	12.9	3.2	0.0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1.0	1.5	1.2	2.1	0.7	0.0	4.8	1.2	0.0	0.4	0.7	0.5	0.7	1.6	1.0	2.5	0.6	6.2	1.2	7.0	10.2	1.5	0.7	0.7	2.1	0.1	1.0	36.6	11.8	3.6	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	2.4	6.6	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	7.4	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0.0	0.5	0.1	0.0	1.1	0.0	0.0	2.9	0.0	1.4	0.0	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	15.5	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.4	0.3	1.3	0.1	0.0	0.0	0.0
SOD2		ENSG00000112096	"Superoxide dismutase 2"		6	159669057-159745186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 254.9;skeletal muscle: 475.1"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 286.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"neutrophil: 254.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 254.9"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3"									"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7.0	10.0	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9.0	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3.0	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15.0	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	182.1	6.5	15.1	9.5	2.1	7.5	16.0	5.9	70.6	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.8	7.5	3.4	80.3	7.7	20.6	15.4	4.6	3.3	4.8	10.8	9.0	6.2	3.9	6.2	4.8	6.9	4.4	5.8	8.4	5.6	6.9	12.1	6.0	7.8	3.0	11.2	5.7	2.3	1.6	3.5	3.6	3.1	19.2	6.9	10.1	9.2	3.8	9.8	9.0	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15.0	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	286.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0
SOD2		ENSG00000285441	"Superoxide dismutase 2"	P04179	6	159679119-159762529	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5"	"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 2400.7"									"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0"															NA	NA		140000000																					0.0	0.0	0.0	0.2	0.4	4.9	0.3	0.0	1.7	0.0	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0		0.3	1.0	0.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.6	0.5	0.2	1.0	0.1	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.9	0.4	0.2	0.8	0.2	0.0	0.3	0.4	0.4	1.4	1.3	0.5	0.1	2.0	0.8	1.4	0.5	0.2	0.1	0.4	0.4	0.7	0.3	1.0	1.8	0.5	0.2	0.0	0.2	0.4	0.7	0.6	0.1	0.1	1.0	1.4	1.6	0.0	0.0	0.1	1.0	0.2	0.6	0.4	0.0	0.7	0.1	0.1	0.1	0.0	0.5	0.3	0.4	0.4	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.6	0.6	0.2	0.2	0.2	0.1	0.6	0.4	0.4	0.7	0.2	0.1	3.2	0.6	0.4	0.4	0.9	0.8	0.4	0.9	0.2	0.4	0.2	0.5	0.2											187.6	839.5	86.8	908.7	608.2	42.9	372.0	290.4	132.5	254.8	225.1	43.2	0.0	72.9	1002.5	235.6	199.1	118.6	0.0	1172.3	0.0	582.9	2400.7	104.5	344.0	0.0	30.2	76.4	57.7	302.5	83.4	53.8	537.1	494.3	311.0	86.3	39.8	850.4	109.4	61.2	221.1	55.3	38.8	714.8	49.3	44.9	596.0	0.0	49.4	100.0	611.0
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal keratinocytes: 372.2;Suprabasal keratinocytes: 398.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	37.6	31.0	21.5	38.7	24.7	106.0	37.5	30.1	22.3	29.7	28.2	19.4	25.1	19.1	33.8	34.6	30.3	28.8	27.3	28.9	22.0	22.1	28.5	28.8	29.7	36.1	20.9	21.2	37.1	30.1	23.1	31.2	35.0	22.1	33.0	28.7	23.7	30.3	27.2	81.2	29.3	28.6	30.9	22.6	36.5	27.1	20.4	21.6	53.2	36.3	26.2	39.3	33.4	34.6	26.6	22.3	33.4	27.1	23.9	30.5	14.7	13.8	13.3	30.0	27.4	35.2	39.0	19.6	21.7	73.7	27.8	37.2	25.7	13.2	34.4	13.1	23.8	61.2	18.9	29.1	25.4	36.2	17.9	19.5	34.3	14.5	36.2	29.5	31.0	20.8	46.3	24.7	31.0	41.1	21.3	21.1	33.8	36.8	32.3	29.3	13.9	42.7	41.7	25.4	21.6	11.2	28.5	19.4	24.6	29.9	17.1	28.7	20.9	40.8	23.2	10.7	21.2	10.7	38.5	18.8	19.7	21.4	28.5	31.5	23.4	26.0	53.0	18.1	31.1	19.6	27.2	19.2	22.6	23.4	24.3	26.4	26.6	28.3	27.8	22.3	23.8	25.6	25.8	33.4	23.9	27.1	18.9	30.5	14.7	21.5	24.7	30.1	22.3	22.0	22.1	20.9	21.2	22.1	21.6	32.8	59.0	84.2	176.7	372.2	29.5	46.6	84.1	36.1	35.2	57.6	33.4	93.4	72.9	99.7	34.1	64.1	45.2	46.7	70.5	105.3	82.6	229.3	39.3	81.8	67.3	35.0	59.1	50.3	77.6	39.5	60.4	106.3	231.2	127.2	57.7	39.0	73.8	54.5	47.7	75.7	31.8	71.1	169.7	61.3	74.5	398.0	124.8	111.7	56.9	130.8
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 168.5;Exocrine glandular cells: 155.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 48.1"					"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.7	6.3	42.7	16.3	6.1	11.3	1.4	5.9	7.1	14.1	24.4	24.5	8.6	5.6	3.0	4.7	48.1	6.5	17.7	46.2	16.7	3.3	18.1	13.1	10.2	40.6	6.1	7.6	3.5	6.1	3.4	23.3	10.0	2.1	6.9	16.0	14.1	9.6	8.5	11.9	13.0	12.1	14.3	6.7	4.6	8.1	9.6	17.4	32.9	8.7	11.4	6.5	6.9	4.5	2.4	2.0	8.5	15.1	4.3	5.2	4.5	7.3	15.2	4.6	8.4	13.8	1.5	14.9	7.8	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2											11.9	35.5	24.6	29.0	23.2	14.0	1.2	40.8	20.1	21.6	19.2	2.0	44.4	59.7	47.3	168.5	10.9	23.5	0.0	155.7	84.2	22.6	31.4	12.7	55.7	46.8	12.7	16.4	12.9	10.5	110.0	12.7	23.1	28.7	92.8	21.4	21.8	47.0	17.5	18.0	33.8	19.6	0.0	34.0	14.7	48.7	18.3	29.4	26.6	23.3	27.6
TCP1	"CCT1, Ccta, D6S230E"	ENSG00000120438	"T-complex 1"	P17987	6	159778498-159789749	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017460, HPA027337, HPA031082"	Approved					NA	NA		3900000			"CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990"	"prognostic unfavorable (8.88e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	51.6	37.4	40.5	34.8	38.2	61.4	58.9	40.6	43.6	32.7	40.9	34.7	31.7	28.3	40.4	35.4	41.7	38.8	28.6	49.1	39.6	40.7	46.3	57.1	33.3	40.4	45.5	30.4	52.3	42.9	45.9	29.5	41.3	43.4	35.4	45.3	26.1	48.0	31.3	63.2	38.7	35.7	42.7	46.5	32.9	35.0	65.9	39.9	50.7	36.7	60.4	49.8	41.9	108.6	38.6	35.9	35.6	48.6	38.4	46.5	39.4	31.1	38.4	40.1	56.5	37.2	30.1	62.9	46.3	23.4	59.2	45.3	75.9	23.4	77.2	32.5	37.3	67.8	46.1	109.2	47.5	85.0	39.5	51.1	79.5	42.7	71.6	28.6	65.1	42.8	29.0	30.1	58.0	55.6	33.8	52.2	67.1	112.1	36.5	55.4	26.0	80.4	77.1	44.5	40.8	41.9	60.0	30.2	63.6	47.8	22.9	51.0	33.1	43.2	63.9	21.0	56.3	29.3	63.2	35.2	29.2	43.6	64.7	96.7	32.9	67.9	85.3	41.3	76.5	45.7	28.8	28.9	35.6	35.8	38.9	46.5	38.6	39.9	38.7	35.9	29.5	41.3	40.1	13.8	38.4	48.6	22.3	40.7	39.4	40.5	38.2	40.6	43.6	39.6	40.7	45.5	30.4	43.4	39.9	47.6	32.1	99.0	245.2	152.5	34.9	60.1	68.8	89.7	72.8	26.2	27.5	135.9	97.8	169.8	345.2	87.2	81.6	23.3	117.8	235.0	112.5	191.8	102.7	42.4	105.4	28.6	100.1	38.6	55.0	436.7	79.7	76.7	102.9	118.2	53.7	57.9	131.9	68.4	86.7	123.7	44.5	71.1	157.9	232.1	217.7	129.5	201.0	89.7	87.9	218.0
MRPL18	HSPC071	ENSG00000112110	"Mitochondrial ribosomal protein L18"	Q9H0U6	6	159789812-159798436	"Predicted intracellular proteins, Ribosomal proteins"	Transport	"Chaperone, Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028774, HPA028775"	Enhanced					NA	NA					"HPA028774: AB_10600113, HPA028775: AB_10601440"	"unprognostic (4.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (3.51e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.22e-2)"	24.0	34.3	40.7	26.0	38.9	25.6	38.3	27.9	40.0	27.9	31.2	25.0	20.3	27.3	29.1	35.2	31.1	35.7	24.4	40.2	38.0	33.4	41.3	41.9	22.6	31.5	34.5	30.6	29.1	25.8	24.7	24.7	27.8	28.9	27.4	30.8	21.0	27.8	30.4	44.0	25.9	24.3	31.4	33.4	26.2	25.9	16.6	28.0	22.0	32.6	29.0	29.9	31.1	55.0	47.2	52.1	32.3	50.9	32.1	44.8	52.5	17.2	33.9	12.9	32.4	18.9	20.9	25.7	24.3	20.9	29.2	30.8	38.9	15.9	26.7	20.7	20.2	43.8	24.8	48.1	29.9	28.4	18.2	39.2	26.7	28.5	68.2	21.0	26.0	23.4	16.3	26.9	31.0	23.1	18.9	25.4	28.0	38.0	27.9	26.5	26.7	34.3	57.3	17.9	33.7	33.3	24.0	12.7	44.3	32.4	11.3	21.7	14.0	23.6	38.6	14.7	13.8	23.8	64.3	16.1	22.1	25.0	37.5	47.7	23.1	42.6	31.2	33.7	55.2	27.0	31.1	37.4	32.3	31.1	46.1	35.4	47.2	39.8	34.3	41.9	39.7	44.8	40.2	7.5	32.1	50.9	52.1	41.4	52.5	40.7	38.9	27.9	40.0	38.0	33.4	34.5	30.6	28.9	28.0	47.6	22.5	71.6	195.8	113.1	25.4	49.4	94.3	89.7	58.0	50.6	15.7	83.6	179.1	117.6	182.2	67.1	68.9	0.0	97.2	172.1	84.5	209.7	94.3	86.4	111.9	22.3	137.5	36.2	37.1	35.4	83.7	97.9	101.3	83.0	64.7	63.9	109.2	86.2	78.1	147.3	31.7	84.1	107.2	178.6	86.9	104.3	62.6	66.0	92.6	129.7
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 26.7"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 7.6;Early spermatids: 13.6;Late spermatids: 10.3;Spermatocytes: 11.1;Spermatogonia: 9.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basal ganglia: 5.7;cerebral cortex: 3.9"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.8;HAP1: 2.3;hTCEpi: 3.8;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA					"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.6	0.5	0.6	0.5	5.7	0.4	1.4	0.2	3.9	0.3	0.3	0.3	0.0	0.2	0.3	1.3	0.2	3.6	0.3	0.2	0.7	0.2	0.8	0.8	0.5	0.4	0.4	0.7	0.8	2.3	0.3	0.3	0.3	0.3	0.4	0.3	0.0	1.2	0.4	0.5	1.4	0.3	0.3	0.4	0.5	0.3	26.7	0.3	0.5	0.4	0.3	0.7	0.2	0.0	0.1	1.7	0.0	1.8	0.4	1.0	0.4	0.0	0.4	0.2	1.8	1.0	0.0	1.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.2	0.3	0.1	0.1	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	3.8	0.0	0.1	0.2	0.0	1.0	0.1	0.8	0.2	0.1	0.8	0.1	0.9	0.3	0.8	0.1	0.0	2.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.2	0.3	0.0	0.3	0.7	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.1	1.8	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	0.4	0.0	1.7	0.5	0.4	0.6	5.7	0.2	3.9	0.7	0.2	0.4	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	13.6	0.0	0.0	0.0	0.8	0.0	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	11.1	9.0	0.0	0.0	0.0	0.0	0.1
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159906690-159916530	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 1.9"	"Cell type enhanced"	"Detected in some"	7	"Alveolar cells type 1: 3.0;Cone photoreceptor cells: 2.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 13.3"	"Group enriched"	"Detected in many"	25	"amygdala: 40.1;basal ganglia: 26.8;cerebral cortex: 31.9;hippocampal formation: 71.0"	"Group enriched"	"Detected in many"	7	"amygdala: 8.6;cerebral cortex: 13.2;hippocampal formation: 26.9"	HPA079325	Approved					NA	NA					"HPA079325: "	"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.1	0.0	0.9	0.0	0.0	0.8	0.0	0.0	4.5	1.9	0.0			0.0	0.3	0.7	0.0	0.3	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.7	0.0		0.4	0.0	0.0	0.0	0.0		0.2	0.0		0.2	1.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.3			0.0		0.0	0.0	1.0	0.5	0.3	1.5	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.6	0.1	1.5	0.2	0.3	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	1.5	0.3	0.1	0.3	0.1	0.1											3.0	1.1	0.5	1.1	0.0	1.2	0.7	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.5	0.2	0.0	0.0	1.3	1.5	0.0	0.9	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	1.6	0.0	0.1	0.4	0.7	0.0	0.2	0.0	0.0	1.4
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969099-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		150000000	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	28.0	22.2	6.8	13.5	8.1	16.7	39.4	6.4	8.2	14.9	17.3	9.5	13.0	9.4	19.6	16.0	16.7	13.1	17.9	27.9	6.7	6.2	20.6	26.6	32.6	44.7	12.3	3.6	18.0	19.6	23.5	13.6	15.5	10.0	14.1	13.3	13.9	18.2	13.5	62.0	15.9	15.4	16.5	7.6	30.2	14.4	13.8	9.0	37.9	18.5	17.3	14.1	16.3	26.9	0.4	2.9	13.3	2.0	1.0	3.6	0.9	7.7	7.0	12.4	17.4	45.2	25.0	16.8	12.2	26.3	10.1	17.4	10.6	12.2	3.2	13.7	13.4	40.7	10.4	9.3	59.5	17.0	16.8	6.6	1.4	12.2	19.1	26.7	7.4	12.1	19.8	19.1	21.0	60.6	24.4	6.5	13.9	13.8	17.4	15.8	5.7	3.4	7.4	5.5	7.1	7.5	8.0	8.5	16.3	14.2	7.8	4.1	9.1	16.5	14.8	16.5	17.8	6.2	21.0	9.8	9.8	10.3	21.0	22.3	10.3	14.4	3.3	18.9	10.1	15.1	0.1	2.0	1.1	3.6	0.8	1.4	0.3	1.2	1.7	0.3	0.4	1.0	2.4	13.3	1.0	1.4	2.9	0.7	0.9	6.8	8.1	6.4	8.2	6.7	6.2	12.3	3.6	10.0	9.0	44.7	38.9	12.8	8.9	19.7	14.1	33.2	33.1	6.7	19.4	15.7	19.6	6.2	0.0	29.2	5.3	22.4	21.3	0.0	16.6	11.0	16.7	15.0	3.5	54.4	22.3	14.3	21.5	30.7	48.2	3.6	44.0	26.4	11.8	8.2	20.6	13.6	37.4	14.4	36.0	21.7	13.9	64.7	17.0	6.5	9.6	17.2	7.8	21.8	20.1	15.6
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121789-160158718	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"liver: 175.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 709.2"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Not detected"	"Not detected"			HPA029846	Approved					NA	NA					"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	175.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.3	0.3	0.0	0.5	0.0	0.0	0.9	0.9	1.8	1.6	0.6	0.7	0.4	0.2	0.5	0.5	1.4	0.4	0.5	1.0	0.1	3.1	0.3	0.0	1.8	0.7	1.5	0.9	0.6	0.6	2.4	0.0	1.5	1.1	0.0	2.0	0.0	1.0	0.3	0.1	0.9	0.5	0.3	0.3	0.2	0.0	1.1	0.0	0.3	0.7	0.0	1.8	1.5	0.2	0.9	0.6	0.0	2.5	0.0	1.6	1.5	0.3	0.1	0.0	0.6	0.7	1.7	1.2	1.4	2.8	0.9	0.2	1.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	7.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.3	43.3	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	709.2	0.1	0.0	0.0	14.1	12.6	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	1.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	2.9	0.0	0.1
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 61.8"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 77.9;Proximal tubular cells: 187.0"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA					"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	61.8	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.3	0.2	1.9	0.1	0.0	2.7	0.0	0.6	0.3	0.0	0.1	0.1	6.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.2	0.1	0.0	0.2	0.0	3.8	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.6	0.3	0.2	0.1	0.8	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.4	0.0	0.0	77.9	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	187.0	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.0	23.6	14.7	0.8	0.0	0.0	0.5	4.5	2.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	7.5	4.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6	14.9	62.8	0.0	0.3	4.1	0.0	1.6	5.1	1.4	10.3	0.0	0.0	0.4	5.0	9.1	0.4	0.3	0.7	0.0	2.5	0.2	11.0	3.4	2.3	56.3	0.6	0.0	0.0	0.0	0.6	0.9	31.4	1.5	3.3	0.0	0.4	0.0	33.9	0.0	23.0	2.1	0.0	0.0	11.4	0.2	0.1	5.8	0.3	0.0	0.4	0.7
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"liver: 43.4"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 79.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 4.7"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	2900000000			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.7	0.0	0.0	0.0	1.3	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.2
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1391.0"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6"									"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.9	0.0	0.0	0.4	4.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	2.2	0.0	0.0	0.0	0.6	28.1	2.7	0.0	1.8	0.0	0.0	16.6	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	1.1	1391.0	0.1	0.0	0.0	26.4	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	12.0	8.0	13.1	17.7	12.6	9.1	14.6	23.1	14.0	16.4	13.9	9.3	12.2	9.5	22.2	11.9	21.4	14.1	11.4	12.4	11.9	7.8	9.4	8.2	15.9	14.4	12.8	8.9	17.4	12.1	15.8	16.2	12.4	9.2	14.2	9.8	9.4	15.0	15.4	24.4	15.1	13.3	13.9	7.7	10.6	11.1	13.5	12.4	16.2	10.6	13.0	16.8	15.8	23.9	8.8	5.4	17.5	3.8	3.5	8.9	2.2	4.7	5.4	10.3	8.8	6.4	7.5	6.7	5.4	4.8	6.2	6.6	7.7	3.5	9.8	3.9	13.7	8.9	11.9	10.5	10.8	7.6	7.1	8.6	12.8	5.0	7.5	4.9	13.2	6.2	4.7	12.6	6.5	5.9	9.7	8.1	7.4	32.2	11.3	6.6	4.9	8.9	6.7	6.3	3.4	8.3	9.8	9.5	7.8	5.7	3.5	5.9	5.3	10.1	10.8	0.9	9.4	4.4	16.2	7.5	7.6	9.8	7.1	25.5	6.6	5.3	9.0	9.0	13.7	8.0	17.5	3.8	2.3	5.0	3.0	8.9	6.2	7.1	4.5	4.3	8.8	5.0	4.9	0.2	3.5	1.7	5.4	4.8	2.2	13.1	12.6	23.1	14.0	11.9	7.8	12.8	8.9	9.2	12.4	17.9	12.6	14.2	8.2	8.8	15.7	17.9	10.2	8.1	19.4	14.0	21.6	16.7	3.3	8.0	2.6	11.3	5.9	0.0	6.5	9.4	7.8	10.8	3.5	7.3	6.4	22.3	14.8	4.3	7.0	2.5	10.6	9.0	0.0	18.0	9.4	18.9	9.7	7.0	11.7	5.9	28.6	6.5	8.0	13.5	29.6	10.3	27.7	12.1	10.9	12.9
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 51.8;Late spermatids: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	9.2	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	7.1	4.6	2.3	7.3	6.8	1.8	0.0	1.0	1.6	4.7	0.0	7.5	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	8.1	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8	3.0	5.6	5.2	4.6	2.9	1.0	4.0	2.5	10.7	5.7	5.2	0.0	16.0	0.0	4.3	51.8	12.2	0.0	0.0	7.0	10.7	11.3	0.8	10.5	0.4	16.7	0.0	1.7	9.8	7.6	44.8	5.5	15.4	3.3	11.8	0.0	4.0	5.9	0.0	8.1	0.3	0.9	19.4	6.2	3.6	2.9	2.3	18.5	7.4	0.0	3.2
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.4;Distal tubular cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;HEL: 9.2;Karpas-707: 5.9;RPMI-8226: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.1	0.3	1.3	3.7	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.9	0.0	0.2	0.2	0.0	0.4	0.6	9.2	0.2	0.0	0.9	0.2	0.1	3.2	0.1	0.0	0.5	0.6	0.0	0.4	0.4	5.9	1.0	0.5	0.1	0.1	0.2	0.6	0.9	0.0	0.0	5.9	0.7	0.1	1.0	2.5	0.0	0.0	0.3	1.2	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.2	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8	8.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.4	1.8	0.0	0.4	16.6	0.8	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.3;pituitary gland: 55.9;testis: 44.6"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 96.4;Early spermatids: 253.8;Late spermatids: 263.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced					NA	NA					"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.7	2.3	8.6	1.0	15.5	4.7	1.8	2.3	10.6	2.3	1.1	6.5	4.4	1.2	4.7	8.6	2.7	30.3	4.3	10.7	10.3	12.1	6.8	4.1	5.5	1.4	4.7	9.4	3.8	3.4	2.0	55.9	0.4	17.7	3.2	2.3	2.0	2.5	3.4	1.8	4.3	0.7	1.9	3.7	1.5	1.7	44.6	5.9	0.0	3.7	0.0	0.9	4.5	0.9	1.7	1.1	6.0	2.0	0.1	3.3	0.5	0.8	2.5	1.1	1.6	0.0	1.0	1.8	0.6	2.3	0.0	0.5	5.1	0.6	4.6	0.6	0.0	0.5	2.7	1.2	0.0	2.6	0.0	1.7	0.0	2.6	0.0	0.0	0.6	0.8	2.1	0.0	0.9	0.0	1.0	0.0	1.6	0.8	0.9	0.5	0.1	0.3	1.7	0.0	4.1	4.4	0.8	0.0	0.0	5.5	5.4	10.6	4.8	0.0	0.0	0.0	0.4	0.0	1.6	1.8	1.1	0.6	0.0	0.4	2.1	0.7	1.7	0.5	1.3	2.0	4.3	2.0	1.4	1.9	0.6	1.4	0.9	2.6	1.2	0.3	1.7	3.3	1.6	6.0	0.1	0.2	1.1	1.1	0.5	8.6	15.5	2.3	10.6	10.3	12.1	4.7	9.4	17.7	5.9	0.0	1.7	0.0	3.4	0.2	1.7	43.4	0.0	96.4	6.8	5.2	7.9	0.1	46.4	2.6	253.8	0.9	0.0	0.0	6.4	0.1	1.0	3.0	0.0	3.6	0.1	0.0	6.3	0.0	0.6	263.8	3.4	0.1	0.0	0.0	0.3	6.3	2.3	0.3	2.5	5.1	7.7	0.0	0.9	13.4	3.6	0.3	0.2	0.0	0.4	2.2
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578596	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 100.3"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 308.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	32.4	12.4	37.5	16.2	63.5	27.1	14.6	15.1	100.3	14.9	12.2	83.9	3.7	4.0	14.7	4.9	16.0	12.3	15.7	64.0	43.7	18.1	11.1	18.4	24.9	11.4	72.5	31.9	18.4	7.6	7.8	4.7	23.4	46.5	7.9	8.4	7.1	10.2	11.1	59.9	12.4	7.1	21.1	68.8	16.9	8.9	20.5	74.3	5.0	10.4	10.8	11.4	15.8	17.7	1.7	7.3	10.8	8.4	7.4	3.8	1.3	4.3	18.2	64.8	21.5	19.6	21.9	15.1	11.8	27.9	19.3	23.4	12.3	4.0	5.2	9.9	29.5	13.2	6.5	34.3	12.2	31.4	10.5	11.1	20.6	10.1	13.8	24.0	11.0	6.3	25.6	5.0	20.7	32.9	18.9	26.6	7.8	30.2	12.4	12.4	8.2	7.3	2.3	8.3	4.3	9.2	11.3	40.4	10.5	10.6	13.7	1.3	7.5	12.6	6.8	5.2	27.5	2.6	18.0	27.0	13.4	11.3	14.4	21.6	7.9	9.6	6.4	11.5	9.7	31.4	3.4	8.4	3.8	2.3	5.4	3.8	1.4	1.6	2.0	4.3	1.7	1.5	2.5	10.8	7.4	5.5	7.3	1.1	1.3	37.5	63.5	15.1	41.4	43.7	18.1	72.5	31.9	46.5	74.3	140.0	54.6	32.8	29.3	136.6	56.8	308.9	40.8	21.4	36.4	19.2	55.0	41.8	18.3	21.6	45.5	100.3	0.0	46.7	10.3	40.7	66.9	33.8	60.0	61.0	75.9	30.2	0.0	146.1	189.4	77.1	80.3	114.7	108.0	31.5	0.0	113.1	17.4	0.0	92.6	25.9	30.1	45.3	91.7	34.4	14.6	118.9	46.1	25.8	0.0	35.3
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309607	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 329.2;Early spermatids: 104.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 7.4;SCLC-21H: 4.3"					"Low region specificity"	"Detected in many"			"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.3	0.3	4.4	0.3	11.4	0.3	0.3	0.1	0.8	1.5	0.3	7.5	0.1	0.3	1.0	7.2	0.3	23.9	0.3	0.3	4.3	2.7	0.3	0.3	4.7	0.3	0.3	1.0	3.4	0.3	0.3	10.4	0.3	14.5	0.3	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.3	0.8	0.3	0.3	9.6	3.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.4	0.1	0.8	4.3	2.7	0.3	1.0	14.5	3.9	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	329.2	22.7	0.0	0.0	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.0	0.9	0.0	0.0	0.0	0.0	0.1
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165986603	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 15.9;Muller glia cells: 21.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.7;LHCN-M2: 14.0;RH-30: 8.2;RT4: 8.5;SH-SY5Y: 8.6;TIME: 14.5;U-2 OS: 7.9"	"Region enriched"	"Detected in many"	11	"basal ganglia: 307.0"	"Group enriched"	"Detected in all"	4	"basal ganglia: 155.2;cerebellum: 80.7"	"CAB045998, HPA047200"	Supported					NA	NA					"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	3.1	1.9	1.7	1.0	36.8	0.0	3.4	4.5	6.9	2.2	1.0	1.1	4.3	0.8	2.9	7.5	0.7	3.1	3.2	3.6	2.6	2.1	8.8	0.9	4.3	1.4	2.7	1.1	3.4	0.8	1.2	2.5	5.3	1.7	2.6	0.5	0.6	0.7	4.9	0.9	0.6	0.8	4.3	1.1	2.5	1.2	8.7	16.0	0.0	12.2	1.0	0.8	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	5.0	0.0	2.8	0.0	0.0	0.0	3.4	0.0	7.7	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	7.5	0.0	0.0	0.0	14.0	0.1	1.1	0.0	1.5	0.0	5.6	1.7	8.2	0.0	7.4	8.5	2.2	8.6	0.0	0.0	0.4	0.6	0.0	0.0	14.5	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	36.8	4.5	6.9	2.6	2.1	2.7	1.1	1.7	16.0	0.0	0.0	0.0	2.8	0.3	8.8	6.9	0.0	1.4	1.2	5.2	2.0	6.0	3.3	1.7	8.9	10.3	0.0	0.0	0.0	5.2	2.0	11.7	1.1	0.0	0.7	15.9	0.0	9.8	0.0	11.8	0.0	0.0	1.7	0.0	0.0	21.0	0.2	0.0	0.4	6.5	0.6	0.0	2.1	6.6	0.5	0.3	2.4	0.0	0.0	2.2
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.2;pituitary gland: 5.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.0"	"Group enriched"	"Detected in some"	24	"naive B-cell: 2.3;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"B-cells: 2.3;NK-cells: 2.5"	"Cell line enriched"	"Detected in some"	4	"HeLa: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.3	0.0	0.1	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	5.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.9	0.0	0.0	1.2	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.9	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 35.7"	"Cell type enhanced"	"Detected in some"	23	"Cholangiocytes: 5.1;Collecting duct cells: 1.8;Hepatocytes: 2.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 9.3;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077250	Enhanced					NA	NA					"HPA077250: AB_2732336"	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	1.3	0.9	12.4	0.9	17.3	0.9	0.9	1.7	34.8	1.1	0.9	35.7	0.0	1.4	0.9	0.9	0.9	4.4	0.9	0.9	18.6	9.0	1.0	6.4	1.1	0.9	23.1	7.0	1.0	1.1	3.3	0.4	0.9	11.0	1.3	0.9	0.0	1.0	1.1	0.9	0.9	1.0	0.9	21.7	0.9	1.2	0.9	18.9	0.0	1.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.3	5.5	0.6	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	17.3	1.7	14.9	18.6	9.0	23.1	7.0	11.0	18.9	0.0	0.0	0.0	0.1	0.0	1.0	0.6	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342591	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	21.1	24.6	33.6	21.7	31.8	16.4	24.5	15.6	25.0	20.2	27.9	43.4	23.4	23.5	14.7	37.0	19.6	18.8	18.6	15.6	34.9	26.2	27.6	12.5	27.2	23.9	43.9	18.6	18.3	32.6	13.4	11.8	25.9	27.8	27.3	26.8	15.0	38.0	19.4	11.2	12.5	24.9	16.0	61.2	24.6	27.6	18.3	32.8	20.6	24.9	15.3	23.7	17.1	16.1	25.5	57.6	50.1	30.1	14.9	21.7	24.2	13.3	13.0	10.7	22.4	19.6	17.5	16.8	20.8	17.9	14.7	22.3	27.1	27.5	11.8	15.9	17.0	25.7	16.3	15.6	17.1	22.5	16.3	28.5	13.9	11.0	38.2	17.7	35.2	28.3	16.4	20.4	16.9	14.8	21.2	7.8	19.6	25.7	11.9	22.6	21.5	10.3	60.1	10.5	39.9	12.8	7.3	12.3	27.5	36.0	13.9	2.0	9.3	14.2	23.2	18.5	12.6	12.6	63.7	7.3	9.2	17.7	24.3	21.5	11.4	8.2	12.9	19.5	22.2	22.4	29.5	28.5	34.7	18.1	28.1	11.3	25.5	14.7	15.1	30.4	21.2	15.9	15.9	50.1	14.9	30.1	57.6	21.7	24.2	33.6	31.8	15.6	25.0	34.9	26.2	43.9	18.6	27.8	32.8	38.7	55.2	94.6	100.0	76.8	8.2	23.0	58.6	44.2	44.3	102.9	0.0	131.5	76.3	136.4	33.1	53.4	86.8	23.3	110.4	203.9	98.4	175.7	146.5	20.8	187.8	14.3	27.6	63.3	172.6	14.5	78.9	142.4	94.5	228.2	114.9	23.5	133.8	128.7	44.6	126.0	8.4	84.1	53.6	137.2	79.4	89.8	109.7	82.0	105.5	178.5
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 875.4;Distal tubular cells: 1458.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	27.9	23.6	13.6	12.0	7.5	12.2	11.8	11.5	9.9	4.6	13.7	13.6	11.6	9.5	6.2	12.1	9.5	8.3	9.3	20.8	6.8	10.1	32.9	9.8	26.2	8.9	10.9	13.4	9.6	6.9	3.6	9.5	21.3	23.6	21.9	7.3	10.4	18.2	48.6	4.1	37.3	9.2	10.0	13.5	34.2	22.0	5.2	25.5	22.6	8.7	38.0	8.6	7.0	9.0	39.4	6.6	6.9	7.1	24.2	7.7	15.0	10.3	11.4	6.3	32.4	10.9	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8	110.2	37.1	53.6	36.9	40.5	51.2	875.4	183.4	44.2	47.8	101.2	9.8	19.1	1458.9	78.7	46.1	45.8	147.2	23.3	122.5	67.4	59.4	34.7	70.3	365.8	104.2	46.1	35.7	38.6	74.2	5.6	61.5	76.9	123.2	111.8	87.8	137.3	56.8	120.7	84.5	301.3	55.1	90.5	90.6	126.5	39.4	48.8	20.4	54.3	110.8	45.7
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0.0	3.9	5.7	48.4	35.5	0.0	4.1	8.1	2.3	3.2	0.0	1.2	0.2	1.3	14.6	1.8	1.7	2.0	9.0	2.1	0.8	0.5	0.0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0.0	0.0	9.5	0.4	0.1	0.4	1.0	1.9	2.3	0.6	2.0	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1.0	0.1	3.0	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0.0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10.0	12.8	12.0	47.2	0.5	0.0	20.9	0.2	8.0	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5.0	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3.0	0.2	1.3	1.2	5.8
AL159163.1		ENSG00000249141			6	166858094-166956124	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 2.2;Hofbauer cells: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.3;OE19: 10.0;SK-BR-3: 4.2;U-937: 4.0"															NA	NA						"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.76e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.28e-3)"	3.3	4.2	8.0	6.1	6.7	3.5	2.9	2.5	5.0	5.3	9.3	7.5	10.7	5.2	2.6	10.5	4.3	2.6	6.4	2.6	7.1	4.0	2.8	3.3	4.0	14.1	10.8	1.8	2.5	15.5	2.3	5.5	3.0	7.1	4.2	10.5	1.7	8.8	16.6	2.9	3.0	5.0	3.9	13.3	21.6	5.5	3.2	10.3	4.3	3.8	0.8	7.9	3.2	3.5	1.5	6.7	2.1	8.6	0.3	2.3	1.5	0.3	0.0	1.3	0.7	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	1.0	1.6	0.4	0.0	1.0	0.8	0.6	1.6	0.9	1.9	0.0	0.8	2.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.5	1.4	7.3	0.2	10.0	0.0	0.0	0.0	1.5	2.5	0.3	0.4	0.6	0.0	4.2	0.0	1.0	0.3	1.7	0.0	0.0	0.8	3.6	0.0	1.2	2.3	0.0	1.3	4.0	0.0	2.1	3.9	0.3	0.7	5.5	1.1	1.0	2.3	0.7	6.1	1.5	1.3	0.2	1.9	0.3	8.6	6.7	2.3	1.5	8.0	6.7	2.5	5.0	7.1	4.0	10.8	1.8	7.1	10.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RNASET2	"bA514O12.3, FLJ10907, RNASE6PL"	ENSG00000026297	"Ribonuclease T2"	O00584	6	166929504-166957191	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Endonuclease, Hydrolase, Lyase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.7"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 343.2;Kupffer cells: 367.0;Macrophages: 275.2;Paneth cells: 280.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 40.0;THP-1: 99.3"									"HPA029013, HPA066509"	Approved				"Secreted to blood"	NA	NA		16000000			"HPA029013: AB_10602922, HPA066509: AB_2685682"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.70e-14)"	"unprognostic (5.03e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	13.0	9.9	27.8	21.9	23.7	29.4	13.9	3.7	18.6	46.0	21.0	26.3	35.5	15.4	13.8	40.5	10.6	37.6	22.9	8.8	24.9	18.7	12.3	14.3	15.1	45.7	36.0	9.2	13.4	39.5	11.6	12.1	12.9	24.9	18.0	25.0	9.1	30.7	53.1	2.9	10.1	24.6	7.5	43.2	84.7	25.7	5.7	34.5	16.7	22.2	6.3	25.0	13.2	13.9	20.9	56.6	105.7	57.0	4.5	28.0	22.3	3.2	2.7	2.5	7.5	11.7	8.3	2.3	3.3	4.1	1.4	1.4	6.5	4.0	2.4	40.0	8.0	3.3	8.9	4.1	3.6	0.8	4.1	8.0	1.9	4.1	15.9	3.9	31.8	8.9	4.8	6.7	0.8	0.5	6.1	1.9	4.3	5.0	18.6	2.1	8.4	2.7	24.7	1.4	26.9	2.9	6.0	3.4	29.8	26.9	1.9	1.0	7.0	6.9	20.1	1.6	4.7	2.5	99.3	3.9	3.0	2.2	9.6	3.2	4.0	4.5	0.2	6.6	30.6	2.0	16.6	28.7	105.7	5.0	44.5	9.2	20.9	28.0	12.5	36.7	17.6	21.5	6.8	78.7	4.5	57.0	56.6	13.9	22.3	27.8	23.7	3.7	18.6	24.9	18.7	36.0	9.2	24.9	34.5	17.9	34.3	199.1	101.2	38.5	10.0	8.7	48.4	20.1	19.4	36.6	0.0	45.4	19.9	56.6	8.7	19.9	139.7	0.0	24.1	40.5	36.8	50.6	70.4	20.7	343.2	12.7	72.4	20.9	367.0	8.0	32.8	275.2	55.6	38.7	135.0	25.1	53.1	280.5	27.6	13.9	6.8	25.8	14.1	7.1	12.2	30.2	23.2	107.8	184.1	89.4
FGFR1OP	FOP	ENSG00000213066	"FGFR1 oncogene partner"	O95684	6	166999182-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.3"	"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 225.5;Late spermatids: 194.1;Spermatocytes: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876	Approved		Supported	Centrosome		NA	NA			Centrosome		"HPA071876: AB_2686467"	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.2	12.2	11.2	12.9	12.5	9.8	10.2	11.9	13.0	10.1	9.5	6.9	11.8	10.8	13.6	14.1	8.8	19.1	7.9	6.4	10.8	9.1	12.2	24.9	6.7	9.4	6.4	11.5	11.8	10.2	8.2	17.2	6.6	9.4	7.4	12.1	8.9	8.1	11.6	5.8	7.9	13.0	7.4	7.4	9.4	7.8	50.3	8.0	14.5	12.5	6.2	11.8	7.0	8.2	6.8	10.0	24.1	4.1	3.5	6.8	3.0	11.6	6.5	16.5	11.2	9.7	7.3	20.0	15.1	10.1	12.4	12.0	24.0	9.9	13.9	8.6	9.2	33.0	11.0	14.4	10.7	23.3	8.7	12.4	9.6	11.7	26.0	5.2	17.0	10.1	4.0	7.9	25.3	11.9	7.7	8.5	15.8	31.2	11.9	15.8	10.7	13.7	25.0	14.0	22.5	5.0	15.8	11.2	11.5	12.9	6.3	12.3	12.3	12.3	13.2	5.2	12.1	10.9	21.1	5.5	12.3	20.6	14.7	18.8	10.2	14.0	14.1	13.9	16.0	15.0	0.2	4.1	13.5	3.3	3.6	4.9	6.8	3.9	3.1	6.5	5.0	2.3	3.7	24.1	3.5	3.6	10.0	6.8	3.0	11.2	12.5	11.9	13.0	10.8	9.1	6.4	11.5	9.4	8.0	11.9	15.6	12.7	7.4	5.4	20.9	11.2	15.3	30.8	12.5	5.2	21.6	12.3	10.0	11.1	225.5	5.5	15.2	46.7	6.4	13.6	6.8	4.7	4.7	18.8	9.2	9.5	10.3	6.2	7.6	194.1	12.0	7.7	5.0	15.4	12.7	9.3	8.4	12.9	12.0	14.3	55.1	6.5	6.6	97.9	28.4	5.6	5.3	13.1	13.2	4.3
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 30.7;intestine: 9.9;lymphoid tissue: 33.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 21.0;Late spermatids: 20.6;T-cells: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 30.7;memory B-cell: 23.8;memory CD4 T-cell: 11.9;naive B-cell: 28.2;T-reg: 20.9"	"Group enriched"	"Detected in many"	5	"B-cells: 28.2;T-cells: 30.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.6;Hep G2: 14.1;OE19: 4.9"	"Region enriched"	"Detected in single"	8	"basal ganglia: 0.9"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved					NA	NA					"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.3	1.0	24.4	1.5	1.3	1.1	0.3	1.1	0.6	3.0	0.1	0.0	1.4	0.3	0.8	2.1	0.5	3.1	0.3	0.9	0.9	1.0	0.5	3.3	27.3	0.6	0.0	0.3	0.3	0.0	0.4	0.5	0.2	0.5	1.2	0.3	5.0	0.8	0.3	1.1	9.9	0.0	0.4	23.4	2.2	2.7	0.1	3.7	0.6	2.1	33.7	4.8	0.4	28.2	5.4	0.2	0.0	0.4	30.7	2.5	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	1.3	0.3	0.0	0.0	0.0	0.3	0.2	0.1	2.6	0.7	0.1	0.3	14.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.1	4.9	0.0	0.2	0.2	0.2	0.4	0.0	0.8	0.4	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.8	0.1	0.3	0.5	0.3	0.4	0.0	0.2	0.6	0.0	0.0	0.1	1.6	0.0	30.7	23.8	11.9	4.7	5.4	28.2	0.1	0.0	0.2	0.4	0.0	0.6	20.9	2.5	1.0	1.5	0.3	1.1	0.9	0.9	0.6	0.0	0.2	0.1	0.0	6.2	21.0	0.3	0.9	0.9	0.0	0.0	1.4	3.4	0.0	2.0	0.0	1.7	0.1	5.7	0.0	0.0	0.0	0.2	0.0	0.7	0.1	2.3	0.8	0.1	0.0	0.0	1.3	0.0	20.6	0.0	5.1	1.7	4.6	0.3	0.4	0.1	0.0	0.4	0.3	3.8	0.0	0.1	2.3	0.4	0.4	0.1	11.4	0.0	0.1
TCP10L2	bA517H2.3	ENSG00000166984	"T-complex 10 like 2"	B9ZVM9	6	167146414-167196913	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"epididymis: 5.2;testis: 14.8"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.1"									"CAB034197, HPA044709"	Uncertain					NA	NA					"CAB034197: AB_2202388, HPA044709: AB_10961410"			"unprognostic (5.07e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"		"unprognostic (2.52e-1)"			"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.40e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.6	0.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	14.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	45.1	0.5	0.0	0.0	0.0	0.3	0.0
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167156271-167158329	"G-protein coupled receptors, Predicted membrane proteins"	"Lipid metabolism"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	28	"myeloid DC: 2.7"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain					NA	NA					"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.1	0.9	0.1	0.2	0.1	0.0	0.1	0.1	0.1			0.5	0.0	2.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	4.5	0.2		0.0	0.0	0.0	0.1	0.0		0.0	0.1		0.1	0.0	0.0	0.0	0.9	0.0	0.2	2.1	0.3	1.1			0.1		1.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316019	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.8;liver: 17.4;skin 1: 18.8"	"Cell type enhanced"	"Detected in some"	25	"Collecting duct cells: 10.4;Hepatocytes: 4.9;Mucus-secreting cells: 2.4;Undifferentiated cells: 1.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 10.4;Hep G2: 4.3;OE19: 10.6;SCLC-21H: 4.6"					"Not detected"	"Not detected"			HPA035729	Uncertain					NA	NA					"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.5	1.4	0.1	0.1	9.2	0.1	0.5	5.9	1.0	1.6	0.1	0.1	0.0	2.5	17.4	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.5	0.1	0.1	18.8	9.8	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.1	3.9	2.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
TTLL2	"C6orf104, dJ366N23.3, NYD-TSPG"	ENSG00000120440	"Tubulin tyrosine ligase like 2"	Q9BWV7	6	167325086-167359503	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 54.1"	"Group enriched"	"Detected in some"	167	"Early spermatids: 407.9;Late spermatids: 161.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 6.3"	"Not detected"	"Not detected"							HPA027985			Approved	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane, Nucleoli"		"HPA027985: AB_2211832"	"unprognostic (5.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.47e-4)"		"unprognostic (7.57e-2)"	"unprognostic (2.63e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0
TCP10		ENSG00000203690	"T-complex 10"	Q12799	6	167357031-167384510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"testis: 16.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 50.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 2.5;SCLC-21H: 1.9"									"HPA044709, HPA078219"	Enhanced					NA	NA					"HPA044709: AB_10961410, HPA078219: "			"unprognostic (8.33e-2)"				"unprognostic (1.52e-1)"			"unprognostic (2.27e-1)"				"unprognostic (7.79e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	16.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	50.1	0.4	0.0	0.0	0.0	0.2	0.0
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	17.0	7.4	14.9	13.0	17.2	1.8	23.5	17.8	19.3	19.6	26.3	16.1	25.5	22.2	15.8	17.7	59.5	27.9	18.2	13.9	15.6	7.2	20.6	29.3	26.3	5.1	17.1	12.5	16.2	29.7	16.4	27.4	18.7	16.1	20.9	27.2	15.3	38.6	18.6	12.7	24.8	42.3	17.4	13.0	13.5	21.1	16.3	15.2	2.1	25.7	13.7	24.5	16.3	27.9	3.5	0.6	2.9	0.5	0.0	1.2	0.0	18.9	5.9	41.5	14.8	4.0	3.4	30.9	7.7	4.0	6.7	8.3	25.3	11.9	3.4	14.3	4.6	10.5	9.1	17.2	15.8	12.0	21.4	17.8	0.1	2.5	19.1	6.1	2.1	9.1	2.4	10.7	11.2	26.5	10.7	12.3	7.4	38.0	13.3	4.3	8.1	0.2	0.1	10.1	27.1	2.7	12.3	10.9	14.4	12.2	9.3	19.2	11.7	7.8	29.8	11.8	40.5	3.5	0.8	18.0	3.1	15.1	13.4	12.7	0.2	16.1	6.9	9.3	4.4	27.2	0.0	0.5	0.0	1.0	0.5	0.6	3.5	1.2	0.4	0.6	2.7	0.0	0.5	2.9	0.0	0.3	0.0	0.6	0.0	14.9	17.2	17.8	19.3	15.6	7.2	17.1	12.5	16.1	15.2	157.8	72.9	0.0	0.0	0.0	0.0	0.0	0.0	85.6	75.1	90.7	0.0	27.0	18.3	58.2	0.0	0.0	0.0	0.0	34.2	28.5	0.0	0.0	8.1	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.0	0.0	0.0	52.1	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045089	"Predicted intracellular proteins"		"Motor protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.2;brain: 9.9"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 3.5;granulocytes: 4.6;Horizontal cells: 3.2;Spermatogonia: 2.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.2;HDLM-2: 5.3;HMC-1: 2.8;SiHa: 2.2;U-266/84: 3.2;U-937: 3.1;WM-115: 2.3"					"Not detected"	"Not detected"			HPA046153	Uncertain					NA	NA					"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	6.2	0.0	2.0	0.2	3.1	0.1	1.3	9.9	2.7	0.2	0.3			0.2	0.1	0.9	0.0	0.6	1.5	1.9	2.7	2.3	0.0	0.3	0.3	0.9	3.5		2.0	0.0	0.0	0.0	1.9		0.8	1.1		1.0	0.1	3.1	2.0	0.2	0.2	3.1	0.8	0.3	1.6			0.0		0.3	1.6	0.0	0.7	0.3	1.7	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.7	5.3	0.9	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.2	0.5	0.4	0.1	0.5	1.6	0.1	0.0	0.8	0.2	0.5	2.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	1.0	0.1	0.1	0.1	3.2	0.1	0.1	3.1	2.3	1.7	0.3	0.9	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	1.4	0.1	0.2	0.3	0.1	0.1											0.0	0.0	0.0	0.0	0.3	1.7	0.6	0.0	0.0	0.0	3.5	0.0	0.9	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.1	4.6	0.0	0.1	3.2	0.0	0.6	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.8;lymphoid tissue: 29.4"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 26.3;Paneth cells: 59.6;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 4.7;RPMI-8226: 7.5"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			6.4	0.1	0.0	6.0	0.2	0.0	10.8	0.2	0.1	0.2	9.8	0.0	0.0	2.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	5.6	0.2	0.1	0.0	1.5	0.2	0.2	0.2	0.0	0.1	0.3	0.6	0.1	6.8	1.1	1.7	0.0	2.6	0.2	4.5	0.1	1.0	2.9	7.5	8.1	0.0	29.4	0.1	1.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.7	0.0	26.3	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	0.0	0.0	10.1	0.6	0.0	0.0	0.0	14.0	0.0	0.0	59.6	1.4	14.4	0.0	0.0	0.0	13.7	4.3	0.0	0.1	0.0	13.7	0.1
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 14.2;placenta: 54.8"	"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 180.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5"	"Low region specificity"	"Detected in many"							HPA030251	Enhanced	Supported				NA	NA					"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	1.0	1.3	0.5	0.4	14.2	0.0	0.4	1.5	1.4	2.3	1.1	1.2	1.0	0.9	3.7	2.2	0.7	2.2	2.9	2.7	0.9	0.5	2.2	2.4	2.0	0.4	1.1	0.9	0.9	1.6	0.0	0.4	54.8	1.7	6.1	0.4	1.6	5.3	0.5	0.4	5.6	0.8	0.8	0.7	0.4	0.5	1.0	0.7	0.9	0.4	0.4	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	15.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.2	1.5	1.4	0.9	0.5	1.1	0.9	1.7	0.7	0.0	1.3	0.0	1.8	2.7	9.8	0.5	2.5	0.0	2.3	1.8	0.0	38.3	0.0	1.5	0.0	0.1	0.0	0.0	0.2	4.7	1.1	0.8	0.0	0.0	4.6	0.0	5.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	1.1	22.6	0.4	0.0	0.0	4.9	0.7	0.0	0.0	0.0	0.0	1.3	180.9	0.0	1.8	0.0
SMOC2	SMAP2	ENSG00000112562	"SPARC related modular calcium binding 2"	Q9H3U7	6	168441151-168673445	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Leydig cells: 298.0;Peritubular cells: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;EFO-21: 3.3;RPMI-8226: 12.6;RPTEC TERT1: 4.5;SuSa: 11.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (3.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.20e-3)"	17.9	3.4	1.9	17.2	5.0	0.0	26.2	0.8	2.3	37.3	11.7	2.5	5.0	5.1	57.7	40.6	17.9	34.4	73.2	25.3	1.9	1.7	3.0	1.3	5.3	4.8	2.7	2.9	45.0	8.5	1.8	1.5	5.4	6.0	22.3	6.4	76.2	6.9	15.1	21.8	8.0	9.4	53.9	1.6	1.3	50.0	31.1	1.3	2.3	13.6	12.3	3.5	36.8	11.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	1.2	0.0	0.0	0.0	0.0	12.6	4.5	0.0	2.0	0.4	0.0	0.4	0.1	11.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	5.0	0.8	2.3	1.9	1.7	2.7	2.9	6.0	1.3	0.0	1.7	0.0	6.1	9.8	2.8	7.0	0.0	4.0	3.4	10.4	0.0	2.0	0.0	0.0	2.3	3.5	1.6	0.0	0.0	1.6	18.5	5.5	0.0	0.0	1.2	0.0	18.9	4.3	0.0	5.7	298.0	0.6	3.3	0.0	3.0	0.4	0.1	0.0	723.1	0.0	0.6	45.3	73.7	2.7	4.5	2.4	2.2	0.0	12.5	0.6
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 77.0;Fibroblasts: 41.1;Ito cells: 25.2;Melanocytes: 54.0;Smooth muscle cells: 28.6;Suprabasal keratinocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 83.6;ASC TERT1: 57.4;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HHSteC: 23.4;HSkMC: 31.0;hTEC/SVTERT24-B: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.6	0.3	83.6	57.4	0.0	15.9	21.9	22.1	27.8	0.1	0.0	0.0	0.0	19.0	0.1	0.0	0.7	0.8	12.6	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	31.0	0.0	29.8	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	10.1	0.1	22.5	1.9	0.0	0.3	0.0	6.2	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2	6.0	0.0	0.0	1.2	77.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	41.1	1.1	0.0	0.0	0.2	0.0	0.0	25.2	0.0	0.0	7.5	0.9	54.0	0.0	0.0	0.3	0.8	0.0	15.2	0.3	0.3	0.0	28.6	0.0	0.0	36.9	0.1	0.0	0.0	0.7
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037497: AB_10671503, HPA037498: AB_2675509"	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	6.7	8.0	8.6	11.8	9.2	7.0	9.3	10.1	10.9	9.9	7.9	10.3	7.1	8.1	17.2	10.2	8.9	13.4	8.1	5.0	6.1	4.1	7.2	6.3	6.6	8.2	5.9	5.1	18.2	8.5	8.4	9.9	5.9	7.2	9.2	6.3	8.4	11.2	5.9	5.9	7.5	8.6	9.1	4.7	7.8	7.7	21.5	8.6	7.6	12.7	4.2	9.0	10.2	10.8	4.7	2.1	1.5	1.1	0.7	6.0	1.2	4.4	6.3	15.8	8.9	4.7	6.2	7.9	6.1	1.5	2.9	4.5	8.4	6.6	4.5	4.7	1.9	6.3	9.1	5.0	4.3	4.5	6.0	8.9	8.5	11.3	5.4	3.4	4.7	1.3	6.1	3.8	3.9	4.6	7.5	5.8	9.2	19.8	9.3	4.8	6.7	3.0	11.7	7.4	4.8	5.5	7.9	5.5	6.6	3.7	4.0	9.0	10.8	5.0	3.6	3.8	5.6	4.4	8.0	5.6	4.3	5.4	6.3	7.1	8.8	3.5	10.0	5.3	9.3	7.4	0.2	1.1	1.5	1.9	0.7	3.2	2.1	2.0	2.5	1.1	4.7	6.0	1.7	0.5	0.7	0.5	2.1	1.2	1.2	8.6	9.2	10.1	10.9	6.1	4.1	5.9	5.1	7.2	8.6	8.9	3.8	5.6	5.1	1.9	12.7	3.2	7.6	14.7	3.4	12.2	5.9	4.2	0.0	2.2	21.5	5.8	3.3	0.0	1.3	2.3	4.5	3.7	3.5	3.9	1.9	20.6	4.1	11.1	1.3	6.8	7.5	2.5	3.3	1.0	4.2	7.0	1.7	5.1	9.2	1.3	13.8	0.0	2.7	14.9	9.4	1.0	1.6	4.4	6.0	4.7
C6orf120	bA160E12.4	ENSG00000185127	"Chromosome 6 open reading frame 120"	Q7Z4R8	6	169702190-169704856	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 93.3;Late spermatids: 214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039626	Uncertain				"Secreted to blood"	NA	NA					"HPA039626: AB_10673361"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-3)"	22.1	23.5	18.4	14.8	20.8	7.0	16.8	12.3	25.1	15.5	18.9	16.0	8.9	17.4	15.2	13.2	14.9	14.2	14.4	21.2	15.5	11.3	21.3	29.9	13.8	16.0	16.2	17.0	20.9	20.0	12.2	11.6	23.7	15.3	14.1	16.0	14.0	15.4	14.1	17.1	11.4	23.5	14.8	13.0	20.2	16.7	16.5	16.2	17.0	12.3	10.8	16.2	16.6	11.4	7.1	9.0	9.6	10.6	4.1	9.6	4.7	5.8	4.7	11.6	17.6	32.3	27.0	13.1	12.3	17.8	10.3	12.1	6.3	5.5	5.0	10.0	15.0	17.2	9.0	7.5	11.3	17.4	8.4	18.2	7.1	4.4	13.3	22.9	11.8	11.4	33.1	9.3	12.3	14.3	18.2	12.5	11.6	18.7	14.4	17.7	10.6	6.4	8.1	9.8	10.3	5.5	4.7	6.3	13.4	12.8	6.6	4.7	10.6	10.2	6.5	8.2	13.7	10.9	15.6	13.7	4.4	8.5	23.0	8.3	18.7	28.6	7.2	14.5	11.0	11.4	8.1	10.6	9.6	4.9	10.6	6.6	4.7	7.2	8.5	9.0	7.1	9.6	7.7	5.9	4.1	8.2	3.1	4.7	4.7	18.4	20.8	12.3	25.1	15.5	11.3	16.2	17.0	15.3	16.2	14.9	4.0	8.2	8.2	8.8	12.7	7.7	2.5	8.1	9.1	14.0	23.6	23.7	8.3	9.2	93.3	7.3	18.3	23.3	13.9	27.1	15.5	11.6	9.2	15.5	14.6	7.9	13.7	9.8	16.8	214.1	16.4	9.0	18.6	11.8	9.0	25.6	10.2	11.6	11.0	11.0	22.8	0.0	8.3	5.2	14.5	8.9	24.3	7.5	10.3	10.9
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703905-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	19.2	34.3	19.9	21.2	39.0	18.7	19.8	18.3	22.4	17.1	20.8	23.1	26.1	12.9	16.7	17.0	26.5	17.9	21.6	20.1	23.2	10.5	18.6	27.9	20.3	23.3	35.3	13.1	33.5	23.6	25.8	22.1	17.7	28.5	22.1	14.6	21.6	22.2	19.8	30.0	23.1	20.3	23.8	29.0	27.0	21.7	23.3	28.3	26.9	23.0	13.6	24.4	22.7	33.5	4.8	3.0	6.3	3.3	2.4	6.2	1.8	8.8	8.9	35.7	37.3	12.5	7.6	14.7	12.1	11.0	15.0	16.5	25.8	9.3	26.3	7.4	8.4	9.5	11.3	27.4	13.2	21.8	21.0	24.4	26.2	15.7	33.6	12.8	38.2	1.6	5.7	13.9	9.6	8.9	24.9	23.6	19.0	29.0	17.1	10.7	15.2	7.2	32.9	11.2	19.7	5.6	34.7	25.3	21.1	18.6	9.5	17.1	22.8	16.5	5.5	11.8	15.6	10.8	45.9	15.8	8.5	14.3	10.8	15.3	15.2	12.9	32.8	11.1	25.7	13.5	3.0	3.0	6.3	3.4	3.2	3.3	4.8	6.0	4.8	3.0	4.2	5.9	6.2	0.5	2.4	3.3	2.8	3.7	1.8	19.9	39.0	18.3	22.4	23.2	10.5	35.3	13.1	28.5	28.3	23.8	26.7	23.0	19.5	26.6	11.6	51.3	40.8	18.7	27.3	10.4	39.3	11.2	11.6	11.6	10.8	27.7	12.3	0.0	11.1	7.8	24.4	23.2	5.8	23.7	10.0	11.1	24.9	23.9	10.0	6.1	20.8	11.8	18.6	5.4	23.0	27.0	14.2	19.5	19.8	9.5	24.7	19.4	41.5	16.3	19.4	20.6	14.5	15.0	18.0	25.0
TCTE3	TCTEX1D3	ENSG00000184786	"T-complex-associated-testis-expressed 3"	Q8IZS6	6	169740114-169751587	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.6"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 126.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5;MCF7: 1.7"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.11e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.56e-5)"	0.9	1.0	1.3	3.0	3.8	1.2	1.0	3.8	3.8	0.9	1.3	0.4	1.2	0.9	1.1	0.9	0.9	0.9	0.9	0.9	3.0	0.8	1.0	0.9	0.9	0.9	4.2	0.8	1.6	0.9	0.9	4.9	0.9	2.8	1.0	0.9	0.7	1.0	0.9	0.9	1.0	1.1	1.0	2.7	1.1	0.9	23.6	2.9	1.8	1.1	0.4	1.1	1.0	5.3	0.7	0.0	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.7	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.7	0.5	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	3.8	3.8	3.8	3.0	0.8	4.2	0.8	2.8	2.9	0.0	1.0	5.4	5.7	0.0	5.8	1.0	2.5	1.4	3.4	8.7	19.6	1.2	0.0	0.8	126.4	2.2	0.8	0.0	0.7	1.0	1.7	2.4	3.5	0.9	1.0	11.1	1.2	2.5	7.5	17.6	6.4	0.8	0.0	0.0	1.1	4.8	0.4	0.0	4.2	0.9	9.8	6.5	0.8	24.1	7.5	0.0	1.4	3.8	1.8	3.5
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781584	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 35.6;Late spermatids: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	12.6	14.4	11.9	16.6	15.6	10.6	13.2	12.4	16.0	10.9	10.1	17.5	18.6	8.6	21.8	25.0	10.1	13.3	11.0	7.2	10.0	9.3	12.1	16.4	9.9	16.6	10.9	14.6	18.7	13.3	14.1	17.7	13.6	12.1	12.0	11.1	16.1	15.4	15.6	13.0	21.8	12.4	12.8	11.7	16.7	10.1	27.4	11.8	15.5	14.8	12.1	15.8	11.2	9.9	7.1	7.0	2.2	13.4	7.3	9.8	6.3	4.0	5.0	9.3	14.2	10.7	12.3	3.7	5.3	10.5	6.4	6.8	3.3	9.4	7.7	5.4	7.7	7.9	11.7	4.3	11.8	6.7	8.1	4.7	10.2	7.4	3.3	15.0	12.6	6.8	12.9	13.0	6.5	18.1	10.8	7.2	13.1	9.6	10.3	10.5	7.4	5.9	11.3	3.1	9.0	4.0	7.4	6.3	11.9	10.0	4.6	3.3	6.2	8.3	10.1	4.1	8.1	6.4	14.1	5.5	5.1	3.0	8.0	5.7	11.0	12.5	6.8	7.8	10.4	8.1	2.2	5.7	1.9	6.9	11.1	6.9	6.2	7.2	7.5	7.0	7.1	8.1	7.5	0.9	7.3	13.4	5.3	9.8	6.3	11.9	15.6	12.4	16.0	10.0	9.3	10.9	14.6	12.1	11.8	3.0	12.0	3.0	3.8	3.7	11.1	2.0	0.0	18.7	5.7	5.2	9.8	10.7	10.0	8.2	35.6	3.6	3.3	0.0	7.4	7.0	5.6	2.3	2.3	7.4	5.2	4.8	5.8	7.4	7.1	38.1	4.0	4.0	3.3	4.6	2.8	12.8	4.6	2.9	4.2	6.8	10.5	6.5	5.2	27.7	15.3	2.8	5.9	3.8	3.9	3.1
DLL1		ENSG00000198719	"Delta like canonical Notch ligand 1"	O00548	6	170282206-170306565	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.9"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 59.4;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 7.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.0;HBEC3-KT: 10.8;NB-4: 17.8;THP-1: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078298			Uncertain	Nucleoplasm		NA	NA		210000	Nucleoplasm		"HPA078298: "	"unprognostic (1.03e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.66e-1)"	8.9	5.7	4.1	5.5	9.0	3.2	8.6	2.5	13.8	7.4	10.3	18.5	2.6	8.1	6.0	3.0	11.1	5.7	11.4	7.2	5.2	4.0	5.8	13.5	6.8	5.6	5.5	5.2	2.5	13.8	2.2	3.1	5.0	10.0	14.5	5.2	14.3	8.9	7.1	3.8	14.3	13.1	3.9	4.6	36.9	5.9	1.6	7.3	0.9	6.1	5.3	6.3	4.5	11.0	0.0	0.0	0.1	0.9	7.3	0.5	0.2	0.9	0.1	4.3	2.7	0.3	0.2	2.3	0.2	0.6	0.3	0.5	1.1	0.1	0.0	0.2	0.1	0.7	7.0	2.7	10.8	0.0	0.2	0.9	0.0	0.0	0.0	0.3	0.0	3.1	0.1	2.0	0.0	1.1	0.2	1.1	0.1	0.0	0.0	0.4	3.0	0.0	17.8	0.6	0.4	0.0	0.8	4.3	0.1	0.0	1.3	1.9	0.1	0.3	0.0	0.0	1.6	0.7	14.7	0.5	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.8	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.3	0.1	7.3	0.9	0.0	0.0	0.2	4.1	9.0	2.5	11.2	5.2	4.0	5.5	5.2	10.0	7.3	0.0	0.3	0.0	15.5	59.4	0.7	4.6	0.0	10.7	10.3	1.8	21.6	2.4	0.0	0.3	0.3	18.9	1.6	0.0	1.5	5.2	8.9	3.8	5.7	0.0	1.0	0.0	49.7	20.9	3.9	1.2	0.3	2.5	6.8	0.0	76.5	1.0	0.9	2.9	1.1	0.0	0.6	12.9	9.0	0.5	1.9	11.2	3.1	0.0	2.6	0.9
FAM120B	"CCPG, KIAA1838, PGCC1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407065	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	32	"Early spermatids: 546.2;Late spermatids: 1520.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	18.4	20.6	18.5	21.1	28.7	10.7	20.5	28.4	27.7	20.5	16.6	28.5	16.3	15.8	28.3	24.1	16.5	26.8	18.1	18.4	18.1	22.8	17.3	15.6	18.3	16.7	20.6	19.5	23.4	17.0	24.7	32.0	19.5	26.1	22.4	18.6	19.1	21.4	21.2	25.7	18.4	16.2	20.1	21.1	16.9	16.9	20.7	20.4	24.7	22.3	15.3	22.0	19.8	16.3	7.4	9.2	14.7	13.6	15.9	10.2	8.5	5.9	6.1	9.3	11.1	13.4	13.0	5.5	10.0	11.7	8.9	8.9	5.4	4.6	8.4	6.0	14.3	10.4	7.1	9.6	11.5	11.7	12.1	5.9	8.9	5.7	7.1	12.0	8.8	7.2	15.7	12.3	8.2	10.9	15.6	13.7	9.4	9.8	6.9	14.9	12.2	6.4	7.9	4.6	12.3	4.2	5.5	8.7	8.7	9.2	5.3	6.6	10.1	8.6	7.7	3.0	12.0	7.6	17.6	11.6	3.8	6.3	10.0	6.9	8.5	7.1	8.9	10.4	7.3	13.9	14.7	8.1	10.0	8.3	9.0	9.5	6.6	7.9	8.9	9.2	7.4	10.2	8.1	13.9	15.9	13.6	5.3	8.4	8.5	18.5	28.7	28.4	27.7	18.1	22.8	20.6	19.5	26.1	20.4	20.8	14.5	2.7	4.7	3.2	15.0	15.7	15.3	14.7	13.6	14.0	31.4	8.9	0.0	8.3	546.2	15.3	8.6	0.0	8.0	6.4	6.5	11.1	9.3	7.6	9.5	6.4	9.2	11.1	8.2	1520.1	17.8	8.7	18.6	1.8	13.9	6.6	7.9	8.5	13.4	4.9	11.5	32.3	5.3	16.1	11.5	5.1	11.2	5.1	7.4	5.5
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome subunit beta 1"	P20618	6	170535117-170553341	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		14000000	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	60.8	59.3	38.5	40.4	53.7	53.2	55.0	31.4	46.4	40.5	48.6	37.9	49.9	45.1	56.8	90.6	51.7	49.8	43.1	71.9	40.9	40.1	56.4	93.2	46.9	66.7	40.8	41.1	43.7	67.3	35.4	48.4	80.6	48.4	40.6	52.7	43.8	43.6	50.0	109.3	56.1	46.0	59.7	44.9	51.4	46.9	47.1	38.1	47.1	47.9	75.2	60.4	50.1	42.0	71.0	98.1	51.9	81.9	71.6	79.3	104.1	43.1	40.6	57.9	74.7	51.8	40.7	61.7	41.3	60.8	69.0	70.5	88.7	37.3	63.2	54.0	55.3	63.5	43.7	64.1	65.7	72.0	64.2	72.2	54.0	41.2	111.2	60.8	63.2	48.1	46.4	40.4	66.5	43.2	47.5	58.8	40.0	106.5	54.3	62.8	116.2	47.3	88.3	52.8	78.8	55.9	45.9	45.9	80.1	71.5	26.0	57.9	47.3	39.7	61.8	31.6	53.9	42.2	91.6	44.7	28.1	45.1	68.3	76.3	46.5	61.4	78.4	65.6	71.7	60.2	40.1	81.9	51.9	53.2	75.8	62.1	71.0	62.2	57.7	98.1	53.4	59.2	57.2	47.5	71.6	67.6	55.8	79.3	104.1	38.5	53.7	31.4	46.4	40.9	40.1	40.8	41.1	48.4	38.1	104.2	145.5	160.9	308.1	192.9	104.7	211.7	249.7	199.4	117.2	134.3	39.3	748.5	339.8	368.1	245.5	214.1	220.2	116.8	565.6	684.7	208.1	230.0	184.8	268.0	350.5	112.8	158.7	149.8	159.1	57.7	237.3	212.8	219.4	422.0	169.6	196.7	419.2	227.4	221.7	419.5	99.6	187.5	291.5	198.6	166.3	188.6	1001.7	194.1	216.2	303.9
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	11.9	12.3	10.2	14.9	15.8	18.4	13.1	18.1	19.3	13.9	12.7	17.5	15.2	11.4	16.1	12.1	13.3	14.0	11.7	11.5	10.3	10.5	12.3	12.4	11.8	16.8	11.5	13.8	17.3	14.0	10.1	13.2	20.0	18.0	13.1	12.1	14.4	13.7	15.5	14.5	14.5	14.7	13.9	11.7	17.7	13.2	51.4	9.9	15.7	13.7	11.7	15.9	13.1	13.1	32.0	26.3	30.8	25.6	19.6	31.9	12.4	7.4	8.4	14.8	18.5	7.9	8.8	13.8	12.3	9.0	11.8	12.3	16.6	7.5	15.5	9.7	9.6	16.7	11.2	18.9	9.9	13.2	17.9	13.0	16.2	9.6	14.4	10.7	18.3	14.0	8.8	11.3	13.9	15.7	9.4	9.0	21.1	27.7	9.8	10.5	11.8	18.8	18.5	15.1	14.7	6.4	16.5	12.0	13.6	8.9	4.0	6.1	14.3	14.3	10.7	9.5	12.8	7.6	23.5	10.4	8.3	11.9	13.6	18.4	14.7	19.7	25.0	11.3	15.8	13.2	30.8	19.9	23.5	25.0	19.4	28.9	30.9	24.3	25.1	18.5	32.0	31.9	26.6	28.6	19.6	25.6	26.3	22.0	12.4	10.2	15.8	18.1	19.3	10.3	10.5	11.5	13.8	18.0	9.9	8.9	8.6	8.3	4.8	4.8	7.5	8.3	15.3	4.0	9.1	12.2	7.9	13.8	3.3	6.2	14.2	8.7	6.2	0.0	4.0	10.9	7.2	7.0	1.1	7.3	9.0	0.0	6.9	13.5	15.6	3.2	10.0	5.1	1.7	4.6	7.4	6.6	5.4	8.4	9.9	5.8	6.4	12.9	5.7	53.3	16.6	5.8	11.3	6.4	7.5	5.3
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	22.8	24.2	18.1	25.4	16.7	20.0	73.3	14.2	20.2	19.6	25.6	12.0	26.6	21.6	23.1	28.5	29.8	23.3	28.3	32.0	17.0	15.6	28.5	33.4	27.5	52.9	16.5	12.8	24.3	53.4	19.9	16.4	21.2	15.4	21.6	26.8	18.0	27.0	32.0	30.8	19.1	26.1	20.7	20.8	30.3	26.3	17.2	10.5	44.3	31.9	28.5	32.9	25.2	22.3	13.8	15.3	9.6	12.3	16.4	17.5	10.6	13.4	9.9	15.0	35.2	21.7	23.9	16.6	16.1	18.5	19.1	21.4	17.7	11.9	24.5	13.1	17.7	25.6	19.4	32.2	26.7	28.1	20.0	35.2	34.7	12.8	32.0	26.4	43.0	23.4	21.7	26.3	24.2	39.3	20.1	26.5	34.1	68.8	16.0	23.3	29.4	29.8	31.1	21.6	43.7	15.2	21.3	11.6	31.7	28.8	8.0	27.7	28.9	18.3	30.0	18.8	17.1	15.2	44.1	20.0	9.4	20.3	22.4	28.4	21.6	25.1	26.6	17.6	42.1	24.0	3.7	11.0	9.6	13.4	10.6	15.7	13.3	15.3	14.1	15.3	13.8	15.2	14.1	4.7	16.4	12.3	14.2	17.5	10.6	18.1	16.7	14.2	20.2	17.0	15.6	16.5	12.8	15.4	10.5	11.9	11.7	52.0	64.7	44.0	33.6	21.0	35.7	14.7	10.3	27.9	11.8	52.7	66.3	54.2	13.5	31.8	31.0	23.3	64.2	59.4	32.4	48.8	16.1	24.6	43.9	15.9	45.3	38.6	37.4	12.9	45.5	39.8	33.7	35.1	39.8	22.3	51.7	35.1	38.2	65.4	32.9	19.4	39.1	28.4	93.3	40.3	39.0	65.7	63.8	68.2
